PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ellner, A				Ellner, A			Rethinking prescribing in the United States	BMJ-BRITISH MEDICAL JOURNAL			English	Article									BMJ Knowledge, London WC1H 9JR, England		Ellner, A (corresponding author), BMJ Knowledge, London WC1H 9JR, England.	aellner@bmjgroup.com						*AM COLL PHYS, 2001, AMB CAR FORM PHARM B; [Anonymous], 2002, WORLD HLTH REP 2002; Blumenthal D, 2000, DESCRIPTION ANAL VA; Goff V V, 2001, Issue Brief Natl Health Policy Forum, P1; Holmer AF, 2002, NEW ENGL J MED, V346, P526, DOI 10.1056/NEJM200202143460714; Horn SD, 1996, LANCET, V348, P619, DOI 10.1016/S0140-6736(05)64839-8; Ioannides-Demos LL, 2002, PHARMACOECONOMICS, V20, P577, DOI 10.2165/00019053-200220090-00002; KITCHMAN M, 2002, SENIORS PRESCRIPTION; *NIH CAR MAN FDN, 2000, PRESCR DRUGS MASS ME; *PROD COMM, 2001, INT PHARM PRIC DIFF; *REF DRUG PROGR CO, 2002, REP MIN HLTH PLANN; Rennie D, 2000, JAMA-J AM MED ASSOC, V283, P2158, DOI 10.1001/jama.283.16.2158; Rosenthal MB, 2002, NEW ENGL J MED, V346, P498, DOI 10.1056/NEJMsa012075; RossDegnan D, 1996, LANCET, V347, P1264, DOI 10.1016/S0140-6736(96)90782-5; Schneeweiss S, 2002, NEW ENGL J MED, V346, P822, DOI 10.1056/NEJMsa003087; Schneeweiss S, 2002, CAN MED ASSOC J, V166, P737; Steinbrook R, 2002, NEW ENGL J MED, V346, P790, DOI 10.1056/NEJM200203143461102; STUART B, 2000, REPORT PRESIDENT PRE; World Health Organization, WHO MOD LIST ESS MED	19	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2003	327	7428					1397	1400		10.1136/bmj.327.7428.1397	http://dx.doi.org/10.1136/bmj.327.7428.1397			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670892	Green Published			2022-12-28	WOS:000187417900030
J	Ausmees, N; Kuhn, JR; Jacobs-Wagner, C				Ausmees, N; Kuhn, JR; Jacobs-Wagner, C			The bacterial cytoskeleton: An intermediate filament-like function	CELL			English	Article							PENICILLIN-BINDING-PROTEINS; ACTIN-LIKE FILAMENTS; CELL-SHAPE; CHROMOSOMAL INSERTION; LINEAR MOTOR; COILED COILS; DIVISION; PREDICTION; PHOSPHORYLATION; SEGREGATION	Various cell shapes are encountered in the prokaryotic world, but how they are achieved is poorly understood. Intermediate filaments (IFs) of the eukaryotic cytoskeleton play an important role in cell shape in higher organisms. No such filaments have been found in prokaryotes. Here, we describe a bacterial equivalent to IF proteins, named crescentin, whose cytoskeletal function is required for the vibrioid and helical shapes of Caulobacter crescentus. Without crescentin, the cells adopt a straight-rod morphology. Crescentin has characteristic features of IF proteins including the ability to assemble into filaments in vitro without energy or cofactor requirements. In vivo, crescentin forms a helical structure that colocalizes with the inner cell curvatures beneath the cytoplasmic membrane. We propose that IF-like filaments of crescentin assemble into a helical structure, which by applying its geometry to the cell, generates a vibrioid or helical cell shape depending on the length of the cell.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Jacobs-Wagner, C (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	christine.jacobs-wagner@yale.edu		Jacobs-Wagner, Christine/0000-0003-0980-5334	NIGMS NIH HHS [GM26338, GM065835] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026338, R01GM065835] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Brown JH, 1996, PROTEINS, V26, P134; Carballido-Lopez R, 2003, DEV CELL, V4, P19, DOI 10.1016/S1534-5807(02)00403-3; CONCHELLO JA, 1996, 3 DIMENSIONAL MICROS, P199; Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; DOMINGO A, 1992, P223; Dusenbery DB, 1998, J BACTERIOL, V180, P5978, DOI 10.1128/JB.180.22.5978-5983.1998; ELY B, 1991, METHOD ENZYMOL, V204, P372; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Gindullis F, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-9; HENNING U, 1972, EUR J BIOCHEM, V26, P570, DOI 10.1111/j.1432-1033.1972.tb01800.x; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; HUIATT TW, 1980, J BIOL CHEM, V255, P6981; IP W, 1985, J MOL BIOL, V183, P365, DOI 10.1016/0022-2836(85)90007-5; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kruse T, 2003, EMBO J, V22, P5283, DOI 10.1093/emboj/cdg504; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Mayordomo I, 2002, BIOCHEM J, V365, P51, DOI 10.1042/BJ20020053; Mewes HW, 1998, NUCLEIC ACIDS RES, V26, P33, DOI 10.1093/nar/26.1.33; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; Nelson DE, 2000, J BACTERIOL, V182, P1714, DOI 10.1128/JB.182.6.1714-1721.2000; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; RENNER W, 1981, J MOL BIOL, V149, P285, DOI 10.1016/0022-2836(81)90303-X; Roberts RC, 1996, J BACTERIOL, V178, P1829, DOI 10.1128/jb.178.7.1829-1841.1996; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Shih YL, 2003, P NATL ACAD SCI USA, V100, P7865, DOI 10.1073/pnas.1232225100; SHOHAYEB M, 1987, J GEN MICROBIOL, V133, P1733; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246; TAMAKI S, 1980, J BACTERIOL, V141, P52, DOI 10.1128/JB.141.1.52-57.1980; TOWNSEND R, 1980, J BACTERIOL, V142, P694, DOI 10.1128/JB.142.2.694-700.1980; Trachtenberg S, 2003, MOL MICROBIOL, V47, P671, DOI 10.1046/j.1365-2958.2003.t01-1-03200.x; Trachtenberg S, 2001, MOL MICROBIOL, V41, P827, DOI 10.1046/j.1365-2958.2001.02527.x; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; van Hemert MJ, 2003, J BIOL CHEM, V278, P15049, DOI 10.1074/jbc.M212495200; van Hemert MJ, 2002, P NATL ACAD SCI USA, V99, P5390, DOI 10.1073/pnas.072556099; Vollmer W, 2001, CURR OPIN MICROBIOL, V4, P625, DOI 10.1016/S1369-5274(01)00261-2; WACHI M, 1987, J BACTERIOL, V169, P4935, DOI 10.1128/jb.169.11.4935-4940.1987; Wortinger MA, 1998, MOL MICROBIOL, V29, P963, DOI 10.1046/j.1365-2958.1998.00959.x	52	272	279	1	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2003	115	6					705	713		10.1016/S0092-8674(03)00935-8	http://dx.doi.org/10.1016/S0092-8674(03)00935-8			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675535	Bronze			2022-12-28	WOS:000187366100010
J	Darwin, KH; Ehrt, S; Gutierrez-Ramos, JC; Weich, N; Nathan, CF				Darwin, KH; Ehrt, S; Gutierrez-Ramos, JC; Weich, N; Nathan, CF			The proteasome of Mycobacterium tuberculosis is required for resistance to nitric oxide	SCIENCE			English	Article							20S PROTEASOME; SYNTHASE; DEGRADATION; INCREASES; PROTEINS; LUNG	The production of nitric oxide and other reactive nitrogen intermediates (RNI) by macrophages helps to control infection by Mycobacterium tuberculosis (Mtb). However, the protection is imperfect and infection persists. To identify genes that Mtb requires to resist RNI, we screened 10,100 Mtb transposon mutants for hypersusceptibility to acidified nitrite. We found 12 mutants with insertions in seven genes representing six pathways, including the repair of DNA (uvrB) and the synthesis of a flavin cofactor (fbiC). Five mutants had insertions in proteasome-associated genes. An Mtb mutant deficient in a presumptive proteasomal adenosine triphosphatase was attenuated in mice, and exposure to proteasomal protease inhibitors markedly sensitized wild-type Mtb to RNI. Thus, the mycobacterial proteasome serves as a defense against oxidative or nitrosative stress.	Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; Millennium Pharmaceut, Cambridge, MA 02139 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Immunol, New York, NY 10021 USA; Cornell Univ, Weill Grad Sch Med Sci, Program Mol Biol, New York, NY 10021 USA	Cornell University; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Cornell University; Cornell University	Nathan, CF (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA.			Darwin, K Heran/0000-0002-5043-7548	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007621] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL61241] Funding Source: Medline; NIAID NIH HHS [T32 AI07621, AI055549] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; De Mot R, 1999, TRENDS MICROBIOL, V7, P88, DOI 10.1016/S0966-842X(98)01432-2; Facchetti F, 1999, AM J PATHOL, V154, P145, DOI 10.1016/S0002-9440(10)65261-3; Grune T, 1998, J BIOL CHEM, V273, P10857, DOI 10.1074/jbc.273.18.10857; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Knipfer N, 1997, MOL MICROBIOL, V25, P375, DOI 10.1046/j.1365-2958.1997.4721837.x; Long R, 1999, ANTIMICROB AGENTS CH, V43, P403, DOI 10.1128/AAC.43.2.403; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Nagy I, 1998, J BACTERIOL, V180, P5448, DOI 10.1128/JB.180.20.5448-5453.1998; Nathan C, 2002, AM J RESP CRIT CARE, V166, P130, DOI 10.1164/rccm.2205016; NATHAN C, 2003, TUBERCULOSIS, P215; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schaible UE, 1998, J IMMUNOL, V160, P1290; SCHON T, 2002, THESIS LINKOPING U S; St John G, 2001, P NATL ACAD SCI USA, V98, P9901; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Wolf S, 1998, J MOL BIOL, V277, P13, DOI 10.1006/jmbi.1997.1589	22	406	423	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1963	1966		10.1126/science.1091176	http://dx.doi.org/10.1126/science.1091176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671303				2022-12-28	WOS:000187174000060
J	Burbank, DW; Blythe, AE; Putkonen, J; Pratt-Sitaula, B; Gabet, E; Oskin, M; Barros, A; Ojha, TP				Burbank, DW; Blythe, AE; Putkonen, J; Pratt-Sitaula, B; Gabet, E; Oskin, M; Barros, A; Ojha, TP			Decoupling of erosion and precipitation in the Himalayas	NATURE			English	Article							CENTRAL NEPAL HIMALAYA; FISSION-TRACK ANALYSIS; MAIN CENTRAL THRUST; MOUNTAIN BELTS; NEW-ZEALAND; TECTONICS; EVOLUTION; TOPOGRAPHY; SEDIMENT; INCISION	The hypothesis that abrupt spatial gradients in erosion can cause high strain rates in active orogens has been supported by numerical models that couple erosional processes with lithospheric deformation via gravitational feedbacks(1 - 3). Most such models invoke a ' stream- power' rule, in which either increased discharge or steeper channel slopes cause higher erosion rates. Spatial variations in precipitation and slopes are therefore predicted to correlate with gradients in both erosion rates and crustal strain. Here we combine observations from a meteorological network across the Greater Himalaya, Nepal, along with estimates of erosion rates at geologic timescales ( greater than 100,000 yr) from low- temperature thermochronometry. Across a zone of about 20km length spanning the Himalayan crest and encompassing a more than fivefold difference in monsoon precipitation, significant spatial variations in geologic erosion rates are not detectable. Decreased rainfall is not balanced by steeper channels. Instead, additional factors that influence river incision rates, such as channel width and sediment concentrations, must compensate for decreasing precipitation. Overall, spatially constant erosion is a response to uniform, upward tectonic transport of Greater Himalayan rock above a crustal ramp.	Univ Calif Santa Barbara, Dept Geol Sci, Santa Barbara, CA 93106 USA; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Himalayan Experience, Kathmandu 3, Nepal	University of California System; University of California Santa Barbara; University of Southern California; University of Washington; University of Washington Seattle; Harvard University	Burbank, DW (corresponding author), Univ Calif Santa Barbara, Dept Geol Sci, Santa Barbara, CA 93106 USA.		Barros, Ana/A-3562-2011	Barros, Ana/0000-0003-4606-3106				Beaumont C, 2001, NATURE, V414, P738, DOI 10.1038/414738a; Burbank DW, 1996, NATURE, V379, P505, DOI 10.1038/379505a0; Burchfiel B.C., 1992, GEOLOGICAL SOC AM SP, V269, P1, DOI 10.1130/SPE269-p1; Catlos EJ, 2001, J GEOPHYS RES-SOL EA, V106, P16177, DOI 10.1029/2000JB900375; Dodson MH, 1979, LECT ISOTOPE GEOLOGY, P194, DOI DOI 10.1007/978-3-642-67161-6_14; Duncan CC, 1998, QUATERNARY RES, V49, P241, DOI 10.1006/qres.1998.1958; Ehlers TA, 2001, PHYS EARTH PLANET IN, V126, P179, DOI 10.1016/S0031-9201(01)00254-0; Fort M, 1986, GOTTINGER GEOGRAPHIS, V81, P105; Hallet B, 1996, GLOBAL PLANET CHANGE, V12, P213, DOI 10.1016/0921-8181(95)00021-6; HARRISON TM, 1997, EARTH PLANET SC LETT, V146, P1; Hodges KV, 1996, TECTONICS, V15, P1264, DOI 10.1029/96TC01791; Hodges KV, 2000, GEOL SOC AM BULL, V112, P324, DOI 10.1130/0016-7606(2000)112<324:TOTHAS>2.0.CO;2; Hurtado JM, 2001, GEOL SOC AM BULL, V113, P222, DOI 10.1130/0016-7606(2001)113<0222:NOTTGA>2.0.CO;2; KOONS PO, 1989, AM J SCI, V289, P1041, DOI 10.2475/ajs.289.9.1041; PANDEY MR, 1995, GEOPHYS RES LETT, V22, P751, DOI 10.1029/94GL02971; PORTER SC, 1989, QUATERNARY RES, V32, P245, DOI 10.1016/0033-5894(89)90092-6; Robinson DM, 2003, GEOLOGY, V31, P359, DOI 10.1130/0091-7613(2003)031<0359:KMFTMC>2.0.CO;2; SEEBER L, 1983, TECTONOPHYSICS, V92, P335, DOI 10.1016/0040-1951(83)90201-9; Sklar LS, 2001, GEOLOGY, V29, P1087, DOI 10.1130/0091-7613(2001)029<1087:SARSCO>2.0.CO;2; STUWE K, 1994, EARTH PLANET SC LETT, V124, P63, DOI 10.1016/0012-821X(94)00068-9; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; TIPPETT JM, 1993, J GEOPHYS RES-SOL EA, V98, P16119, DOI 10.1029/92JB02115; Wang Q, 2001, SCIENCE, V294, P574, DOI 10.1126/science.1063647; Whipple KX, 1999, NATURE, V401, P39, DOI 10.1038/43375; Willett SD, 1999, J GEOPHYS RES-SOL EA, V104, P28957, DOI 10.1029/1999JB900248; Willett SD, 2002, GEOLOGY, V30, P175, DOI 10.1130/0091-7613(2002)030<0175:OSSIMB>2.0.CO;2; Willett SD, 2001, AM J SCI, V301, P455, DOI 10.2475/ajs.301.4-5.455; ZEITLER PK, 1985, TECTONICS, V4, P127, DOI 10.1029/TC004i001p00127	28	423	456	8	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					652	655		10.1038/nature02187	http://dx.doi.org/10.1038/nature02187			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668861				2022-12-28	WOS:000187132800038
J	Davidson, BL				Davidson, BL			Hepatic diseases - Hitting the target with inhibitory RNAs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTERFERENCE; MICE		Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Iowa	Davidson, BL (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.							McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828	2	12	13	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					2357	2359		10.1056/NEJMcibr031609	http://dx.doi.org/10.1056/NEJMcibr031609			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668464				2022-12-28	WOS:000187125000014
J	Offit, PA; Peter, G				Offit, PA; Peter, G			The meningococcal vaccine - Public policy and individual choices	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							C CONJUGATE VACCINE; POLYSACCHARIDE VACCINES; COLLEGE-STUDENTS; GROUP-A; DISEASE; CHILDREN; IMMUNOGENICITY; PREVENTION; INFANTS; ANTIBODIES		Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Rhode Isl Hosp, Div Pediat Infect Dis, Providence, RI USA; Brown Med Sch, Dept Pediat, Providence, RI USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Offit, PA (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA.							Abramson JS, 2000, PEDIATRICS, V106, P1500, DOI 10.1542/peds.106.6.1500; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; ARTENSTEIN MS, 1970, NEW ENGL J MED, V282, P417, DOI 10.1056/NEJM197002192820803; Balmer P, 2002, J MED MICROBIOL, V51, P717, DOI 10.1099/0022-1317-51-9-717; Borrow R, 2001, J INFECT DIS, V184, P377, DOI 10.1086/322024; Campbell JD, 2002, J INFECT DIS, V186, P1848, DOI 10.1086/345763; *CDCP, 2002, ACT BACT COR SURV AB; Centers for Disease Control and Prevention (CDC), 1985, MMWR-MORBID MORTAL W, V34, P255; FINNE J, 1983, LANCET, V2, P355; GOLD R, 1979, J INFECT DIS, V140, P690, DOI 10.1093/infdis/140.5.690; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307; GRIFFISS JM, 1982, INFECT IMMUN, V37, P205, DOI 10.1128/IAI.37.1.205-208.1982; KAYHTY H, 1980, J INFECT DIS, V142, P861, DOI 10.1093/infdis/142.6.861; Kirsch EA, 1996, PEDIATR INFECT DIS J, V15, P967, DOI 10.1097/00006454-199611000-00009; Lebel MH, 2001, JAMA-J AM MED ASSOC, V285, P1578, DOI 10.1001/jama.285.12.1578; MacLennan JM, 2000, JAMA-J AM MED ASSOC, V283, P2795, DOI 10.1001/jama.283.21.2795; Meningococcal disease and college students, 2000, MMWR RECOMM REP, V49, P13; PICKERING LK, 2003, 2003 RED BOOK, P389; Ramsay ME, 2001, LANCET, V357, P195, DOI 10.1016/S0140-6736(00)03594-7; REINGOLD AL, 1985, LANCET, V2, P114; RIEDO FX, 1995, PEDIATR INFECT DIS J, V14, P643, DOI 10.1097/00006454-199508000-00001; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Scott RD, 2002, AM J PREV MED, V23, P98, DOI 10.1016/S0749-3797(02)00462-2; WYLE FA, 1972, J INFECT DIS, V126, P514, DOI 10.1093/infdis/126.5.514; ZANGWILL KM, 1994, J INFECT DIS, V169, P847, DOI 10.1093/infdis/169.4.847	25	25	27	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					2353	2356		10.1056/NEJMsb035678	http://dx.doi.org/10.1056/NEJMsb035678			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668463				2022-12-28	WOS:000187125000013
J	Smaglik, P				Smaglik, P			Best of both worlds	NATURE			English	Article																			0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					706	707		10.1038/426706	http://dx.doi.org/10.1038/426706			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668875	Bronze			2022-12-28	WOS:000187132800052
J	Vellai, T; Takacs-Vellai, K; Zhang, Y; Kovacs, AL; Orosz, L; Muller, F				Vellai, T; Takacs-Vellai, K; Zhang, Y; Kovacs, AL; Orosz, L; Muller, F			Genetics - Influence of TOR kinase on lifespan in C-elegans	NATURE			English	Editorial Material							CAENORHABDITIS-ELEGANS		Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; Eotvos Lorand Univ, Dept Gen Zool, H-1117 Budapest, Hungary; Eotvos Lorand Univ, Dept Genet, H-1117 Budapest, Hungary; Agr Biotechnol Ctr, H-2100 Godollo, Hungary	University of Fribourg; Eotvos Lorand University; Eotvos Lorand University	Vellai, T (corresponding author), Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland.	fritz.mueller@unifr.ch	Vellai, Tibor/AAG-2154-2020	Takacs-Vellai, Krisztina/0000-0002-4472-0363				Abraham RT, 2002, CELL, V111, P9, DOI 10.1016/S0092-8674(02)01009-7; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dillin A, 2002, SCIENCE, V298, P830, DOI 10.1126/science.1074240; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KENYON C, 1997, C ELEGANS, V2, P701; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Riddle DL, 1997, C ELEGANS, P739; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Tissenbaum HA, 1998, GENETICS, V148, P703	11	774	817	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					620	620		10.1038/426620a	http://dx.doi.org/10.1038/426620a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668850	Bronze, Green Published			2022-12-28	WOS:000187132800027
J	Lieberman, DA; Prindiville, S; Weiss, DG; Willett, W				Lieberman, DA; Prindiville, S; Weiss, DG; Willett, W		VA Cooperative Study Grp 380	Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLORECTAL-CANCER; PHYSICAL-ACTIVITY; LARGE-BOWEL; ASPIRIN USE; SCREENING SIGMOIDOSCOPY; SERUM-CHOLESTEROL; CIGARETTE-SMOKING; REDUCED RISK; VITAMIN-D; ADENOMA	Context Knowledge of risk factors for colorectal neoplasia could inform risk reduction strategies for asymptomatic individuals. Few studies have evaluated risk factors for advanced colorectal neoplasia in asymptomatic individuals, compared risk factors between persons with and without polyps, or included most purported risk factors in a multivariate analysis. Objective To determine risk factors associated with advanced colorectal neoplasia in a cohort of asymptomatic persons with complete colonoscopy. Design, Setting, and Participants Prospective, cross-sectional study of 3121 asymptomatic patients aged 50 to 75 years from 13 Veterans Affairs medical centers conducted between February 1994 and January 1997. All participants had complete colonoscopy to determine the prevalence of advanced neoplasia, defined as an adenoma that was 10 mm or more in diameter, a villous adenoma, an adenoma with high-grade dysplasia, or invasive cancer. Variables examined included history of first-degree relative with colorectal cancer, prior cholecystectomy, serum cholesterol level, physical activity, smoking, alcohol use, and dietary factors. Main Outcome Measures An age-adjusted analysis was performed for each variable to calculate the odds ratios (ORs) and 95% confidence intervals (CIS) associated with having advanced neoplasia compared with having no polyps. We developed a multivariate logistic regression model to identify the most informative risk factors. A secondary analysis examined risk factors for having hyperplastic polyps compared with having no polyps and compared with having advanced neoplasia. Results Three hundred twenty-nine participants had advanced neoplasia and 1441 had no polyps. In multivariate analyses, we found positive associations for history of a first-degree relative with colorectal cancer (OR, 1.66; 95% Cl, 1.16-2.35), current-smoking (OR, 1.85; 95% Cl, 1.33-2.58), and current moderate to heavy alcohol use (OR, 1.02; 95% Cl, 1.01 -1.03). Inverse associations were found for cereal fiber intake (OR, 0.95; 95% Cl, 0.91-0.99), vitamin D intake (OR, 0.94; 95% Cl, 0.90-0.99), and use of nonsteroidal anti-inflammatory drugs (NSAIDs) (OR, 0.66; 95% Cl, 0.48-0.91). In the univariate analysis, the inverse association was found with cereal fiber intake greater than 4.2 g/d, vitamin D intake greater than 645 IU/d, and daily use of NSAIDs. Marginal factors included physical activity, daily multivitamin use, and intake of calcium and fat derived from red meat. No association was found for body mass index, prior cholecystectomy, or serum cholesterol level. Three hundred ninety-one patients had hyperplastic polyps as the worst lesion found at colonoscopy. Risk variables were similar to those for patients with no polyps, except that past and current smoking were associated with an increased risk of hyperplastic polyps. Conclusions Our data endorse several important risk factors for advanced colonic neoplasia and provide a rationale for prudent risk reduction strategies. Further study is needed to determine if lifestyle changes can moderate the risk of colorectal cancer.	Dept Vet Affairs Med Ctr, Portland, OR USA; NCI, Bethesda, MD 20892 USA; Dept Vet Affairs Med Ctr, Perry Point, MD USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health	Lieberman, DA (corresponding author), Portland VA Med Ctr, Div Gastroenterol, P3-GI,POB 1034, Portland, OR 97207 USA.	lieberma@ohsu.edu			NCI NIH HHS [K07CA75159] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K07CA075159] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Alberts DS, 2000, NEW ENGL J MED, V342, P1156, DOI 10.1056/NEJM200004203421602; Bardou M, 2002, GUT, V50, P38, DOI 10.1136/gut.50.1.38; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Bonithon-Kopp C, 2000, LANCET, V356, P1300, DOI 10.1016/S0140-6736(00)02813-0; CANNONALBRIGHT LA, 1988, NEW ENGL J MED, V319, P533, DOI 10.1056/NEJM198809013190902; ChasanTaber S, 1996, EPIDEMIOLOGY, V7, P81, DOI 10.1097/00001648-199601000-00014; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; GARLAND C, 1985, LANCET, V1, P307, DOI 10.1016/S0140-6736(85)91082-7; GARLAND CF, 1989, LANCET, V2, P1176, DOI 10.1016/s0140-6736(89)91789-3; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; GIOVANNUCCI E, 1995, JNCI-J NATL CANCER I, V87, P265, DOI 10.1093/jnci/87.4.265; GIOVANNUCCI E, 1994, ANN INTERN MED, V121, P241, DOI 10.7326/0003-4819-121-4-199408150-00001; GIOVANNUCCI E, 1993, GASTROENTEROLOGY, V105, P130, DOI 10.1016/0016-5085(93)90018-8; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; GIOVANNUCCI E, 1994, J NATL CANCER I, V86, P183, DOI 10.1093/jnci/86.3.183; GREENBERG ER, 1993, JNCI-J NATL CANCER I, V85, P912, DOI 10.1093/jnci/85.11.912; HOSMER DW, 1989, APPL LOGISTIC REGRES; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; KIKENDALL JW, 1989, GASTROENTEROLOGY, V97, P660, DOI 10.1016/0016-5085(89)90637-9; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lagergren J, 2001, GASTROENTEROLOGY, V121, P542, DOI 10.1053/gast.2001.27083; LEE IM, 1992, J NATL CANCER I, V84, P1326, DOI 10.1093/jnci/84.17.1326; LIEBERMAN DA, 1992, AM J GASTROENTEROL, V87, P1085; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MANNES GA, 1986, NEW ENGL J MED, V315, P1634, DOI 10.1056/NEJM198612253152602; Martinez ME, 1998, CANCER EPIDEM BIOMAR, V7, P163; MCFARLANE MJ, 1993, AM J GASTROENTEROL, V88, P1994; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; Niv Y, 2002, GUT, V50, P33, DOI 10.1136/gut.50.1.33; Pariente A, 1998, GASTROENTEROLOGY, V115, P7, DOI 10.1016/S0016-5085(98)70358-0; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; POTTER JD, 1996, PREVENTION EARLY DET, P23; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; ROSENBERG L, 1991, J NATL CANCER I, V83, P355, DOI 10.1093/jnci/83.5.355; SANDLER RS, 1993, GASTROENTEROLOGY, V104, P1445, DOI 10.1016/0016-5085(93)90354-F; Sandler RS, 1998, GASTROENTEROLOGY, V114, P441, DOI 10.1016/S0016-5085(98)70526-8; Schatzkin A, 2000, NEW ENGL J MED, V342, P1149, DOI 10.1056/NEJM200004203421601; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; SHABAHANG M, 1994, CANCER RES, V54, P4057; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; STJOHN DJB, 1993, ANN INTERN MED, V118, P785, DOI 10.7326/0003-4819-118-10-199305150-00005; Sturmer T, 1998, ANN INTERN MED, V128, P713, DOI 10.7326/0003-4819-128-9-199805010-00003; THUN MJ, 1991, NEW ENGL J MED, V325, P1593, DOI 10.1056/NEJM199112053252301; TORNBERG SA, 1986, NEW ENGL J MED, V315, P1629, DOI 10.1056/NEJM198612253152601; Ulvik A, 2001, AM J MED GENET, V101, P246, DOI 10.1002/ajmg.1370; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Willett W., 2012, NUTR EPIDEMIOLOGY; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407	57	351	362	3	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2003	290	22					2959	2967		10.1001/jama.290.22.2959	http://dx.doi.org/10.1001/jama.290.22.2959			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751WH	14665657	Bronze			2022-12-28	WOS:000187112700027
J	Hayman, GR; Bansal, JA; Bansal, AS				Hayman, GR; Bansal, JA; Bansal, AS			Knowledge about using auto-injectable adrenaline: review of patients' case notes and interviews with general practitioners	BRITISH MEDICAL JOURNAL			English	Article									Epsom & St Helier NHS Trust, Dept Immunol, Carshalton SM5 1AA, Surrey, England		Hayman, GR (corresponding author), Epsom & St Helier NHS Trust, Dept Immunol, Carshalton SM5 1AA, Surrey, England.							Chamberlain D, 2001, RESUSCITATION, V48, P241; Davies H, 1996, BRIT MED J, V312, P638; Sicherer SH, 2000, PEDIATRICS, V105, P359, DOI 10.1542/peds.105.2.359	3	24	24	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 6	2003	327	7427					1328	1328		10.1136/bmj.327.7427.1328	http://dx.doi.org/10.1136/bmj.327.7427.1328			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752DE	14656843	Green Published			2022-12-28	WOS:000187131100021
J	Smith, GCS; Pell, JP; Dobbie, R				Smith, GCS; Pell, JP; Dobbie, R			Caesarean section and risk of unexplained stillbirth in subsequent pregnancy	LANCET			English	Article							PLACENTAL ABRUPTION; PERINATAL DEATH; ARTERY DOPPLER; DELIVERY; TERM; BIRTH; OUTCOMES; LABOR; MORTALITY; SCOTLAND	Background Caesarean section is associated with an increased risk of disorders of placentation in subsequent pregnancies, but effects on the rate of antepartum stillbirth are unknown. We aimed to establish whether previous caesarean delivery is associated with an increased risk of antepartum stillbirth. Methods We linked pregnancy discharge data from the Scottish Morbidity Record (1980-98) and the Scottish Stillbirth and Infant Death Enquiry (1985-98). We estimated the relative risk of antepartum stillbirth in second pregnancies using time-to-event analyses. Findings For 120 633 singleton second births, there were 68 antepartum stillbirths in 17 754 women previously delivered by caesarean section (2.39 per 10 000 women per week) and 244 in 102879 women previously delivered vaginally (1.44; p<0.001). Risk of unexplained stillbirth associated with previous caesarean delivery differed significantly with gestational age (p=0.04); the excess risk was apparent from 34 weeks (hazard ratio 2.23 [95% CI 1.48-3.36]). Risk was not attenuated by adjustment for maternal characteristics or outcome of the first pregnancy (2.74 [1.74-4.30]). The absolute risk of unexplained stillbirth at or after 39 weeks' gestation was 1.1 per 1000 women who had had a previous caesarean section and 0.5 per 1000 in those who had not. The difference was due mostly to an excess of unexplained stillbirths among women previously delivered by caesarean section. Interpretation Delivery by caesarean section in the first pregnancy could increase the risk of unexplained stillbirth in the second. In women with one previous caesarean delivery, the risk of unexplained antepartum stillbirth at or after 39 weeks' gestation is about double the risk of stillbirth or neonatal death from intrapartum uterine rupture.	Univ Cambridge, Dept Obstet & Gynaecol, Cambridge CB2 2SW, England; Greater Glasgow NHS Board, Dept Publ Hlth, Glasgow, Lanark, Scotland; Common Serv Agcy, Informat & Stat Div, Edinburgh, Midlothian, Scotland	University of Cambridge	Smith, GCS (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Rosie Matern Hosp, Cambridge CB2 2SW, England.	gcss2@cam.ac.uk	Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997; Pell, Jill/0000-0002-8898-7035				ALFIREVIC Z, 1995, AM J OBSTET GYNECOL, V172, P1379, DOI 10.1016/0002-9378(95)90466-2; Ananth CV, 2001, AM J EPIDEMIOL, V153, P332, DOI 10.1093/aje/153.4.332; Campbell S., 1993, ULTRASOUND OBSTET GY, P1432; Castro LC, 2002, CURR OPIN OBSTET GYN, V14, P601, DOI 10.1097/00001703-200212000-00005; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; COLE SK, 1986, BRIT J OBSTET GYNAEC, V93, P1204, DOI 10.1111/j.1471-0528.1986.tb07853.x; COLE SK, 1980, PERINATAL AUDIT SURV, P39; FELDMAN GB, 1992, OBSTET GYNECOL, V79, P547; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; Hemminki E, 1996, AM J OBSTET GYNECOL, V174, P1569, DOI 10.1016/S0002-9378(96)70608-7; Hosmer D. W., 1999, APPL SURVIVAL ANAL; *INF STAT DIV NHS, 2000, SCOTT PER INF MORT M; Jensen H, 1999, ACTA OBSTET GYN SCAN, V78, P799, DOI 10.1034/j.1600-0412.1999.780911.x; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; Kingdom JCP, 1997, ULTRASOUND OBST GYN, V9, P271, DOI 10.1046/j.1469-0705.1997.09040271.x; Lees C, 2001, OBSTET GYNECOL, V98, P369, DOI 10.1016/S0029-7844(01)01474-0; Lieberman E, 1997, CURR PROB OBST GYN F, V20, P98; Lydon-Rochelle M, 2001, NEW ENGL J MED, V345, P3, DOI 10.1056/NEJM200107053450101; Lydon-Rochelle M, 2001, OBSTET GYNECOL, V97, P765, DOI 10.1016/S0029-7844(01)01121-8; MACARA LM, 1994, AM J OBSTET GYNECOL, V171, P71, DOI 10.1016/S0002-9378(94)70080-X; Maller RA., 1996, SURVIVAL ANAL LONG T; MCILWAINE GM, 1985, BRIT J OBSTET GYNAEC, V92, P9, DOI 10.1111/j.1471-0528.1985.tb01041.x; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; Moore T. R., 1999, MATERNAL FETAL MED, P964; MORRISON JJ, 1995, BRIT J OBSTET GYNAEC, V102, P101, DOI 10.1111/j.1471-0528.1995.tb09060.x; PARRISH KM, 1994, JAMA-J AM MED ASSOC, V271, P443, DOI 10.1001/jama.271.6.443; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Porreco RP, 1996, AM J OBSTET GYNECOL, V175, P369, DOI 10.1016/S0002-9378(96)70148-5; Rasmussen S, 1999, PAEDIATR PERINAT EP, V13, P9; Smith GCS, 2002, JAMA-J AM MED ASSOC, V287, P2684, DOI 10.1001/jama.287.20.2684; Smith GCS, 2001, AM J OBSTET GYNECOL, V184, P489, DOI 10.1067/mob.2001.109735; SOPER DE, 1993, CURR OPIN OBSTET GYN, V5, P517; THORPEBEESTON JG, 1992, BRIT MED J, V305, P746, DOI 10.1136/bmj.305.6856.746; YUDKIN PL, 1987, LANCET, V1, P1192	35	252	260	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1779	1784		10.1016/S0140-6736(03)14896-9	http://dx.doi.org/10.1016/S0140-6736(03)14896-9			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654315	Green Accepted			2022-12-28	WOS:000186872900008
J	Lee, SJ; Sekimoto, T; Yamashita, E; Nagoshi, E; Nakagawa, A; Imamoto, N; Yoshimura, M; Sakai, H; Chong, KT; Tsukihara, T; Yoneda, Y				Lee, SJ; Sekimoto, T; Yamashita, E; Nagoshi, E; Nakagawa, A; Imamoto, N; Yoshimura, M; Sakai, H; Chong, KT; Tsukihara, T; Yoneda, Y			The structure of importin-beta bound to SREBP-2: Nuclear import of a transcription factor	SCIENCE			English	Article							CLEAVAGE-ACTIVATING PROTEIN; ELEMENT-BINDING PROTEIN-2; 2.3 ANGSTROM RESOLUTION; NUCLEOCYTOPLASMIC TRANSPORT; LOCALIZATION SIGNAL; B/HLH/Z DOMAIN; IDENTIFICATION; RECOGNITION; ALPHA; MECHANISMS	The sterol regulatory element - binding protein 2 (SREBP-2), a nuclear transcription factor that is essential for cholesterol metabolism, enters the nucleus through a direct interaction of its helix-loop-helix leucine zipper domain with importin-beta. We show the crystal structure of importin-beta complexed with the active form of SREBP-2. Importin-beta uses characteristic long helices like a pair of chopsticks to interact with an SREBP-2 dimer. Importin-beta changes its conformation to reveal a pseudo-twofold symmetry on its surface structure so that it can accommodate a symmetric dimer molecule. Importin-beta may use a similar strategy to recognize other dimeric cargoes.	Osaka Univ, Grad Sch Frontier Biosci, Dept Frontier Biosci, Suita, Osaka 5650871, Japan; Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Tsukihara, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Dept Frontier Biosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Imamoto, Naoko/A-7458-2015; Nakagawa, Atsushi/M-5731-2019; Nakagawa, Atsushi/D-4329-2009; Yamashita, Eiki/V-6758-2019	Imamoto, Naoko/0000-0002-2886-3022; Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861; Yamashita, Eiki/0000-0002-4278-0039; Nagoshi, Emi/0000-0002-6365-4074; Yoshimura, Masato/0000-0002-7466-2192				Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chan CK, 1998, GENE THER, V5, P1204, DOI 10.1038/sj.gt.3300708; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Corbett AH, 1997, MICROBIOL MOL BIOL R, V61, P193, DOI 10.1128/.61.2.193-211.1997; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DANG CV, 1988, MOL CELL BIOL, V8, P4048, DOI 10.1128/MCB.8.10.4048; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; Fortelle E., 1997, METHOD ENZYMOL, P472; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Kurisaki A, 2001, MOL BIOL CELL, V12, P1079, DOI 10.1091/mbc.12.4.1079; Lam MHC, 1999, J BIOL CHEM, V274, P7391, DOI 10.1074/jbc.274.11.7391; Lee SJ, 2000, J MOL BIOL, V302, P251, DOI 10.1006/jmbi.2000.4055; Luo X, 1996, MOL CELL BIOL, V16, P1367; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Moore JD, 1999, J CELL BIOL, V144, P213, DOI 10.1083/jcb.144.2.213; Nagoshi E, 1999, MOL BIOL CELL, V10, P2221, DOI 10.1091/mbc.10.7.2221; Nagoshi E, 2001, MOL CELL BIOL, V21, P2779, DOI 10.1128/MCB.21.8.2779-2789.2001; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Palmeri D, 1999, MOL CELL BIOL, V19, P1218; Parraga A, 1998, STRUCT FOLD DES, V6, P661, DOI 10.1016/S0969-2126(98)00067-7; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; Saphire ACS, 1998, J BIOL CHEM, V273, P29764, DOI 10.1074/jbc.273.45.29764; Truant R, 1999, MOL CELL BIOL, V19, P1210; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5	33	167	176	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1571	1575		10.1126/science.1088372	http://dx.doi.org/10.1126/science.1088372			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645851				2022-12-28	WOS:000186802200046
J	Sheng, GJ; dos Reis, M; Stern, CD				Sheng, GJ; dos Reis, M; Stern, CD			Churchill, a zinc finger transcriptional activator, regulates the transition between gastrulation and neurulation	CELL			English	Article							SMAD-INTERACTING PROTEIN-1; PRIMITIVE STREAK; NEURAL INDUCTION; CHICK-EMBRYO; MORPHOGENETIC MOVEMENT; MESODERM INDUCTION; XENOPUS-BRACHYURY; CELL MOVEMENTS; FGF; EXPRESSION	Gastrulation generates mesoderm and endoderm from embryonic epiblast; soon after, the neural plate is established within the epiblast-both events require FGF signaling. We describe a zinc finger transcriptional activator, Churchill (ChCh), which acts as a switch between different roles of FGF. FGF induces ChCh slowly; this activates Smad-interacting-protein-1 (Sip1), which blocks further induction of the mesoderm markers brachyury and Tbx6L by FGF. ChCh is first expressed as cells stop migrating through the primitive streak, and we show that it regulates cell ingression. We propose a simple mechanism by which FGF sensitizes cells to BMP signals. These results reveal that neural induction requires cessation of mesoderm formation at the midline in addition to the decision between epidermis and neural plate.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England	University of London; University College London	Stern, CD (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	c.stern@ucl.ac.uk	Stern, Claudio/AAZ-7381-2021; Sheng, Guojun/G-8746-2013; Reis, Mario dos/B-4938-2009; Sheng, Guojun/I-4900-2015; Sheng, Guojun/G-4116-2014; Stern, Claudio D/C-6265-2008	Stern, Claudio/0000-0002-9907-889X; Reis, Mario dos/0000-0001-9514-3976; Stern, Claudio D/0000-0002-9907-889X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060156] Funding Source: NIH RePORTER; NIMH NIH HHS [5R01MH060156] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Bertocchini F, 2002, DEV CELL, V3, P735, DOI 10.1016/S1534-5807(02)00318-0; Cacheux V, 2001, HUM MOL GENET, V10, P1503, DOI 10.1093/hmg/10.14.1503; Chapman DL, 1998, NATURE, V391, P695, DOI 10.1038/35624; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; CHRISTIAN JL, 1992, EMBO J, V11, P33, DOI 10.1002/j.1460-2075.1992.tb05024.x; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Ciruna BG, 1997, DEVELOPMENT, V124, P2829; CORNELL RA, 1994, DEVELOPMENT, V120, P453; CORNELL RA, 1995, DEVELOPMENT, V121, P2429; Cox WG, 1995, DEVELOPMENT, V121, P4349; DIAS MS, 1990, ANAT RECORD, V228, P437, DOI 10.1002/ar.1092280410; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; Eisaki A, 2000, BIOCHEM BIOPH RES CO, V271, P151, DOI 10.1006/bbrc.2000.2545; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; GALLERA J, 1975, EXPERIENTIA, V31, P584, DOI 10.1007/BF01932472; GALLERA J, 1964, J EMBRYOL EXP MORPH, V12, P693; Gallera J., 1971, EXPERIENTIA, V26, P1953; GARCIAMARTINEZ V, 1993, J EXP ZOOL, V267, P431, DOI 10.1002/jez.1402670409; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HATADA Y, 1994, DEVELOPMENT, V120, P2879; HEMMATIBRIVANLO.A, 1989, DEVELOPMENT, V106, P611; Holowacz T, 1999, DEV BIOL, V205, P296, DOI 10.1006/dbio.1998.9108; Joubin K, 1999, CELL, V98, P559, DOI 10.1016/S0092-8674(00)80044-6; KIMELMAN D, 1992, DEVELOPMENT, V116, P1; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; Knezevic V, 1997, DEVELOPMENT, V124, P411; LABONNE C, 1994, DEVELOPMENT, V120, P463; Launay C, 1996, DEVELOPMENT, V122, P869; Lerchner W, 2000, DEVELOPMENT, V127, P2729; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Newton A, 2001, J BIOL CHEM, V276, P35794, DOI 10.1074/jbc.M106256200; NICOLET G., 1965, ACTA EMBRYOL MORPHOL EXP, V8, P213; Nicolet G, 1970, J Embryol Exp Morphol, V23, P70; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Papin C, 2002, MECH DEVELOP, V111, P37, DOI 10.1016/S0925-4773(01)00599-8; Paterno G D, 1989, Prog Growth Factor Res, V1, P79, DOI 10.1016/0955-2235(89)90002-1; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Postigo AA, 2003, EMBO J, V22, P2443, DOI 10.1093/emboj/cdg225; Psychoyos D, 1996, DEVELOPMENT, V122, P1523; ROSENQUIST GC, 1971, DEV BIOL, V26, P323, DOI 10.1016/0012-1606(71)90131-X; ROSENQUIST GC, 1972, J EXP ZOOL, V180, P95, DOI 10.1002/jez.1401800108; ROSENQUIST GLENN C., 1966, CARNEGIE INST WASH PUBL, V38, P71; Sasai Y, 1996, EMBO J, V15, P4547, DOI 10.1002/j.1460-2075.1996.tb00832.x; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; Stern CD, 1998, CURR TOP DEV BIOL, V36, P223; STERN CD, 1981, ANAT EMBRYOL, V163, P245, DOI 10.1007/BF00315703; STOREY KG, 1992, DEVELOPMENT, V114, P729; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Streit A, 1997, DEVELOPMENT, V124, P1191; Streit A, 1998, DEVELOPMENT, V125, P507; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Tada M, 2000, DEVELOPMENT, V127, P2227; Teakle GR, 1998, TRENDS BIOCHEM SCI, V23, P100, DOI 10.1016/S0968-0004(98)01174-8; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Van de Putte T, 2003, AM J HUM GENET, V72, P465, DOI 10.1086/346092; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0; Wilson V, 1997, DEV BIOL, V192, P45, DOI 10.1006/dbio.1997.8701; WILSON V, 1995, DEVELOPMENT, V121, P877; Yamada K, 2001, AM J HUM GENET, V69, P1178, DOI 10.1086/324343; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3	65	152	155	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 26	2003	115	5					603	613		10.1016/S0092-8674(03)00927-9	http://dx.doi.org/10.1016/S0092-8674(03)00927-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651851	Bronze			2022-12-28	WOS:000186885600010
J	Okamoto, I; Otte, AP; Allis, CD; Reinberg, D; Heard, E				Okamoto, I; Otte, AP; Allis, CD; Reinberg, D; Heard, E			Epigenetic dynamics of imprinted X inactivation during early mouse development	SCIENCE			English	Article							CHROMOSOME INACTIVATION; XIST EXPRESSION; LINKED GENES; FEMALE MOUSE; HISTONE H3; PREIMPLANTATION EMBRYOS; CELL-DIFFERENTIATION; STEM-CELLS; IMPLANTATION; METHYLATION	The initiation of X-chromosome inactivation is thought to be tightly correlated with early differentiation events during mouse development. Here, we show that although initially active, the paternal X chromosome undergoes imprinted inactivation from the cleavage stages, well before cellular differentiation. A reversal of the inactive state, with a loss of epigenetic marks such as histone modi. cations and polycomb proteins, subsequently occurs in cells of the inner cell mass (ICM), which give rise to the embryo-proper in which random X inactivation is known to occur. This reveals the remarkable plasticity of the X-inactivation process during preimplantation development and underlines the importance of the ICM in global reprogramming of epigenetic marks in the early embryo.	Inst Curie, CNRS, UMR218, F-75005 Paris, France; Univ Amsterdam, BioCtr Amsterdam, Swammerdam Inst Life Sci, NL-1018 TV Amsterdam, Netherlands; Rockefeller Univ, New York, NY 10021 USA; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Howard Hughes Med Inst, Dept Biochem,Div Nucleic Acids Enzymol, Piscataway, NJ 08854 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); University of Amsterdam; Rockefeller University; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center	Heard, E (corresponding author), Inst Curie, CNRS, UMR218, 26 Rue Ulm, F-75005 Paris, France.	edith.heard@curie.fr	Heard, Edith/D-7197-2017	Heard, Edith/0000-0001-8052-7117; Reinberg, Danny/0000-0003-4288-2016				Chaumeil J, 2002, CYTOGENET GENOME RES, V99, P75, DOI 10.1159/000071577; CHAUMEIL J, UNPUB; Costanzi C, 2000, DEVELOPMENT, V127, P2283; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; EPSTEIN CJ, 1978, NATURE, V274, P500, DOI 10.1038/274500a0; Gurdon JB, 2003, P NATL ACAD SCI USA, V100, P11819, DOI 10.1073/pnas.1834207100; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; KRATZER PG, 1978, NATURE, V274, P503, DOI 10.1038/274503a0; LATHAM KE, 1995, DEV GENET, V17, P212, DOI 10.1002/dvg.1020170306; LEBON JM, 1995, GENET RES, V65, P223, DOI 10.1017/S0016672300033292; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; LYON MF, 1984, DIFFERENTIATION, V26, P63, DOI 10.1111/j.1432-0436.1984.tb01375.x; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Matsui J, 2001, HUM MOL GENET, V10, P1393, DOI 10.1093/hmg/10.13.1393; MONK M, 1981, J EMBRYOL EXP MORPH, V63, P75; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; Monk M, 2002, CYTOGENET GENOME RES, V99, P200, DOI 10.1159/000071594; MOORE T, 1995, DEV GENET, V17, P206, DOI 10.1002/dvg.1020170305; Nesterova TB, 2001, DEV BIOL, V235, P343, DOI 10.1006/dbio.2001.0295; Okamoto I, 2000, DEVELOPMENT, V127, P4137; Otte AP, 2003, CURR OPIN GENET DEV, V13, P448, DOI 10.1016/S0959-437X(03)00108-4; PAPAIOANNOU VE, 1981, GENET RES, V37, P183, DOI 10.1017/S0016672300020152; Patturajan M, 1998, MOL CELL BIOL, V18, P2406, DOI 10.1128/MCB.18.4.2406; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; RASTAN S, 1982, J EMBRYOL EXP MORPH, V71, P11; ROSSANT J, 1975, J EMBRYOL EXP MORPH, V33, P991; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; SINGERSAM J, 1992, P NATL ACAD SCI USA, V89, P10469, DOI 10.1073/pnas.89.21.10469; SUGAWARA O, 1985, CYTOGENET CELL GENET, V39, P210, DOI 10.1159/000132137; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; TAKAGI N, 1982, CHROMOSOMA, V85, P275, DOI 10.1007/BF00294971; TAKAGI N, 1974, EXP CELL RES, V86, P127, DOI 10.1016/0014-4827(74)90657-0; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Zuccotti M, 2002, MOL REPROD DEV, V61, P14, DOI 10.1002/mrd.1126	40	602	630	2	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2004	303	5658					644	649		10.1126/science.1092727	http://dx.doi.org/10.1126/science.1092727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768EN	14671313				2022-12-28	WOS:000188530800032
J	Asanuma, Y; Oeser, A; Shintani, AK; Turner, E; Olsen, N; Fazio, S; Linton, MF; Raggi, P; Stein, CM				Asanuma, Y; Oeser, A; Shintani, AK; Turner, E; Olsen, N; Fazio, S; Linton, MF; Raggi, P; Stein, CM			Premature coronary-artery atherosclerosis in systemic lupus erythematosus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BEAM COMPUTED-TOMOGRAPHY; RISK-FACTORS; MYOCARDIAL-INFARCTION; ACCELERATED ATHEROSCLEROSIS; DISEASE; CALCIUM; WOMEN; PREVALENCE; PREDICTION; PLAQUE	BACKGROUND: Premature coronary artery disease is a major cause of illness and death in patients with systemic lupus erythematosus, but little is known about the prevalence, extent, and causes of coronary-artery atherosclerosis. METHODS: We used electron-beam computed tomography to screen for the presence of coronary-artery calcification in 65 patients with systemic lupus erythematosus (mean [+/-SD] age, 40.3+/-11.6 years) and 69 control subjects (mean age, 42.7+/-12.6 years) with no history of coronary artery disease. When calcification was detected, the extent was measured by means of the Agatston score. The frequency of risk factors for coronary artery disease was compared in patients and controls, and the relation between the patients' clinical characteristics and the presence or absence of coronary-artery calcification was examined. RESULTS: The two groups were similar with respect to age, race, and sex. Coronary-artery calcification was more frequent in patients with lupus (20 of 65 patients) than in control subjects (6 of 69 subjects) (P=0.002). The mean calcification score was 68.9+/-244.2 in the patients and 8.8+/-41.8 (P<0.001) in controls. Levels of total, high-density lipoprotein, and low-density lipoprotein cholesterol were not elevated in patients with lupus, but levels of triglycerides (P=0.02) and homocysteine (P<0.001) were. Among patients with lupus, measures of disease activity were similar in those with and those without coronary-artery calcification, but those with calcification were more likely to be older (P<0.001) and male (P=0.008). CONCLUSIONS: In patients with systemic lupus erythematosus, the prevalence of coronary-artery atherosclerosis is elevated and the age at onset is reduced. Early detection of atherosclerosis may provide an opportunity for therapeutic intervention.	Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Div Gen Internal Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Div Rheumatol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Nashville, TN 37212 USA; Tulane Univ, Sch Med, Cardiol Sect, New Orleans, LA 70112 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Tulane University	Asanuma, Y (corresponding author), Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026657] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL04012] Funding Source: Medline; NIDDK NIH HHS [DK26657] Funding Source: Medline; NIGMS NIH HHS [GM5M01-RR00095] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1259; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Arad Y, 2000, J AM COLL CARDIOL, V36, P1253, DOI 10.1016/S0735-1097(00)00872-X; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Bruce IN, 2000, J RHEUMATOL, V27, P2372; Budoff MJ, 2002, CIRCULATION, V105, P1791, DOI 10.1161/01.CIR.0000014483.43921.8C; BULKLEY BH, 1975, AM J MED, V58, P243, DOI 10.1016/0002-9343(75)90575-6; Callister TQ, 1998, NEW ENGL J MED, V339, P1972, DOI 10.1056/NEJM199812313392703; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Gladman DD, 1997, ARTHRITIS RHEUM-US, V40, P809, DOI 10.1002/art.1780400506; Jara LJ, 2003, CLIN REV ALLERG IMMU, V25, P79, DOI 10.1385/CRIAI:25:1:79; Keelan PC, 2001, CIRCULATION, V104, P412, DOI 10.1161/hc2901.093112; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Manzi S, 1999, ARTHRITIS RHEUM-US, V42, P51, DOI 10.1002/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Pearson TA, 2002, CIRCULATION, V105, P886, DOI 10.1161/hc0702.103727; PETRI M, 1992, AM J MED, V93, P513, DOI 10.1016/0002-9343(92)90578-Y; Petri M, 1996, LANCET, V348, P1120, DOI 10.1016/S0140-6736(96)03032-2; Raggi P, 2001, AM HEART J, V141, P375, DOI 10.1067/mhj.2001.113220; Raggi P, 2000, CIRCULATION, V101, P850, DOI 10.1161/01.CIR.101.8.850; Roman MJ, 2003, NEW ENGL J MED, V349, P2399, DOI 10.1056/NEJMoa035471; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; RUBIN LA, 1985, Q J MED, V55, P87; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; RUMBERGER JA, 1995, CIRCULATION, V91, P1363, DOI 10.1161/01.CIR.91.5.1363; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Schmermund A, 2002, AM J CARDIOL, V90, P168, DOI 10.1016/S0002-9149(02)02445-1; Schmermund A, 1999, J AM COLL CARDIOL, V34, P777, DOI 10.1016/S0735-1097(99)00265-X; Svenungsson E, 2001, CIRCULATION, V104, P1887, DOI 10.1161/hc4101.097518; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; von der Thusen JH, 2003, PHARMACOL REV, V55, P133, DOI 10.1124/pr.55.1.5; Ward MM, 1999, ARTHRITIS RHEUM, V42, P338, DOI 10.1002/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U	34	628	648	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					2407	2415		10.1056/NEJMoa035611	http://dx.doi.org/10.1056/NEJMoa035611			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681506				2022-12-28	WOS:000187326200006
J	Gawande, A				Gawande, A			Notes of a surgeon: Dispatch from India	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Gawande, A (corresponding author), Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA.			Gawande, Atul/0000-0002-1824-9176					0	5	5	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					2383	2386		10.1056/NEJMp038180	http://dx.doi.org/10.1056/NEJMp038180			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681503				2022-12-28	WOS:000187326200003
J	Clauw, D				Clauw, D			The health consequences of the first Gulf war - The lessons are general (and for many patients) rather than specific to that war	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GULF-WAR; VETERANS; ILLNESS		Univ Michigan, Ann Arbor, MI 48106 USA	University of Michigan System; University of Michigan	Clauw, D (corresponding author), Univ Michigan, POB 385, Ann Arbor, MI 48106 USA.	dclauw@umich.edu						Barrett DH, 2002, EPIDEMIOL REV, V24, P218, DOI 10.1093/epirev/mxf003; Clauw DJ, 2003, BEST PRACT RES CL RH, V17, P685, DOI 10.1016/S1521-6942(03)00035-4; Clauw DJ, 2003, J OCCUP ENVIRON MED, V45, P1040, DOI 10.1097/01.jom.0000091693.43121.2f; Doebbeling BN, 2000, AM J MED, V108, P695, DOI 10.1016/S0002-9343(00)00405-8; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Haley RW, 2000, RADIOLOGY, V215, P807, DOI 10.1148/radiology.215.3.r00jn48807; Horner RD, 2003, NEUROLOGY, V61, P742, DOI 10.1212/01.WNL.0000069922.32557.CA; Hotopf M, 2003, BRIT MED J, V327, P1370, DOI 10.1136/bmj.327.7428.1370; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; Kang HK, 2002, ARCH ENVIRON HEALTH, V57, P61, DOI 10.1080/00039890209602918; Macfarlane GJ, 2003, BRIT MED J, V327, P1373, DOI 10.1136/bmj.327.7428.1373; Sharief MK, 2002, NEUROLOGY, V59, P1518, DOI 10.1212/01.WNL.0000032755.27372.FC	12	16	17	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2003	327	7428					1357	1358		10.1136/bmj.327.7428.1357	http://dx.doi.org/10.1136/bmj.327.7428.1357			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670850	Green Published			2022-12-28	WOS:000187417900001
J	Cifelli, RL; Davis, BM				Cifelli, RL; Davis, BM			Marsupial origins	SCIENCE			English	Editorial Material							TRIBOSPHENIC MAMMALS; EVOLUTION		Univ Oklahoma, Oklahoma Museum Nat Hist, Norman, OK 73072 USA; Univ Oklahoma, Dept Zool, Norman, OK 73072 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Cifelli, RL (corresponding author), Univ Oklahoma, Oklahoma Museum Nat Hist, Norman, OK 73072 USA.	rlc@ou.edu; bmdavi@ou.edu						Cifelli RL, 1996, NATURE, V379, P715, DOI 10.1038/379715a0; Huxley TH., 1880, P R SOC LOND, V43, P649, DOI DOI 10.1111/J.1469-7998.1869.TB07343.X; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; KIELANJAWOROWSK.Z, IN PRESS MAMMALS AGE; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; LILLEGRAVEN JA, 1987, BIOL J LINN SOC, V32, P281, DOI 10.1111/j.1095-8312.1987.tb00434.x; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; Messer Michael, 1998, Journal of Mammalian Evolution, V5, P95, DOI 10.1023/A:1020523120739; Rougier Guillermo W., 1996, American Museum Novitates, V3183, P1; ROWE T, 1993, MAMMAL PHYLOGENY, P129; SIGOGNEAURUSSELL D, 1994, CR ACAD SCI II, V319, P833; Woodburne MO, 2003, MOL PHYLOGENET EVOL, V28, P360, DOI 10.1016/S1055-7903(03)00113-1	14	28	31	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1899	1900		10.1126/science.1092272	http://dx.doi.org/10.1126/science.1092272			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671280				2022-12-28	WOS:000187174000035
J	Hornekaer, L; Baurichter, A; Petrunin, VV; Field, D; Luntz, AC				Hornekaer, L; Baurichter, A; Petrunin, VV; Field, D; Luntz, AC			Importance of surface morphology in interstellar H-2 formation	SCIENCE			English	Article							MOLECULAR-HYDROGEN FORMATION; VIBRATIONAL-RELAXATION	Detailed laboratory experiments on the formation of HD from atom recombination on amorphous solid water films show that this process is extremely efficient in a temperature range of 8 to 20 kelvin, temperatures relevant for H-2 formation on dust grain surfaces in the interstellar medium (ISM). The fate of the 4.5 electron volt recombination energy is highly dependent on film morphology. These results suggest that grain morphology, rather than the detailed chemical nature of the grain surface, is most important in determining the energy content of the H 2 as it is released from the grain into the ISM.	Univ So Denmark, Dept Phys, Esbjerg, Denmark; Univ Aarhus, Dept Phys & Astron, DK-8000 Aarhus C, Denmark	University of Southern Denmark; Aarhus University	Hornekaer, L (corresponding author), Univ So Denmark, Dept Phys, Esbjerg, Denmark.	hornekaer@fysik.sdu.dk	Hornekær, Liv/B-3043-2019	Hornekær, Liv/0000-0003-0828-3642				ANDERSSON S, 1989, PHYS REV B, V40, P8146, DOI 10.1103/PhysRevB.40.8146; BONN M, 1995, CHEM PHYS LETT, V233, P309, DOI 10.1016/0009-2614(94)01411-N; CHANG HC, 1990, J ELECTRON SPECTROSC, V54, P39, DOI 10.1016/0368-2048(90)80199-K; Collings MP, 2003, ASTROPHYS J, V583, P1058, DOI 10.1086/345389; Diekhoner L, 2001, J CHEM PHYS, V115, P3356, DOI 10.1063/1.1386810; DULEY WW, 1993, MON NOT R ASTRON SOC, V260, P37, DOI 10.1093/mnras/260.1.37; FLOWER DR, 1990, MON NOT R ASTRON SOC, V247, P500; Greenberg JM, 2002, SURF SCI, V500, P793, DOI 10.1016/S0039-6028(01)01555-2; Gry C, 2002, ASTRON ASTROPHYS, V391, P675, DOI 10.1051/0004-6361:20020691; HOLLENBACH D, 1971, ASTROPHYS J, V163, P155, DOI 10.1086/150754; HORNEKAER L, UNPUB; JURA M, 1975, ASTROPHYS J, V197, P575, DOI 10.1086/153545; Katz N, 1999, ASTROPHYS J, V522, P305, DOI 10.1086/307642; Manico G, 2001, ASTROPHYS J, V548, pL253, DOI 10.1086/319116; Schnaiter M, 1999, ASTROPHYS J, V519, P687, DOI 10.1086/307396; Stevenson KP, 1999, SCIENCE, V283, P1505, DOI 10.1126/science.283.5407.1505; Takahashi J, 1999, ASTROPHYS J, V520, P724, DOI 10.1086/307461	18	143	143	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1943	1946		10.1126/science.1090820	http://dx.doi.org/10.1126/science.1090820			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671297				2022-12-28	WOS:000187174000054
J	Kanadia, RN; Johnstone, KA; Mankodi, A; Lungu, C; Thornton, CA; Esson, D; Timmers, AM; Hauswirth, WW; Swanson, MS				Kanadia, RN; Johnstone, KA; Mankodi, A; Lungu, C; Thornton, CA; Esson, D; Timmers, AM; Hauswirth, WW; Swanson, MS			A muscleblind knockout model for myotonic dystrophy	SCIENCE			English	Article							PRE-MESSENGER-RNA; TRINUCLEOTIDE REPEAT; SKELETAL-MUSCLE; NUCLEAR FOCI; IN-VIVO; TRANSCRIPTS; EXPANSION; PROTEIN; DROSOPHILA; MBNL	The neuromuscular disease myotonic dystrophy (DM) is caused by microsatellite repeat expansions at two different genomic loci. Mutant DM transcripts are retained in the nucleus together with the muscleblind (Mbnl) proteins, and these abnormal RNAs somehow interfere with pre-mRNA splicing regulation. Here, we show that disruption of the mouse Mbnl1 gene leads to muscle, eye, and RNA splicing abnormalities that are characteristic of DM disease. Our results support the hypothesis that manifestations of DM can result from sequestration of specific RNA binding proteins by a repetitive element expansion in a mutant RNA.	Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Rochester	Swanson, MS (corresponding author), Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA.	mswanson@ufl.edu		Swanson, Maurice/0000-0001-6245-5367; Mankodi, Ami/0000-0002-5131-7767	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR048143, R01AR046799, R01AR046806] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR48143, R01 AR046799, AR46799, AR46806] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Artero R, 1998, DEV BIOL, V195, P131, DOI 10.1006/dbio.1997.8833; Begemann G, 1997, DEVELOPMENT, V124, P4321; Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fardaei M, 2001, NUCLEIC ACIDS RES, V29, P2766, DOI 10.1093/nar/29.13.2766; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Filippova GN, 2001, NAT GENET, V28, P335, DOI 10.1038/ng570; Harper P.S., 1989, MYOTONIC DYSTROPHY; HO T, UNPUB; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; MANKODI A, IN PRESS ANN NEUROL; MANKODI A, UNPUB; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum LPW, 2002, CURR OPIN GENET DEV, V12, P266, DOI 10.1016/S0959-437X(02)00297-6; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Wang J, 1997, GENE, V193, P105, DOI 10.1016/S0378-1119(97)00100-5; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	25	549	574	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1978	1980		10.1126/science.1088583	http://dx.doi.org/10.1126/science.1088583			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671308				2022-12-28	WOS:000187174000065
J	Clyde, PW; Harari, AE; Getka, EJ; Shakir, KMM				Clyde, PW; Harari, AE; Getka, EJ; Shakir, KMM			Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUBCLINICAL HYPOTHYROIDISM; REPLACEMENT THERAPY; L-THYROXINE; THYROTROPIN ASSAY; TRIIODOTHYRONINE; EUTHYROIDISM; POPULATION; COMMUNITY; TISSUES; HEALTH	Context Standard therapy for patients with primary hypothyroidism is replacement with synthetic thyroxine, which undergoes peripheral conversion to triiodothyronine, the active form of thyroid hormone. Within the lay population and in some medical communities, there is a perception that adding synthetic triiodothyronine, or liothyronine, to levothyroxine improves the symptoms of hypothyroidism despite insufficient evidence to support this practice. Objective To evaluate the benefits of treating primary hypothyroidism with levothyroxine plus liothyronine combination therapy vs levothyroxine monotherapy. Design, Setting, and Patients Randomized, double-blind, placebo-controlled trial conducted from May 2000 to February 2002 at a military treatment facility that serves active duty and retired military personnel and their family members. The trial included a total of 46 patients aged 24 to 65 years with at least a 6-month history of treatment with levothyroxine for primary hypothyroidism. Intervention Patients received either their usual dose of levothyroxine (n = 23) or combination therapy (n = 23), in which their usual levothyroxine dose was reduced by 50 mug/d and substituted with liothyronine, 7.5 mug, taken twice daily for 4 months. Main Outcome Measures Scores on a hypothyroid-specif ic health -related quality-of-life (HRQL) questionnaire, body weight, serum lipid levels, and 13 neuropsychological tests measured before and after treatment. Results Serum thyrotropin levels remained similar and within the normal range in both treatment groups from baseline to 4 months. Body weight and serum lipid levels did not change. The HRQL questionnaire scores improved significantly in both the control group (23%; P<.001) and the combination therapy group (12%; P=.02), but these changes were statistically similar (P=.54). In 12 of 13 neuropsychological tests, outcomes between groups were not significantly different; the 1 remaining test (Grooved Peg Board) showed better performance in the control group. Conclusion Compared with levothyroxine alone, treatment of primary hypothyroidism with combination levothyroxine plus liothyronine demonstrated no beneficial changes in body weight, serum lipid levels, hypothyroid symptoms as measured by a HRQL questionnaire, and standard measures of cognitive performance.	Natl Naval Med Res Inst, Dept Endocrinol & Metab, Bethesda, MD 20889 USA; Naval Med Ctr San Diego, Dept Psychol, San Diego, CA USA; Naval Med Ctr San Diego, Dept Endocrinol & Metab, San Diego, CA USA	Naval Medical Research Center (NMRC); United States Department of Defense; United States Navy; Naval Medical Center San Diego; United States Department of Defense; United States Navy; Naval Medical Center San Diego	Clyde, PW (corresponding author), Natl Naval Med Res Inst, Dept Endocrinol & Metab, 8901 Wisconsin Ave, Bethesda, MD 20889 USA.	pwclyde@mar.med.navy.mil						*AACE THYR TASK FO, 2002, ENDOCR PRACT, V8, P457; Baldini IM, 1997, PROG NEURO-PSYCHOPH, V21, P925, DOI 10.1016/S0278-5846(97)00089-4; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Brent G. A, 2000, WERNER INGBARS THYRO, P853; Bunevicius R, 2000, INT J NEUROPSYCHOPH, V3, P167, DOI 10.1017/S1461145700001826; Bunevicius R, 1999, NEW ENGL J MED, V340, P424, DOI 10.1056/NEJM199902113400603; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; CARR D, 1988, CLIN ENDOCRINOL, V28, P325, DOI 10.1111/j.1365-2265.1988.tb01219.x; COOPER DS, 1984, ANN INTERN MED, V101, P18, DOI 10.7326/0003-4819-101-1-18; EscobarMorreale HF, 1996, ENDOCRINOLOGY, V137, P2490, DOI 10.1210/en.137.6.2490; EscobarMorreale HF, 1995, J CLIN INVEST, V96, P2828, DOI 10.1172/JCI118353; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; HANNAY HJ, 1985, J CLIN EXP NEUROPSYC, V7, P251, DOI 10.1080/01688638508401258; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Jaeschke R, 1996, J GEN INTERN MED, V11, P744, DOI 10.1007/BF02598988; JAESCHKE R, 1994, QUAL LIFE RES, V3, P323, DOI 10.1007/BF00451724; Klove H., 1963, MED CLIN N AM; Larsen PR, 1998, WILLIAMS TXB ENDOCRI, P389; MACGREGOR A, 1961, LANCET, V1, P329; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x; SCHLOTE B, 1992, BIOL PSYCHIAT, V32, P48, DOI 10.1016/0006-3223(92)90141-L; SMITH RN, 1970, BRIT MED J, V4, P145, DOI 10.1136/bmj.4.5728.145; SPENCER CA, 1990, J CLIN ENDOCR METAB, V70, P453, DOI 10.1210/jcem-70-2-453; SPENCER CA, 2002, LAB MED PRACTICE GUI; Stuss D, 1987, CLIN NEUROPSYCHOL, V1, P139, DOI [10.1080/13854048708520046, DOI 10.1080/13854048708520046]; TAYLOR S, 1970, BRIT MED J, V2, P270, DOI 10.1136/bmj.2.5704.270; Thurstone, 1962, PRIMARY MENTAL ABILI; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Wechsler D., 1997, WECHSLER MEMORY SCAL	30	128	135	1	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2003	290	22					2952	2958		10.1001/jama.290.22.2952	http://dx.doi.org/10.1001/jama.290.22.2952			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751WH	14665656	Bronze			2022-12-28	WOS:000187112700026
J	Girou, E; Brun-Buisson, C; Taille, S; Lemaire, F; Brochard, L				Girou, E; Brun-Buisson, C; Taille, S; Lemaire, F; Brochard, L			Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE RESPIRATORY-FAILURE; POSITIVE-PRESSURE VENTILATION; RANDOMIZED CONTROLLED-TRIAL; CONVENTIONAL MECHANICAL VENTILATION; OBSTRUCTIVE LUNG-DISEASE; FACE MASK; MULTICENTER; SURVIVAL; SUPPORT; THERAPY	Context Randomized controlled trials have shown that the use of noninvasive ventilation (NIV) reduces the need for endotracheal intubation and invasive mechanical ventilation and reduces complication rates and mortality in selected groups of patients. But whether these benefits translate to a clinical setting is unclear. Objective To evaluate longitudinally the routine implementation of NIV and its effect on patients admitted to the intensive care unit (ICU) with acute exacerbation of chronic obstructive pulmonary disease (COPD) or severe cardiogenic pulmonary edema (CPE). Design Retrospective, observational cohort study using prospectively collected data from January 1, 1994, through December 31, 2001. Setting A 26-bed medical intensive care unit (ICU) of a French university referral hospital. Participants A cohort of 479 consecutive patients ventilated for acute exacerbation of COPD or CPE. Main Outcome Measures The ICU mortality and incidence rates of ICU-acquired infections. Results A significant increase in NIV use and a concomitant decrease in mortality and ICU-acquired infection rates were observed over the study years. With adjustment for relevant covariates and propensity scores, NIV was identified as an independent factor linked with a reduced risk of death in the cohort (odds ratio [OR], 0.37; 95% confidence interval [CI], 0.18-0.78), whereas a high severity score on admission (OR, 1.05; 95% Cl, 1.01-1.10) and the occurrence of a nosocomial infection (OR, 3.08; 95% Cl, 1.62-5.84) were independently associated with death. Rates of ICU-acquired pneumonia decreased from 20% in 1994 to 8% in 2001 (P=.04). Conclusion Implementing routine use of NIV in critically ill patients with acute exacerbation of COPD or severe CPE was associated with improved survival and reduction of nosocomial infections.	Hop Henri Mondor, Assistance Publ Hop Paris, Unite Hyg & Prevent Infect, F-94010 Creteil, France; Hop Henri Mondor, Assistance Publ Hop Paris, Serv Reanimat Med, F-94010 Creteil, France; Hop Henri Mondor, Assistance Publ Hop Paris, INSERM, U492, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Brun-Buisson, C (corresponding author), Hop Henri Mondor, Unite Hyg & Prevent Infect, F-94010 Creteil, France.	emmanuelle.girou@hmn.ap-hop-paris.fr						Antonelli M, 2001, INTENS CARE MED, V27, P1718, DOI 10.1007/s00134-001-1114-4; Antonelli M, 1998, NEW ENGL J MED, V339, P429, DOI 10.1056/NEJM199808133390703; Antonelli M, 2000, JAMA-J AM MED ASSOC, V283, P235, DOI 10.1001/jama.283.2.235; Auriant I, 2001, AM J RESP CRIT CARE, V164, P1231, DOI 10.1164/ajrccm.164.7.2101089; Azoulay E, 2001, CRIT CARE MED, V29, P519, DOI 10.1097/00003246-200103000-00009; Barbe F, 1996, EUR RESPIR J, V9, P1240, DOI 10.1183/09031936.96.09061240; BERSTEN AD, 1991, NEW ENGL J MED, V325, P1825, DOI 10.1056/NEJM199112263252601; BOTT J, 1993, LANCET, V341, P1555, DOI 10.1016/0140-6736(93)90696-E; Brochard L, 2002, JAMA-J AM MED ASSOC, V288, P932, DOI 10.1001/jama.288.8.932; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; BROCHARD L, 1990, NEW ENGL J MED, V323, P1523, DOI 10.1056/NEJM199011293232204; Calverley PMA, 2001, EUR RESPIR J, V18, p60S, DOI 10.1183/09031936.01.00229801; Carlucci A, 2001, AM J RESP CRIT CARE, V163, P874, DOI 10.1164/ajrccm.163.4.2006027; Carlucci A, 2003, INTENS CARE MED, V29, P419, DOI 10.1007/s00134-002-1574-1; Celikel T, 1998, CHEST, V114, P1636, DOI 10.1378/chest.114.6.1636; CHEVROLET JC, 1991, CHEST, V100, P775, DOI 10.1378/chest.100.3.775; Confalonieri M, 1999, AM J RESP CRIT CARE, V160, P1585, DOI 10.1164/ajrccm.160.5.9903015; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Delclaux C, 2000, JAMA-J AM MED ASSOC, V284, P2352, DOI 10.1001/jama.284.18.2352; Ely JW, 1997, INFECT CONT HOSP EP, V18, P267; Evans T W, 2001, Intensive Care Med, V27, P166, DOI 10.1007/s001340000721; Fagon J Y, 1996, Semin Respir Infect, V11, P109; Fein A, 2000, Curr Opin Pulm Med, V6, P122; Girou E, 2000, JAMA-J AM MED ASSOC, V284, P2361, DOI 10.1001/jama.284.18.2361; Girou E, 1998, AM J RESP CRIT CARE, V157, P1151, DOI 10.1164/ajrccm.157.4.9701129; Gregoretti C, 2002, INTENS CARE MED, V28, P278, DOI 10.1007/s00134-002-1208-7; Hilbert G, 2001, NEW ENGL J MED, V344, P481, DOI 10.1056/NEJM200102153440703; Hill NS, 2002, INTENS CARE MED, V28, P227, DOI 10.1007/s00134-002-1228-3; Keenan SP, 2002, JAMA-J AM MED ASSOC, V287, P3238, DOI 10.1001/jama.287.24.3238; KRAMER N, 1995, AM J RESP CRIT CARE, V151, P1799, DOI 10.1164/ajrccm.151.6.7767523; LeGall JR, 1996, JAMA-J AM MED ASSOC, V276, P802, DOI 10.1001/jama.276.10.802; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Lightowler JV, 2003, BMJ-BRIT MED J, V326, P185, DOI 10.1136/bmj.326.7382.185; Martin TJ, 2000, AM J RESP CRIT CARE, V161, P807, DOI 10.1164/ajrccm.161.3.9808143; Masip J, 2000, LANCET, V356, P2126, DOI 10.1016/S0140-6736(00)03492-9; Mehta S, 2001, AM J RESP CRIT CARE, V163, P540, DOI 10.1164/ajrccm.163.2.9906116; Nava S, 1997, CHEST, V111, P1631, DOI 10.1378/chest.111.6.1631; Nava S, 1998, ANN INTERN MED, V128, P721, DOI 10.7326/0003-4819-128-9-199805010-00004; Nourdine K, 1999, INTENS CARE MED, V25, P567, DOI 10.1007/s001340050904; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0; Radford MJ, 2001, JAMA-J AM MED ASSOC, V286, P1228, DOI 10.1001/jama.286.10.1228; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; SENEFF MG, 1995, JAMA-J AM MED ASSOC, V274, P1852, DOI 10.1001/jama.274.23.1852; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wood KA, 1998, CHEST, V113, P1339, DOI 10.1378/chest.113.5.1339	46	165	181	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2003	290	22					2985	2991		10.1001/jama.290.22.2985	http://dx.doi.org/10.1001/jama.290.22.2985			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751WH	14665660	Bronze			2022-12-28	WOS:000187112700030
J	Sokol, RJ; Delaney-Black, V; Nordstrom, B				Sokol, RJ; Delaney-Black, V; Nordstrom, B			Fetal alcohol spectrum disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRENATAL ALCOHOL; IN-UTERO; EXPOSURE; AGE; ATTENTION; CHILDREN; IDENTIFICATION; RECOGNITION; PREVALENCE; CHILDHOOD		Wayne State Univ, CS Mott Ctr Human Growth & Dev, Childrens Res Ctr, Detroit, MI 48201 USA; Wayne State Univ, Dept Obstet & Gynecol, Detroit, MI 48201 USA; E Tennessee State Univ, Dept Family Med, Johnson City, TN USA	Wayne State University; Wayne State University; East Tennessee State University	Sokol, RJ (corresponding author), Wayne State Univ, CS Mott Ctr Human Growth & Dev, Childrens Res Ctr, 275 E Hancock, Detroit, MI 48201 USA.	rsokol@moose.med.wayne.edu						Abel EL, 1998, ALCOHOL CLIN EXP RES, V22, P979, DOI 10.1111/j.1530-0277.1998.tb03692.x; [Anonymous], 1981, FDA Drug Bull, V11, P9; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P261; Chang G, 1998, OBSTET GYNECOL, V91, P892, DOI 10.1016/S0029-7844(98)00088-X; Chang G, 2000, J SUBST ABUSE TREAT, V18, P365, DOI 10.1016/S0740-5472(99)00105-1; Coles CD, 2000, J STUD ALCOHOL, V61, P607, DOI 10.15288/jsa.2000.61.607; COLES CD, 1991, NEUROTOXICOL TERATOL, V13, P357, DOI 10.1016/0892-0362(91)90084-A; Connor PD, 2000, DEV NEUROPSYCHOL, V18, P331, DOI 10.1207/S1532694204Connor; Connor PD, 1999, ALCOHOL CLIN EXP RES, V23, P1395; Cook JD, 2003, CLIN BIOCHEM, V36, P9, DOI 10.1016/S0009-9120(02)00424-1; Ebrahim SH, 1998, OBSTET GYNECOL, V92, P187, DOI 10.1016/S0029-7844(98)00205-1; ERNHART CB, 1988, ALCOHOL CLIN EXP RES, V12, P506, DOI 10.1111/j.1530-0277.1988.tb00233.x; FRIED PA, 1992, NEUROTOXICOL TERATOL, V14, P299, DOI 10.1016/0892-0362(92)90036-A; Handmaker NS, 1999, J STUD ALCOHOL, V60, P285, DOI 10.15288/jsa.1999.60.285; Handmaker NS, 2001, ALCOHOL RES HEALTH, V25, P219; HANKIN JR, 1995, SEMIN PERINATOL, V19, P286, DOI 10.1016/S0146-0005(05)80043-6; HANKIN JR, 1993, ALCOHOL CLIN EXP RES, V17, P284, DOI 10.1111/j.1530-0277.1993.tb00764.x; Jacobson JL, 1996, ALCOHOL CLIN EXP RES, V20, P359, DOI 10.1111/j.1530-0277.1996.tb01653.x; JACOBSON SW, 1994, ALCOHOL CLIN EXP RES, V18, P1125, DOI 10.1111/j.1530-0277.1994.tb00092.x; JONES KL, 1973, LANCET, V2, P999; Kaskutas L. A., 1998, J HLTH ED, V28, P11; Klein J, 2002, NEW ENGL J MED, V347, P2086, DOI 10.1056/NEJM200212193472523; Korkman M, 2003, CHILD NEUROPSYCHOL, V9, P117, DOI 10.1076/chin.9.2.117.14503; LANDESMANDWYER S, 1981, NEUROBEH TOXICOL TER, V3, P187; Langbehn DR, 2001, COMPR PSYCHIAT, V42, P272, DOI 10.1053/comp.2001.24579; LARSSON G, 1983, ACTA OBSTET GYN SCAN, V62, P171, DOI 10.3109/00016348309155786; LITTLE BB, 1990, AM J DIS CHILD, V144, P1142, DOI 10.1001/archpedi.1990.02150340088030; Mattson SN, 1999, ALCOHOL CLIN EXP RES, V23, P1808, DOI 10.1111/j.1530-0277.1999.tb04077.x; May PA, 2001, ALCOHOL RES HEALTH, V25, P159; Miller W, 2002, MOTIVATIONAL INTERVI, V2nd; Nevin Alexandra C, 2002, BMC Fam Pract, V3, P2, DOI 10.1186/1471-2296-3-2; O'Connor MJ, 2002, AM J DRUG ALCOHOL AB, V28, P745, DOI 10.1081/ADA-120015880; OLSON HC, 1992, DEV PSYCHOPATHOL, V4, P341, DOI 10.1017/S0954579400000821; Roebuck TM, 1999, ALCOHOL CLIN EXP RES, V23, P1070, DOI 10.1111/j.1530-0277.1999.tb04227.x; ROSETT HL, 1983, JAMA-J AM MED ASSOC, V249, P2029; Sampson PD, 1997, TERATOLOGY, V56, P317, DOI 10.1002/(SICI)1096-9926(199711)56:5<317::AID-TERA5>3.0.CO;2-U; SOKOL RJ, 1989, AM J OBSTET GYNECOL, V160, P863, DOI 10.1016/0002-9378(89)90302-5; Sood B, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.2.e34; Stoler JM, 1999, J PEDIATR-US, V135, P430, DOI 10.1016/S0022-3476(99)70164-2; Stratton K., 1996, FETAL ALCOHOL SYNDRO; STREISSGUTH AP, 1989, NEUROTOXICOL TERATOL, V11, P493, DOI 10.1016/0892-0362(89)90026-3; STREISSGUTH AP, 1990, ALCOHOL CLIN EXP RES, V14, P662, DOI 10.1111/j.1530-0277.1990.tb01224.x; STREISSGUTH AP, 1986, NEUROTOXICOL TERATOL, V8, P717; STREISSGUTH AP, 1984, CIBA F SYMP, V105, P176; STREISSGUTH AP, 1994, ALCOHOL CLIN EXP RES, V18, P202, DOI 10.1111/j.1530-0277.1994.tb00904.x; Yates WR, 1998, ALCOHOL CLIN EXP RES, V22, P914, DOI 10.1111/j.1530-0277.1998.tb03889.x; 1997, MMWR MORB MORTAL WKL, V46, P346; 2002, MMWR MORB MORTAL WKL, V51, P433	48	467	475	0	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2003	290	22					2996	2999		10.1001/jama.290.22.2996	http://dx.doi.org/10.1001/jama.290.22.2996			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	751WH	14665662				2022-12-28	WOS:000187112700032
J	Harries, M				Harries, M			ABC of resuscitation - Near drowning	BRITISH MEDICAL JOURNAL			English	Review									Northwick Pk & St Marks NHS Trust, Harrow, Middx, England	Imperial College London	Harries, M (corresponding author), Northwick Pk & St Marks NHS Trust, Harrow, Middx, England.							Gilbert M, 2000, LANCET, V355, P375, DOI 10.1016/S0140-6736(00)01021-7; Golden F S, 1991, J R Nav Med Serv, V77, P139; GOLDEN FS, 1998, OXFORD TXB SPORTS ME, P241; ORLOWSKI JP, 1987, CRIT CARE MED, V15, P126, DOI 10.1097/00003246-198702000-00009; WALPOTH BH, 1997, NEW ENGL J MED, V337, P500	5	20	23	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 6	2003	327	7427					1336	1338		10.1136/bmj.327.7427.1336	http://dx.doi.org/10.1136/bmj.327.7427.1336			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752DE	14656846	Green Published			2022-12-28	WOS:000187131100024
J	Walker, A; Sirel, JM; Marsden, AK; Cobbe, SM; Pell, JP				Walker, A; Sirel, JM; Marsden, AK; Cobbe, SM; Pell, JP			Cost effectiveness and cost utility model of public place defibrillators in improving survival after prehospital cardiopulmonary arrest	BRITISH MEDICAL JOURNAL			English	Article							AMERICAN-HEART-ASSOCIATION; HOSPITAL CARDIAC-ARREST; ACCESS DEFIBRILLATION; PERINATAL-MORTALITY; TASK-FORCE; RISK; PROFESSIONALS; RESUSCITATION; STATEMENT; COHORT	Objective To determine the cost effectiveness and cost utility of locating defibrillators in all major airports, railway stations, and bus stations throughout Scotland. Design Economic modelling exercise with data from Heartstart (Scotland). Parameters used in economic model included direct costs derived for increased accident and emergency attendances, increased hospital bed days, purchase and maintenance of defibrillators, and training in their use; life years gained calculated from increased discharges from hospital and mean survival after discharge; utility (quality of life) obtained from published data. Sensitivity analyses tested the robustness of model. Future gains discounted at 1.5% a year and future costs at 6%. Setting Whole of Scotland. Subjects Records,of all prehospital cardiac arrests due to presumed heart disease that occurred in a major airport, railway, or bus station between May 1991 and March 1998 and were not witnessed by ambulance or medical staff. Main outcome measures Observed survival to hospital admission and observed survival to discharge. Predicted survival calculated by applying observed survival in patients attended by ambulance staff within three minutes to those who waited longer. Results The total discounted direct costs were pound18 325 a year. The cost per life year gained was pound29 625 ($49 625, (sic)43 151) and the cost per quality adjusted life year (QALY) gained was pound41 146 ($68 924, (sic)59 932). More widespread provision of public place defibrillators would increase these figures. Conclusions The cost per QALY calculated for public place defibrillators represents poorer value for money than some alternative strategies for improving survival after prehospital cardiopulmonary arrest, such as the use of other trained first responders. The figure exceeds the commonly discussed cut off levels for funding in the United Kingdom and United States of pound30 000 and $50 000 per QALY, respectively.	Greater Glasgow NHS Board, Glasgow G3 8YZ, Lanark, Scotland; Scottish Ambulance Serv Headquarters, Edinburgh EH10 5UU, Midlothian, Scotland; Univ Glasgow, Dept Med Cardiol, Glasgow G32 2ER, Lanark, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Pell, JP (corresponding author), Greater Glasgow NHS Board, Glasgow G3 8YZ, Lanark, Scotland.			Pell, Jill/0000-0002-8898-7035				Banister J., 1987, CHINAS CHANGING POPU; Chu JH, 2001, POPUL DEV REV, V27, P259; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Gratton M, 1999, Prehosp Emerg Care, V3, P303, DOI 10.1080/10903129908958958; GROENEVELD P, 2001, JAMA-J AM MED ASSOC, V28, P1482; Hummel S, 1997, PHARMACOECONOMICS, V12, P182, DOI 10.2165/00019053-199712020-00008; *I POP STUD, 2000, ZHONG GUO REN KOU NI; *INF STAT DIV, 2001, SCOTT HLTH SERV COST; Kane R, 1999, BRIT MED J, V319, P992, DOI 10.1136/bmj.319.7215.992; Kulmala T, 2000, PAEDIATR PERINAT EP, V14, P219, DOI 10.1046/j.1365-3016.2000.00270.x; Kuntz KM, 1996, CIRCULATION, V94, P957, DOI 10.1161/01.CIR.94.5.957; Lee KH, 1996, CRIT CARE MED, V24, P2046, DOI 10.1097/00003246-199612000-00019; LI XT, 1995, ZHONG GUO FU YOU BAO, V10, P246; Liu Y, 2001, WORLD J MICROB BIOT, V17, P111, DOI 10.1023/A:1016625209839; MU L, 1995, ZHONG GUO CHU JI WEI, V9, P34; *NAT I CLIN EXC, 2000, GUID IMPL CARD DEF A; NETTEN A, 2002, UNIT COSTS HLTH SOCI; Nichol G, 1998, CIRCULATION, V97, P1309, DOI 10.1161/01.CIR.97.13.1309; Nichol G, 1998, CIRCULATION, V97, P1315, DOI 10.1161/01.CIR.97.13.1315; Nichol G, 1996, ANN EMERG MED, V27, P711, DOI 10.1016/S0196-0644(96)70188-9; Pell JP, 2002, BRIT MED J, V325, P515, DOI 10.1136/bmj.325.7363.515; Pell JP, 2001, BRIT MED J, V322, P1385, DOI 10.1136/bmj.322.7299.1385; Pickin DM, 1999, HEART, V82, P325, DOI 10.1136/hrt.82.3.325; RAYMOND EG, 1994, BRIT J OBSTET GYNAEC, V101, P301, DOI 10.1111/j.1471-0528.1994.tb13614.x; *SECR STAT HLTH, 1999, SAV LIV OUR HLTH NAT; Shah D, 2000, INT J GYNECOL OBSTET, V71, P209, DOI 10.1016/S0020-7292(00)00215-0; Shah NM, 2000, SOC SCI MED, V51, P539, DOI 10.1016/S0277-9536(99)00485-2; WEI YZ, 1992, GUI YANG YI XUE YUAN, V17, P42; WEISFELDT ML, 1995, CIRCULATION, V92, P2763, DOI 10.1161/01.CIR.92.9.2763; Woollard M, 2001, J PUBLIC HEALTH MED, V23, P98, DOI 10.1093/pubmed/23.2.98; XU BZ, 1995, PERINATAL MORTALITY; Yao J S, 1991, Zhonghua Fu Chan Ke Za Zhi, V26, P224; ZHANG J, 1991, INT J EPIDEMIOL, V20, P958, DOI 10.1093/ije/20.4.958; ZHU XL, 1996, XIN JIANG YI XUE YUA, V19, P83	34	27	28	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 6	2003	327	7427					1316	1319		10.1136/bmj.327.7427.1316	http://dx.doi.org/10.1136/bmj.327.7427.1316			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752DE	14656838	Green Published, Bronze			2022-12-28	WOS:000187131100016
J	Webster, CR; Heymsfield, AJ				Webster, CR; Heymsfield, AJ			Water isotope ratios D/H, O-18/O-16, O-17/O-16 in and out of clouds map dehydration pathways	SCIENCE			English	Article							TROPICAL TROPOPAUSE; OZONE DEPLETION; CLIMATE-CHANGE; CIRRUS CLOUDS; VAPOR; DEUTERIUM; STRATOSPHERE; TRANSPORT; O-18; MECHANISM	Water isotope ratios have been measured by laser absorption spectroscopy in and out of cirrus clouds formed in situ and convectively generated in anvils over subtropical regions. Water vapor in the tropical and subtropical upper troposphere shows a wide range of isotopic depletion not observed previously. The range suggests that dehydration of upper tropospheric air occurs both by convective dehydration and by gradual dehydration mechanisms. Twenty-five percent of upper tropospheric water sampled is in ice particles whose isotopic signatures are used to identify those grown in situ from those lofted from below.	CALTECH, Jet Prop Lab, Div Space Sci, Pasadena, CA 91109 USA; Natl Ctr Atmospher Res, Boulder, CO 80301 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Center Atmospheric Research (NCAR) - USA	Webster, CR (corresponding author), CALTECH, Jet Prop Lab, Div Space Sci, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	chris.r.webster@jpl.nasa.gov	Heymsfield, Andrew J/E-7340-2011; Webster, Chris/M-9315-2019	Heymsfield, Andrew J/0000-0003-4107-7533; 				BRASSEUR G, 1985, AERONOMY MIDDLE ATMO; BREWER AW, 1949, Q J ROY METEOR SOC, V75, P351, DOI 10.1002/qj.49707532603; CRAIG H, 1961, SCIENCE, V133, P1833, DOI 10.1126/science.133.3467.1833; Criss R. E., 1999, PRINCIPLES STABLE IS; DANIELSEN EF, 1982, GEOPHYS RES LETT, V9, P605, DOI 10.1029/GL009i006p00605; DESSLER AE, 2003, ATMOS CHEM PHYS DISC, V3, P44; Dinelli BM, 1997, GEOPHYS RES LETT, V24, P2003, DOI 10.1029/97GL02022; EHHALT DH, 1974, 100 TNSTR NCAR; Fahey DW, 1996, GEOPHYS RES LETT, V23, P1653, DOI 10.1029/96GL01476; Forster PMD, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013909; Gedzelman S. D., 1988, Tellus, Series B (Chemical and Physical Meteorology), V40B, P134, DOI 10.1111/j.1600-0889.1988.tb00217.x; Hartmann DL, 2002, SCIENCE, V295, P811, DOI 10.1126/science.1068447; Hartmann DL, 2001, GEOPHYS RES LETT, V28, P1969, DOI 10.1029/2000GL012833; Heymsfield AJ, 2002, J ATMOS SCI, V59, P3, DOI 10.1175/1520-0469(2002)059<0003:AGAFDT>2.0.CO;2; Highwood EJ, 1998, Q J ROY METEOR SOC, V124, P1579, DOI 10.1002/qj.49712454911; Holton JR, 2001, GEOPHYS RES LETT, V28, P2799, DOI 10.1029/2001GL013148; Johnson DG, 2001, J GEOPHYS RES-ATMOS, V106, P12211, DOI 10.1029/2000JD900763; Johnson DG, 2001, J GEOPHYS RES-ATMOS, V106, P12219, DOI 10.1029/2000JD900764; JOHNSTON HS, 1979, J GEOPHYS RES-OC ATM, V84, P3155, DOI 10.1029/JC084iC06p03155; KAYE JA, 1990, J ATMOS CHEM, V10, P39, DOI 10.1007/BF01980037; KAYE JA, 1987, REV GEOPHYS, V25, P1609, DOI 10.1029/RG025i008p01609; Keith DW, 2000, J GEOPHYS RES-ATMOS, V105, P15167, DOI 10.1029/2000JD900130; Kirk-Davidoff DB, 1999, NATURE, V402, P399, DOI 10.1038/46521; KNIGHT CA, 1981, J ATMOS SCI, V38, P2485, DOI 10.1175/1520-0469(1981)038<2485:DCOSIA>2.0.CO;2; Kuang ZM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017023; LIOU KN, 1986, MON WEATHER REV, V114, P1167, DOI 10.1175/1520-0493(1986)114<1167:IOCCOW>2.0.CO;2; Mote PW, 1996, J GEOPHYS RES-ATMOS, V101, P3989, DOI 10.1029/95JD03422; Moyer EJ, 1996, GEOPHYS RES LETT, V23, P2385, DOI 10.1029/96GL01489; NEWELL RE, 1981, J ATMOS SCI, V38, P2789, DOI 10.1175/1520-0469(1981)038<2789:ASF>2.0.CO;2; PALUCH IR, 1979, J ATMOS SCI, V36, P2467, DOI 10.1175/1520-0469(1979)036<2467:TEMICC>2.0.CO;2; POLLOCK W, 1980, J GEOPHYS RES-OCEANS, V85, P5555, DOI 10.1029/JC085iC10p05555; POTTER BE, 1995, J ATMOS SCI, V52, P1034, DOI 10.1175/1520-0469(1995)052<1034:TROMCI>2.0.CO;2; RAMANATHAN V, 1991, NATURE, V351, P27, DOI 10.1038/351027a0; Randel WJ, 2000, J GEOPHYS RES-ATMOS, V105, P15509, DOI 10.1029/2000JD900155; Ridal M, 2001, J GEOPHYS RES-ATMOS, V106, P32283, DOI 10.1029/2000JD000268; RINSLAND CP, 1991, J GEOPHYS RES-ATMOS, V96, P1057, DOI 10.1029/90JD02234; Rosenlof KH, 2001, GEOPHYS RES LETT, V28, P1195, DOI 10.1029/2000GL012502; SCHOLZ TG, 1970, J GEOPHYS RES, V75, P3049, DOI 10.1029/JC075i015p03049; Sherwood SC, 2000, GEOPHYS RES LETT, V27, P677, DOI 10.1029/1999GL010868; Sherwood SC, 2000, GEOPHYS RES LETT, V27, P2513, DOI 10.1029/2000GL011438; Sherwood SC, 2001, J ATMOS SCI, V58, P765, DOI 10.1175/1520-0469(2001)058<0765:AMFTAT>2.0.CO;2; SHINE KP, 1991, NATURE, V354, P382, DOI 10.1038/354382a0; SMITH RB, 1992, J ATMOS SCI, V49, P2041, DOI 10.1175/1520-0469(1992)049<2041:DINAST>2.0.CO;2; Solomon S, 1999, REV GEOPHYS, V37, P275, DOI 10.1029/1999RG900008; *SPARC ASS UT LS W, 2000, WCRP113 SPARC ASS UT; Stowasser M, 1999, J GEOPHYS RES-ATMOS, V104, P19213, DOI 10.1029/1999JD900239; WEBSTER CR, 1994, APPL OPTICS, V33, P454, DOI 10.1364/AO.33.000454; Zahn A, 1998, J ATMOS CHEM, V30, P25, DOI 10.1023/A:1005896532640	48	146	147	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2003	302	5651					1742	1745		10.1126/science.1089496	http://dx.doi.org/10.1126/science.1089496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657493				2022-12-28	WOS:000186970100041
J	Ingelfinger, JR				Ingelfinger, JR			Forestalling fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article																		BARICOS WH, 1995, KIDNEY INT, V47, P1039, DOI 10.1038/ki.1995.150; Eddy AA, 2002, AM J PHYSIOL-RENAL, V283, pF209, DOI 10.1152/ajprenal.00032.2002; Huang YF, 2003, J CLIN INVEST, V112, P379, DOI 10.1172/JCI200318038; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; LEWIS EJ, 1993, NEW ENGL J MED, V330, P152; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x	6	15	16	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2003	349	23					2265	2266		10.1056/NEJMcibr032288	http://dx.doi.org/10.1056/NEJMcibr032288			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LH	14657436				2022-12-28	WOS:000186921700016
J	Srinivasan, S; Gray, DG				Srinivasan, S; Gray, DG			Choroidal metastasis from renal-cell carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ayr Hosp, Ayr KA6 6DX, Scotland		Srinivasan, S (corresponding author), Ayr Hosp, Ayr KA6 6DX, Scotland.								0	2	2	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2003	349	23					E22	E22		10.1056/ENEJMicm010902	http://dx.doi.org/10.1056/ENEJMicm010902			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LH	14657445				2022-12-28	WOS:000186921700009
J	Mairesse, Y; de Bohan, A; Frasinski, LJ; Merdji, H; Dinu, LC; Monchicourt, P; Breger, P; Kovacev, M; Taieb, R; Carre, B; Muller, HG; Agostini, P; Salieres, P				Mairesse, Y; de Bohan, A; Frasinski, LJ; Merdji, H; Dinu, LC; Monchicourt, P; Breger, P; Kovacev, M; Taieb, R; Carre, B; Muller, HG; Agostini, P; Salieres, P			Attosecond synchronization of high-harmonic soft x-rays	SCIENCE			English	Article							HIGH-ORDER HARMONICS; PROBING MOLECULAR-DYNAMICS; LASER FIELDS; GENERATION; PULSES; IONIZATION; EMISSION	Subfemtosecond light pulses can be obtained by superposing several high harmonics of an intense laser pulse. Provided that the harmonics are emitted simultaneously, increasing their number should result in shorter pulses. However, we found that the high harmonics were not synchronized on an attosecond time scale, thus setting a lower limit to the achievable x-ray pulse duration. We showed that the synchronization could be improved considerably by controlling the underlying ultrafast electron dynamics, to provide pulses of 130 attoseconds in duration. We discuss the possibility of achieving even shorter pulses, which would allow us to trackfast electron processes in matter.	Ctr Etud Saclay, CEA, DRECAM, SPAM, F-91191 Gif Sur Yvette, France; Univ Reading, JJ Thomson Phys Lab, Reading RG6 6AF, Berks, England; FOM, Inst Atom & Mol Phys, NL-1098 SJ Amsterdam, Netherlands; Univ Paris 06, Lab Chim Phys Mat & Rayonnement, F-75231 Paris 05, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Reading; AMOLF; UDICE-French Research Universities; Sorbonne Universite	Mairesse, Y (corresponding author), Ctr Etud Saclay, CEA, DRECAM, SPAM, F-91191 Gif Sur Yvette, France.		Kovacev, Milutin/F-1110-2014; Mairesse, Yann/B-3049-2015; SALIERES, Pascal/L-7776-2014	Kovacev, Milutin/0000-0002-2813-9608; Mairesse, Yann/0000-0002-9098-7421; SALIERES, Pascal/0000-0001-5899-8246; Frasinski, Leszek/0000-0001-9308-4925; Merdji, Hamed/0000-0003-3512-3855	Engineering and Physical Sciences Research Council [GR/S22424/01] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Antoine P, 1996, PHYS REV LETT, V77, P1234, DOI 10.1103/PhysRevLett.77.1234; Antoine P, 1997, PHYS REV A, V56, P4960, DOI 10.1103/PhysRevA.56.4960; Balcou P, 1997, PHYS REV A, V55, P3204, DOI 10.1103/PhysRevA.55.3204; Baltuska A, 2003, NATURE, V421, P611, DOI 10.1038/nature01414; Bartels R, 2000, NATURE, V406, P164, DOI 10.1038/35018029; Brabec T, 2000, REV MOD PHYS, V72, P545, DOI 10.1103/RevModPhys.72.545; Chang ZH, 1997, PHYS REV LETT, V79, P2967, DOI 10.1103/PhysRevLett.79.2967; Christov IP, 1997, PHYS REV LETT, V78, P1251, DOI 10.1103/PhysRevLett.78.1251; CORKUM PB, 1994, OPT LETT, V19, P1870, DOI 10.1364/OL.19.001870; CORKUM PB, 1993, PHYS REV LETT, V71, P1994, DOI 10.1103/PhysRevLett.71.1994; Dinu LC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.063901; Drescher M, 2002, NATURE, V419, P803, DOI 10.1038/nature01143; FARKAS G, 1992, PHYS LETT A, V168, P447, DOI 10.1016/0375-9601(92)90534-S; Gaarde MB, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.213901; HARRIS SE, 1993, OPT COMMUN, V100, P487, DOI 10.1016/0030-4018(93)90250-9; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; LEWENSTEIN M, 1994, PHYS REV A, V49, P2117, DOI 10.1103/PhysRevA.49.2117; Niikura H, 2003, NATURE, V421, P826, DOI 10.1038/nature01430; Niikura H, 2002, NATURE, V417, P917, DOI 10.1038/nature00787; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413; Salieres P, 2001, SCIENCE, V292, P902, DOI 10.1126/science.108836; SALIERES P, 1995, PHYS REV LETT, V74, P3776, DOI 10.1103/PhysRevLett.74.3776; Salieres P, 1998, PHYS REV LETT, V81, P5544, DOI 10.1103/PhysRevLett.81.5544; Salieres P., 1999, ADV ATOM MOL OPT PHY, V41, P83; SCHAFER KJ, 1993, PHYS REV LETT, V70, P1599, DOI 10.1103/PhysRevLett.70.1599; Schnurer M, 1998, PHYS REV LETT, V80, P3236, DOI 10.1103/PhysRevLett.80.3236; Sheehy B, 1999, PHYS REV LETT, V83, P5270, DOI 10.1103/PhysRevLett.83.5270; Veniard V, 1996, PHYS REV A, V54, P721, DOI 10.1103/PhysRevA.54.721	28	692	727	4	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1540	1543		10.1126/science.1090277	http://dx.doi.org/10.1126/science.1090277			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645841				2022-12-28	WOS:000186802200035
J	Weinberg, S				Weinberg, S			Four golden lessons	NATURE			English	Editorial Material									Univ Texas, Dept Phys, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Weinberg, S (corresponding author), Univ Texas, Dept Phys, Austin, TX 78712 USA.								0	10	11	11	182	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					389	389		10.1038/426389a	http://dx.doi.org/10.1038/426389a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647361	Bronze			2022-12-28	WOS:000186800800019
J	Nolan, MF; Malleret, G; Lee, KH; Gibbs, E; Dudman, JT; Santoro, B; Yin, DQ; Thompson, RF; Siegelbaum, SA; Kandel, ER; Morozov, A				Nolan, MF; Malleret, G; Lee, KH; Gibbs, E; Dudman, JT; Santoro, B; Yin, DQ; Thompson, RF; Siegelbaum, SA; Kandel, ER; Morozov, A			The hyperpolarization-activated HCN1 channel is important for motor learning and neuronal integration by cerebellar Purkinje cells	CELL			English	Article							LONG-TERM DEPRESSION; MUTANT MICE; NUCLEAR NEURONS; BASKET CELLS; COORDINATION; INHIBITION; RESPONSES; PACEMAKER; CURRENTS; CORTEX	In contrast to our increasingly detailed understanding of how synaptic plasticity provides a cellular substrate for learning and memory, it is less clear how a neuron's voltage-gated ion channels interact with plastic changes in synaptic strength to influence behavior. We find, using generalized and regional knockout mice, that deletion of the HCN1 channel causes profound motor learning and memory deficits in swimming and rotarod tasks. In cerebellar Purkinje cells, which are a key component of the cerebellar circuit for learning of correctly timed movements, HCN1 mediates an inward current that stabilizes the integrative properties of Purkinje cells and ensures that their input-output function is independent of the previous history of their activity. We suggest that this nonsynaptic integrative function of HCN1 is required for accurate decoding of input patterns and thereby enables synaptic plasticity to appropriately influence the performance of motor activity.	Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, Dept Physiol, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, Dept Psychiat, New York, NY 10032 USA; Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA; NIMH, Unit Behav Genet, Bethesda, MD 20892 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Nolan, MF (corresponding author), Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA.		Nolan, Matthew/A-1356-2009	Nolan, Matthew/0000-0003-1062-6501; Dudman, Joshua/0000-0002-4436-1057; Santoro, Bina/0000-0002-4277-1992	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045923, R37MH045923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036658] Funding Source: NIH RePORTER; NIMH NIH HHS [MH045923] Funding Source: Medline; NINDS NIH HHS [NS36658] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ANDERSEN P, 1964, J NEUROPHYSIOL, V27, P1138, DOI 10.1152/jn.1964.27.6.1138; [Anonymous], [No title captured]; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; CREPEL F, 1986, J PHYSIOL-LONDON, V372, P1; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Dragatsis I, 2000, GENESIS, V26, P133, DOI 10.1002/(SICI)1526-968X(200002)26:2<133::AID-GENE10>3.0.CO;2-V; EKEROT CF, 1985, BRAIN RES, V342, P357, DOI 10.1016/0006-8993(85)91136-9; Fairbanks CA, 1997, J PHARMACOL EXP THER, V282, P1408; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; HESSLOW G, 1994, NEUROREPORT, V5, P649, DOI 10.1097/00001756-199401000-00030; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; LI SJ, 1993, BRAIN RES, V617, P87, DOI 10.1016/0006-8993(93)90617-V; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MCCORMICK DA, 1984, J NEUROSCI, V4, P2811; MCCORMICK DA, 1982, P NATL ACAD SCI-BIOL, V79, P2731, DOI 10.1073/pnas.79.8.2731; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nam SC, 1997, J NEUROBIOL, V33, P18, DOI 10.1002/(SICI)1097-4695(199707)33:1<18::AID-NEU3>3.0.CO;2-G; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Paylor R, 1999, LEARN MEMORY, V6, P521, DOI 10.1101/lm.6.5.521; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Raman IM, 1999, J NEUROSCI, V19, P1663; Raymond JL, 1998, J NEUROSCI, V18, P9112; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x; Saitow F, 2000, J NEUROPHYSIOL, V84, P2026, DOI 10.1152/jn.2000.84.4.2026; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; Southan AP, 2000, J PHYSIOL-LONDON, V526, P91, DOI 10.1111/j.1469-7793.2000.t01-1-00091.x; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; Thach WT, 1998, NEUROBIOL LEARN MEM, V70, P177, DOI 10.1006/nlme.1998.3846; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; Williams SR, 2002, J PHYSIOL-LONDON, V539, P469, DOI 10.1113/jphysiol.2001.013136; YEO CH, 1985, EXP BRAIN RES, V60, P99, DOI 10.1007/BF00237023	45	245	251	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 26	2003	115	5					551	564		10.1016/S0092-8674(03)00884-5	http://dx.doi.org/10.1016/S0092-8674(03)00884-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651847	Bronze			2022-12-28	WOS:000186885600006
J	Wu, YW; Escobar, GJ; Grether, JK; Croen, LA; Greene, JD; Newman, TB				Wu, YW; Escobar, GJ; Grether, JK; Croen, LA; Greene, JD; Newman, TB			Chorioamnionitis and cerebral palsy in term and near-term infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AUSTRALIAN CASE-CONTROL; V-LEIDEN MUTATION; NEONATAL ENCEPHALOPATHY; NEWBORN ENCEPHALOPATHY; MATERNAL FEVER; BRAIN-DAMAGE; RISK-FACTORS; APGAR SCORE; CHILDREN; ANTECEDENTS	Context Half of all cases of cerebral palsy (CP) occur in term infants, for whom risk factors have not been clearly defined. Recent studies suggest a possible role of chorioamnionitis. Objective To determine whether clinical chorioamnionitis increases the risk of CP in term and near-term infants. Design, Setting, and Patients Case-control study nested within a cohort of 231582 singleton infants born at 36 or more weeks' gestation between January 1, 1991, and December 31,1998, in the Kaiser Permanente Medical Care Program, a managed care organization providing care for more than 3 million residents of northern California. Case patients were identified from electronic records and confirmed by chart review by a child neurologist, and comprised all children with moderate to severe spastic or. dyskinetic CP not due to postnatal brain injury or developmental abnormalities (n=109). Controls (n=218) were randomly selected from the study population. Main Outcome Measure Association between clinical chorioamnionitis and increased risk of CP in term and near-term infants. Results Most CP cases had hemiparesis (40%) or quadriparesis (38%); 87% had been diagnosed by a neurologist and 83% had undergone neuroimaging. Chorioamnionitis, considered present if a treating physician made a diagnosis of chorioamnionitis or endometritis clinically, was noted in 14% of cases and 4% of controls (odds ratio [OR], 3.8; 95% confidence interval [CI], 1.5-10.1; P=.001). Independent risk factors identified in multiple logistic regression included chorioamnionitis (OR, 4.1; 95% CI, 1.6-10.1), intrauterine growth restriction (OR, 4.0;95% CI, 1.3-12.0), maternal black ethnicity (OR, 3.6; 95% CI, 1.4-9.3), maternal age older than 25 years (OR, 2.6; 95% CI, 1.3-5.2), and nulliparity (OR, 1.8; 95% CI, 1.0-3.0). The population-attributable fraction of chorioamnionitis for CP is 11%. Conclusion Our data suggest that chorioamnionitis is an independent risk factor for CP among term and near-term infants.	Univ Calif San Francisco, Dept Neurol, Div Child Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Kaiser Permanente Div Res, Oakland, CA USA; Calif Dept Hlth Serv, Sacramento, CA 95814 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; California Department of Health Care Services	Wu, YW (corresponding author), Univ Calif San Francisco, Dept Neurol, Div Child Neurol, Box 0136,500 Parnassus Ave,MUE 411, San Francisco, CA 94143 USA.			Croen, Lisa/0000-0001-7849-9428	NINDS NIH HHS [5 K12 NSO1692] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K12NS001692] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 2003, NEON ENC CER PALS; Badawi N, 1998, DEV MED CHILD NEUROL, V40, P520; Badawi N, 1998, BMJ-BRIT MED J, V317, P1549, DOI 10.1136/bmj.317.7172.1549; Badawi N, 1998, BMJ-BRIT MED J, V317, P1554, DOI 10.1136/bmj.317.7172.1554; BLAIR E, 1993, DEV MED CHILD NEUROL, V35, P449; Bloomenthal D, 2002, AM J PERINAT, V19, P37, DOI 10.1055/s-2002-20172; Colver AF, 2000, ARCH DIS CHILD-FETAL, V83, pF7, DOI 10.1136/fn.83.1.F7; Cowan F, 2003, LANCET, V361, P736, DOI 10.1016/S0140-6736(03)12658-X; Dammann O, 1998, Semin Pediatr Neurol, V5, P190, DOI 10.1016/S1071-9091(98)80034-X; Dite GS, 1998, AUST NZ J OBSTET GYN, V38, P377, DOI 10.1111/j.1479-828X.1998.tb03091.x; EASTMAN NJ, 1955, AM J OBSTET GYNECOL, V69, P950, DOI 10.1016/0002-9378(55)90094-6; Eun BL, 2000, PEDIATR RES, V47, P73, DOI 10.1203/00006450-200001000-00014; Foster-Barber A, 2002, MENT RETARD DEV D R, V8, P20, DOI 10.1002/mrdd.10009; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Grether J K, 1992, Paediatr Perinat Epidemiol, V6, P339, DOI 10.1111/j.1365-3016.1992.tb00774.x; Grether JK, 2003, ARCH PEDIAT ADOL MED, V157, P26, DOI 10.1001/archpedi.157.1.26; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; Gugino, 1998, Prim Care Update Ob Gyns, V5, P148, DOI 10.1016/S1068-607X(98)00026-2; Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532; Hagstrom JN, 1998, J PEDIATR-US, V133, P777, DOI 10.1016/S0022-3476(98)70150-7; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Humphreys P, 2000, CAN J NEUROL SCI, V27, P210; Kim Y, 1996, STROKE, V27, P2274, DOI 10.1161/01.STR.27.12.2274; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; KUBAN KCK, 1994, NEW ENGL J MED, V330, P188, DOI 10.1056/NEJM199401203300308; Lieberman E, 2000, PEDIATRICS, V105, P8, DOI 10.1542/peds.105.1.8; Lynch JK, 2002, PEDIATRICS, V109, P116, DOI 10.1542/peds.109.1.116; Lynch JK, 2001, J CHILD NEUROL, V16, P735, DOI 10.1177/088307380101601006; MARTIN D, 1994, EXP NEUROL, V130, P362, DOI 10.1006/exnr.1994.1215; MENKES JH, 1994, AM J NEURORADIOL, V15, P451; MINAMISAWA H, 1990, ANN NEUROL, V28, P26, DOI 10.1002/ana.410280107; Moster D, 2001, J PEDIATR-US, V138, P798, DOI 10.1067/mpd.2001.114694; MURPHY CC, 1993, J PEDIATR-US, V123, pS13, DOI 10.1016/S0022-3476(05)80892-3; MUTCH L, 1992, DEV MED CHILD NEUROL, V34, P547; NELSON KB, 1982, PEDIATRICS, V69, P529; NELSON KB, 1985, AM J DIS CHILD, V139, P1031, DOI 10.1001/archpedi.1985.02140120077032; Nelson KB, 1998, ANN NEUROL, V44, P665, DOI 10.1002/ana.410440413; NELSON KB, 1986, NEW ENGL J MED, V315, P81, DOI 10.1056/NEJM198607103150202; Nelson KB, 2002, MENT RETARD DEV D R, V8, P146, DOI 10.1002/mrdd.10037; Pasternak JF, 1998, PEDIATR NEUROL, V18, P391, DOI 10.1016/S0887-8994(98)00002-2; Perlman JN, 1999, CLIN PEDIATR, V38, P287, DOI 10.1177/000992289903800506; *PMIC, 1999, INT CLASS DIS 9 REV; Roland EP, 1998, ANN NEUROL, V44, P161, DOI 10.1002/ana.410440205; Russel P., 1979, AM J DIAG GYN OBSTET, V1, P127; Shalak LF, 2002, MENT RETARD DEV D R, V8, P14, DOI 10.1002/mrdd.10006; Smulian JC, 1999, OBSTET GYNECOL, V94, P1000, DOI 10.1016/S0029-7844(99)00416-0; *STAT CA DEP HLTH, 1976, INTR GROWTH NEON RIS; Suzuki J, 2002, BRAIN DEV-JPN, V24, P39, DOI 10.1016/S0387-7604(01)00395-3; Thorngren-Jerneck K, 2001, OBSTET GYNECOL, V98, P65, DOI 10.1016/S0029-7844(01)01370-9; Topp M, 2001, PAEDIATR PERINAT EP, V15, P271, DOI 10.1046/j.1365-3016.2001.00354.x; Uvebrant P, 1988, Acta Paediatr Scand Suppl, V345, P1; Walstab J, 2002, AUST NZ J OBSTET GYN, V42, P138, DOI 10.1111/j.0004-8666.2002.00138.x; Winter S, 2002, PEDIATRICS, V110, P1220, DOI 10.1542/peds.110.6.1220; Wu YW, 2000, JAMA-J AM MED ASSOC, V284, P1417, DOI 10.1001/jama.284.11.1417; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676; [No title captured]; 2000, STATA 7 REFERENCE MA	57	369	378	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2003	290	20					2677	2684		10.1001/jama.290.20.2677	http://dx.doi.org/10.1001/jama.290.20.2677			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747CR	14645309				2022-12-28	WOS:000186788100019
J	Zhou, DP; Cantu, C; Sagiv, Y; Schrantz, N; Kulkarni, AB; Qi, XY; Mahuran, DJ; Morales, CR; Grabowski, GA; Benlagha, K; Savage, P; Bendelac, A; Teyton, L				Zhou, DP; Cantu, C; Sagiv, Y; Schrantz, N; Kulkarni, AB; Qi, XY; Mahuran, DJ; Morales, CR; Grabowski, GA; Benlagha, K; Savage, P; Bendelac, A; Teyton, L			Editing of CD1d-bound lipid antigens by endosomal lipid transfer proteins	SCIENCE			English	Article							ACTIVATOR PROTEIN; CYTOPLASMIC TAIL; T-CELLS; INTRACELLULAR TRAFFICKING; ALPHA-GALACTOSIDASE; NKT CELLS; MOLECULES; MOUSE; CD1B; SPECIFICITY	It is now established that CD1 molecules present lipid antigens to T cells, although it is not clear how the exchange of lipids between membrane compartments and the CD1 binding groove is assisted. We report that mice deficient in prosaposin, the precursor to a family of endosomal lipid transfer proteins (LTP), exhibit specific defects in CD1d-mediated antigen presentation and lack Valpha14 NKT cells. In vitro, saposins extracted monomeric lipids from membranes and from CD1, thereby promoting the loading as well as the editing of lipids on CD1. Transient complexes between CD1, lipid, and LTP suggested a "tug-of-war" model in which lipid exchange between CD1 and LTP is on the basis of their respective affinities for lipids. LTPs constitute a previously unknown link between lipid metabolism and immunity and are likely to exert a profound influence on the repertoire of self, tumor, and microbial lipid antigens.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; Univ Toronto, Dept Med & Pathobiol, Toronto, ON M5G 1X8, Canada; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	University of Chicago; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Cincinnati Children's Hospital Medical Center; University of Toronto; McGill University; Brigham Young University	Bendelac, A (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	abendela@bsd.uchicago.edu; lteyton@scripps.edu	Benlagha, Kamel/I-5035-2016; Benlagha, Kamel/GLQ-8342-2022; Morales, Carlos R./H-1055-2011; Zhou, Dapeng/A-6446-2019; Savage, Paul B/HGB-3414-2022; zhou, dapeng/GXG-9715-2022; Savage, Paul B/E-1448-2011	Zhou, Dapeng/0000-0003-1347-3811; Savage, Paul B/0000-0002-4642-6109; Savage, Paul B/0000-0002-4642-6109; benlagha, kamel/0000-0002-3251-9195	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050867, R37AI038339, R01AI038339, P01AI053725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000698] Funding Source: NIH RePORTER; Canadian Institutes of Health Research [10435] Funding Source: Medline; NIAID NIH HHS [R01 AI050867, R01 AI038339, AI50867, P01 AI053725, P01 AI53725, R37 AI038339, AI38339] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn VE, 2003, P NATL ACAD SCI USA, V100, P38, DOI 10.1073/pnas.0136947100; Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Briken V, 2002, EMBO J, V21, P825, DOI 10.1093/emboj/21.4.825; Cantu C, 2003, J IMMUNOL, V170, P4673, DOI 10.4049/jimmunol.170.9.4673; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Chiu YH, 1999, J EXP MED, V189, P103, DOI 10.1084/jem.189.1.103; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Fujita N, 1996, HUM MOL GENET, V5, P711, DOI 10.1093/hmg/5.6.711; Godfrey DI, 2000, IMMUNOL TODAY, V21, P573, DOI 10.1016/S0167-5699(00)01735-7; HARDING CV, 1991, CELL, V64, P393, DOI 10.1016/0092-8674(91)90647-H; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Kang SJ, 2002, EMBO J, V21, P1650, DOI 10.1093/emboj/21.7.1650; Kase R, 1996, FEBS LETT, V393, P74, DOI 10.1016/0014-5793(96)00863-0; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Moody DB, 2000, J EXP MED, V192, P965, DOI 10.1084/jem.192.7.965; Moody DB, 2003, NAT REV IMMUNOL, V3, P11, DOI 10.1038/nri979; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; QI XY, 1994, J BIOL CHEM, V269, P16746; RUECKERT DG, 1990, CHEM PHYS LIPIDS, V56, P1, DOI 10.1016/0009-3084(90)90083-4; Sakai N, 1996, J NEUROCHEM, V66, P1118, DOI 10.1046/j.1471-4159.1996.66031118.x; Sandhoff K, 1998, ANN NY ACAD SCI, V845, P139, DOI 10.1111/j.1749-6632.1998.tb09667.x; Shamshiev A, 2000, IMMUNITY, V13, P255, DOI 10.1016/S1074-7613(00)00025-X; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; Vogler C, 2001, PEDIATR RES, V49, P342, DOI 10.1203/00006450-200103000-00007; Wright CS, 2003, J MOL BIOL, V331, P951, DOI 10.1016/S0022-2836(03)00794-0; WU YY, 1994, J BIOL CHEM, V269, P16276; Zhao Q, 2000, J BIOL CHEM, V275, P24829, DOI 10.1074/jbc.M003497200	33	259	270	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 23	2004	303	5657					523	527		10.1126/science.1092009	http://dx.doi.org/10.1126/science.1092009			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765XM	14684827	Green Accepted			2022-12-28	WOS:000188316400038
J	Mizuguchi, G; Shen, XT; Landry, J; Wu, WH; Sen, S; Wu, C				Mizuguchi, G; Shen, XT; Landry, J; Wu, WH; Sen, S; Wu, C			ATP-Driven exchange of histone H2AZ variant catalyzed by SWR1 chromatin remodeling complex	SCIENCE			English	Article							ACTIN-RELATED PROTEINS; NUCLEOSOME CORE PARTICLE; NUCLEAR ACTIN; SACCHAROMYCES-CEREVISIAE; RSC	The conserved histone variant H2AZ has an important role in the regulation of gene expression and the establishment of a buffer to the spread of silent heterochromatin. How histone variants such as H2AZ are incorporated into nucleosomes has been obscure. We have found that Swr1, a Swi2/Snf2-related adenosine triphosphatase, is the catalytic core of a multisubunit, histone-variant exchanger that efficiently replaces conventional histone H2A with histone H2AZ in nucleosome arrays. Swr1 is required for the deposition of histone H2AZ at specific chromosome locations in vivo, and Swr1 and H2AZ commonly regulate a subset of yeast genes. These findings de. ne a previously unknown role for the adenosine triphosphate - dependent chromatin remodeling machinery.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Wu, C (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bldg 37,Room 6068, Bethesda, MD 20892 USA.	carlwu@helix.nih.gov	Sen, Subhojit/I-9033-2012	Sen, Subhojit/0000-0001-8457-915X; Shen, Xuetong/0000-0002-4267-5298	NATIONAL CANCER INSTITUTE [ZIABC005263, Z01BC005263] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; [Anonymous], COMMUNICATION; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Begley TJ, 2002, MOL CANCER RES, V1, P103; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Clarkson MJ, 1999, NATURE, V399, P694, DOI 10.1038/21436; Fazzio TG, 2003, MOL CELL, V12, P1333, DOI 10.1016/S1097-2765(03)00436-2; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Goodson HV, 2002, J CELL SCI, V115, P2619; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; Harata M, 1999, MOL BIOL CELL, V10, P2595, DOI 10.1091/mbc.10.8.2595; HATCH CL, 1983, SCIENCE, V221, P468, DOI 10.1126/science.6306766; Hsu JM, 2003, MOL CELL BIOL, V23, P3202, DOI 10.1128/MCB.23.9.3202-3215.2003; ISHIMI Y, 1991, J BIOL CHEM, V266, P7025; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Luger K, 1999, METHOD ENZYMOL, V304, P3; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; MIZUGUCHI G, UNPUB; NAKATANI Y, COMMUNICATION; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Richmond T. J., 2000, CHROMATIN STRUCTURE; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Shen XT, 2003, MOL CELL, V12, P147, DOI 10.1016/S1097-2765(03)00264-8; Smith MM, 2002, CURR OPIN CELL BIOL, V14, P279, DOI 10.1016/S0955-0674(02)00331-9; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Szerlong H, 2003, EMBO J, V22, P3175, DOI 10.1093/emboj/cdg296; van Holde KE., 1989, SPRINGER SERIES MOL; VANHOLDE KE, 1995, CHROMATIN STRUCTURE; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003	39	952	998	5	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2004	303	5656					343	348		10.1126/science.1090701	http://dx.doi.org/10.1126/science.1090701			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14645854	Green Published			2022-12-28	WOS:000188111800035
J	Wilson, RI; Turner, GC; Laurent, G				Wilson, RI; Turner, GC; Laurent, G			Transformation of olfactory representations in the Drosophila antennal lobe	SCIENCE			English	Article							PRESYNAPTIC INHIBITION; FLY BRAIN; NEURONS; MELANOGASTER; MECHANISMS; BULB; MAP; TRANSMISSION; GLOMERULI; REVEALS	Molecular genetics has revealed a precise stereotypy in the projection of primary olfactory sensory neurons onto secondary neurons. A major challenge is to understand how this mapping translates into odor responses in these second-order neurons. We investigated this question in Drosophila using whole-cell recordings in vivo. We observe that monomolecular odors generally elicit responses in large ensembles of antennal lobe neurons. Comparison of odor-evoked activity from afferents and postsynaptic neurons in the same glomerulus revealed that second-order neurons display broader tuning and more complex responses than their primary afferents. This indicates a major transformation of odor representations, implicating lateral interactions within the antennal lobe.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Laurent, G (corresponding author), CALTECH, Div Biol, 139-74, Pasadena, CA 91125 USA.		Wilson, Rachel/E-2227-2012; Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X; Turner, Glenn/0000-0002-5341-2784; Wilson, Rachel/0000-0001-8573-9266				Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; Christensen TA, 2002, CURR OPIN NEUROBIOL, V12, P393, DOI 10.1016/S0959-4388(02)00336-7; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Goldberg F, 1999, J PHYSIOL-LONDON, V514, P759, DOI 10.1111/j.1469-7793.1999.759ad.x; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; Korsching S, 2002, CURR OPIN NEUROBIOL, V12, P387, DOI 10.1016/S0959-4388(02)00348-3; Laissue PP, 1999, J COMP NEUROL, V405, P543; Laurent G, 1996, J NEUROSCI, V16, P3837; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Oertner TG, 2001, J NEUROPHYSIOL, V85, P439, DOI 10.1152/jn.2001.85.1.439; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; STOCKER RF, 1983, CELL TISSUE RES, V232, P237, DOI 10.1007/BF00213783; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Willmore B, 2001, NETWORK-COMP NEURAL, V12, P255, DOI 10.1088/0954-898X/12/3/302; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	28	391	395	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2004	303	5656					366	370		10.1126/science.1090782	http://dx.doi.org/10.1126/science.1090782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14684826				2022-12-28	WOS:000188111800042
J	Hanley, JA; Turner, E; Bellera, C; Teltsch, D				Hanley, JA; Turner, E; Bellera, C; Teltsch, D			How long did their hearts go on? A Titanic study	BRITISH MEDICAL JOURNAL			English	Article							JAZZ MUSICIANS		McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; McGill Univ, Dept Math & Stat, Montreal, PQ H3A 1A2, Canada	McGill University; McGill University	Hanley, JA (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave W, Montreal, PQ H3A 1A2, Canada.			Bellera, Carine/0000-0001-7926-4671				[Anonymous], ENCY TITANICA; *NAT CTR HLTH STAT, 2002, NAT VITAL STAT REPOR, V51, P26; ROTHMAN KJ, 1992, AM J PUBLIC HEALTH, V82, P761, DOI 10.2105/AJPH.82.5.761; SPENCER FJ, 1991, AM J PUBLIC HEALTH, V81, P804, DOI 10.2105/AJPH.81.6.804-a; *U CA BERK M PLANC, HUM MORT DAT LIF TAB	5	0	0	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1457	1458		10.1136/bmj.327.7429.1457	http://dx.doi.org/10.1136/bmj.327.7429.1457			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	757LA	14684648	Green Published, Green Accepted			2022-12-28	WOS:000187562700019
J	Suvarna, R; Pirmohamed, M; Henderson, L				Suvarna, R; Pirmohamed, M; Henderson, L			Drug point - Possible interaction between warfarin and cranberry juice	BRITISH MEDICAL JOURNAL			English	Article									Med & Healthcare Prod Regulatory Agcy, Pharmacovigilance Risk Assessement Unit, London SW8 5NQ, England; Univ Liverpool, Dept Pharmacol, Liverpool L69 3GE, Merseyside, England	The Medicines & Healthcare Products Regulatory Agency; University of Liverpool	Suvarna, R (corresponding author), Med & Healthcare Prod Regulatory Agcy, Pharmacovigilance Risk Assessement Unit, London SW8 5NQ, England.		Pirmohamed, Munir/H-6004-2011	Pirmohamed, Munir/0000-0002-7534-7266				Hodek P, 2002, CHEM-BIOL INTERACT, V139, P1, DOI 10.1016/S0009-2797(01)00285-X; Kontiokari T, 2001, BMJ-BRIT MED J, V322, P1571, DOI 10.1136/bmj.322.7302.1571; RETTIE AE, 1992, CHEM RES TOXICOL, V5, P54, DOI 10.1021/tx00025a009	3	79	85	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1454	1454		10.1136/bmj.327.7429.1454	http://dx.doi.org/10.1136/bmj.327.7429.1454			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684645	Green Published			2022-12-28	WOS:000187562700016
J	Whitelaw, CA; Barbazuk, WB; Pertea, G; Chan, AP; Cheung, F; Lee, Y; Zheng, L; van Heeringen, S; Karamycheva, S; Bennetzen, JL; SanMiguel, P; Lakey, N; Bedell, J; Yuan, Y; Budiman, MA; Resnick, A; Van Aken, S; Utterback, T; Riedmuller, S; Williams, M; Feldblyum, T; Schubert, K; Beachy, R; Fraser, CM; Quackenbush, J				Whitelaw, CA; Barbazuk, WB; Pertea, G; Chan, AP; Cheung, F; Lee, Y; Zheng, L; van Heeringen, S; Karamycheva, S; Bennetzen, JL; SanMiguel, P; Lakey, N; Bedell, J; Yuan, Y; Budiman, MA; Resnick, A; Van Aken, S; Utterback, T; Riedmuller, S; Williams, M; Feldblyum, T; Schubert, K; Beachy, R; Fraser, CM; Quackenbush, J			Enrichment of gene-coding sequences in maize by genome filtration	SCIENCE			English	Article							DNA; ORGANIZATION; ELEMENTS	Approximately 80% of the maize genome comprises highly repetitive sequences interspersed with single-copy, gene-rich sequences, and standard genome sequencing strategies are not readily adaptable to this type of genome. Methodologies that enrich for genic sequences might more rapidly generate useful results from complex genomes. Equivalent numbers of clones from maize selected by techniques called methylation filtering and High C(0)t selection were sequenced to generate similar to 200,000 reads ( approximately 132 megabases), which were assembled into contigs. Combination of the two techniques resulted in a sixfold reduction in the effective genome size and a fourfold increase in the gene identification rate in comparison to a nonenriched library.	Inst Genom Res TIGR, Rockville, MD 20850 USA; Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; Univ Georgia, Dept Genet, Athens, GA 30602 USA; Purdue Univ, Purdue Genom Core Facil, W Lafayette, IN 47907 USA; Orion Genom, St Louis, MO 63108 USA; J Craig Venter Sci fdn Joint Technol Ctr, Rockville, MD 20850 USA	J. Craig Venter Institute; Donald Danforth Plant Science Center; University System of Georgia; University of Georgia; Purdue University System; Purdue University; Purdue University West Lafayette Campus; J. Craig Venter Institute	Barbazuk, WB (corresponding author), Inst Genom Res TIGR, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	BBarbazuk@danforthcenter.org; Johnq@tigr.org	van Heeringen, Simon/H-4937-2012; Jones, Cathy/A-7135-2011; Whitelaw, Catherine Ann/AAD-3716-2021; van Heeringen, Simon/Q-8530-2017; SanMiguel, Phillip J/I-2196-2015	Jones, Cathy/0000-0003-2844-2161; van Heeringen, Simon/0000-0002-0411-3219; SanMiguel, Phillip J/0000-0002-3742-9527; Barbazuk, William/0000-0002-0909-4563; Quackenbush, John/0000-0002-2702-5879; Fraser, Claire/0000-0003-1462-2428; Chan, Agnes/0000-0003-2373-9580				Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Bennetzen JL, 2002, GENETICA, V115, P29, DOI 10.1023/A:1016015913350; BENNETZEN JL, 1994, GENOME, V37, P565, DOI 10.1139/g94-081; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; BRITTEN RJ, 1976, P NATL ACAD SCI USA, V73, P415, DOI 10.1073/pnas.73.2.415; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; FREELING M, 1984, ANNU REV PLANT PHYS, V35, P277; GISH WR, 2003, WU BLAST 2 0; HAKE S, 1980, CHROMOSOMA, V79, P251, DOI 10.1007/BF00327318; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; LANDER E S, 1988, Genomics, V2, P231; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; SPRINGER PS, 1994, P NATL ACAD SCI USA, V91, P863, DOI 10.1073/pnas.91.3.863; YUAN Y, 2003, PLANT J, V33, P1	18	166	195	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2118	2120		10.1126/science.1090047	http://dx.doi.org/10.1126/science.1090047			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684821				2022-12-28	WOS:000187385200043
J	Dennis, LK; Freeman, LEB; VanBeek, MJ				Dennis, LK; Freeman, LEB; VanBeek, MJ			Sunscreen use and the risk for melanoma: A quantitative review	ANNALS OF INTERNAL MEDICINE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; SUN EXPOSURE; SKIN-CANCER; METAANALYSIS; CHILDHOOD; SUNLIGHT; EPIDEMIOLOGY; ADOLESCENTS; QUEENSLAND; REDUCTION	Background: Originally developed to protect against sunburn, sunscreen has been assumed to prevent skin cancer. However, conflicting reports include claims that sunscreen increases risk for melanoma. Objective: To examine the strength and consistency of associations between melanoma and sunscreen use in the published literature. Data Sources: A comprehensive MEDLINE search of articles published from 1966 to 2003 that reported information on sunscreen use and melanoma in humans. Study Selection: Analytic studies reporting data on sunscreen use before diagnosis of melanoma. Data Extraction: Two independent reviewers extracted data. Inconsistencies were rereviewed until agreement was achieved. When necessary, a third party resolved discrepancies. Data Synthesis: Odds ratios were pooled across studies by using standard meta-analytic techniques. Pooled odds ratios for ever use among 18 heterogeneous studies did not support an association between melanoma and sunscreen use. Variation among odds ratios was explained by studies that did not adjust for confounding effects of sun sensitivity. The lack of a dose-response effect with frequency of use (never, sometimes, or always) or years of use provided further evidence of a null association. Conclusions: No association was seen between melanoma and sunscreen use. Failure to control for confounding factors may explain previous reports of positive associations linking melanoma to sunscreen use. In addition, it may take decades to detect a protective association between melanoma and use of the newer formulations of sunscreens.	Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Iowa City, IA USA	University of Iowa; University of Iowa	Dennis, LK (corresponding author), Univ Iowa, Coll Publ Hlth, Dept Epidemiol, 200 Hawkins Dr,C21H-GH, Iowa City, IA 52242 USA.	leslie-dennis@uiowa.edu	Freeman, Laura E. Beane/C-4468-2015	Freeman, Laura E. Beane/0000-0003-1294-4124; Van Beek, Marta/0000-0003-2467-5830	NCI NIH HHS [1R03CA88834-01, R03 CA088834-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R03CA088834] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1978, FED REGISTER, V43, P38206; ARMSTRONG BK, 1988, J DERMATOL SURG ONC, V14, P835, DOI 10.1111/j.1524-4725.1988.tb03588.x; Armstrong BK, 1992, MONOGRAPHS EPIDEMIOL, V21; Arranz JE, 1999, MELANOMA RES, V9, P199, DOI 10.1097/00008390-199904000-00013; Autier P, 1997, MELANOMA RES, V7, pS115; Autier P, 1999, JNCI-J NATL CANCER I, V91, P1304, DOI 10.1093/jnci/91.15.1304; AUTIER P, 1995, INT J CANCER, V61, P749, DOI 10.1002/ijc.2910610602; Autier P, 1998, INT J CANCER, V77, P533, DOI 10.1002/(SICI)1097-0215(19980812)77:4<533::AID-IJC10>3.0.CO;2-7; Bakos L, 2002, INT J DERMATOL, V41, P557, DOI 10.1046/j.1365-4362.2002.01412.x; BANKS BA, 1992, PEDIATRICS, V89, P40; Bastuji-Garin S, 2002, BRIT J DERMATOL, V146, P24, DOI 10.1046/j.1365-2133.146.s61.9.x; BEITNER H, 1990, BRIT J DERMATOL, V122, P43, DOI 10.1111/j.1365-2133.1990.tb08238.x; BISSONNETTE R, 1997, SKIN THERAPY LETT, V2, P5; CRESS RD, 1995, EPIDEMIOLOGY, V6, P538, DOI 10.1097/00001648-199509000-00013; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DOBAK J, 1992, INT J DERMATOL, V31, P544, DOI 10.1111/j.1365-4362.1992.tb02714.x; Dubin N, 1986, Recent Results Cancer Res, V102, P56; Fisher J, 1996, AM J EPIDEMIOL, V143, P34; FREEMAN LEB, 2003, ARSENIC EXPOSURE ART; Garland C F, 1993, Ann Epidemiol, V3, P103; Geller AC, 2002, PEDIATRICS, V109, P1009, DOI 10.1542/peds.109.6.1009; GRAHAM S, 1985, AM J EPIDEMIOL, V122, P606, DOI 10.1093/oxfordjournals.aje.a114140; Green A, 1986, Recent Results Cancer Res, V102, P76; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; HERZFELD PM, 1993, CANCER DETECT PREV, V17, P601; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P923, DOI 10.1093/oxfordjournals.aje.a117359; Holman C D, 1986, Recent Results Cancer Res, V102, P18; HOLMAN CDJ, 1986, J NATL CANCER I, V76, P403; HORNROSS PL, 1991, CANCER CAUSE CONTROL, V2, P299, DOI 10.1007/BF00051669; Huncharek M, 2002, AM J PUBLIC HEALTH, V92, P1173, DOI 10.2105/AJPH.92.7.1173; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; KIM HJ, 2001, ADOLESC MED, V12, P181; KLEPP O, 1979, INT J CANCER, V23, P482, DOI 10.1002/ijc.2910230407; MOAN J, 1994, J PHOTOCH PHOTOBIO B, V24, P201, DOI 10.1016/1011-1344(94)07022-9; Naldi L, 2000, INT J CANCER, V86, P879, DOI 10.1002/(SICI)1097-0215(20000615)86:6<879::AID-IJC19>3.0.CO;2-N; Naylor MF, 1997, ARCH DERMATOL, V133, P373, DOI 10.1001/archderm.133.3.373; OSTERLIND A, 1988, INT J CANCER, V42, P319, DOI 10.1002/ijc.2910420303; Pruim B, 1999, Australas J Dermatol, V40, P14, DOI 10.1046/j.1440-0960.1999.00309.x; Ries LA, 2002, SEER CANC STAT REV 1; Rigel DS, 2000, ARCH DERMATOL, V136, P1447, DOI 10.1001/archderm.136.12.1447; ROBERTS LK, 1995, MELANOMA RES, V5, P377, DOI 10.1097/00008390-199510000-00012; Rodenas JM, 1996, CANCER CAUSE CONTROL, V7, P275, DOI 10.1007/BF00051303; SETLOW RB, 1989, P NATL ACAD SCI USA, V86, P8922, DOI 10.1073/pnas.86.22.8922; STENBERG C, 1985, ARCH DERMATOL, V121, P1400, DOI 10.1001/archderm.121.11.1400; STERN RS, 1986, ARCH DERMATOL, V122, P537, DOI 10.1001/archderm.122.5.537; Stokes R, 1997, PHOTODERMATOL PHOTO, V13, P186, DOI 10.1111/j.1600-0781.1997.tb00227.x; Weinstock MA, 1999, J INVEST DERM SYMP P, V4, P97, DOI 10.1038/sj.jidsp.; Westerdahl J, 2000, INT J CANCER, V87, P145, DOI 10.1002/1097-0215(20000701)87:1<145::AID-IJC22>3.0.CO;2-3; WESTERDAHL J, 1995, MELANOMA RES, V5, P59, DOI 10.1097/00008390-199502000-00007; Whiteman DC, 1997, INT J CANCER, V70, P26; Wolf P, 1998, MELANOMA RES, V8, P370, DOI 10.1097/00008390-199808000-00012; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Youl P, 2002, INT J CANCER, V98, P92, DOI 10.1002/ijc.10117	54	139	143	2	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2003	139	12					966	978		10.7326/0003-4819-139-12-200312160-00006	http://dx.doi.org/10.7326/0003-4819-139-12-200312160-00006			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756AG	14678916				2022-12-28	WOS:000187443200002
J	Goldman, AP; Cassidy, J; de Leval, M; Haynes, S; Brown, K; Whitmore, P; Cohen, G; Tsang, V; Elliott, M; Davison, A; Hamilton, L; Bolton, D; Wray, J; Hasan, A; Radley-Smith, R; Macrae, D; Smith, J				Goldman, AP; Cassidy, J; de Leval, M; Haynes, S; Brown, K; Whitmore, P; Cohen, G; Tsang, V; Elliott, M; Davison, A; Hamilton, L; Bolton, D; Wray, J; Hasan, A; Radley-Smith, R; Macrae, D; Smith, J			The waiting game: bridging to paediatric heart transplantation	LANCET			English	Article							MECHANICAL CIRCULATORY SUPPORT; VENTRICULAR ASSIST DEVICE; CLINICAL-EXPERIENCE; CHILDREN; CARDIOMYOPATHY; INFANTS; SYSTEM; VAD	Background Although mechanical circulatory support might not increase the number of adults surviving to transplantation, because of the shortage of donor organs, the situation might be different for children. Our aim was to assess the effect of mechanical assist devices to bridge children with end-stage cardiomyopathy to heart transplantation. Methods A 5-year retrospective review was undertaken with data from the UK paediatric transplant programme and from bridging to transplant done at two paediatric transplant centres in the UK. Findings Between Jan 1, 1998 and Dec 31, 2002, 22 children with end-stage cardiomyopathy, median age 5.7 years (range 1.2-17), were supported by a mechanical assist device as a bridge to first heart transplantation, with a 77% survival rate to hospital discharge. Nine were supported by a paracorporeal ventricular assist device, six received transplantation, five survived to discharge (55%), with one late death. 13 were supported by extra-corporeal membrane oxygenation, and 12 were transplanted and survived to discharge (92%) with one late death. With urgent listing, the median waiting time for a heart was 7.5 days (range 1.5-22 days). The correlation between the proportion of patients bridged to transplantation and the proportion of patients dying while on the transplant waiting list was r=-0.93, p=0.02. Interpretation Our findings lend support to the hypothesis that a national mechanical assist programme to bridge children to transplantation can minimise the number dying while on the heart transplant waiting list. In the context of urgent listing and a short waiting time, extra-corporeal membrane oxygenation seems to provide the safest form of support.	Great Ormond St Hosp Children, London WC1N 3JY, England; Freeman Rd Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; Royal Brompton & Harefield NHS Trust, London SW3 6NP, England; Childrens Hosp & Reg Med Ctr, Ctr Heart, Seattle, WA 98115 USA	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Newcastle Freeman Hospital; Newcastle University - UK; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Seattle Children's Hospital	Goldman, AP (corresponding author), Great Ormond St Hosp Children, Great Ormond St, London WC1N 3JY, England.		Macrae, Duncan/AAC-9564-2020	Brown, Katherine/0000-0002-0729-4959; SixNajn, Takashi/0000-0001-7521-1126; Macrae, Duncan/0000-0002-7158-6585; Wray, Jo/0000-0002-4769-1211				Daily BB, 1996, ANN THORAC SURG, V61, P437, DOI 10.1016/0003-4975(95)00991-4; Deng MC, 2000, BRIT MED J, V321, P540, DOI 10.1136/bmj.321.7260.540; DUNCAN B, 2002, J THORAC CARDIOV SUR, V117, P529; Duncan BW, 2001, J THORAC CARDIOV SUR, V122, P440, DOI 10.1067/mtc.2001.115243; Frazier OH, 2002, CIRCULATION, V105, P2855, DOI 10.1161/01.CIR.0000018167.47314.AF; Hetzer R, 1998, ANN THORAC SURG, V66, P1498, DOI 10.1016/S0003-4975(98)00914-X; Holman WL, 2002, ANN THORAC SURG, V73, P1489, DOI 10.1016/S0003-4975(02)03502-6; Hosenpud JD, 2000, J HEART LUNG TRANSPL, V19, P909, DOI 10.1016/S1053-2498(00)00138-8; Ibrahim AE, 2000, ANN THORAC SURG, V69, P186, DOI 10.1016/S0003-4975(99)01194-7; Kirshbom PM, 2002, J THORAC CARDIOV SUR, V123, P130, DOI 10.1067/mtc.2002.118504; Konertz W, 1997, ANN THORAC SURG, V63, P1138, DOI 10.1016/S0003-4975(97)00063-5; Levi D, 2002, J HEART LUNG TRANSPL, V21, P760, DOI 10.1016/S1053-2498(02)00386-8; Nield LE, 2000, CARDIOL YOUNG, V10, P358; Reinhartz O, 2001, J HEART LUNG TRANSPL, V20, P439, DOI 10.1016/S1053-2498(00)00236-9; Reinhartz O, 2002, ASAIO J, V48, P455, DOI 10.1097/00002480-200209000-00002	15	72	75	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					1967	1970		10.1016/S0140-6736(03)15015-5	http://dx.doi.org/10.1016/S0140-6736(03)15015-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683656				2022-12-28	WOS:000187210700009
J	Clapham, DE				Clapham, DE			Symmetry, selectivity, and the 2003 Nobel Prize	CELL			English	Editorial Material							INTEGRAL MEMBRANE-PROTEIN; DEPENDENT K+ CHANNEL; CELL CHIP28 PROTEIN; X-RAY-STRUCTURE; POTASSIUM CHANNEL; WATER CHANNELS; MOLECULAR-BASIS; BETA-SUBUNIT; CONDUCTION; MECHANISM		Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Clapham, DE (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp,Dept Neurobiol, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; 				AGRE P, 1987, J BIOL CHEM, V262, P17497; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Fujiyoshi Y, 2002, CURR OPIN STRUC BIOL, V12, P509, DOI 10.1016/S0959-440X(02)00355-X; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P449, DOI 10.1113/jphysiol.1952.sp004717; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P473, DOI 10.1113/jphysiol.1952.sp004718; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Pomes R, 2002, BIOPHYS J, V82, P2304, DOI 10.1016/S0006-3495(02)75576-8; PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385; PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; ZEIDEL ML, 1994, BIOCHEMISTRY-US, V33, P1606, DOI 10.1021/bi00172a042; ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	33	8	10	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2003	115	6					641	646		10.1016/S0092-8674(03)00980-2	http://dx.doi.org/10.1016/S0092-8674(03)00980-2			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675526	Bronze			2022-12-28	WOS:000187366100001
J	Ben-Shem, A; Frolow, F; Nelson, N				Ben-Shem, A; Frolow, F; Nelson, N			Crystal structure of plant photosystem I	NATURE			English	Article							LIGHT-HARVESTING COMPLEX; FAST-ELECTRON TRANSFER; CHLAMYDOMONAS-REINHARDTII; ARABIDOPSIS-THALIANA; ANGSTROM RESOLUTION; THYLAKOID MEMBRANES; CYTOCHROME C(6); IRON-DEFICIENCY; ENERGY-TRANSFER; ANTENNA RING	Oxygenic photosynthesis is the principal producer of both oxygen and organic matter on Earth. The conversion of sunlight into chemical energy is driven by two multisubunit membrane protein complexes named photosystem I and II. We determined the crystal structure of the complete photosystem I ( PSI) from a higher plant ( Pisum sativum var. alaska) to 4.4 Angstrom resolution. Its intricate structure shows 12 core subunits, 4 different light- harvesting membrane proteins ( LHCI) assembled in a half- moon shape on one side of the core, 45 transmembrane helices, 167 chlorophylls, 3 Fe - S clusters and 2 phylloquinones. About 20 chlorophylls are positioned in strategic locations in the cleft between LHCI and the core. This structure provides a framework for exploration not only of energy and electron transfer but also of the evolutionary forces that shaped the photosynthetic apparatus of terrestrial plants after the divergence of chloroplasts from marine cyanobacteria one billion years ago.	Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Nelson, N (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel.	nelson@post.tau.ac.il	Frolow, Felix/A-1760-2013	Nelson, Nathan/0000-0003-3588-7265; Ben-Shem, Adam/0000-0003-0297-8662				Bailey S, 2001, PLANTA, V213, P794, DOI 10.1007/s004250100556; Barber J, 2002, CURR OPIN STRUC BIOL, V12, P523, DOI 10.1016/S0959-440X(02)00357-3; Ben-Shem A, 2003, ACTA CRYSTALLOGR D, V59, P1824, DOI 10.1107/S0907444903016056; BENGIS C, 1977, J BIOL CHEM, V252, P4564; Bibby TS, 2001, NATURE, V412, P743, DOI 10.1038/35089098; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; CHITNIS PR, 1991, J BIOL CHEM, V266, P20146; Chitnis PR, 2001, ANNU REV PLANT PHYS, V52, P593, DOI 10.1146/annurev.arplant.52.1.593; Cramer WA, 1996, ANNU REV PLANT PHYS, V47, P477, DOI 10.1146/annurev.arplant.47.1.477; Croce R, 1998, BIOCHEMISTRY-US, V37, P17355, DOI 10.1021/bi9813227; Croce R, 2002, BBA-BIOENERGETICS, V1556, P29, DOI 10.1016/S0005-2728(02)00304-3; Durnford DG, 1999, J MOL EVOL, V48, P59, DOI 10.1007/PL00006445; Ganeteg U, 2001, PLANT PHYSIOL, V127, P150, DOI 10.1104/pp.127.1.150; Herrmann RG, 1999, BIOSCIENCE REP, V19, P355, DOI 10.1023/A:1020251903707; Hippler M, 1998, P NATL ACAD SCI USA, V95, P7339, DOI 10.1073/pnas.95.13.7339; Hippler M, 1996, EMBO J, V15, P6374, DOI 10.1002/j.1460-2075.1996.tb01028.x; Ihalainen JA, 2002, BIOPHYS J, V83, P2190, DOI 10.1016/S0006-3495(02)73979-9; Jansson S, 1996, PLANT PHYSIOL, V112, P409, DOI 10.1104/pp.112.1.409; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jennings RC, 2003, BBA-BIOENERGETICS, V1557, P91, DOI 10.1016/S0005-2728(02)00399-7; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Junge W, 1999, P NATL ACAD SCI USA, V96, P4735, DOI 10.1073/pnas.96.9.4735; Kargul J, 2003, J BIOL CHEM, V278, P16135, DOI 10.1074/jbc.M300262200; Knoetzel H, 2002, FEBS LETT, V510, P145, DOI 10.1016/S0014-5793(01)03253-7; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lunde C, 2000, NATURE, V408, P613, DOI 10.1038/35046121; Melkozernov AN, 2003, BIOCHEMISTRY-US, V42, P3893, DOI 10.1021/bi026987u; Morosinotto T, 2002, J BIOL CHEM, V277, P36253, DOI 10.1074/jbc.M205062200; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Nelson N, 2002, PHOTOSYNTH RES, V73, P193, DOI 10.1023/A:1020403231100; Nield J, 2003, BIOCHEMISTRY-US, V42, P3180, DOI 10.1021/bi026933k; Raymond J, 2002, SCIENCE, V298, P1616, DOI 10.1126/science.1075558; Rivadossi A, 1999, PHOTOSYNTH RES, V60, P209, DOI 10.1023/A:1006236829711; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Schmid VHR, 2002, BIOCHEMISTRY-US, V41, P9126, DOI 10.1021/bi016042x; Schmid VHR, 2002, J BIOL CHEM, V277, P37307, DOI 10.1074/jbc.M205889200; Sommer F, 2002, J BIOL CHEM, V277, P6573, DOI 10.1074/jbc.M110633200; TRISSL HW, 1993, TRENDS BIOCHEM SCI, V18, P415, DOI 10.1016/0968-0004(93)90136-B; Xiong J, 2002, ANNU REV PLANT BIOL, V53, P503, DOI 10.1146/annurev.arplant.53.100301.135212; Xue YF, 1998, PROTEIN SCI, V7, P2099, DOI 10.1002/pro.5560071006	40	628	682	6	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					630	635		10.1038/nature02200	http://dx.doi.org/10.1038/nature02200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668855				2022-12-28	WOS:000187132800032
J	Moore, P; Clayton, J				Moore, P; Clayton, J			To affinity and beyond	NATURE			English	Article																			0	6	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					725	+		10.1038/426725a	http://dx.doi.org/10.1038/426725a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668881	Bronze			2022-12-28	WOS:000187132800058
J	Warren, HS; Gonzalez, RG; Hedley-Whyte, ET; Agus, M; Smith, EE; Jones, RM; Tian, D; Tan, WH				Warren, HS; Gonzalez, RG; Hedley-Whyte, ET; Agus, M; Smith, EE; Jones, RM; Tian, D; Tan, WH			Case 38-2003: A 12-year-old girl with fever and coma - Meningoencephalitis and sepsis due to Neisseria meningitidis infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MENINGOCOCCAL INFECTIONS; SEPTIC SHOCK; PROTEIN-C; THERAPY		Massachusetts Gen Hosp, Serv Pediat, Pediat Infect Dis Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Neuroradiol Div, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Div Neuropathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Pediat, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Warren, HS (corresponding author), Massachusetts Gen Hosp, Serv Pediat, Pediat Infect Dis Unit, Boston, MA 02114 USA.		Smith, Eric E/C-5443-2012; Hedley-Whyte, E Tessa/AAJ-9975-2021	Smith, Eric E/0000-0003-3956-1668; Hedley-Whyte, E Tessa/0000-0002-1687-8905				Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; BANKS HS, 1948, LANCET, V255, P635; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; DEWALS P, 1981, J INFECTION, V3, P53, DOI 10.1016/S0163-4453(81)80009-6; Faust SN, 2001, NEW ENGL J MED, V345, P408, DOI 10.1056/NEJM200108093450603; HARDMAN JM, 1968, MIL MED, V133, P951, DOI 10.1093/milmed/133.12.951; Harris P, 2001, NEW ENGL J MED, V345, P841; HORWITZ SJ, 1980, ANN NEUROL, V7, P524, DOI 10.1002/ana.410070605; LEVIN S, 1966, ANN INTERN MED, V64, P1049, DOI 10.7326/0003-4819-64-5-1049; MOORE PS, 1990, JAMA-J AM MED ASSOC, V264, P1271, DOI 10.1001/jama.264.10.1271; Offit PA, 2003, NEW ENGL J MED, V349, P2353, DOI 10.1056/NEJMsb035678; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Sparling PF, 2002, AM J MED, V112, P72, DOI 10.1016/S0002-9343(01)01072-5; STIEHM ER, 1966, J PEDIATR-US, V68, P457, DOI 10.1016/S0022-3476(66)80250-0; Thomas HM, 1943, J AMER MED ASSOC, V123, P264, DOI 10.1001/jama.1943.02840400012004; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; WOLF RE, 1968, AM J MED, V44, P243, DOI 10.1016/0002-9343(68)90156-3	17	8	8	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					2341	2349		10.1056/NEJMcpc030033	http://dx.doi.org/10.1056/NEJMcpc030033			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668461				2022-12-28	WOS:000187125000011
J	Rosenlof, KH				Rosenlof, KH			Atmospheric science - How water enters the stratosphere	SCIENCE			English	Editorial Material							VAPOR		NOAA, Aeron Lab, Boulder, CO 80305 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Rosenlof, KH (corresponding author), NOAA, Aeron Lab, Boulder, CO 80305 USA.		Rosenlof, Karen H/B-5652-2008	Rosenlof, Karen H/0000-0002-0903-8270				BREWER AW, 1949, Q J ROY METEOR SOC, V75, P351, DOI 10.1002/qj.49707532603; KAYE JA, 1990, J ATMOS CHEM, V10, P39, DOI 10.1007/BF01980037; KUANG ZM, 2003, GEOPHYS RES LETT, V30; MOTE PW, 1995, GEOPHYS RES LETT, V22, P1093, DOI 10.1029/95GL01234; NEWELL RE, 1982, J ATMOS SCI, V38, P2789; Oltmans SJ, 2000, GEOPHYS RES LETT, V27, P3453, DOI 10.1029/2000GL012133; Sherwood SC, 2000, GEOPHYS RES LETT, V27, P677, DOI 10.1029/1999GL010868; SMITH RB, 1992, J ATMOS SCI, V49, P2041, DOI 10.1175/1520-0469(1992)049<2041:DINAST>2.0.CO;2; Webster CR, 2003, SCIENCE, V302, P1742, DOI 10.1126/science.1089496; Zhou XL, 2001, J CLIMATE, V14, P1823, DOI 10.1175/1520-0442(2001)014<1823:TCPTCD>2.0.CO;2	10	49	54	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1691	1692		10.1126/science.1092703	http://dx.doi.org/10.1126/science.1092703			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657481				2022-12-28	WOS:000186970100028
J	Renault, L; Guibert, B; Cherfils, J				Renault, L; Guibert, B; Cherfils, J			Structural snapshots of the mechanism and inhibition of a guanine nucleotide exchange factor	NATURE			English	Article							ADP-RIBOSYLATION FACTOR-1; BREFELDIN-A; SEC7 DOMAIN; ARF; PROTEIN; BINDING; RAS; FAMILY; GDP; ACTIVATION	Small GTP-binding (G) proteins are activated by GDP/GTP nucleotide exchange stimulated by guanine nucleotide exchange factors ( GEFs). Nucleotide dissociation from small G protein - GEF complexes involves transient GDP-bound intermediates whose structures have never been described. In the case of Arf proteins, small G proteins that regulate membrane traffic in eukaryotic cells, such intermediates can be trapped either by the natural inhibitor brefeldin A or by charge reversal at the catalytic glutamate of the Sec7 domain of their GEFs. Here we report the crystal structures of these intermediates that show that membrane recruitment of Arf and nucleotide dissociation are separate reactions stimulated by Sec7. The reactions proceed through sequential rotations of the Arf.GDP core towards the Sec7 catalytic site, and are blocked by interfacial binding of brefeldin A and unproductive stabilization of GDP by charge reversal. The structural characteristics of the reaction and its modes of inhibition reveal unexplored ways in which to inhibit the activation of small G proteins.	CNRS, UPR 9063, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Cherfils, J (corresponding author), CNRS, UPR 9063, Lab Enzymol & Biochim Struct, Ave Terrasse, F-91198 Gif Sur Yvette, France.	cherfils@lebs.cnrs-gif.fr		RENAULT, Louis/0000-0003-1722-074X				AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Baumgartner F, 2001, MOL MICROBIOL, V41, P1151, DOI 10.1046/j.1365-2958.2001.02572.x; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Beraud-Dufour S, 1999, J BIOL CHEM, V274, P37629, DOI 10.1074/jbc.274.53.37629; Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Cherfils J, 1998, NATURE, V392, P101, DOI 10.1038/32210; Cherfils J, 2001, FEBS LETT, V507, P280, DOI 10.1016/S0014-5793(01)02970-2; Choi Jai-Pil, 1996, EUROPEAN J POLITICAL, V12, P273, DOI DOI 10.1016/0176-2680(95)00017-8; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; Cox AD, 2002, CANCER BIOL THER, V1, P599, DOI 10.4161/cbt.306; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Goody RS, 2002, EUR BIOPHYS J BIOPHY, V31, P268, DOI 10.1007/s00249-002-0225-3; HELMS JB, 1992, NATURE, V360, P352, DOI 10.1038/360352a0; Jackson C L, 2000, Subcell Biochem, V34, P233; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P12543, DOI 10.1021/bi00039a008; Lenzen C, 1998, BIOCHEMISTRY-US, V37, P7420, DOI 10.1021/bi972621j; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Mansour SJ, 1999, P NATL ACAD SCI USA, V96, P7968, DOI 10.1073/pnas.96.14.7968; Mayer G, 2001, P NATL ACAD SCI USA, V98, P4961, DOI 10.1073/pnas.091100698; McCormick F, 2000, CURR OPIN BIOTECH, V11, P593, DOI 10.1016/S0958-1669(00)00149-X; Menetrey J, 2000, NAT STRUCT BIOL, V7, P466; Nie ZZ, 2003, CURR OPIN CELL BIOL, V15, P396, DOI 10.1016/S0955-0674(03)00071-1; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; PASQUALATO S, IN PRESS ARF BOOK, pCH3; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Renault L, 2002, BIOCHEMISTRY-US, V41, P3605, DOI 10.1021/bi012123h; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Robineau S, 2000, P NATL ACAD SCI USA, V97, P9913, DOI 10.1073/pnas.170290597; Sata M, 1999, P NATL ACAD SCI USA, V96, P2752, DOI 10.1073/pnas.96.6.2752; Schmidt S, 2002, FEBS LETT, V523, P35, DOI 10.1016/S0014-5793(02)02928-9; TORII S, 1995, J BIOL CHEM, V270, P11574, DOI 10.1074/jbc.270.19.11574; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WEBER HP, 1971, HELV CHIM ACTA, V54, P2763, DOI 10.1002/hlca.19710540839; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Wurtele M, 2003, EMBO J, V22, P987, DOI 10.1093/emboj/cdg104; Zhu JW, 2000, BIOORGAN MED CHEM, V8, P455, DOI 10.1016/S0968-0896(99)00297-7	45	245	252	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					525	530		10.1038/nature02197	http://dx.doi.org/10.1038/nature02197			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654833				2022-12-28	WOS:000186944300030
J	Mills, EM; Banks, ML; Sprague, JE; Finkel, T				Mills, EM; Banks, ML; Sprague, JE; Finkel, T			Pharmacology: Uncoupling the agony from ecstasy - A mitochondrial protein may mediate a dangerous side-effect of some recreational drugs	NATURE			English	Editorial Material							MDMA		NHLBI, Cardiovasc Branch, NIH, Bethesda, MD 20892 USA; Ohio No Univ, Dept Pharmaceut & Biomed Sci, Ada, OH 45810 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Ohio Northern University	Mills, EM (corresponding author), NHLBI, Cardiovasc Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	j-sprague@onu.edu	Sprague, Jon/AAE-6346-2021; Banks, Matthew L/CAF-1091-2022; Banks, Matthew L/K-4429-2014	Banks, Matthew L/0000-0003-4949-5246; Banks, Matthew L/0000-0003-4949-5246	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005012, ZIAHL005012] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Dar KJ, 1996, INTENS CARE MED, V22, P995; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; GONG DW, 1997, J BIOL CHEM, V272; Green AR, 2003, PHARMACOL REV, V55, P463, DOI 10.1124/pr.55.3.3; Landry MJ, 2002, J PSYCHOACTIVE DRUGS, V34, P163, DOI 10.1080/02791072.2002.10399950; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Sprague JE, 2003, J PHARMACOL EXP THER, V305, P159, DOI 10.1124/jpet.102.044982; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; 1964, NATURE, V204, P387; 2003, PSYCHOPHARMACOLOGY, V166, P202	11	117	118	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2003	426	6965					403	404		10.1038/426403a	http://dx.doi.org/10.1038/426403a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647371				2022-12-28	WOS:000186800800027
J	Kerr, D				Kerr, D			Of Struldbruggs, sugar, and gatekeepers: a tale of our times	BRITISH MEDICAL JOURNAL			English	Article							PEOPLE; CARE; RISK		Royal Bournemouth Hosp, Bournemouth Diabet & Endocrine Ctr, Bournemouth BH7 7DW, Dorset, England		Kerr, D (corresponding author), Royal Bournemouth Hosp, Bournemouth Diabet & Endocrine Ctr, Bournemouth BH7 7DW, Dorset, England.							Armitage M, 2002, CLIN MED, V2, P331, DOI 10.7861/clinmedicine.2-4-331; Basile JN, 2002, BMJ-BRIT MED J, V325, P917, DOI 10.1136/bmj.325.7370.917; Evans JMM, 2002, DIABETIC MED, V19, P685, DOI 10.1046/j.1464-5491.2002.00749.x; GRANKS P, 1992, NEW ENGL J MED, V327, P424; Gregg EW, 2002, BRIT MED J, V325, P916, DOI 10.1136/bmj.325.7370.916; GROVES JE, 1978, NEW ENGL J MED, V298, P883, DOI 10.1056/NEJM197804202981605; Hampton JR, 2002, AGE AGEING, V31, P3, DOI 10.1093/ageing/31.1.3; McGouran RCM, 2002, CLIN MED, V2, P43, DOI 10.7861/clinmedicine.2-1-43; Schwartz AV, 2002, DIABETES CARE, V25, P1749, DOI 10.2337/diacare.25.10.1749; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SWIFT J, GULLIVERS TRAVELS 3, pCH10; Trewby PN, 2002, CLIN MED, V2, P527, DOI 10.7861/clinmedicine.2-6-527; WILSON AN, 2002, DAILY TELEGRAPH 0127; Winocour PH, 2002, BMJ-BRIT MED J, V324, P1577, DOI 10.1136/bmj.324.7353.1577	14	1	1	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1451	1453		10.1136/bmj.327.7429.1451	http://dx.doi.org/10.1136/bmj.327.7429.1451			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684643	Green Published, Green Submitted			2022-12-28	WOS:000187562700014
J	Szasz, T				Szasz, T			The psychiatric protection order for the "battered mental patient"	BRITISH MEDICAL JOURNAL			English	Article									SUNY Syracuse, Upstate Med Univ, Dept Psychiat, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Szasz, T (corresponding author), 4739 Limberlost Lane, New York, NY 13104 USA.							Menninger K., 1989, B MENNINGER CLIN, V53, P350; SATEL S, 1998, WALL STREET J   0107, P6; Szasz T., 2002, LIBERATION OPPRESSIO; Szasz T.S., 1987, INSANITY IDEA ITS CO; Szasz Thomas S., 2001, PHARMACRACY MED POLI; SZASZ TS, 1982, AM PSYCHOL, V37, P762, DOI 10.1037/0003-066X.37.7.762; THURBER J, 1968, FABLES OUR TIME	7	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1449	1451		10.1136/bmj.327.7429.1449	http://dx.doi.org/10.1136/bmj.327.7429.1449			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	757LA	14684642	Green Published			2022-12-28	WOS:000187562700013
J	Harris, AC; Kamenetsky, VS; White, NC; van Achterbergh, E; Ryan, CG				Harris, AC; Kamenetsky, VS; White, NC; van Achterbergh, E; Ryan, CG			Melt inclusions in veins: Linking magmas and porphyry Cu deposits	SCIENCE			English	Article							FLUID INCLUSIONS; COPPER-DEPOSIT; VAPOR; SYSTEM; BRINE	At a porphyry copper-gold deposit in Bajo de la Alumbrera, Argentina, silicate-melt inclusions coexist with hypersaline liquid- and vapor-rich inclusions in the earliest magmatic-hydrothermal quartz veins. Copper concentrations of the hypersaline liquid and vapor inclusions reached maxima of 10.0 weight % (wt %) and 4.5 wt %, respectively. These unusually copper-rich inclusions are considered to be the most primitive ore fluid found thus far. Their preservation with coexisting melt allows for the direct quanti. cation of important ore-forming processes, including determination of bulk partition coefficients of metals from magma into ore-forming magmatic volatile phases.	Univ Tasmania, Ctr Ore Deposit Res, Hobart, Tas 7001, Australia; Commonwealth Sci & Ind Res Org Explorat & Min, N Ryde, NSW 1670, Australia	University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Harris, AC (corresponding author), Univ Tasmania, Ctr Ore Deposit Res, Private Bag 79, Hobart, Tas 7001, Australia.	A.Harris@utas.edu.au	Kamenetsky, Vadim/K-2200-2019; Kamenetsky, Vadim/CAF-7424-2022; Kamenetsky, Vadim S/B-1019-2008; Ryan, Chris G/A-6032-2011	Kamenetsky, Vadim S/0000-0002-2734-8790; Ryan, Chris G/0000-0003-2891-3912				Beane R.E., 1981, SOC EC GEOL US, V75, P235; BODNAR RJ, 1985, GEOCHIM COSMOCHIM AC, V49, P1861, DOI 10.1016/0016-7037(85)90081-X; Bodnar RJ, 1995, MINERALOGICAL ASS CA, V23, P139; Burnham CW, 1997, GEOCHEMISTRY HYDROTH, V3, P63; Candela PA, 1995, MINERALOGICAL ASS CA, V23, P101; Davidson P, 2001, ECON GEOL BULL SOC, V96, P1921, DOI 10.2113/96.8.1921; GUSTAFSON LB, 1975, ECON GEOL, V70, P857, DOI 10.2113/gsecongeo.70.5.857; HARRIS AC, MINERAL EXPLOITATION, P275; HEDENQUIST JW, 1994, NATURE, V370, P519, DOI 10.1038/370519a0; Heinrich CA, 1999, GEOLOGY, V27, P755, DOI 10.1130/0091-7613(1999)027<0755:MFBMBA>2.3.CO;2; HEINRICH CA, 1992, ECON GEOL BULL SOC, V87, P1566, DOI 10.2113/gsecongeo.87.6.1566; HEMLEY JJ, 1992, ECON GEOL BULL SOC, V87, P23, DOI 10.2113/gsecongeo.87.1.23; Hezarkhani A, 1998, ECON GEOL BULL SOC, V93, P651, DOI 10.2113/gsecongeo.93.5.651; Kamenetsky VS, 2003, DEV VOLCANO, V5, P65; KAMENETSKY VS, IN PRESS CHEM GEOL; LOWENSTERN JB, 1991, SCIENCE, V252, P1405, DOI 10.1126/science.252.5011.1405; Ulrich T., 2002, ECON GEOL, V97, P1888; WILLIAMS TJ, 1995, CONTRIB MINERAL PETR, V121, P388, DOI 10.1007/s004100050104	18	135	160	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2109	2111		10.1126/science.1089927	http://dx.doi.org/10.1126/science.1089927			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684818	Green Accepted			2022-12-28	WOS:000187385200040
J	Wechsler, A; Brafman, A; Shafir, M; Heverin, M; Gottlieb, H; Damari, G; Gozlan-Kelner, S; Spivak, I; Moshkin, O; Fridman, E; Becker, Y; Skaliter, R; Einat, P; Faerman, A; Bjorkhem, I; Feinstein, E				Wechsler, A; Brafman, A; Shafir, M; Heverin, M; Gottlieb, H; Damari, G; Gozlan-Kelner, S; Spivak, I; Moshkin, O; Fridman, E; Becker, Y; Skaliter, R; Einat, P; Faerman, A; Bjorkhem, I; Feinstein, E			Generation of viable cholesterol-free mice	SCIENCE			English	Article							MOUSE MODEL; STEROL		Quark Biotech Inc, Cleveland, OH 44106 USA; H3 30 Huddinge Univ Hosp, Karolinska Inst, Div Clin Chem, Dept Med Lab Sci & Technol, SE-14186 Huddinge, Sweden; Chaim Sheba Med Ctr, Sackler Sch Med, Dept Pathol, IL-52621 Tel Hashomer, Israel	Karolinska Institutet; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Feinstein, E (corresponding author), Quark Biotech Inc, 10265 Carnegie Ave, Cleveland, OH 44106 USA.	elenaf@qbi.co.il	Heverin, Maura B/J-4101-2012	Bjorkhem, Ingemar/0000-0002-0575-9425; Fridman, Eddie/0000-0002-0317-7085				Andersson H. C., 2000, Journal of Inherited Metabolic Disease, V23, P200; Chevy F, 2002, J LIPID RES, V43, P1192, DOI 10.1194/jlr.M200082-JLR200; Fitzky BU, 2001, J CLIN INVEST, V108, P905, DOI 10.1172/JCI200112103; FitzPatrick DR, 1998, AM J MED GENET, V75, P145, DOI 10.1002/(SICI)1096-8628(19980113)75:2<145::AID-AJMG5>3.0.CO;2-S; Herz J, 1999, J NUTR, V129, p473S, DOI 10.1093/jn/129.2.473S; ROTHBLAT GH, 1970, SCIENCE, V169, P880, DOI 10.1126/science.169.3948.880; Singh SK, 2003, REPROD TOXICOL, V17, P37, DOI 10.1016/S0890-6238(02)00075-8; Wassif CA, 2001, HUM MOL GENET, V10, P555, DOI 10.1093/hmg/10.6.555	8	145	148	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2087	2087		10.1126/science.1090776	http://dx.doi.org/10.1126/science.1090776			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684813				2022-12-28	WOS:000187385200033
J	McConnell, JD; Roehrborn, CG; Bautista, OM; Andriole, GL; Dixon, CM; Kusek, JW; Lepor, H; McVary, KT; Nyberg, LM; Clarke, HS; Crawford, ED; Diokno, A; Foley, JP; Foster, HE; Jacobs, SC; Kaplan, SA; Kreder, KJ; Lieber, MM; Lucia, MS; Miller, GJ; Menon, M; Milam, DF; Ramsdell, JW; Schenkman, NS; Slawin, KM; Smith, JA; Kusek, JW; Nyberg, LM; Briggs, JP; McConnell, JD; Crawford, ED; Homan, K; Donohue, R; Parker, D; Easterday, K; Robertson, K; Kaplan, S; Wentland, M; Hardy, L; Roehrborn, C; Ahrens, A; McConnell, J; Hall, D; Cutts, D; Carter, S; Waldrep, K; Schenkman, N; Sanetrik, K; Sihelnik, S; Zorn, B; McLeod, D; Moul, J; Peay, K; Szkutnik, A; Travis, J; Brawer, M; Earl, D; Mayo, M; Dixon, C; Hirschfield, S; Lepor, H; Hoffman, D; Brassil, D; Castro, M; Kramer, P; Slawin, K; Pavlik, V; Morton, R; Miles, B; Harrison, S; Valdez, R; Foley, J; Jones, A; Thompson, I; Morey, A; Canby-Hagino, E; Dobbs, R; Rozanski, T; Sloat, G; Ramsdell, J; Parman, Z; Schmidt, J; Albo, M; Guy, H; Eskew, D; Sparks, D; Menon, M; David, C; Kirkemo, A; Diokno, A; Burks, D; Stricker, H; Peabody, J; Littleton, R; Leemon, B; Steinert, B; Kuzara, J; Peabody, M; Lieber, M; Smith, J; Patterson, D; Blute, M; Van Oort, C; Fitch, D; Mann, D; Hyland, K; Wieland, H; McVary, K; Perez, E; Grayhack, J; Bushman, W; Haldes, K; Manzera, M; Smith, J; Hughes, B; Milam, D; Sisk, P; Andriole, G; Faust, J; Sundaram, C; Nicolai, C; Johnson, A; Shelly, N; Foster, H; Martin, T; Anderson, K; Puklin, C; Chodkowshi, D; Alfano, S; Sopp, K; Clarke, H; Lopez, B; Tenover, L; Elmer, S; Lachenmeyer, K; Kreder, K; Fearing, M; See, W; Ziegler, B; Schultz, S; Tuftee, T; Jacobs, S; Hershner, M; Naslund, M; Greene, B; Markowitz, G; Miller, GJ; Lucia, MS; Lepoff, R; Covey-Magnuson, C; Johnson, G; Torkko, K; Bautista, O; Burrows, P; Gersnoviez, R; Bain, R; Greenhouse, S; Bamdad, J; Mason, W; Sherif, H; Temprosa, M; Minkoff, N; Barry, M; Bruskewitz, R; Cockett, A; Litwin, M; Mostwin, J; Reda, D; Roberts, R; Rous, S; Williford, W; Smith-West, D; Greene, P; Round, E; Gormley, G; Mallen, S; Sigel, R; Grossman, E				McConnell, JD; Roehrborn, CG; Bautista, OM; Andriole, GL; Dixon, CM; Kusek, JW; Lepor, H; McVary, KT; Nyberg, LM; Clarke, HS; Crawford, ED; Diokno, A; Foley, JP; Foster, HE; Jacobs, SC; Kaplan, SA; Kreder, KJ; Lieber, MM; Lucia, MS; Miller, GJ; Menon, M; Milam, DF; Ramsdell, JW; Schenkman, NS; Slawin, KM; Smith, JA; Kusek, JW; Nyberg, LM; Briggs, JP; McConnell, JD; Crawford, ED; Homan, K; Donohue, R; Parker, D; Easterday, K; Robertson, K; Kaplan, S; Wentland, M; Hardy, L; Roehrborn, C; Ahrens, A; McConnell, J; Hall, D; Cutts, D; Carter, S; Waldrep, K; Schenkman, N; Sanetrik, K; Sihelnik, S; Zorn, B; McLeod, D; Moul, J; Peay, K; Szkutnik, A; Travis, J; Brawer, M; Earl, D; Mayo, M; Dixon, C; Hirschfield, S; Lepor, H; Hoffman, D; Brassil, D; Castro, M; Kramer, P; Slawin, K; Pavlik, V; Morton, R; Miles, B; Harrison, S; Valdez, R; Foley, J; Jones, A; Thompson, I; Morey, A; Canby-Hagino, E; Dobbs, R; Rozanski, T; Sloat, G; Ramsdell, J; Parman, Z; Schmidt, J; Albo, M; Guy, H; Eskew, D; Sparks, D; Menon, M; David, C; Kirkemo, A; Diokno, A; Burks, D; Stricker, H; Peabody, J; Littleton, R; Leemon, B; Steinert, B; Kuzara, J; Peabody, M; Lieber, M; Smith, J; Patterson, D; Blute, M; Van Oort, C; Fitch, D; Mann, D; Hyland, K; Wieland, H; McVary, K; Perez, E; Grayhack, J; Bushman, W; Haldes, K; Manzera, M; Smith, J; Hughes, B; Milam, D; Sisk, P; Andriole, G; Faust, J; Sundaram, C; Nicolai, C; Johnson, A; Shelly, N; Foster, H; Martin, T; Anderson, K; Puklin, C; Chodkowshi, D; Alfano, S; Sopp, K; Clarke, H; Lopez, B; Tenover, L; Elmer, S; Lachenmeyer, K; Kreder, K; Fearing, M; See, W; Ziegler, B; Schultz, S; Tuftee, T; Jacobs, S; Hershner, M; Naslund, M; Greene, B; Markowitz, G; Miller, GJ; Lucia, MS; Lepoff, R; Covey-Magnuson, C; Johnson, G; Torkko, K; Bautista, O; Burrows, P; Gersnoviez, R; Bain, R; Greenhouse, S; Bamdad, J; Mason, W; Sherif, H; Temprosa, M; Minkoff, N; Barry, M; Bruskewitz, R; Cockett, A; Litwin, M; Mostwin, J; Reda, D; Roberts, R; Rous, S; Williford, W; Smith-West, D; Greene, P; Round, E; Gormley, G; Mallen, S; Sigel, R; Grossman, E		MTOPS Res Grp	The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE URINARY RETENTION; ASSOCIATION SYMPTOM INDEX; TRACT SYMPTOMS; DOUBLE-BLIND; EFFICACY; MEN; PLACEBO; SAFETY; SURGERY; TRIAL	BACKGROUND: Benign prostatic hyperplasia is commonly treated with alpha-adrenergic-receptor antagonists (alpha-blockers) or 5(alpha)-reductase inhibitors. The long-term effect of these drugs, singly or combined, on the risk of clinical progression is unknown. METHODS: We conducted a long-term, double-blind trial (mean follow-up, 4.5 years) involving 3047 men to compare the effects of placebo, doxazosin, finasteride, and combination therapy on measures of the clinical progression of benign prostatic hyperplasia. RESULTS: The risk of overall clinical progression -- defined as an increase above base line of at least 4 points in the American Urological Association symptom score, acute urinary retention, urinary incontinence, renal insufficiency, or recurrent urinary tract infection -- was significantly reduced by doxazosin (39 percent risk reduction, P<0.001) and finasteride (34 percent risk reduction, P=0.002), as compared with placebo. The reduction in risk associated with combination therapy (66 percent for the comparison with placebo, P<0.001) was significantly greater than that associated with doxazosin (P<0.001) or finasteride (P<0.001) alone. The risks of acute urinary retention and the need for invasive therapy were significantly reduced by combination therapy (P<0.001) and finasteride (P<0.001) but not by doxazosin. Doxazosin (P<0.001), finasteride (P=0.001), and combination therapy (P<0.001) each resulted in significant improvement in symptom scores, with combination therapy being superior to both doxazosin (P=0.006) and finasteride (P<0.001) alone. CONCLUSIONS: Long-term combination therapy with doxazosin and finasteride was safe and reduced the risk of overall clinical progression of benign prostatic hyperplasia significantly more than did treatment with either drug alone. Combination therapy and finasteride alone reduced the long-term risk of acute urinary retention and the need for invasive therapy.	Univ Texas, SW Med Ctr, Dallas, TX 75390 USA; George Washington Univ, Rockville, MD USA; Washington Univ, St Louis, MO USA; NYU, New York, NY USA; NIDDKD, Bethesda, MD 20892 USA; Northwestern Univ, Chicago, IL 60611 USA; Emory Univ, Atlanta, GA 30322 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA; William Beaumont Hosp, Royal Oak, MI 48072 USA; Brooke Army Med Ctr, Ft Sam Houston, TX 78234 USA; Yale Univ, New Haven, CT USA; Univ Maryland, Baltimore, MD 21201 USA; New York Presbyterian Hosp, New York, NY USA; Univ Iowa, Iowa City, IA USA; Mayo Clin, Rochester, MN USA; Henry Ford Hosp, Detroit, MI 48202 USA; Vanderbilt Univ, Nashville, TN USA; Univ Calif San Diego, San Diego, CA 92103 USA; Walter Reed Army Med Ctr, Washington, DC 20307 USA; Baylor Coll Med, Houston, TX 77030 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; George Washington University; Washington University (WUSTL); New York University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Northwestern University; Emory University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Beaumont Health; San Antonio Military Medical Center; United States Department of Defense; United States Army; Yale University; University System of Maryland; University of Maryland Baltimore; NewYork-Presbyterian Hospital; University of Iowa; Mayo Clinic; Henry Ford Health System; Henry Ford Hospital; Vanderbilt University; University of California System; University of California San Diego; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Baylor College of Medicine	Roehrborn, CG (corresponding author), Univ Texas, SW Med Ctr, 5323 Harry Hines Blvd,J8-130, Dallas, TX 75390 USA.	claus.roehrborn@utsouthwestern.edu	Briggs, Josephine P/B-9394-2009; Litwin, Mieczyslaw/C-3868-2012; Litwin, Mieczyslaw/ABH-4315-2020	Briggs, Josephine P/0000-0003-0798-1190; Litwin, Mieczyslaw/0000-0002-5241-2483; Kreder, Karl/0000-0002-8981-5286	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK049960, U01DK049963, R01DK041418, U01DK046472, U01DK049880, U01DK049912, U01DK046468, U01DK049971, U01DK046431, U01DK046437, U01DK049951, U01DK046429, U01DK046416, U01DK049964, U01DK049954, U01DK049977, U01DK049980] Funding Source: NIH RePORTER; NIDDK NIH HHS [U01 DK-49880, U01 DK-49960, U01 DK41418, U01 DK46416, U01 DK49980, U01 DK49977, U01 DK46429, U01 DK46431, U01 DK46437, U01 DK46468, U01 DK49971, U01 DK49964, U01 DK49963, U01 DK49954, U01 DK46472, U01 DK49912, U01 DK49951] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andersen JT, 1997, UROLOGY, V49, P839, DOI 10.1016/S0090-4295(97)00185-4; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; BARRY MJ, 1995, J UROLOGY, V154, P1770, DOI 10.1016/S0022-5347(01)66780-6; Bautista OM, 2003, CONTROL CLIN TRIALS, V24, P224, DOI 10.1016/S0197-2456(02)00263-5; COCKETT ATK, 1992, CANCER, V70, P280, DOI 10.1002/1097-0142(19920701)70:1+<280::AID-CNCR2820701315>3.0.CO;2-E; Flanigan RC, 1998, J UROLOGY, V160, P12, DOI 10.1016/S0022-5347(01)63011-8; Girman CJ, 1998, UROLOGY, V51, P428, DOI 10.1016/S0090-4295(97)00717-6; GORMLEY GJ, 1992, NEW ENGL J MED, V327, P1185, DOI 10.1056/NEJM199210223271701; GUP DI, 1990, J UROLOGY, V143, P179, DOI 10.1016/S0022-5347(17)39906-8; KAWABE K, 1995, BRIT J UROL, V76, P63; Kirby RS, 2003, UROLOGY, V61, P119, DOI 10.1016/S0090-4295(02)02114-3; KORN EL, 1991, AM STAT, V45, P201, DOI 10.2307/2684290; Kusek JW, 2002, UROLOGY, V59, P63, DOI 10.1016/S0090-4295(01)01454-6; Lachin J. M., 2000, WILEY SER PROB STAT; Lachin JL, 2000, CONTROL CLIN TRIALS, V21, P526, DOI 10.1016/S0197-2456(00)00092-1; LACHIN JM, 1992, STAT MED, V11, P1151, DOI 10.1002/sim.4780110903; Lee E, 2013, STAT METHODS SURVIVA; LEPOR H, 1990, PROSTATE, P75; Lepor H, 1996, NEW ENGL J MED, V335, P533, DOI 10.1056/NEJM199608223350801; LEPOR H, 1991, J UROLOGY, V145, pA1265; LIN DY, 1991, J AM STAT ASSOC, V86, P725, DOI 10.2307/2290404; Marberger MJ, 1998, UROLOGY, V51, P677, DOI 10.1016/S0090-4295(98)00094-6; McConnell JD, 1998, NEW ENGL J MED, V338, P557, DOI 10.1056/NEJM199802263380901; MCCONNELL JD, 1991, J ANDROL, V12, P356; McNeill SA, 2001, EUR UROL, V39, P7, DOI 10.1159/000052593; Nickel JC, 1996, CAN MED ASSOC J, V155, P1251; Roehrborn C G, 2001, Curr Opin Urol, V11, P17, DOI 10.1097/00042307-200101000-00003; Roehrborn C. G., 2002, CAMPBELLS UROLOGY, V2, P1297; Roehrborn CG, 1996, UROLOGY, V48, P406, DOI 10.1016/S0090-4295(96)00208-7; Roehrborn CG, 2000, EUR UROL, V37, P528, DOI 10.1159/000020189; Roehrborn CG, 2000, J UROLOGY, V163, P13, DOI 10.1016/S0022-5347(05)67962-1; Roehrborn CG, 1997, UROLOGY, V49, P548, DOI 10.1016/S0090-4295(97)00031-9; Roehrborn CG, 1999, UROLOGY, V53, P473, DOI 10.1016/S0090-4295(98)00654-2; Roehrborn CG, 2002, UROLOGY, V60, P434, DOI 10.1016/S0090-4295(02)01905-2; Roehrborn CG, 1996, UROLOGY, V47, P159, DOI 10.1016/S0090-4295(99)80409-9; Roehrborn CG, 2001, UROLOGY, V58, P953, DOI 10.1016/S0090-4295(01)01448-0; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P153; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; WASSON JH, 1995, NEW ENGL J MED, V332, P75, DOI 10.1056/NEJM199501123320202; WEI LJ, 1988, CONTROL CLIN TRIALS, V9, P345, DOI 10.1016/0197-2456(88)90048-7; WEI LJ, 1989, CONTROL CLIN TRIALS, V10, P127; Welch G, 2002, UROLOGY, V59, P245, DOI 10.1016/S0090-4295(01)01506-0	42	1328	1425	1	63	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					2387	2398		10.1056/NEJMoa030656	http://dx.doi.org/10.1056/NEJMoa030656			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681504				2022-12-28	WOS:000187326200004
J	Lawrenson, G; Ogden, J				Lawrenson, G; Ogden, J			Security duties in Northern Ireland and the mental health of soldiers: prospective study	BRITISH MEDICAL JOURNAL			English	Article							WAR VETERANS; STRESS; ILLNESS		Guys Kings & St Thomass Med Sch, Dept Gen Practice, London SE11 6SP, England; Colchester Garrison, Colchester, Essex, England	University of London; King's College London	Ogden, J (corresponding author), Guys Kings & St Thomass Med Sch, Dept Gen Practice, London SE11 6SP, England.			Ogden, Jane/0000-0003-4271-5621				Bartone PT, 1998, MIL MED, V163, P587, DOI 10.1093/milmed/163.9.587; GOLDBERG DP, 1970, BMJ-BRIT MED J, V2, P439, DOI 10.1136/bmj.2.5707.439; Hotopf M, 2003, PSYCHOL MED, V33, P155, DOI 10.1017/S0033291702006840; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; ORNER RJ, 1993, BRIT J CLIN PSYCHOL, V32, P457, DOI 10.1111/j.2044-8260.1993.tb01079.x	5	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1382	1382		10.1136/bmj.327.7428.1382	http://dx.doi.org/10.1136/bmj.327.7428.1382			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755PL	14670882	Bronze, Green Submitted, Green Published			2022-12-28	WOS:000187417900021
J	Pieters, J; Ploegh, H				Pieters, J; Ploegh, H			Chemical warfare and mycobacterial Defense	SCIENCE			English	Editorial Material							PROTEASOME; TUBERCULOSIS; MACROPHAGES; UBIQUITIN; GENES		Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Basel; Harvard University; Harvard Medical School	Pieters, J (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.			Pieters, Jean/0000-0002-5284-9757				ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Ehrt S, 1997, J EXP MED, V186, P1885, DOI 10.1084/jem.186.11.1885; Horak J, 2003, BBA-BIOMEMBRANES, V1614, P139, DOI 10.1016/S0005-2736(03)00195-0; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Ruan J, 1999, INFECT IMMUN, V67, P3276, DOI 10.1128/IAI.67.7.3276-3283.1999; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Via LE, 1998, J CELL SCI, V111, P897; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522	14	15	27	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1900	1902		10.1126/science.1092873	http://dx.doi.org/10.1126/science.1092873			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671281				2022-12-28	WOS:000187174000036
J	Colvin, RB				Colvin, RB			Chronic allograft neuropathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							WORKING CLASSIFICATION; REJECTION; NEPHROPATHY; PATHOLOGY		Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Colvin, RB (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.							Krieger NR, 2003, TRANSPLANTATION, V75, P1677, DOI 10.1097/01.TP.0000063830.60937.06; Mauiyyedi S, 2001, J AM SOC NEPHROL, V12, P574, DOI 10.1681/ASN.V123574; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Shishido S, 2003, J AM SOC NEPHROL, V14, P1046, DOI 10.1097/01.ASN.0000056189.02819.32; SOLEZ K, 1993, KIDNEY INT, V44, P411, DOI 10.1038/ki.1993.259	5	86	99	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					2288	2290		10.1056/NEJMp038178	http://dx.doi.org/10.1056/NEJMp038178			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668453	Green Published			2022-12-28	WOS:000187125000003
J	Detavernier, C; Ozcan, AS; Jordan-Sweet, J; Stach, EA; Tersoff, J; Ross, FM; Lavoie, C				Detavernier, C; Ozcan, AS; Jordan-Sweet, J; Stach, EA; Tersoff, J; Ross, FM; Lavoie, C			An off-normal fibre-like texture in thin films on single-crystal substrates	NATURE			English	Article							BEAM-ASSISTED DEPOSITION; EPITAXIAL-GROWTH; INPLANE TEXTURE; METALLIZATION; INHERITANCE	In the context of materials science, texture describes the statistical distribution of grain orientations. It is an important characteristic of the microstructure of polycrystalline films(1 - 5), determining various electrical, magnetic and mechanical properties. Three types of texture component are usually distinguished in thin films: random texture, when grains have no preferred orientation; fibre texture(6 - 10), for which one crystallographic axis of the film is parallel to the substrate normal, while there is a rotational degree of freedom around the fibre axis; and epitaxial alignment ( or in- plane texture) on single- crystal substrates(11 - 15), where an in- plane alignment fixes all three axes of the grain with respect to the substrate. Here we report a fourth type of texture - which we call axiotaxy - identified from complex but symmetrical patterns of lines on diffraction pole figures for thin films formed by solid- state reactions. The texture is characterized by the alignment of planes in the film and substrate that share the same d- spacing. This preferred alignment of planes across the interface manifests itself as a fibre texture lying off- normal to the sample surface, with the fibre axis perpendicular to certain planes in the substrate. This texture forms because it results in an interface, which is periodic in one dimension, preserved independently of interfacial curvature. This new type of preferred orientation may be the dominant type of texture for a wide class of materials and crystal structures.	IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA; State Univ Ghent, Dept Solid State Phys, B-9000 Ghent, Belgium; Boston Univ, Dept Phys, Boston, MA 02215 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Natl Ctr Electron Microscopy, Berkeley, CA 94720 USA	International Business Machines (IBM); Ghent University; Boston University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Detavernier, C (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA.		Lavoie, Christian/AAX-8174-2020; Stach, Eric Andrew/M-6455-2019; Stach, Eric A/D-8545-2011; Detavernier, Christophe/I-2766-2014; Ross, Frances/P-8919-2015	Stach, Eric Andrew/0000-0002-3366-2153; Stach, Eric A/0000-0002-3366-2153; Lavoie, Christian/0000-0001-8516-6904; Ross, Frances/0000-0003-0838-9770; Ozcan, Ahmet/0000-0002-4689-7971				BULLELIEUWMA CWT, 1992, J APPL PHYS, V71, P2211, DOI 10.1063/1.351119; BULLELIEUWMA CWT, 1993, APPL SURF SCI, V68, P1, DOI 10.1016/0169-4332(93)90211-S; BUNGE YHJ, 1982, TEXTURE ANAL MAT SCI; Dong L, 1998, J APPL PHYS, V84, P5261, DOI 10.1063/1.368794; Dong L, 2001, J MATER RES, V16, P210, DOI 10.1557/JMR.2001.0033; Harper JME, 1997, J VAC SCI TECHNOL B, V15, P763, DOI 10.1116/1.589407; Harper JME, 1997, J APPL PHYS, V82, P4319, DOI 10.1063/1.366239; *JOINT COMM POWD D, 1998, 380844 INT CTR DIFFR; Kilaas R, 1998, J MICROSC-OXFORD, V190, P45, DOI 10.1046/j.1365-2818.1998.3070861.x; Knorr DB, 1998, J VAC SCI TECHNOL B, V16, P2734, DOI 10.1116/1.590265; Kocks U. F., 1976, TEXTURE ANISOTROPY P; Lucadamo G, 2001, J MATER RES, V16, P1449, DOI 10.1557/JMR.2001.0202; Murray CE, 2001, J APPL PHYS, V89, P2337, DOI 10.1063/1.1337938; NOKINOV V, 1997, GRAIN GROWTH CONTROL; Ozcan AS, 2002, J APPL PHYS, V92, P5011, DOI 10.1063/1.1509849; Randle V., 2000, INTRO TEXTURE ANAL M; Schell N, 2002, J APPL PHYS, V91, P2037, DOI 10.1063/1.1436558; THOMPSON CV, 1995, MAT SCI ENG B-SOLID, V32, P211, DOI 10.1016/0921-5107(95)03011-5; TRACY DP, 1994, J APPL PHYS, V76, P2671, DOI 10.1063/1.357564; TSUKADA M, 1993, J VAC SCI TECHNOL B, V11, P326, DOI 10.1116/1.586678	20	174	177	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					641	645		10.1038/nature02198	http://dx.doi.org/10.1038/nature02198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668858	Green Published			2022-12-28	WOS:000187132800035
J	Huskamp, HA; Deverka, PA; Epstein, AM; Epstein, RS; McGuigan, KA; Frank, RG				Huskamp, HA; Deverka, PA; Epstein, AM; Epstein, RS; McGuigan, KA; Frank, RG			The effect of incentive-based formularies on prescription-drug utilization and spending	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRICES; CARE	BACKGROUND: Many employers and health plans have adopted incentive-based formularies in an attempt to control prescription-drug costs. METHODS: We used claims data to compare the utilization of and spending on drugs in two employer-sponsored health plans that implemented changes in formulary administration with those in comparison groups of enrollees covered by the same insurers. One plan simultaneously switched from a one-tier to a three-tier formulary and increased all enrollee copayments for medications. The second switched from a two-tier to a three-tier formulary, changing only the copayments for tier-3 drugs. We examined the utilization of angiotensin-converting-enzyme (ACE) inhibitors, proton-pump inhibitors, and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins). RESULTS: Enrollees covered by the employer that implemented more dramatic changes experienced slower growth than the comparison group in the probability of the use of a drug and a major shift in spending from the plan to the enrollee. Among the enrollees who were initially taking tier-3 statins, more enrollees in the intervention group than in the comparison group switched to tier-1 or tier-2 medications (49 percent vs. 17 percent, P<0.001) or stopped taking statins entirely (21 percent vs. 11 percent, P=0.04). Patterns were similar for ACE inhibitors and proton-pump inhibitors. The enrollees covered by the employer that implemented more moderate changes were more likely than the comparison enrollees to switch to tier-1 or tier-2 medications but not to stop taking a given class of medications altogether. CONCLUSIONS: Different changes in formulary administration may have dramatically different effects on utilization and spending and may in some instances lead enrollees to discontinue therapy. The associated changes in copayments can substantially alter out-of-pocket spending by enrollees, the continuation of the use of medications, and possibly the quality of care.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Sect Hlth Serv & Policy Res, Boston, MA 02115 USA; Medco Hlth Solut, Franklin Lakes, NJ USA	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Huskamp, HA (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.		Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P01HS010803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH066109] Funding Source: NIH RePORTER; AHRQ HHS [5 P01 HS10803] Funding Source: Medline; NIMH NIH HHS [1 K01 MH66109] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Blumenthal D, 2000, DESCRIPTION ANAL VA; Cook T.C., 1979, QUASIEXPERIMENTATION; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Frank RG, 2001, HEALTH AFFAIR, V20, P115, DOI 10.1377/hlthaff.20.2.115; Gabel J, 2002, HEALTH AFFAIR, V21, P143, DOI 10.1377/hlthaff.21.5.143; Horn SD, 1998, AM J MANAG CARE, V4, P1105; Huber PJ, 1967, P 5 BERK S MATH STAT, P221; Huskamp HA, 2003, HEALTH AFFAIR, V22, P149, DOI 10.1377/hlthaff.22.3.149; Joyce GF, 2002, JAMA-J AM MED ASSOC, V288, P2409; Kaiser Family Foundation and Health Research and Educational Trust, EMPL HLTH BEN 2002 S, V[cited 2010 Jun 7]. Available from; MANNING WG, 1987, AM ECON REV, V77, P251; Motheral B, 2001, MED CARE, V39, P1293, DOI 10.1097/00005650-200112000-00005; Motheral BR, 1999, INQUIRY-J HEALTH CAR, V36, P481; Rector TS, 2003, MED CARE, V41, P398, DOI 10.1097/00005650-200303000-00008; THOMAS CP, IMPACT HLTH PLAN DES; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934	16	266	268	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2003	349	23					2224	2232		10.1056/NEJMsa030954	http://dx.doi.org/10.1056/NEJMsa030954			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LH	14657430				2022-12-28	WOS:000186921700010
J	Getahun, H; Lambein, F; Vanhoorne, M; Van der Stuyft, P				Getahun, H; Lambein, F; Vanhoorne, M; Van der Stuyft, P			Food-aid cereals to reduce neurolathyrism related to grass-pea preparations during famine	LANCET			English	Article							EPIDEMIC	Neurolathyrism is a spastic paraparesis that can be caused by excessive consumption of the drought-resistant grass pea (Lathyrus sativus). Devastating neurolathyrism epidemics have occurred during major famine crises in various parts of the world. We investigated in a case-control study the effects of food aid on risk of paralysis. Risk increased with consumption of boiled grass pea (adjusted odds ratio 2.78, 95% CI 1.09-7.13 with cereals; 5.22, 2.01-13.55 without cereal) and raw unripe green grass pea (1.96, 1-1.6-3.31; p=0.011), but not with the fermented pancake, unleavened bread, and gravy preparations. In a correlational study there was an inverse relation between the number of new cases and the amount of food-aid cereals distributed per person. During famine, cereals and nutritional information should reach people before they have grass pea as the only food.	S Gonder Hlth Dept, Debre Tabor, Amhara Regional, Ethiopia; Univ Ghent, Fac Med & Hlth Sci, Physiol Chem Lab, B-9000 Ghent, Belgium; Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; Univ Ghent, Inst Plant Biotechnol Dev Countries, B-9000 Ghent, Belgium; Inst Trop Med, Epidemiol Unit, B-2000 Antwerp, Belgium	Ghent University; Ghent University; Ghent University; Institute of Tropical Medicine (ITM)	Lambein, F (corresponding author), Josef Kluyskensstr 27, B-9000 Ghent, Belgium.	fernand.lambein@UGent.be	Getahun, Haileyesus/ABC-5181-2020					Getahun H, 2002, TROP MED INT HEALTH, V7, P118, DOI 10.1046/j.1365-3156.2002.00836.x; Getahun H, 1999, LANCET, V354, P306, DOI 10.1016/S0140-6736(99)02532-5; KUO YH, 1995, J SCI FOOD AGR, V69, P81, DOI 10.1002/jsfa.2740690113; Moszynski P, 2002, LANCET, V360, P1952, DOI 10.1016/S0140-6736(02)11949-0; *US AG INT DEV CHE, FAM EARL WARN SYST N	5	48	52	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1808	1810		10.1016/S0140-6736(03)14902-1	http://dx.doi.org/10.1016/S0140-6736(03)14902-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654321				2022-12-28	WOS:000186872900014
J	Spencer, PS; Palmer, VS				Spencer, PS; Palmer, VS			Lathyrism: aqueous leaching reduces grass-pea neurotoxicity	LANCET			English	Editorial Material									Third World Med Res Fdn, Portland, OR USA; Oregon Hlth Sci Univ, Sch Med, Ctr Res Occupat & Environm Toxicol, Dept Neurol, Portland, OR 97201 USA	Oregon Health & Science University	Spencer, PS (corresponding author), Third World Med Res Fdn, Portland, OR USA.							ABEGAZ BM, 1994, NUTR NEUROTOXINS LAT; Gebre-ab T, 1978, Ethiop Med J, V16, P1; KAUL AK, 1986, LATHYRUS LATHYRISM; MOHAN VS, 1966, INDIAN J MED RES, V54, P410; Spencer P. S, 1989, GRASS PEA THREAT PRO; TEKLEHAIMANOT R, 1993, NUTR RES, V13, P1113, DOI 10.1016/S0271-5317(05)80736-5	6	7	7	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 29	2003	362	9398					1775	1776		10.1016/S0140-6736(03)14940-9	http://dx.doi.org/10.1016/S0140-6736(03)14940-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654311				2022-12-28	WOS:000186872900004
J	Berwick, D; Ham, C; Smith, R				Berwick, D; Ham, C; Smith, R			Would the NHS benefit from a single, identifiable leader? An email conversation	BRITISH MEDICAL JOURNAL			English	Article									BMJ, London WC1H 9JR, England; Inst Healthcare Improvement, Boston, MA 02215 USA; Dept Hlth, Strategy Unit, London SW1A 2NS, England	Institute for Healthcare Improvement	Smith, R (corresponding author), BMJ, London WC1H 9JR, England.							Ham C, 2003, LANCET, V361, P1978, DOI 10.1016/S0140-6736(03)13593-3; POWELL JE, 1976, NEW LOOK MED, P83; SMITH R, 2003, BMJ, V326	3	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1421	1424		10.1136/bmj.327.7429.1421	http://dx.doi.org/10.1136/bmj.327.7429.1421			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684634	Green Published			2022-12-28	WOS:000187562700005
J	Roman, MJ; Shanker, B; Davis, A; Lockshin, MD; Sammaritano, L; Simantov, R; Crow, MK; Schwartz, JE; Paget, SA; Devereux, RB; Salmon, JE				Roman, MJ; Shanker, B; Davis, A; Lockshin, MD; Sammaritano, L; Simantov, R; Crow, MK; Schwartz, JE; Paget, SA; Devereux, RB; Salmon, JE			Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY DISEASE; APPARENTLY HEALTHY-MEN; RISK-FACTORS; CAROTID ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; FOLLOW-UP; CLASSIFICATION; EVENTS; PLASMA	BACKGROUND: Although systemic lupus erythematosus is associated with premature myocardial infarction, the prevalence of underlying atherosclerosis and its relation to traditional risk factors for cardiovascular disease and lupus-related factors have not been examined in a case-control study. METHODS: In 197 patients with lupus and 197 matched controls, we performed carotid ultrasonography, echocardiography, and an assessment for risk factors for cardiovascular disease. The patients were also evaluated with respect to their clinical and serologic features, inflammatory mediators, and disease treatment. RESULTS: The risk factors for cardiovascular disease were similar among patients and controls. Atherosclerosis (carotid plaque) was more prevalent among patients than the controls (37.1 percent vs. 15.2 percent, P<0.001). In multivariate analysis, only older age, the presence of systemic lupus erythematosus (odds ratio, 4.8; 95 percent confidence interval, 2.6 to 8.7), and a higher serum cholesterol level were independently related to the presence of plaque. As compared with patients without plaque, patients with plaque were older, had a longer duration of disease and more disease-related damage, and were less likely to have multiple autoantibodies or to have been treated with prednisone, cyclophosphamide, or hydroxychloroquine. In multivariate analyses including patients with lupus, independent predictors of plaque were a longer duration of disease, a higher damage-index score, a lower incidence of the use of cyclophosphamide, and the absence of anti-Smith antibodies. CONCLUSIONS: Atherosclerosis occurs prematurely in patients with systemic lupus erythematosus and is independent of traditional risk factors for cardiovascular disease. The clinical profile of patients with lupus and atherosclerosis suggests a role for disease-related factors in atherogenesis and underscores the need for trials of more focused and effective antiinflammatory therapy.	Cornell Univ, Weill Med Coll, Div Cardiol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Div Rheumatol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Div Hematol Oncol, New York, NY 10021 USA; Hosp Special Surg, New York, NY 10021 USA; SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA	Cornell University; Cornell University; Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Roman, MJ (corresponding author), Cornell Univ, Weill Med Coll, Div Cardiol, 525 E 68th St, New York, NY 10021 USA.		Crow, Mary/R-8480-2019	Schwartz, Joseph/0000-0002-8944-3566	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000047] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL047540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045591] Funding Source: NIH RePORTER; NCRR NIH HHS [M10RR0047] Funding Source: Medline; NHLBI NIH HHS [HL 47540, P01 HL047540] Funding Source: Medline; NIAMS NIH HHS [AR 45591] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Asanuma Y, 2003, NEW ENGL J MED, V349, P2407, DOI 10.1056/NEJMoa035611; Belcaro G, 1996, ARTERIOSCL THROM VAS, V16, P851, DOI 10.1161/01.ATV.16.7.851; DEVEREUX RB, 1995, HYPERTENSION PATHOPH, V2, P1969; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; JOHNSON H, 1989, MEDICINE, V68, P141; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Manzi S, 1999, ARTHRITIS RHEUM-US, V42, P51, DOI 10.1002/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D; PETRI M, 1992, MEDICINE, V71, P291, DOI 10.1097/00005792-199209000-00004; PETRI M, 1994, AM J MED, V96, P254, DOI 10.1016/0002-9343(94)90151-1; PETRI M, 1992, AM J MED, V93, P513, DOI 10.1016/0002-9343(92)90578-Y; Petri M, 2002, ARTHRITIS RHEUM-US, V46, pS458; Petri M, 1996, LANCET, V348, P1120, DOI 10.1016/S0140-6736(96)03032-2; Petri M, 1998, ARTHRITIS RHEUM, V41, pS218; Ridker PM, 1997, NEW ENGL J MED, V337, P356; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Roman MJ, 1996, J AM COLL CARDIOL, V28, P1642; Roman MJ, 1996, J AM COLL CARDIOL, V28, P751, DOI 10.1016/0735-1097(96)00225-2; Roman MJ, 2001, AM J CARDIOL, V87, P663, DOI 10.1016/S0002-9149(00)01453-3; Salmon JE, 2001, CURR OPIN RHEUMATOL, V13, P341, DOI 10.1097/00002281-200109000-00001; SALONEN JT, 1993, CIRCULATION, V87, P56; Schnall PL, 1998, PSYCHOSOM MED, V60, P697, DOI 10.1097/00006842-199811000-00007; Schonbeck U, 2001, CIRCULATION, V104, P2266, DOI 10.1161/hc4401.099447; SIMANTOV R, 1995, J CLIN INVEST, V96, P2211, DOI 10.1172/JCI118276; Svenungsson E, 2001, CIRCULATION, V104, P1887, DOI 10.1161/hc4101.097518; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; UELAND PM, 1993, CLIN CHEM, V39, P1764; UROWITZ MB, 1976, AM J MED, V60, P221, DOI 10.1016/0002-9343(76)90431-9; Vaarala O, 2000, J INTERN MED, V247, P381, DOI 10.1046/j.1365-2796.2000.00657.x; Vakkalanka RK, 1999, ARTHRITIS RHEUM, V42, P871, DOI 10.1002/1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J; Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F	33	1035	1104	1	19	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					2399	2406		10.1056/NEJMoa035471	http://dx.doi.org/10.1056/NEJMoa035471			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681505				2022-12-28	WOS:000187326200005
J	McNamara, RL; Tamariz, LJ; Segal, JB; Bass, EB				McNamara, RL; Tamariz, LJ; Segal, JB; Bass, EB			Management of atrial fibrillation: Review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography	ANNALS OF INTERNAL MEDICINE			English	Review							VENTRICULAR RATE CONTROL; HEART-RATE CONTROL; INTRAVENOUSLY ADMINISTERED DOFETILIDE; ANTIARRHYTHMIC-DRUG THERAPY; MAINTAINING SINUS RHYTHM; PLACEBO-CONTROLLED TRIAL; FIXED MINIDOSE WARFARIN; LOW-DOSE DILTIAZEM; RECENT-ONSET; DOUBLE-BLIND	Purpose: This review summarizes the available evidence regarding the efficacy of medications used for ventricular rate control, stroke prevention, acute conversion, and maintenance of sinus rhythm, as well as the efficacy of electrical cardioversion and the use of echocardiography in patients with atrial fibrillation. Data Sources: The Cochrane Collaboration's database of controlled clinical trials and MEDLINE. Study Selection: Primarily randomized, controlled trials of medications. Data Extraction: Paired reviewers obtained data on efficacy and safety. Strength of evidence was assessed. Data Synthesis: Recent clinical trial results showed that most patients with atrial fibrillation have similar outcomes with strategies for controlling ventricular rate compared with strategies for restoring sinus rhythm. For efficacy of primary stroke prevention, compared with placebo, evidence was strong for warfarin suggestive for aspirin. The evidence for an increased risk for major bleeding was suggestive for warfarin and inconclusive for aspirin. For ventricular rate control, verapamil, diltiazem, atenolol, and metoprolol were qualitatively superior to digoxin and placebo, particularly during exercise. For efficacy of acute conversion, compared with placebo, evidence was strong for ibutilide, flecainide, dofetilide, propafenone, amiodarone, and quinidine. For efficacy of maintenance of sinus rhythm after conversion from atrial fibrillation, evidence was strong for amiodarone, propafenone, disopyramide, and sotalol. Echocardiography was found to be useful in estimating risk for thromboembolism and potentially useful in estimating likelihood of successful cardioversion and maintenance. Conclusions: For several key questions in the pharmacologic management of atrial fibrillation, strong evidence exists to support 1 or more treatment options.	Yale Univ, Cardiovasc Sect, Sch Med, New Haven, CT 06520 USA; Johns Hopkins Univ, Baltimore, MD USA	Yale University; Johns Hopkins University	McNamara, RL (corresponding author), Yale Univ, Cardiovasc Sect, Sch Med, 333 Cedar St,316 FMP,POB 208017, New Haven, CT 06520 USA.	robert.mcnamara@yale.edu		Bass, Eric/0000-0001-9106-527X; Tamariz, Leonardo/0000-0003-1583-3534	NHLBI NIH HHS [T32HL07180] Funding Source: Medline; PHS HHS [290-97-0006] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007180] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abi-Mansour P, 1998, AM HEART J, V136, P632, DOI 10.1016/S0002-8703(98)70010-9; AHUJA RC, 1989, INT J CARDIOL, V25, P325, DOI 10.1016/0167-5273(89)90223-4; Aliot E, 1996, AM J CARDIOL, V77, pA66; Alp NJ, 2000, HEART, V84, P37, DOI 10.1136/heart.84.1.37; Alt E, 1997, EUR HEART J, V18, P1796; ANDERSON DC, 1992, ANN INTERN MED, V116, P6; ANG EL, 1990, BRIT HEART J, V64, P256; [Anonymous], 1989, NEW ENGL J MED, V321, P406; [Anonymous], 1997, Eur Heart J, V18, P649; Antonielli E, 2002, J AM COLL CARDIOL, V39, P1443, DOI 10.1016/S0735-1097(02)01800-4; Azpitarte J, 1997, EUR HEART J, V18, P1649; BALDI N, 1993, NEW TRENDS ARRHYTHMI, V9, P899; BAROFFIO R, 1995, CLIN DRUG INVEST, V9, P277, DOI 10.2165/00044011-199509050-00005; BARRANCO F, 1994, INTENS CARE MED, V20, P42, DOI 10.1007/BF02425054; Bellandi F, 2001, AM J CARDIOL, V88, P640, DOI 10.1016/S0002-9149(01)01806-9; Bellandi F, 1996, CARDIOVASC DRUG THER, V10, P153, DOI 10.1007/BF00823593; BELLANDI F, 1995, CURR THER RES CLIN E, V56, P1154, DOI 10.1016/0011-393X(95)85125-9; BELLANDI F, 1995, CLIN CARDIOL, V18, P631, DOI 10.1002/clc.4960181108; Benditt DG, 1999, AM J CARDIOL, V84, P270, DOI 10.1016/S0002-9149(99)00275-1; BERTINI G, 1990, Journal of Emergency Medicine, V8, P15, DOI 10.1016/0736-4679(90)90380-E; BIALY D, 1992, Journal of the American College of Cardiology, V19, p41A; Bianconi L, 1996, J AM COLL CARDIOL, V28, P700, DOI 10.1016/0735-1097(96)00230-6; Bianconi L, 1998, AM J CARDIOL, V82, P584, DOI 10.1016/S0002-9149(98)00412-3; Bianconi L, 2000, EUR HEART J, V21, P1265, DOI 10.1053/euhj.1999.2039; BIANCONI L, 1993, NEW TRENDS ARRHYTHMI, V9, P1017; BJERKELUND CJ, 1969, AM J CARDIOL, V23, P208, DOI 10.1016/0002-9149(69)90068-X; Blackshear JL, 1996, LANCET, V348, P633; Blanc JJ, 1999, AM J CARDIOL, V84, P1029, DOI 10.1016/S0002-9149(99)00493-2; BORIANI G, 1995, CHEST, V108, P355, DOI 10.1378/chest.108.2.355; Boriani G, 1997, ANN INTERN MED, V126, P621, DOI 10.7326/0003-4819-126-8-199704150-00006; Botto GL, 1998, CLIN CARDIOL, V21, P837, DOI 10.1002/clc.4960211110; Botto GL, 1997, INT J CARDIOL, V58, P55, DOI 10.1016/S0167-5273(96)02841-0; BOUDONAS G, 1995, ACTA CARDIOL, V50, P125; BRAND FN, 1985, JAMA-J AM MED ASSOC, V254, P3449, DOI 10.1001/jama.254.24.3449; BRODSKY MA, 1994, AM J CARDIOL, V73, P1227, DOI 10.1016/0002-9149(94)90190-2; BYRNEQUINN E, 1970, BRIT HEART J, V32, P370; CAPUCCI A, 1994, INT J CARDIOL, V43, P305, DOI 10.1016/0167-5273(94)90211-9; CAPUCCI A, 1992, AM J CARDIOL, V70, P69, DOI 10.1016/0002-9149(92)91392-H; Chan Kwan-Leung, 1998, Annals of Internal Medicine, V128, P639; CHANNER KS, 1987, EUR HEART J, V8, P141, DOI 10.1093/oxfordjournals.eurheartj.a062241; CHANNER KS, 1994, BRIT J CLIN PHARMACO, V37, P53, DOI 10.1111/j.1365-2125.1994.tb04238.x; COBBE SM, 1995, CIRCULATION, V92, P2550; CONNOLLY SJ, 1991, J AM COLL CARDIOL, V18, P349, DOI 10.1016/0735-1097(91)90585-W; COPLEN SE, 1990, CIRCULATION, V82, P1106, DOI 10.1161/01.CIR.82.4.1106; Cotter G, 1999, EUR HEART J, V20, P1833, DOI 10.1053/euhj.1999.1747; COWAN JC, 1986, J CARDIOVASC PHARM, V8, P252, DOI 10.1097/00005344-198603000-00005; Crijns HJGM, 1996, CARDIOVASC DRUG THER, V10, P145, DOI 10.1007/BF00823592; DAHLSTROM CG, 1992, CLIN CARDIOL, V15, P280, DOI 10.1002/clc.4960150411; de Paola AAV, 1999, AM J CARDIOL, V84, P1033; Deedwania PC, 1998, CIRCULATION, V98, P2574, DOI 10.1161/01.CIR.98.23.2574; Deeks~ JJ, 2001, SYSTEMATIC REV HLTH; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DIBIANCO R, 1984, AM HEART J, V108, P1121, DOI 10.1016/0002-8703(84)90592-1; DONOVAN KD, 1995, AM J CARDIOL, V75, P693, DOI 10.1016/S0002-9149(99)80655-9; ELLENBOGEN KA, 1991, J AM COLL CARDIOL, V18, P891, DOI 10.1016/0735-1097(91)90743-S; Ellenbogen KA, 1996, J AM COLL CARDIOL, V28, P130, DOI 10.1016/0735-1097(96)00121-0; Ezekowitz M, 1998, ARCH INTERN MED, V158, P1316; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; FALK RH, 1987, ANN INTERN MED, V106, P503, DOI 10.7326/0003-4819-106-4-503; FALK RH, 1992, ANN INTERN MED, V117, P141, DOI 10.7326/0003-4819-117-2-141; Falk RH, 1997, J AM COLL CARDIOL, V29, P385, DOI 10.1016/S0735-1097(96)00506-2; Farshi R, 1999, J AM COLL CARDIOL, V33, P304, DOI 10.1016/S0735-1097(98)00561-0; Fatkin D, 1996, AM J CARDIOL, V77, P321, DOI 10.1016/S0002-9149(97)89406-4; FATKIN D, 1994, J AM COLL CARDIOL, V23, P307, DOI 10.1016/0735-1097(94)90412-X; FLEGEL KM, 1987, LANCET, V1, P526; Fresco C, 1996, CLIN CARDIOL, V19, P409, DOI 10.1002/clc.4960190515; FURBERG CD, 1994, AM J CARDIOL, V74, P236, DOI 10.1016/0002-9149(94)90363-8; Fuster V, 2001, J AM COLL CARDIOL, V38, P1231, DOI 10.1016/S0735-1097(01)01587-X; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; Galperin Jorge, 2001, Journal of Cardiovascular Pharmacology and Therapeutics, V6, P341, DOI 10.1177/107424840100600403; Galve E, 1996, J AM COLL CARDIOL, V27, P1079, DOI 10.1016/0735-1097(95)00595-1; Ganau G, 1998, J Emerg Med, V16, P383, DOI 10.1016/S0736-4679(98)00003-1; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; GOLDENBERG IF, 1994, AM J CARDIOL, V74, P884, DOI 10.1016/0002-9149(94)90580-0; GOLDMAN MJ, 1960, PROG CARDIOVASC DIS, V2, P465, DOI 10.1016/S0033-0620(60)80005-9; GULLESTAD L, 1993, CLIN CARDIOL, V16, P429, DOI 10.1002/clc.4960160512; Gullov AL, 1998, ARCH INTERN MED, V158, P1513, DOI 10.1001/archinte.158.14.1513; GUNNING JF, 1970, BRIT HEART J, V32, P462; Guo GBF, 1996, J AM COLL CARDIOL, V27, P1083, DOI 10.1016/0735-1097(95)00607-9; HALINEN MO, 1995, AM J CARDIOL, V76, P495, DOI 10.1016/S0002-9149(99)80137-4; HAMER ME, 1994, AM J CARDIOL, V74, P826, DOI 10.1016/0002-9149(94)90448-0; HARENBERG J, 1993, SEMIN THROMB HEMOST, V19, P116; Harjai K, 1998, AM J CARDIOL, V81, P1125, DOI 10.1016/S0002-9149(98)00141-6; Hart RG, 2000, J AM COLL CARDIOL, V35, P183, DOI 10.1016/S0735-1097(99)00489-1; HAYS JV, 1994, ANN EMERG MED, V24, P61, DOI 10.1016/S0196-0644(94)70163-6; Hellemons BSP, 1999, BMJ-BRIT MED J, V319, P958, DOI 10.1136/bmj.319.7215.958; HILLESTAD L, 1971, BRIT HEART J, V33, P518; Hirsh J, 2001, CHEST, V119, p1S, DOI 10.1378/chest.119.1_suppl.1S; Hohnloser SH, 2000, LANCET, V356, P1789, DOI 10.1016/S0140-6736(00)03230-X; HOHNLOSER SH, 1995, J AM COLL CARDIOL, V26, P852, DOI 10.1016/0735-1097(95)00286-5; HOU ZY, 1995, EUR HEART J, V16, P521, DOI 10.1093/oxfordjournals.eurheartj.a060945; HWANG JJ, 1993, AM J CARDIOL, V72, P677; Innes GD, 1997, ANN EMERG MED, V29, P126, DOI 10.1016/S0196-0644(97)70318-4; JAMES MA, 1989, EUR HEART J, V10, P83, DOI 10.1093/oxfordjournals.eurheartj.a059386; Jones EF, 1996, AM J CARDIOL, V78, P425, DOI 10.1016/S0002-9149(96)00331-1; Jordaens L, 1997, EUR HEART J, V18, P643; Joseph AP, 2000, ANN EMERG MED, V36, P1, DOI 10.1067/mem.2000.107655; Joshi P P, 1995, J Assoc Physicians India, V43, P529; JUULMOLLER S, 1990, CIRCULATION, V82, P1932, DOI 10.1161/01.CIR.82.6.1932; KANNEL WB, 1983, AM HEART J, V106, P389, DOI 10.1016/0002-8703(83)90208-9; KINGMA JH, 1992, AM J CARDIOL, V70, pA56, DOI 10.1016/0002-9149(92)91079-J; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; Klein AL, 2001, J AM COLL CARDIOL, V37, P691, DOI 10.1016/S0735-1097(00)01178-5; Klein AL, 2001, NEW ENGL J MED, V344, P1411, DOI 10.1056/NEJM200105103441901; Kochiadakis GE, 2000, PACE, V23, P1883; Kochiadakis GE, 1998, PACE, V21, P2475, DOI 10.1111/j.1540-8159.1998.tb01204.x; Kochiadakis GE, 1999, J AM COLL CARDIOL, V33, P966, DOI 10.1016/S0735-1097(98)00678-0; Kochiadakis GE, 1998, AM J CARDIOL, V81, P995, DOI 10.1016/S0002-9149(98)00078-2; KOH KK, 1995, AM J CARDIOL, V75, P88, DOI 10.1016/S0002-9149(99)80538-4; Koh KK, 1995, INT J CARDIOL, V52, P167, DOI 10.1016/0167-5273(95)02480-K; KOPECKY SL, 1987, NEW ENGL J MED, V317, P669, DOI 10.1056/NEJM198709103171104; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; LANG R, 1983, AM HEART J, V105, P820, DOI 10.1016/0002-8703(83)90246-6; LAWSONMATTHEW PJ, 1995, AGE AGEING, V24, P321, DOI 10.1093/ageing/24.4.321; Lee SH, 1997, AM J CARDIOL, V79, P905, DOI 10.1016/S0002-9149(97)00025-8; Lee SH, 1996, J INTERN MED, V239, P253, DOI 10.1046/j.1365-2796.1996.451805000.x; Leung DY, 1997, AM J CARDIOL, V79, P626, DOI 10.1016/S0002-9149(96)00828-4; LEUNG DYC, 1994, J AM COLL CARDIOL, V24, P755, DOI 10.1016/0735-1097(94)90025-6; LEVI G, 1973, CARDIOLOGY, V58, P364, DOI 10.1159/000169654; LEVY S, 1992, CIRCULATION, V86, P1415, DOI 10.1161/01.CIR.86.5.1415; Levy S, 1999, CIRCULATION, V99, P3028, DOI 10.1161/01.CIR.99.23.3028; LEWIS RV, 1988, EUR HEART J, V9, P279, DOI 10.1093/oxfordjournals.eurheartj.a062497; LEWIS RV, 1989, J CARDIOVASC PHARM, V13, P1, DOI 10.1097/00005344-198901000-00002; LEWIS RV, 1988, EUR HEART J, V9, P777, DOI 10.1093/eurheartj/9.7.777; LIN SK, 1986, J CARDIOVASC PHARM, V8, pS112, DOI 10.1097/00005344-198608004-00025; Lindeboom JE, 2000, AM J CARDIOL, V85, P1031, DOI 10.1016/S0002-9149(99)00927-3; Lok NS, 1997, CHEST, V111, P934, DOI 10.1378/chest.111.4.934; LOWN B, 1963, NEW ENGL J MED, V269, P325, DOI 10.1056/NEJM196308152690701; LUNDSTROM T, 1990, J AM COLL CARDIOL, V16, P86, DOI 10.1016/0735-1097(90)90461-W; LUNDSTROM T, 1992, AM HEART J, V124, P917, DOI 10.1016/0002-8703(92)90973-Y; MADRID AH, 1993, EUR HEART J, V14, P1127, DOI 10.1093/eurheartj/14.8.1127; Maisel WH, 1997, ANN INTERN MED, V127, P281, DOI 10.7326/0003-4819-127-4-199708150-00004; MANNING WJ, 1993, NEW ENGL J MED, V328, P750, DOI 10.1056/NEJM199303183281102; MANNING WJ, 1995, ANN INTERN MED, V123, P817, DOI 10.7326/0003-4819-123-11-199512010-00001; Martinez-Marcos FJ, 2000, AM J CARDIOL, V86, P950, DOI 10.1016/S0002-9149(00)01128-0; MCBRIDE R, 1994, LANCET, V343, P687; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; MCCARTHY C, 1969, BRIT HEART J, V31, P496; McNamara R. L., 2001, AGENCY HEALTHCARE RE; Miller MR, 2000, J FAM PRACTICE, V49, P1033; Mittal S, 2000, CIRCULATION, V101, P1282, DOI 10.1161/01.CIR.101.11.1282; MOREYRA E, 1995, AM HEART J, V129, P71, DOI 10.1016/0002-8703(95)90045-4; Morocutti C, 1997, STROKE, V28, P1015, DOI 10.1161/01.STR.28.5.1015; MYERS J, 1987, J APPL PHYSIOL, V63, P97, DOI 10.1152/jappl.1987.63.1.97; Naccarelli GV, 1996, AM J CARDIOL, V77, pA53, DOI 10.1016/S0002-9149(97)89118-7; Niebauer MJ, 2000, CIRCULATION, V102, P574; NOC M, 1990, AM J CARDIOL, V65, P679, DOI 10.1016/0002-9149(90)91053-9; Norgaard BL, 1999, AM HEART J, V137, P1062, DOI 10.1016/S0002-8703(99)70363-7; Oral H, 1999, NEW ENGL J MED, V340, P1849, DOI 10.1056/NEJM199906173402401; OSTRANDER LD, 1965, CIRCULATION, V31, P888, DOI 10.1161/01.CIR.31.6.888; Page RL, 2002, J AM COLL CARDIOL, V39, P1956, DOI 10.1016/S0735-1097(02)01898-3; PANIDIS IP, 1983, AM J CARDIOL, V52, P1197, DOI 10.1016/0002-9149(83)90573-8; Pedersen OD, 2001, CIRCULATION, V104, P292, DOI 10.1161/01.CIR.104.3.292; Pengo V, 1998, AM J CARDIOL, V82, P433, DOI 10.1016/S0002-9149(98)00357-9; PETERSEN P, 1989, LANCET, V1, P175; Peuhkurinen K, 2000, AM J CARDIOL, V85, P462, DOI 10.1016/S0002-9149(99)00789-4; POMFRET SM, 1988, CLIN SCI, V74, P351, DOI 10.1042/cs0740351; Posada IS, 1999, AM HEART J, V138, P137, DOI 10.1016/S0002-8703(99)70259-0; Pritchett ELC, 2000, J AM COLL CARDIOL, V36, P794, DOI 10.1016/S0735-1097(00)00773-7; Protheroe J, 2000, BRIT MED J, V320, P1380, DOI 10.1136/bmj.320.7246.1380; PRYSTOWSKY EN, 1994, CLIN CARDIOL S2, V17, P7; Psaty BM, 1997, CIRCULATION, V96, P2455; RASMUSSEN K, 1981, ACTA MED SCAND, P23; REIMOLD SC, 1993, AM J CARDIOL, V71, P558, DOI 10.1016/0002-9149(93)90511-A; Reisinger J, 1998, AM J CARDIOL, V81, P1450, DOI 10.1016/S0002-9149(98)00223-9; RODEN DM, 1994, NEW ENGL J MED, V331, P785; ROTH A, 1992, ANN INTERN MED, V116, P388, DOI 10.7326/0003-4819-116-5-388; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; SALERNO DM, 1989, AM J CARDIOL, V63, P1046, DOI 10.1016/0002-9149(89)90076-3; SCARDI S, 1993, LANCET, V341, P1211, DOI 10.1016/0140-6736(93)91038-N; Schreck DM, 1997, ANN EMERG MED, V29, P135, DOI 10.1016/S0196-0644(97)70319-6; Scott M E, 1968, Ulster Med J, V37, P155; Segal JB, 2000, J GEN INTERN MED, V15, P56, DOI 10.1046/j.1525-1497.2000.04329.x; Segal JB, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001938.PUB2]; Seidl K, 2002, J AM COLL CARDIOL, V39, P1436, DOI 10.1016/S0735-1097(02)01785-0; Seto TB, 1997, J AM COLL CARDIOL, V29, P122, DOI 10.1016/S0735-1097(96)00448-2; Singh S, 2000, CIRCULATION, V102, P2385, DOI 10.1161/01.CIR.102.19.2385; SINGH S, 1991, AM J CARDIOL, V68, P1227, DOI 10.1016/0002-9149(91)90200-5; SMIT AJ, 1990, EUR J CLIN PHARMACOL, V38, P335, DOI 10.1007/BF00315571; SODERMARK T, 1975, BRIT HEART J, V37, P486; Stambler BS, 1996, CIRCULATION, V94, P1613, DOI 10.1161/01.CIR.94.7.1613; STERN EH, 1982, CHEST, V81, P308, DOI 10.1378/chest.81.3.308; STODDARD MF, 1995, AM HEART J, V129, P1204, DOI 10.1016/0002-8703(95)90405-0; Stollberger C, 1998, ANN INTERN MED, V128, P630, DOI 10.7326/0003-4819-128-8-199804150-00004; Stroobandt R, 1997, AM J CARDIOL, V79, P418, DOI 10.1016/S0002-9149(96)00779-5; SUNG RJ, 1995, AM HEART J, V129, P739, DOI 10.1016/0002-8703(95)90324-0; SUTTORP MJ, 1989, AM J CARDIOL, V63, P693, DOI 10.1016/0002-9149(89)90253-1; SUTTORP MJ, 1990, J AM COLL CARDIOL, V16, P1722, DOI 10.1016/0735-1097(90)90326-K; SWEANY AE, 1985, CLIN PHARMACOL THER, V37, P124, DOI 10.1038/clpt.1985.23; TOMMASO C, 1983, ARCH INTERN MED, V143, P877, DOI 10.1001/archinte.143.5.877; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; VANGELDER IC, 1989, AM J CARDIOL, V64, P1317, DOI 10.1016/0002-9149(89)90574-2; VANWIJK LM, 1989, J CARDIOVASC PHARM, V13, P32, DOI 10.1097/00005344-198901000-00005; Vardas PE, 2000, CHEST, V117, P1538, DOI 10.1378/chest.117.6.1538; Volgman AS, 1998, J AM COLL CARDIOL, V31, P1414, DOI 10.1016/S0735-1097(98)00078-3; Vos MA, 1998, HEART, V79, P568, DOI 10.1136/hrt.79.6.568; Wattanasuwan N, 2001, CHEST, V119, P502, DOI 10.1378/chest.119.2.502; WEINER P, 1994, CHEST, V105, P1013, DOI 10.1378/chest.105.4.1013; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973; WONG CK, 1990, AM J CARDIOL, V66, P1212, DOI 10.1016/0002-9149(90)91102-C; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Yamaguchi T, 2000, STROKE, V31, P817, DOI 10.1161/01.STR.31.4.817; Zabalgoitia M, 1998, J AM COLL CARDIOL, V31, P1622, DOI 10.1016/S0735-1097(98)00146-6; ZEHENDER M, 1992, J AM COLL CARDIOL, V19, P1054, DOI 10.1016/0735-1097(92)90294-W; Zimetbaum PJ, 1999, AM J CARDIOL, V83, P450, DOI 10.1016/S0002-9149(98)00885-6; ZOBLE RG, 1987, AM J CARDIOL, V60, pD39; 1993, LANCET, V342, P1255	209	153	167	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2003	139	12					1018	1033		10.7326/0003-4819-139-12-200312160-00012	http://dx.doi.org/10.7326/0003-4819-139-12-200312160-00012			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756AG	14678922				2022-12-28	WOS:000187443200018
J	Kolodgie, FD; Gold, HK; Burke, AP; Fowler, DR; Kruth, HS; Weber, DK; Farb, A; Guerrero, LJ; Hayase, M; Kutys, R; Narula, J; Finn, AV; Virmani, R				Kolodgie, FD; Gold, HK; Burke, AP; Fowler, DR; Kruth, HS; Weber, DK; Farb, A; Guerrero, LJ; Hayase, M; Kutys, R; Narula, J; Finn, AV; Virmani, R			Intraplaque hemorrhage and progression of coronary atheroma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RED-BLOOD-CELLS; LOW-DENSITY-LIPOPROTEIN; ATHEROSCLEROTIC LESIONS; PLAQUE MORPHOLOGY; CHOLESTEROL; ERYTHROCYTES; MEMBRANE; RECEPTOR; DISEASE; HYPERCHOLESTEROLEMIA	BACKGROUND: Intraplaque hemorrhage is common in advanced coronary atherosclerotic lesions. The relation between hemorrhage and the vulnerability of plaque to disruption may involve the accumulation of free cholesterol from erythrocyte membranes. METHODS: We stained multiple coronary lesions from 24 randomly selected patients who had died suddenly of coronary causes with an antibody against glycophorin A (a protein specific to erythrocytes that facilitates anion exchange) and Mallory's stain for iron (hemosiderin), markers of previous intraplaque hemorrhage. Coronary lesions were classified as lesions with pathologic intimal thickening, fibrous-cap atheromas with cores in an early or late stage of necrosis, or thin-cap fibrous atheromas (vulnerable plaques). The arterial response to plaque hemorrhage was further defined in a rabbit model of atherosclerosis. RESULTS: Only traces of glycophorin A and iron were found in lesions with pathologic intimal thickening or fibrous-cap atheromas with cores in an early stage of necrosis. In contrast, fibroatheromas with cores in a late stage of necrosis or thin caps had a marked increase in glycophorin A in regions of cholesterol clefts surrounded by iron deposits. Larger amounts of both glycophorin A and iron were associated with larger necrotic cores and greater macrophage infiltration. Rabbit lesions with induced intramural hemorrhage consistently showed cholesterol crystals with erythrocyte fragments, foam cells, and iron deposits. In contrast, control lesions from the same animals had a marked reduction in macrophages and lipid content. CONCLUSIONS: By contributing to the deposition of free cholesterol, macrophage infiltration, and enlargement of the necrotic core, the accumulation of erythrocyte membranes within an atherosclerotic plaque may represent a potent atherogenic stimulus. These factors may increase the risk of plaque destabilization.	Armed Forces Inst Pathol, Dept Cardiovasc Pathol, Washington, DC 20306 USA; Massachusetts Gen Hosp, Dept Internal Med, Cardiac Unit, Boston, MA 02114 USA; Univ Maryland, Dept Pathol, Baltimore, MD 21201 USA; NHLBI, Sect Expt Atherosclerosis, NIH, Bethesda, MD 20892 USA; Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	United States Department of Defense; Harvard University; Massachusetts General Hospital; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Drexel University	Virmani, R (corresponding author), Armed Forces Inst Pathol, Dept Cardiovasc Pathol, Bldg 54,Rm 2005,6825 16th St, Washington, DC 20306 USA.				NHLBI NIH HHS [R01 HL61799-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061799, Z01HL002832, ZIAHL002832] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arbustini E, 2002, HEART, V88, P177, DOI 10.1136/heart.88.2.177; Auffray I, 2001, BLOOD, V97, P2872, DOI 10.1182/blood.V97.9.2872; Balkan J, 2002, BIOSCI BIOTECH BIOCH, V66, P2701, DOI 10.1271/bbb.66.2701; BARGER AC, 1984, NEW ENGL J MED, V310, P175, DOI 10.1056/NEJM198401193100307; Bloch K., 1991, NEW COMPREHENSIVE BI, V20, P363; Burke AP, 2002, CIRCULATION, V105, P297, DOI 10.1161/hc0302.102610; Burke AP, 1999, JAMA-J AM MED ASSOC, V281, P921, DOI 10.1001/jama.281.10.921; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; COFFEY MD, 1995, J CLIN INVEST, V96, P1866, DOI 10.1172/JCI118232; DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442; Felton CV, 1997, ARTERIOSCL THROM VAS, V17, P1337, DOI 10.1161/01.ATV.17.7.1337; Guyton JR, 1996, ARTERIOSCL THROM VAS, V16, P4, DOI 10.1161/01.ATV.16.1.4; Ishikawa K, 2001, CIRC RES, V88, P506, DOI 10.1161/01.RES.88.5.506; ITO N, 1990, HISTOCHEM J, V22, P113, DOI 10.1007/BF01885790; Kempaiah RK, 2002, MOL CELL BIOCHEM, V236, P155, DOI 10.1023/A:1016199000149; Kockx MM, 2003, ARTERIOSCL THROM VAS, V23, P440, DOI 10.1161/01.ATV.0000057807.28754.7F; Koeppen AH, 1995, J NEUROL SCI, V134, P102, DOI 10.1016/0022-510X(95)00215-N; Koter M, 2002, EUR J CLIN PHARMACOL, V58, P501, DOI 10.1007/s00228-002-0507-9; KRUTH HS, 1984, AM J PATHOL, V114, P201; LALONDE JMA, 1977, VIRCHOWS ARCH B, V25, P221; Leon ME, 2002, ARCH PATHOL LAB MED, V126, P217; Martinez M, 1996, THROMB RES, V83, P375, DOI 10.1016/0049-3848(96)00147-8; McCarthy MJ, 1999, J VASC SURG, V30, P261, DOI 10.1016/S0741-5214(99)70136-9; Mofidi R, 2001, BRIT J SURG, V88, P945, DOI 10.1046/j.0007-1323.2001.01823.x; NEOTE K, 1993, J BIOL CHEM, V268, P12247; PATTERSON JC, 1954, S ATH; SAMBRANO GR, 1994, P NATL ACAD SCI USA, V91, P3265, DOI 10.1073/pnas.91.8.3265; SCHICK BP, 1985, BIOCHIM BIOPHYS ACTA, V833, P281, DOI 10.1016/0005-2760(85)90200-0; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Tabas I, 2000, BBA-MOL CELL BIOL L, V1529, P164, DOI 10.1016/S1388-1981(00)00146-3; Tulenko TN, 1998, J LIPID RES, V39, P947; Virmani R, 1998, AM HEART J, V136, P937, DOI 10.1016/S0002-8703(98)70144-9; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Virmani R., 1987, ADULT CONGENITAL HEA, P77; VIRMANI R, 1996, ATLAS CARDIOVASCULAR, P103; Wartman WB, 1938, AM HEART J, V15, P459, DOI 10.1016/S0002-8703(38)90300-X; WARTMAN WB, 1949, AM J PATHOL, V25, P383; WINTERNITZ MC, 1938, BIOL ARTERIOSCLEROSI, P94; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; YUAN XM, 1995, ARTERIOSCL THROM VAS, V15, P1345, DOI 10.1161/01.ATV.15.9.1345	40	1044	1110	4	48	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					2316	2325		10.1056/NEJMoa035655	http://dx.doi.org/10.1056/NEJMoa035655			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668457				2022-12-28	WOS:000187125000007
J	Llovet, JM; Burroughs, A; Bruix, J				Llovet, JM; Burroughs, A; Bruix, J			Hepatocellular carcinoma	LANCET			English	Review							RANDOMIZED CONTROLLED-TRIAL; HEPATITIS-C-VIRUS; TRANSARTERIAL LIPIODOL CHEMOEMBOLIZATION; PERCUTANEOUS RADIOFREQUENCY ABLATION; ETHANOL INJECTION THERAPY; B SURFACE-ANTIGEN; LIVER-TRANSPLANTATION; NATURAL-HISTORY; COST-EFFECTIVENESS; ARTERIAL EMBOLIZATION	Hepatocellular carcinoma (HCC) is the fifth most common cause of cancer, and its incidence is increasing worldwide because of the dissemination of hepatitis B and C virus infection. Patients with cirrhosis are at the highest risk and should be monitored every 6 months. Surveillance can lead to diagnosis at early stages, when the tumour might be curable by resection, liver transplantation, or percutaneous treatment. In the West and Japan, these treatments can be applied to 30% of patients, and result in 5-year survival rates higher than 50%. Resection is indicated among patients who have one tumour and well-preserved liver function. Liver transplantation benefits patients who have decompensated cirrhosis and one tumour smaller than 5 cm or three nodules smaller than 3 cm, but donor shortage greatly limits its applicability. This difficulty might be overcome by living donation. Most HCC patients are diagnosed at advanced stages and receive palliative treatments, which have been assessed in the setting of 63 randomised controlled trials during the past 25 years. Meta-analysis shows that only chemoembolisation improves survival in well-selected patients with unresectable HCC.	Univ Barcelona, Hosp Clin & Prov, IDIBAPS,Digest Dis Inst, Barcelona Clin Liver Canc Grp, E-08036 Barcelona, Spain; Royal Free Hosp, London NW3 2QG, England	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Bruix, J (corresponding author), Univ Barcelona, Hosp Clin & Prov, IDIBAPS,Digest Dis Inst, Barcelona Clin Liver Canc Grp, Villarroel 170, E-08036 Barcelona, Spain.	jbruix@clinic.ub.es	Llovet, Josep M/D-4340-2014; Forner, Alejandro/C-8884-2016; Llovet, Josep M/ABB-6264-2021	Llovet, Josep M/0000-0003-0547-2667; Forner, Alejandro/0000-0002-9014-4950; Llovet, Josep M/0000-0003-0547-2667; Bruix, Jordi/0000-0002-9826-0753				Arii S, 2000, HEPATOLOGY, V32, P1224, DOI 10.1053/jhep.2000.20456; BARBARA L, 1992, HEPATOLOGY, V16, P132, DOI 10.1002/hep.1840160122; BEASLEY RP, 1981, LANCET, V2, P1129; Befeler AS, 2002, GASTROENTEROLOGY, V122, P1609, DOI 10.1053/gast.2002.33411; Bismuth H, 2000, J HEPATOL, V32, P208, DOI 10.1016/S0168-8278(00)80427-4; BISMUTH H, 1993, ANN SURG, V218, P145, DOI 10.1097/00000658-199308000-00005; Bismuth H, 1999, SEMIN LIVER DIS, V19, P311, DOI 10.1055/s-2007-1007120; BOIX L, 1993, J HEPATOL, V17, P187, DOI 10.1016/S0168-8278(05)80036-4; Bolondi L, 2001, GUT, V48, P251, DOI 10.1136/gut.48.2.251; Bosch FX, 1999, SEMIN LIVER DIS, V19, P271, DOI 10.1055/s-2007-1007117; Brechot C, 2001, HEPATOLOGY, V34, P194, DOI 10.1053/jhep.2001.25172; BRUIX J, 1989, LANCET, V2, P1004; Bruix J, 1998, HEPATOLOGY, V27, P1578, DOI 10.1002/hep.510270617; Bruix J, 1996, GASTROENTEROLOGY, V111, P1018, DOI 10.1016/S0016-5085(96)70070-7; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2002, HEPATOLOGY, V35, P519, DOI 10.1053/jhep.2002.32089; Bruno S, 1997, HEPATOLOGY, V25, P754, DOI 10.1002/hep.510250344; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Burrel M, 2003, HEPATOLOGY, V38, P1034, DOI 10.1053/jhep.2003.50409; Buscarini L, 2001, EUR RADIOL, V11, P914, DOI 10.1007/s003300000659; CASTELLS A, 1995, GASTROENTEROLOGY, V109, P917, DOI 10.1016/0016-5085(95)90402-6; CEREZO FJM, 1994, J HEPATOL, V20, P702, DOI 10.1016/S0168-8278(05)80138-2; Chang MH, 2000, JAMA-J AM MED ASSOC, V284, P3040, DOI 10.1001/jama.284.23.3040; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chevret S, 1999, J HEPATOL, V31, P133, DOI 10.1016/S0168-8278(99)80173-1; Choi D, 2001, J COMPUT ASSIST TOMO, V25, P777, DOI 10.1097/00004728-200109000-00018; Chow PKH, 2002, HEPATOLOGY, V36, P1221, DOI 10.1053/jhep.2002.36824; Collier J, 1998, HEPATOLOGY, V27, P273, DOI 10.1002/hep.510270140; Colombo M, 2003, FALK SYMP, V127, P67; COLOMBO M, 1991, NEW ENGL J MED, V325, P675, DOI 10.1056/NEJM199109053251002; Cronin DC, 2001, NEW ENGL J MED, V344, P1633, DOI 10.1056/NEJM200105243442112; Deuffic S, 1998, LANCET, V351, P214, DOI 10.1016/S0140-6736(05)78179-4; Durand F, 2001, J HEPATOL, V35, P254, DOI 10.1016/S0168-8278(01)00108-8; EBARA M, 1986, GASTROENTEROLOGY, V90, P289, DOI 10.1016/0016-5085(86)90923-6; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; ELBA S, 1994, ITAL J GASTROENTEROL, V26, P66; FATTOVICH G, 1995, HEPATOLOGY, V21, P77; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Fong YM, 1999, ANN SURG, V229, P790, DOI 10.1097/00000658-199906000-00005; Forns X, 2002, J HEPATOL, V37, P684, DOI 10.1016/S0168-8278(02)00308-2; Freeman RB, 2002, LIVER TRANSPLANT, V8, P851, DOI 10.1053/jlts.2002.35927; Gallo C, 1998, LANCET, V352, P17; GONDOLESI G, IN PRESS ANN SURG; Grimaldi C, 1998, J CLIN ONCOL, V16, P411, DOI 10.1200/JCO.1998.16.2.411; HADLER S. C., 1997, VIRAL INFECT HUMANS, P363; *INT WORK PART, 1995, HEPATOLOGY, V17, P27; IWATSUKI S, 1991, ANN SURG, V214, P221, DOI 10.1097/00000658-199109000-00005; Jonas S, 2001, HEPATOLOGY, V33, P1080, DOI 10.1053/jhep.2001.23561; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; KAWAI S, 1992, CANCER CHEMOTH PHARM, V31, pS1, DOI 10.1007/BF00687096; Kawai S, 1997, Semin Oncol, V24, pS6; KAWAI S, 1994, CANCER CHEMOTH PHARM, V33, pS97, DOI 10.1007/BF00686677; Kim CK, 2001, J ULTRAS MED, V20, P99; Kojiro M, 2002, PERSP MED V, V6, P113; Kouroumalis E, 1998, GUT, V42, P442, DOI 10.1136/gut.42.3.442; LAI CL, 1993, HEPATOLOGY, V17, P389; Lau WY, 1999, LANCET, V353, P797, DOI 10.1016/S0140-6736(98)06475-7; Lencioni R, 2002, EUR RADIOL, V12, P151, DOI 10.1007/s003300101022; Lencioni R, 1997, EUR RADIOL, V7, P514, DOI 10.1007/s003300050194; Lencioni RA, 2003, RADIOLOGY, V228, P235, DOI 10.1148/radiol.2281020718; Leung TWT, 2002, CANCER, V94, P1760, DOI 10.1002/cncr.10384; LIAW YF, 1986, GASTROENTEROLOGY, V90, P263, DOI 10.1016/0016-5085(86)90919-4; LIN DY, 1988, GASTROENTEROLOGY, V94, P453, DOI 10.1016/0016-5085(88)90436-2; Liu CL, 2000, AM J GASTROENTEROL, V95, P218; Livraghi T, 1999, RADIOLOGY, V210, P655, DOI 10.1148/radiology.210.3.r99fe40655; LIVRAGHI T, 1995, J HEPATOL, V22, P522, DOI 10.1016/0168-8278(95)80445-5; LIVRAGHI T, 1995, RADIOLOGY, V197, P101, DOI 10.1148/radiology.197.1.7568806; Llovet JM, 2000, HEPATOLOGY, V31, P54, DOI 10.1002/hep.510310111; Llovet JM, 2000, J HEPATOL, V33, P423, DOI 10.1016/S0168-8278(00)80278-0; Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Llovet JM, 2003, J HEPATOL, V38, pS136, DOI 10.1016/S0168-8278(02)00432-4; Llovet JM, 2002, GUT, V50, P123, DOI 10.1136/gut.50.1.123; Llovet JM, 2001, HEPATOLOGY, V33, P1124, DOI 10.1053/jhep.2001.24233; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Majno PE, 1997, ANN SURG, V226, P688, DOI 10.1097/00000658-199712000-00006; MAKUUCHI M, 1993, SEMIN SURG ONCOL, V9, P298, DOI 10.1002/ssu.2980090404; MANESIS EK, 1995, HEPATOLOGY, V21, P1535; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mion F, 1996, GASTROENTEROLOGY, V111, P1587, DOI 10.1016/S0016-5085(96)70021-5; Mor E, 1998, ANN INTERN MED, V129, P643, DOI 10.7326/0003-4819-129-8-199810150-00013; Mulier S, 2002, BRIT J SURG, V89, P1206, DOI 10.1046/j.1365-2168.2002.02168.x; Muto Y, 1996, NEW ENGL J MED, V334, P1561, DOI 10.1056/NEJM199606133342402; NAGASUE N, 1993, GASTROENTEROLOGY, V105, P488, DOI 10.1016/0016-5085(93)90724-Q; Nair S, 2002, HEPATOLOGY, V35, P1179, DOI 10.1053/jhep.2002.33160; NIEDERAU C, 1985, NEW ENGL J MED, V313, P1256, DOI 10.1056/NEJM198511143132004; OBERTI F, 1995, NEW ENGL J MED, V332, P1256; Okada S, 1999, SEMIN LIVER DIS, V19, P323, DOI 10.1055/s-2007-1007121; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; PELLETIER G, 1990, J HEPATOL, V11, P181, DOI 10.1016/0168-8278(90)90110-D; Pelletier G, 1998, J HEPATOL, V29, P129, DOI 10.1016/S0168-8278(98)80187-6; Perrone F, 2000, HEPATOLOGY, V31, P840; Poon RTP, 2002, ANN SURG, V235, P466, DOI 10.1097/00000658-200204000-00004; Raoul JL, 1997, HEPATOLOGY, V26, P1156; Riestra S, 1998, J CLIN GASTROENTEROL, V26, P200, DOI 10.1097/00004836-199804000-00010; RINGE B, 1991, WORLD J SURG, V15, P270, DOI 10.1007/BF01659064; Rossi S, 1996, AM J ROENTGENOL, V167, P759, DOI 10.2214/ajr.167.3.8751696; Sakamoto M, 1998, JPN J CLIN ONCOL, V28, P604, DOI 10.1093/jjco/28.10.604; Sarasin FP, 2001, HEPATOLOGY, V33, P1073, DOI 10.1053/jhep.2001.23311; Sarasin FP, 1996, AM J MED, V101, P422, DOI 10.1016/S0002-9343(96)00197-0; Sato S, 2001, J HEPATOL, V35, P225, DOI 10.1016/S0168-8278(01)00083-6; Schwartz JD, 2002, LANCET ONCOL, V3, P593, DOI 10.1016/S1470-2045(02)00873-2; Sun ZT, 1999, HEPATOLOGY, V30, P379, DOI 10.1002/hep.510300204; Takayama T, 1998, HEPATOLOGY, V28, P1241, DOI 10.1002/hep.510280511; Takayama T, 2000, LANCET, V356, P802, DOI 10.1016/S0140-6736(00)02654-4; TAKAYAMA T, 1990, LANCET, V336, P1150, DOI 10.1016/0140-6736(90)92768-D; Takayama T, 2001, JPN J CLIN ONCOL, V31, P297, DOI 10.1093/jjco/hye080; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P15584, DOI 10.1073/pnas.242608099; TANG ZY, 1993, J SURG ONCOL, P55; The Liver Cancer Study Group of Japan, 1994, CANCER, V74, P2272; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Trotter JF, 2002, NEW ENGL J MED, V346, P1074, DOI 10.1056/NEJMra011629; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; *UN NETW ORG SHAR, ANN REP 2002; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; Villa E, 2000, HEPATOLOGY, V32, P233, DOI 10.1053/jhep.2000.9603; Villa E, 2001, BRIT J CANCER, V84, P881, DOI 10.1054/bjoc.2000.1534; Wayne JD, 2002, ANN SURG, V235, P722, DOI 10.1097/00000658-200205000-00015; *WHO, 1997, WKLY EPIDEMIOL REC, V72, P341; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Yao FY, 2002, LIVER TRANSPLANT, V8, P873, DOI 10.1053/jlts.2002.34923; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563; Yuen MF, 2002, HEPATOLOGY, V36, P687, DOI 10.1053/jhep.2002.35071; Zhou XD, 2001, CANCER-AM CANCER SOC, V91, P1479, DOI 10.1002/1097-0142(20010415)91:8<1479::AID-CNCR1155>3.0.CO;2-0	129	3518	3733	23	721	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2003	362	9399					1907	1917		10.1016/S0140-6736(03)14964-1	http://dx.doi.org/10.1016/S0140-6736(03)14964-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667750				2022-12-28	WOS:000187011600024
J	Razavi, R; Hill, DLG; Keevil, SF; Miquel, ME; Muthurangu, V; Hegde, S; Rhode, K; Barnett, M; van Vaals, J; Hawkes, DJ; Baker, E				Razavi, R; Hill, DLG; Keevil, SF; Miquel, ME; Muthurangu, V; Hegde, S; Rhode, K; Barnett, M; van Vaals, J; Hawkes, DJ; Baker, E			Cardiac catheterisation guided by MRI in children and adults with congenital heart disease	LANCET			English	Article							ANIMAL-MODEL; PLACEMENT; ANATOMY; CLOSURE; ARTERY; SWINE; RISK	Background Fluoroscopically guided cardiac catheterisation is an essential tool for diagnosis and treatment of congenital heart disease. Drawbacks include poor soft tissue visualisation and exposure to radiation. We describe the first 16 cases of a novel method of cardiac catheterisation guided by MRI with radiographic support. Methods In our cardiac catheterisation laboratory, we combine magnetic resonance and radiographic imaging facilities. We used MRI to measure flow and morphology, and real-time MRI sequences to visualise balloon angiographic catheters. 12 patients underwent diagnostic cardiac catheterisation, two had interventional cardiac catheterisations, and for two patients, MRI was used to plan radiofrequency ablation for treatment of tachyarrhythmias. Findings In 14 patients, some or all of the cardiac catheterisation was guided by MRI. In two patients undergoing radiofrequency ablation, catheters were manipulated with use of fluoroscopic guidance and outcome was assessed with MRI. All patients received lower amounts of radiation than controls. There was some discrepancy between pulmonary vascular resistance calculated by flow derived from MRI and the traditional Fick method. We were able to superimpose fluoroscopic images of electrophysiology electrode catheters on the three dimensional MRI of the cardiac anatomy. Interpretation We have shown that cardiac catheterisation guided by MRI is safe and practical in a clinical setting, allows better soft tissue visualisation, provides more pertinent physiological information, and results in lower radiation exposure than do fluoroscopically guided procedures. MRI guidance could become the method of choice for diagnostic cardiac catheterisation in patients with congenital heart disease, and an important tool in interventional cardiac catheterisation and radiofrequency ablation.	Univ London Kings Coll, Div Imaging, Cardiac Magnet Resonance Res Grp, London WC2R 2LS, England; Philips Med Syst, Best, Netherlands; Guys Hosp, Dept Congenital Heart Dis, London SE1 9RT, England; Guys Hosp, Dept Anaesthet, London SE1 9RT, England	University of London; King's College London; Philips; Philips Healthcare; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust	Razavi, R (corresponding author), Univ London Kings Coll, Div Imaging Sci, Guys Hosp Campus, London SE1 9RT, England.		muthurangu, vivek/B-6877-2009; Hegde, Sanjeet/T-5209-2019	Miquel, Marc/0000-0003-2209-2076; Razavi, Reza/0000-0003-1065-3008; Hill, Derek/0000-0003-1970-1432; Muthurangu, Vivek/0000-0002-4292-6456				Beerbaum P, 2001, CIRCULATION, V103, P2476; Bos C, 2000, MAGN RESON MED, V44, P575, DOI 10.1002/1522-2594(200010)44:4<575::AID-MRM11>3.0.CO;2-S; Buecker A, 2002, J MAGN RESON IMAGING, V16, P201, DOI 10.1002/jmri.10148; Buecker A, 2002, CIRCULATION, V106, P511, DOI 10.1161/01.CIR.0000023621.88708.62; Dargie H, 2002, HEART, V88, P1, DOI 10.1136/heart.88.1.1; FAULKNER K, 1986, BRIT J RADIOL, V59, P359, DOI 10.1259/0007-1285-59-700-359; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; ICRP, 2007, ANN ICRP, V103; Konings MK, 2000, J MAGN RESON IMAGING, V12, P79, DOI 10.1002/1522-2586(200007)12:1<79::AID-JMRI9>3.0.CO;2-T; Kovoor P, 1998, CIRCULATION, V98, P1534, DOI 10.1161/01.CIR.98.15.1534; Kucharczyk J, 2001, NEUROIMAG CLIN N AM, V11, P767; Kuehne T, 2003, RADIOLOGY, V226, P475, DOI 10.1148/radiol.2262011639; Miquel ME, 2003, INT J CARDIOVAS IMAG, V19, P239, DOI 10.1023/A:1023671031207; MIQUEL ME, 2002, P IPEM 8 ANN SCI M, P39; Modan B, 2000, INT J EPIDEMIOL, V29, P424, DOI 10.1093/ije/29.3.424; *NRPB, 1999, RAD PROT BOARD, V10; Orlic D, 2002, CIRC RES, V91, P1092, DOI 10.1161/01.RES.0000046045.00846.B0; Pihkala J, 1999, PEDIATR CLIN N AM, V46, P441, DOI 10.1016/S0031-3955(05)70128-0; Razavi R, 1999, CARDIOL YOUNG, V9, P529, DOI 10.1017/S1047951100005503; RAZAVI R, 2002, EUR RADIOL, V12, pF1; RHODE K, 2003, J CARDIOV MAGN RESON, V1, P234; Rickers C, 2003, CIRCULATION, V107, P132, DOI 10.1161/01.CIR.0000039343.95540.CF; Spuentrup E, 2002, CIRCULATION, V105, P874, DOI 10.1161/hc0702.104165; van Vaals JJ, 1999, INT CONGR SER, V1192, P111	24	231	236	0	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1877	1882		10.1016/S0140-6736(03)14956-2	http://dx.doi.org/10.1016/S0140-6736(03)14956-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667742				2022-12-28	WOS:000187011600007
J	Sharp, D				Sharp, D			The West Nile season	LANCET			English	Editorial Material							VIRUS		Lancet, London NW1 7BY, England		Sharp, D (corresponding author), Lancet, London NW1 7BY, England.							Buckley A, 2003, J GEN VIROL, V84, P2807, DOI 10.1099/vir.0.19341-0; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; *CDCP, 2003, W NIL ACT 2003 HUM C; Centers for Disease Control and Prevention, 2003, MMWR-MORBID MORTAL W, V52, P886; Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316; Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969; Pletnev AG, 2003, VIROLOGY, V314, P190, DOI 10.1016/S0042-6822(03)00450-1	7	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1870	1870		10.1016/S0140-6736(03)14999-9	http://dx.doi.org/10.1016/S0140-6736(03)14999-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667740				2022-12-28	WOS:000187011600005
J	Enzinger, PC; Mayer, RJ				Enzinger, PC; Mayer, RJ			Medical progress - Esophageal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PROSPECTIVE RANDOMIZED TRIAL; SQUAMOUS-CELL CARCINOMA; SYMPTOMATIC GASTROESOPHAGEAL REFLUX; ADVANCED ESOPHAGOGASTRIC CANCER; EXPANDABLE METAL STENTS; HIGH-GRADE DYSPLASIA; PHASE-II TRIAL; TERM FOLLOW-UP; BARRETTS-ESOPHAGUS; GASTRIC CARDIA		Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Enzinger, PC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.							Adam A, 1997, RADIOLOGY, V202, P344, DOI 10.1148/radiology.202.2.9015054; Ahsan H, 1998, ANN INTERN MED, V128, P114, DOI 10.7326/0003-4819-128-2-199801150-00007; AlSarraf, 1997, J CLIN ONCOL, V15, P866; AlSarraf M, 1997, J CLIN ONCOL, V15, P277, DOI 10.1200/JCO.1997.15.1.277; Ando N, 1997, J THORAC CARDIOV SUR, V114, P205, DOI 10.1016/S0022-5223(97)70146-6; APINOP C, 1994, HEPATO-GASTROENTEROL, V41, P391; Arber N, 1996, CANCER EPIDEM BIOMAR, V5, P457; Arnott SJ, 1998, INT J RADIAT ONCOL, V41, P579, DOI 10.1016/S0360-3016(97)00569-5; Avisar E, 2000, ANN THORAC SURG, V69, P288, DOI 10.1016/S0003-4975(99)01201-1; Bancewicz J, 2002, LANCET, V359, P1727; BENENNE L, 2002, PROG P AM SOC CLIN O, V21, pA130; Bleiberg H, 1997, EUR J CANCER, V33, P1216, DOI 10.1016/S0959-8049(97)00088-9; Blot WJ, 1999, SEMIN ONCOL, V26, P2; Bosset JF, 1997, NEW ENGL J MED, V337, P161, DOI 10.1056/NEJM199707173370304; Brown LM, 2001, AM J EPIDEMIOL, V153, P114, DOI 10.1093/aje/153.2.114; Burmeister BH, 2002, P AN M AM SOC CLIN, V21, p130a; BURT M, 1991, ANN THORAC SURG, V52, P1222, DOI 10.1016/0003-4975(91)90005-B; Buttar NS, 2001, GASTROENTEROLOGY, V120, P1630, DOI 10.1053/gast.2001.25111; Canto MI, 2002, GASTROINTEST ENDOSC, V55, pAB100; Chow WH, 1998, CANCER RES, V58, P588; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; Collard JM, 2001, ANN SURG, V234, P25, DOI 10.1097/00000658-200107000-00005; Cooper JS, 1999, JAMA-J AM MED ASSOC, V281, P1623, DOI 10.1001/jama.281.17.1623; Corti L, 2000, INT J RADIAT ONCOL, V47, P419, DOI 10.1016/S0360-3016(00)00450-8; CSIKOS M, 1985, LANGENBECK ARCH CHIR, V365, P231, DOI 10.1007/BF01459611; Dallal HJ, 2001, GASTROINTEST ENDOSC, V54, P549, DOI 10.1067/mge.2001.118947; Daly JM, 1996, CANCER, V78, P1820, DOI 10.1002/(SICI)1097-0142(19961015)78:8<1820::AID-CNCR25>3.0.CO;2-Z; Daly JM, 2000, J AM COLL SURGEONS, V190, P562, DOI 10.1016/S1072-7515(00)00238-6; DEBESI P, 1986, CANCER TREAT REP, V70, P909; DESTEFANI E, 1993, EUR J CANCER, V29A, P763, DOI 10.1016/S0959-8049(05)80363-6; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Downey RJ, 2003, J CLIN ONCOL, V21, P428, DOI 10.1200/JCO.2003.04.013; EARLAM R, 1980, BRIT J SURG, V67, P457, DOI 10.1002/bjs.1800670702; Ellis A, 1994, Eur J Cancer B Oral Oncol, V30B, P102, DOI 10.1016/0964-1955(94)90061-2; Enzinger PC, 1999, SEMIN ONCOL, V26, P12; ENZINGER PC, 2000, P AN M AM SOC CLIN, V19, pA315; Erkal HS, 2001, J CLIN ONCOL, V19, P1358, DOI 10.1200/JCO.2001.19.5.1358; Falk GW, 1999, GASTROINTEST ENDOSC, V49, P170, DOI 10.1016/S0016-5107(99)70482-7; Farrow DC, 2000, CANCER CAUSE CONTROL, V11, P231, DOI 10.1023/A:1008913828105; FEIN R, 1985, CANCER, V56, P2512, DOI 10.1002/1097-0142(19851115)56:10<2512::AID-CNCR2820561032>3.0.CO;2-9; FINDLAY M, 1994, ANN ONCOL, V5, P609, DOI 10.1093/oxfordjournals.annonc.a058932; Flamen P, 2000, J CLIN ONCOL, V18, P3202, DOI 10.1200/JCO.2000.18.18.3202; FOK M, 1993, SURGERY, V113, P138; Freifeld A, 1999, NEW ENGL J MED, V341, P305, DOI 10.1056/NEJM199907293410501; Gammon MD, 1997, J NATL CANCER I, V89, P1277, DOI 10.1093/jnci/89.17.1277; Garidou A, 1996, INT J CANCER, V68, P295, DOI 10.1002/(SICI)1097-0215(19961104)68:3&lt;295::AID-IJC5&gt;3.0.CO;2-X; Gerson LB, 2002, GASTROENTEROLOGY, V123, P461, DOI 10.1053/gast.2002.34748; Ghavamzadeh A, 2001, SEMIN ONCOL, V28, P153, DOI [10.1053/sonc.2001.21957, 10.1016/S0093-7754(01)90086-7]; GOLDMINC M, 1993, BRIT J SURG, V80, P367, DOI 10.1002/bjs.1800800335; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Headrick JR, 2002, ANN THORAC SURG, V73, P1697, DOI 10.1016/S0003-4975(02)03496-3; HERSKOVIC A, 1992, NEW ENGL J MED, V326, P1593, DOI 10.1056/NEJM199206113262403; Hosch SB, 2001, J CLIN ONCOL, V19, P1970, DOI 10.1200/JCO.2001.19.7.1970; Hulscher JBF, 2002, NEW ENGL J MED, V347, P1662, DOI 10.1056/NEJMoa022343; Ilson DH, 2000, CANCER J, V6, P316; Ilson DH, 1999, J CLIN ONCOL, V17, P3270, DOI 10.1200/JCO.1999.17.10.3270; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; JOCHEM VJ, 1992, GASTROENTEROLOGY, V102, P1400; Katada N, 1997, ARCH SURG-CHICAGO, V132, P728; Katz D, 1998, AM J GASTROENTEROL, V93, P536; KELSEN DP, 1990, J CLIN ONCOL, V8, P1352, DOI 10.1200/JCO.1990.8.8.1352; Kelsen DP, 1998, NEW ENGL J MED, V339, P1979, DOI 10.1056/NEJM199812313392704; Krasna MJ, 1996, J THORAC CARDIOV SUR, V111, P800, DOI 10.1016/S0022-5223(96)70340-9; Krishnadath KK, 1997, J PATHOL, V182, P331; Lagergren J, 2000, CANCER EPIDEM BIOMAR, V9, P757; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lagergren J, 2000, GUT, V47, P26, DOI 10.1136/gut.47.1.26; Lagergren J, 2000, ANN INTERN MED, V133, P165, DOI 10.7326/0003-4819-133-3-200008010-00007; LARSSON LG, 1975, CANCER RES, V35, P3308; LAW S, 1998, CAN J GASTROENTEROL, V12, pB56; Le Prise E, 1994, CANCER, V73, P1179; Mariette C, 2001, GASTROEN CLIN BIOL, V25, P468; Mealy K, 1996, EUR J SURG ONCOL, V22, P505, DOI 10.1016/S0748-7983(96)92998-4; Minsky BD, 2002, J CLIN ONCOL, V20, P1167, DOI 10.1200/JCO.20.5.1167; Morales TG, 1999, ARCH INTERN MED, V159, P1411, DOI 10.1001/archinte.159.13.1411; Morris CD, 2001, BRIT J SURG, V88, P1357, DOI 10.1046/j.0007-1323.2001.01926.x; NEBEL OT, 1976, AM J DIG DIS, V21, P953, DOI 10.1007/BF01071906; Nilsson M, 2002, SCAND J GASTROENTERO, V37, P626, DOI 10.1080/00365520212502; NYGAARD K, 1992, WORLD J SURG, V16, P1104, DOI 10.1007/BF02067069; O'Connor JB, 1999, AM J GASTROENTEROL, V94, P2037; PERA M, 1992, ANN THORAC SURG, V54, P199, DOI 10.1016/0003-4975(92)91370-O; Peters FTM, 1999, GUT, V45, P489, DOI 10.1136/gut.45.4.489; Peters FTM, 2000, GUT, V47, P154; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Pisani P, 1999, INT J CANCER, V83, P870; Polkowski W, 1999, ANN SURG ONCOL, V6, P290, DOI 10.1007/s10434-999-0290-2; Pommier RF, 1998, AM J SURG, V175, P422, DOI 10.1016/S0002-9610(98)00055-5; Raijman I, 1998, GASTROINTEST ENDOSC, V48, P172, DOI 10.1016/S0016-5107(98)70159-2; Reed C E, 1999, Oncologist, V4, P95; Ries LA, 2002, SEER CANC STAT REV 1; Risk JM, 1999, DIS ESOPHAGUS, V12, P173, DOI 10.1046/j.1442-2050.1999.00042.x; Romero Y, 2002, AM J GASTROENTEROL, V97, P1127; Ross P, 2002, J CLIN ONCOL, V20, P1996, DOI 10.1200/JCO.2002.08.105; SANDLER RS, 1995, JAMA-J AM MED ASSOC, V274, P1359, DOI 10.1001/jama.274.17.1359; Shaheen N, 2002, JAMA-J AM MED ASSOC, V287, P1972, DOI 10.1001/jama.287.15.1972; Sharma P, 1999, GASTROINTEST ENDOSC, V49, P442, DOI 10.1016/S0016-5107(99)70040-4; Sharma P, 2001, Curr Gastroenterol Rep, V3, P219, DOI 10.1007/s11894-001-0025-4; Sharma P, 1997, AM J GASTROENTEROL, V92, P582; Shirvani VN, 2000, GASTROENTEROLOGY, V118, P487, DOI 10.1016/S0016-5085(00)70254-X; Siewert JR, 2001, ANN SURG, V234, P360, DOI 10.1097/00000658-200109000-00010; Singh SP, 1998, CANCER RES, V58, P1730; Spechler SJ, 2002, NEW ENGL J MED, V346, P836, DOI 10.1056/NEJMcp012118; Spiridonidis CH, 1996, CANCER, V78, P2070, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2070::AID-CNCR6>3.0.CO;2-S; Swanson SJ, 2001, ANN THORAC SURG, V72, P1918, DOI 10.1016/S0003-4975(01)03203-9; TENIERE P, 1991, SURG GYNECOL OBSTET, V173, P123; Terry P, 2000, INT J CANCER, V87, P750, DOI 10.1002/1097-0215(20000901)87:5&lt;750::AID-IJC19&gt;3.0.CO;2-6; Terry P, 2001, EUR J CANCER PREV, V10, P365, DOI 10.1097/00008469-200108000-00010; Urba SG, 2001, J CLIN ONCOL, V19, P305, DOI 10.1200/JCO.2001.19.2.305; VanDam J, 1997, CHEST, V112, pS184, DOI 10.1378/chest.112.4_Supplement.184S; Varis A, 2001, CANCER GENET CYTOGEN, V127, P53, DOI 10.1016/S0165-4608(00)00423-4; Vaughan TL, 1998, CANCER EPIDEM BIOMAR, V7, P749; Vazquez-Sequeiros E, 2001, GASTROINTEST ENDOSC, V53, P751, DOI 10.1067/mge.2001.112741; Vicari JJ, 1998, GASTROENTEROLOGY, V115, P50, DOI 10.1016/S0016-5085(98)70364-6; Walch AK, 2000, AM J PATHOL, V156, P555, DOI 10.1016/S0002-9440(10)64760-8; Walsh TN, 1996, NEW ENGL J MED, V335, P462, DOI 10.1056/NEJM199608153350702; Warburton-Timms VJ, 2001, GUT, V49, P341, DOI 10.1136/gut.49.3.341; Webb A, 1997, J CLIN ONCOL, V15, P261, DOI 10.1200/JCO.1997.15.1.261; Wijnhoven BPL, 2001, ANN SURG, V233, P322, DOI 10.1097/00000658-200103000-00005; Wu AH, 2001, CANCER CAUSE CONTROL, V12, P721, DOI 10.1023/A:1011290704728; Wu AH, 2003, INT J CANCER, V103, P815, DOI 10.1002/ijc.10887; Yacoub L, 1997, MODERN PATHOL, V10, P105; Yang HH, 2002, ACTA CYTOL, V46, P445, DOI 10.1159/000326859	122	2304	2441	9	185	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2003	349	23					2241	2252		10.1056/NEJMra035010	http://dx.doi.org/10.1056/NEJMra035010			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LH	14657432				2022-12-28	WOS:000186921700012
J	Edelson, PJ				Edelson, PJ			Quarantine and social inequity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BUBONIC PLAGUE		Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA	Columbia University	Edelson, PJ (corresponding author), Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA.							Barbera J, 2001, JAMA-J AM MED ASSOC, V286, P2711, DOI 10.1001/jama.286.21.2711; GOODMAN RA, 2003, LAW PUBLIC HLTH PRAC, P14; Kraut Alan M., 1994, SILENT TRAVELERS GER, P84; Lerner BH, 1999, WESTERN J MED, V171, P44; MARKEL H, 1997, QUARANTINE EUROPEAN; MCCLAIN C, 1988, LAW SOCIAL INQUIRY, V13, P447, DOI 10.1111/j.1747-4469.1988.tb00059.x; RISSE GB, 1992, B HIST MED, V66, P260	7	10	10	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2874	2874		10.1001/jama.290.21.2874	http://dx.doi.org/10.1001/jama.290.21.2874			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QP	14657075				2022-12-28	WOS:000186872800033
J	Menzies, D; Popa, J; Hanley, JA; Rand, T; Milton, DK				Menzies, D; Popa, J; Hanley, JA; Rand, T; Milton, DK			Effect of ultraviolet germicidal lights installed in office ventilation systems on workers' health and wellbeing: double-blind multiple crossover trial	LANCET			English	Article							SICK BUILDING SYNDROME; HYPERSENSITIVITY PNEUMONITIS; HUMIDIFIER LUNG; VARYING LEVELS; SYMPTOMS; EXPOSURE; MICROORGANISMS; OUTBREAK; DUST	Background Workers in modern office buildings frequently have unexplained work-related symptoms or combinations of symptoms. We assessed whether ultraviolet germicidal irradiation (UVGI) of drip pans and cooling coils within ventilation systems of office buildings would reduce microbial contamination, and thus occupants' work-related symptoms. Methods We undertook a double blind, multiple crossover trial of 771 participants, In office buildings in Montreal, Canada, UVGI was alternately off for 12 weeks, then turned on for 4 weeks. We did this three times with UVGI on and three times with it off, for 48 consecutive weeks. Primary outcomes of self-reported work-related symptoms, and secondary outcomes of endotoxin and viable microbial concentrations in air and on surfaces, and other environmental covariates were measured six times. Findings Operation of UVGI resulted in 99% (95% CI 67-100) reduction of microbial and endotoxin concentrations on irradiated surfaces within the ventilation systems. 771 participants appeared to remain masked, and reported no adverse effects. On the basis of within-person estimates, use of UVGI was associated with significantly fewer work-related symptoms overall (adjusted odds ratio 0.8 [95% CI 0.7-0.99]), as well as respiratory (0.6 [0.4-0.9]) and mucosal (0.7 [0.6-0.9]) symptoms than was non-use. Reduction of work-related mucosal symptoms was greatest among atopic workers (0.6 [0.5-0.8]), and never-smokers (0.7 [0.5-0.9]). With UVGI on, never-smokers also had large reduction of work-related respiratory (0.4 [0.2-0.9]), and musculoskeletal symptoms (0.5 [0.3-0.9]). Interpretation Installation of UGVI in most North American offices could resolve work-related symptoms in about 4 million employees, caused by microbial contamination of heating, ventilation, and air-conditioning systems. The cost of UVGI installation could in the long run prove cost-effective compared with the yearly losses from absence because of building-related illness.	McGill Univ, Montreal Chest Inst, Resp Epidemiol Unit, Montreal, PQ H3A 1A3, Canada; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ H3A 1A3, Canada; St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada; Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	McGill University; McGill University; Saint Marys University - Canada; Harvard University; Harvard T.H. Chan School of Public Health	Menzies, D (corresponding author), McGill Univ, Montreal Chest Inst, Resp Epidemiol Unit, 1110 Pine Ave W, Montreal, PQ H3A 1A3, Canada.	dick.menzies@mcgill.ca	Milton, Donald K/G-3286-2010	Milton, Donald K/0000-0002-0550-7834	NIOSH CDC HHS [1 R01 OH03693-01A1] Funding Source: Medline; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH003693] Funding Source: NIH RePORTER	NIOSH CDC HHS; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))		ARNOW PM, 1978, AM J MED, V64, P236, DOI 10.1016/0002-9343(78)90051-7; *ASTM, 1990, ASTM STAND TEST METH, P425; BAUR X, 1992, RESPIRATION, V59, P211; BERNSTEIN RS, 1983, AM IND HYG ASSOC J, V44, P161, DOI 10.1080/15298668391404581; BURGE PS, 1985, THORAX, V40, P248, DOI 10.1136/thx.40.4.248; DAWSONSAUNDERS B, 1990, BASIC CLIN BIOSTATIS; DILLON KH, 1996, FIELD GUIDE DETERMIN; Efron B., 1994, CHAPMAN HALL CRC MON, V57; GANIER M, 1980, CHEST, V77, P183, DOI 10.1378/chest.77.2.183; GERGEN PJ, 1992, J ALLERGY CLIN IMMUN, V90, P579, DOI 10.1016/0091-6749(92)90130-T; HUGENHOLTZ P, 1992, APPL ENVIRON MICROB, V58, P3914, DOI 10.1128/AEM.58.12.3914-3920.1992; JAAKKOLA JJK, 1989, ENVIRON INT, V15, P163, DOI 10.1016/0160-4120(89)90022-6; KATEMAN E, 1990, SCAND J WORK ENV HEA, V16, P428, DOI 10.5271/sjweh.1764; Li CS, 1997, ARCH ENVIRON HEALTH, V52, P200, DOI 10.1080/00039899709602887; MALMBERG P, 1993, CHEST, V103, P1202, DOI 10.1378/chest.103.4.1202; MENDELL MJ, 1990, AM J PUBLIC HEALTH, V80, P1193, DOI 10.2105/AJPH.80.10.1193; Mendell MJ, 2002, AM J PUBLIC HEALTH, V92, P1430, DOI 10.2105/AJPH.92.9.1430; Mendell MJ., 1993, INDOOR AIR, V3, P227, DOI DOI 10.1111/J.1600-0668.1993.00003.X; Menzies D, 1996, AM J PUBLIC HEALTH, V86, P1629, DOI 10.2105/AJPH.86.11.1629; Menzies D, 1997, NEW ENGL J MED, V337, P1524, DOI 10.1056/NEJM199711203372107; Menzies D, 1999, OCCUP ENVIRON MED, V56, P397, DOI 10.1136/oem.56.6.397; Menzies D, 1998, J ALLERGY CLIN IMMUN, V101, P38, DOI 10.1016/S0091-6749(98)70191-5; MENZIES R, 1993, NEW ENGL J MED, V328, P821, DOI 10.1056/NEJM199303253281201; MILTON DK, 1995, AM J IND MED, V28, P469, DOI 10.1002/ajim.4700280404; MLTON DK, 1990, AM IND HYG ASSOC J, V51, P331; *NIOSH, 1977, MAN AN METH; Noble JA, 1997, J MED VET MYCOL, V35, P405; REINIKAINEN LM, 1992, ARCH ENVIRON HEALTH, V47, P8, DOI 10.1080/00039896.1992.9935938; Rothman K., 1998, MODERN EPIDEMIOLOGY; SCHEIR R, 1996, HPAC, P109; Schlessman JJ., 1982, CASE CONTROL STUDIES; SKOV P, 1990, SCAND J WORK ENV HEA, V16, P363, DOI 10.5271/sjweh.1772; SMID T, 1994, AM J IND MED, V25, P877, DOI 10.1002/ajim.4700250611; TAMBLYN RM, 1992, J CLIN EPIDEMIOL, V45, P603, DOI 10.1016/0895-4356(92)90132-7; WOLFINGER R, 1993, J STAT COMPUT SIM, P48; WOODARD ED, 1988, JAMA-J AM MED ASSOC, V259, P1965, DOI 10.1001/jama.259.13.1965; WYON DP, 1992, ENVIRON TECHNOL, V13, P313, DOI 10.1080/09593339209385159; YABUCHI E, 1995, JPN ASS INFECT DIS, V69, P654; Zweers T, 1992, INDOOR AIR, V2, P127, DOI DOI 10.1111/J.1600-0668.1992.00001.X; [No title captured]	40	97	98	1	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1785	1791		10.1016/S0140-6736(03)14897-0	http://dx.doi.org/10.1016/S0140-6736(03)14897-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654316				2022-12-28	WOS:000186872900009
J	Ye, KQ; Malinina, L; Patel, DJ				Ye, KQ; Malinina, L; Patel, DJ			Recognition of small interfering RNA by a viral suppressor of RNA silencing	NATURE			English	Article							DOUBLE-STRANDED-RNA; GENE; SYSTEM; PCR	RNA silencing (also known as RNA interference) is a conserved biological response to double-stranded RNA that regulates gene expression, and has evolved in plants as a defence against viruses(1-3). The response is mediated by small interfering RNAs (siRNAs), which guide the sequence-specific degradation of cognate messenger RNAs. As a counter-defence, many viruses encode proteins that specifically inhibit the silencing machinery(3,4). The p19 protein from the tombusvirus is such a viral suppressor of RNA silencing(5) and has been shown to bind specifically to siRNA(6). Here, we report the 1.85-Angstrom crystal structure of p19 bound to a 21-nucleotide siRNA, where the 19-basepair RNA duplex is cradled within the concave face of a continuous eight-stranded beta-sheet, formed across the p19 homodimer interface. Direct and water-mediated intermolecular contacts are restricted to the backbone phosphates and sugar 20-OH groups, consistent with sequence-independent p19-siRNA recognition. Two alpha-helical 'reading heads' project from opposite ends of the p19 homodimer and position pairs of tryptophans for stacking over the terminal base pairs, thereby measuring and bracketing both ends of the siRNA duplex. Our structure provides an illustration of siRNA sequestering by a viral protein.	Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10021 USA.	pateld@mskcc.org	Malinina, Lucy/B-8161-2013		NCI NIH HHS [P30 CA008748] Funding Source: Medline; NIAID NIH HHS [R01 AI068776] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068776] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Casimiro DR, 1997, STRUCTURE, V5, P1407, DOI 10.1016/S0969-2126(97)00291-8; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Li WX, 2001, CURR OPIN BIOTECH, V12, P150, DOI 10.1016/S0958-1669(00)00190-7; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramos A, 2000, EMBO J, V19, P997, DOI 10.1093/emboj/19.5.997; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8	24	320	336	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2003	426	6968					874	878		10.1038/nature02213	http://dx.doi.org/10.1038/nature02213			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14661029	Green Accepted			2022-12-28	WOS:000187342000067
J	Goldman, L; Kirtane, AJ				Goldman, L; Kirtane, AJ			Triage of patients with acute chest pain and possible cardiac ischemia: The elusive search for diagnostic perfection	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-CARE-UNIT; EMERGENCY-DEPARTMENT PATIENTS; ATTACK ALERT PROGRAM; LOW-RISK PATIENTS; SHORT-STAY UNIT; PREDICTIVE INSTRUMENT; CLINICAL CHARACTERISTICS; PRACTICE GUIDELINES; COST-EFFECTIVENESS	Few diagnostic decisions in medicine have been more heavily researched than the approach to the patient with acute chest pain. Despite the advances in both diagnosing and treating patients presenting with this symptom, cases of missed myocardial infarctions still cause substantial morbidity and mortality. This article examines a case in which a patient was sent home from the emergency department after presenting with chest pain and was subsequently found to have a myocardial infarction. In the context of the case, the article discusses clinical decision making about the diagnosis and triage of patients presenting with acute chest pain or with symptoms consistent with possible cardiac ischemia. A standardized approach to addressing the management of these patients is essential, given the adverse consequences of missing a life-threatening condition.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Goldman, L (corresponding author), Univ Calif San Francisco, Dept Med, 505 Parnassus Ave, San Francisco, CA 94143 USA.							Amsterdam EA, 2002, J AM COLL CARDIOL, V40, P251, DOI 10.1016/S0735-1097(02)01968-X; Balk EM, 2001, ANN EMERG MED, V37, P478, DOI 10.1067/mem.2001.114905; Baxt WG, 1996, LANCET, V347, P12, DOI 10.1016/S0140-6736(96)91555-X; BAYER AJ, 1986, J AM GERIATR SOC, V34, P263, DOI 10.1111/j.1532-5415.1986.tb04221.x; Brailer DJ, 1997, MED DECIS MAKING, V17, P80, DOI 10.1177/0272989X9701700109; Braunwald E, 2002, CIRCULATION, V106, P1893, DOI 10.1161/01.CIR.0000037106.76139.53; Braunwald E, 1994, AHCPR PUBLICATION, V94-0602, P1; Brotons C, 1999, J CLIN EPIDEMIOL, V52, P959, DOI 10.1016/S0895-4356(99)00117-1; BRUSH JE, 1985, NEW ENGL J MED, V312, P1137, DOI 10.1056/NEJM198505023121801; Calvin JE, 2000, J AM COLL CARDIOL, V36, P1803, DOI 10.1016/S0735-1097(00)00977-3; Canto JG, 2000, JAMA-J AM MED ASSOC, V283, P3223, DOI 10.1001/jama.283.24.3223; deFilippi CR, 2001, J AM COLL CARDIOL, V37, P2042, DOI 10.1016/S0735-1097(01)01300-6; Dracup K, 1997, ANN INTERN MED, V126, P645, DOI 10.7326/0003-4819-126-8-199704150-00010; DRACUP K, 1995, SOC SCI MED, V40, P379, DOI 10.1016/0277-9536(94)00278-2; Farkouh ME, 1998, NEW ENGL J MED, V339, P1882, DOI 10.1056/NEJM199812243392603; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; FINEBERG HV, 1984, NEW ENGL J MED, V310, P1301, DOI 10.1056/NEJM198405173102006; Gaspoz JM, 1996, HEART, V76, P150, DOI 10.1136/hrt.76.2.150; GASPOZ JM, 1994, J AM COLL CARDIOL, V24, P1249, DOI 10.1016/0735-1097(94)90106-6; GASPOZ JM, 1991, AM J CARDIOL, V68, P145, DOI 10.1016/0002-9149(91)90734-3; Ghaemmaghami CA, 2001, EMERG MED CLIN N AM, V19, P351, DOI 10.1016/S0733-8627(05)70188-7; Goldberg RJ, 1998, AM HEART J, V136, P189, DOI 10.1053/hj.1998.v136.88874; GOLDMAN L, 1982, NEW ENGL J MED, V307, P588, DOI 10.1056/NEJM198209023071004; GOLDMAN L, 1988, NEW ENGL J MED, V318, P797, DOI 10.1056/NEJM198803313181301; Goldman L, 1996, NEW ENGL J MED, V334, P1498, DOI 10.1056/NEJM199606063342303; Gomez MA, 1996, J AM COLL CARDIOL, V28, P25, DOI 10.1016/0735-1097(96)00093-9; GRAFF L, 1995, AM J CARDIOL, V76, P1036, DOI 10.1016/S0002-9149(99)80291-4; Graff LG, 1997, AM J CARDIOL, V80, P563, DOI 10.1016/S0002-9149(97)00422-0; Hamm CW, 1997, NEW ENGL J MED, V337, P1648, DOI 10.1056/NEJM199712043372302; Hand M, 1998, J THROMB THROMBOLYS, V6, P9, DOI 10.1023/A:1008868020782; Heden B, 1997, CIRCULATION, V96, P1798, DOI 10.1161/01.CIR.96.6.1798; Hildebrandt DE, 2003, J FAM PRACTICE, V52, P222; HILLSON SD, 1995, MED DECIS MAKING, V15, P107, DOI 10.1177/0272989X9501500202; Iliadis EA, 1999, J AM COLL CARDIOL, V34, P1689, DOI 10.1016/S0735-1097(99)00405-2; Ioannidis JPA, 2001, ANN EMERG MED, V37, P471, DOI 10.1067/mem.2001.114901; Itchhaporia D, 1996, J AM COLL CARDIOL, V28, P515, DOI 10.1016/0735-1097(96)00174-X; JAYES RL, 1992, J CLIN EPIDEMIOL, V45, P621, DOI 10.1016/0895-4356(92)90134-9; Jha AK, 2001, AHRQ PUBLICATION, V01-E058; JUSTIS DL, 1992, ANN EMERG MED, V21, P1, DOI 10.1016/S0196-0644(05)82228-0; Katz DA, 1996, JAMA-J AM MED ASSOC, V276, P1568; Kim C, 2001, AM HEART J, V141, P73, DOI 10.1067/mhj.2001.111546; Kohn KT, 2000, ERR IS HUMAN BUILDIN; KUHN M, 1992, ANN EMERG MED, V21, P10, DOI 10.1016/S0196-0644(05)82229-2; LAINE C, 1993, JAMA-J AM MED ASSOC, V269, P374, DOI 10.1001/jama.269.3.374; Lateef F, 2000, AM J EMERG MED, V18, P793, DOI 10.1053/ajem.2000.18023; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; Lee TH, 2000, NEW ENGL J MED, V342, P1187, DOI 10.1056/NEJM200004203421607; LEE TH, 1995, ANN INTERN MED, V122, P434, DOI 10.7326/0003-4819-122-6-199503150-00006; LEE TH, 1985, ARCH INTERN MED, V145, P65, DOI 10.1001/archinte.145.1.65; LEE TH, 1991, NEW ENGL J MED, V324, P1239, DOI 10.1056/NEJM199105023241803; LEE TH, 1987, AM J CARDIOL, V60, P219, DOI 10.1016/0002-9149(87)90217-7; LEE TH, 1990, J GEN INTERN MED, V5, P381, DOI 10.1007/BF02599421; LEWIS LM, 1995, ANN EMERG MED, V25, P9, DOI 10.1016/S0196-0644(95)70348-9; Luepker RV, 2000, JAMA-J AM MED ASSOC, V284, P60, DOI 10.1001/jama.284.1.60; Mather PJ, 2001, EMERG MED CLIN N AM, V19, P339, DOI 10.1016/S0733-8627(05)70187-5; MCCARTHY BD, 1993, ANN EMERG MED, V22, P579, DOI 10.1016/S0196-0644(05)81945-6; Meischke H, 1997, AM J PUBLIC HEALTH, V87, P1705, DOI 10.2105/AJPH.87.10.1705; Newby LK, 2001, CIRCULATION, V103, P1832; Nichol G, 1997, ANN INTERN MED, V127, P996, DOI 10.7326/0003-4819-127-11-199712010-00009; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Panju AA, 1998, JAMA-J AM MED ASSOC, V280, P1256, DOI 10.1001/jama.280.14.1256; PEARSON SD, 1994, J GEN INTERN MED, V9, P241, DOI 10.1007/BF02599648; PEARSON SD, 1995, J GEN INTERN MED, V10, P557, DOI 10.1007/BF02640365; Petersen L A, 1998, Jt Comm J Qual Improv, V24, P77; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Pope JH, 2003, EMERG MED CLIN N AM, V21, P27, DOI 10.1016/S0733-8627(02)00079-2; Pope JH, 1998, J THROMB THROMBOLYS, V6, P63, DOI 10.1023/A:1008876322599; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; POZEN MW, 1984, NEW ENGL J MED, V310, P1273, DOI 10.1056/NEJM198405173102001; Reilly B, 1999, AM J MED, V106, P285, DOI 10.1016/S0002-9343(99)00024-8; Reilly BM, 2002, JAMA-J AM MED ASSOC, V288, P342, DOI 10.1001/jama.288.3.342; Reilly BM, 2002, AM J MED, V112, P95, DOI 10.1016/S0002-9343(01)01054-3; Roberts RR, 1997, JAMA-J AM MED ASSOC, V278, P1670, DOI 10.1001/jama.278.20.1670; ROUAN GW, 1989, AM J CARDIOL, V64, P1087, DOI 10.1016/0002-9149(89)90857-6; Rydman RJ, 1997, ANN EMERG MED, V29, P109, DOI 10.1016/S0196-0644(97)70316-0; SCHOR S, 1976, JAMA-J AM MED ASSOC, V236, P941; SELKER HP, 1991, MED CARE, V29, P610, DOI 10.1097/00005650-199107000-00002; Selker HP, 1997, ANN EMERG MED, V29, P13, DOI 10.1016/S0196-0644(97)70298-1; Selker HP, 2002, ANN INTERN MED, V137, P87, DOI 10.7326/0003-4819-137-2-200207160-00006; Selker HP, 1998, ANN INTERN MED, V129, P845, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00002; Sheifer SE, 2001, ANN INTERN MED, V135, P801, DOI 10.7326/0003-4819-135-9-200111060-00010; SLATER DK, 1987, AM J CARDIOL, V60, P766, DOI 10.1016/0002-9149(87)91020-4; Stein RA, 2000, CIRCULATION, V102, P1463, DOI 10.1161/01.CIR.102.12.1463; Tatum JL, 1997, ANN EMERG MED, V29, P116, DOI 10.1016/S0196-0644(97)70317-2; TING HH, 1991, AM J MED, V91, P401, DOI 10.1016/0002-9343(91)90158-T; Todd KH, 1996, ANN EMERG MED, V27, P16, DOI 10.1016/S0196-0644(96)70290-1; Tosteson ANA, 1996, CIRCULATION, V94, P143, DOI 10.1161/01.CIR.94.2.143; Udelson JE, 2002, JAMA-J AM MED ASSOC, V288, P2693, DOI 10.1001/jama.288.21.2693; Weinger MB, 2002, JAMA-J AM MED ASSOC, V287, P955, DOI 10.1001/jama.287.8.955; WESTDORP EJ, 1992, ANN EMERG MED, V21, P541, DOI 10.1016/S0196-0644(05)82521-1; WILLEMS JL, 1991, NEW ENGL J MED, V325, P1767, DOI 10.1056/NEJM199112193252503; Zalenski RJ, 2000, ANN EMERG MED, V35, P462, DOI 10.1016/S0196-0644(00)70007-2; Zalenski RJ, 1998, EMERG MED CLIN N AM, V16, P495, DOI 10.1016/S0733-8627(05)70015-8; 2000, ANN EMERG MED, V35, P541; 2000, ANN EMERG MED, V35, P539	96	57	58	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2003	139	12					987	995		10.7326/0003-4819-139-12-200312160-00008	http://dx.doi.org/10.7326/0003-4819-139-12-200312160-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756AG	14678918				2022-12-28	WOS:000187443200004
J	Bason, C; Corrocher, R; Lunardi, C; Puccetti, P; Olivieri, O; Girelli, D; Navone, R; Beri, R; Millo, E; Margonato, A; Martinelli, N; Puccetti, A				Bason, C; Corrocher, R; Lunardi, C; Puccetti, P; Olivieri, O; Girelli, D; Navone, R; Beri, R; Millo, E; Margonato, A; Martinelli, N; Puccetti, A			Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis	LANCET			English	Article							CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; ENDOTHELIAL-CELL APOPTOSIS; CHEMOKINE RECEPTOR US28; AUTOIMMUNE-DISEASE; MOLECULAR MIMICRY; INFECTION; AUTOANTIBODIES; MORTALITY; SEROPOSITIVITY	Background Infections and autoimmunity have been implicated in the pathogenesis of atherosclerosis. Cytomegalovirus has been shown to contribute to the disease. Autoantibodies against human heat-shock protein (HSP) 60 are present in most atherosclerotic patients, and their titre correlates with disease severity, suggesting that anti-HSP60 might be implicated in disease pathogenesis. We postulated that cytomegalovirus infection might induce antibodies able to bind human HSP60 and to cause endothelial-cell damage. Methods We studied 180 patients with coronary-artery disease, raised high sensitivity C-reactive protein concentrations, and presence or absence of traditional risk factors; 90 patients with coronary-artery disease, normal values for high sensitivity C-reactive protein, and no traditional risk factors; and 98 controls. Individual sera were used to define the relevant epitope of HSP60 by ELISA. Affinity purified IgGs were used to identify endothelial cell-surface ligands by western blot and to induce apoptotic cell death. Findings We identified an 11 aminoacid sequence of HSP60 that was recognised by most patients with coronary-artery disease. This peptide shares homology with cytomegalovirus-derived proteins UL122 and US28. The same patients' sera recognised UL122-derived and US28-derived peptides. Purified IgGs against HSP60 and the viral peptides bound non-stressed human endothelial cells and induced endothelial-cell apoptosis by interaction with cell-surface molecules. Interpretation During cytomegalovirus infection, antibodies against the virus can arise that are able to crossreact with human HSP60 and cause apoptosis of non-stressed endothelial cells, which is judged a primary event in the pathogenosis of atherosclerosis.	Univ Verona, Policlin GB Rossi, Dept Clin & Expt Med, Sect Internal Med, I-37134 Verona, Italy; Univ Genoa, Dept Expt Med, Genoa, Italy; Inst Giannina Gaslini, Genoa, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini	Lunardi, C (corresponding author), Univ Verona, Policlin GB Rossi, Dept Clin & Expt Med, Sect Internal Med, Piazzale LA Scuro, I-37134 Verona, Italy.		Olivieri, Oliviero/A-9126-2008; MARGONATO, ALBERTO/B-4185-2015; Girelli, Domenico/B-1183-2008; Millo, Enrico/K-3218-2018; Martinelli, Nicola/J-5622-2016	Olivieri, Oliviero/0000-0001-8209-9056; Girelli, Domenico/0000-0001-9684-1899; Millo, Enrico/0000-0002-4019-0051; Martinelli, Nicola/0000-0001-6465-5119				Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Blankenberg S, 2001, CIRCULATION, V103, P2915, DOI 10.1161/01.CIR.103.24.2915; Blum A, 1998, AM J CARDIOL, V81, P866, DOI 10.1016/S0002-9149(98)00019-8; Bocharov AV, 2000, BIOCHEM BIOPH RES CO, V277, P228, DOI 10.1006/bbrc.2000.3663; Casarosa P, 2001, J BIOL CHEM, V276, P1133, DOI 10.1074/jbc.M008965200; Choy JC, 2001, J MOL CELL CARDIOL, V33, P1673, DOI 10.1006/jmcc.2001.1419; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Dimmeler S, 2000, CIRC RES, V87, P434; Fraile-Ramos A, 2001, MOL BIOL CELL, V12, P1737, DOI 10.1091/mbc.12.6.1737; Girelli D, 2000, NEW ENGL J MED, V343, P774, DOI 10.1056/NEJM200009143431104; Greaves DR, 2002, TRENDS IMMUNOL, V23, P535, DOI 10.1016/S1471-4906(02)02331-1; Guetta E, 2001, CARDIOVASC RES, V50, P538, DOI 10.1016/S0008-6363(01)00269-3; Horne BD, 2003, CIRCULATION, V107, P258, DOI 10.1161/01.CIR.0000045668.71683.92; Horvath R, 2000, J CLIN VIROL, V16, P17, DOI 10.1016/S1386-6532(99)00064-5; Jarvis MA, 2002, CURR OPIN MICROBIOL, V5, P403, DOI 10.1016/S1369-5274(02)00334-X; Kruger O, 2000, DEVELOPMENT, V127, P4179; Leinonen M, 2002, LANCET INFECT DIS, V2, P11, DOI 10.1016/S1473-3099(01)00168-2; Lunardi C, 2002, LANCET, V360, P915, DOI 10.1016/S0140-6736(02)11028-2; Lunardi C, 2000, NAT MED, V6, P1183, DOI 10.1038/80533; Marchini A, 2001, J VIROL, V75, P1870, DOI 10.1128/JVI.75.4.1870-1878.2001; MELNICK JL, 1994, J MED VIROL, V42, P170, DOI 10.1002/jmv.1890420213; Muhlestein JB, 2000, CIRCULATION, V102, P1917, DOI 10.1161/01.CIR.102.16.1917; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Sambiase NV, 2000, MODERN PATHOL, V13, P173, DOI 10.1038/modpathol.3880032; Schett G, 1995, J CLIN INVEST, V96, P2569, DOI 10.1172/JCI118320; Shahgasempour S, 1997, ARCH VIROL, V142, P125, DOI 10.1007/s007050050063; Sincock PM, 1999, J CELL SCI, V112, P833; Streblow DN, 1999, CELL, V99, P511, DOI 10.1016/S0092-8674(00)81539-1; Tedgui A, 2001, THROMB HAEMOSTASIS, V86, P420; van Veen TAB, 2001, CARDIOVASC RES, V51, P217, DOI 10.1016/S0008-6363(01)00324-8; Wellings DA, 1997, METHOD ENZYMOL, V289, P44; Wick G, 2000, HERZ, V25, P87, DOI 10.1007/PL00001957; Wick G, 2001, TRENDS IMMUNOL, V22, P665, DOI 10.1016/S1471-4906(01)02089-0; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; Zhao ZS, 1998, SCIENCE, V279, P1344, DOI 10.1126/science.279.5355.1344; Zhu JH, 2000, CIRCULATION, V102, P2491, DOI 10.1161/01.CIR.102.20.2491; Zhu JH, 2001, CIRCULATION, V103, P1071, DOI 10.1161/01.CIR.103.8.1071	37	83	89	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					1971	1977		10.1016/S0140-6736(03)15016-7	http://dx.doi.org/10.1016/S0140-6736(03)15016-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683657				2022-12-28	WOS:000187210700010
J	Bucknall, DG; Anderson, HL				Bucknall, DG; Anderson, HL			Polymers get organized	SCIENCE			English	Editorial Material							BLOCK-COPOLYMERS; DIBLOCK COPOLYMERS; ORIENTATION		Univ Oxford, Dept Mat, Oxford OX1 3PH, England; Univ Oxford, Dept Chem, Oxford OX1 3QY, England	University of Oxford; University of Oxford	Bucknall, DG (corresponding author), Univ Oxford, Dept Mat, Parks Rd, Oxford OX1 3PH, England.		Bucknall, David G/F-7568-2016; Anderson, Harry Laurence/E-7843-2011	Bucknall, David G/0000-0003-4558-6933; Anderson, Harry Laurence/0000-0002-1801-8132				Bendejacq D, 2002, MACROMOLECULES, V35, P6645, DOI 10.1021/ma020158z; Edrington AC, 2001, ADV MATER, V13, P421, DOI 10.1002/1521-4095(200103)13:6<421::AID-ADMA421>3.0.CO;2-#; Forster S, 2002, ANGEW CHEM INT EDIT, V41, P689; Heischkel Y, 1998, MACROMOL CHEM PHYSIC, V199, P869, DOI 10.1002/macp.1998.021990522; Kim SO, 2003, NATURE, V424, P411, DOI 10.1038/nature01775; Ma QG, 2002, P NATL ACAD SCI USA, V99, P5058, DOI 10.1073/pnas.052653099; Maring D, 1997, MACROMOLECULES, V30, P660, DOI 10.1021/ma961234z; Morkved TL, 1996, SCIENCE, V273, P931, DOI 10.1126/science.273.5277.931; Park M, 1997, SCIENCE, V276, P1401, DOI 10.1126/science.276.5317.1401; Pyun J, 2003, J MATER CHEM, V13, P2653, DOI 10.1039/b304682f; *ROYAL SOC CHEM, 2003, MAT DISC C CONTR POL, V6; Salvage JP, 2003, J CONTROL RELEASE, V87, P230; Segalman RA, 2001, ADV MATER, V13, P1152, DOI 10.1002/1521-4095(200108)13:15<1152::AID-ADMA1152>3.0.CO;2-5; Stupp SI, 1997, SCIENCE, V276, P384, DOI 10.1126/science.276.5311.384; Vriezema DM, 2003, ANGEW CHEM INT EDIT, V42, P772, DOI 10.1002/anie.200390204	15	100	100	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1904	1905		10.1126/science.1091064	http://dx.doi.org/10.1126/science.1091064			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671284				2022-12-28	WOS:000187174000039
J	Dietz, T; Ostrom, E; Stern, PC				Dietz, T; Ostrom, E; Stern, PC			The struggle to govern the commons	SCIENCE			English	Review							IRRIGATION SYSTEMS; DESIGN PRINCIPLES; MANAGEMENT; INSTITUTIONS; SUSTAINABILITY; CONFLICT; TRAGEDY; ECOLOGY	Human institutions-ways of organizing activities-affect the resilience of the environment. Locally evolved institutional arrangements governed by stable communities and buffered from outside forces have sustained resources successfully for centuries, although they often fail when rapid change occurs. Ideal conditions for governance are increasingly rare. Critical problems, such as transboundary pollution, tropical deforestation, and climate change, are at larger scales and involve nonlocal influences. Promising strategies for addressing these problems include dialogue among interested parties, officials, and scientists; complex, redundant, and layered institutions; a mix of institutional types; and designs that facilitate experimentation, learning, and change.	Natl Acad, Div Social & Behav Sci & Educ, Washington, DC 20001 USA; Michigan State Univ, Environm Sci & Policy Program, E Lansing, MI 48824 USA; Michigan State Univ, Dept Sociol, E Lansing, MI 48824 USA; Michigan State Univ, Dept Crop & Soil Sci, E Lansing, MI 48824 USA; Indiana Univ, Ctr Study Inst Populat & Environm Change, Bloomington, IN 47408 USA; Indiana Univ, Workshop Polit Theory & Policy Anal, Bloomington, IN 47408 USA	National Academies of Sciences, Engineering & Medicine; Michigan State University; Michigan State University; Michigan State University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Stern, PC (corresponding author), Natl Acad, Div Social & Behav Sci & Educ, Washington, DC 20001 USA.	pstern@nas.edu	Quinn, Patrick/B-5489-2010	Dietz, Thomas/0000-0001-9399-0784				ABERNATHY A, 2000, J APPL IRRIG STUD, V35, P177; Acheson J., 2003, CAPTURING COMMONS DE; Adams WM, 2003, SCIENCE, V302, P1915, DOI 10.1126/science.1087771; Agrawal A., 2002, DRAMA COMMONS, P41, DOI DOI 10.17226/10287; *AM AM GEOGR GLOB, 2003, GLOB CHANG LOC PLAC; [Anonymous], 1996, HALTING DEGRADATION; [Anonymous], 2002, NEW TOOLS ENV PROTEC; [Anonymous], 1990, ECOSYSTEM APPROACH A; [Anonymous], 2002, NEW TOOLS ENV PROTEC; Aragon-Correa JA, 2003, ACAD MANAGE REV, V28, P71; Auer MR, 2000, POLICY SCI, V33, P155, DOI 10.1023/A:1026563821056; BAILEY EM, 1998, 98005 MIT; BARRETT G, 1984, J CAN STUD, V19, P125, DOI 10.3138/jcs.19.1.125; Barrett GW, 2002, BIOSCIENCE, V52, P282, DOI 10.1641/0006-3568(2002)052[0282:TCCBAB]2.0.CO;2; Bebbington A, 1997, GEOGR J, V163, P189, DOI 10.2307/3060182; BECKER CD, 1995, ANNU REV ECOL SYST, V26, P113, DOI 10.1146/annurev.es.26.110195.000553; Beierle Thomas C., 2002, DEMOCRACY PRACTICE P; Berkes F., 2003, NAVIGATING SOCIAL EC, V1, P30; Berkes F., 1998, LINKING SOCIAL ECOLO, V1st, DOI DOI 10.1017/CBO9780511541957; Brander JA, 1998, AM ECON REV, V88, P119; Burger Joanna, 2001, PROTECTING COMMONS F; CLARK WC, 1986, SUSTAINABLE DEV BIOS; Colby Bonnie, 1995, HDB ENV EC, P475; Cole D.H., 2002, POLLUTION PROPERTY C; COOP P, 1999, AUSTRALAS J ENV MAN, V6, P48; COSTANZA R, 1987, BIOSCIENCE, V37, P407, DOI 10.2307/1310564; Costanza R, 1998, SCIENCE, V281, P198, DOI 10.1126/science.281.5374.198; COSTANZA R, 2001, I ECOSYSTEMS SUSTAIN, P169; COSTANZA R, 2001, I ECOSYSTEMS SUSTAIN; Crook DS, 1999, MT RES DEV, V19, P79, DOI 10.2307/3674250; Cross J.G., 1980, SOCIAL TRAPS; CURRAN LM, UNPUB; Dieperink C, 2000, WATER INT, V25, P347, DOI 10.1080/02508060008686842; Dietz T, 1998, BIOSCIENCE, V48, P441, DOI 10.2307/1313241; DIETZ T, 1992, ACTA SOCIOL, V35, P187, DOI 10.1177/000169939203500302; Dietz T., 2003, HUMAN ECOLOGY REV, V10, P60; Dietz T., 2002, HDB ENV SOCIOLOGY, P370; Dolsak N., 2003, COMMONS NEW MILLENNI; DOLSAK N, 2000, THESIS INDIANA U BLO; ELLERMAN AD, 1997, EMISSIONS TRADING US; Finlayson A.C., 1994, FISHING TRUTH SOCIOL; Finlayson C.A., 1998, LINKING SOCIAL ECOLO, P311; Frank R. H., 1988, PASSIONS REASON STRA; Gardner G.T., 1996, ENV PROBLEMS HUMAN B; GIBSON C, UNPUB; Gibson C., 2000, PEOPLE FORESTS; Gregory R, 2001, J POLICY ANAL MANAG, V20, P415, DOI 10.1002/pam.1001.abs; Gunderson L. H., 2001, PANARCHY UNDERSTANDI; Hanna S, 1998, NORTHERN WATERS: MANAGEMENT ISSUES AND PRACTICE, P25; HANNA SS, 1996, RIGHTS NATURE; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hardin G, 1998, SCIENCE, V280, P682, DOI 10.1126/science.280.5364.682; Heal G., 1998, VALUING FUTURE EC TH; HESS C, COMPREHENSIVE BIBLIO; HESS C, 1999, CD ROM WORKSH POL TH; Hsu SL, 1997, ECOL LAW QUART, V24, P799; Janssen M., 2002, COMPLEXITY ECOSYSTEM; KARLSSON S, 2000, THESIS LINKOPING U S; Keohane R. O., 1995, LOCAL COMMONS GLOBAL; KEOHANE RO, 1996, I ENV AID; *KIRB TASK FORC AT, 1982, NAV TROUBL WAT NEW P; Krech S., 1999, ECOLOGICAL INDIAN MY; KRELL A, 2002, DEVILS ROPE CULTURE; Lansing J. Stephen, 1991, PRIESTS PROGRAMMERS; Leach WD, 2002, J POLICY ANAL MANAG, V21, P645, DOI 10.1002/pam.10079; Lee K., 1993, COMPASS GYROSCOPE IN; Levin S., 1999, FRAGILE DOMINION; LIBECAP GD, 1990, CONTRACTING PROPERTY; LILE RD, 1996, ASSESSMENT EPAS SO2; Liu JG, 2003, SCIENCE, V300, P1240, DOI 10.1126/science.1078868; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Low B., 2003, NAVIGATING SOCIAL EC, P83; MARTIN C, 1995, FISHERIES, V20, P6; McCay BJ, 2002, DRAMA COMMONS, P361, DOI DOI 10.17226/10287; McGinnis M., 1999, POLYCENTRIC GOVERNAN; McGinnis Michael D., 2000, WORKSH POL THEOR POL; Meinzen-Dick R, 2002, WORLD DEV, V30, P649, DOI 10.1016/S0305-750X(01)00130-9; MERREY DJ, 1995, IRRIGATION MANAGEMEN; Miles EdwardL., 2001, EXPLAINING REGIME EF; Morrow CE, 1996, WORLD DEV, V24, P1641, DOI 10.1016/0305-750X(96)00064-2; Moss R. H., 2000, GUIDANCE PAPERS CROS, P33; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Nash Jennifer, 2002, NEW TOOLS ENV PROTEC, P235; *NAT RES COUNC BOA, 1999, OUR COMM JOURN TRANS; National Research Council, 1986, P C COMM PROP RES MA; National Research Council Committee on Noneconomic and Economic Value of Biodiversity, 1999, PERSP BIOD VAL ITS R; National Research Council (U.S.). Committee on risk perception and communication, 1989, IMPR RISK COMM; Netting R., 1981, BALANCING ALP ECOLOG; Nilsson T., 2001, THESIS ROYAL I TECHN; North Douglass C., 1981, STRUCTURE CHANGE EC; NUSSBAUM BD, 1992, CLIMATE CHANGE DESIG, P22; OLEARY R, 2003, PROMISE PEFORMANCE E; Ostrom E, 1999, SCIENCE, V284, P278, DOI 10.1126/science.284.5412.278; Ostrom E., 2003, WORKSH RES CHANG EC; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E., 1994, RULES GAMES COMMON P; OSTROM V, 1993, PUBLIC CHOICE, V77, P163, DOI 10.1007/BF01049230; Ostrom V., 1997, MEANING DEMOCRACY VU; Parson E.A., 2003, PROTECTING OZONE LAY; Pinkerton Evelyn, 1989, COOPERATIVE MANAGEME; PLATT J, 1973, AM PSYCHOL, V28, P641, DOI 10.1037/h0035723; POLMAN N, 2002, ENV COOPERATION I CH; Prakash A, 2001, BUS STRATEG ENVIRON, V10, P286, DOI DOI 10.1002/BSE.305; Pretty J, 2003, SCIENCE, V302, P1912, DOI 10.1126/science.1090847; Princen T., 2003, GLOBAL ENVIRON POLIT, V3, P33, DOI [10.1162/, DOI 10.1162/152638003763336374]; Putnam R. D., 2001, BOWLING ALONE COLLAP; Randall A, 2002, NEW TOOLS ENV PROTEC, P311; Robertson R., 1992, GLOBALIZATION SOCIAL; ROSA E, 2003, RISK SOC THEORETICAL; Rose C., 2002, DRAMA COMMONS, P233; Sarker A, 2001, AGR WATER MANAGE, V48, P89, DOI 10.1016/S0378-3774(00)00125-6; SCHLAGER E, 1994, LAND ECON, V70, P294, DOI 10.2307/3146531; Singleton S. G., 1998, CONSTRUCTING COOPERA, DOI [10.3998/mpub.14466, DOI 10.3998/MPUB.14466]; SKLAR FH, 1989, COASTAL ECOLOGICAL L; STAVINS RN, 1998, J ECON PERSPECT, V12, P133; Stern P., 1999, J CONSUM POLICY, V22, P461, DOI [DOI 10.1023/A:1006211709570, 10.1023/A:1006211709570]; Stern P. C., 1996, UNDERSTANDING RISK I; Stern Paul C., 1999, MAKING CLIMATE FOREC; Stern Paul C., 2002, ENVIRONMENTAL PRACTI, V4, P61, DOI [10.1017/S1466046602021038, DOI 10.1017/S1466046602021038]; STERN PC, 1991, POLICY SCI, V24, P99, DOI 10.1007/BF00146466; STERN PC, 1993, SCIENCE, V260, P1897, DOI 10.1126/science.260.5116.1897; Stern PC, 1992, GLOBAL ENV CHANGE UN; Stokke O.S., 2001, GOVERNING HIGH SEAS; SUSSMAN RW, 1994, HUM ECOL, V22, P333, DOI 10.1007/BF02168856; Tietenberg T, 2001, FRONTIERS OF ENVIRONMENTAL ECONOMICS, P85; TIETENBERG T, 2002, DRAMA COMMONS, P233; TUCKER C, 1999, PRAXIS, V15, P47; TURNER BL, 1990, GLOBAL ENVIRON CHANG, V1, P14, DOI 10.1016/0959-3780(90)90004-S; *UN ENV PROGR, 1999, PROD CONS OZ DEPL SU; UNDERDAL A, 1998, INT ENV AGREEMENTS D; Underdal A., 1998, POLITICS INT ENV MAN; VAYDA AP, 1984, ECOLOGY PRACTICE; Verweij M., 2000, TRANSBOUNDARY ENV PR; WEBER U, 2000, UNESCO COURIER   JUN, P9; Webler, 1995, FAIRNESS COMPETENCE, DOI 10.1007/978-94-011-0131-8; Weiner S., 1993, DIMENSIONS MANAGING; Weinstein M., 2000, GEORGETOWN INT ENV L, V12, P375; WEISS EB, 1998, ENGAGING COUNTRIES S; Wilen JE, 2000, J ENVIRON ECON MANAG, V39, P306, DOI 10.1006/jeem.1999.1110; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; WILSON J A, 1990, Ocean and Shoreline Management, V13, P179, DOI 10.1016/0951-8312(90)90002-Y; WILSON JA, 1994, MAR POLICY, V18, P291, DOI 10.1016/0308-597X(94)90044-2; Wilson James, 2002, DRAMA COMMONS, P327; World Resources Institute, 2003, WORLD RES 2002 2004; WUNSCH J, 1995, FAILURE CENTALIZED S; Yandle T, 2003, POLIT SCI ENVIRON, P101; York R, 2003, AM SOCIOL REV, V68, P279, DOI 10.2307/1519769; Young O. R., 1999, EFFECTIVENESS INT EN; Young O.R., 2002, I DIMENSIONS ENV CHA, V1st ed., DOI DOI 10.7551/MITPRESS/3807.001.0001; [No title captured]	150	2301	2367	25	1089	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1907	1912		10.1126/science.1091015	http://dx.doi.org/10.1126/science.1091015			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752NL	14671286				2022-12-28	WOS:000187174000041
J	Methe, BA; Nelson, KE; Eisen, JA; Paulsen, IT; Nelson, W; Heidelberg, JF; Wu, D; Wu, M; Ward, N; Beanan, MJ; Dodson, RJ; Madupu, R; Brinkac, LM; Daugherty, SC; DeBoy, RT; Durkin, AS; Gwinn, M; Kolonay, JF; Sullivan, SA; Haft, DH; Selengut, J; Davidsen, TM; Zafar, N; White, O; Tran, B; Romero, C; Forberger, HA; Weidman, J; Khouri, H; Feldblyum, TV; Utterback, TR; Van Aken, SE; Lovley, DR; Fraser, CM				Methe, BA; Nelson, KE; Eisen, JA; Paulsen, IT; Nelson, W; Heidelberg, JF; Wu, D; Wu, M; Ward, N; Beanan, MJ; Dodson, RJ; Madupu, R; Brinkac, LM; Daugherty, SC; DeBoy, RT; Durkin, AS; Gwinn, M; Kolonay, JF; Sullivan, SA; Haft, DH; Selengut, J; Davidsen, TM; Zafar, N; White, O; Tran, B; Romero, C; Forberger, HA; Weidman, J; Khouri, H; Feldblyum, TV; Utterback, TR; Van Aken, SE; Lovley, DR; Fraser, CM			Genome of Geobacter sulfurreducens: Metal reduction in subsurface environments	SCIENCE			English	Article							URANIUM-CONTAMINATED AQUIFER; MYXOCOCCUS-XANTHUS; OXYGEN; EXPRESSION; SEDIMENTS; SEQUENCE; PROTEIN	The complete genome sequence of Geobacter sulfurreducens, a delta-proteobacterium, reveals unsuspected capabilities, including evidence of aerobic metabolism, one-carbon and complex carbon metabolism, motility, and chemotactic behavior. These characteristics, coupled with the possession of many two-component sensors and many c-type cytochromes, reveal an ability to create alternative, redundant, electron transport networks and offer insights into the process of metal ion reduction in subsurface environments. As well as playing roles in the global cycling of metals and carbon, this organism clearly has the potential for use in bioremediation of radioactive metals and in the generation of electricity.	Inst Genom Res, Rockville, MD 20850 USA; Univ Massachusetts, Dept Microbiol, Amherst, MA 01002 USA	J. Craig Venter Institute; University of Massachusetts System; University of Massachusetts Amherst	Methe, BA (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.		Nelson, William C/E-9263-2016; Eisen, Jonathan A./H-2706-2019; Paulsen, Ian T/K-3832-2012	Nelson, William C/0000-0002-1873-3929; Eisen, Jonathan A./0000-0002-0159-2197; Paulsen, Ian T/0000-0001-9015-9418; Heidelberg, John/0000-0003-0673-3224; Wu, Martin/0000-0003-3093-4077; Fraser, Claire/0000-0003-1462-2428				Anderson RT, 2003, APPL ENVIRON MICROB, V69, P5884, DOI 10.1128/AEM.69.10.5884-5891.2003; BLAUT M, 1994, ANTON LEEUW INT J G, V66, P187, DOI 10.1007/BF00871639; Bond DR, 2002, SCIENCE, V295, P483, DOI 10.1126/science.1066771; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Cypionka H, 2000, ANNU REV MICROBIOL, V54, P827, DOI 10.1146/annurev.micro.54.1.827; Dailey TA, 1998, J BIOL CHEM, V273, P13658, DOI 10.1074/jbc.273.22.13658; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; HEISE R, 1993, FEMS MICROBIOL LETT, V112, P261, DOI 10.1111/j.1574-6968.1993.tb06460.x; Holmes DE, 2002, APPL ENVIRON MICROB, V68, P2300, DOI 10.1128/AEM.68.5.2300-2306.2002; Jolley KA, 2000, MICROBIOL-UK, V146, P1061, DOI 10.1099/00221287-146-5-1061; Kirby JR, 2003, P NATL ACAD SCI USA, V100, P2008, DOI 10.1073/pnas.0330944100; LEHMANN M, 1995, J BIOL CHEM, V270, P14420, DOI 10.1074/jbc.270.24.14420; Lemos RS, 2001, FEBS LETT, V496, P40, DOI 10.1016/S0014-5793(01)02399-7; Lovley D.R., 1997, IRON RELATED TRANSIT, P187; LOVLEY DR, 2003, PROKARYOTES RELEASE; Schnarrenberger C, 2002, EUR J BIOCHEM, V269, P868, DOI 10.1046/j.0014-2956.2001.02722.x; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Thelwell C, 1998, P NATL ACAD SCI USA, V95, P10728, DOI 10.1073/pnas.95.18.10728; Tsujibo H, 2000, APPL ENVIRON MICROB, V66, P3778, DOI 10.1128/AEM.66.9.3778-3783.2000; WHITE DC, 2000, PHYSL BIOCH PROKARYO, V2	20	548	1011	20	304	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1967	1969		10.1126/science.1088727	http://dx.doi.org/10.1126/science.1088727			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671304				2022-12-28	WOS:000187174000061
J	Petro, JB; Relman, DA				Petro, JB; Relman, DA			Public health - Understanding threats to scientific openness	SCIENCE			English	Editorial Material									Joint Mil Intelligence Coll, Bolling AFB, Washington, DC 20340 USA; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	United States Department of Defense; United States Air Force; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Petro, JB (corresponding author), Joint Mil Intelligence Coll, Bolling AFB, Washington, DC 20340 USA.			Relman, David A./0000-0001-8331-1354				CARUS WS, 2001, BIOTERRORISM BIOCRIM, P7; Gordon Michael R., 2002, NEW YORK TIMES  0908, pA1; *US NAT AC SCI, IN PRESS BIOTECHNOLO	3	20	20	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1898	1898		10.1126/science.1092493	http://dx.doi.org/10.1126/science.1092493			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671279	Green Submitted			2022-12-28	WOS:000187174000034
J	Shcherbina, AY; Talley, LD; Rudnick, DL				Shcherbina, AY; Talley, LD; Rudnick, DL			Direct observations of North Pacific ventilation: Brine rejection in the Okhotsk Sea	SCIENCE			English	Article							WATER PRODUCTION; HEAT-BUDGET; DEEP-WATER; OCEAN; SHELF; ICE; INTERMEDIATE; CIRCULATION; CONVECTION; POLYNYA	Brine rejection that accompanies ice formation in coastal polynyas is responsible for ventilating several globally important water masses in the Arctic and Antarctic. However, most previous studies of this process have been indirect, based on heat budget analyses or on warm-season water column inventories. Here, we present direct measurements of brine rejection and formation of North Pacific Intermediate Water in the Okhotsk Sea from moored winter observations. A steady, nearly linear salinity increase unambiguously caused by local ice formation was observed for more than a month.	Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Talley, LD (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA.		Rudnick, Daniel L/J-8948-2016	Rudnick, Daniel L/0000-0002-2624-7074; Shcherbina, Andrey/0000-0002-4246-487X; Talley, Lynne/0000-0003-1574-729X				CAVALIERI DJ, 1994, J GEOPHYS RES-OCEANS, V99, P12561, DOI 10.1029/94JC00707; Chapman DC, 1997, J PHYS OCEANOGR, V27, P555, DOI 10.1175/1520-0485(1997)027<0555:SCABEI>2.0.CO;2; DICKSON RR, 1994, J GEOPHYS RES-OCEANS, V99, P12319, DOI 10.1029/94JC00530; Fahrbach E, 2001, J GEOPHYS RES-OCEANS, V106, P2761, DOI 10.1029/2000JC900142; Gladyshev S, 2000, J GEOPHYS RES-OCEANS, V105, P26281, DOI 10.1029/1999JC000067; Gladyshev S, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC000877; HAYS J, IN PRESS DEEP SEA RE; Keigwin LD, 1998, PALEOCEANOGRAPHY, V13, P323, DOI 10.1029/98PA00874; Kitani K., 1973, B FAR SEAS FISH RES, V9, P45; Macdonald AM, 1998, PROG OCEANOGR, V41, P281, DOI 10.1016/S0079-6611(98)00020-2; MANZELLA G, 1999, OCEANOGRAPHY ROSS SE; MARKUS T, 1998, ANTARCTIC SEA ICE PH; Martin S, 1998, J GEOPHYS RES-OCEANS, V103, P27771, DOI 10.1029/98JC02242; MASLANIK J, 1990, DEFENSE METEOROLOGIC; Ohshima KI, 2003, J METEOROL SOC JPN, V81, P653, DOI 10.2151/jmsj.81.653; OHSHIMA KI, IN PRESS J PHYS OCEA; PRICE JF, 1994, PROG OCEANOGR, V33, P161, DOI 10.1016/0079-6611(94)90027-2; Reid J. L., 1965, INTERMEDIATE WATERS; RINTOUL SR, 1998, ANTARCTIC RES SERIES, V75; Rudels B, 2000, J MARINE SYST, V25, P77, DOI 10.1016/S0924-7963(00)00009-9; SCHUMACHER JD, 1983, J GEOPHYS RES-OCEANS, V88, P2723, DOI 10.1029/JC088iC05p02723; Talley LD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016451; TALLEY LD, 1993, J PHYS OCEANOGR, V23, P517, DOI 10.1175/1520-0485(1993)023<0517:DAFONP>2.0.CO;2; Talley LD, 2003, J PHYS OCEANOGR, V33, P530, DOI 10.1175/1520-0485(2003)033<0530:SIADOC>2.0.CO;2; Weeks, 1974, J GLACIOL, V13, P109, DOI [DOI 10.1017/S0022143000023418, DOI 10.3189/S0022143000023418]; Weingartner TJ, 1998, J GEOPHYS RES-OCEANS, V103, P7647, DOI 10.1029/98JC00374; Williams GD, 2003, DEEP-SEA RES PT II, V50, P1373, DOI 10.1016/S0967-0645(03)00074-2; [No title captured]	28	144	148	4	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1952	1955		10.1126/science.1088692	http://dx.doi.org/10.1126/science.1088692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671300				2022-12-28	WOS:000187174000057
J	Plotz, S; Simon, H; Darsow, U; Simon, D; Vassina, E; Yousefi, S; Hein, R; Smith, T; Behrendt, H; Ring, J				Plotz, S; Simon, H; Darsow, U; Simon, D; Vassina, E; Yousefi, S; Hein, R; Smith, T; Behrendt, H; Ring, J			Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							T-CELLS; IMATINIB; INTERLEUKIN-5; KINASE; FUSION; AIRWAY; CLONES		Univ Bern, Dept Pharmacol, CH-3010 Bern, Switzerland; Tech Univ Munich, Div Environm Dermatol & Allergy GSF, TUM, Ctr Allergy & Environm, D-8000 Munich, Germany; Tech Univ Munich, Dept Dermatol & Allergy, D-8000 Munich, Germany; Univ Bern, Dept Dermatol, Bern, Switzerland; GlaxoSmithKline, Harlow, Essex, England	University of Bern; Technical University of Munich; Technical University of Munich; University of Bern; GlaxoSmithKline	Simon, H (corresponding author), Univ Bern, Dept Pharmacol, Friedbuhlstr 49, CH-3010 Bern, Switzerland.	hus@pki.unibe.ch	Ring, Johannes/GLN-4341-2022; Yousefi, Shida/AAU-7986-2020; Simon, Hans-Uwe/AAU-5079-2020; Vassina, Ekaterina/A-9218-2012; Yousefi, Shida/L-9689-2016; Simon, Hans-Uwe/AAU-7410-2020	Ring, Johannes/0000-0001-8236-3152; Yousefi, Shida/0000-0002-9855-4305; Yousefi, Shida/0000-0002-9855-4305; Simon, Hans-Uwe/0000-0002-9404-7736				CHUSID MJ, 1975, MEDICINE, V54, P1, DOI 10.1097/00005792-197501000-00001; COGAN E, 1994, NEW ENGL J MED, V330, P535, DOI 10.1056/NEJM199402243300804; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; de Lavareille A, 2002, J ALLERGY CLIN IMMUN, V110, P476, DOI 10.1067/mai.2002.127003; Flood-Page PT, 2003, AM J RESP CRIT CARE, V167, P199, DOI 10.1164/rccm.200208-789OC; Gleich GJ, 2002, LANCET, V359, P1577, DOI 10.1016/S0140-6736(02)08505-7; Griffin JH, 2003, P NATL ACAD SCI USA, V100, P7830, DOI 10.1073/pnas.0932698100; KAZMIEROWSKI JA, 1978, ARCH DERMATOL, V114, P531, DOI 10.1001/archderm.114.4.531; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Mattes J, 2002, J EXP MED, V195, P1433, DOI 10.1084/jem.20020009; Pardanani A, 2003, BLOOD, V101, P3391, DOI 10.1182/blood-2002-10-3103; Plotz S, 1998, ALLERGOLOGIE, V21, P489; Simon HU, 1999, NEW ENGL J MED, V341, P1112, DOI 10.1056/NEJM199910073411503; Simon HU, 2001, INT ARCH ALLERGY IMM, V124, P242, DOI 10.1159/000053723; Simon HU, 1997, J IMMUNOL, V158, P3902; WELLER PF, 1994, BLOOD, V83, P2759, DOI 10.1182/blood.V83.10.2759.2759	16	204	209	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					2334	2339		10.1056/NEJMoa031261	http://dx.doi.org/10.1056/NEJMoa031261			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668459				2022-12-28	WOS:000187125000008
J	Dash, P; Gowman, N; Traynor, M				Dash, P; Gowman, N; Traynor, M			Increasing the impact of health services research	BRITISH MEDICAL JOURNAL			English	Article									Hlth Fdn, London WC2E 9RA, England		Traynor, M (corresponding author), Hlth Fdn, London WC2E 9RA, England.		North, Natasha L/K-9718-2018; North, Natasha/ABC-6043-2020	North, Natasha L/0000-0001-5317-8919; North, Natasha/0000-0001-5317-8919				Canadian Health Services Research Foundation, IS RES WORK YOU SELF; DASH P, 2003, INCREASING IMPACT HL; *DEP HLTH, 2001, NHS PRIOR NEEDS R D; HARRISON A, 2001, HLTH CARE UK 2001; *NAT COORD CTR SER, 2003, REFR NAT LIST EX REP	5	21	22	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 6	2003	327	7427					1339	1341		10.1136/bmj.327.7427.1339	http://dx.doi.org/10.1136/bmj.327.7427.1339			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752DE	14656847	Green Published			2022-12-28	WOS:000187131100025
J	Akimoto, H				Akimoto, H			Global air quality and pollution	SCIENCE			English	Article							TROPOSPHERIC OZONE; NITROGEN-OXIDES; CARBON-MONOXIDE; ASIAN EMISSIONS; SURFACE OZONE; UNITED-STATES; APRIL 1998; TRANSPORT; PACIFIC; AEROSOLS	The impact of global air pollution on climate and the environment is a new focus in atmospheric science. Intercontinental transport and hemispheric air pollution by ozone jeopardize agricultural and natural ecosystems worldwide and have a strong effect on climate. Aerosols, which are spread globally but have a strong regional imbalance, change global climate through their direct and indirect effects on radiative forcing. In the 1990s, nitrogen oxide emissions from Asia surpassed those from North America and Europe and should continue to exceed them for decades. International initiatives to mitigate global air pollution require participation from both developed and developing countries.	Frontier Res Syst Global Change, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan	Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Akimoto, H (corresponding author), Frontier Res Syst Global Change, Kanazawa Ku, 3173-25 Showa Machi, Yokohama, Kanagawa 2360001, Japan.							Bergamaschi P, 1998, J GEOPHYS RES-ATMOS, V103, P8227, DOI 10.1029/97JD03738; Berntsen TK, 1999, GEOPHYS RES LETT, V26, P2171, DOI 10.1029/1999GL900477; Borrell P, 2003, ATMOS ENVIRON, V37, P2567, DOI 10.1016/S1352-2310(03)00150-X; Brunner D, 2001, J GEOPHYS RES-ATMOS, V106, P27673, DOI 10.1029/2001JD900239; CRUTZEN PJ, 1979, NATURE, V282, P253, DOI 10.1038/282253a0; Derwent RG, 1998, ATMOS ENVIRON, V32, P145, DOI 10.1016/S1352-2310(97)00338-5; Edwards DP, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002927; FISHMAN J, 1986, J GEOPHYS RES-ATMOS, V91, P14451, DOI 10.1029/JD091iD13p14451; Haywood J, 2000, REV GEOPHYS, V38, P513, DOI 10.1029/1999RG000078; Higurashi A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015357; HOLLOWAY T, IN PRESS ENV SCI TEC; HOUGHTON JT, 2001, CLIMATE CHANGE 2001, P260; Husar RB, 2001, J GEOPHYS RES-ATMOS, V106, P18317, DOI 10.1029/2000JD900788; Jacob DJ, 1999, GEOPHYS RES LETT, V26, P2175, DOI 10.1029/1999GL900450; Jaffe D, 2003, ATMOS ENVIRON, V37, P391, DOI 10.1016/S1352-2310(02)00862-2; Jaffe D, 1999, GEOPHYS RES LETT, V26, P711, DOI 10.1029/1999GL900100; Jaffe D, 2001, J GEOPHYS RES-ATMOS, V106, P7449, DOI 10.1029/2000JD900636; Jeker DP, 2000, J GEOPHYS RES-ATMOS, V105, P3679, DOI 10.1029/1999JD901053; KATO N, 1992, ATMOS ENVIRON A-GEN, V26, P2997, DOI 10.1016/0960-1686(92)90291-R; Kaufman YJ, 2002, NATURE, V419, P215, DOI 10.1038/nature01091; Klimont Z, 2001, WATER AIR SOIL POLL, V130, P193, DOI 10.1023/A:1013886429786; Lamarque JF, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017503; Lelieveld J, 2000, J GEOPHYS RES-ATMOS, V105, P3531, DOI 10.1029/1999JD901011; Li QB, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001422; Molina LT, 2002, AIR QUALITY MEXICO M, P21, DOI 10.1007/978-94-010-0454-1; MUSSELMAN RC, 1994, J AIR WASTE MANAGE, V44, P1383; Naja M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002477; Nakajima T, 2001, GEOPHYS RES LETT, V28, P1171, DOI 10.1029/2000GL012186; Newell RE, 2000, GEOPHYS RES LETT, V27, P2509, DOI 10.1029/2000GL011501; *OECD, 1993, OECD ENV DAT COMP 19; PARRISH DD, 1992, J GEOPHYS RES-ATMOS, V97, P15883, DOI 10.1029/92JD01242; Pochanart P, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD001412; Pochanart P, 2002, ATMOS ENVIRON, V36, P4235, DOI 10.1016/S1352-2310(02)00339-4; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; REICHLE HG, 1986, J GEOPHYS RES-ATMOS, V91, P865, DOI 10.1029/JD091iD10p10865; ROECKMAN T, 1999, CHEMOSPHERE GLOBAL C, V1, P219; Stohl A, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001396; Stohl A, 2001, J GEOPHYS RES-ATMOS, V106, P27757, DOI 10.1029/2001JD000749; Stohl A, 1999, J GEOPHYS RES-ATMOS, V104, P30445, DOI 10.1029/1999JD900803; Streets DG, 2001, WATER AIR SOIL POLL, V130, P187, DOI 10.1023/A:1013883628877; Tyndall G.S., 1999, ATMOSPHERIC CHEM GLO; *UN POP DIV DEP EC, 2002, WORLD URB PROSP 2001; Uno I, 2001, J GEOPHYS RES-ATMOS, V106, P18331, DOI 10.1029/2000JD900748; *US EPA, 1999, EPA454R00002; *WHO, 2000, UPD REV WHO AIR QUAL; Wild O, 2001, J GEOPHYS RES-ATMOS, V106, P27729, DOI 10.1029/2000JD000123; Wilkening KE, 2000, SCIENCE, V290, P65, DOI 10.1126/science.290.5489.65	47	774	821	23	381	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1716	1719		10.1126/science.1092666	http://dx.doi.org/10.1126/science.1092666			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657488				2022-12-28	WOS:000186970100035
J	Tanser, FC; Sharp, B; le Sueur, D				Tanser, FC; Sharp, B; le Sueur, D			Potential effect of climate change on malaria transmission in Africa	LANCET			English	Article							DISEASE; MODEL	Background Climate change is likely to affect transmission of vector-borne diseases such as malaria. We quantitatively estimated current malaria exposure and assessed the potential effect of projected climate scenarios on malaria transmission. Methods We produced a spatiotemporally validated (against 3791 parasite surveys) model of Plasmodium falciparum malaria transmission in Africa. Using different climate scenarios from the Hadley Centre global climate model (HAD CM3) climate experiments, we projected the potential effect of climate change on transmission patterns. Findings Our model showed sensitivity and specificity of 63% and 96%, respectively (within 1 month temporal accuracy), when compared with the parasite surveys. We estimate that on average there are 3.1 billion person-months of exposure (445 million people exposed) in Africa per year. The projected scenarios would estimate a 5-7% potential increase (mainly altitudinal) in malaria distribution with surprisingly little increase in the latitudinal extents of the disease by 2100. Of the overall potential increase (although transmission will decrease in some countries) of 16-28% in person-months of exposure (assuming a constant population), a large proportion will be seen in areas of existing transmission. Interpretation The effect of projected climate change indicates that a prolonged transmission season is as important as geographical expansion in correct assessment of the effect of changes in transmission patterns. Our model constitutes a valid baseline against which climate scenarios can be assessed and interventions planned.	MRC, Malaria Res Lead Programme, ZA-4067 Overport, South Africa; Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa	University of Kwazulu Natal	Tanser, FC (corresponding author), MRC, Malaria Res Lead Programme, ZA-4067 Overport, South Africa.	tanserf@mrc.ac.za	Tanser, Frank/ABE-8326-2021	Tanser, Frank/0000-0001-9797-0000				Akhtar R, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, P451; [Anonymous], 1999, WORLD HLTH REPORT 19; Barnett TP, 1999, J CLIMATE, V12, P511, DOI 10.1175/1520-0442(1999)012<0511:CONSAT>2.0.CO;2; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; DEICHMANN U, 1996, AFRICA POPULATION DA; Fisher R. W., 1996, FUTURE RES Q, V31, P43; Hammond A., 1996, WHICH WORLD; Hay SI, 1998, T ROY SOC TROP MED H, V92, P12, DOI 10.1016/S0035-9203(98)90936-1; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hutchinson M. F., 1995, AFRICA TOPOGRAPHIC C; Johns TC, 2003, CLIM DYNAM, V20, P583, DOI 10.1007/s00382-002-0296-y; Kleinschmidt I, 2000, INT J EPIDEMIOL, V29, P355, DOI 10.1093/ije/29.2.355; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; MARA, 1998, ATL MAL RISK AFR 1 T; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Molineaux L, 1988, MALARIA PRINCIPLES P, P919; Nabarro DN, 1998, SCIENCE, V280, P2067, DOI 10.1126/science.280.5372.2067; Nakicenovic N., 2000, SPECIAL REPORT EMISS; ONORI E, 1980, B WORLD HEALTH ORGAN, V58, P91; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; Reiter P, 2000, EMERG INFECT DIS, V6, P1; Reiter P, 1998, LANCET, V351, P839, DOI 10.1016/S0140-6736(05)78979-0; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Rogers DJ, 2000, SCIENCE, V289, P1763, DOI 10.1126/science.289.5485.1763; SLOOFF R., 1961, Tropical and Geographical Medicine, V13, P67; Snow RW, 1998, T ROY SOC TROP MED H, V92, P601, DOI 10.1016/S0035-9203(98)90781-7; STUCKENBERG BR, 1969, ZOOL AFR, P145; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; World Health Organization, 1993, GLOB STRAT MAL CONTR	30	263	273	3	100	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1792	1798		10.1016/S0140-6736(03)14898-2	http://dx.doi.org/10.1016/S0140-6736(03)14898-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654317				2022-12-28	WOS:000186872900010
J	Hagmann, C; Berger, TM				Hagmann, C; Berger, TM			Congenital pulmonary lymphangiectasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Childrens Hosp Lucerne, CH-6000 Luzern 16, Switzerland		Hagmann, C (corresponding author), Childrens Hosp Lucerne, CH-6000 Luzern 16, Switzerland.								0	7	7	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2003	349	22					E21	E21		10.1056/ENEJMicm010476	http://dx.doi.org/10.1056/ENEJMicm010476			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746ZV	14645654				2022-12-28	WOS:000186779700007
J	Mertz, HR				Mertz, HR			Drug therapy: Irritable bowel syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							QUALITY-OF-LIFE; 5-HT3 RECEPTOR ANTAGONIST; FUNCTIONAL GASTROINTESTINAL DISORDERS; RANDOMIZED CONTROLLED-TRIAL; CONTROLLED CLINICAL-TRIAL; PLACEBO-CONTROLLED TRIAL; SMOOTH-MUSCLE RELAXANTS; GUINEA-PIG INTESTINE; DOUBLE-BLIND; CHRONIC CONSTIPATION		Vanderbilt Univ, Dept Med, Div Gastroenterol, Nashville, TN USA; Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Mertz, HR (corresponding author), Nashville Gastrointestinal Specialists, 4130 Harding Rd,Suite 309 W, Nashville, TN 37205 USA.				NIDDK NIH HHS [DK 57047] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK057047] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Al-Chaer ED, 2000, GASTROENTEROLOGY, V119, P1276, DOI 10.1053/gast.2000.19576; Attar A, 1999, GUT, V44, P226, DOI 10.1136/gut.44.2.226; Bennett EJ, 1998, GUT, V43, P256, DOI 10.1136/gut.43.2.256; Bensoussan A, 1998, JAMA-J AM MED ASSOC, V280, P1585, DOI 10.1001/jama.280.18.1585; Bjornsson ES, 1998, AM J PHYSIOL-GASTR L, V275, pG498, DOI 10.1152/ajpgi.1998.275.3.G498; BOTNEY M, 1983, ANN NEUROL, V13, P160, DOI 10.1002/ana.410130209; Camilleri M, 2000, LANCET, V355, P1035, DOI 10.1016/S0140-6736(00)02033-X; Camilleri M, 2001, ARCH INTERN MED, V161, P1733, DOI 10.1001/archinte.161.14.1733; Camilleri M, 1999, ALIMENT PHARM THERAP, V13, P1149; CANN PA, 1984, DIGEST DIS SCI, V29, P239, DOI 10.1007/BF01296258; CANN PA, 1984, GUT, V25, P168, DOI 10.1136/gut.25.2.168; Chey WY, 2001, AM J GASTROENTEROL, V96, P1499; Colwell LJ, 1998, AM J GASTROENTEROL, V93, P901; Corazziari E, 2000, GUT, V46, P522, DOI 10.1136/gut.46.4.522; Degen L, 2001, ALIMENT PHARM THERAP, V15, P1745, DOI 10.1046/j.1365-2036.2001.01103.x; Delvaux M, 1998, ALIMENT PHARM THER, V12, P849, DOI 10.1046/j.1365-2036.1998.00375.x; Drossman DA, 2003, GASTROENTEROLOGY, V125, P19, DOI 10.1016/S0016-5085(03)00669-3; DROSSMAN DA, 1993, DIGEST DIS SCI, V38, P1569, DOI 10.1007/BF01303162; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; DROSSMAN DA, 1988, GASTROENTEROLOGY, V95, P701, DOI 10.1016/S0016-5085(88)80017-9; Drossman DA, 2000, AM J GASTROENTEROL, V95, P999; El-Serag HB, 2002, ALIMENT PHARM THER, V16, P1171, DOI 10.1046/j.1365-2036.2002.01290.x; FORD MJ, 1995, GASTROENTEROLOGY, V109, P1772, DOI 10.1016/0016-5085(95)90743-2; FoxxOrenstein AE, 1996, GASTROENTEROLOGY, V111, P1281, DOI 10.1053/gast.1996.v111.pm8898642; FRANCIS CY, 1994, LANCET, V344, P39, DOI 10.1016/S0140-6736(94)91055-3; Friedel D, 2001, GASTROENTEROLOGY, V120, P557, DOI 10.1053/gast.2001.21177; Fukudo S, 1998, GUT, V42, P845, DOI 10.1136/gut.42.6.845; Glatzle J, 2002, GASTROENTEROLOGY, V123, P217, DOI 10.1053/gast.2002.34245; Gorelick AB, 1998, AM J PHYSIOL-GASTR L, V275, pG460, DOI 10.1152/ajpgi.1998.275.3.G460; Gralnek IM, 2000, GASTROENTEROLOGY, V119, P654, DOI 10.1053/gast.2000.16484; GREENBAUM DS, 1987, DIGEST DIS SCI, V32, P257, DOI 10.1007/BF01297051; Grider JR, 1998, GASTROENTEROLOGY, V115, P370, DOI 10.1016/S0016-5085(98)70203-3; Gunput MD, 1999, ALIMENT PHARM THER, V13, P70, DOI 10.1046/j.1365-2036.1999.00009.x; GUTHRIE E, 1991, GASTROENTEROLOGY, V100, P450, DOI 10.1016/0016-5085(91)90215-7; Heymann-Monnikes I, 2000, AM J GASTROENTEROL, V95, P981; Horwitz BJ, 2001, NEW ENGL J MED, V344, P1846, DOI 10.1056/NEJM200106143442407; Jackson JL, 2000, AM J MED, V108, P65, DOI 10.1016/S0002-9343(99)00299-5; Jailwala J, 2000, ANN INTERN MED, V133, P136, DOI 10.7326/0003-4819-133-2-200007180-00013; Jin JG, 1999, J PHARMACOL EXP THER, V288, P93; Jones J, 2000, GUT, V47, pII1, DOI 10.1136/gut.47.suppl_2.ii1; Jones RH, 1999, ALIMENT PHARM THER, V13, P1419; Kellow J, 2003, GUT, V52, P671, DOI 10.1136/gut.52.5.671; KELLOW JE, 1987, GASTROENTEROLOGY, V92, P1885, DOI 10.1016/0016-5085(87)90620-2; Kim HJ, 2003, ALIMENT PHARM THER, V17, P895, DOI 10.1046/j.1365-2036.2003.01543.x; KING JC, 1966, CURR THER RES CLIN E, V8, P535; Kozlowski CM, 2000, GUT, V46, P474, DOI 10.1136/gut.46.4.474; LANCASTERSMITH MJ, 1982, ACTA PSYCHIAT SCAND, V66, P33, DOI 10.1111/j.1600-0447.1982.tb00912.x; LICHSTEIN J, 1959, J Chronic Dis, V9, P394, DOI 10.1016/0021-9681(59)90059-1; LUCEY MR, 1987, GUT, V28, P221, DOI 10.1136/gut.28.2.221; MATHIAS JR, 1994, DIGEST DIS SCI, V39, P1155, DOI 10.1007/BF02093778; Mathias JR, 1998, DIGEST DIS SCI, V43, P1347, DOI 10.1023/A:1018888631286; MAX MB, 1987, NEUROLOGY, V37, P589, DOI 10.1212/WNL.37.4.589; MCKEE DP, 1993, DIGEST DIS SCI, V38, P1761, DOI 10.1007/BF01296097; McQuay HJ, 1997, BRIT MED J, V314, P763, DOI 10.1136/bmj.314.7083.763; Mertz H, 1998, AM J GASTROENTEROL, V93, P160, DOI 10.1111/j.1572-0241.1998.00160.x; Mertz H, 1997, GASTROENTEROLOGY, V113, P1054; Mertz H, 1999, AM J GASTROENTEROL, V94, P131; Mertz H, 1999, AM J GASTROENTEROL, V94, P609, DOI 10.1016/S0002-9270(98)00803-X; Miura M, 1999, DIGEST DIS SCI, V44, P20, DOI 10.1023/A:1026633629141; Muller-Lissner SA, 2001, ALIMENT PHARM THER, V15, P1655, DOI 10.1046/j.1365-2036.2001.01094.x; MULLERLISSNER SA, 1988, BRIT MED J, V296, P615, DOI 10.1136/bmj.296.6622.615; NANDA R, 1989, GUT, V30, P1099, DOI 10.1136/gut.30.8.1099; NARDUCCI F, 1985, DIGEST DIS SCI, V30, P40, DOI 10.1007/BF01318369; Novick J, 2002, ALIMENT PHARM THER, V16, P1877, DOI 10.1046/j.1365-2036.2002.01372.x; OWENS DM, 1995, ANN INTERN MED, V122, P107, DOI 10.7326/0003-4819-122-2-199501150-00005; Peghini PL, 1998, GUT, V42, P807, DOI 10.1136/gut.42.6.807; Pimentel M, 2003, AM J GASTROENTEROL, V98, P412, DOI 10.1016/S0002-9270(02)05902-6; Pimentel M, 2000, AM J GASTROENTEROL, V95, P3503, DOI 10.1111/j.1572-0241.2000.03368.x; Pittler MH, 1998, AM J GASTROENTEROL, V93, P1131, DOI 10.1111/j.1572-0241.1998.00343.x; Poitras P, 2002, DIGEST DIS SCI, V47, P914, DOI 10.1023/A:1014729125428; POULSEN L, 1995, PAIN, V60, P287, DOI 10.1016/0304-3959(94)00142-2; Poynard T, 2001, ALIMENT PHARM THER, V15, P355, DOI 10.1046/j.1365-2036.2001.00937.x; POYNARD T, 1994, ALIMENT PHARM THERAP, V8, P499; Prather CM, 2000, GASTROENTEROLOGY, V118, P463, DOI 10.1016/S0016-5085(00)70251-4; PRIOR A, 1987, GUT, V28, P1510, DOI 10.1136/gut.28.11.1510; PRIOR A, 1993, ALIMENT PHARM THERAP, V7, P175; Rao SSC, 1998, AM J GASTROENTEROL, V93, P985, DOI 10.1016/S0002-9270(98)00174-9; RHODES JB, 1978, J CLIN PHARMACOL, V18, P340, DOI 10.1002/j.1552-4604.1978.tb01603.x; RITCHIE J, 1973, GUT, V14, P125, DOI 10.1136/gut.14.2.125; ROGERS J, 1989, GUT, V30, P634, DOI 10.1136/gut.30.5.634; SCIARRETTA G, 1992, AM J GASTROENTEROL, V87, P1852; Serra J, 2002, GASTROENTEROLOGY, V123, P700, DOI 10.1053/gast.2002.35394; SMITH B, 1968, GUT, V9, P139, DOI 10.1136/gut.9.2.139; Stam R, 1996, AM J PHYSIOL-REG I, V271, pR1270, DOI 10.1152/ajpregu.1996.271.5.R1270; Su X, 1998, PAIN, V76, P105, DOI 10.1016/S0304-3959(98)00031-1; SULLIVAN MA, 1978, NEW ENGL J MED, V298, P878, DOI 10.1056/NEJM197804202981604; SVEDLUND J, 1983, LANCET, V2, P589; Talley NJ, 1996, AM J GASTROENTEROL, V91, P277; Talley NJ, 1997, GUT, V41, P394, DOI 10.1136/gut.41.3.394; TALLEY NJ, 1990, DIGEST DIS SCI, V35, P477, DOI 10.1007/BF01536922; THOMPSON WG, 1986, AM J GASTROENTEROL, V81, P95; Thompson WG, 2000, ROME 2 FUNCTIONAL GA, V2nd, P351; TOLLIVER BA, 1994, AM J GASTROENTEROL, V89, P176; Vanner SJ, 1999, AM J GASTROENTEROL, V94, P2912; WALSH TD, 1983, CLIN NEUROPHARMACOL, V6, P271; Watson ME, 2001, AM J GASTROENTEROL, V96, P455; WELGAN P, 1988, GASTROENTEROLOGY, V94, P1150, DOI 10.1016/0016-5085(88)90006-6; WHITEHEAD WE, 1988, GASTROENTEROLOGY, V95, P709, DOI 10.1016/S0016-5085(88)80018-0; WHORWELL PJ, 1984, LANCET, V2, P1232, DOI 10.1016/S0140-6736(84)92793-4; 2002, FDA TALK PAPER  0724; 2002, MED GUID LOTRONEX TA; 2002, PRESCRIBING PROGRAM	102	139	159	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2003	349	22					2136	2146		10.1056/NEJMra035579	http://dx.doi.org/10.1056/NEJMra035579			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746ZV	14645642				2022-12-28	WOS:000186779700010
J	Huang, TT; Wuerzbrger-Davis, SM; Wu, ZH; Miyamoto, S				Huang, TT; Wuerzbrger-Davis, SM; Wu, ZH; Miyamoto, S			Sequential modification of NEMO/IKK gamma by SUMO-1 and ubiquitin mediates NF-kappa B activation by genotoxic stress	CELL			English	Article							NUCLEAR EXPORT SIGNAL; DNA-DAMAGE; TRANSCRIPTIONAL ACTIVATION; ECTODERMAL DYSPLASIA; IONIZING-RADIATION; GENE-EXPRESSION; IKK ACTIVATION; FAMILY-MEMBERS; KINASE COMPLEX; PORE COMPLEX	The transcription factor NF-kappaB is critical for setting the cellular sensitivities to apoptotic stimuli, including DNA damaging anticancer agents. Central to NF-kappaB signaling pathways is NEMO/IKKgamma, the regulatory subunit of the cytoplasmic IkappaB kinase (IKK) complex. While NF-kappaB activation by genotoxic stress provides an attractive paradigm for nuclear-to-cytoplasmic signaling pathways, the mechanism by which nuclear DNA damage modulates NEMO to activate cytoplasmic IKK remains unknown. Here, we show that genotoxic stress causes nuclear localization of IKK-unbound NEMO via site-specific SUMO-1 attachment. Surprisingly, this sumoylation step is ATM-independent, but nuclear localization allows subsequent ATM-dependent ubiquitylation of NEMO to ultimately activate IKK in the cytoplasm. Thus, genotoxic stress induces two independent signaling pathways, SUMO-1 modification and ATM activation, which work in concert to sequentially cause nuclear targeting and ubiquitylation of free NEMO to permit the NF-kappaB survival pathway. These SUMO and ubiquitin modification pathways may serve as anticancer drug targets.	Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA; Univ Wisconsin, Program Mol & Cellular Biol, Madison, WI 53706 USA; Univ Wisconsin, Program Canc Biol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Miyamoto, S (corresponding author), Univ Wisconsin, Dept Pharmacol, 301 SMI,1300 Univ Ave, Madison, WI 53706 USA.	smiyamot@wisc.edu			NATIONAL CANCER INSTITUTE [R01CA077474, R01CA081065] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA081065, R01-CA077474] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Criswell T, 2003, ONCOGENE, V22, P5813, DOI 10.1038/sj.onc.1206680; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; DEVARY Y, 1992, CELL, V71, P1081, DOI 10.1016/S0092-8674(05)80058-3; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2000, J BIOL CHEM, V275, P9501, DOI 10.1074/jbc.275.13.9501; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Huang TT, 2001, MOL CELL BIOL, V21, P4737, DOI 10.1128/MCB.21.14.4737-4747.2001; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Hur GM, 2003, GENE DEV, V17, P873, DOI 10.1101/gad.1062403; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kurepa J, 2003, J BIOL CHEM, V278, P6862, DOI 10.1074/jbc.M209694200; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; Makris C, 2002, MOL CELL BIOL, V22, P6573, DOI 10.1128/MCB.22.18.6573-6581.2002; Malek S, 2001, J BIOL CHEM, V276, P45225, DOI 10.1074/jbc.M105865200; Mao Y, 2000, P NATL ACAD SCI USA, V97, P4046, DOI 10.1073/pnas.080536597; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Miyamoto S, 1998, MOL CELL BIOL, V18, P19, DOI 10.1128/MCB.18.1.19; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Rui HL, 2002, J BIOL CHEM, V277, P42981, DOI 10.1074/jbc.M208099200; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Smahi A, 2000, NATURE, V405, P466; Sun SC, 1999, ONCOGENE, V18, P6948, DOI 10.1038/sj.onc.1203220; Tam WF, 2001, J BIOL CHEM, V276, P7701, DOI 10.1074/jbc.C000916200; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Weil R, 2003, IMMUNITY, V18, P13, DOI 10.1016/S1074-7613(02)00506-X; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	56	455	477	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 26	2003	115	5					565	576		10.1016/S0092-8674(03)00895-X	http://dx.doi.org/10.1016/S0092-8674(03)00895-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651848	Bronze			2022-12-28	WOS:000186885600007
J	Forgacs, I				Forgacs, I			Referee's half-time analysis	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1474	1474		10.1136/bmj.327.7429.1474	http://dx.doi.org/10.1136/bmj.327.7429.1474			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684656	Green Published			2022-12-28	WOS:000187562700026
J	Aggarwal, A; Leavitt, BJ				Aggarwal, A; Leavitt, BJ			Giant Lambl's excrescences	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Vermont, Coll Med, Burlington, VT 05402 USA	University of Vermont	Aggarwal, A (corresponding author), Univ Vermont, Coll Med, Burlington, VT 05402 USA.								0	9	10	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					E24	E24		10.1056/ENEJMicm010900	http://dx.doi.org/10.1056/ENEJMicm010900			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681522				2022-12-28	WOS:000187326200009
J	Peter, G; Arvin, AM; Davis, JP; Decker, MD; Pasteur, A; Fast, P; Guerra, FA; Helms, CM; Hinman, AR; Katz, R; Klein, JO; Koslap-Petraco, MB; Paradiso, PR; Schaffner, W; Whitley-Williams, PN; Williamson, DE; Gellin, B; Santoli, JM				Peter, G; Arvin, AM; Davis, JP; Decker, MD; Pasteur, A; Fast, P; Guerra, FA; Helms, CM; Hinman, AR; Katz, R; Klein, JO; Koslap-Petraco, MB; Paradiso, PR; Schaffner, W; Whitley-Williams, PN; Williamson, DE; Gellin, B; Santoli, JM		Natl Vaccine Advisory Comm	Strengthening the supply of routinely recommended vaccines in the United States - Recommendations from the National Vaccine Advisory Committee	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Between late 2000 and the spring of 2003, the United States experienced shortages of vaccines against 8 of 11 preventable diseases in children. In response, the Department of Health and Human Services requested that the National Vaccine Advisory Committee (NVAC) make recommendations on strengthening the supply of routinely recommended vaccines. The NVAC appointed a Working Group to identify potential causes of vaccine supply shortages, develop strategies to alleviate or prevent shortages, and enlist stakeholders to consider the applicability and feasibility of these strategies. The NVAC concluded that supply disruptions are likely to continue to occur. Strategies to be implemented in the immediate future include expansion of vaccine stockpiles, increased support for regulatory agencies, maintenance and strengthening of liability protections, improved communication among stakeholders, increased availability of public information, and a campaign to emphasize the benefits of vaccination. Strategies requiring further study include evaluation of appropriate financial incentives to manufacturers and streamlining the regulatory process without compromising safety or efficacy.	Brown Med Sch, Providence, RI USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA; Wisconsin Dept Hlth & Social Serv, Madison, WI USA; Aventis Pasteur, Swiftwater, PA USA; Int AIDS Vaccine Initiat, New York, NY USA; San Antonio Metropolitan Hlth Dist, San Antonio, TX USA; Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA; Task Force Child Survival & Dev, Decatur, GA USA; George Washington Univ, Sch Publ Hlth, Washington, DC USA; George Washington Univ, Hlth Serv, Washington, DC USA; Boston Med Ctr, Boston, MA USA; Suffolk Cty Dept Hlth Serv, Lindenhurst, NY USA; Wyeth Vaccines, Henrietta, NY USA; Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; Univ Med & Dent New Jersey, New Brunswick, NJ USA; Alabama Dept Publ Hlth, Montgomery, AL USA; NVAC, Washington, DC USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Brown University; Stanford University; Sanofi-Aventis; International AIDS Vaccine Initiative; University of Iowa; George Washington University; George Washington University; Boston Medical Center; Pfizer; Vanderbilt University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Centers for Disease Control & Prevention - USA	Peter, G (corresponding author), US Dept HHS, Natl Vaccine Program Off, Hubert H Humphrey Bldg,Room 725 H, Washington, DC 20201 USA.	gpeter@lifespan.org	Williamson, Ethel Diane/AAQ-8878-2020	Decker, Michael/0000-0003-1008-7472; Klein, Jerome/0000-0002-0001-693X				Barker LE, 2001, AM J PREV MED, V20, P28, DOI 10.1016/S0749-3797(01)00283-5; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P783; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P598; *CDCP, NAT VACC PROGR OFF W; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P1140; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P241; *CDCP, CURR VACC DEL SHORT; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P1029; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P679; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P190; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P529; *CDCP, 2002, MMWR-MORBID MORTAL W, V50, P1159; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P189; Davies P, 2002, ARCH DIS CHILD, V87, P22, DOI 10.1136/adc.87.1.22; DAVIS MM, IN PRESS J PEDIAT; *FOOD DRUG ADM, PRESCR DRUG US FEES; *FOOD DRUG ADM, INF CTR BIOL EV RES; *FOOD DRUG ADM, COMM TECHN DOC IMPL; *FOOD DRUG ADM, FDA COMPL 1 STEPS IT; *HLTH RES SERV ADM, INF NAT VACC INJ COM; *I MED, 2003, FIN VACC 21 CENT ASS; *I MED, IMM SAF REV; PAULEY M, 1996, SUPPLYING VACCINE EC; *US GAO, 2002, PUBL US GAO; WILDER E, 2003, NAT VACC ADV COMM M; Wolfe RM, 2002, JAMA-J AM MED ASSOC, V287, P3245, DOI 10.1001/jama.287.24.3245	26	43	43	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2003	290	23					3122	3128						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753ZB	14679275				2022-12-28	WOS:000187277300031
J	Pickard, S; Baraitser, P; Rymer, J; Piper, J				Pickard, S; Baraitser, P; Rymer, J; Piper, J			Can gynaecology teaching associates provide high quality effective training for medical students in the United Kingdom? Comparative study	BRITISH MEDICAL JOURNAL			English	Article								Objectives To train laywomen to become professional patients in order to teach medical students speculum and bimanual examination, to assess their effectiveness in this role, and to incorporate this method of teaching into the undergraduate curriculum of a medical school in the United Kingdom. Design Comparative study. Setting Guy's, King's, and St Thomas's School of Medicine, London. Participants 44 medical students trained by gynaecology teaching associates; 48 control students. Main outcome measure Skills in pelvic examination. Results Six laywomen were recruited and all successfully graduated to become gynaecology teaching associates. At assessment 1, in the third week of the reproductive and sexual health block, the mean score achieved by students trained by gynaecology teaching associates was 155, compared with 104 for control group students (difference in mean scores 51 (95% confidence interval 41 to 61), P < 0.001). Similar results were obtained at assessment 2, at the end of the attachment-the mean score for trained students was 148, compared with a mean score of 114 for control group students (difference in mean scores 34 (21 to 46), P < 0.001). Conclusions Laywomen can be trained to teach pelvic examination to medical students in the United Kingdom. Students who receive this training have better skills than students who receive the traditional training alone.	Lewisham Primary Care Trust, Dept Reprod Hlth Care, London SE5 7RN, England; Southwark Primary Care Trust, Dept Reprod Hlth Care, London, England; Guys Kings & St Thomass Sch Med, Dept Obstet & Gynaecol, London SE1 9RT, England; Southwark Primary Care Trust, Res Support Unit Primary & Community Care, London SE1 8RG, England	University of London; King's College London	Pickard, S (corresponding author), Dept Family Planning, Bedford House,Havelock Pl, Stoke On Trent ST1 4PR, Staffs, England.			Baraitser, Paula/0000-0002-3354-6494					0	51	52	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1389	1392		10.1136/bmj.327.7428.1389	http://dx.doi.org/10.1136/bmj.327.7428.1389			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670887	Bronze, Green Published			2022-12-28	WOS:000187417900026
J	Rosegrant, MW; Cline, SA				Rosegrant, MW; Cline, SA			Global food security: Challenges and policies	SCIENCE			English	Article							AGRICULTURE; POVERTY; INDIA	Global food security will remain a worldwide concern for the next 50 years and beyond. Recently, crop yield has fallen in many areas because of declining investments in research and infrastructure, as well as increasing water scarcity. Climate change and HIV/AIDS are also crucial factors affecting food security in many regions. Although agroecological approaches offer some promise for improving yields, food security in developing countries could be substantially improved by increased investment and policy reforms.	Int Food Policy Res Inst, Washington, DC 20006 USA	CGIAR; International Food Policy Research Institute (IFPRI)	Rosegrant, MW (corresponding author), Int Food Policy Res Inst, 2033 K St NW, Washington, DC 20006 USA.		Zhong, Hong Lin/C-2633-2012					Adams R.M, 1999, CHOICES, V14, P22; Alston, 2000, 113 IFPRI; [Anonymous], 2005, CONDITIONS AGR GROWT; BARGHOUTI SM, 2001, SUSTAIN DEV INT, V1, P127; Brown L. R., 1994, FULL HOUSE REASSESSI; Bruinsma J, 2003, WORLD AGR 2015 2030; BYERLEE D, 2000, ACCESSING MODERN SCI; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Ceccarelli Salvatore, 1996, P99; Clark Colin, 1970, STARVATION PLENTY; Croppenstedt A, 2000, ECON DEV CULT CHANGE, V48, P475, DOI 10.1086/452607; Downing ET, 1993, RENEWABLE ENERGY, V3, P491, DOI [10.1016/0960-1481(93)90115-W, DOI 10.1016/0960-1481(93)90115-W]; EHRLICH PR, 1990, POPULATION EXPLOSION; Evans L., 1998, FEEDING 10 BILLION P; Fan SG, 2000, AM J AGR ECON, V82, P1038, DOI 10.1111/0002-9092.00101; Fan Shenggen, 2002, GROWTH INEQUALITY PO; *FOOD AGR POL RES, 2003, US WORLD AGR OUTL 20; GAIHA R, 1994, DESIGN POVERTY ALEVI; Haddad L., 2001, Journal of International Development, V13, P487, DOI 10.1002/jid.799; IFAD, 1995, STAT WORLD RUR POV P; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 IMP; Kassouf AL, 1996, ECON DEV CULT CHANGE, V44, P817, DOI 10.1086/452246; KOMEGAY J, 1996, PARTICIPATORY PLANT, P151; LIPTON M, 1998, SUCCESS ANTIPOVERTY; Malthus TR, 2003, ESSAY PRINCIPLE POPU; Meadows D. H., 1992, LIMITS CONFRONTING G; *ORG EC COOP DEV, 2003, AGR OUTL 2003 2008; OWEIS T, 1999, 7 INT WAT MAN I; Pretty J., 1999, ENVIRON DEV SUSTAIN, V1, P253, DOI DOI 10.1016/j.jaridenv.2014.01.016; PRETTY JN, 1995, WORLD DEV, V23, P1247, DOI 10.1016/0305-750X(95)00046-F; Rosegrant M.W., 2002, INT MODEL POLICY ANA; Rosegrant M.W., 2002, INT FOOD POLICY RES; Simon JL, 1998, ULTIMATE RESOURCE; SINGH RP, 1993, ECON POLIT WEEKLY, V28, pA9; *UN FAO, 2000, CROPS DROPS; *UN FAO, 2001, COMM WORLD FOOD SEC; *UNAIDS, 2003, JOINT UN PROGR HIV A; *USDA, 2003, WAOB20031 USDA; *W AFR RIC DEV ASS, CONS FORM RAP DISS N; Witcover J., 2001, GLOBAL FOOD PROJECTI; *WORLD BANK, 1990, POV WORLD DEV IND; World Bank, 1996, POV RED WORLD BANK P; *WORLD BANK GROUP, 2003, MILL DEV GOALS GOALS	43	504	538	13	289	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1917	1919		10.1126/science.1092958	http://dx.doi.org/10.1126/science.1092958			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752NL	14671289	Green Submitted			2022-12-28	WOS:000187174000044
J	Roszak, AW; Howard, TD; Southall, J; Gardiner, AT; Law, CJ; Isaacs, NW; Cogdell, RJ				Roszak, AW; Howard, TD; Southall, J; Gardiner, AT; Law, CJ; Isaacs, NW; Cogdell, RJ			Crystal structure of the RC-LH1 core complex from Rhodopseudomonas palustris	SCIENCE			English	Article							PHOTOSYNTHETIC REACTION-CENTER; LIGHT-HARVESTING COMPLEX; CYTOCHROME BC(1) COMPLEX; RHODOBACTER-SPHAEROIDES; PUFX PROTEIN; RHODOSPIRILLUM-RUBRUM; ALPHA-POLYPEPTIDE; RESOLUTION; CAPSULATUS; BACTERIA	The crystal structure at 4.8 angstrom resolution of the reaction center-light harvesting 1 (RC-LH1) core complex from Rhodopseudomonas palustris shows the reaction center surrounded by an oval LH1 complex that consists of 15 pairs of transmembrane helical alpha- and beta-apoproteins and their coordinated bacteriochlorophylls. Complete closure of the RC by the LH1 is prevented by a single transmembrane helix, out of register with the array of inner LH1 alpha-apoproteins. This break, located next to the binding site in the reaction center for the secondary electron acceptor ubiquinone (UQ(B)), may provide a portal through which UQ(B) can transfer electrons to cytochrome b/c(1).	Univ Glasgow, Inst Biomed & Life Sci, Dept Chem, Glasgow G12 8QQ, Lanark, Scotland; Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	Isaacs, NW (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Dept Chem, Glasgow G12 8QQ, Lanark, Scotland.		Gardiner, Alastair T/N-8385-2017; Law, Christopher/E-7174-2011	Southall, June/0000-0002-5496-1531				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; BARZ WP, 1995, BIOCHEMISTRY-US, V34, P15248, DOI 10.1021/bi00046a033; BARZ WP, 1995, BIOCHEMISTRY-US, V34, P15235, DOI 10.1021/bi00046a032; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cogdell RJ, 1999, J BACTERIOL, V181, P3869, DOI 10.1128/JB.181.13.3869-3879.1999; Cogdell RJ, 1996, PHOTOSYNTH RES, V48, P55, DOI 10.1007/BF00040996; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Frese RN, 2000, P NATL ACAD SCI USA, V97, P5197, DOI 10.1073/pnas.090083797; Fritzsch G, 2002, ACTA CRYSTALLOGR D, V58, P1660, DOI 10.1107/S0907444902014178; GALL A, 1994, THESIS U GLASGOW UK; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410; Jungas C, 1999, EMBO J, V18, P534, DOI 10.1093/emboj/18.3.534; KARRASCH S, 1995, EMBO J, V14, P631, DOI 10.1002/j.1460-2075.1995.tb07041.x; LILBURN TG, 1992, BIOCHIM BIOPHYS ACTA, V1100, P160; McAuley KE, 1999, P NATL ACAD SCI USA, V96, P14706, DOI 10.1073/pnas.96.26.14706; McAuley KE, 2000, BIOCHEMISTRY-US, V39, P15032, DOI 10.1021/bi000557r; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; MCGLYNN P, 1994, FEBS LETT, V349, P349, DOI 10.1016/0014-5793(94)00701-2; McGlynn P, 1996, J BIOL CHEM, V271, P3285, DOI 10.1074/jbc.271.6.3285; Moser CC, 2003, ADV PROTEIN CHEM, V63, P71; Papiz MZ, 2003, J MOL BIOL, V326, P1523, DOI 10.1016/S0022-2836(03)00024-X; Parkes-Loach PS, 2001, BIOCHEMISTRY-US, V40, P5593, DOI 10.1021/bi002580i; Recchia PA, 1998, BIOCHEMISTRY-US, V37, P11055, DOI 10.1021/bi980657l; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; Stowell MHB, 1997, SCIENCE, V276, P812, DOI 10.1126/science.276.5313.812; VANGRONDELLE R, 1994, BBA-BIOENERGETICS, V1187, P1, DOI 10.1016/0005-2728(94)90166-X; Walz T, 1998, J MOL BIOL, V282, P833, DOI 10.1006/jmbi.1998.2050; Walz T, 1997, J MOL BIOL, V265, P107, DOI 10.1006/jmbi.1996.0714	29	561	604	4	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1969	1972		10.1126/science.1088892	http://dx.doi.org/10.1126/science.1088892			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671305				2022-12-28	WOS:000187174000062
J	Gao, WT; Tamin, A; Soloff, A; D'Aiuto, L; Nwanegbo, E; Robbins, PD; Bellini, WJ; Barratt-Boyes, S; Gambotto, A				Gao, WT; Tamin, A; Soloff, A; D'Aiuto, L; Nwanegbo, E; Robbins, PD; Bellini, WJ; Barratt-Boyes, S; Gambotto, A			Effects of a SARS-associated coronavirus vaccine in monkeys	LANCET			English	Article							VIRUS	The causative agent of severe acute respiratory syndrome (SARS) has been identified as a new type of coronavirus. Here, we have investigated the ability of adenoviral delivery of codon-optimised SARS-CoV strain Urbani structural antigens spike protein S1 fragment, membrane protein, and nucleocapsid protein to induce virus-specific broad immunity in rhesus macaques. We immunised rhesus macaques intramuscularly with a combination of the three Ads-SARS-CoV vectors or a control vector and gave a booster vaccination on day 28. The vaccinated animals all had antibody responses against spike protein S1 fragment and T-cell responses against the nucleocapsid protein. All vaccinated animals showed strong neutralising antibody responses to SARS-CoV infection in vitro. These results show that an adenoviral-based vaccine can induce strong SARS-CoV-specific immune responses in the monkey, and hold promise for development of a protective vaccine against the SARS causal agent.	Univ Pittsburgh, Sch Med, Inst Mol Med, Dept Surg,Div Infect Dis, Pittsburgh, PA 15219 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA USA; Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Div Infect Dis, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Med, Div Infect Dis, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gambotto, A (corresponding author), Univ Pittsburgh, Sch Med, Inst Mol Med, Dept Surg,Div Infect Dis, Suite 412,300 Technol Dr, Pittsburgh, PA 15219 USA.			Barratt Boyes, Simon/0000-0002-8869-4945; D'Aiuto, Leonardo/0000-0002-7102-2093; Soloff, Adam/0000-0002-1467-8168	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066949] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL66949-01S1, U01 HL066949] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anton IM, 1996, VIRUS RES, V46, P111, DOI 10.1016/S0168-1702(96)01390-1; BROWN K, IN PRESS J IMMUNOL; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; WEISS RC, 1981, COMP IMMUNOL MICROB, V4, P175, DOI 10.1016/0147-9571(81)90003-5	5	211	247	0	27	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1895	1896		10.1016/S0140-6736(03)14962-8	http://dx.doi.org/10.1016/S0140-6736(03)14962-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667748	Green Published, Bronze			2022-12-28	WOS:000187011600012
J	Nathan, DM				Nathan, DM			Isolated pancreas transplantation for type 1 diabetes - A doctor's dilemma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY-OF-LIFE; LONG-TERM COMPLICATIONS; RENAL-TRANSPLANTATION; INTENSIVE TREATMENT; NEPHROPATHY; MELLITUS; KIDNEY; PROGRESSION; THERAPY; TRIAL		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Diabet, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gen Clin Res Ctr, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Nathan, DM (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Diabet, Boston, MA 02114 USA.	dnathan@partners.org						COSIMI AB, 1988, ARCH SURG-CHICAGO, V123, P621; DAFOE DC, 1988, DIABETES CARE, V11, P669; Diabet Contr Complicat Trial Res Grp, 1998, ARCH OPHTHALMOL-CHIC, V116, P874; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; Gross CR, 2000, TRANSPLANTATION, V70, P1736, DOI 10.1097/00007890-200012270-00013; KELLY WD, 1967, SURGERY, V61, P827; KENNEDY WR, 1990, NEW ENGL J MED, V322, P1031, DOI 10.1056/NEJM199004123221503; Kinkhabwala M, 1996, AM J SURG, V171, P516, DOI 10.1016/S0002-9610(97)89613-4; NATHAN DM, 1991, TRANSPLANTATION, V52, P85, DOI 10.1097/00007890-199107000-00018; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Robertson R Paul, 2003, Diabetes Care, V26 Suppl 1, pS120; Robertson RP, 2000, DIABETES CARE, V23, P112, DOI 10.2337/diacare.23.1.112; Robertson RP, 1998, J CLIN ENDOCR METAB, V83, P1868, DOI 10.1210/jc.83.6.1868; RUSSELL JD, 1992, TRANSPLANTATION, V54, P656, DOI 10.1097/00007890-199210000-00018; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; SHAW GB, 1954, DOCTORS DILEMMA; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Venstrom JM, 2003, JAMA-J AM MED ASSOC, V290, P2817, DOI 10.1001/jama.290.21.2817; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; 1998, ARCH OPTHALMOL, V116, P1469	22	8	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2861	2863		10.1001/jama.290.21.2861	http://dx.doi.org/10.1001/jama.290.21.2861			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QP	14657072				2022-12-28	WOS:000186872800030
J	Gines, P; Guevara, M; Arroyo, V; Rodes, J				Gines, P; Guevara, M; Arroyo, V; Rodes, J			Hepatorenal syndrome	LANCET			English	Review							INTRAHEPATIC PORTOSYSTEMIC SHUNT; SPONTANEOUS BACTERIAL PERITONITIS; PERIPHERAL ARTERIAL VASODILATION; PRETRANSPLANT RENAL-FUNCTION; INTRARENAL BLOOD-FLOW; CIRRHOTIC-PATIENTS; PREDICTIVE FACTORS; INTRAVENOUS ALBUMIN; REFRACTORY ASCITES; WATER-RETENTION	Hepatorenal syndrome (HRS) is a common complication of advanced cirrhosis, characterised by renal failure and major disturbances in circulatory function. Renal failure is caused by intense vasoconstriction of the renal circulation. The syndrome is probably the final consequence of extreme underfilling of the arterial circulation secondary to arterial vasodilatation in the splanchnic vascular bed. As well as the renal circulation, most extrasplanchnic vascular beds are vasoconstricted. The diagnosis of HRS is currently based on the exclusion of other causes of renal failure. The prognosis is very poor, particularly when there is rapidly progressive renal failure (type 1). Liver transplantation is the best option in patients without contraindications to the procedure, but it is not always possible owing to the short survival expectancy. Therapies introduced during the past few years, such as vasoconstrictor drugs (vasopressin analogues, alpha-adrenergic agonists) or the transjugular intrahepatic portosystemic shunt, are effective in improving renal function. Nevertheless, liver transplantation should still be done in suitable patients even after improvement of renal function because the outcome of HRS is poor. Finally, recent findings suggest that the risk of developing HRS in the setting of spontaneous bacterial peritonitis may be reduced by the administration of albumin together with antibiotic therapy, and that of HRS occurring in severe alcoholic hepatitis can be lowered by administration of pentoxifylline. Although these findings need to be confirmed, these two strategies represent innovative approaches to lower the frequency of HRS in clinical practice.	Univ Barcelona, Sch Med, Hosp Clin,Inst Invest Biomed August Pi Sunyer, Liver Unit, Barcelona 08036, Catalunya, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Gines, P (corresponding author), Univ Barcelona, Sch Med, Hosp Clin,Inst Invest Biomed August Pi Sunyer, Liver Unit, Villarroel 170, Barcelona 08036, Catalunya, Spain.	gines@medicina.ub.es	Gines, Pere/B-6646-2009; Arroyo, Vicente/F-9189-2015	Gines, Pere/0000-0003-4657-4504; Arroyo, Vicente/0000-0002-2728-1848				Akriviadis E, 2000, GASTROENTEROLOGY, V119, P1637, DOI 10.1053/gast.2000.20189; Alessandria C, 2002, EUR J GASTROEN HEPAT, V14, P1363, DOI 10.1097/00042737-200212000-00013; Amirkhosravi A, 1998, THROMB HAEMOSTASIS, V80, P598; Angeli P, 1999, HEPATOLOGY, V29, P1690, DOI 10.1002/hep.510290629; Arroyo V, 1999, ASCITES AND RENAL DYSFUNCTION IN LIVER DISEASE, P492; Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1053/jhep.1996.v23.ajhep0230164; Arroyo V, 2002, J HEPATOL, V36, P315, DOI 10.1016/S0168-8278(02)00028-4; Arroyo V, 2002, GASTROENTEROLOGY, V122, P1658, DOI 10.1053/gast.2002.33575; BARRETT BJ, 1994, NEW ENGL J MED, V331, P1449, DOI 10.1056/NEJM199411243312111; Bataller R, 1997, SEMIN LIVER DIS, V17, P233, DOI 10.1055/s-2007-1007201; Bosch J, 2001, J HEPATOL, V35, P658, DOI 10.1016/S0168-8278(01)00238-0; BOYER TD, 1979, GASTROENTEROLOGY, V77, P215; Brensing KA, 2000, GUT, V47, P288, DOI 10.1136/gut.47.2.288; Cardenas A, 2001, HEPATOLOGY, V34, P671, DOI 10.1053/jhep.2001.27830; CAREGARO L, 1994, ARCH INTERN MED, V154, P201, DOI 10.1001/archinte.154.2.201; Carvounis CP, 2002, KIDNEY INT, V62, P2223, DOI 10.1046/j.1523-1755.2002.00683.x; Dagher L, 2001, GUT, V49, P729, DOI 10.1136/gut.49.5.729; del Olmo JA, 2000, J HEPATOL, V32, P19; DUDLEY FJ, 1986, HEPATOLOGY, V6, P248, DOI 10.1002/hep.1840060216; Duvoux C, 2002, HEPATOLOGY, V36, P374, DOI 10.1053/jhep.2002.34343; Ellis AJ, 1999, ASCITES AND RENAL DYSFUNCTION IN LIVER DISEASE, P63; EPSTEIN M, 1970, AM J MED, V49, P175, DOI 10.1016/S0002-9343(70)80073-0; Epstein M., 1996, KIDNEY LIVER DIS, P75; Epstein M, 1996, KIDNEY LIVER DIS, V4th, P517; FERNANDEZSEARA J, 1989, GASTROENTEROLOGY, V97, P1304, DOI 10.1016/0016-5085(89)91704-6; FOLLO A, 1994, HEPATOLOGY, V20, P1495, DOI 10.1002/hep.1840200619; GINES A, 1993, GASTROENTEROLOGY, V105, P229, DOI 10.1016/0016-5085(93)90031-7; Gines P, 1998, HEPATOLOGY, V28, P851, DOI 10.1002/hep.510280337; GINES P, 1988, GASTROENTEROLOGY, V94, P1493, DOI 10.1016/0016-5085(88)90691-9; Gines P, 2002, HEPATOLOGY, V36, P504, DOI 10.1053/jhep.2002.35273; Gines P, 2002, GASTROENTEROLOGY, V123, P1839, DOI 10.1053/gast.2002.37073; Gines P, 1999, ASCITES AND RENAL DYSFUNCTION IN LIVER DISEASE, P36; GINES P, 1999, EVIDENCE BASED GASTR, P427; GONWA TA, 1995, TRANSPLANTATION, V59, P361, DOI 10.1097/00007890-199502150-00010; GONWA TA, 1996, KIDNEY LIVER DIS, P529; Guevara M, 1998, HEPATOLOGY, V27, P35, DOI 10.1002/hep.510270107; Guevara M, 1998, HEPATOLOGY, V28, P39, DOI 10.1002/hep.510280107; Gulberg V, 1999, HEPATOLOGY, V30, P870, DOI 10.1002/hep.510300430; Hadengue A, 1998, J HEPATOL, V29, P565, DOI 10.1016/S0168-8278(98)80151-7; Halimi C, 2002, EUR J GASTROEN HEPAT, V14, P153, DOI 10.1097/00042737-200202000-00009; HECKER R, 1956, LANCET, V271, P1121, DOI 10.1016/S0140-6736(56)90149-0; HENRIKSEN JH, 1993, HEPATOLOGY, V18, P688; Holt S, 1999, LANCET, V353, P294, DOI 10.1016/S0140-6736(05)74933-3; Jeyarajah DR, 1997, TRANSPLANTATION, V64, P1760, DOI 10.1097/00007890-199712270-00024; Kam I, 2002, LIVER TRANSPLANT, V8, P347, DOI 10.1053/jlts.2002.33194; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; KEW MC, 1971, LANCET, V2, P504; Lhotta K, 2002, SEMIN NEPHROL, V22, P302, DOI 10.1053/snep.2002.33671; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; MAROTO A, 1993, HEPATOLOGY, V17, P788, DOI 10.1016/0270-9139(93)90153-E; MAROTO A, 1994, HEPATOLOGY, V20, P839, DOI 10.1002/hep.1840200411; Martin PY, 1998, NEW ENGL J MED, V339, P533, DOI 10.1056/NEJM199808203390807; Michl P, 2000, SCAND J GASTROENTERO, V35, P654, DOI 10.1080/003655200750023642; Mitzner SR, 2000, LIVER TRANSPLANT, V6, P277, DOI 10.1053/lv.2000.6355; Moreau R, 2002, GASTROENTEROLOGY, V122, P923, DOI 10.1053/gast.2002.32364; Mulkay JP, 2001, ACTA GASTRO-ENT BELG, V64, P15; Nair S, 2002, HEPATOLOGY, V35, P1179, DOI 10.1053/jhep.2002.33160; Navasa M, 1997, SEMIN LIVER DIS, V17, P323, DOI 10.1055/s-2007-1007209; OCHS A, 1995, NEW ENGL J MED, V332, P1192, DOI 10.1056/NEJM199505043321803; Ortega R, 2002, HEPATOLOGY, V36, P941, DOI 10.1053/jhep.2002.35819; PAPADAKIS MA, 1987, AM J MED, V82, P945, DOI 10.1016/0002-9343(87)90156-2; PAPPER S, 1959, ANN INTERN MED, V51, P759, DOI 10.7326/0003-4819-51-4-759; PAPPER S, 1978, KIDNEY LIVER DISEASE, P91; Pham P T, 2000, Clin Liver Dis, V4, P567, DOI 10.1016/S1089-3261(05)70127-6; PLATT JF, 1992, RADIOLOGY, V183, P801, DOI 10.1148/radiology.183.3.1584937; Pomfret EA, 2001, J HEPATOL, V34, P613, DOI 10.1016/S0168-8278(01)00031-9; Pomier-Layrargues G, 2003, HEPATOLOGY, V38, P238, DOI 10.1053/jhep.2003.50276; Restuccia T, 2003, J HEPATOL, V38, P69, DOI 10.1016/S0168-8278(03)80292-1; RIMOLA A, 1987, GASTROENTEROLOGY, V93, P148, DOI 10.1016/0016-5085(87)90327-1; Rimola A, 2000, J HEPATOL, V32, P142, DOI 10.1016/S0168-8278(00)80201-9; Rimola A, 1999, ASCITES AND RENAL DYSFUNCTION IN LIVER DISEASE, P522; RINGLARSEN H, 1977, SCAND J CLIN LAB INV, V37, P635, DOI 10.3109/00365517709100657; RODES J, 1975, POSTGRAD MED J, V51, P492, DOI 10.1136/pgmj.51.598.492; Rossle M, 2000, NEW ENGL J MED, V342, P1701, DOI 10.1056/NEJM200006083422303; Rossle M, 1998, LIVER, V18, P73; Salerno F, 1999, ASCITES AND RENAL DYSFUNCTION IN LIVER DISEASE, P511; Sanyal AJ, 2003, GASTROENTEROLOGY, V124, P634, DOI 10.1053/gast.2003.50088; SCHRIER RW, 1988, HEPATOLOGY, V8, P1151, DOI 10.1002/hep.1840080532; SCHRIER RW, 1994, SEMIN LIVER DIS, V14, P14, DOI 10.1055/s-2007-1007294; SCHROEDER ET, 1967, AM J MED, V43, P887, DOI 10.1016/0002-9343(67)90247-1; SHEAR L, 1965, AM J MED, V39, P184, DOI 10.1016/0002-9343(65)90041-0; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; Sugano S, 2001, J HEPATOL, V34, P373, DOI 10.1016/S0168-8278(00)00035-0; TRISTANI FE, 1967, J CLIN INVEST, V46, P1894, DOI 10.1172/JCI105679; Uriz J, 2000, J HEPATOL, V33, P43, DOI 10.1016/S0168-8278(00)80158-0; VESIN P, 1962, AKTUELLE PROBLEME HE, P98; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Wiesner RH, 2001, LIVER TRANSPLANT, V7, P567, DOI 10.1053/jlts.2001.25879; WIESNER RH, 1999, TREATMENT LIVER DIS, P159; Wiest R, 1999, SEMIN LIVER DIS, V19, P411, DOI 10.1055/s-2007-1007129; WILKINSON SP, 1974, BMJ-BRIT MED J, V1, P186, DOI 10.1136/bmj.1.5900.186	91	379	418	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1819	1827		10.1016/S0140-6736(03)14903-3	http://dx.doi.org/10.1016/S0140-6736(03)14903-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654322				2022-12-28	WOS:000186872900023
J	Morris, I; Varughese, G; Mattingly, P				Morris, I; Varughese, G; Mattingly, P			Lesson of the week - Colchicine in acute gout	BRITISH MEDICAL JOURNAL			English	Review							ARTHRITIS		Gen Hosp Kettering, Dept Rheumatol, Kettering NN16 8UZ, Northants, England		Morris, I (corresponding author), Gen Hosp Kettering, Dept Rheumatol, Kettering NN16 8UZ, Northants, England.							AHERN MJ, 1987, AUST NZ J MED, V17, P301, DOI 10.1111/j.1445-5994.1987.tb01232.x; *BRIT MED ASS ROY, 2002, 44 BMA RPS, P500; COHEN A, 1936, AM J MED SCI, V192, P448; Fam AG, 2002, BRIT MED J, V325, P980, DOI 10.1136/bmj.325.7371.980; SNAITH ML, 1995, BRIT MED J, V310, P521, DOI 10.1136/bmj.310.6978.521	5	46	62	1	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 29	2003	327	7426					1275	1276		10.1136/bmj.327.7426.1275	http://dx.doi.org/10.1136/bmj.327.7426.1275			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749VD	14644973	Green Published			2022-12-28	WOS:000186948800022
J	Liu, ZM; Yasseri, AA; Lindsey, JS; Bocian, DF				Liu, ZM; Yasseri, AA; Lindsey, JS; Bocian, DF			Molecular memories that survive silicon device processing and real-world operation	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; CHARGE-STORAGE; SI(100)	If molecular components are to be used as functional elements in place of the semiconductor-based devices present in conventional microcircuitry, they must compete with semiconductors under the extreme conditions required for processing and operating a practical device. Herein, we demonstrate that porphyrin-based molecules bound to Si( 100), which exhibit redox behavior useful for information storage, can meet this challenge. These molecular media in an inert atmosphere are stable under extremes of temperature ( 400 degreesC) for extended periods ( approaching 1 hour) and do not degrade under large numbers of read-write cycles (10(12)).	Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; N Carolina State Univ, Dept Chem, Raleigh, NC 27695 USA	University of California System; University of California Riverside; University of North Carolina; North Carolina State University	Bocian, DF (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	David.Bocian@ucr.edu	Lindsey, Jonathan S/J-7761-2012					AVIRAM A, 1974, CHEM PHYS LETT, V29, P277, DOI 10.1016/0009-2614(74)85031-1; BALAKUMAR A, IN PRESS J ORG CHEM; Callot H. J., 2000, PORPHYRIN HDB VOLUME, V1, P349; Carroll RL, 2002, ANGEW CHEM INT EDIT, V41, P4379, DOI 10.1002/1521-3773(20021202)41:23<4378::AID-ANIE4378>3.0.CO;2-A; Choi CH, 2002, J AM CHEM SOC, V124, P8730, DOI 10.1021/ja012454h; Fajer J., 1979, PORPHYRINS, V4, P197; Gryko D, 2001, J MATER CHEM, V11, P1162, DOI 10.1039/b008224o; Kwok K.S., 2002, MATER TODAY, V5, P28, DOI [DOI 10.1016/S1369-7021(02)05227-6, 10.1016/S1369-7021(02)05227-6]; Mandelman JA, 2002, IBM J RES DEV, V46, P187, DOI 10.1147/rd.462.0187; Roth KM, 2003, J AM CHEM SOC, V125, P505, DOI 10.1021/ja021169a; Roth KM, 2002, LANGMUIR, V18, P4030, DOI 10.1021/la025525e; Roth KM, 2000, J VAC SCI TECHNOL B, V18, P2359, DOI 10.1116/1.1310657	12	499	517	3	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1543	1545		10.1126/science.1090677	http://dx.doi.org/10.1126/science.1090677			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645842				2022-12-28	WOS:000186802200036
J	Battin, TJ; Kaplan, LA; Newbold, JD; Hansen, CME				Battin, TJ; Kaplan, LA; Newbold, JD; Hansen, CME			Contributions of microbial biofilms to ecosystem processes in stream mesocosms	NATURE			English	Article							MASS-TRANSPORT; DEPOSITION; NITROGEN; SIZE	In many aquatic ecosystems, most microbes live in matrix-enclosed biofilms(1-3) and contribute substantially to energy flow and nutrient cycling. Little is known, however, about the coupling of structure and dynamics of these biofilms to ecosystem function(2). Here we show that microbial biofilms changed the physical and chemical microhabitat and contributed to ecosystem processes in 30-m-long stream mesocosms. Biofilm growth increased hydrodynamic transient storage-streamwater detained in quiescent zones, which is a major physical template for ecological processes in streams(4,5) - by 300% and the retention of suspended particles by 120%. In addition, by enhancing the relative uptake of organic molecules of lower bioavailability, the interplay of biofilm microarchitecture and mass transfer changed their downstream linkage. As living zones of transient storage, biofilms bring hydrodynamic retention and biochemical processing into close spatial proximity and influence biogeochemical processes and patterns in streams. Thus, biofilms are highly efficient and successful ecological communities that may also contribute to the influence that headwater streams have on rivers, estuaries and even oceans(6,7) through longitudinal linkages of local biogeochemical and hydrodynamic processes.	Univ Vienna, IECB, Dept Limnol, A-1090 Vienna, Austria; Stroud Water Res Ctr, Avondale, PA 19311 USA; Univ Innsbruck, Inst Limnol & Zool, A-6020 Innsbruck, Austria	University of Vienna; University of Innsbruck	Battin, TJ (corresponding author), Univ Vienna, IECB, Dept Limnol, Waehringer Guertel 18, A-1090 Vienna, Austria.	tomba@pflaphy.pph.univie.ac.at	BAttin, Tom/H-7971-2012					Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; Battin TJ, 2003, APPL ENVIRON MICROB, V69, P5443, DOI 10.1128/AEM.69.9.5443-5452.2003; Cheng XH, 2001, ANAL CHEM, V73, P458, DOI 10.1021/ac001059r; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; DRURY WJ, 1993, WATER RES, V27, P1119, DOI 10.1016/0043-1354(93)90003-Z; GANTZER CJ, 1988, WATER RES, V22, P709, DOI 10.1016/0043-1354(88)90182-0; Gomi T, 2002, BIOSCIENCE, V52, P905, DOI 10.1641/0006-3568(2002)052[0905:UPADLO]2.0.CO;2; Grady CPL, 1999, BIOL WASTEWATER TREA; Jones JB, 2000, STREAMS GROUND WATER; Kaplan L.A., 2003, AQUATIC ECOSYSTEMS I, P97; KIM BK, 1990, WATER RESOUR RES, V26, P505, DOI 10.1029/WR026i003p00505; KUGAPRASATHAM S, 1992, WATER RES, V26, P1629, DOI 10.1016/0043-1354(92)90162-W; Lawrence JR, 1998, J MICROBIOL METH, V32, P253, DOI 10.1016/S0167-7012(98)00027-X; Minshall GW, 2000, J N AM BENTHOL SOC, V19, P1, DOI 10.2307/1468278; MULHOLLAND PJ, 1994, OECOLOGIA, V98, P40, DOI 10.1007/BF00326088; NEWBOLD JD, 1981, CAN J FISH AQUAT SCI, V38, P860, DOI 10.1139/f81-114; Packman AI, 2000, WATER RESOUR RES, V36, P2351, DOI 10.1029/2000WR900059; Palmer RJ, 1997, TRENDS MICROBIOL, V5, P435, DOI 10.1016/S0966-842X(97)01142-6; Peterson BJ, 2001, SCIENCE, V292, P86, DOI 10.1126/science.1056874; Picioreanu C, 2000, BIOTECHNOL BIOENG, V68, P355, DOI 10.1002/(SICI)1097-0290(20000520)68:4<355::AID-BIT1>3.0.CO;2-A; RUNKLE RL, 1998, 984018 US GEOL SURV; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Thomas SA, 2001, LIMNOL OCEANOGR, V46, P1415, DOI 10.4319/lo.2001.46.6.1415; Yang XM, 2000, J MICROBIOL METH, V39, P109, DOI 10.1016/S0167-7012(99)00097-4	24	512	522	12	347	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2003	426	6965					439	442		10.1038/nature02152	http://dx.doi.org/10.1038/nature02152			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647381				2022-12-28	WOS:000186800800037
J	Michaels, D; Wagner, W				Michaels, D; Wagner, W			Disclosure in regulatory science	SCIENCE			English	Editorial Material							CONFLICTS-OF-INTEREST; SPONSORSHIP		George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Environm & Occupat Hlth, Washington, DC 20052 USA; Univ Texas, Sch Med, Austin, TX 78705 USA	George Washington University; University of Texas System; University of Texas Austin	Michaels, D (corresponding author), George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Environm & Occupat Hlth, Washington, DC 20052 USA.			Michaels, David/0000-0001-8558-7733				Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Brodeur Paul, 1985, OUTRAGEOUS MISCONDUC; Cho MK, 2000, JAMA-J AM MED ASSOC, V284, P2203, DOI 10.1001/jama.284.17.2203; Davidoff F, 2001, JAMA-J AM MED ASSOC, V286, P1232, DOI 10.1001/jama.286.10.1232; Glantz S.A., 1996, CIGARETTE PAPERS; Krimsky S., 2004, SCI PRIVATE INTEREST; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Markowitz G.E., 2002, DECEIT DENIAL DEADLY; OMB (U. S. Office of Management and Budget), 2002, FED REG, V67, P8452; Rennie D, 1997, JAMA-J AM MED ASSOC, V277, P1238, DOI 10.1001/jama.277.15.1238; Rennie D, 1999, JAMA-J AM MED ASSOC, V282, P1766, DOI 10.1001/jama.282.18.1766; U.S. General Accounting Office, 2001, GAO0289; US General Accounting Office, 1994, GAORCED94103; 2001, UNIFORM REQUIREMENTS	14	17	17	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2073	2073		10.1126/science.1093718	http://dx.doi.org/10.1126/science.1093718			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684806				2022-12-28	WOS:000187385200026
J	Palmer, LE; Rabinowicz, PD; O'Shaughnessy, AL; Balija, VS; Nascimento, LU; Dike, S; de la Bastide, M; Martienssen, RA; McCombie, WR				Palmer, LE; Rabinowicz, PD; O'Shaughnessy, AL; Balija, VS; Nascimento, LU; Dike, S; de la Bastide, M; Martienssen, RA; McCombie, WR			Maize genome sequencing by methylation filtrations	SCIENCE			English	Article							DNA METHYLATION; TRANSPOSABLE ELEMENTS; DRAFT SEQUENCE; GENE; RETROTRANSPOSONS; REGIONS; PLANTS	Gene enrichment strategies offer an alternative to sequencing large and repetitive genomes such as that of maize. We report the generation and analysis of nearly 100,000 undermethylated (or methylation filtration) maize sequences. Comparison with the rice genome reveals that methylation filtration results in a more comprehensive representation of maize genes than those that result from expressed sequence tags or transposon insertion sites sequences. About 7% of the repetitive DNA is unmethylated and thus selected in our libraries, but potentially active transposons and unmethylated organelle genomes can be identified. Reverse transcription polymerase chain reaction can be used to finish the maize transcriptome.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.org; mccombie@cshl.edu		McCombie, W. Richard/0000-0003-1899-0682	NATIONAL CANCER INSTITUTE [T32CA009311] Funding Source: NIH RePORTER; NCI NIH HHS [2 T32-CA09311-25] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; ANTEQUERA F, 1988, EMBO J, V7, P2295, DOI 10.1002/j.1460-2075.1988.tb03072.x; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; BENNETT MD, 1995, ANN BOT-LONDON, V76, P113, DOI 10.1006/anbo.1995.1085; BENNETZEN JL, 1994, GENOME, V37, P565, DOI 10.1139/g94-081; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; CRESSE AD, 1995, GENETICS, V140, P315; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; FLAVELL RB, 1994, P NATL ACAD SCI USA, V91, P3490, DOI 10.1073/pnas.91.9.3490; Gaut BS, 1997, P NATL ACAD SCI USA, V94, P6809, DOI 10.1073/pnas.94.13.6809; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; HAKE S, 1980, CHROMOSOMA, V79, P251, DOI 10.1007/BF00327318; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Lunde China F., 2003, Functional & Integrative Genomics, V3, P25; MAIER RM, 1995, J MOL BIOL, V251, P614, DOI 10.1006/jmbi.1995.0460; Mao L, 2000, GENOME RES, V10, P982, DOI 10.1101/gr.10.7.982; Martienssen R, 1998, TRENDS GENET, V14, P263, DOI 10.1016/S0168-9525(98)01518-2; MAY BP, IN PRESS P NATL ACAD; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Morishige DT, 2002, PLANT PHYSIOL, V130, P1614, DOI 10.1104/pp.012567; Papa CM, 2001, PLANT CELL, V13, P1919, DOI 10.1105/tpc.13.8.1919; Rabinowicz PD, 1999, NAT GENET, V23, P305, DOI 10.1038/15479; Rabinowicz PD, 2003, GENOME RES, V13, P2658, DOI 10.1101/gr.1784803; Rabinowicz PD, 2003, CURR OPIN PLANT BIOL, V6, P150, DOI 10.1016/S1369-5266(03)00008-6; Raizada MN, 2001, PLANT CELL, V13, P1587, DOI 10.1105/tpc.13.7.1587; RALEIGH EA, 1988, NUCLEIC ACIDS RES, V16, P1563, DOI 10.1093/nar/16.4.1563; *RIC CHROM 10 SEQ, 2003, SCIENCE NEW YORK NY, V0300; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; WALBOT V, 1990, PLANT MOL BIOL, V15, P121, DOI 10.1007/BF00017729; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yuan YN, 2003, PLANT J, V34, P249, DOI 10.1046/j.1365-313X.2003.01716.x	33	173	192	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2115	2117		10.1126/science.1091265	http://dx.doi.org/10.1126/science.1091265			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684820				2022-12-28	WOS:000187385200042
J	Heckmann, JG; Tomandl, B				Heckmann, JG; Tomandl, B			Cavernous sinus thrombosis	LANCET			English	Editorial Material									Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Dept Neuroradiol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Heckmann, JG (corresponding author), Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany.		tomandl, bernd f/B-4532-2017						0	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					1958	1958		10.1016/S0140-6736(03)15013-1	http://dx.doi.org/10.1016/S0140-6736(03)15013-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683654				2022-12-28	WOS:000187210700007
J	Hoogewerf, M; Regez, RM; Schouten, WEM; Weigel, HM; Frissen, PHJ; Brinkman, K				Hoogewerf, M; Regez, RM; Schouten, WEM; Weigel, HM; Frissen, PHJ; Brinkman, K			Change to abacavir-lamivudine-tenofovir combination treatment in patients with HIV-1 who had complete virological suppression	LANCET			English	Article							ACTIVE ANTIRETROVIRAL THERAPY	Patients who have not received previous antiretroviral treatment (ART) have a high failure rate on the combination treatment of abacavir, lamivudine, and tenovir. We assessed the virological failure rate in eight patients with HIV-1 who switched to this combination after having complete virological suppression from their previous long-term ART (median 8.0 months, range 7.5-18.0). Five of the eight patients showed virological failure. Four of these five patients had either the K65R mutation, the M184V/l mutation, or both. This combination of drugs cannot therefore be recommended as alternative treatment in patients with HIV-1 who are fully virologically suppressed.	Onze Lieve Vrouw Hosp, Dept Internal Med, Amsterdam, Netherlands	Onze Lieve Vrouwe Gasthuis Hospital	Brinkman, K (corresponding author), Onze Lieve Vrouw Hosp, Dept Internal Med, Amsterdam, Netherlands.							Clumeck N, 2001, AIDS, V15, P1517, DOI 10.1097/00002030-200108170-00009; FARTHING C, 2003, 2 INT AIDS SOC IAS P; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; GALLANT J, 2003, 43 INT C MICR AG CHE; Katlama C, 2003, HIV Med, V4, P79, DOI 10.1046/j.1468-1293.2003.00139.x; Martinez E, 2003, NEW ENGL J MED, V349, P1036, DOI 10.1056/NEJMoa021589; PILIERO P, 2003, 43 INT C MICR AG CHE	7	40	42	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					1979	1980		10.1016/S0140-6736(03)15018-0	http://dx.doi.org/10.1016/S0140-6736(03)15018-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683659				2022-12-28	WOS:000187210700012
J	Stephenson, I; Nicholson, KG; Gluck, R; Mischler, R; Newman, RW; Palache, AM; Verlander, NQ; Warburton, F; Wood, JM; Zambon, MC				Stephenson, I; Nicholson, KG; Gluck, R; Mischler, R; Newman, RW; Palache, AM; Verlander, NQ; Warburton, F; Wood, JM; Zambon, MC			Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial	LANCET			English	Article							A H5N1 VIRUS; ANTIBODY; ORIGIN	Background In 1999, avian influenza A/Hong Kong/1073/99 (H9N2) virus emerged as a pandemic threat to human beings. We aimed to assess safety, tolerability, and antigenicity of whole virus and subunit H9N2 vaccines in healthy volunteers. Methods In a phase I randomised trial we randomly assigned 60 participants to whole virus or subunit H9N2 vaccine. Two doses of 7.5 mug, 15 mug, or 30 mug haemagglutinin influenza A H9N2 vaccine, were given 3 weeks apart. We measured antibody responses by haemagglutination-inhibition and microneutralisation. The primary outcome was geometric mean antibody titre 21 days after vaccination. Analysis was per protocol. Findings Both vaccines were safe and well tolerated. The antibody titres after vaccination did not differ significantly between subunit and whole virus vaccine. 24 of 60 prevaccination serum samples had unexpected reactivity to H9N2, but only in participants older than 32 years, in whom one dose of either vaccine evoked antibody responses associated with protection. In participants aged 32 years or younger, antibody responses to one dose of whole virus or subunit vaccine were poor, fulfilling none of the criteria used for yearly relicensing of interpandemic vaccines. Whole virus vaccine produced a significantly higher probability of seroconversion compared with subunit virus for this age-group. Interpretation In immunologically naive patients whole-virus vaccine produced better responses than subunit vaccine. Two doses of subunit or whole virus vaccine would leave a large proportion of the naive population (less than or equal to32 years) unprotected against A/Hong Kong/1073/99 (H9N2). Primed patients should be protected with a single dose of either vaccine.	Leicester Royal Infirm, Infect Dis Unit, Leicester LE1 5WW, Leics, England; Berna Biotech Ltd, Bern, Switzerland; Solvay Pharmaceut, Weesp, Netherlands; Cent Publ Hlth Lab, Publ Hlth Lab Serv, Stat Unit, Colindale, England; Cent Publ Hlth Lab, Enter Resp & Neurol Virus Lab, Colindale, England; Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England	University of Leicester; Johnson & Johnson; Solvay SA; National Institute for Biological Standards & Control	Nicholson, KG (corresponding author), Leicester Royal Infirm, Infect Dis Unit, Leicester LE1 5WW, Leics, England.	karl.nicholson@uhl-tr.nhs.uk						Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; COCKBURN WC, 1969, B WORLD HEALTH ORGAN, V41, P345; EICK A, 2000, INT C EM INF DIS 200; Ellis JS, 1997, EUR J EPIDEMIOL, V13, P369, DOI 10.1023/A:1007391222905; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guo Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P105; Ha Y, 2002, EMBO J, V21, P865, DOI 10.1093/emboj/21.5.865; Hehme N, 2002, MED MICROBIOL IMMUN, V191, P203, DOI 10.1007/s00430-002-0147-9; Kunz C, 1977, Dev Biol Stand, V39, P297; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Nguyen-Van-Tam JS, 1998, TXB INFLUENZA, P181; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; NICHOLSON KG, 1979, J BIOL STAND, V7, P123, DOI 10.1016/S0092-1157(79)80044-X; Peiris JSM, 2001, INT CONGR SER, V1219, P195, DOI 10.1016/S0531-5131(01)00667-7; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Peiris M, 1999, J CLIN MICROBIOL, V37, P3426, DOI 10.1128/JCM.37.10.3426-3427.1999; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Saito T, 2001, VACCINE, V20, P125, DOI 10.1016/S0264-410X(01)00279-1; Scholtissek C., 1998, TXB INFLUENZA, P137; SHORTRIDGE KF, 1998, CHIN J EXP CLIN VIRO, V3, P75; Stephenson I, 2003, J MED VIROL, V70, P391, DOI 10.1002/jmv.10408; Stephenson I, 2003, VACCINE, V21, P1687, DOI 10.1016/S0264-410X(02)00632-1; The Committee of Stratigraphy of China, 1996, CPMPBWP21496, P1; WEBSTER RG, 1998, TXB INFLUENZA, P109; *WHO, INFL A H5N1 ONG KONG; WOOD JM, 2001, P OPTIONS CONTROL IN, V4, P461; WRIGHT PF, 1977, J INFECT DIS, V136, pS731, DOI 10.1093/infdis/136.Supplement_3.S731	27	123	133	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2003	362	9400					1959	1966		10.1016/S0140-6736(03)15014-3	http://dx.doi.org/10.1016/S0140-6736(03)15014-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683655				2022-12-28	WOS:000187210700008
J	Stollberger, C; Finsterer, J				Stollberger, C; Finsterer, J			Atherosclerosis: infection-induced involvement of mitochondrial chaperonins	LANCET			English	Editorial Material							ENDOTHELIAL-CELL APOPTOSIS; HEAT-SHOCK PROTEINS; HUMAN HEAT-SHOCK-PROTEIN-60; CYTOMEGALOVIRUS-INFECTION; EPITOPES; ANTIBODIES		Krankenanstalt Rudolfstiftung Wien, Dept Med 2, A-1030 Vienna, Austria; Krankenanstalt Rudolfstiftung Wien, Dept Neurol, A-1030 Vienna, Austria	Rudolfstiftung Hospital; Rudolfstiftung Hospital	Stollberger, C (corresponding author), Krankenanstalt Rudolfstiftung Wien, Dept Med 2, A-1030 Vienna, Austria.							Blankenberg S, 2001, CIRCULATION, V103, P2915, DOI 10.1161/01.CIR.103.24.2915; Choy JC, 2001, J MOL CELL CARDIOL, V33, P1673, DOI 10.1006/jmcc.2001.1419; Hausmann D, 1996, J AM COLL CARDIOL, V27, P1562, DOI 10.1016/0735-1097(96)00048-4; Hsich E, 2001, ATHEROSCLEROSIS, V156, P23, DOI 10.1016/S0021-9150(00)00608-0; Kervinen H, 2003, ATHEROSCLEROSIS, V169, P339, DOI 10.1016/S0021-9150(03)00229-6; Lewthwaite J, 2002, CIRCULATION, V106, P196, DOI 10.1161/01.CIR.0000021121.26290.2C; Perschinka H, 2003, ARTERIOSCL THROM VAS, V23, P1060, DOI 10.1161/01.ATV.0000071701.62486.49; Raz I, 2001, LANCET, V358, P1749, DOI 10.1016/S0140-6736(01)06801-5; Schett G, 1995, J CLIN INVEST, V96, P2569, DOI 10.1172/JCI118320; Schett G, 1999, CARDIOVASC RES, V42, P685, DOI 10.1016/S0008-6363(99)00012-7; Tricot O, 2000, CIRCULATION, V101, P2450, DOI 10.1161/01.CIR.101.21.2450; Ulmansky R, 2002, J IMMUNOL, V168, P6463, DOI 10.4049/jimmunol.168.12.6463; Uray K, 2003, INT IMMUNOL, V15, P1229, DOI 10.1093/intimm/dxg122; Xu QB, 2002, ARTERIOSCL THROM VAS, V22, P1547, DOI 10.1161/01.ATV.0000029720.59649.50	14	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					1949	1950		10.1016/S0140-6736(03)15082-9	http://dx.doi.org/10.1016/S0140-6736(03)15082-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683650				2022-12-28	WOS:000187210700003
J	Luo, ZX; Ji, Q; Wible, JR; Yuan, CX				Luo, ZX; Ji, Q; Wible, JR; Yuan, CX			An early Cretaceous tribosphenic mammal and metatherian evolution	SCIENCE			English	Article							EUTHERIAN MAMMALS; ORIGIN; MARSUPIALS; PHYLOGENY	Derived features of a new boreosphenidan mammal from the Lower Cretaceous Yixian Formation of China suggest that it has a closer relationship to metatherians (including extant marsupials) than to eutherians (including extant placentals). This fossil dates to 125 million years ago and extends the record of marsupial relatives with skeletal remains by 50 million years. It also has many foot structures known only from climbing and tree-living extant mammals, suggesting that early crown therians exploited diverse niches. New data from this fossil support the view that Asia was likely the center for the diversification of the earliest metatherians and eutherians during the Early Cretaceous.	Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA; Nanjing Univ, Dept Earth Sci, Nanjing 200017, Peoples R China; Chinese Acad Geol Sci, Beijing 100037, Peoples R China; China Univ Geosci, Beijing 100083, Peoples R China	Nanjing University; Chinese Academy of Geological Sciences; China University of Geosciences	Luo, ZX (corresponding author), Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA.	luoz@carnegiemuseums.org	Luo, Zhe-XI/AAU-2263-2021					Archibald JD, 2001, NATURE, V414, P62, DOI 10.1038/35102048; Argot C, 2002, J MORPHOL, V253, P76, DOI 10.1002/jmor.1114; Argot C, 2001, J MORPHOL, V247, P51, DOI 10.1002/1097-4687(200101)247:1<51::AID-JMOR1003>3.0.CO;2-#; Averianov A, 1999, ACTA PALAEONTOL POL, V44, P71; BEARD KC, 1992, PRIMATES THEIR RELAT, P63; Cifelli Richard L., 1997, Journal of Mammalian Evolution, V4, P241, DOI 10.1023/A:1027394430433; Cifelli RL, 1999, NATURE, V401, P363, DOI 10.1038/43861; Cifelli RL, 1996, NATURE, V379, P715, DOI 10.1038/379715a0; Clemens W.A., 1966, U CALIFORNIA PUBLICA, V62, P1; de Muizon Christian, 1998, Geodiversitas, V20, P19; deMuizon C, 1997, NATURE, V389, P486, DOI 10.1038/39029; Horovitz I, 2003, CLADISTICS, V19, P181, DOI 10.1016/S0748-3007(03)00045-8; Horovitz I, 2000, J VERTEBR PALEONTOL, V20, P547, DOI 10.1671/0272-4634(2000)020[0547:TTOUNE]2.0.CO;2; Hu YM, 1997, NATURE, V390, P137, DOI 10.1038/36505; Hu YM, 2002, CHINESE SCI BULL, V47, P933, DOI 10.1360/02tb9209; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Ji Q, 1999, NATURE, V398, P326; Kielan-Jaworowska Z., 1979, Palaeontologia Polonica, V38, P5; Kielan-Jaworowska Z, 2001, ACTA PALAEONTOL POL, V46, P377; KIELAN-JAWOROWSKA Z, 1975, Palaeontologia Polonica, V33, P103; KIELANJAWOROWSK.Z, IN PRESS MAMMALS AGE; KIELANJAWOROWSKA Z, 1989, ZOOL SCR, V18, P347, DOI 10.1111/j.1463-6409.1989.tb00460.x; Lillegraven J.A., 1974, Annual Rev Ecol Syst, V5, P263, DOI 10.1146/annurev.es.05.110174.001403; LILLEGRAVEN JA, 1984, U TENN STUD GEOL, V8, P1; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; Marshall Larry G., 1995, Memoires du Museum National d'Histoire Naturelle, V165, P1; McKenna MC, 1997, CLASSIFICATION MAMMA; Novacek MJ, 1997, NATURE, V389, P483, DOI 10.1038/39020; Reig O.A., 1987, P1; Rich Thomas H., 1999, Records of the Queen Victoria Museum, V106, P1; Rougier G.W., 1993, THESIS U NACL BUENOS; Rougier GW, 1998, NATURE, V396, P459, DOI 10.1038/24856; Sanchez-Villagra Marcelo R., 1997, Journal of Mammalian Evolution, V4, P119, DOI 10.1023/A:1027318213347; SIGOGNEAURUSSELL D, 1992, ZOOL SCR, V21, P205, DOI 10.1111/j.1463-6409.1992.tb00322.x; Springer Mark S., 1997, Journal of Mammalian Evolution, V4, P285, DOI 10.1023/A:1027378615412; Springer Mark S., 1997, P129; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Szalay F. S., 1994, EVOLUTIONARY HIST MA; Szalay Frederick S., 2001, Geodiversitas, V23, P139; Szalay FS, 1996, J VERTEBR PALEONTOL, V16, P474, DOI 10.1080/02724634.1996.10011335; Tyndale-Biscoe CH, 1987, REPROD PHYSL MARSUPI; Wang YQ, 2001, SCIENCE, V294, P357, DOI 10.1126/science.1063830; Weil A, 2002, NATURE, V416, P798, DOI 10.1038/416798a; [No title captured]	46	296	333	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1934	1940		10.1126/science.1090718	http://dx.doi.org/10.1126/science.1090718			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671295				2022-12-28	WOS:000187174000052
J	Zhang, FX; Su, KH; Yang, XY; Bowe, DB; Paterson, AJ; Kudlow, JE				Zhang, FX; Su, KH; Yang, XY; Bowe, DB; Paterson, AJ; Kudlow, JE			O-GIcNAc modification is an endogenous inhibitor of the proteasome	CELL			English	Article							PANCREATIC BETA-CELLS; N-ACETYLGLUCOSAMINE; GLCNAC TRANSFERASE; CYTOSOLIC PROTEINS; TETRATRICOPEPTIDE REPEATS; DEPENDENT DEGRADATION; PROTEOLYTIC PATHWAY; GENE-TRANSCRIPTION; RESEARCH TOOLS; LINKED GLCNAC	The ubiquitin proteasome system classically selects its substrates for degradation by tagging them with ubiquitin. Here, we describe another means of controlling proteasome function in a global manner. The 26S proteasome can be inhibited by modification with the enzyme, O-GlcNAc transferase (OGT). This reversible modification of the proteasome inhibits the proteolysis of the transcription factor Sp1 and a hydrophobic peptide through inhibition of the ATPase activity of 26S proteasomes. The Rpt2 ATPase in the mammalian proteasome 19S cap is modified by O-GlcNAc in vitro and in vivo and as its modification increases, proteasome function decreases. This mechanism may couple proteasomes to the general metabolic state of the cell. The O-GlcNAc modification of proteasomes may allow the organism to respond to its metabolic needs by controlling the availability of amino acids and regulatory proteins.	Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; Univ Alabama, Dept Pharmacol, Birmingham, AL 35294 USA; Univ Alabama, Dept Med, Div Endocrinol Diabet & Metabolism, Birmingham, AL 35294 USA; Gene Express Lab, Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Salk Institute	Kudlow, JE (corresponding author), Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA.				NATIONAL CANCER INSTITUTE [R01CA095021] Funding Source: NIH RePORTER; NCI NIH HHS [CA095021] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Adams J, 1999, CANCER RES, V59, P2615; Bajorek M, 2003, CURR BIOL, V13, P1140, DOI 10.1016/S0960-9822(03)00417-2; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen F, 2000, CELL GROWTH DIFFER, V11, P239; Comer FI, 2000, J BIOL CHEM, V275, P29179, DOI 10.1074/jbc.R000010200; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; Donath MY, 1999, DIABETES, V48, P738, DOI 10.2337/diabetes.48.4.738; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2002, NAT MED, V8, P338, DOI 10.1038/nm0402-338; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Han I, 2000, BIOCHEM J, V350, P109, DOI 10.1042/0264-6021:3500109; Hanover JA, 1999, ARCH BIOCHEM BIOPHYS, V362, P38, DOI 10.1006/abbi.1998.1016; Hanover JA, 2001, FASEB J, V15, P1865, DOI 10.1096/fj.01-0094rev; Hattendorf DA, 2002, EMBO J, V21, P12, DOI 10.1093/emboj/21.1.12; Hideshima T, 2001, CANCER RES, V61, P3071; Hoffman L, 1996, J BIOL CHEM, V271, P32538, DOI 10.1074/jbc.271.51.32538; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; LECKER SH, 2002, J PHYSL, V545, P819; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Liu K, 2000, P NATL ACAD SCI USA, V97, P2820, DOI 10.1073/pnas.97.6.2820; Lopes UG, 1997, J BIOL CHEM, V272, P12893, DOI 10.1074/jbc.272.20.12893; Lubas WA, 1997, J BIOL CHEM, V272, P9316; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; MOSS B, 1991, SCIENCE, V252, P1662, DOI 10.1126/science.2047875; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Pasquini LA, 2000, J NEUROSCI RES, V59, P601, DOI 10.1002/(SICI)1097-4547(20000301)59:5<601::AID-JNR3>3.0.CO;2-1; Price SR, 1996, J CLIN INVEST, V98, P1703, DOI 10.1172/JCI118968; Qiu JH, 2000, J NEUROSCI, V20, P259, DOI 10.1523/JNEUROSCI.20-01-00259.2000; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; Roos MD, 1998, P ASSOC AM PHYSICIAN, V110, P422; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Russell SJ, 2001, CHEM BIOL, V8, P941, DOI 10.1016/S1074-5521(01)00060-6; Sayeski PP, 1996, J BIOL CHEM, V271, P15237, DOI 10.1074/jbc.271.25.15237; Su KH, 1999, J BIOL CHEM, V274, P15194, DOI 10.1074/jbc.274.21.15194; Su KH, 2000, BIOCHEM J, V348, P281, DOI 10.1042/0264-6021:3480281; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wells L, 2003, BIOCHEM BIOPH RES CO, V302, P435, DOI 10.1016/S0006-291X(03)00175-X; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; WING SS, 1993, AM J PHYSIOL, V264, P668; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998	53	329	355	3	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 12	2003	115	6					715	725		10.1016/S0092-8674(03)00974-7	http://dx.doi.org/10.1016/S0092-8674(03)00974-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675536	Bronze			2022-12-28	WOS:000187366100011
J	McNab, BK				McNab, BK			Metabolism - Ecology shapes bird bioenergetics	NATURE			English	Editorial Material							ENERGY-EXPENDITURE; MAMMALS; ENERGETICS; BASAL; RATES		Univ Florida, Dept Zool, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	McNab, BK (corresponding author), Univ Florida, Dept Zool, Gainesville, FL 32611 USA.							BARTHOLOMEW GA, 1983, PHYSIOL ZOOL, V56, P370, DOI 10.1086/physzool.56.3.30152601; Beehler B.M., 1989, ACT 19 C INT ORN, P816, DOI 10.1515/9781400880713; FRITH CB, 1998, BRIDS PARADISE; GLAZIER DS, 1985, COMP BIOCHEM PHYS A, V80, P587, DOI 10.1016/0300-9629(85)90417-7; KOTEJA P, 1991, FUNCT ECOL, V5, P56, DOI 10.2307/2389555; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; MCNAB BK, 1980, AM NAT, V116, P106, DOI 10.1086/283614; McNab BK, 2001, AUK, V118, P916, DOI 10.1642/0004-8038(2001)118[0916:EOTABA]2.0.CO;2; McNab BK, 2000, COMP BIOCHEM PHYS A, V127, P309, DOI 10.1016/S1095-6433(00)00268-3; NAGY KA, 1994, AUST J ZOOL, V42, P43, DOI 10.1071/ZO9940043; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; Reynolds PS, 1996, AM NAT, V147, P735, DOI 10.1086/285877; Ricklefs RE, 1996, AM NAT, V147, P1047, DOI 10.1086/285892	13	38	39	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					620	621		10.1038/426620b	http://dx.doi.org/10.1038/426620b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668851				2022-12-28	WOS:000187132800028
J	Reiners, PW; Ehlers, TA; Mitchell, SG; Montgomery, DR				Reiners, PW; Ehlers, TA; Mitchell, SG; Montgomery, DR			Coupled spatial variations in precipitation and long-term erosion rates across the Washington Cascades	NATURE			English	Article							MOUNTAIN BELTS; STATE; EXHUMATION; TECTONICS; CLIMATE; UPLIFT; LIMITS; MODEL; RANGE	Past studies of tectonically active mountain ranges have suggested strong coupling and feedbacks between climate, tectonics and topography(1 - 5). For example, rock uplift generates topographic relief, thereby enhancing precipitation, which focuses erosion and in turn influences rates and spatial patterns of further rock uplift. Although theoretical links between climate, erosion and uplift have received much attention(2,6 - 10), few studies have shown convincing correlations between observable indices of these processes on mountain- range scales(11,12). Here we show that strongly varying long- term(> 10(6) - 10(7) yr) erosion rates inferred from apatite ( U - Th)/ He cooling ages across the Cascades mountains of Washington state closely track modern mean annual precipitation rates. Erosion and precipitation rates vary over an order of magnitude across the range with maxima of 0.33 mm yr(-1) and 3.5 m yr(-1), respectively, with both maxima located 50 km west ( windward) of the topographic crest of the range. These data demonstrate a strong coupling between precipitation and long- term erosion rates on the mountain- range scale. If the range is currently in topographic steady state, rock uplift on the west flank is three to ten times faster than elsewhere in the range, possibly in response to climatically focused erosion.	Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA	Yale University; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle	Reiners, PW (corresponding author), Yale Univ, Dept Geol & Geophys, 210 Whitney Ave, New Haven, CT 06511 USA.		Ehlers, Todd A/A-9582-2012	Ehlers, Todd A/0000-0001-9436-0303				[Anonymous], 2001, GSA TODAY, DOI [10.1130/1052-5173(2001)0112.0.CO;2, DOI 10.1130/1052-5173(2001)011<0004:EHGATG>2.0.C0;2]; BEAUMONT C, 1991, THRUST TECTONICS, P1; BEAUMONT C., 2000, GEOMORPHOLOGY GLOBAL, P29; BLACKWELL DD, 1990, J GEOPHYS RES-SOLID, V95, P19495, DOI 10.1029/JB095iB12p19495; Brandon MT, 1998, GEOL SOC AM BULL, V110, P985, DOI 10.1130/0016-7606(1998)110<0985:LCEOTC>2.3.CO;2; Brozovic N, 1997, SCIENCE, V276, P571, DOI 10.1126/science.276.5312.571; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Farley KA, 2000, J GEOPHYS RES-SOL EA, V105, P2903, DOI 10.1029/1999JB900348; KOONS PO, 1989, AM J SCI, V289, P1041, DOI 10.2475/ajs.289.9.1041; Miller MM, 2001, TECTONICS, V20, P161, DOI 10.1029/2000TC001224; Montgomery DR, 2001, GEOLOGY, V29, P579, DOI 10.1130/0091-7613(2001)029<0579:CTATMO>2.0.CO;2; Montgomery DR, 2002, EARTH PLANET SC LETT, V201, P481, DOI 10.1016/S0012-821X(02)00725-2; Reiners PW, 2002, GEOLOGY, V30, P767, DOI 10.1130/0091-7613(2002)030<0767:LMEAUO>2.0.CO;2; SMILEY CHARLES J., 1963, UNIV CALIFORNIA PUBL GEOL SCI, V35, P159; TUCKER GE, 1994, J GEOPHYS RES-SOL EA, V99, P12229, DOI 10.1029/94JB00320; Whipple KX, 1999, NATURE, V401, P39, DOI 10.1038/43375; WILLETT S, 1993, GEOLOGY, V21, P371, DOI 10.1130/0091-7613(1993)021<0371:MMFTTO>2.3.CO;2; Willett SD, 1999, J GEOPHYS RES-SOL EA, V104, P28957, DOI 10.1029/1999JB900248; Willett SD, 2001, AM J SCI, V301, P455, DOI 10.2475/ajs.301.4-5.455	19	233	244	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					645	647		10.1038/nature02111	http://dx.doi.org/10.1038/nature02111			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668859	Green Published			2022-12-28	WOS:000187132800036
J	Jaffe, AB; Hall, A				Jaffe, AB; Hall, A			Cell biology - Smurfing at the leading edge	SCIENCE			English	Editorial Material							RAC ACTIVATION; DEGRADATION; POLARITY; RHOA		UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Cell Biol Unit, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Jaffe, AB (corresponding author), UCL, MRC, Mol Cell Biol Lab, Mortimer St, London WC1E 6BT, England.	a.jaffe@ucl.ac.uk; alan.hall@ucl.ac.uk		Jaffe, Aron/0000-0002-6220-0476				Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Gardiner EM, 2002, CURR BIOL, V12, P2029, DOI 10.1016/S0960-9822(02)01334-9; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Lerm M, 2002, INFECT IMMUN, V70, P4053, DOI 10.1128/IAI.70.8.4053-4058.2002; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3	10	22	22	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1690	1691		10.1126/science.1092874	http://dx.doi.org/10.1126/science.1092874			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657480				2022-12-28	WOS:000186970100027
J	Journet, L; Agrain, C; Broz, P; Cornelis, GR				Journet, L; Agrain, C; Broz, P; Cornelis, GR			The needle length of bacterial injectisomes is determined by a molecular ruler	SCIENCE			English	Article							FLAGELLAR HOOK LENGTH; III SECRETION SYSTEM; SALMONELLA-TYPHIMURIUM; SUBSTRATE-SPECIFICITY; SHIGELLA-FLEXNERI; YOP SECRETION; TAIL LENGTH; PROTEIN; COMPLEX; YSCP	Size determination represents a fundamental requirement for multicomponent biological structures. Some pathogenic bacteria possess a weapon derived from the flagellum. Like the flagellum, this type-III secretion apparatus, called the injectisome, has a transmembrane basal body, but the external component is a needle-like structure instead of a hook and a. lament. Here, we provide evidence that the length of this needle is determined by the size of a protein, YscP, acting as a molecular ruler.	Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	University of Basel	Cornelis, GR (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.		Broz, Petr/AAC-7940-2019	Broz, Petr/0000-0002-2334-7790; Journet, Laure/0000-0002-5847-2962				ABULADZE NK, 1994, VIROLOGY, V199, P301, DOI 10.1006/viro.1994.1128; Aizawa S, 2001, FEMS MICROBIOL LETT, V202, P157, DOI 10.1111/j.1574-6968.2001.tb10797.x; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; COLLAZO CM, 1995, MOL MICROBIOL, V15, P25, DOI 10.1111/j.1365-2958.1995.tb02218.x; Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200; Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932; DUDA RL, 1986, VIROLOGY, V151, P296, DOI 10.1016/0042-6822(86)90051-6; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994; Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798; KATSURA I, 1987, NATURE, V327, P73, DOI 10.1038/327073a0; KATSURA I, 1984, CELL, V39, P691, DOI 10.1016/0092-8674(84)90476-8; Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002; Makishima S, 2001, SCIENCE, V291, P2411, DOI 10.1126/science.1058366; Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000; Minamino T, 1999, MOL MICROBIOL, V34, P295, DOI 10.1046/j.1365-2958.1999.01597.x; Payne PL, 1999, J BACTERIOL, V181, P2852, DOI 10.1128/JB.181.9.2852-2862.1999; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Stainier I, 2000, MOL MICROBIOL, V37, P1005, DOI 10.1046/j.1365-2958.2000.02026.x; Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002	23	235	246	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1757	1760		10.1126/science.1091422	http://dx.doi.org/10.1126/science.1091422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657497				2022-12-28	WOS:000186970100046
J	Greiner, M; Regal, CA; Jin, DS				Greiner, M; Regal, CA; Jin, DS			Emergence of a molecular Bose-Einstein condensate from a Fermi gas	NATURE			English	Article							BCS-SUPERCONDUCTIVITY; TRANSITION; CROSSOVER	The realization of superfluidity in a dilute gas of fermionic atoms, analogous to superconductivity in metals, represents a long-standing goal of ultracold gas research. In such a fermionic superfluid, it should be possible to adjust the interaction strength and tune the system continuously between two limits: a Bardeen Cooper - Schrieffer (BCS)-type superfluid ( involving correlated atom pairs in momentum space) and a Bose - Einstein condensate (BEC), in which spatially local pairs of atoms are bound together. This crossover between BCS-type superfluidity and the BEC limit has long been of theoretical interest, motivated in part by the discovery of high-temperature superconductors(1-10). In atomic Fermi gas experiments superfluidity has not yet been demonstrated; however, long-lived molecules consisting of locally paired fermions have been reversibly created(11-15). Here we report the direct observation of a molecular Bose - Einstein condensate created solely by adjusting the interaction strength in an ultracold Fermi gas of atoms. This state of matter represents one extreme of the predicted BCS - BEC continuum.	Natl Inst Stand & Technol, JILA, Boulder, CO 80309 USA; Univ Colorado, Dept Phys, Boulder, CO 80309 USA; Natl Inst Stand & Technol, Quantum Phys Div, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA	Greiner, M (corresponding author), Natl Inst Stand & Technol, JILA, Boulder, CO 80309 USA.	markus.greiner@colorado.edu	Greiner, Markus/E-9512-2017; Greiner, Markus/A-8502-2010	REGAL, CINDY/0000-0002-0000-2140				ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; [Anonymous], 1980, J PHYS PARIS C; Bradley CC, 1997, PHYS REV LETT, V78, P985, DOI 10.1103/PhysRevLett.78.985; CARR LD, 2003, CONDMAT0308306; Chin C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.033201; CUBIZOLLES J, 2003, CONDMAT0308018; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; Donley EA, 2002, NATURE, V417, P529, DOI 10.1038/417529a; DRECHSLER M, 1992, ANN PHYS-LEIPZIG, V1, P15, DOI 10.1002/andp.19925040105; DURR S, 2003, CONDMAT0307440; Giorgini S, 1996, PHYS REV A, V54, pR4633, DOI 10.1103/PhysRevA.54.R4633; HAUSSMANN R, 1994, PHYS REV B, V49, P12975, DOI 10.1103/PhysRevB.49.12975; Herbig J, 2003, SCIENCE, V301, P1510, DOI 10.1126/science.1088876; Holland M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.120406; JOCHIM S, 2003, CONDMAT0308095; Loftus T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.173201; Milstein JN, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.043604; NOZIERES P, 1985, J LOW TEMP PHYS, V59, P195, DOI 10.1007/BF00683774; Ohashi Y, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.033603; Ohashi Y, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.130402; PETROV DS, 2003, CONDMAT0309010; Randeria M., 1995, BOSE EINSTEIN CONDEN, P355; RATCLIFF LB, 1987, J MOL SPECTROSC, V122, P293, DOI 10.1016/0022-2852(87)90006-3; Regal CA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.230404; Regal CA, 2003, NATURE, V424, P47, DOI 10.1038/nature01738; REGAL CA, 2003, CONDMAT0308606; SHVARCHUCK I, 2002, PHYS REV LETT, V89, P270; Strecker KE, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.080406; STWALLEY WC, 1976, PHYS REV LETT, V37, P1628, DOI 10.1103/PhysRevLett.37.1628; Timmermans E, 2001, PHYS LETT A, V285, P228, DOI 10.1016/S0375-9601(01)00346-2; XU K, 2003, CONDMAT0310027	32	1113	1132	6	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					537	540		10.1038/nature02199	http://dx.doi.org/10.1038/nature02199			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14647340	Green Published			2022-12-28	WOS:000186944300033
J	Hull, MC; Morris, CG; Pepine, CJ; Mendenhall, NP				Hull, MC; Morris, CG; Pepine, CJ; Mendenhall, NP			Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NASOPHARYNGEAL CARCINOMA; HEART-DISEASE; RADIOTHERAPY; IRRADIATION; STENOSIS; REGURGITATION; PERICARDITIS; MORTALITY; EFFUSION; RISK	Context The majority of patients with Hodgkin lymphoma are young and highly curable. This necessitates concern for prevention, diagnosis, and optimal management of potential treatment-related complications. Objective To identify and quantify the incidence of and factors contributing to long-term cardiac and vascular complications after radiation therapy for Hodgkin lymphoma. Design and Setting Retrospective study comparing patients treated from 1962 to 1998 at a university-based referral center with a matched general population. Patients Four hundred fifteen consecutive patients who fulfilled the inclusion criteria of a minimum 2-year follow-up (median, 11.2 years) and whose radiation fields included the heart or carotid or subclavian arteries. Main Outcome Measures Multivariable analyses of potential risk factors and observed-to-expected ratios for cardiac valve surgery, coronary artery bypass graft surgery, percutaneous coronary intervention, or both based on Surveillance, Epidemiology, and End Results (SEER) and National Hospital Discharge Survey (NHDS) data. Results Forty-two patients (10.4%) developed coronary artery disease at a median of 9 years after treatment, 30 patients (7.4%) developed carotid and/or subclavian artery disease at a median of 17 years after treatment, and 25 patients (6.2%) developed clinically significant valvular dysfunction at a median of 22 years. The most common valve lesion was aortic stenosis, which occurred in 14 valves. The observed-to-expected ratio for valve surgery was 8.42 (95% confidence interval [CI], 3.20-13.65) and the observed-to-expected ratio for coronary artery bypass graft surgery or percutaneous coronary intervention was 1.63 (95% Cl, 0.98-2.28). At least 1 cardiac risk factor was present in all patients who developed coronary artery disease. The only treatment-related factor associated with the development of coronary artery disease was utilization of a radiation technique that resulted in a higher total dose to a portion of the heart (relative risk, 7.8; 95% Cl, 1.1-53.2; P=.04). No specific treatment-related factor was associated with carotid or subclavian artery disease or valvular dysfunction., Freedom from any cardiovascular morbidity was 88% at 15 years and 84% at 20 years. Conclusions Among patients treated with radiation therapy for Hodgkin lymphoma, there are statistically higher than expected rates of valve surgery and coronary revascularization procedures over the next 10 to 20 years. Coronary vascular disease is associated with higher radiation doses and traditional coronary heart disease risk factors. Noncoronary vascular disease and clinically important valvular dysfunction are less well understood complications at 15 to 20 years after radiation, requiring surveillance and further study.	Univ Florida, Coll Med, Dept Radiat Oncol, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Mendenhall, NP (corresponding author), 2000 SW Archer Rd, Gainesville, FL 32608 USA.							Achenbach S, 1998, NEW ENGL J MED, V339, P1964, DOI 10.1056/NEJM199812313392702; AHUJA A, 1995, NEUROSURGERY, V36, P399, DOI 10.1227/00006123-199502000-00023; BOIVIN JF, 1992, CANCER, V69, P1241; BYHARDT R, 1975, CANCER-AM CANCER SOC, V35, P795, DOI 10.1002/1097-0142(197503)35:3<795::AID-CNCR2820350335>3.0.CO;2-M; *CDCP NAT CTR HLTH, 2002, CDCP NAT CTR HLTH ST, V13; Cheng SWK, 2000, ARCH OTOLARYNGOL, V126, P517, DOI 10.1001/archotol.126.4.517; COHN KE, 1967, MEDICINE, V46, P281, DOI 10.1097/00005792-196705000-00003; CONOMY JP, 1975, CANCER, V36, P1702, DOI 10.1002/1097-0142(197511)36:5<1702::AID-CNCR2820360525>3.0.CO;2-V; COSSET JM, 1991, INT J RADIAT ONCOL, V21, P447, DOI 10.1016/0360-3016(91)90794-5; COX DR, 1972, J R STAT SOC B, V34, P187; Dubec JJ, 1998, BRIT J RADIOL, V71, P872, DOI 10.1259/bjr.71.848.9828801; ELERDING SC, 1981, ANN SURG, V194, P609, DOI 10.1097/00000658-198111000-00009; Fletcher G, 1980, TXB RADIOTHERAPY; Glanzmann C, 1998, RADIOTHER ONCOL, V46, P51, DOI 10.1016/S0167-8140(97)00125-4; GUSTAVSSON A, 1990, ANN ONCOL, V1, P355, DOI 10.1093/oxfordjournals.annonc.a057774; Hancock SL, 1999, HODGKIN'S DISEASE, P647; HENRYAMAR M, 1990, INT J RADIAT ONCOL, V19, P1155, DOI 10.1016/0360-3016(90)90221-5; Hoppe RT, 1997, ANN ONCOL, V8, P115, DOI 10.1023/A:1008238908676; Houdart E, 2001, STROKE, V32, P118, DOI 10.1161/01.STR.32.1.118; HUDSON BV, 1994, ANN ONCOL         S2, V5, P65; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kim WY, 2001, NEW ENGL J MED, V345, P1863, DOI 10.1056/NEJMoa010866; King LJ, 1999, RADIOLOGY, V213, P167, DOI 10.1148/radiology.213.1.r99oc07167; King V, 1996, INT J RADIAT ONCOL, V36, P881, DOI 10.1016/S0360-3016(96)00295-7; KREUSER ED, 1993, BRIT J HAEMATOL, V84, P615, DOI 10.1111/j.1365-2141.1993.tb03136.x; Lam WMM, 2001, CANCER, V92, P2357, DOI 10.1002/1097-0142(20011101)92:9<2357::AID-CNCR1583>3.0.CO;2-K; Lee CKK, 2000, INT J RADIAT ONCOL, V48, P169, DOI 10.1016/S0360-3016(00)00647-7; Lund MB, 1996, HEART, V75, P591, DOI 10.1136/hrt.75.6.591; Mauch P M, 1995, Cancer J Sci Am, V1, P33; Mendenhall NP, 1999, INT J RADIAT ONCOL, V44, P551, DOI 10.1016/S0360-3016(99)00087-5; MENDENHALL NP, 2000, CLIN RAD ONCOLOGY, P1123; MORTON DL, 1973, CHEST, V64, P291, DOI 10.1378/chest.64.3.291; *NCI DCCPS SURV RE, 2002, SURV EP END RES SEER; PERRAULT DJ, 1985, J CLIN ONCOL, V3, P546, DOI 10.1200/JCO.1985.3.4.546; POHJOLASINTONEN S, 1987, CANCER-AM CANCER SOC, V60, P31, DOI 10.1002/1097-0142(19870701)60:1<31::AID-CNCR2820600107>3.0.CO;2-D; PRENTICE RT, 1965, LANCET, V2, P388; Reinders JG, 1999, RADIOTHER ONCOL, V51, P35, DOI 10.1016/S0167-8140(99)00026-2; Santoro A, 2000, J Neurosurg Sci, V44, P159; *SAS I INC, 1999, SAS ONL COMP PROGR V	39	421	446	0	17	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2831	2837		10.1001/jama.290.21.2831	http://dx.doi.org/10.1001/jama.290.21.2831			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QP	14657067	Bronze			2022-12-28	WOS:000186872800025
J	Le Marchand, L; Seifried, A; Lum-Jones, A; Donlon, T; Wilkens, LR				Le Marchand, L; Seifried, A; Lum-Jones, A; Donlon, T; Wilkens, LR			Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SQUAMOUS-CELL CARCINOMA; D1 POLYMORPHISM; GENE POLYMORPHISM; INCREASED RISK; EXPRESSION; SURVIVAL; HAWAII; HEAD; AGE	Context Cyclin D1 (CCND1) is a key cell cycle regulatory, protein, the overexpression of which is often found in human tumors and is associated with cell proliferation and poor prognosis. A common adenine-to-guanine substitution polymorphism (A870G) in the CCND1 gene results in an altered messenger RNA transcript and a longer-life protein, which are preferentially encoded by the A allele. Objective To test the overall and stage-specific associations of the CCND1 870A allele with colorectal cancer. Design, Setting, and Participants A population-based case-control study conducted in the multiethnic population of Hawaii between January 1, 1994, and August 31,1998, which included 504 patients with incident colorectal cancer and 624 population-based participants of Japanese, white, or Native Hawaiian origin. Participation rates were 58% for cases and 52% for controls. Main Outcome Measurement Ethnicity, gene-dosage effects, and stage (regional/ distant) and subsite (colon vs rectal) of cancer. Results The odds ratio (OR) for the CCND1 870 GA and AA genotypes compared with the GG genotype was 1.2 (95% confidence interval [01, 0.9-1.7) and 1.5 (95% Cl, 1.0-2.1), respectively (P=.03 for gene-dosage effect). These risk estimates were significantly greater for patients diagnosed at a regional or distant stage (GA vs GG: OR, 1.7; 95% Cl, 1.1 -2.5 and AA vs GG: OR, 1.9; 95% Cl, 1.2-3.1; P=.008 for gene-dosage effect) compared with those estimates for patients diagnosed at an earlier stage (P=.048). In subset analyses, the association between the A allele and advanced colorectal cancer was statistically significant in white and Hawaiian participants but not in Japanese, and was stronger for rectal cancer. Conclusion The CCND1 870A allele may be Associated with colorectal cancer, and particularly with forms of the disease that result in severe morbidity and mortality.	Univ Hawaii, Canc Res Ctr Hawaii, Etiol Program, Honolulu, HI 96813 USA	Cancer Research Center of Hawaii; University of Hawaii System	Le Marchand, L (corresponding author), Univ Hawaii, Canc Res Ctr Hawaii, Etiol Program, 1236 Lauhala St,Suite 407, Honolulu, HI 96813 USA.				DIVISION OF CANCER PREVENTION AND CONTROL [N01CN055424] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA072520, R01CA060987] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CN55424, R01 CA60987, CA72520] Funding Source: Medline	DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arber N, 1997, CANCER RES, V57, P1569; Arber N, 1996, GASTROENTEROLOGY, V110, P669, DOI 10.1053/gast.1996.v110.pm8608874; Bala S, 2001, CANCER RES, V61, P6042; BETTICHER DC, 1995, ONCOGENE, V11, P1005; Holley SL, 2001, AM J PATHOL, V159, P1917, DOI 10.1016/S0002-9440(10)63038-6; HOSMER DW, 1989, APPL LOGISTIC REGRES; Izzo JG, 2003, JNCI-J NATL CANCER I, V95, P198, DOI 10.1093/jnci/95.3.198; Kong SM, 2001, JNCI-J NATL CANCER I, V93, P1106, DOI 10.1093/jnci/93.14.1106; Kong SM, 2000, CANCER RES, V60, P249; Le Marchand L, 2002, JNCI-J NATL CANCER I, V94, P454, DOI 10.1093/jnci/94.6.454; Le Marchand L, 2001, CANCER EPIDEM BIOMAR, V10, P1259; Maohua Le, 2002, Smarandache Notions Journal, V13, P239; McKay JA, 2000, INT J CANCER, V88, P77, DOI 10.1002/1097-0215(20001001)88:1<77::AID-IJC12>3.0.CO;2-O; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; OYAMA N, 1986, 54 HAW STAT DEP HLTH; Pagano IS, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-5; Porter TR, 2002, ONCOGENE, V21, P1928, DOI 10.1038/sj.onc.1205245; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Wang LZ, 2002, CARCINOGENESIS, V23, P257, DOI 10.1093/carcin/23.2.257; WEGNER EL, 1982, CANCER, V49, P2208, DOI 10.1002/1097-0142(19820515)49:10<2208::AID-CNCR2820491038>3.0.CO;2-6; Zheng YX, 2001, CARCINOGENESIS, V22, P1195, DOI 10.1093/carcin/22.8.1195	21	80	81	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2843	2848						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QP	14657069	Bronze			2022-12-28	WOS:000186872800027
J	Buhre, W; Rossaint, R				Buhre, W; Rossaint, R			Perioperative management and monitoring in anaesthesia	LANCET			English	Review							RESIDUAL NEUROMUSCULAR BLOCK; CLOSED CLAIMS ANALYSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY EXAMINATION; PULMONARY-ARTERY CATHETERIZATION; SOCIETY-OF-ECHOCARDIOGRAPHY; INTRAVASCULAR VOLUME STATUS; EXTRAVASCULAR LUNG WATER; SURGICAL-WOUND INFECTION; CORONARY-BYPASS SURGERY; 2000 INCIDENT REPORTS	In recent years, several risk factors for adverse outcome in patients undergoing anaesthesia have been identified. Besides human errors, cardiovascular and respiratory complications are associated with substantial morbidity. Assessment of complications has promoted the introduction of basic physiological monitoring in clinical practice. Whether monitoring directly affects outcome is not proven; however, circumstantial evidence suggests that basic cardiorespiratory monitoring decreases the incidence of serious accidents. Prevention of hypothermia also reduces anaesthesia-related morbidity. Measurement of body temperature is mandatory, and active warming is a simple, effective technique to avoid hypothermia. Evidence is growing that patients with known or suspected coronary artery disease should be treated with beta blockers perioperatively. Whether the type of anaesthesia-ie, general or regional-is relevant to perioperative mortality remains unclear. In subgroups of patients at high risk, neuraxial anaesthesia reduces the rate of respiratory and cardiovascular complications.	Univ Hosp Aachen, Dept Anaesthesiol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	Buhre, W (corresponding author), Univ Klinikum Aachen, Anasthesiol Klin, Pauwels Str 30, D-52074 Aachen, Germany.	wbuhre@ukaachen.de	Buhre, Wolfgang/X-9192-2018	Buhre, Wolfgang/0000-0002-8296-9426				Akca O, 1999, ANESTHESIOLOGY, V91, P991, DOI 10.1097/00000542-199910000-00019; ALI HH, 1970, BRIT J ANAESTH, V42, P967, DOI 10.1093/bja/42.11.967; [Anonymous], 2002, ANESTHESIOL CLIN N A; Arbous MS, 2001, ANAESTHESIA, V56, P1141, DOI 10.1046/j.1365-2044.2001.02051.x; ARNDT JO, 1986, EUR J ANAESTH, V3, P343; Aronson S, 2002, ANESTH ANALG, V95, P1476, DOI 10.1097/00000539-200212000-00004; Auerbach AD, 2002, JAMA-J AM MED ASSOC, V287, P1435, DOI 10.1001/jama.287.11.1435; Baumert JH, 2001, ANAESTHESIST, V50, P649, DOI 10.1007/s001010100198; Beattie WS, 2001, ANESTH ANALG, V93, P853, DOI 10.1097/00000539-200110000-00010; Bender JS, 1997, ANN SURG, V226, P229, DOI 10.1097/00000658-199709000-00002; BENSON MJ, 1995, ECHOCARDIOGR-J CARD, V12, P171, DOI 10.1111/j.1540-8175.1995.tb00537.x; Berg H, 1997, ACTA ANAESTH SCAND, V41, P1095, DOI 10.1111/j.1399-6576.1997.tb04851.x; Bernard GR, 2000, JAMA-J AM MED ASSOC, V283, P2568, DOI 10.1001/jama.283.19.2568; Brauer A, 2000, ANASTH INTENSIV NOTF, V35, P435, DOI 10.1055/s-2000-12475; Brauer A, 2002, ACTA ANAESTH SCAND, V46, P965, DOI 10.1034/j.1399-6576.2002.460807.x; Brauer A, 2003, ACTA ANAESTH SCAND, V47, P58, DOI 10.1034/j.1399-6576.2003.470110.x; BROWNER WS, 1992, JAMA-J AM MED ASSOC, V268, P228, DOI 10.1001/jama.268.2.228; Bruhn J, 2000, ANESTHESIOLOGY, V93, P981, DOI 10.1097/00000542-200010000-00018; Buhre G, 1999, J CARDIOTHOR VASC AN, V13, P437; Buhre W, 1999, EUR J ANAESTH, V16, P11, DOI 10.1046/j.1365-2346.1999.00406.x; Buhre W, 2001, EUR J ANAESTH, V18, P662; BUZELLO W, 1985, ANESTHESIOLOGY, V62, P201, DOI 10.1097/00000542-198502000-00025; Cahalan MK, 2002, J AM SOC ECHOCARDIOG, V15, P647, DOI 10.1067/mje.2002.123956; Caplan RA, 1997, ANESTHESIOLOGY, V87, P741, DOI 10.1097/00000542-199710000-00006; CHENEY FW, 1991, ANESTHESIOLOGY, V75, P932, DOI 10.1097/00000542-199112000-00002; Cheney FW, 1999, ANESTHESIOLOGY, V91, P552, DOI 10.1097/00000542-199908000-00030; Comunale ME, 1998, ANESTHESIOLOGY, V88, P945, DOI 10.1097/00000542-199804000-00014; COOPER JB, 1993, J CLIN ANESTH, V5, P79, DOI 10.1016/0952-8180(93)90095-V; COOPER JB, 1978, ANESTHESIOLOGY, V49, P399, DOI 10.1097/00000542-197812000-00004; Cooper JB, 2002, ANESTHESIOLOGY, V97, P1335, DOI 10.1097/00000542-200212000-00003; CORK RC, 1983, ANESTH ANALG, V62, P211; COTTON P, 1994, JAMA-J AM MED ASSOC, V272, P8; Daunderer M, 2001, ANAESTHESIST, V50, P231, DOI 10.1007/s001010050997; Drummond JC, 2000, ANESTHESIOLOGY, V93, P876, DOI 10.1097/00000542-200009000-00039; Eichhorn J H, 1988, J Clin Anesth, V1, P55; EICHHORN JH, 1989, ANESTHESIOLOGY, V70, P572, DOI 10.1097/00000542-198904000-00002; EICHHORN JH, 1986, JAMA-J AM MED ASSOC, V256, P1017; ELLIS JE, 1994, ANESTH ANALG, V79, P1133; Emerson CE, 2003, BRIT J ANAESTH, V90, P380, DOI 10.1093/oxfordjournals.bja.a000403; ENGBAEK J, 1989, BRIT J ANAESTH, V62, P274, DOI 10.1093/bja/62.3.274; ENGBAEK J, 1989, ANESTHESIOLOGY, V71, P391, DOI 10.1097/00000542-198909000-00014; English M, 1998, ANASTH INTENSIV NOTF, V33, P386, DOI 10.1055/s-2007-994269; ERIKSSON LI, 1992, ACTA ANAESTH SCAND, V36, P710, DOI 10.1111/j.1399-6576.1992.tb03550.x; Eriksson LI, 1997, ANESTHESIOLOGY, V87, P1035, DOI 10.1097/00000542-199711000-00005; Fasting S, 2002, CAN J ANAESTH, V49, P545, DOI 10.1007/BF03017379; FOWKES FGR, 1982, BRIT J ANAESTH, V54, P819, DOI 10.1093/bja/54.8.819; Frank SM, 1999, ANESTH ANALG, V88, P373, DOI 10.1097/00000539-199902000-00028; Gaba DM, 2002, NEW ENGL J MED, V347, P1249, DOI 10.1056/NEJMsa020846; GABA DM, 1989, ANESTH ANALG, V68, P444; GABA DM, 1992, ANESTHESIOLOGY, V76, P491; Grass J A, 2000, Anesthesiol Clin North Am, V18, P407, DOI 10.1016/S0889-8537(05)70170-X; Gravenstein J S, 2000, Surg Oncol Clin N Am, V9, P81; GRAVENSTEIN JS, 1989, J CLIN MONITOR, V5, P17, DOI 10.1007/BF01618365; Gravenstein JS, 2002, ANAESTHESIST, V51, P754, DOI 10.1007/s00101-002-0319-4; Gravenstein JS, 1998, J CLIN MONIT COMPUT, V14, P451, DOI 10.1023/A:1009955402338; GRAVENSTEIN JS, 1986, THEOR MED, P299; Greif R, 2000, NEW ENGL J MED, V342, P161, DOI 10.1056/NEJM200001203420303; HALLAN S, 1990, Tidsskrift for den Norske Laegeforening, V110, P38; HOEFT A, 1994, ANESTHESIOLOGY, V81, P76, DOI 10.1097/00000542-199407000-00012; Holte K, 2002, Minerva Anestesiol, V68, P157; Hynson J M, 1992, J Clin Anesth, V4, P194, DOI 10.1016/0952-8180(92)90064-8; Jain U, 1997, ANESTHESIOLOGY, V86, P576, DOI 10.1097/00000542-199703000-00009; JANSEN JRC, 1995, INTENS CARE MED, V21, P691, DOI 10.1007/BF01711553; JANSEN JRC, 1990, INTENS CARE MED, V16, P422, DOI 10.1007/BF01711218; JEDEIKIN R, 1987, ANAESTHESIA, V42, P858, DOI 10.1111/j.1365-2044.1987.tb04111.x; Kamada Y, 1999, Masui, V48, P1121; KAPLAN JA, 1976, ANESTHESIOLOGY, V45, P570; KHOURY M, 1992, AM J SURG, V164, P205, DOI 10.1016/S0002-9610(05)81071-2; KONSTADT S, 1985, MT SINAI J MED, V52, P521; Kopman AF, 1997, ANESTHESIOLOGY, V86, P765, DOI 10.1097/00000542-199704000-00005; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; KURZ A, 1995, J CLIN ANESTH, V7, P359, DOI 10.1016/0952-8180(95)00028-G; KURZ A, 1993, ANESTH ANALG, V77, P89; Lagasse RS, 2002, ANESTHESIOLOGY, V97, P1609, DOI 10.1097/00000542-200212000-00038; Lambert AS, 1999, ANESTH ANALG, V88, P1205, DOI 10.1097/00000539-199906000-00004; Lehmann A, 2002, ANESTH ANALG, V95, P639, DOI 10.1097/00000539-200209000-00027; Lehmann A, 2001, ANASTH INTENSIV NOTF, V36, P683, DOI 10.1055/s-2001-18048; Lennmarken C, 2002, ACTA ANAESTH SCAND, V46, P229, DOI 10.1034/j.1399-6576.2002.t01-1-460301.x; LENNON RL, 1990, ANESTH ANALG, V70, P424; Linton RA, 2000, INTENS CARE MED, V26, P1507, DOI 10.1007/s001340051347; LINTON RAF, 1993, BRIT J ANAESTH, V71, P262, DOI 10.1093/bja/71.2.262; Loick HM, 1999, ANESTH ANALG, V88, P701, DOI 10.1097/00000539-199904000-00001; MANGANO DT, 1990, NEW ENGL J MED, V323, P1781, DOI 10.1056/NEJM199012273232601; Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798; MANGANO DT, 1989, ANESTHESIOLOGY, V70, P175; MANGANO DT, 1994, WESTERN J MED, V161, P87; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; MARSCH SCU, 1992, ANAESTHESIA, V47, P34, DOI 10.1111/j.1365-2044.1992.tb01951.x; Martin E, 1997, ANESTHESIOLOGY, V86, P346; MOLLER JT, 1993, ANESTHESIOLOGY, V78, P445, DOI 10.1097/00000542-199303000-00007; Mondello E, 2002, Minerva Anestesiol, V68, P715; Morray JP, 2000, ANESTHESIOLOGY, V93, P6, DOI 10.1097/00000542-200007000-00007; MORTENSEN CR, 1995, ACTA ANAESTH SCAND, V39, P797, DOI 10.1111/j.1399-6576.1995.tb04173.x; Muravchick S, 1998, Acta Anaesthesiol Belg, V49, P85; O'Hara DA, 2000, ANESTHESIOLOGY, V92, P947, DOI 10.1097/00000542-200004000-00011; Park WY, 2001, ANN SURG, V234, P560; PateCornell ME, 1997, RISK ANAL, V17, P511, DOI 10.1111/j.1539-6924.1997.tb00892.x; PEDERSEN T, 1994, DAN MED BULL, V41, P319; Poldermans D, 1999, NEW ENGL J MED, V341, P1789, DOI 10.1056/NEJM199912093412402; Rigg JRA, 2002, LANCET, V359, P1276, DOI 10.1016/S0140-6736(02)08266-1; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Ropcke H, 2001, ANESTHESIOLOGY, V94, P390; Ropcke H, 2001, J CLIN ANESTH, V13, P198, DOI 10.1016/S0952-8180(01)00255-0; RUNCIMAN WB, 1993, ANAESTH INTENS CARE, V21, P543, DOI 10.1177/0310057X9302100509; RUNCIMAN WB, 1993, EUR J ANAESTH, V10, P16; RUPP SM, 1987, ANESTHESIOLOGY, V67, P45, DOI 10.1097/00000542-198707000-00008; Russell SH, 1996, ANAESTHESIA, V51, P338, DOI 10.1111/j.1365-2044.1996.tb07743.x; Sakka SG, 1999, J CRIT CARE, V14, P78, DOI 10.1016/S0883-9441(99)90018-7; Sakka SG, 2002, CHEST, V122, P2080, DOI 10.1378/chest.122.6.2080; Sakka SG, 2000, J CARDIOTHOR VASC AN, V14, P119, DOI 10.1016/S1053-0770(00)90002-8; Sandin RH, 2000, LANCET, V355, P707, DOI 10.1016/S0140-6736(99)11010-9; Scheer BV, 2002, CRIT CARE, V6, P198, DOI 10.1186/cc1489; Schiffmann H, 2002, J CARDIOTHOR VASC AN, V16, P592, DOI 10.1053/jcan.2002.126954; Schmied H, 1996, LANCET, V347, P289, DOI 10.1016/S0140-6736(96)90466-3; SCHULZ R, 1989, CARDIOVASC DRUG THER, V3, P43, DOI 10.1007/BF01881528; Schwilden H, 1999, Acta Anaesthesiol Belg, V50, P177; Sessler DI, 2000, ANESTHESIOLOGY, V92, P578, DOI 10.1097/00000542-200002000-00042; Sessler DI, 2002, CLIN INFECT DIS, V35, P1397, DOI 10.1086/344275; Sfeir R, 1996, Cardiovasc Surg, V4, P456, DOI 10.1016/0967-2109(95)00078-X; Shanewise J S, 2001, Anesthesiol Clin North Am, V19, P727; SHANEWISE JS, 1994, ANESTH ANALG, V79, P577; Shanewise JS, 1999, ANESTH ANALG, V89, P870, DOI 10.1097/00000539-199910000-00010; Shoemaker WC, 1998, CRIT CARE MED, V26, P1760, DOI 10.1097/00003246-199810000-00037; SHORTEN GD, 1995, CAN J ANAESTH, V42, P711, DOI 10.1007/BF03012670; SPAHN DR, 1995, ANESTHESIOLOGY, V82, P581, DOI 10.1097/00000542-199502000-00029; SWAN HJC, 1970, NEW ENGL J MED, V283, P447, DOI 10.1056/NEJM197008272830902; Takaki O, 1993, Masui, V42, P1013; Tayefeh F, 1997, ANESTH ANALG, V85, P657, DOI 10.1097/00000539-199709000-00031; Thomassen A R, 1994, Ugeskr Laeger, V156, P31; TINKER JH, 1989, ANESTHESIOLOGY, V71, P541, DOI 10.1097/00000542-198910000-00010; VIBYMOGENSEN J, 1988, ACTA ANAESTH SCAND, V32, P45; VIBYMOGENSEN J, 2001, ANAESTHESIA, P1351; Vincent JL, 1998, CRIT CARE MED, V26, P1283, DOI 10.1097/00003246-199807000-00035; Wallace A, 1998, ANESTHESIOLOGY, V88, P7, DOI 10.1097/00000542-199801000-00005; Wallace A, 1997, WESTERN J MED, V166, P203; WEBB RK, 1993, ANAESTH INTENS CARE, V21, P529, DOI 10.1177/0310057X9302100508; Weldon B C, 2000, Anesthesiol Clin North Am, V18, P705, DOI 10.1016/S0889-8537(05)70190-5; Weller JM, 2003, BRIT J ANAESTH, V90, P43, DOI 10.1093/bja/aeg002; Weyland W, 1998, ANASTH INTENSIV NOTF, V33, P381, DOI 10.1055/s-2007-994267; Weyland W, 1998, ANASTH INTENSIV NOTF, V33, P395, DOI 10.1055/s-2007-994272; Williams Gareth, 2002, Curr Opin Crit Care, V8, P251, DOI 10.1097/00075198-200206000-00009; Wilson R J, 2001, Curr Opin Crit Care, V7, P195, DOI 10.1097/00075198-200106000-00009	142	79	83	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1839	1846		10.1016/S0140-6736(03)14905-7	http://dx.doi.org/10.1016/S0140-6736(03)14905-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654324				2022-12-28	WOS:000186872900025
J	Lionakis, MS; Kontoyiannis, DP				Lionakis, MS; Kontoyiannis, DP			Glucocorticoids and invasive fungal infections	LANCET			English	Review							PNEUMOCYSTIS-CARINII-PNEUMONIA; SYSTEMIC-LUPUS-ERYTHEMATOSUS; COLONY-STIMULATING FACTOR; ALTERNATE-DAY PREDNISONE; FACTOR-KAPPA-B; RISK-FACTORS; ASPERGILLUS-FUMIGATUS; TRANSPLANT RECIPIENTS; CUSHINGS-SYNDROME; CANDIDA-ALBICANS	Since the 1990s, opportunistic fungal infections have emerged as a substantial cause of morbidity and mortality in profoundly immunocompromised patients. Hypercortisolaemic patients, both those with endogenous Cushing's syndrome and, much more frequently, those receiving exogenous glucocorticoid therapy, are especially at risk of such infections. This vulnerability is attributed to the complex dysregulation of immunity caused by glucocorticoids. We critically review the spectrum and presentation of invasive fungal infections that arise in the setting of hypercortisolism, and the ways in which glucocorticoids contribute to their pathogenesis. A better knowledge of the interplay between glucocorticoid-induced immunosuppression and invasive fungal infections should assist in earlier recognition and treatment of such infections. Efforts to decrease the intensity of glucocorticoid therapy should help to improve outcomes of opportunistic fungal infections.	Univ Texas, MD Anderson Canc Ctr, Dept Infect Dis Infest Control & Employee Hlth, Unit 402, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Kontoyiannis, DP (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Infect Dis Infest Control & Employee Hlth, Unit 402, 1515 Holcombe Blvd, Houston, TX 77030 USA.	dkontoyi@mdanderson.org	Lionakis, Michail/J-8840-2017	Lionakis, Michail/0000-0003-4994-9500				ABERER W, 1984, J IMMUNOL, V133, P792; ABERNATHYCARVER KJ, 1994, PEDIATR PULM, V18, P135, DOI 10.1002/ppul.1950180303; Almawi WY, 1999, CLIN TRANSPLANT, V13, P365, DOI 10.1034/j.1399-0012.1999.130501.x; Amsterdam A, 2002, MOL CELL ENDOCRINOL, V189, P1, DOI 10.1016/S0303-7207(01)00722-5; Anaissie EJ, 1998, ANN INTERN MED, V129, P559, DOI 10.7326/0003-4819-129-7-199810010-00010; ASHMAN RB, 1995, MICROBIOL REV, V59, P646, DOI 10.1128/MMBR.59.4.646-672.1995; Baddley JW, 2001, CLIN INFECT DIS, V32, P1319, DOI 10.1086/319985; Bakker RC, 1998, J ENDOCRINOL INVEST, V21, P329, DOI 10.1007/BF03350337; BALOW JE, 1975, J IMMUNOL, V114, P1072; BELL MJ, 1972, J PEDIATR SURG, V7, P223, DOI 10.1016/0022-3468(72)90499-X; BERENGUER J, 1995, AM J RESP CRIT CARE, V152, P1079, DOI 10.1164/ajrccm.152.3.7663787; Bodey GP, 2002, AM J MED, V112, P380, DOI 10.1016/S0002-9343(01)01130-5; Boss B, 1999, ANN NY ACAD SCI, V876, P198, DOI 10.1111/j.1749-6632.1999.tb07639.x; BOTAS CM, 1995, PEDIATRICS, V95, P883; Brummer E, 2001, MED MYCOL, V39, P509, DOI 10.1080/mmy.39.6.509.515; Bykov V L, 1989, Akush Ginekol (Mosk), P35; CARRADABRAVO T, 1975, ANN TROP MED PARASIT, V69, P267, DOI 10.1080/00034983.1975.11687010; Cenci E, 1997, INFECT IMMUN, V65, P564, DOI 10.1128/IAI.65.2.564-570.1997; CHAGUA MR, 2002, 40 ANN M INF DIS SOC; Chang JY, 2000, NEUROCHEM RES, V25, P903, DOI 10.1023/A:1007511221666; Clemons KV, 2000, MED MYCOL, V38, P99, DOI 10.1080/mmy.38.s1.99.111; COHEN DJ, 1984, ANN INTERN MED, V101, P667, DOI 10.7326/0003-4819-101-5-667; DALE DC, 1974, NEW ENGL J MED, V291, P1154, DOI 10.1056/NEJM197411282912203; Dandona P, 2001, METABOLISM, V50, P548, DOI 10.1053/meta.2001.22511; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; DeRijk RH, 2002, J STEROID BIOCHEM, V81, P103, DOI 10.1016/S0960-0760(02)00062-6; DIAMOND RD, 1983, J INFECT DIS, V147, P160, DOI 10.1093/infdis/147.1.160; DIAMOND RD, 1974, ANN INTERN MED, V80, P176, DOI 10.7326/0003-4819-80-2-176; DIMOPOULOS MA, 1992, CANCER, V69, P66, DOI 10.1002/1097-0142(19920101)69:1<66::AID-CNCR2820690113>3.0.CO;2-2; DISMUKES WE, 1978, JAMA-J AM MED ASSOC, V240, P1495, DOI 10.1001/jama.240.14.1495; Dromer F, 1996, CLIN INFECT DIS, V23, P82, DOI 10.1093/clinids/23.1.82; Dromer F, 1996, CLIN INFECT DIS, V23, P91, DOI 10.1093/clinids/23.1.91; Duong M, 1998, J INFECT DIS, V178, P1472, DOI 10.1086/314425; Fairfax AJ, 1999, THORAX, V54, P860, DOI 10.1136/thx.54.9.860; FAUCI AS, 1976, CLIN EXP IMMUNOL, V24, P54; FERGUSON RM, 1985, AM J KIDNEY DIS, V5, P296, DOI 10.1016/S0272-6386(85)80158-X; FINDLING JW, 1981, ANN INTERN MED, V95, P392, DOI 10.7326/0003-4819-95-3-392_1; Gilman A.G., 2001, GOODMAN GILMANS PHAR; GODEAU B, 1994, J RHEUMATOL, V21, P246; GOODMAN DH, 1973, ANN ALLERGY, V31, P205; Goulding NJ, 1998, INFLAMM RES, V47, pS158; GRAHAM BS, 1984, ANN INTERN MED, V101, P334, DOI 10.7326/0003-4819-101-3-334; Graybill JR, 1998, ANTIMICROB AGENTS CH, V42, P2467, DOI 10.1128/AAC.42.10.2467; Gross NT, 1996, MYCOPATHOLOGIA, V136, P1, DOI 10.1007/BF00436653; Grow WB, 2002, BONE MARROW TRANSPL, V29, P15, DOI 10.1038/sj.bmt.1703332; GUDEWICZ PW, 1981, CIRC SHOCK, V8, P95; Gumbo T, 1999, MEDICINE, V78, P220, DOI 10.1097/00005792-199907000-00002; GUSTAFSON TL, 1983, J INFECT DIS, V148, P230, DOI 10.1093/infdis/148.2.230; Hansen KE, 1998, SEMIN ARTHRITIS RHEU, V28, P193, DOI 10.1016/S0049-0172(98)80036-X; Hartel B, 1991, Anasthesiol Intensivmed Notfallmed Schmerzther, V26, P102, DOI 10.1055/s-2007-1000545; HAYES MJ, 1994, CLIN TRANSPLANT, V8, P499; HEIDENREICH S, 1994, CELL IMMUNOL, V157, P320, DOI 10.1006/cimm.1994.1230; HELLMANN DB, 1987, MEDICINE, V66, P341, DOI 10.1097/00005792-198709000-00002; HENSON JW, 1991, ARCH NEUROL-CHICAGO, V48, P406, DOI 10.1001/archneur.1991.00530160074017; Hovi L, 2000, BONE MARROW TRANSPL, V26, P999, DOI 10.1038/sj.bmt.1702654; Huizenga NATM, 1998, J CLIN ENDOCR METAB, V83, P144, DOI 10.1210/jc.83.1.144; Iriya SM, 2001, ARCH INTERN MED, V161, P1557, DOI 10.1001/archinte.161.12.1557; Jantunen E, 1997, BONE MARROW TRANSPL, V19, P801, DOI 10.1038/sj.bmt.1700737; Jimenez C, 2002, TRANSPLANTATION, V73, P476; JOHNSON WM, 1983, J RHEUMATOL, V10, P79; KHOO SH, 1994, CLIN INFECT DIS, V19, pS41, DOI 10.1093/clinids/19.Supplement_1.S41; Klein NC, 2001, INFECT DIS CLIN N AM, V15, P423, DOI 10.1016/S0891-5520(05)70154-9; Kleinert H, 1996, MOL PHARMACOL, V49, P15; Kleinschmidt-DeMasters BK, 2002, HUM PATHOL, V33, P116, DOI 10.1053/hupa.2002.30186; Kontoyiannis DP, 2002, INFECT CONT HOSP EP, V23, P542, DOI 10.1086/502104; Kontoyiannis DP, 2002, EUR J CLIN MICROBIOL, V21, P161, DOI 10.1007/s10096-002-0699-z; Kontoyiannis DP, 2001, CLIN INFECT DIS, V32, pE145, DOI 10.1086/320524; Kontoyiannis DP, 2000, CLIN INFECT DIS, V30, P851, DOI 10.1086/313803; Kontoyiannis DP, 2001, CLIN INFECT DIS, V33, P1676, DOI 10.1086/323812; KONTOYIANNIS DP, IN PRESS LEUK LYMPHO; Kovalovsky D, 2000, J NEUROIMMUNOL, V109, P23, DOI 10.1016/S0165-5728(00)00298-8; Kremery V, 1999, SUPPORT CARE CANCER, V7, P428; LANGHOFF E, 1987, INT J IMMUNOPHARMACO, V9, P469, DOI 10.1016/0192-0561(87)90021-X; Lanza L, 1999, ANN NY ACAD SCI, V876, P193, DOI 10.1111/j.1749-6632.1999.tb07638.x; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Leav BA, 2000, NEW ENGL J MED, V343, P586, DOI 10.1056/NEJM200008243430818; LILES WC, 1995, BLOOD, V86, P3181; Liu PYF, 1998, DIAGN MICR INFEC DIS, V30, P33, DOI 10.1016/S0732-8893(97)00190-9; LOOSE DS, 1981, NATURE, V293, P477, DOI 10.1038/293477a0; Lortholary O, 2000, CLIN INFECT DIS, V30, P41, DOI 10.1086/313592; Lyytikainen O, 1996, BONE MARROW TRANSPL, V17, P1057; MACGREGO.RR, 1969, NEW ENGL J MED, V280, P1427, DOI 10.1056/NEJM196906262802601; Maraki S, 1999, J CHEMOTHERAPY, V11, P363, DOI 10.1179/joc.1999.11.5.363; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Marr KA, 2002, CLIN INFECT DIS, V34, P909, DOI 10.1086/339202; Martino R, 2002, BRIT J HAEMATOL, V116, P475, DOI 10.1046/j.1365-2141.2002.03259.x; Masera RG, 1999, EUR J ENDOCRINOL, V140, P299, DOI 10.1530/eje.0.1400299; MENZEL F, 2002, 42 INT C ANT AG CHEM, pM858; MORRISON VA, 1994, AM J MED, V96, P497, DOI 10.1016/0002-9343(94)90088-4; MOSER M, 1995, EUR J IMMUNOL, V25, P2818, DOI 10.1002/eji.1830251016; MUKAIDA N, 1994, J BIOL CHEM, V269, P13289; MYEROWITZ RL, 1981, ARCH PATHOL LAB MED, V105, P138; NAEF M, 1994, CHIRURG, V65, P785; NG TTC, 1994, MICROBIOL-UK, V140, P2475, DOI 10.1099/13500872-140-9-2475; NietoRodriguez JA, 1996, ANN SURG, V223, P70, DOI 10.1097/00000658-199601000-00010; Nucci M, 2003, CANCER, V98, P315, DOI 10.1002/cncr.11510; Nucci M, 2002, EUR J CLIN MICROBIOL, V21, P209, DOI 10.1007/s10096-002-0697-1; ODAY DM, 1984, INVEST OPHTH VIS SCI, V25, P331; ODONNELL MR, 1994, J CLIN ONCOL, V12, P827, DOI 10.1200/JCO.1994.12.4.827; OGNIBENE FP, 1995, AM J RESP CRIT CARE, V151, P795; Ohtsuka T, 1996, J BIOL CHEM, V271, P1651, DOI 10.1074/jbc.271.3.1651; ORTH DN, 1995, NEW ENGL J MED, V332, P791, DOI 10.1056/NEJM199503233321207; Patterson J E, 1999, Transpl Infect Dis, V1, P229, DOI 10.1034/j.1399-3062.1999.010402.x; PERFECT JR, 1985, SABOURAUDIA, V23, P37; PERFECT JR, 1983, MEDICINE, V62, P98, DOI 10.1097/00005792-198303000-00003; Peter E, 2002, CLIN INFECT DIS, V35, pE54, DOI 10.1086/341971; Ponton J, 2000, MED MYCOL, V38, P225, DOI 10.1080/mmy.38.s1.225.236; PORGES AJ, 1992, J RHEUMATOL, V19, P1191; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Ray KP, 1997, BIOCHEM J, V328, P707; RECHT LD, 1982, AM REV RESPIR DIS, V125, P359; Ribaud P, 1999, CLIN INFECT DIS, V28, P322, DOI 10.1086/515116; RINEHART JJ, 1974, J CLIN INVEST, V54, P1337, DOI 10.1172/JCI107880; ROILIDES E, 1993, INFECT IMMUN, V61, P4870, DOI 10.1128/IAI.61.11.4870-4877.1993; Rossmann SN, 1996, CLIN INFECT DIS, V22, P73, DOI 10.1093/clinids/22.1.73; Ruffini E, 2001, SARCOIDOSIS VASC DIF, V18, P181; Sampathkumar P, 2001, CLIN INFECT DIS, V32, P1237, DOI 10.1086/319753; Sarlis NJ, 2000, J CLIN ENDOCR METAB, V85, P42, DOI 10.1210/jc.85.1.42; SCHAFFNER A, 1985, J CLIN INVEST, V76, P1755, DOI 10.1172/JCI112166; Sepkowitz KA, 2002, CLIN INFECT DIS, V34, P1098, DOI 10.1086/339548; SEPKOWITZ KA, 1992, JAMA-J AM MED ASSOC, V267, P832, DOI 10.1001/jama.267.6.832; Shimoyama M, 1997, INVEST OPHTH VIS SCI, V38, P2427; SLIVKA A, 1993, AM J MED, V94, P216, DOI 10.1016/0002-9343(93)90187-T; Strozik KS, 1998, PEDIATR INFECT DIS J, V17, P658, DOI 10.1097/00006454-199807000-00020; Sung JM, 2001, NEPHROL DIAL TRANSPL, V16, P2348, DOI 10.1093/ndt/16.12.2348; Torres HA, 2002, MEDICINE, V81, P201, DOI 10.1097/00005792-200205000-00004; VazquezTorres A, 1997, MICROBIOL MOL BIOL R, V61, P170; VINCENTI F, 1980, AM J MED, V69, P107, DOI 10.1016/0002-9343(80)90507-0; WAJSZCZUK CP, 1985, TRANSPLANTATION, V40, P347, DOI 10.1097/00007890-198510000-00002; Wald A, 1997, J INFECT DIS, V175, P1459, DOI 10.1086/516480; Walsh T J, 1999, Transpl Infect Dis, V1, P247, DOI 10.1034/j.1399-3062.1999.010404.x; WALZER PD, 1980, INFECT IMMUN, V27, P928, DOI 10.1128/IAI.27.3.928-937.1980; WURZBURGER MI, 1986, POSTGRAD MED J, V62, P657, DOI 10.1136/pgmj.62.729.657; Yale SH, 1996, MAYO CLIN PROC, V71, P5, DOI 10.4065/71.1.5	134	406	430	1	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1828	1838		10.1016/S0140-6736(03)14904-5	http://dx.doi.org/10.1016/S0140-6736(03)14904-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654323				2022-12-28	WOS:000186872900024
J	Lumley, JM				Lumley, JM			Unexplained antepartum stillbirth in pregnancies after a caesarean delivery	LANCET			English	Editorial Material							PLACENTAL ABRUPTION; RISK; HISTORY; PREVIA; DEATH; BIRTH		Ctr Study Mothers & Childrens Hlth, Carlton, Vic 3053, Australia		Lumley, JM (corresponding author), Ctr Study Mothers & Childrens Hlth, Carlton, Vic 3053, Australia.							Ananth CV, 1997, AM J OBSTET GYNECOL, V177, P1071, DOI 10.1016/S0002-9378(97)70017-6; Joseph KS, 2003, BMC Pregnancy Childbirth, V3, P3, DOI 10.1186/1471-2393-3-3; Lydon-Rochelle M, 2001, OBSTET GYNECOL, V97, P765, DOI 10.1016/S0029-7844(01)01121-8; Rasmussen S, 1999, PAEDIATR PERINAT EP, V13, P9; Roberts CL, 2000, BRIT MED J, V321, P137, DOI 10.1136/bmj.321.7254.137; Smith GCS, 2003, BRIT MED J, V327, P313, DOI 10.1136/bmj.327.7410.313; Smith GCS, 2002, JAMA-J AM MED ASSOC, V287, P2684, DOI 10.1001/jama.287.20.2684; YUDKIN PL, 1987, LANCET, V1, P1192	8	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 29	2003	362	9398					1774	1775		10.1016/S0140-6736(03)14938-0	http://dx.doi.org/10.1016/S0140-6736(03)14938-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654309				2022-12-28	WOS:000186872900002
J	Vokes, EE; Stenson, KM				Vokes, EE; Stenson, KM			Therapeutic options for laryngeal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; Univ Chicago, Dept Surg, Sect Otolaryngol Head & Neck Surg, Chicago, IL 60637 USA; Univ Chicago, Ctr Canc Res, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Vokes, EE (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, 5841 S Maryland Ave, Chicago, IL 60637 USA.		Vokes, Everett/Q-2146-2019						0	21	22	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2003	349	22					2087	2089		10.1056/NEJMp038171	http://dx.doi.org/10.1056/NEJMp038171			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746ZV	14645634				2022-12-28	WOS:000186779700001
J	Wehr, M; Zador, AM				Wehr, M; Zador, AM			Balanced inhibition underlies tuning and sharpens spike timing in auditory cortex	NATURE			English	Article							VISUAL CORTICAL-NEURONS; DIRECTION SELECTIVITY; RESPONSE PROPERTIES; RECEPTIVE-FIELDS; SIMPLE CELLS; IN-VIVO; CAT; INPUT; ORIENTATION; SENSITIVITY	Neurons in the primary auditory cortex are tuned to the intensity and specific frequencies of sounds, but the synaptic mechanisms underlying this tuning remain uncertain. Inhibition seems to have a functional role in the formation of cortical receptive fields, because stimuli often suppress similar or neighbouring responses(1-3), and pharmacological blockade of inhibition broadens tuning curves(4,5). Here we use whole-cell recordings in vivo to disentangle the roles of excitatory and inhibitory activity in the tone-evoked responses of single neurons in the auditory cortex. The excitatory and inhibitory receptive fields cover almost exactly the same areas, in contrast to the predictions of classical lateral inhibition models. Thus, although inhibition is typically as strong as excitation, it is not necessary to establish tuning, even in the receptive field surround. However, inhibition and excitation occurred in a precise and stereotyped temporal sequence: an initial barrage of excitatory input was rapidly quenched by inhibition, truncating the spiking response within a few (1-4) milliseconds. Balanced inhibition might thus serve to increase the temporal precision(6) and thereby reduce the randomness of cortical operation, rather than to increase noise as has been proposed previously(7).	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Zador, AM (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.			Zador, Anthony/0000-0002-8431-9136				Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; BRUGGE JF, 1969, J NEUROPHYSIOL, V32, P1005, DOI 10.1152/jn.1969.32.6.1005; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chen QC, 2000, HEARING RES, V150, P161, DOI 10.1016/S0378-5955(00)00197-0; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Covey E, 1996, J NEUROSCI, V16, P3009; De Ribaupierre F, 1972, Brain Res, V48, P185, DOI 10.1016/0006-8993(72)90178-3; DeWeese MR, 2003, J NEUROSCI, V23, P7940; HARTLINE HK, 1956, J GEN PHYSIOL, V39, P651, DOI 10.1085/jgp.39.5.651; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; MITANI A, 1985, J COMP NEUROL, V235, P417, DOI 10.1002/cne.902350402; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Ojima H, 2002, CEREB CORTEX, V12, P1079, DOI 10.1093/cercor/12.10.1079; PHILLIPS DP, 1988, J NEUROPHYSIOL, V59, P1524, DOI 10.1152/jn.1988.59.5.1524; PHILLIPS DP, 1985, HEARING RES, V18, P87, DOI 10.1016/0378-5955(85)90112-1; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; SCHULTE F J, 1969, Neuropaediatrie, V1, P36, DOI 10.1055/s-0028-1091862; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHAMMA SA, 1985, HEARING RES, V19, P1, DOI 10.1016/0378-5955(85)90094-2; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Sutter ML, 1999, J NEUROPHYSIOL, V82, P2358, DOI 10.1152/jn.1999.82.5.2358; VOLKOV IO, 1992, EXP BRAIN RES, V91, P115; Wang JA, 2002, BRAIN RES, V944, P219, DOI 10.1016/S0006-8993(02)02926-8; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796	30	975	985	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					442	446		10.1038/nature02116	http://dx.doi.org/10.1038/nature02116			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647382				2022-12-28	WOS:000186800800038
J	Ebralidze, A; Wang, Y; Petkova, V; Ebralidse, K; Junghans, RP				Ebralidze, A; Wang, Y; Petkova, V; Ebralidse, K; Junghans, RP			RNA leaching of transcription factors disrupts transcription in myotonic dystrophy	SCIENCE			English	Article							CUG-BINDING PROTEIN; CHLORIDE CHANNEL; MESSENGER-RNA; TRINUCLEOTIDE REPEAT; MUSCLE; GENE; EXPANSION; EXPRESSION; CLONING; DISEASE	Myotonic dystrophy type 1 (DM1) is caused by a CUG(n) expansion (n approximate to 50 to 5000) in the 3' untranslated region of the mRNA of the DM protein kinase gene. We show that mutant RNA binds and sequesters transcription factors (TFs), with up to 90% depletion of selected TFs from active chromatin. Diverse genes are consequently reduced in expression, including the ion transporter CIC-1, which has been implicated in myotonia. When TF specificity protein 1 (Sp1) was overexpressed in DM1-affected cells, low levels of messenger RNA for CIC-1 were restored to normal. Transcription factor leaching from chromatin by mutant RNA provides a potentially unifying pathomechanistic explanation for this disease.	Harvard Univ, Sch Med, Harvard Inst Human Genet, Biotherapeut Dev Lab, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Junghans, RP (corresponding author), Harvard Univ, Sch Med, Harvard Inst Human Genet, Biotherapeut Dev Lab, 4 Blackfan Circle, Boston, MA 02215 USA.							Bergmann E, 2001, TRENDS GENET, V17, P279, DOI 10.1016/S0168-9525(01)02280-6; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; EBRALIDZE A, UNPUB; Finsterer J, 2002, EUR J NEUROL, V9, P441, DOI 10.1046/j.1468-1331.2002.00453.x; Freiman RN, 2002, SCIENCE, V296, P2149, DOI 10.1126/science.1073845; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Junghans RP, 2001, NEUROGENETICS, V3, P59, DOI 10.1007/s100480000103; Kimura T, 2000, NEUROSCI LETT, V295, P93, DOI 10.1016/S0304-3940(00)01598-6; Le Page F, 2000, CELL, V101, P159, DOI 10.1016/S0092-8674(00)80827-2; LORENZ C, 1994, HUM MOL GENET, V3, P941, DOI 10.1093/hmg/3.6.941; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1911, DOI 10.1093/hmg/11.17.1911; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Michalowski S, 1999, NUCLEIC ACIDS RES, V27, P3534, DOI 10.1093/nar/27.17.3534; Nicolas M, 2001, J BIOL CHEM, V276, P22126, DOI 10.1074/jbc.M010740200; Ohshima K, 1996, J BIOL CHEM, V271, P16773, DOI 10.1074/jbc.271.28.16773; OTTEN AD, 1995, P NATL ACAD SCI USA, V92, P5465, DOI 10.1073/pnas.92.12.5465; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rajavel KS, 2001, MOL CELL BIOL, V21, P5512, DOI 10.1128/MCB.21.16.5512-5519.2001; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Timchenko NA, 2001, J BIOL CHEM, V276, P7820, DOI 10.1074/jbc.M005960200; VERMEULEN W, 1994, COLD SPRING HARB SYM, V59, P317, DOI 10.1101/SQB.1994.059.01.036	27	115	118	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2004	303	5656					383	387		10.1126/science.1088679	http://dx.doi.org/10.1126/science.1088679			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14657503				2022-12-28	WOS:000188111800047
J	Hahn, BH				Hahn, BH			Systemic lupus erythematosus and accelerated atherosclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hahn, BH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90024 USA.							Chan TM, 2000, NEW ENGL J MED, V343, P1156, DOI 10.1056/NEJM200010193431604; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Petri M, 1996, LANCET, V348, P1120, DOI 10.1016/S0140-6736(96)03032-2; UROWITZ MB, 1976, AM J MED, V60, P221, DOI 10.1016/0002-9343(76)90431-9	4	97	103	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					2379	2380		10.1056/NEJMp038168	http://dx.doi.org/10.1056/NEJMp038168			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681501				2022-12-28	WOS:000187326200001
J	Peipert, JF				Peipert, JF			Genital chlamydial infections	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PELVIC-INFLAMMATORY-DISEASE; TRACHOMATIS-INFECTIONS; ECTOPIC PREGNANCY; SELF-COLLECTION; HEALTH; WOMEN; ENDOMETRITIS; GONORRHEA; UPDATE; SWEDEN		Brown Univ, Women & Infants Hosp, Div Res, Providence, RI 02905 USA; Brown Univ, Sch Med, Dept Obstet & Gynecol & Community Hlth, Div Res, Providence, RI 02912 USA	Brown University; Women & Infants Hospital Rhode Island; Brown University	Peipert, JF (corresponding author), Brown Univ, Women & Infants Hosp, Div Res, 101 Dudley St, Providence, RI 02905 USA.	jpeipert@wihri.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001298] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		*AM COLL OBST GYN, 2003, HLTH CAR AD; *AM MED ASS, 1997, GUID AD PREV SERV; American Academy of Pediatrics, 2000, PEDIATRICS, V105, P645; Andrews WW, 2000, AM J OBSTET GYNECOL, V183, P662, DOI 10.1067/mob.2000.106556; Berg AO, 2001, AM J PREV MED, V20, P90, DOI 10.1016/S0749-3797(01)00254-9; Brocklehurst P, 2000, COCHRANE DB SYST REV, V2; Burstein GR, 1998, JAMA-J AM MED ASSOC, V280, P521, DOI 10.1001/jama.280.6.521; *CDCP, 2002, SEX TRANSM DIS SURV; Cecil JA, 2001, J INFECT DIS, V184, P1216, DOI 10.1086/323662; COHEN I, 1990, JAMA-J AM MED ASSOC, V263, P3160, DOI 10.1001/jama.263.23.3160; Davies HD, 1996, CAN MED ASSOC J, V154, P1631; Egger M, 1998, BRIT MED J, V316, P1776, DOI 10.1136/bmj.316.7147.1776; ENG TR, 1997, HIDDEN EPIDEMIC CONF; FARO S, 2001, INFECT DIS WOMEN, P261; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Gaydos CA, 2003, SEX TRANSM DIS, V30, P539, DOI 10.1097/00007435-200307000-00002; Gaydos CA, 1998, NEW ENGL J MED, V339, P739, DOI 10.1056/NEJM199809103391105; Gaydos Charlotte A., 2002, Curr Infect Dis Rep, V4, P148, DOI 10.1007/s11908-002-0057-4; Guaschino S, 2000, ANN NY ACAD SCI, V900, P293, DOI 10.1111/j.1749-6632.2000.tb06241.x; Hardick J, 2003, SEX TRANSM DIS, V30, P64, DOI 10.1097/00007435-200301000-00013; HERRMANN B, 1995, SEX TRANSM DIS, V22, P253, DOI 10.1097/00007435-199507000-00009; Hillis SD, 1997, AM J OBSTET GYNECOL, V176, P103, DOI 10.1016/S0002-9378(97)80020-8; HILLIS SD, 1993, AM J OBSTET GYNECOL, V168, P1503, DOI 10.1016/S0002-9378(11)90790-X; Hollblad-Fadiman K, 2003, AM J PREV MED, V24, P287, DOI 10.1016/S0749-3797(02)00636-0; Howell MR, 1999, SEX TRANSM DIS, V26, P519, DOI 10.1097/00007435-199910000-00007; Jacobson GF, 2001, AM J OBSTET GYNECOL, V184, P1352, DOI 10.1067/mob.2001.115050; Jain S, 1999, J Matern Fetal Med, V8, P130; Johnson Robert E, 2002, MMWR Recomm Rep, V51, P1; Kacmar J, 2001, Infect Dis Obstet Gynecol, V9, P197, DOI 10.1155/S1064744901000321; Kamwendo F, 1996, SEX TRANSM DIS, V23, P384, DOI 10.1097/00007435-199609000-00007; Klausner JD, 2003, SEX TRANSM DIS, V30, P509, DOI 10.1097/00007435-200306000-00007; KORN AP, 1995, OBSTET GYNECOL, V85, P387, DOI 10.1016/0029-7844(94)00400-8; LaMontagne DS, 2003, AM J PREV MED, V24, P36, DOI 10.1016/S0749-3797(02)00573-1; Low W., 1999, SEX TRANSM DIS, P407; Mardh PA, 2002, BEST PRACT RES CL OB, V16, P847, DOI 10.1053/beog.2002.0329; MARTIN DH, 1992, NEW ENGL J MED, V327, P921, DOI 10.1056/NEJM199209243271304; Ness RB, 2002, AM J OBSTET GYNECOL, V186, P929, DOI 10.1067/mob.2002.121625; Newman SB, 2003, SEX TRANSM DIS, V30, P306, DOI 10.1097/00007435-200304000-00006; Paavonen J, 1998, OBSTET GYNECOL, V92, P292, DOI 10.1016/S0029-7844(98)00167-7; Paavonen J, 1999, HUM REPROD UPDATE, V5, P433, DOI 10.1093/humupd/5.5.433; RYAN GM, 1990, AM J OBSTET GYNECOL, V162, P34, DOI 10.1016/0002-9378(90)90815-O; Schiller JH, 2003, SEMIN ONCOL, V30, P49, DOI [10.1053/sonc.2003.50032, 10.1097/00007435-200301000-00011]; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; Tobin JM, 2002, CURR OPIN INFECT DIS, V15, P31, DOI 10.1097/00001432-200202000-00006; Turner CF, 2002, JAMA-J AM MED ASSOC, V287, P726, DOI 10.1001/jama.287.6.726; Verhoeven V, 2002, SEX TRANSM DIS, V29, P426, DOI 10.1097/00007435-200207000-00012; WESTROM L, 1992, SEX TRANSM DIS, V19, P185, DOI 10.1097/00007435-199207000-00001; Wiesenfeld HC, 2002, OBSTET GYNECOL, V100, P456, DOI 10.1016/S0029-7844(02)02118-X; Wiesenfeld HC, 2001, SEX TRANSM DIS, V28, P321, DOI 10.1097/00007435-200106000-00003; 2002, MMWR RECOMM REP, V51, P30	50	267	280	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					2424	2430		10.1056/NEJMcp030542	http://dx.doi.org/10.1056/NEJMcp030542			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681509				2022-12-28	WOS:000187326200010
J	Jain, A				Jain, A			Extracts from 'BestTreatments" - Treating nicotine addiction	BRITISH MEDICAL JOURNAL			English	Article									BMJ Publishing Grp, London WC1H 9JR, England	BMJ Publishing Group Ltd	Jain, A (corresponding author), BMJ Publishing Grp, London WC1H 9JR, England.								0	22	23	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1394	1395		10.1136/bmj.327.7428.1394	http://dx.doi.org/10.1136/bmj.327.7428.1394			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670889	Green Published			2022-12-28	WOS:000187417900027
J	Lawlor, DA; Smith, GD; Ebrahim, S				Lawlor, DA; Smith, GD; Ebrahim, S			Association of insulin resistance with depression: cross sectional findings from the British women's heart and health study	BRITISH MEDICAL JOURNAL			English	Article									Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol	Lawlor, DA (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England.		Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Lawlor, Debbie A/0000-0002-6793-2262				*ER U ROTT, EUROQOL INSTRUMENT V; FRAYN K, 1995, J CLIN NUTR S, V62, pS250; Golomb BA, 2002, J CLIN EPIDEMIOL, V55, P767, DOI 10.1016/S0895-4356(02)00407-9; Lawlor DA, 2002, BRIT MED J, V325, P805, DOI 10.1136/bmj.325.7368.805; Lipsett D, 1973, LIFE SCI, V9, P215	5	86	90	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1383	1384		10.1136/bmj.327.7428.1383	http://dx.doi.org/10.1136/bmj.327.7428.1383			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670883	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000187417900022
J	Watson, RT				Watson, RT			Climate change: The political situation	SCIENCE			English	Editorial Material									World Bank, Washington, DC 20433 USA	The World Bank	Watson, RT (corresponding author), World Bank, 1818 H St NW, Washington, DC 20433 USA.								0	14	20	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1925	1926		10.1126/science.1093160	http://dx.doi.org/10.1126/science.1093160			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671293				2022-12-28	WOS:000187174000048
J	Piatelli-Palmarini, M				Piatelli-Palmarini, M			To put it simply ...	NATURE			English	Editorial Material									Univ Arizona, Dept Linguist, Tucson, AZ 85721 USA	University of Arizona	Piatelli-Palmarini, M (corresponding author), Univ Arizona, Dept Linguist, 1103 E Univ Blvd, Tucson, AZ 85721 USA.							Fodor J.A., 1998, CONCEPTS COGNITIVE S, DOI DOI 10.1093/0198236360.001.0001; Margolis E., 1999, CONCEPTS CORE READIN; Murphy G. L., 2002, BIG BOOK CONCEPTS	3	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					607	607		10.1038/426607a	http://dx.doi.org/10.1038/426607a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668839	Bronze			2022-12-28	WOS:000187132800018
J	Singer, PA; Benatar, SR; Bernstein, M; Daar, AS; Dickens, BM; MacRae, SK; Upshur, REG; Wright, L; Shaul, RZ				Singer, PA; Benatar, SR; Bernstein, M; Daar, AS; Dickens, BM; MacRae, SK; Upshur, REG; Wright, L; Shaul, RZ			Ethics and SARS: lessons from Toronto	BRITISH MEDICAL JOURNAL			English	Article									Univ Toronto, Joint Ctr Bioeth, Toronto, ON M5G 1L4, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Univ Toronto, Div Neurosurg, Toronto, ON, Canada; Univ Toronto, Fac Law, Toronto, ON M5S 1A1, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Singer, PA (corresponding author), Univ Toronto, Joint Ctr Bioeth, 88 Coll St, Toronto, ON M5G 1L4, Canada.			Upshur, Ross/0000-0003-1128-0557				Barbera J, 2001, JAMA-J AM MED ASSOC, V286, P2711, DOI 10.1001/jama.286.21.2711; Benatar SR, 2003, INT AFF, V79, P107, DOI 10.1111/1468-2346.00298; Bernstein M, 2003, CRIT CARE, V7, P269, DOI 10.1186/cc2336; BOOTH CM, IN PRESS JAMA; Maunder R, 2003, CAN MED ASSOC J, V168, P1245; Upshur REG, 2002, CAN J PUBLIC HEALTH, V93, P101, DOI 10.1007/BF03404547	6	135	141	0	17	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 6	2003	327	7427					1342	1344		10.1136/bmj.327.7427.1342	http://dx.doi.org/10.1136/bmj.327.7427.1342			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752DE	14656848	Green Published, Green Submitted			2022-12-28	WOS:000187131100026
J	Weeks, AD; Alia, G; Ononge, S; Mutungi, A; Otolorin, EO; Mirembe, FM				Weeks, AD; Alia, G; Ononge, S; Mutungi, A; Otolorin, EO; Mirembe, FM			Introducing criteria based audit into Ugandan maternity units	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Problem Maternal mortality in Uganda has remained unchanged at 500/100 000 over the past 10 years despite concerted efforts to improve the standard of maternity care. It is especially difficult to improve standards in rural areas, where there is little money for improvements. Furthermore, staff may be isolated, poorly paid, disempowered, lacking in morale, and have few skills to bring about change. Design Training programme to introduce criteria based audit into rural Uganda. Setting Makerere University Medical School, Mulago Hospital (large government teaching hospital in Kampala), and Mpigi District (rural area with 10 small health centres around a district hospital). Strategies for change Didactic teaching about criteria based audit followed by practical work in own units, with ongoing support and follow up workshops. Effects of change Improvements were seen in many standards of care. Staff showed universal enthusiasm for the training; many staff produced simple, cost-free improvements in their standard of care. Lessons learnt Teaching of criteria based audit to those providing health care in developing countries can produce low cost improvements in the standards of care. Because the method is simple and can be used to provide improvements even without new funding, it has the potential to produce sustainable and cost effective changes in the standard of health care. Follow up is needed to prevent a waning of enthusiasm with time.	Makerere Univ, Dept Obstet & Gynaecol, Kampala, Uganda; Makerere Univ, Reg Ctr Qual Hlth Care, Kampala, Uganda	Makerere University; Makerere University	Weeks, AD (corresponding author), Liverpool Womens Hosp, Dept Obstet & Gynaecol, Liverpool L8 7SS, Merseyside, England.	aweeks@liverpool.ac.uk	Sandall, Jane/D-4146-2009	Sandall, Jane/0000-0003-2000-743X; Weeks, Andrew/0000-0002-1909-337X; OTOLORIN, EMMANUEL/0000-0001-7474-0683				Graham W, 2000, B WORLD HEALTH ORGAN, V78, P614; Jahn A, 2001, STUD HLTH SERV ORGAN, V17, P229; LANDE RE, 2002, POPULATION REPORTS J, V52; *MAK I SOC RES, 2001, HUM RES DEM ASS PERS; Mathai M, 2000, MANAGING COMPLICATIO; Miller E, 1998, BRIT MED J, V316, P875, DOI 10.1136/bmj.316.7135.875; *MIN HLTH, 2001, ESS MAT NEON CAR CLI; MORREL C, 1999, CLIN AUDIT HDB; National Institute for Clinical Excellence, 2002, PRINC BEST PRACT CLI; *PRIME 2 PROJ, PERF IMPR STAG STEPS; Uganda Bureau of Statistics and ORC Macro, 2001, UG DEM HLTH SURV 200	11	16	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 6	2003	327	7427					1329	1331		10.1136/bmj.327.7427.1329	http://dx.doi.org/10.1136/bmj.327.7427.1329			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752DE	14656844	Green Submitted, Green Published			2022-12-28	WOS:000187131100022
J	Zwart, S; Rovers, MM; de Melker, RA; Hoes, AW				Zwart, S; Rovers, MM; de Melker, RA; Hoes, AW			Penicillin for acute sore throat in children: randomised, double blind trial	BRITISH MEDICAL JOURNAL			English	Article							HEMOLYTIC STREPTOCOCCAL PHARYNGITIS; IMMEDIATE; DIAGNOSIS; PLACEBO	Objective To assess the effectiveness of penicillin for three days and treatment for seven days compared with placebo in resolving symptoms in children with sore throat. Design Randomised, double blind, placebo controlled trial. Setting 43 family practices in the Netherlands. Participants 156 children aged 4-15 who had a sore throat for less than seven days and at least two of the four Centor criteria (history of fever, absence of cough, swollen tender anterior cervical lymph nodes, and tonsillar exudate). Interventions Patients were randomly assigned to penicillin for seven days, penicillin for three days followed by placebo for four days, or placebo for seven days. Main outcome measures Duration of symptoms, mean consumption of analgesics, number of days of absence from school, occurrence of streptococcal sequelae, eradication of the initial pathogen, and recurrences of sore throat after six months. Results Penicillin treatment was not more beneficial than placebo in resolving symptoms of sore throat, neither in the total group nor in the 96 children with group A streptococci. In the groups randomised to seven days of penicillin, three days of penicillin, or placebo, one, two, and eight children, respectively, experienced a streptococcal sequela. Conclusion Penicillin treatment had no beneficial effect in children with sore throat on the average duration of symptoms. Penicillin may, however, reduce streptococcal sequelae.	Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 AB Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Zwart, S (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Stratenum 6-131,POB 85060, NL-3508 AB Utrecht, Netherlands.		Rovers, Maroeska/F-2969-2014	Rovers, Maroeska/0000-0002-3095-170X				Bisno AL, 2002, CLIN INFECT DIS, V35, P113, DOI 10.1086/340949; DAGNELIE CF, 2002, NHG STANDARD ACUTE S; DELMAR C, 1992, MED J AUSTRALIA, V156, P572, DOI 10.5694/j.1326-5377.1992.tb121422.x; DELMAR CB, 2000, COCHRANE DATABASE SY; ELDAHER NT, 1991, PEDIATR INFECT DIS J, V10, P126, DOI 10.1097/00006454-199102000-00010; GERBER MA, 1990, J PEDIATR-US, V117, P853, DOI 10.1016/S0022-3476(05)80121-0; Murray P, 1999, MANUAL CLIN MICROBIO, P283; PICHICHERO ME, 1987, PEDIATR INFECT DIS J, V6, P635, DOI 10.1097/00006454-198707000-00004; Roos K, 1996, SCAND J INFECT DIS, V28, P459, DOI 10.3109/00365549609037940; *SCOTT INT GUID NE, 2001, GUID 34 MAN SOR THRO; Zwart S, 2000, SCAND J INFECT DIS, V32, P377, DOI 10.1080/003655400750044944; Zwart S, 2003, BRIT MED J, V327, P1324, DOI 10.1136/bmj.327.7427.1324; Zwart S, 2000, BRIT MED J, V320, P150, DOI 10.1136/bmj.320.7228.150	13	50	56	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 6	2003	327	7427					1324	1326		10.1136/bmj.327.7427.1324	http://dx.doi.org/10.1136/bmj.327.7427.1324			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752DE	14656841	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000187131100019
J	Ridley, AJ; Schwartz, MA; Burridge, K; Firtel, RA; Ginsberg, MH; Borisy, G; Parsons, JT; Horwitz, AR				Ridley, AJ; Schwartz, MA; Burridge, K; Firtel, RA; Ginsberg, MH; Borisy, G; Parsons, JT; Horwitz, AR			Cell migration: Integrating signals from front to back	SCIENCE			English	Review							N-WASP; NEUTROPHIL CHEMOTAXIS; ACTIN POLYMERIZATION; RAC ACTIVATION; POLARITY; ADHESION; CDC42; INTEGRINS; COMPLEX; PHOSPHORYLATION	Cell migration is a highly integrated multistep process that orchestrates embryonic morphogenesis; contributes to tissue repair and regeneration; and drives disease progression in cancer, mental retardation, atherosclerosis, and arthritis. The migrating cell is highly polarized with complex regulatory pathways that spatially and temporally integrate its component processes. This review describes the mechanisms underlying the major steps of migration and the signaling pathways that regulate them, and outlines recent advances investigating the nature of polarity in migrating cells and the pathways that establish it.	UCL Royal Free & Univ Coll Sch Med, Ludwig Inst Canc Res, London W1W 7BS, England; Univ Virginia, Sch Med, Cardiovasc Res Ctr, Dept Microbiol, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Cardiovasc Res Ctr, Dept Biomed Engn, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Mellon Prostate Canc Res Inst, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Northwestern Univ, Sch Med, Dept Cellular & Mol Biol, Chicago, IL 60611 USA	Ludwig Institute for Cancer Research; University of London; University College London; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Northwestern University	Ridley, AJ (corresponding author), UCL Royal Free & Univ Coll Sch Med, Ludwig Inst Canc Res, London W1W 7BS, England.			Borisy, Gary/0000-0002-0266-8018; Ridley, Anne/0000-0001-8186-5708; schwartz, martin/0000-0002-2071-1243				Alahari SK, 2002, INT REV CYTOL, V220, P145; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Brahmbhatt AA, 2003, J BIOL CHEM, V278, P13016, DOI 10.1074/jbc.M211873200; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Cory GOC, 2002, J BIOL CHEM, V277, P45115, DOI 10.1074/jbc.M203346200; Cory GOC, 2002, NATURE, V418, P732, DOI 10.1038/418732a; Cotran R. S., 1999, ROBBINS PATHOLOGIC B, V6th; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Evers EE, 2000, EUR J CANCER, V36, P1269, DOI 10.1016/S0959-8049(00)00091-5; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Gardiner EM, 2002, CURR BIOL, V12, P2029, DOI 10.1016/S0960-9822(02)01334-9; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gilbert S.F., 2003, DEV BIOL, V7th Edn; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; HENDEY B, 1992, SCIENCE, V258, P296, DOI 10.1126/science.1384129; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Kiosses WB, 2001, NAT CELL BIOL, V3, P316, DOI 10.1038/35060120; Knight B, 2000, CURR BIOL, V10, P576, DOI 10.1016/S0960-9822(00)00486-3; Larsen M, 2003, NAT REV MOL CELL BIO, V4, P700, DOI 10.1038/nrm1199; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2; Merlot S, 2003, J CELL SCI, V116, P3471, DOI 10.1242/jcs.00703; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Sasahara Y, 2002, MOL CELL, V10, P1269, DOI 10.1016/S1097-2765(02)00728-1; Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4; Serrador JM, 1999, TRENDS CELL BIOL, V9, P228, DOI 10.1016/S0962-8924(99)01553-6; SHATTIL SJ, 1995, THROMB HAEMOSTASIS, V74, P149; Small JV, 2003, CURR OPIN CELL BIOL, V15, P40, DOI 10.1016/S0955-0674(02)00008-X; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Suetsugu S, 2002, DEV CELL, V3, P645, DOI 10.1016/S1534-5807(02)00324-6; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tsuji T, 2002, J CELL BIOL, V157, P819, DOI 10.1083/jcb.200112107; Turner CE, 2001, CURR OPIN CELL BIOL, V13, P593, DOI 10.1016/S0955-0674(00)00256-8; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5	58	3642	3754	17	812	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2003	302	5651					1704	1709		10.1126/science.1092053	http://dx.doi.org/10.1126/science.1092053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657486	Green Submitted			2022-12-28	WOS:000186970100033
J	Andersen, JS; Wilkinson, CJ; Mayor, T; Mortensen, P; Nigg, EA; Mann, M				Andersen, JS; Wilkinson, CJ; Mayor, T; Mortensen, P; Nigg, EA; Mann, M			Proteomic characterization of the human centrosome by protein correlation profiling	NATURE			English	Article							COMPONENT; CYCLE; GENE; IDENTIFICATION; DUPLICATION; ALMS1	The centrosome is the major microtubule-organizing centre of animal cells and through its influence on the cytoskeleton is involved in cell shape, polarity and motility. It also has a crucial function in cell division because it determines the poles of the mitotic spindle that segregates duplicated chromosomes between dividing cells(1-5). Despite the importance of this organelle to cell biology and more than 100 years of study, many aspects of its function remain enigmatic and its structure and composition are still largely unknown. We performed a mass-spectrometry-based proteomic analysis of human centrosomes in the interphase of the cell cycle by quantitatively profiling hundreds of proteins across several centrifugation fractions. True centrosomal proteins were revealed by both correlation with already known centrosomal proteins and in vivo localization. We identified and validated 23 novel components and identified 41 likely candidates as well as the vast majority of the known centrosomal proteins in a large background of nonspecific proteins. Protein correlation profiling permits the analysis of any multiprotein complex that can be enriched by fractionation but not purified to homogeneity.	Univ So Denmark, Dept Biochem & Mol Biol, Ctr Expt Bioinformat, DK-5230 Odense M, Denmark; Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany	University of Southern Denmark; Max Planck Society	Nigg, EA (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Ctr Expt Bioinformat, Campusvej 55, DK-5230 Odense M, Denmark.	nigg@biochem.mpg.de; mann@bmb.sdu.dk	Andersen, Jens S/L-2100-2015; Mann, Matthias/A-3454-2013	Andersen, Jens S/0000-0002-6091-140X; Mann, Matthias/0000-0003-1292-4799; nigg, erich/0000-0003-4835-5719; Wilkinson, Christopher/0000-0002-7448-0938				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Bornens M, 1999, METHOD CELL BIOL, V61, P13; Brown CR, 1996, J BIOL CHEM, V271, P824, DOI 10.1074/jbc.271.2.824; Casenghi M, 2003, DEV CELL, V5, P113, DOI 10.1016/S1534-5807(03)00193-X; Chang P, 2000, NAT CELL BIOL, V2, P30, DOI 10.1038/71350; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Collin GB, 2002, NAT GENET, V31, P74, DOI 10.1038/ng867; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Gascard P, 1998, BLOOD, V92, P4404, DOI 10.1182/blood.V92.11.4404.423k50_4404_4414; Gergely F, 2000, P NATL ACAD SCI USA, V97, P14352, DOI 10.1073/pnas.97.26.14352; Hearn T, 2002, NAT GENET, V31, P79, DOI 10.1038/ng874; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; KELLOGG DR, 1994, ANNU REV BIOCHEM, V63, P639, DOI 10.1146/annurev.bi.63.070194.003231; Kenedy AA, 2003, GENE, V303, P35, DOI 10.1016/S0378-1119(02)01141-1; Kilmartin JV, 2003, J CELL BIOL, V162, P1211, DOI 10.1083/jcb.200307064; KLOTZ C, 1990, J CELL BIOL, V110, P405, DOI 10.1083/jcb.110.2.405; Lamond AI, 1997, TRENDS CELL BIOL, V7, P139, DOI 10.1016/S0962-8924(97)01031-3; Lange BMH, 2000, EMBO J, V19, P1252, DOI 10.1093/emboj/19.6.1252; Mayor T, 2000, J CELL BIOL, V151, P837, DOI 10.1083/jcb.151.4.837; Nakagawa Y, 2001, MOL BIOL CELL, V12, P1687, DOI 10.1091/mbc.12.6.1687; Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924; Ohta T, 2002, J CELL BIOL, V156, P87, DOI 10.1083/jcb.200108088; Pfannenschmid F, 2003, J CELL SCI, V116, P1449, DOI 10.1242/jcs.00337; Pietromonaco SF, 1996, BLOOD CELL MOL DIS, V22, P225, DOI 10.1006/bcmd.1996.0103; Popovici C, 1999, BLOOD, V93, P1381, DOI 10.1182/blood.V93.4.1381.404k30_1381_1389; Rieder CL, 2001, TRENDS CELL BIOL, V11, P413, DOI 10.1016/S0962-8924(01)02085-2; Romio L, 2003, J AM SOC NEPHROL, V14, P680, DOI 10.1097/01.ASN.0000054497.48394.D2; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; Yang J, 2002, J CELL BIOL, V159, P431, DOI 10.1083/jcb.200207153	30	1012	1070	3	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					570	574		10.1038/nature02166	http://dx.doi.org/10.1038/nature02166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654843				2022-12-28	WOS:000186944300042
J	Saleska, SR; Miller, SD; Matross, DM; Goulden, ML; Wofsy, SC; da Rocha, HR; de Camargo, PB; Crill, P; Daube, BC; de Freitas, HC; Hutyra, L; Keller, M; Kirchhoff, V; Menton, M; Munger, JW; Pyle, EH; Rice, AH; Silva, H				Saleska, SR; Miller, SD; Matross, DM; Goulden, ML; Wofsy, SC; da Rocha, HR; de Camargo, PB; Crill, P; Daube, BC; de Freitas, HC; Hutyra, L; Keller, M; Kirchhoff, V; Menton, M; Munger, JW; Pyle, EH; Rice, AH; Silva, H			Carbon in amazon forests: Unexpected seasonal fluxes and disturbance-induced losses	SCIENCE			English	Article							TROPICAL FORESTS; RAIN-FOREST; EL-NINO; DIOXIDE UPTAKE; CLIMATE; DYNAMICS; STORAGE; TREE; CO2; VARIABILITY	The net ecosystem exchange of carbon dioxide was measured by eddy covariance methods for 3 years in two old-growth forest sites near Santarem, Brazil. Carbon was lost in the wet season and gained in the dry season, which was opposite to the seasonal cycles of both tree growth and model predictions. The 3-year average carbon loss was 1.3 (confidence interval: 0.0 to 2.0) megagrams of carbon per hectare per year. Biometric observations confirmed the net loss but imply that it is a transient effect of recent disturbance superimposed on long-term balance. Given that episodic disturbances are characteristic of old-growth forests, it is likely that carbon sequestration is lower than has been inferred from recent eddy covariance studies at undisturbed sites.	Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; Univ Sao Paulo, Dept Atmospher Sci, BR-05508900 Sao Paulo, Brazil; Univ Sao Paulo, Ctr Energia Nucl Agr, BR-13416000 Piracicaba, Brazil; Univ New Hampshire, Complex Syst Res Ctr, Durham, NH 03824 USA; US Forest Serv, USDA, Int Inst Trop Forestry, San Juan, PR 00926 USA; INPE, BR-12227010 Sao Paulo, Brazil	Harvard University; University of California System; University of California Irvine; Universidade de Sao Paulo; Universidade de Sao Paulo; University System Of New Hampshire; University of New Hampshire; United States Department of Agriculture (USDA); United States Forest Service; Instituto Nacional de Pesquisas Espaciais (INPE)	Saleska, SR (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	saleska@fas.harvard.edu	Silva, Hudson/D-1564-2013; Keller, Michael/A-8976-2012; Crill, Patrick/ABC-1357-2021; Munger, J William/H-4502-2013; Saleska, Scott R/K-1733-2016; Goulden, Michael L/B-9934-2008; de Camargo, Plínio B./D-6635-2012; Freitas, Helber Custódio/D-3293-2012; Mitchard, Edward T A/C-6346-2009	Keller, Michael/0000-0002-0253-3359; Munger, J William/0000-0002-1042-8452; Saleska, Scott R/0000-0002-4974-3628; de Camargo, Plínio B./0000-0002-0696-3778; Mitchard, Edward T A/0000-0002-5690-4055; Goulden, Michael/0000-0002-9379-3948; Crill, Patrick/0000-0003-1110-3059; Menton, Mary/0000-0002-9892-2657				Andreae MO, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000524; Araujo AC, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000676; Botta A, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013607; Carswell FE, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000284; Clark DA, 2002, ECOL APPL, V12, P3, DOI 10.1890/1051-0761(2002)012[0003:ATFAIC]2.0.CO;2; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; DENNING AS, 1995, NATURE, V376, P240, DOI 10.1038/376240a0; GOULDEN ML, IN PRESS ECOL APPL; Grace J, 1996, GLOBAL CHANGE BIOL, V2, P209, DOI 10.1111/j.1365-2486.1996.tb00073.x; GRACE J, 1995, SCIENCE, V270, P778, DOI 10.1126/science.270.5237.778; Grace J, 2002, NATURE, V416, P594, DOI 10.1038/416594b; Gurney KR, 2002, NATURE, V415, P626, DOI 10.1038/415626a; Keeling RF, 2002, P NATL ACAD SCI USA, V99, P7848, DOI 10.1073/pnas.122154899; Keller M, 1996, SCIENCE, V273, P201, DOI 10.1126/science.273.5272.201; Korner C, 2003, SCIENCE, V300, P1242, DOI 10.1126/science.1084460; KRUIJT B, IN PRESS ECOL APPL; Lee XH, 1998, AGR FOREST METEOROL, V91, P39, DOI 10.1016/S0168-1923(98)00071-9; MAHLI Y, 1998, J GEOPHYS RES, V103, P31593, DOI DOI 10.1029/98JD02647; Malhi Y, 2002, J VEG SCI, V13, P439, DOI 10.1111/j.1654-1103.2002.tb02068.x; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; MARTENS C, IN PRESS GLOB CHANGE; McPhaden MJ, 1999, NATURE, V398, P559, DOI 10.1038/19193; MILLER SD, IN PRESS ECOL APPL; Moorcroft PR, 2001, ECOL MONOGR, V71, P557, DOI 10.1890/0012-9615(2001)071[0557:AMFSVD]2.0.CO;2; NEPSTAD DC, 1994, NATURE, V372, P666, DOI 10.1038/372666a0; Nepstad DC, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000360; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Phillips OL, 2002, ECOL APPL, V12, P576, DOI 10.1890/1051-0761(2002)012[0576:CIGOTF]2.0.CO;2; PHILLIPS OL, 1994, SCIENCE, V263, P954, DOI 10.1126/science.263.5149.954; Potter C, 2001, J GEOPHYS RES-ATMOS, V106, P10423, DOI 10.1029/2000JD900563; Prentice IC, 1998, NATURE, V396, P619, DOI 10.1038/25224; RICE AH, IN PRESS ECOL APPL; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; ROCHA HR, IN PRESS ECOL APPL; Ropelewski CF, 1989, J CLIMATE, V2, P268, DOI 10.1175/1520-0442(1989)002<0268:PPAWTH>2.0.CO;2; Sakai RK, 2001, J APPL METEOROL, V40, P2178, DOI 10.1175/1520-0450(2001)040<2178:IOLFCT>2.0.CO;2; Savage KE, 2001, GLOBAL BIOGEOCHEM CY, V15, P337, DOI 10.1029/1999GB001248; SCOTT RL, IN PRESS AGR FOR MET; Sheil D, 2003, TRENDS ECOL EVOL, V18, P18, DOI 10.1016/S0169-5347(02)00005-8; Telles EDC, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001953; Tian H, 2000, GLOBAL ECOL BIOGEOGR, V9, P315, DOI 10.1046/j.1365-2699.2000.00198.x; Tian HQ, 1998, NATURE, V396, P664, DOI 10.1038/25328; Trenberth KE, 1997, GEOPHYS RES LETT, V24, P3057, DOI 10.1029/97GL03092; Williamson GB, 2000, CONSERV BIOL, V14, P1538, DOI 10.1046/j.1523-1739.2000.99298.x	45	518	543	2	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1554	1557		10.1126/science.1091165	http://dx.doi.org/10.1126/science.1091165			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645845	Green Submitted			2022-12-28	WOS:000186802200040
J	Benkova, E; Michniewicz, M; Sauer, M; Teichmann, T; Seifertova, D; Jurgens, G; Friml, J				Benkova, E; Michniewicz, M; Sauer, M; Teichmann, T; Seifertova, D; Jurgens, G; Friml, J			Local, efflux-dependent auxin gradients as a common module for plant organ formation	CELL			English	Article							LATERAL ROOT INITIATION; GNOM ARF-GEF; ARABIDOPSIS-THALIANA; OVULE DEVELOPMENT; POLAR TRANSPORT; GENE; GRAVITROPISM; LOCALIZATION; ORGANIZATION; EXPRESSION	Plants, compared to animals, exhibit an amazing adaptability and plasticity in their development. This is largely dependent on the ability of plants to form new organs, such as lateral roots, leaves, and flowers during postembryonic development. Organ primordia develop from founder cell populations into organs by coordinated cell division and differentiation. Here, we show that organ formation in Arabidopsis involves dynamic gradients of the signaling molecule auxin with maxima at the primordia tips. These gradients are mediated by cellular efflux requiring asymmetrically localized PIN proteins, which represent a functionally redundant network for auxin distribution in both aerial and underground organs. PIN1 polar localization undergoes a dynamic rearrangement, which correlates with establishment of auxin gradients and primordiurn development. Our results suggest that PIN-dependent, local auxin gradients represent a common module for formation of all plant organs, regardless of their mature morphology or developmental origin.	Univ Tubingen, Zentrum Molekularbiol Pflanzen, D-72076 Tubingen, Germany; Max Planck Gesell, Max Delbruck Lab, D-50829 Cologne, Germany; ASCR, Inst Biophys, Brno, Czech Republic	Eberhard Karls University of Tubingen; Max Planck Society; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences	Benkova, E (corresponding author), Univ Tubingen, Zentrum Molekularbiol Pflanzen, Morgenstelle 1, D-72076 Tubingen, Germany.		Benkova, Eva/E-2910-2012; Sauer, Michael/F-6519-2014; Friml, Jiri/D-9511-2012; Sauer, Michael/G-3424-2011	Sauer, Michael/0000-0002-4014-9825; Friml, Jiri/0000-0002-8302-7596; 				Barlier I, 2000, P NATL ACAD SCI USA, V97, P14819, DOI 10.1073/pnas.260502697; BLAKELY LM, 1979, PLANT SCI LETT, V14, P79, DOI 10.1016/0304-4211(79)90158-5; Cadigan KM, 2002, SEMIN CELL DEV BIOL, V13, P83, DOI 10.1016/S1084-9521(02)00014-9; Caruso John L., 1995, P433; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Dubrovsky JG, 2000, PLANT PHYSIOL, V124, P1648, DOI 10.1104/pp.124.4.1648; Elliott RC, 1996, PLANT CELL, V8, P155, DOI 10.1105/tpc.8.2.155; Esau K., 1977, ANATOMY SEED PLANTS; FERREIRA PCG, 1994, PLANT CELL, V6, P1763, DOI 10.1105/tpc.6.12.1763; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2003, PLANT J, V34, P115, DOI 10.1046/j.1365-313X.2003.01705.x; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; FRIML J., 2003, PLANT BIOLOGY, V6, P7; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; GELDNER N, 2003, IN PRESS DEVELOPMENT; Gross-Hardt R, 2002, GENE DEV, V16, P1129, DOI 10.1101/gad.225202; Haseloff J, 1999, METHOD CELL BIOL, V58, P139; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; LASKOWSKI MJ, 1995, DEVELOPMENT, V121, P3303; Lomax Terri L., 1995, P509; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Maves L, 1999, CURR TOP DEV BIOL, V43, P115; MAYER U, 1991, NATURE, V353, P402, DOI 10.1038/353402a0; MAYER U, 1993, DEVELOPMENT, V117, P149; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Nemhauser JL, 2000, DEVELOPMENT, V127, P3877; Oka M, 1999, PLANT CELL PHYSIOL, V40, P231, DOI 10.1093/oxfordjournals.pcp.a029532; OKADA K, 1991, PLANT CELL, V3, P677, DOI 10.1105/tpc.3.7.677; Reinhardt D, 2000, PLANT CELL, V12, P507, DOI 10.1105/tpc.12.4.507; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vroemen CW, 2003, PLANT CELL, V15, P1563, DOI 10.1105/tpc.012203	39	1845	1940	30	520	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 26	2003	115	5					591	602		10.1016/S0092-8674(03)00924-3	http://dx.doi.org/10.1016/S0092-8674(03)00924-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651850	Bronze			2022-12-28	WOS:000186885600009
J	Nambu, Y; Sugai, M; Gonda, H; Lee, CG; Katakai, T; Agata, Y; Yokota, Y; Shimizu, A				Nambu, Y; Sugai, M; Gonda, H; Lee, CG; Katakai, T; Agata, Y; Yokota, Y; Shimizu, A			Transcription-coupled events associating with immunoglobulin switch region chromatin	SCIENCE			English	Article							RNA EDITING ENZYME; ANTIBODY DIVERSIFICATION; V(D)J RECOMBINATION; ACCESSIBILITY CONTROL; HISTONE ACETYLATION; DNA DEAMINATION; AID; MECHANISM; INTERLEUKIN-4; HYPERMUTATION	Class switch recombination (CSR) at the antibody immunoglobulin locus is regulated by germline transcription (GLT) - coupled modi. cations in the accessibility of the switch region, where CSR takes place. Here we show that histone acetylation of switch regions is linked to CSR but that histone acetylation cannot alone promote CSR or GLT. Activation-induced cytidine deaminase (AID) specifically associates with the CSR target chromatin in a GLT-coupled manner, which may occur potentially by means of physical interaction between AID and the transcription machinery. These data indicate an important role of GLT in the regulation of chromatin accessibility, strongly suggesting that the target of AID is chromatin DNA. Our results give insights on the role of AID and the regulatory mechanism of CSR.	Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ Hosp, Translat Res Ctr, Sakyo Ku, Kyoto 068507, Japan; Alton Ochsner Med Fdn & Ochsner Clin, Cellular Immunol Lab, New Orleans, LA 70121 USA; Fukui Med Univ, Dept Biochem, Fukui 9101193, Japan	Kyoto University; Kyoto University; Ochsner Health System; University of Fukui	Sugai, M (corresponding author), Kyoto Univ, Ctr Mol Biol & Genet, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.		Katakai, Tomoya/AAX-1434-2021	Agata, Yasutoshi/0000-0001-9642-6994; Sugai, Manabu/0000-0003-1668-7647; Katakai, Tomoya/0000-0002-4290-7028; Nambu, Yukiko/0000-0001-6030-4530				Agata Y, 2001, J EXP MED, V193, P873, DOI 10.1084/jem.193.7.873; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; GAUCHAT JF, 1992, INT IMMUNOL, V4, P397, DOI 10.1093/intimm/4.3.397; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hempel WM, 1998, ADV IMMUNOL, V69, P309, DOI 10.1016/S0065-2776(08)60610-0; Hesslein DGT, 2001, ADV IMMUNOL, V78, P169, DOI 10.1016/S0065-2776(01)78004-2; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lee CG, 2001, J EXP MED, V194, P365, DOI 10.1084/jem.194.3.365; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Martin A, 2002, NAT REV IMMUNOL, V2, P605, DOI 10.1038/nri858; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; NAMBU Y, UNPUB; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Schlissel M S, 1997, Semin Immunol, V9, P161, DOI 10.1006/smim.1997.0066; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183; Sugai M, 2003, NAT IMMUNOL, V4, P25, DOI 10.1038/ni874; Sugai M, 1998, NUCLEIC ACIDS RES, V26, P911, DOI 10.1093/nar/26.4.911; Tripathi R, 2002, J IMMUNOL, V168, P2316, DOI 10.4049/jimmunol.168.5.2316; van Ginkel FW, 1999, J IMMUNOL, V163, P1951; Ye SK, 2001, IMMUNITY, V15, P813, DOI 10.1016/S1074-7613(01)00230-8; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	28	212	215	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2137	2140		10.1126/science.1092481	http://dx.doi.org/10.1126/science.1092481			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684824				2022-12-28	WOS:000187385200049
J	Deeks, SG				Deeks, SG			Treatment of anti retroviral-drug-resistant HIV-1 infection	LANCET			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; PROTEASE INHIBITOR THERAPY; REVERSE-TRANSCRIPTASE INHIBITORS; DYNAMICS IN-VIVO; VIROLOGICAL FAILURE; VIRAL LOAD; HIV-1-INFECTED PATIENTS; REPLICATIVE FITNESS; LOPINAVIR-RITONAVIR	Drug-resistant HIV-1 is a cause of growing clinical and public-health concern. In many patients, combination antiretroviral therapy fails to achieve complete viral suppression (virological failure). Continuing viral replication during therapy leads to the accumulation of drug-resistance mutations, resulting in increased viral load and a greater risk of disease progression. Patients with drug-resistant HIV-1 infection have three therapeutic options: a change to a salvage regimen with the aim of fully suppressing viral replication; interruption of therapy; or continuation of a partially effective regimen. The first strategy is preferred for most patients failing their first or perhaps their second regimen. However, the best approach remains unclear for patients who have failed multiple treatment regimens and who have limited options for complete viral suppression. The management of such patients requires a careful understanding of the pathogenesis of drug-resistant HIV-1, the clinical consequences of virological failure, the potential benefits and limitations of diagnostic assays, and the likelihood that agents in development will be effective.	San Francisco Gen Hosp, San Francisco, CA 94110 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Deeks, SG (corresponding author), San Francisco Gen Hosp, 995 Potrero Ave, San Francisco, CA 94110 USA.	sdeeks@php.ucsf.edu			NIAID NIH HHS [AI55273, R01 AI052745] Funding Source: Medline; NIMH NIH HHS [P30 MH59037] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH059037] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albrecht MA, 2001, NEW ENGL J MED, V345, P398, DOI 10.1056/NEJM200108093450602; Aweeka F, 1999, J ACQ IMMUN DEF SYND, V20, P39, DOI 10.1097/00042560-199901010-00006; Back NKT, 1996, EMBO J, V15, P4040, DOI 10.1002/j.1460-2075.1996.tb00777.x; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Barbour JD, 2002, J VIROL, V76, P11104, DOI 10.1128/JVI.76.21.11104-11112.2002; Benson CA, 2002, J INFECT DIS, V185, P599, DOI 10.1086/339014; Brown AJL, 2003, J INFECT DIS, V187, P683, DOI 10.1086/367989; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; DAQUILA RT, 2002, TOPICS HIV MED, V10, P11; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Deeks SG, 2002, AIDS, V16, P201, DOI 10.1097/00002030-200201250-00009; Deeks SG, 2000, J INFECT DIS, V181, P946, DOI 10.1086/315334; Deeks SG, 2002, J INFECT DIS, V185, P315, DOI 10.1086/338467; Deeks SG, 1999, AIDS, V13, pF35, DOI 10.1097/00002030-199904160-00001; DeGruttola V, 2000, ANTIVIR THER, V5, P41; Demeter LM, 2001, ANN INTERN MED, V135, P954, DOI 10.7326/0003-4819-135-11-200112040-00007; Descamps D, 2000, JAMA-J AM MED ASSOC, V283, P205, DOI 10.1001/jama.283.2.205; Devereux HL, 1999, AIDS, V13, pF123, DOI 10.1097/00002030-199912240-00001; Devereux HL, 2001, J MED VIROL, V65, P218, DOI 10.1002/jmv.2023; Durant J, 2000, AIDS, V14, P1333, DOI 10.1097/00002030-200007070-00005; Duval X, 2002, ANTIMICROB AGENTS CH, V46, P570, DOI 10.1128/AAC.46.2.570-574.2002; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Fellay J, 2001, LANCET, V358, P1322, DOI 10.1016/S0140-6736(01)06413-3; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Fletcher CV, 2000, AIDS, V14, P2495, DOI 10.1097/00002030-200011100-00011; Goudsmit J, 1997, J VIROL, V71, P4479, DOI 10.1128/JVI.71.6.4479-4484.1997; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Gulick RM, 1998, JAMA-J AM MED ASSOC, V280, P35, DOI 10.1001/jama.280.1.35; Gulick RM, 2000, J INFECT DIS, V182, P1375, DOI 10.1086/315867; Gunthard HF, 1999, J VIROL, V73, P9404; Hall CS, 1999, AIDS, V13, P1207, DOI 10.1097/00002030-199907090-00009; Hammer SM, 2002, JAMA-J AM MED ASSOC, V288, P169, DOI 10.1001/jama.288.2.169; Harrigan PR, 2002, ANTIMICROB AGENTS CH, V46, P909, DOI 10.1128/AAC.46.3.909-912.2002; Haubrich RH, 2002, AIDS, V16, pF33, DOI 10.1097/00002030-200210180-00001; Havlir DV, 2001, JAMA-J AM MED ASSOC, V286, P171, DOI 10.1001/jama.286.2.171; Havlir DV, 2000, JAMA-J AM MED ASSOC, V283, P229, DOI 10.1001/jama.283.2.229; Havlir DV, 2000, J INFECT DIS, V182, P321, DOI 10.1086/315683; Henry K, 2001, J INFECT DIS, V183, P571, DOI 10.1086/318527; Hermankova M, 2001, JAMA-J AM MED ASSOC, V286, P196, DOI 10.1001/jama.286.2.196; Hirsch MS, 2000, JAMA-J AM MED ASSOC, V283, P2417, DOI 10.1001/jama.283.18.2417; Hsu A, 2003, ANTIMICROB AGENTS CH, V47, P350, DOI 10.1128/AAC.47.1.350-359.2003; Izopet J, 2000, AIDS, V14, P2247, DOI 10.1097/00002030-200010200-00005; Jackson JB, 2000, AIDS, V14, pF111, DOI 10.1097/00002030-200007280-00001; Katlama C, 2001, HIV Med, V2, P27, DOI 10.1046/j.1468-1293.2001.00043.x; Katlama C, 2003, 10 C RETR OPP INF BO; Kemper CA, 2001, AIDS, V15, P609, DOI 10.1097/00002030-200103300-00010; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lampe FC, 2003, AIDS, V17, P768, DOI 10.1097/00002030-200303280-00021; LAWRENCE J, 2003, 10 C RETR OPP INF BO; Le Moing V, 2002, J INFECT DIS, V185, P471, DOI 10.1086/338929; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Martinez-Picado J, 2000, P NATL ACAD SCI USA, V97, P10948, DOI 10.1073/pnas.97.20.10948; Martinez-Picado J, 1999, J VIROL, V73, P3744, DOI 10.1128/JVI.73.5.3744-3752.1999; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Miller V, 2000, AIDS, V14, P2857, DOI 10.1097/00002030-200012220-00007; Mocroft A, 1998, AIDS, V12, P2161, DOI 10.1097/00002030-199816000-00011; Mocroft A, 2001, AIDS, V15, P201, DOI 10.1097/00002030-200101260-00009; Mocroft A, 2000, AIDS, V14, P1545, DOI 10.1097/00002030-200007280-00010; Montaner J, 2001, LANCET, V357, P1438, DOI 10.1016/S0140-6736(00)04577-3; Montaner JSG, 2001, AIDS, V15, P61, DOI 10.1097/00002030-200101050-00010; Nieuwkerk PT, 2001, ARCH INTERN MED, V161, P1962, DOI 10.1001/archinte.161.16.1962; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; Opravil M, 2002, J INFECT DIS, V185, P1251, DOI 10.1086/340312; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Phillips AN, 2001, JAMA-J AM MED ASSOC, V286, P2560, DOI 10.1001/jama.286.20.2560; Piketty C, 2001, J INFECT DIS, V183, P1328, DOI 10.1086/319861; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; RICHMAN DD, 2001, 41 INT C ANT AG CHEM; Saah AJ, 2003, J INFECT DIS, V187, P1157, DOI 10.1086/368287; Schooley RT, 2002, AIDS, V16, P1257, DOI 10.1097/00002030-200206140-00008; Shulman N, 2002, ANTIMICROB AGENTS CH, V46, P3907, DOI 10.1128/AAC.46.12.3907-3916.2002; Shulman NS, 2002, JAIDS-J ACQ IMM DEF, V31, P121, DOI 10.1097/00126334-200210010-00001; Sklar PA, 2002, AIDS, V16, P2035, DOI 10.1097/00002030-200210180-00008; Solas C, 2003, ANTIMICROB AGENTS CH, V47, P238, DOI 10.1128/AAC.47.1.238-243.2003; Stoddart CA, 2001, NAT MED, V7, P712, DOI 10.1038/89090; Stuart JWTC, 2001, J ACQ IMMUN DEF SYND, V28, P105, DOI 10.1097/00042560-200110010-00001; Tebas P, 1999, AIDS, V13, pF23, DOI 10.1097/00002030-199902040-00002; Walmsley S, 2002, NEW ENGL J MED, V346, P2039, DOI 10.1056/NEJMoa012354; Wu TD, 2003, J VIROL, V77, P4836, DOI 10.1128/JVI.77.8.4836-4847.2003; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222; Yerly S, 2001, AIDS, V15, P2287, DOI 10.1097/00002030-200111230-00010; Youle M, 2002, J ACQ IMMUN DEF SYND, V29, P58, DOI 10.1097/00126334-200201010-00008; Zolopa AR, 1999, ANN INTERN MED, V131, P813, DOI 10.7326/0003-4819-131-11-199912070-00003	90	163	171	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2003	362	9400					2002	2011		10.1016/S0140-6736(03)15022-2	http://dx.doi.org/10.1016/S0140-6736(03)15022-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683662				2022-12-28	WOS:000187210700024
J	Clark, AG; Glanowski, S; Nielsen, R; Thomas, PD; Kejariwal, A; Todd, MA; Tanenbaum, DM; Civello, D; Lu, F; Murphy, B; Ferriera, S; Wang, G; Zheng, XG; White, TJ; Sninsky, JJ; Adams, MD; Cargill, M				Clark, AG; Glanowski, S; Nielsen, R; Thomas, PD; Kejariwal, A; Todd, MA; Tanenbaum, DM; Civello, D; Lu, F; Murphy, B; Ferriera, S; Wang, G; Zheng, XG; White, TJ; Sninsky, JJ; Adams, MD; Cargill, M			Inferring nonneutral evolution from human-chimp-mouse orthologous gene trios	SCIENCE			English	Article							NUCLEOTIDE SUBSTITUTION; DNA-SEQUENCES; SELECTION; FAMILY; RATES	Even though human and chimpanzee gene sequences are nearly 99% identical, sequence comparisons can nevertheless be highly informative in identifying biologically important changes that have occurred since our ancestral lineages diverged. We analyzed alignments of 7645 chimpanzee gene sequences to their human and mouse orthologs. These three-species sequence alignments allowed us to identify genes undergoing natural selection along the human and chimp lineage by fitting models that include parameters specifying rates of synonymous and nonsynonymous nucleotide substitution. This evolutionary approach revealed an informative set of genes with significantly different patterns of substitution on the human lineage compared with the chimpanzee and mouse lineages. Partitions of genes into inferred biological classes identified accelerated evolution in several functional classes, including olfaction and nuclear transport. In addition to suggesting adaptive physiological differences between chimps and humans, human-accelerated genes are significantly more likely to underlie major known Mendelian disorders.	Celera Diagnost, Alameda, CA 94502 USA; Cornell Univ, Ithaca, NY 14853 USA; Appl Biosyst Inc, Rockville, MD 20850 USA; Celera Genom, Prot Informat, Foster City, CA 94404 USA; Celera Genom, Rockville, MD 20850 USA	Cornell University; Thermo Fisher Scientific; Applied Biosystems	Cargill, M (corresponding author), Celera Diagnost, 1401 Harbor Bay Pkwy, Alameda, CA 94502 USA.	michele_cargill@celeradiagnostics.com	Nielsen, Rasmus/D-4405-2009	Nielsen, Rasmus/0000-0003-0513-6591; Thomas, Paul/0000-0002-9074-3507; Hubisz, Melissa/0000-0002-9561-6830; Clark, Andrew/0000-0001-7159-8511				Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Freund HR, 2002, NUTRITION, V18, P287, DOI 10.1016/S0899-9007(01)00740-7; Gadkar S, 2002, BIOL REPROD, V67, P1327, DOI 10.1095/biolreprod67.4.1327; Gilad Y, 2003, AM J HUM GENET, V73, P489, DOI 10.1086/378132; Gilad Y, 2003, P NATL ACAD SCI USA, V100, P3324, DOI 10.1073/pnas.0535697100; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Hellmann I, 2003, GENOME RES, V13, P831, DOI 10.1101/gr.944903; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; Naz S, 2003, J MED GENET, V40, P360, DOI 10.1136/jmg.40.5.360; Sakate R, 2003, GENOME RES, V13, P1022, DOI 10.1101/gr.783103; Satta Y, 2000, MOL PHYLOGENET EVOL, V14, P259, DOI 10.1006/mpev.2000.0704; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1998, J MOL EVOL, V46, P409, DOI 10.1007/PL00006320	23	500	520	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1960	1963		10.1126/science.1088821	http://dx.doi.org/10.1126/science.1088821			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671302				2022-12-28	WOS:000187174000059
J	Antia, R; Regoes, RR; Koella, JC; Bergstrom, CT				Antia, R; Regoes, RR; Koella, JC; Bergstrom, CT			The role of evolution in the emergence of infectious diseases	NATURE			English	Article							TRANSMISSION DYNAMICS; NIPAH VIRUS; MONKEYPOX; HEALTH; SARS; OUTBREAK	It is unclear when, where and how novel pathogens such as human immunodeficiency virus ( HIV), monkeypox and severe acute respiratory syndrome ( SARS) will cross the barriers that separate their natural reservoirs from human populations and ignite the epidemic spread of novel infectious diseases. New pathogens are believed to emerge from animal reservoirs when ecological changes increase the pathogen's opportunities to enter the human population(1) and to generate subsequent human- to-human transmission(2). Effective human- to- human transmission requires that the pathogen's basic reproductive number, R-0, should exceed one, where R-0 is the average number of secondary infections arising from one infected individual in a completely susceptible population(3). However, an increase in R-0, even when insufficient to generate an epidemic, nonetheless increases the number of subsequently infected individuals. Here we show that, as a consequence of this, the probability of pathogen evolution to R-0 > 1 and subsequent disease emergence can increase markedly.	Emory Univ, Dept Biol, Atlanta, GA 30322 USA; Univ Paris 06, Lab Parasitol Evolut, F-75252 Paris, France; Univ Washington, Dept Biol, Seattle, WA 98195 USA	Emory University; UDICE-French Research Universities; Sorbonne Universite; University of Washington; University of Washington Seattle	Antia, R (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	rantia@emory.edu	Bergstrom, Carl T./H-2299-2011; Regoes, Roland R/A-6538-2008	Bergstrom, Carl T./0000-0002-2070-385X; Regoes, Roland R/0000-0001-8319-5293				ANDERSON R M, 1991; Athreya KB, 1972, BRANCHING PROCESSES; Breman JG, 1998, NEW ENGL J MED, V339, P556, DOI 10.1056/NEJM199808203390811; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Cyranoski D, 2003, NATURE, V423, P467, DOI 10.1038/423467a; DEMETRIUS L, 1985, B MATH BIOL, V47, P239; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Elton C. S., 1958, ECOLOGY INVASIONS AN; Enserink M, 2000, SCIENCE, V289, P518, DOI 10.1126/science.289.5479.518; Enserink M, 1999, SCIENCE, V284, P407, DOI 10.1126/science.284.5413.407; Enserink M, 2003, SCIENCE, V300, P1351; FINE PEM, 1988, INT J EPIDEMIOL, V17, P643, DOI 10.1093/ije/17.3.643; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Heymann DL, 1998, BRIT MED BULL, V54, P693, DOI 10.1093/oxfordjournals.bmb.a011720; Holmes EC, 2001, BIOL REV, V76, P239, DOI 10.1017/S1464793101005668; Hutin YJF, 2001, EMERG INFECT DIS, V7, P434; KORNBERG H, 1987, QUANTITATIVE BIOL EC; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lloyd AL, 1996, J THEOR BIOL, V179, P1, DOI 10.1006/jtbi.1996.0042; May RM, 2001, PHILOS T R SOC B, V356, P901, DOI 10.1098/rstb.2001.0866; MAY RM, 1990, PARASITOLOGY, V100, pS89, DOI 10.1017/S0031182000073042; Peeters M, 2002, EMERG INFECT DIS, V8, P451, DOI 10.3201/eid0805.010522; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; SCHRAG SJ, 1995, TRENDS ECOL EVOL, V10, P319, DOI 10.1016/S0169-5347(00)89118-1; Stivers DN, 1996, MATH BIOSCI, V137, P25, DOI 10.1016/S0025-5564(96)00066-1; WALLACE B, 1989, AM NAT, V133, P578, DOI 10.1086/284937; Wilke CO, 2003, GENETICS, V163, P467; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	29	347	351	7	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					658	661		10.1038/nature02104	http://dx.doi.org/10.1038/nature02104			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668863	Green Published, Green Submitted			2022-12-28	WOS:000187132800040
J	Gore, J				Gore, J			Out of the shadows - MRI and the Nobel Prize	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	14	14	2	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					2290	2292		10.1056/NEJMp038193	http://dx.doi.org/10.1056/NEJMp038193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668454				2022-12-28	WOS:000187125000004
J	Lee, JS; Chandraratna, PAN				Lee, JS; Chandraratna, PAN			Peripheral embolism from an aortic-arch atheroma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, San Francisco, CA 94143 USA; Long Beach Vet Affairs Med Ctr, Long Beach, CA 90822 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	Lee, JS (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.								0	5	6	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					E23	E23		10.1056/ENEJMicm010740	http://dx.doi.org/10.1056/ENEJMicm010740			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668474				2022-12-28	WOS:000187125000010
J	Solomon, P; Bout, PV; Carilli, C; Guelin, M				Solomon, P; Bout, PV; Carilli, C; Guelin, M			The essential signature of a massive starburst in a distant quasar	NATURE			English	Article							CLOVERLEAF QUASAR; ULTRALUMINOUS GALAXIES; INFRARED GALAXIES; REDSHIFT; EMISSION; DISK; GAS	Observations of carbon monoxide emission in high- redshift ( z > 2) galaxies indicate the presence of large amounts of molecular gas. Many of these galaxies contain an active galactic nucleus powered by accretion of gas onto a supermassive black hole, and a key question is whether their extremely high infrared luminosities result from the active galactic nucleus, from bursts of massive star formation ( associated with the molecular gas), or both. In the Milky Way, high- mass stars form in the dense cores of interstellar molecular clouds, where gas densities are n(H-2) > 10(5) cm(-3) ( refs 1, 2). Recent surveys show that virtually all galactic sites of high- mass star formation have similarly high densities(3). The bulk of the cloud material traced by CO observations, however, is at a much lower density. For galaxies in the local Universe, the HCN molecule is an effective tracer of highdensity molecular gas(4). Here we report observations of HCN emission from the infrared- luminous ' Cloverleaf ' quasar ( at a redshift z = 2.5579). The HCN line luminosity indicates the presence of 10 billion solar masses of very dense gas, an essential feature of an immense starburst, which contributes, together with the active galactic nucleus it harbours, to its high infrared luminosity.	SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; Natl Radio Astron Observ, Charlottesville, VA 22903 USA; Natl Radio Astron Observ, Socorro, NM 87801 USA; Inst Radioastron Millimetr, F-38406 St Martin Dheres, France	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Radio Astronomy Observatory (NRAO); National Radio Astronomy Observatory (NRAO)	Solomon, P (corresponding author), SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA.							BARVAINIS R, 1994, NATURE, V371, P586, DOI 10.1038/371586a0; Barvainis R, 1997, ASTROPHYS J, V484, P695, DOI 10.1086/304382; Carilli CL, 2003, SCIENCE, V300, P773, DOI 10.1126/science.1082600; Downes D, 1998, ASTROPHYS J, V507, P615, DOI 10.1086/306339; GAO Y, UNPUB ASTROPHYS J; Granato GL, 1996, ASTROPHYS J, V460, pL11, DOI 10.1086/309977; Kneib JP, 1998, ASTRON ASTROPHYS, V329, P827; PENZIAS AA, 1971, ASTROPHYS J, V168, pL53, DOI 10.1086/180784; Plume R, 1997, ASTROPHYS J, V476, P730, DOI 10.1086/303654; SOLOMON PM, 1971, ASTROPHYS J, V168, pL107, DOI 10.1086/180794; SOLOMON PM, 1992, ASTROPHYS J, V387, pL55, DOI 10.1086/186304; Solomon PM, 1997, ASTROPHYS J, V478, P144, DOI 10.1086/303765; Venturini S, 2003, ASTROPHYS J, V590, P740, DOI 10.1086/375050; WEISS A, UNPUB ASTRON ASTROPH	14	75	75	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					636	638		10.1038/nature02149	http://dx.doi.org/10.1038/nature02149			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668856	Green Submitted			2022-12-28	WOS:000187132800033
J	Falcini, F; Vierucci, S; Giani, T; Cimaz, R; Simonini, G				Falcini, F; Vierucci, S; Giani, T; Cimaz, R; Simonini, G			A girl with a sore ear	LANCET			English	Editorial Material							ARTHRITIS		Dept Paediat, Rheumatol Unit, I-50132 Florence, Italy; Univ Florence, Dept Orthodont, I-50121 Florence, Italy; Ist Clin Perfezionamento, Milan, Italy	University of Florence; University of Florence	Falcini, F (corresponding author), Dept Paediat, Rheumatol Unit, I-50132 Florence, Italy.		CIMAZ, Rolando/AAA-9058-2019; SIMONINI, Gabriele/K-2647-2018	CIMAZ, Rolando/0000-0002-3260-4226; SIMONINI, Gabriele/0000-0002-5919-4861				Martini G, 2001, J RHEUMATOL, V28, P1689; Pedersen TK, 2001, J RHEUMATOL, V28, P2109; RONCHEZEL MV, 1995, J RHEUMATOL, V22, P1956; Svensson B, 2001, INT J ORAL MAX SURG, V30, P300, DOI 10.1054/ijom.2001.0058	4	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1894	1894		10.1016/S0140-6736(03)14961-6	http://dx.doi.org/10.1016/S0140-6736(03)14961-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667747				2022-12-28	WOS:000187011600011
J	Domcke, W; Sobolewski, AL				Domcke, W; Sobolewski, AL			Chemistry - Unraveling the molecular mechanisms of photoacidity	SCIENCE			English	Editorial Material							PROTON-TRANSFER; HYDROGEN DETACHMENT; CLUSTERS; WATER; PHENOL		Tech Univ Munich, Inst Phys & Theoret Chem, D-85747 Garching, Germany; Polish Acad Sci, Inst Phys, PL-02668 Warsaw, Poland	Technical University of Munich; Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences	Domcke, W (corresponding author), Tech Univ Munich, Inst Phys & Theoret Chem, D-85747 Garching, Germany.		Domcke, Wolfgang/C-1179-2010; Sobolewski, Andrzej L/K-8868-2016	Sobolewski, Andrzej L./0000-0001-5718-489X				David O, 2002, INT REV PHYS CHEM, V21, P499, DOI 10.1080/01442350210164287; EIGEN M, 1964, ANGEW CHEM INT EDIT, V3, P1, DOI 10.1002/anie.196400011; Marx D, 1999, NATURE, V397, P601, DOI 10.1038/17579; Rini M, 2003, SCIENCE, V301, P349, DOI 10.1126/science.1085762; Sobolewski AL, 2002, PHYS CHEM CHEM PHYS, V4, P1093, DOI 10.1039/b110941n; Sobolewski AL, 2001, J PHYS CHEM A, V105, P9275, DOI 10.1021/jp011260l; SYAGE JA, 1994, Z PHYS D ATOM MOL CL, V30, P1, DOI 10.1007/BF01437471; Tanner C, 2003, SCIENCE, V302, P1736, DOI 10.1126/science.1091708; WELLER A, 1961, PROG REACT KINET MEC, V1, P187; Zwier TS, 1996, ANNU REV PHYS CHEM, V47, P205, DOI 10.1146/annurev.physchem.47.1.205	10	140	148	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1693	1694		10.1126/science.1093081	http://dx.doi.org/10.1126/science.1093081			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657482				2022-12-28	WOS:000186970100029
J	Thomas, CP				Thomas, CP			Incentive-based formularies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02254 USA	Brandeis University	Thomas, CP (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02254 USA.		Thomas, Cindy Parks/L-3204-2015	Thomas, Cindy Parks/0000-0001-5855-1196					0	9	10	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2003	349	23					2186	2188		10.1056/NEJMp038172	http://dx.doi.org/10.1056/NEJMp038172			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LH	14657424				2022-12-28	WOS:000186921700003
J	Velev, OD; Prevo, BG; Bhatt, KH				Velev, OD; Prevo, BG; Bhatt, KH			On-chip manipulation of free droplets	NATURE			English	Editorial Material							ELECTROWETTING-BASED ACTUATION; LIQUID DROPLETS; PARTICLES; SURFACE		N Carolina State Univ, Dept Chem Engn, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Velev, OD (corresponding author), N Carolina State Univ, Dept Chem Engn, Raleigh, NC 27695 USA.		Velev, Orlin D/A-2853-2008	Velev, Orlin D/0000-0003-0473-8056				CHAUDHURY MK, 1992, SCIENCE, V256, P1539, DOI 10.1126/science.256.5063.1539; Cho SK, 2003, J MICROELECTROMECH S, V12, P70, DOI 10.1109/JMEMS.2002.807467; Daniel S, 2001, SCIENCE, V291, P633, DOI 10.1126/science.291.5504.633; DANTET S, 2002, LANGMUIR, V18, P3404; Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868; FUHR G, 1994, NATURWISSENSCHAFTEN, V81, P528; Ichimura K, 2000, SCIENCE, V288, P1624, DOI 10.1126/science.288.5471.1624; Jones TB, 2001, J APPL PHYS, V89, P1441, DOI 10.1063/1.1332799; Lee SW, 2000, J AM CHEM SOC, V122, P5395, DOI 10.1021/ja994076a; Pollack MG, 2000, APPL PHYS LETT, V77, P1725, DOI 10.1063/1.1308534; Rosslee C, 2000, CURR OPIN COLLOID IN, V5, P81, DOI 10.1016/S1359-0294(00)00035-2; Velev OD, 2000, SCIENCE, V287, P2240, DOI 10.1126/science.287.5461.2240; Washizu M, 1998, IEEE T IND APPL, V34, P732, DOI 10.1109/28.703965	13	282	322	4	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2003	426	6966					515	516		10.1038/426515a	http://dx.doi.org/10.1038/426515a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654830				2022-12-28	WOS:000186944300027
J	Sakaguchi, N; Takahashi, T; Hata, H; Nomura, T; Tagami, T; Yamazaki, S; Sakihama, T; Matsurtani, T; Negishi, I; Nakatsuru, S; Sakaguchi, S				Sakaguchi, N; Takahashi, T; Hata, H; Nomura, T; Tagami, T; Yamazaki, S; Sakihama, T; Matsurtani, T; Negishi, I; Nakatsuru, S; Sakaguchi, S			Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice	NATURE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TCR-ZETA-CHAIN; RHEUMATOID-ARTHRITIS; TYROSINE KINASE; TRANSGENIC MICE; RECEPTOR; DISEASE; THYMOCYTES; ANTIGEN	Rheumatoid arthritis (RA), which afflicts about 1% of the world population, is a chronic systemic inflammatory disease of unknown aetiology that primarily affects the synovial membranes of multiple joints(1-3). Although CD4+ T cells seem to be the prime mediators of RA, it remains unclear how arthritogenic CD4(+) T cells are generated and activated(1-3). Given that highly self-reactive T-cell clones are deleted during normal T-cell development in the thymus, abnormality in T-cell selection has been suspected as one cause of autoimmune disease(4,5). Here we show that a spontaneous point mutation of the gene encoding an SH2 domain of ZAP-70, a key signal transduction molecule in T cells(6), causes chronic autoimmune arthritis in mice that resembles human RA in many aspects. Altered signal transduction from T-cell antigen receptor through the aberrant ZAP-70 changes the thresholds of T cells to thymic selection, leading to the positive selection of otherwise negatively selected autoimmune T cells. Thymic production of arthritogenic T cells due to a genetically determined selection shift of the T-cell repertoire towards high self-reactivity might also be crucial to the development of disease in a subset of patients with RA.	Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan; RIKEN, Immunopathol Lab, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan; Shionogi Inst Med Sci, Dept Immunol, Osaka 5660022, Japan; Gunma Univ Hosp, Dept Dermatol, Maebashi, Gumma 3718511, Japan	Kyoto University; RIKEN; Shionogi & Company Limited; Gunma University	Sakaguchi, S (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan.		Sakaguchi, Shimon/C-9535-2009; Tagami, Takashi/HGA-3038-2022	Tagami, Takashi/0000-0001-6953-1932				Atsumi T, 2002, J EXP MED, V196, P979, DOI 10.1084/jem.20020619; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Dayer JM, 1999, ARTHRITIS RES, V1, P17, DOI 10.1186/ar5; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Firestein G.S, 1997, TXB RHEUMATOLOGY, P851; Harris ED, 1997, RHEUMATOID ARTHRITIS; Horai R, 2000, J EXP MED, V191, P313, DOI 10.1084/jem.191.2.313; Itoh M, 1999, J IMMUNOL, V162, P5317; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Nambiar MP, 2001, ARTHRITIS RHEUM, V44, P1336, DOI 10.1002/1529-0131(200106)44:6<1336::AID-ART226>3.0.CO;2-8; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Noraz N, 2000, J BIOL CHEM, V275, P15832, DOI 10.1074/jbc.M908568199; PALS ST, 1985, J IMMUNOL, V134, P1475; Rincon M, 2001, CURR OPIN IMMUNOL, V13, P339, DOI 10.1016/S0952-7915(00)00224-7; SAKAGUCHI S, 1990, J EXP MED, V172, P537, DOI 10.1084/jem.172.2.537; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Takeuchi T, 1998, INT IMMUNOL, V10, P911, DOI 10.1093/intimm/10.7.911; van Oers NSC, 2000, NAT IMMUNOL, V1, P322, DOI 10.1038/79774; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Wiest DL, 1997, IMMUNITY, V6, P663, DOI 10.1016/S1074-7613(00)80442-2; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	30	610	645	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					454	460		10.1038/nature02119	http://dx.doi.org/10.1038/nature02119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647385				2022-12-28	WOS:000186800800041
J	Scanu, AM				Scanu, AM			Lp(a) lipoprotein - Coping with heterogeneity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Chicago, Dept Med, Lipoprot Study Unit, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Scanu, AM (corresponding author), Univ Chicago, Dept Med, Lipoprot Study Unit, 5841 S Maryland Ave, Chicago, IL 60637 USA.							Scanu Angelo M, 2003, Curr Atheroscler Rep, V5, P106, DOI 10.1007/s11883-003-0081-3	1	31	35	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2003	349	22					2089	2090		10.1056/NEJMp038128	http://dx.doi.org/10.1056/NEJMp038128			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746ZV	14645635				2022-12-28	WOS:000186779700002
J	Silberberg, J; Wlodarczyk, J				Silberberg, J; Wlodarczyk, J			Australia versus New Zealand: an emotional meta-analysis of rugby	BRITISH MEDICAL JOURNAL			English	Article									Univ Newcastle, Sch Med & Populat Hlth, Newcastle, NSW 2300, Australia; John Wlodarczyck Consulting Serv, New Lambton, NSW 2305, Australia	University of Newcastle	Silberberg, J (corresponding author), Univ Newcastle, Sch Med & Populat Hlth, 92 Scott St, Newcastle, NSW 2300, Australia.							Sigwart U, 2003, LANCET, V362, P1088, DOI 10.1016/S0140-6736(03)14496-0; THOMAS G, 1998, AUSTR RUGBY ALMANAC	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1475	1475		10.1136/bmj.327.7429.1475	http://dx.doi.org/10.1136/bmj.327.7429.1475			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684657	Green Published			2022-12-28	WOS:000187562700028
J	Meyers, CD; Carr, MC; Park, S; Brunzell, JD				Meyers, CD; Carr, MC; Park, S; Brunzell, JD			Varying cost and free nicotinic acid content in over-the-counter niacin preparations for dyslipidemia	ANNALS OF INTERNAL MEDICINE			English	Article							SUSTAINED-RELEASE NIACIN; FULMINANT HEPATIC-FAILURE; CORONARY-ARTERY-DISEASE; LIPOPROTEIN LP(A); SERUM-CHOLESTEROL; MESO-INOSITOL; EFFICACY; SAFETY; THERAPY; NIASPAN	Background: Nicotinic acid is an effective treatment for dyslipidemia, but the content of over-the-counter niacin is not federally regulated. As a result, patients may use preparations of over-the-counter niacin that do not contain free nicotinic acid. Objective: To characterize the types, costs, and free nicotinic acid content of over-the-counter niacin preparations and to review literature on the use of over-the-counter niacin for dyslipidemia. Data Sources: Commonly used over-the-counter niacin preparations (500-mg tablets or capsules) from the 3 categories of immediate-release, sustained-release, and no-flush were purchased at health food stores and pharmacies and from Internet-based vitamin companies. Pertinent literature on the use of over-the-counter niacin was obtained by. searching PubMed. Measurements: For each preparation studied, the monthly cost of therapy (at 2000 mg/d) and the free nicotinic acid content (quantified by high-performance liquid chromatography) were reported. Data Synthesis: On average, immediate-release niacin preparations cost $7.10 per month, sustained-release preparations cost $9.75 per month, and no-flush preparations cost $21.70 per month. The average content of free nicotinic acid was 520.4 mg for immediate-release niacin, 502.6 mg for sustained-release niacin, and 0 for no-flush niacin. Conclusions: No-flush preparations of over-the-counter niacin contain no free nicotinic acid and should not be used to treat dyslipidemia. Over-the-counter sustained-release niacin contains free nicotinic acid, but some brands are hepatotoxic. Immediate-release niacin contains free nicotinic acid and is the least expensive form of over-the-counter niacin.	Univ Washington, Sch Med, Seattle, WA USA	University of Washington; University of Washington Seattle	Meyers, CD (corresponding author), Vet Affairs Med Ctr, 5901 E 7th St 11-111I, Long Beach, CA 90822 USA.	daniel.meyers@med.va.gov			NCRR NIH HHS [K23 RR16067] Funding Source: Medline; NHLBI NIH HHS [HL30086] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR016067] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030086] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABOUELENEIN AM, 1983, NUTR REP INT, V28, P899; AGUSTI R, 1978, REV INVEST CLIN, V30, P327; ALDERMAN JD, 1989, AM J CARDIOL, V64, P725, DOI 10.1016/0002-9149(89)90754-6; ALTSCHUL R, 1955, ARCH BIOCHEM BIOPHYS, V54, P558, DOI 10.1016/0003-9861(55)90070-9; Altschul R, 1964, NIACIN VASCULAR DISO; [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360; Aronov DM, 1996, ARCH FAM MED, V5, P567, DOI 10.1001/archfami.5.10.567; Azen SP, 1996, CIRCULATION, V93, P34, DOI 10.1161/01.CIR.93.1.34; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; BROWN G, 1990, NEW ENGL J MED, V323, P1289, DOI 10.1056/NEJM199011083231901; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; Capuzzi D M, 2000, Curr Atheroscler Rep, V2, P64, DOI 10.1007/s11883-000-0096-y; Capuzzi DM, 1998, AM J CARDIOL, V82, p74U, DOI 10.1016/S0002-9149(98)00731-0; CARLSON LA, 1989, J INTERN MED, V226, P271, DOI 10.1111/j.1365-2796.1989.tb01393.x; CARLSON LA, 1968, ACTA MED SCAND, V183, P423; Chojnowska-Jezierska J, 1998, INT J CLIN PHARM TH, V36, P326; Cohn G, 2001, Curr Cardiol Rep, V3, P416; DALTON TA, 1992, AM J MED, V93, P102, DOI 10.1016/0002-9343(92)90689-9; Elam MB, 2000, JAMA-J AM MED ASSOC, V284, P1263, DOI 10.1001/jama.284.10.1263; ETCHASON JA, 1991, MAYO CLIN PROC, V66, P23, DOI 10.1016/S0025-6196(12)61171-9; FISCHER DJ, 1991, WESTERN J MED, V155, P410; GAUT ZN, 1971, METABOLISM, V20, P1031, DOI 10.1016/0026-0495(71)90026-6; GIBBONS LW, 1995, AM J MED, V99, P378, DOI 10.1016/S0002-9343(99)80185-5; GRAY DR, 1994, ANN INTERN MED, V121, P252, DOI 10.7326/0003-4819-121-4-199408150-00003; Grundy SM, 2002, ARCH INTERN MED, V162, P1568, DOI 10.1001/archinte.162.14.1568; GURAKAR A, 1985, ATHEROSCLEROSIS, V57, P293, DOI 10.1016/0021-9150(85)90041-3; HARTHON J G, 1964, Arzneimittelforschung, V14, P1170; HARTHON L, 1979, ARZNEIMITTEL-FORSCH, V29-2, P1859; HENKIN Y, 1991, AM J MED, V91, P239, DOI 10.1016/0002-9343(91)90122-E; *I MED US STAND CO, 2000, PAN FOL OTH B VIT CH; KAHN SE, 1989, DIABETES, V38, P562, DOI 10.2337/diabetes.38.5.562; KEENAN JM, 1991, ARCH INTERN MED, V151, P1424, DOI 10.1001/archinte.151.7.1424; Knopp RH, 1998, METABOLISM, V47, P1097, DOI 10.1016/S0026-0495(98)90284-0; KNOPP RH, 1985, METABOLISM, V34, P642, DOI 10.1016/0026-0495(85)90092-7; KRUSE W, 1979, EUR J CLIN PHARMACOL, V16, P11, DOI 10.1007/BF00644960; MCKENNEY JM, 1994, JAMA-J AM MED ASSOC, V271, P672, DOI 10.1001/jama.271.9.672; MIYAUCHI Y, 1993, INT J VITAM NUTR RES, V63, P145; MULLIN GE, 1989, ANN INTERN MED, V111, P253, DOI 10.7326/0003-4819-111-3-253; PARSONS WB, 1961, ARCH INTERN MED, V107, P653, DOI 10.1001/archinte.1961.03620050019003; RADER JI, 1992, AM J MED, V92, P77, DOI 10.1016/0002-9343(92)90018-7; SHEPHERD J, 1979, J CLIN INVEST, V63, P858, DOI 10.1172/JCI109385; SIFTON DW, 2002, DRUG TOPICS RED BOOK; SOMMER H, 1965, ARZNEI-FORSCHUNG, V15, P1337; Spies TD, 1938, J AMER MED ASSOC, V110, P622, DOI 10.1001/jama.1938.02790090004002; SVEDMYR N, 1969, CLIN PHARMACOL THER, V10, P559; WAHLBERG G, 1990, J INTERN MED, V228, P151, DOI 10.1111/j.1365-2796.1990.tb00209.x; Ziliotto G R, 1977, Arch Sci Med (Torino), V134, P359; 1998, ALTERN MED REV, V3, P222	48	46	54	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2003	139	12					996	1002		10.7326/0003-4819-139-12-200312160-00009	http://dx.doi.org/10.7326/0003-4819-139-12-200312160-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756AG	14678919				2022-12-28	WOS:000187443200005
J	Thomas, S; Byford, S				Thomas, S; Byford, S			Research with unaccompanied children seeking asylum	BRITISH MEDICAL JOURNAL			English	Article									Kings Coll London, Inst Psychiat, Hlth Serv Res Dept, Sect Cultural Psychiat PO 25, London SE5 8AF, England; Inst Psychiat, Ctr Econ Mental Hlth, London, England	University of London; King's College London; University of London; King's College London	Thomas, S (corresponding author), Kings Coll London, Inst Psychiat, Hlth Serv Res Dept, Sect Cultural Psychiat PO 25, London SE5 8AF, England.	samantha.thomas@iop.kcl.ac.uk	Byford, Sarah/D-1699-2010	Byford, Sarah/0000-0001-7084-1495; Thomas, Samantha/0000-0003-1427-7775				HEATH T, 2002, IMMIGRATION RES STAT; Leaning J, 2001, LANCET, V357, P1432, DOI 10.1016/S0140-6736(00)04572-4; *NAT CHILDR BUR, GUID RES; RAFTERY J, 1997, AUST J DISASTER TRAU, P2; *ROYAL COLL PAED C, 2000, ARCH DIS CHILD, V82, P77	5	17	17	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1400	1402		10.1136/bmj.327.7428.1400	http://dx.doi.org/10.1136/bmj.327.7428.1400			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670893	Green Published			2022-12-28	WOS:000187417900031
J	Dimitrov, DS				Dimitrov, DS			The secret life of ACE2 as a receptor for the SARS virus	CELL			English	Editorial Material							FUNCTIONAL-CHARACTERIZATION; CORONAVIRUS	The membrane-associated carboxypeptidase angiotensin-converting enzyme 2 (ACE2) is an essential regulator of heart function. Now, Li at al. identify and characterize an unexpected second function of ACE2 as a partner of the SARS-CoV spike glycoprotein in mediating virus entry and cell fusion.	NIH, NCI Frederick, CCR, LECB,Human Immunovirol & Computat Biol Grp, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Dimitrov, DS (corresponding author), NIH, NCI Frederick, CCR, LECB,Human Immunovirol & Computat Biol Grp, Ft Detrick, MD 21702 USA.							Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Breslin JJ, 2003, J VIROL, V77, P4435, DOI 10.1128/JVI.77.7.4435-4438.2003; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Xiao XD, 2003, BIOCHEM BIOPH RES CO, V312, P1159, DOI 10.1016/j.bbrc.2003.11.054; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0	8	101	107	1	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 12	2003	115	6					652	653		10.1016/S0092-8674(03)00976-0	http://dx.doi.org/10.1016/S0092-8674(03)00976-0			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675530	Green Published, Bronze			2022-12-28	WOS:000187366100005
J	Chavarria, JA; Malin, P; Catchings, RD; Shalev, E				Chavarria, JA; Malin, P; Catchings, RD; Shalev, E			A look inside the San Andreas fault at Parkfield through vertical seismic profiling	SCIENCE			English	Article							VELOCITY STRUCTURE; CALIFORNIA; SCATTERING; WAVES	The San Andreas Fault Observatory at Depth pilot hole is located on the southwestern side of the Parkfield San Andreas fault. This observatory includes a vertical seismic pro. ling (VSP) array. VSP seismograms from nearby microearthquakes contain signals between the P and S waves. These signals may be P and S waves scattered by the local geologic structure. The collected scattering points form planar surfaces that we interpret as the San Andreas fault and four other secondary faults. The scattering process includes conversions between P and S waves, the strengths of which suggest large contrasts in material properties, possibly indicating the presence of cracks or fluids.	Duke Univ, Nicholas Sch Environm & Earth Sci, Div Earth & Ocean Sci, Durham, NC 27708 USA; US Geol Survey, Menlo Pk, CA 94025 USA	Duke University; United States Department of the Interior; United States Geological Survey	Chavarria, JA (corresponding author), Duke Univ, Nicholas Sch Environm & Earth Sci, Div Earth & Ocean Sci, Durham, NC 27708 USA.			Catchings, Rufus/0000-0002-5191-6102				AKI K, 1992, B SEISMOL SOC AM, V82, P1969; DIBBLEE TR, 1980, STUDIES SAN ANDREAS, P3; EBERHARTPHILLIPS D, 1993, J GEOPHYS RES-SOL EA, V98, P15737, DOI 10.1029/93JB01029; HICKMAN S, COMMUNICATION; Hole JA, 2001, SCIENCE, V294, P1513, DOI 10.1126/science.1065100; HU LZ, 1986, GEOPHYS PROSPECT, V34, P704, DOI 10.1111/j.1365-2478.1986.tb00489.x; LEES JM, 1990, J GEOPHYS RES-SOLID, V95, P21793, DOI 10.1029/JB095iB13p21793; Li YG, 1997, B SEISMOL SOC AM, V87, P210; LOUIE JN, 1988, GEOPHYSICS, V53, P176, DOI 10.1190/1.1442452; MALIN PE, 1985, GEOPHYS J ROY ASTR S, V80, P603, DOI 10.1111/j.1365-246X.1985.tb05113.x; MICHELINI A, 1991, B SEISMOL SOC AM, V81, P524; Page B.M., 1981, GEOTECTONIC DEV CALI, P329; Shalev E, 1998, B SEISMOL SOC AM, V88, P256; THURBER C, 2003, GEOPHYS RES LETT, V30; TSE ST, 1985, B SEISMOL SOC AM, V75, P709; UM J, 1987, B SEISMOL SOC AM, V77, P717; Unsworth MJ, 1997, GEOLOGY, V25, P359, DOI 10.1130/0091-7613(1997)025<0359:ISOTSA>2.3.CO;2	17	40	49	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1746	1748		10.1126/science.1090711	http://dx.doi.org/10.1126/science.1090711			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657494				2022-12-28	WOS:000186970100042
J	Osteryoung, KW; Nunnari, J				Osteryoung, KW; Nunnari, J			The division of endosymbiotic organelles	SCIENCE			English	Review							DYNAMIN-LIKE PROTEIN; REGULATES MITOCHONDRIAL FISSION; CYANOBACTERIAL CELL-DIVISION; ESCHERICHIA-COLI-FTSZ; RATE-LIMITING STEP; WD REPEAT PROTEIN; CHLOROPLAST DIVISION; PLASTID DIVISION; SACCHAROMYCES-CEREVISIAE; VESICLE FORMATION		Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cellular Biol, Davis, CA 95616 USA	Michigan State University; University of California System; University of California Davis	Osteryoung, KW (corresponding author), Michigan State Univ, Dept Plant Biol, 166 Plant Biol Bldg, E Lansing, MI 48824 USA.				NIGMS NIH HHS [R01GM62942A] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062942] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen JF, 2003, PHILOS T R SOC B, V358, P19, DOI 10.1098/rstb.2002.1191; Arimura S, 2002, P NATL ACAD SCI USA, V99, P5727, DOI 10.1073/pnas.082663299; Beech PL, 2000, SCIENCE, V287, P1276, DOI 10.1126/science.287.5456.1276; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Buchanan B. B., 2002, BIOCH MOL BIOL PLANT; Cerveny KL, 2003, MOL BIOL CELL, V14, P4126, DOI 10.1091/mbc.E03-02-0092; Cerveny KL, 2001, MOL BIOL CELL, V12, P309, DOI 10.1091/mbc.12.2.309; Colletti KS, 2000, CURR BIOL, V10, P507, DOI 10.1016/S0960-9822(00)00466-8; El-Shami M, 2002, MOL GENET GENOMICS, V267, P254, DOI 10.1007/s00438-002-0660-y; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fekkes P, 2000, J CELL BIOL, V151, P333, DOI 10.1083/jcb.151.2.333; Fujiwara M, 2001, BIOCHEM BIOPH RES CO, V287, P462, DOI 10.1006/bbrc.2001.5588; Fukushima NH, 2001, MOL BIOL CELL, V12, P2756, DOI 10.1091/mbc.12.9.2756; Fulgosi H, 2002, P NATL ACAD SCI USA, V99, P11501, DOI 10.1073/pnas.172032599; Gaikwad A, 2000, MOL GEN GENET, V263, P213, DOI 10.1007/s004380051162; Gao HB, 2003, P NATL ACAD SCI USA, V100, P4328, DOI 10.1073/pnas.0530206100; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; GILSON PR, IN PRESS CELL; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Griparic L, 2001, TRAFFIC, V2, P235, DOI 10.1034/j.1600-0854.2001.1r008.x; Hashimoto H, 2003, INT REV CYTOL, V222, P63; Hinshaw JE, 1999, CURR OPIN STRUC BIOL, V9, P260, DOI 10.1016/S0959-440X(99)80036-0; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; Huttner WB, 2000, CURR OPIN NEUROBIOL, V10, P543, DOI 10.1016/S0959-4388(00)00126-4; Itoh R, 2001, PLANT PHYSIOL, V127, P1644, DOI 10.1104/pp.010386; Jakobs S, 2003, J CELL SCI, V116, P2005, DOI 10.1242/jcs.00423; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Jeong WJ, 2002, PLANT PHYSIOL, V129, P112, DOI 10.1104/pp.000588; Kiessling J, 2000, J CELL BIOL, V151, P945, DOI 10.1083/jcb.151.4.945; Koksharova OA, 2002, J BACTERIOL, V184, P5524, DOI 10.1128/JB.184.19.5524-5528.2002; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; LEECH RM, 1986, PLASTICITY PLANTS, P121; Legesse-Miller A, 2003, MOL BIOL CELL, V14, P1953, DOI 10.1091/mbc.E02-10-0657; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Maple J, 2002, PLANT J, V31, P269, DOI 10.1046/j.1365-313X.2002.01358.x; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Marrison JL, 1999, PLANT J, V18, P651, DOI 10.1046/j.1365-313x.1999.00500.x; Marti M, 2003, J BIOL CHEM, V278, P24837, DOI 10.1074/jbc.M302082200; Martin W, 1998, PLANT PHYSIOL, V118, P9, DOI 10.1104/pp.118.1.9; Martin W, 2001, BIOL CHEM, V382, P1521, DOI 10.1515/BC.2001.187; MCANDREW R, UNPUB; McAndrew RS, 2001, PLANT PHYSIOL, V127, P1656, DOI 10.1104/pp.010542; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; McFadden GI, 2001, J PHYCOL, V37, P951, DOI 10.1046/j.1529-8817.2001.01126.x; Miyagishima S, 2003, PLANT CELL, V15, P655, DOI 10.1105/tpc.009373; Miyagishima SY, 2003, TRENDS PLANT SCI, V8, P432, DOI 10.1016/S1360-1385(03)00193-6; Miyagishima SY, 2001, PLANT CELL, V13, P2257, DOI 10.1105/tpc.010185; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Newmyer SL, 2003, DEV CELL, V4, P929, DOI 10.1016/S1534-5807(03)00157-6; Nishida K, 2003, P NATL ACAD SCI USA, V100, P2146, DOI 10.1073/pnas.0436886100; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; NUNNARI J, UNPUB; OHASHI W, UNPUB; Osteryoung KW, 1998, PLANT CELL, V10, P1991, DOI 10.1105/tpc.10.12.1991; OSTERYOUNG KW, 1995, NATURE, V376, P473, DOI 10.1038/376473b0; Osteryoung KW, 2001, CURR OPIN MICROBIOL, V4, P639, DOI 10.1016/S1369-5274(01)00263-6; Osteryoung KW, 2001, ANNU REV PLANT PHYS, V52, P315, DOI 10.1146/annurev.arplant.52.1.315; Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; RUBE D, 2003, 14 INT C EL C 29 JUN; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Sesaki H, 1999, J CELL BIOL, V147, P699, DOI 10.1083/jcb.147.4.699; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Sever S, 2002, CURR OPIN CELL BIOL, V14, P463, DOI 10.1016/S0955-0674(02)00347-2; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stokes KD, 2003, GENE, V320, P97, DOI 10.1016/S0378-1119(03)00814-X; Stokes KD, 2000, PLANT PHYSIOL, V124, P1668, DOI 10.1104/pp.124.4.1668; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Strepp R, 1998, P NATL ACAD SCI USA, V95, P4368, DOI 10.1073/pnas.95.8.4368; TAKAHARA M, 2000, MOL GEN GENET, V7, P245; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; Tieu Q, 2002, J CELL BIOL, V158, P445, DOI 10.1083/jcb.200205031; van den Ent F, 2001, CURR OPIN MICROBIOL, V4, P634, DOI 10.1016/S1369-5274(01)00262-4; van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1; VATER CA, 1992, J CELL BIOL, V119, P773, DOI 10.1083/jcb.119.4.773; Vitha S, 2003, PLANT CELL, V15, P1918, DOI 10.1105/tpc.013292; Vitha S, 2001, J CELL BIOL, V153, P111, DOI 10.1083/jcb.153.1.111; Walter S, 2002, ANGEW CHEM INT EDIT, V41, P1098, DOI 10.1002/1521-3773(20020402)41:7<1098::AID-ANIE1098>3.0.CO;2-9; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003	87	215	226	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1698	1704		10.1126/science.1082192	http://dx.doi.org/10.1126/science.1082192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657485				2022-12-28	WOS:000186970100032
J	Mas, P; Kim, WY; Somers, DE; Kay, SA				Mas, P; Kim, WY; Somers, DE; Kay, SA			Targeted degradation of TOC1 by ZTL modulates circadian function in Arabidopsis thaliana	NATURE			English	Article							CLOCK; PROTEIN; PERIOD; RHYTHMS; DOMAINS; OXYGEN; SLIMB; LIGHT; TIME; SCF	The underlying mechanism of circadian rhythmicity appears to be conserved among organisms, and is based on negative transcriptional feedback loops forming a cellular oscillator ( or 'clock')(1,2). Circadian changes in protein stability, phosphorylation and subcellular localization also contribute to the generation and maintenance of this clock(1,2). In plants, several genes have been shown to be closely associated with the circadian system(3,4). However, the molecular mechanisms proposed to regulate the plant clock are mostly based on regulation at the transcriptional level(3,4). Here we provide genetic and molecular evidence for a role of ZEITLUPE (ZTL)(5-7) in the targeted degradation of TIMING OF CAB EXPRESSION 1 (TOC1)(8,9) in Arabidopsis thaliana (thale cress). The physical interaction of TOC1 with ZTL is abolished by the ztl-1 mutation, resulting in constitutive levels of TOC1 protein expression. The dark-dependent degradation of TOC1 protein requires functional ZTL, and is prevented by inhibiting the proteosome pathway. Our results show that the TOC1 - ZTL interaction is important in the control of TOC1 protein stability, and is probably responsible for the regulation of circadian period by the clock.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Ohio State Univ, Dept Plant Biol, Ctr Plant Biotechnol, Columbus, OH 43210 USA	Scripps Research Institute; University System of Ohio; Ohio State University	Kay, SA (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevek@scripps.edu	Somers, David E/A-9209-2010; Mas, Paloma/B-8215-2016; Kay, Steve A/F-6025-2011	Mas, Paloma/0000-0002-3780-8041; Kay, Steve A/0000-0002-0402-2878				Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Cheng P, 2003, P NATL ACAD SCI USA, V100, P5938, DOI 10.1073/pnas.1031791100; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Jarillo JA, 2001, NATURE, V410, P487, DOI 10.1038/35068589; Kim WY, 2003, P NATL ACAD SCI USA, V100, P4933, DOI 10.1073/pnas.0736949100; Kiyosue T, 2000, PLANT J, V23, P807, DOI 10.1046/j.1365-313x.2000.00850.x; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; McClung CR, 2001, ANNU REV PLANT PHYS, V52, P139, DOI 10.1146/annurev.arplant.52.1.139; MILLAR AJ, 1995, SCIENCE, V267, P1163, DOI 10.1126/science.7855596; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Risseeuw EP, 2003, PLANT J, V34, P753, DOI 10.1046/j.1365-313X.2003.01768.x; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Schultz TF, 2001, PLANT CELL, V13, P2659, DOI 10.1105/tpc.13.12.2659; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 1998, DEVELOPMENT, V125, P485; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yanovsky MJ, 2001, CURR OPIN PLANT BIOL, V4, P429, DOI 10.1016/S1369-5266(00)00196-5; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	30	407	444	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					567	570		10.1038/nature02163	http://dx.doi.org/10.1038/nature02163			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654842				2022-12-28	WOS:000186944300041
J	Wang, XC; Wu, YC; Fadok, VA; Lee, MC; Gengyo-Ando, K; Cheng, LC; Ledwich, D; Hsu, PK; Chen, JY; Chou, BK; Henson, P; Mitani, S; Xue, D				Wang, XC; Wu, YC; Fadok, VA; Lee, MC; Gengyo-Ando, K; Cheng, LC; Ledwich, D; Hsu, PK; Chen, JY; Chou, BK; Henson, P; Mitani, S; Xue, D			Cell corpse engulfment mediated by C-elegans phosphatidylserine receptor through CED-5 and CED-12	SCIENCE			English	Article							CRKII/DOCK180/RAC PATHWAY; APOPTOTIC CELLS; GENERAL FEATURE; PHAGOCYTOSIS; CLEARANCE; MIGRATION; EXPOSURE; MACROPHAGES; ASYMMETRY	During apoptosis, phosphatidylserine, which is normally restricted to the inner lea. et of the plasma membrane, is exposed on the surface of apoptotic cells and has been suggested to act as an "eat-me" signal to trigger phagocytosis. It is unclear how phagocytes recognize phosphatidylserine. Recently, a putative phosphatidylserine receptor (PSR) was identified and proposed to mediate recognition of phosphatidylserine and phagocytosis. We report that psr-1, the Caenorhabditis elegans homolog of PSR, is important for cell corpse engulfment. In vitro PSR-1 binds preferentially phosphatidylserine or cells with exposed phosphatidylserine. In C. elegans, PSR-1 acts in the same cell corpse engulfment pathway mediated by intracellular signaling molecules CED-2 ( homologous to the human CrkII protein), CED-5 (DOCK180), CED-10 (Rac GTPase), and CED-12 (ELMO), possibly through direct interaction with CED-5 and CED-12. Our findings suggest that PSR-1 is likely an upstream receptor for the signaling pathway containing CED-2, CED-5, CED-10, and CED-12 proteins and plays an important role in recognizing phosphatidylserine during phagocytosis.	Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10617, Taiwan; Natl Jewish Med & Res Ctr, Dept Pediat, Cell Biol Program, Denver, CO 80206 USA; Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan	University of Colorado System; University of Colorado Boulder; National Taiwan University; National Jewish Health; Tokyo Women's Medical University	Wu, YC (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	yichun@ntu.edu.tw; ding.xue@colorado.edu	Gengyo-Ando, Keiko/AAC-4504-2019; Wu, Yi-Chun/F-7934-2012; Gengyo-Ando, Keiko/B-2753-2012	Wu, Yi-Chun/0000-0002-8621-4098; XUE, DING/0000-0002-8429-8136				Ashman RF, 1995, IMMUNOL LETT, V48, P159, DOI 10.1016/0165-2478(95)02471-9; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; CHENG L, UNPUB; ELLIS RE, 1991, GENETICS, V129, P79; FADOK V, UNPUB; FADOK VA, 1992, J IMMUNOL, V149, P4029; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Hoffmann PR, 2001, J CELL BIOL, V155, P649, DOI 10.1083/jcb.200108080; Krahling S, 1999, CELL DEATH DIFFER, V6, P183, DOI 10.1038/sj.cdd.4400473; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Shiratsuchi A, 1998, BIOCHEM BIOPH RES CO, V246, P549, DOI 10.1006/bbrc.1998.8663; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; vandenEijnde SM, 1997, CYTOMETRY, V29, P313, DOI 10.1002/(SICI)1097-0320(19971201)29:4<313::AID-CYTO8>3.0.CO;2-A; VandenEijnde SM, 1997, CELL DEATH DIFFER, V4, P311, DOI 10.1038/sj.cdd.4400241; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; WANG X, UNPUB; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	28	157	174	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1563	1566		10.1126/science.1087641	http://dx.doi.org/10.1126/science.1087641			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645848	Green Published			2022-12-28	WOS:000186802200043
J	Yu, L; Lenardo, MJ				Yu, L; Lenardo, MJ			The Paracaspase connection	SCIENCE			English	Editorial Material							NF-KAPPA-B; LYMPHOCYTE-ACTIVATION; GENE		NIAID, Immunol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Yu, L (corresponding author), NIAID, Immunol Lab, Bldg 10, Bethesda, MD 20892 USA.	mlenardo@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000769, ZIAAI000769] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Dierlamm J, 1999, BLOOD, V93, P3601, DOI 10.1182/blood.V93.11.3601; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Ruefli-Brasse AA, 2003, SCIENCE, V302, P1581, DOI 10.1126/science.1090769; Ruland J, 2003, IMMUNITY, V19, P749, DOI 10.1016/S1074-7613(03)00293-0; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X	8	3	3	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1515	1516		10.1126/science.1092951	http://dx.doi.org/10.1126/science.1092951			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645834				2022-12-28	WOS:000186802200027
J	Wang, K; Asinger, RW; Marriott, HJL				Wang, K; Asinger, RW; Marriott, HJL			ST-segment elevation in conditions other than acute myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BUNDLE-BRANCH BLOCK; BRUGADA-SYNDROME; ELECTROCARDIOGRAPHIC DIAGNOSIS; EARLY REPOLARIZATION; SUDDEN-DEATH; EMERGENCY; CARDIOVERSION; PREVALENCE; MECHANISMS; PATTERNS		Univ Minnesota, Hennepin Cty Med Ctr, Div Cardiol, Minneapolis, MN 55415 USA; Univ S Florida, Tampa, FL USA	Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; State University System of Florida; University of South Florida	Wang, K (corresponding author), Univ Minnesota, Hennepin Cty Med Ctr, Div Cardiol, 701 Pk Ave,MC 865A, Minneapolis, MN 55415 USA.							Alings M, 1999, CIRCULATION, V99, P666, DOI 10.1161/01.CIR.99.5.666; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, Lancet, V1, P397; Brady WJ, 2001, ACAD EMERG MED, V8, P349, DOI 10.1111/j.1553-2712.2001.tb02113.x; Brady WJ, 2000, ACAD EMERG MED, V7, P1256, DOI 10.1111/j.1553-2712.2000.tb00471.x; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Brugada R, 2000, CIRCULATION, V101, P510, DOI 10.1161/01.CIR.101.5.510; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chia BL, 2000, AM J CARDIOL, V86, P341, DOI 10.1016/S0002-9149(00)00929-2; CHOU TC, 1996, ELECTROCARDIOGRAPHY, P190; Corrado D, 2001, CIRCULATION, V103, P710; DEWOOD MA, 1980, NEW ENGL J MED, V303, P897, DOI 10.1056/NEJM198010163031601; Ferrari E, 1997, CHEST, V111, P537, DOI 10.1378/chest.111.3.537; Fesmire FM, 2000, ANN EMERG MED, V35, P521, DOI 10.1067/mem.2000.106387; Fletcher GF, 2001, CIRCULATION, V104, P1694, DOI 10.1161/hc3901.095960; Fu YL, 2001, CIRCULATION, V104, P2653, DOI 10.1161/hc4701.099731; Gibson CM, 2001, CIRCULATION, V104, P2632, DOI 10.1161/circ.104.22.2632; GOLDMAN MJ, 1953, AM HEART J, V46, P817, DOI 10.1016/0002-8703(53)90080-5; Gussak I, 1999, J AM COLL CARDIOL, V33, P5, DOI 10.1016/S0735-1097(98)00528-2; HANDS ME, 1988, AM HEART J, V116, P23, DOI 10.1016/0002-8703(88)90245-1; HISS RG, 1960, AM J CARDIOL, V6, P200, DOI 10.1016/0002-9149(60)90047-3; Hurst JW, 1978, HEART ARTERIES VEINS, P1182; JAYES RL, 1992, J GEN INTERN MED, V7, P387, DOI 10.1007/BF02599153; KAMBARA H, 1976, AM J CARDIOL, V38, P157, DOI 10.1016/0002-9149(76)90142-9; Khoury NE, 1996, ANN EMERG MED, V28, P289, DOI 10.1016/S0196-0644(96)70027-6; Kok LC, 2000, AM J CARDIOL, V85, P878, DOI 10.1016/S0002-9149(99)00886-3; LEVINE HD, 1956, CIRCULATION, V13, P29, DOI 10.1161/01.CIR.13.1.29; Littmann L, 2000, MAYO CLIN PROC, V75, P845, DOI 10.4065/75.8.845; Madias JE, 2001, J ELECTROCARDIOL, V34, P87; MASERI A, 1978, AM J CARDIOL, V42, P1019, DOI 10.1016/0002-9149(78)90691-4; McLarin C W, 1981, J Med Assoc Ga, V70, P649; MIRVIS DM, 1982, AM J CARDIOL, V50, P122, DOI 10.1016/0002-9149(82)90017-0; OLIVA PB, 1973, NEW ENGL J MED, V288, P745, DOI 10.1056/NEJM197304122881501; OTTO LA, 1994, ANN EMERG MED, V23, P17, DOI 10.1016/S0196-0644(94)70002-8; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; PRINZMETAL M, 1959, AM J MED, V27, P375, DOI 10.1016/0002-9343(59)90003-8; Rodger M, 2000, AM J CARDIOL, V86, P807, DOI 10.1016/S0002-9149(00)01090-0; Rosner MH, 1998, AM J EMERG MED, V16, P697, DOI 10.1016/S0735-6757(98)90180-2; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; Sgarbossa EB, 1996, NEW ENGL J MED, V334, P481, DOI 10.1056/NEJM199602223340801; SHARKEY SW, 1994, AM J CARDIOL, V73, P550, DOI 10.1016/0002-9149(94)90331-X; SPODICK DH, 1995, CIRCULATION, V91, P1886, DOI 10.1161/01.CIR.91.6.1886; SPODICK DH, 1976, NEW ENGL J MED, V295, P523, DOI 10.1056/NEJM197609022951002; SREERAM N, 1994, AM J CARDIOL, V73, P298, DOI 10.1016/0002-9149(94)90237-2; Surawicz B, 2002, J AM COLL CARDIOL, V40, P1870, DOI 10.1016/S0735-1097(02)02492-0; Tada H, 1998, AM J CARDIOL, V81, P519, DOI 10.1016/S0002-9149(97)00942-9; Tarin N, 1999, PACE, V22, P1264, DOI 10.1111/j.1540-8159.1999.tb00613.x; VANGELDER IC, 1991, AM HEART J, V121, P51, DOI 10.1016/0002-8703(91)90954-G; Wilde AAM, 2002, CIRCULATION, V106, P2514, DOI 10.1161/01.CIR.0000034169.45752.4A; Yan GX, 1999, CIRCULATION, V100, P1660, DOI 10.1161/01.CIR.100.15.1660; Zimetbaum PJ, 1998, AM J CARDIOL, V81, P918, DOI 10.1016/S0002-9149(98)00013-7	51	390	407	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2003	349	22					2128	2135		10.1056/NEJMra022580	http://dx.doi.org/10.1056/NEJMra022580			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746ZV	14645641				2022-12-28	WOS:000186779700009
J	Stone, A				Stone, A			Audit of soap usage by a primary care team	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Canna Surg, Cardiff CF11 9EE, S Glam, Wales		Stone, A (corresponding author), Canna Surg, Cardiff CF11 9EE, S Glam, Wales.	alan_stone@btinternet.com						Cohen HA, 1998, INFECTION, V26, P49, DOI 10.1007/BF02768754; Cookson B, 1999, BRIT MED J, V318, P686; LARSON EL, 1995, AM J INFECT CONTROL, V23, P251, DOI 10.1016/0196-6553(95)90070-5; Rotter ML, 1997, HYG MED, V22, P332, DOI DOI 10.1136/BMJ.319.7208.518	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 20	2003	327	7429					1453	1454		10.1136/bmj.327.7429.1453	http://dx.doi.org/10.1136/bmj.327.7429.1453			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684644	Green Published			2022-12-28	WOS:000187562700015
J	Snow, V; Weiss, KB; LeFevre, M; McNamara, R; Bass, E; Green, LA; Michl, K; Owens, DK; Susman, J; Allen, DI; Mottur-Pilson, C				Snow, V; Weiss, KB; LeFevre, M; McNamara, R; Bass, E; Green, LA; Michl, K; Owens, DK; Susman, J; Allen, DI; Mottur-Pilson, C		Joint AAFP ACP Panel Atrial	Management of newly detected atrial fibrillation: A clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; VENTRICULAR RATE CONTROL; FIXED MINIDOSE WARFARIN; LOW-DOSE DILTIAZEM; HEART-RATE CONTROL; INTRAVENOUS DILTIAZEM; SECONDARY PREVENTION; EXERCISE TOLERANCE; ORAL VERAPAMIL; RHYTHM CONTROL	The Joint Panel of the American Academy of Family Physicians and the American College of Physicians, in collaboration with the Johns Hopkins Evidence-based Practice Center, systematically reviewed the available evidence on the management of newly detected atrial fibrillation and developed recommendations for adult patients with first-detected atrial fibrillation. The recommendations do not apply to patients with postoperative or post-myocardial infarction atrial fibrillation, patients with class IV heart failure, patients already taking antiarrhythmic drugs, or patients with valvular disease. The target physician audience is internists and family physicians dedicated to primary care. The recommendations are as follows: Recommendation 1: Rate control with chronic anticoagulation is the recommended strategy for the majority of patients with atrial fibrillation. Rhythm control has not been shown to be superior to rate control (with chronic anticoagulation) in reducing morbidity and mortality and may be inferior in some patient subgroups to rate control. Rhythm control is appropriate when based on other special considerations, such as patient symptoms, exercise tolerance, and patient preference. Grade: 2A Recommendation 2: Patients with atrial fibrillation should receive chronic anticoagulation with adjusted-dose warfarin, unless they are at low risk of stroke or have a specific contraindication to the use of warfarin (thrombocytopenia, recent trauma or surgery, alcoholism). Grade: 1A Recommendation 3: For patients with atrial fibrillation, the following drugs are recommended for their demonstrated efficacy in rate control during exercise and while at rest. atenolol, metoprolol, diltiazem, and verapamil (drugs listed alphabetically by class). Digoxin is only effective for rate control at rest and therefore should only be used as a second-line agent for rate control in atrial fibrillation. Grade: 1B Recommendation 4: For those patients who elect to undergo acute cardioversion to achieve sinus rhythm in atrial fibrillation, both direct-current cardioversion (Grade: 1C+) and pharmacological conversion (Grade: 2A) are appropriate options. Recommendation 5. Both transesophageal echocardiography with short-term prior anticoagulation followed by early acute cardioversion (in the absence of intracardiac thrombus) with postcardioversion anticoagulation versus delayed cardioversion with pre- and postanticoagulation are appropriate management strategies for those patients who elect to undergo cardioversion. Grade: 2A Recommendation 6: Most patients converted to sinus rhythm from atrial fibrillation should not be placed on rhythm maintenance therapy since the risks outweigh the benefits. in a selected group of patients whose quality of life is compromised by atrial fibrillation, the recommended pharmacologic agents for rhythm maintenance are amiodarone, disopyramide, propafenone, and sotalol (drugs listed in alphabetical order). The choice of agent predominantly depends on specific risk of side effects based on patient characteristics. Grade: 2A.	Amer Coll Physicians, Philadelphia, PA 19106 USA; Indiana Univ, Sch Med, Indianapolis, IN USA; Univ Cincinnati, Cincinnati, OH USA; Stanford Univ, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Univ Vermont, Coll Med, Burlington, VT USA; Univ Michigan, Ann Arbor, MI 48109 USA; Johns Hopkins Univ, Baltimore, MD USA; Yale Univ, Sch Med, New Haven, CT USA; Univ Missouri, Columbia, MO USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; Vet Affairs Edward Hines Jr Hosp, Chicago, IL USA	American College of Physicians; Indiana University System; Indiana University-Purdue University Indianapolis; University System of Ohio; University of Cincinnati; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Vermont; University of Michigan System; University of Michigan; Johns Hopkins University; Yale University; University of Missouri System; University of Missouri Columbia; Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Snow, V (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	vincenza@acponline.org		Bass, Eric/0000-0001-9106-527X				AHUJA RC, 1989, INT J CARDIOL, V25, P325, DOI 10.1016/0167-5273(89)90223-4; ANG EL, 1990, BRIT HEART J, V64, P256; [Anonymous], 1997, Eur Heart J, V18, P649; Blackshear JL, 1996, LANCET, V348, P633; Botto GL, 1998, CLIN CARDIOL, V21, P837, DOI 10.1002/clc.4960211110; CHANNER KS, 1994, BRIT J CLIN PHARMACO, V37, P53, DOI 10.1111/j.1365-2125.1994.tb04238.x; CONNOLLY SJ, 1991, J AM COLL CARDIOL, V18, P349, DOI 10.1016/0735-1097(91)90585-W; DIBIANCO R, 1984, AM HEART J, V108, P1121, DOI 10.1016/0002-8703(84)90592-1; ELLENBOGEN KA, 1991, J AM COLL CARDIOL, V18, P891, DOI 10.1016/0735-1097(91)90743-S; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; FALK RH, 1987, ANN INTERN MED, V106, P503, DOI 10.7326/0003-4819-106-4-503; Falk RH, 2002, NEW ENGL J MED, V347, P1883, DOI 10.1056/NEJMe020137; Farshi R, 1999, J AM COLL CARDIOL, V33, P304, DOI 10.1016/S0735-1097(98)00561-0; Fuster V, 2001, J AM COLL CARDIOL, V38, P1231, DOI 10.1016/S0735-1097(01)01587-X; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; GOLDENBERG IF, 1994, AM J CARDIOL, V74, P884, DOI 10.1016/0002-9149(94)90580-0; Gullov AL, 1998, ARCH INTERN MED, V158, P1513, DOI 10.1001/archinte.158.14.1513; Guyatt G, 2002, MOVING EVIDENCE ACTI; HARENBERG J, 1993, SEMIN THROMB HEMOST, V19, P116; Hellemons BSP, 1999, BMJ-BRIT MED J, V319, P958, DOI 10.1136/bmj.319.7215.958; Hohnloser SH, 2000, LANCET, V356, P1789, DOI 10.1016/S0140-6736(00)03230-X; Jordaens L, 1997, EUR HEART J, V18, P643; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; Klein AL, 2001, NEW ENGL J MED, V344, P1411, DOI 10.1056/NEJM200105103441901; KOH KK, 1995, AM J CARDIOL, V75, P88, DOI 10.1016/S0002-9149(99)80538-4; Koh KK, 1995, INT J CARDIOL, V52, P167, DOI 10.1016/0167-5273(95)02480-K; LAWSONMATTHEW PJ, 1995, AGE AGEING, V24, P321, DOI 10.1093/ageing/24.4.321; LEWIS RV, 1988, EUR HEART J, V9, P279, DOI 10.1093/oxfordjournals.eurheartj.a062497; LEWIS RV, 1989, J CARDIOVASC PHARM, V13, P1, DOI 10.1097/00005344-198901000-00002; LEWIS RV, 1988, EUR HEART J, V9, P777, DOI 10.1093/eurheartj/9.7.777; LIN SK, 1986, J CARDIOVASC PHARM, V8, pS112, DOI 10.1097/00005344-198608004-00025; LUNDSTROM T, 1990, J AM COLL CARDIOL, V16, P86, DOI 10.1016/0735-1097(90)90461-W; LUNDSTROM T, 1992, AM HEART J, V124, P917, DOI 10.1016/0002-8703(92)90973-Y; MCBRIDE R, 1994, LANCET, V343, P687; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; McNamara R. L., 2001, AGENCY HEALTHCARE RE; McNamara RL, 2003, ANN INTERN MED, V139, P1018, DOI 10.7326/0003-4819-139-12-200312160-00012; Morocutti C, 1997, STROKE, V28, P1015, DOI 10.1161/01.STR.28.5.1015; MYERS J, 1987, J APPL PHYSIOL, V63, P97, DOI 10.1152/jappl.1987.63.1.97; PANIDIS IP, 1983, AM J CARDIOL, V52, P1197, DOI 10.1016/0002-9149(83)90573-8; Pengo V, 1998, AM J CARDIOL, V82, P433, DOI 10.1016/S0002-9149(98)00357-9; PETERSEN P, 1989, LANCET, V1, P175; POMFRET SM, 1988, CLIN SCI, V74, P351, DOI 10.1042/cs0740351; Posada IS, 1999, AM HEART J, V138, P137, DOI 10.1016/S0002-8703(99)70259-0; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; SALERNO DM, 1989, AM J CARDIOL, V63, P1046, DOI 10.1016/0002-9149(89)90076-3; Schreck DM, 1997, ANN EMERG MED, V29, P135, DOI 10.1016/S0196-0644(97)70319-6; SWEANY AE, 1985, CLIN PHARMACOL THER, V37, P124, DOI 10.1038/clpt.1985.23; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; WONG CK, 1990, AM J CARDIOL, V66, P1212, DOI 10.1016/0002-9149(90)91102-C; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328; Yamaguchi T, 2000, STROKE, V31, P817, DOI 10.1161/01.STR.31.4.817; 1993, LANCET, V342, P1255; 1999, THORAC CARDIOVASC S3, V47, P333	54	109	117	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2003	139	12					1009	1017		10.7326/0003-4819-139-12-200312160-00011	http://dx.doi.org/10.7326/0003-4819-139-12-200312160-00011			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756AG	14678921				2022-12-28	WOS:000187443200017
J	Hasselmann, K; Latif, M; Hooss, G; Azar, C; Edenhofer, O; Jaeger, CC; Johannessen, OM; Kemfert, C; Welp, M; Wokaun, A				Hasselmann, K; Latif, M; Hooss, G; Azar, C; Edenhofer, O; Jaeger, CC; Johannessen, OM; Kemfert, C; Welp, M; Wokaun, A			The challenge of long-term climate change	SCIENCE			English	Article							MODEL; PATHS; CO2	Climate policy needs to address the multidecadal to centennial time scale of climate change. Although the realization of short-term targets is an important first step, to be effective climate policies need to be conceived as long-term programs that will achieve a gradual transition to an essentially emission-free economy on the time scale of a century. This requires a considerably broader spectrum of policy measures than the primarily market-based instruments invoked for shorter term mitigation policies. A successful climate policy must consist of a dual approach focusing on both short-term targets and long-term goals.	European Climate Forum, Hamburg, Germany; Max Planck Inst Meteorol, Hamburg, Germany; Inst Marine Res, Kiel, Germany; Carl von Ossietzky Univ Oldenburg, D-2900 Oldenburg, Germany; Chalmers Univ Technol, S-41296 Gothenburg, Sweden; Potsdam Inst Climate Impact Res, Potsdam, Germany; Univ Bergen, Inst Geophys, Nansen Environm & Remote Sensing Ctr, Bergen, Norway; ETH, Paul Scherrer Inst, Zurich, Switzerland	Max Planck Society; Carl von Ossietzky Universitat Oldenburg; Chalmers University of Technology; Potsdam Institut fur Klimafolgenforschung; Nansen Environmental & Remote Sensing Center (NERSC); University of Bergen; Swiss Federal Institutes of Technology Domain; ETH Zurich; Paul Scherrer Institute	Hasselmann, K (corresponding author), European Climate Forum, Hamburg, Germany.	klaus.hasselmann@dkrz.de	Latif, Mojib/C-2428-2016; Edenhofer, Ottmar/E-1886-2013	Latif, Mojib/0000-0003-1079-5604; Edenhofer, Ottmar/0000-0001-6029-5208; Kemfert, Claudia/0000-0002-6742-0478				Alcamo J, 1996, GLOBAL ENVIRON CHANG, V6, P305, DOI 10.1016/S0959-3780(96)00030-1; Azar C, 2002, ECOL ECON, V42, P73, DOI 10.1016/S0921-8009(02)00042-3; Barnett TP, 1999, B AM METEOROL SOC, V80, P2631, DOI 10.1175/1520-0477(1999)080<2631:DAAORC>2.0.CO;2; Berry D, 2002, ECOL ECON, V42, P369, DOI 10.1016/S0921-8009(02)00128-3; Brewer PG, 1999, SCIENCE, V284, P943, DOI 10.1126/science.284.5416.943; Brown PG, 1997, CLIMATIC CHANGE, V37, P329, DOI 10.1023/A:1005315618569; Cline W.R., 1992, EC GLOBAL WARMING; CROWLEY TJ, 1995, GEOPHYS RES LETT, V22, P933, DOI 10.1029/95GL00799; Drange H, 2001, GEOPHYS RES LETT, V28, P2637, DOI 10.1029/2000GL012609; EDENHOFER O, UNPUB; ELIASSEN BP, 1999, GREENHOUSE GAS CONTR; GOLDEMBERG J, 2001, WORLD ENERGY ASSESSM; HaDuong M, 1997, NATURE, V390, P270, DOI 10.1038/36825; Hasselmann K, 1997, CLIMATIC CHANGE, V37, P345, DOI 10.1023/A:1005339625015; Hasselmann K, 1999, CLIMATIC CHANGE, V41, P333, DOI 10.1023/A:1005441119269; Heal G, 1997, CLIMATIC CHANGE, V37, P335, DOI 10.1023/A:1005384629724; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Hooss G, 2001, CLIM DYNAM, V18, P189, DOI 10.1007/s003820100170; *INT PAN CLIM CHAN, 2001, CLIM CHAN 2001 WORK; Ipcc (Intergovernmental Panel on Climate Change), 2001, CLIM CHANG 2001 WORK; Lackner KS, 2003, SCIENCE, V300, P1677, DOI 10.1126/science.1079033; Leimbach M, 2003, ENERG POLICY, V31, P1033, DOI 10.1016/S0301-4215(02)00180-5; Nordhaus WD, 1997, CLIMATIC CHANGE, V37, P315, DOI 10.1023/A:1005347001731; Nordhaus WD, 2001, SCIENCE, V294, P1283, DOI 10.1126/science.1065007; O'Neill BC, 2002, SCIENCE, V296, P1971, DOI 10.1126/science.1071238; PECK SC, IN PRESS RISK UNCERT, pCH9	26	65	72	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1923	1925		10.1126/science.1090858	http://dx.doi.org/10.1126/science.1090858			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671292	Green Submitted			2022-12-28	WOS:000187174000047
J	Knight, J				Knight, J			Turning technology into gold	NATURE			English	Article																			0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					708	708		10.1038/426708	http://dx.doi.org/10.1038/426708			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668876	Bronze			2022-12-28	WOS:000187132800053
J	Unger, DL				Unger, DL			One should never forget about heredity	LANCET			English	Editorial Material									Diplomate Amer Board Allergy & Immunol, Thousand Oaks, CA 91362 USA		Unger, DL (corresponding author), Diplomate Amer Board Allergy & Immunol, 1459 Thousand Oaks Blvd, Thousand Oaks, CA 91362 USA.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1934	1934		10.1016/S0140-6736(03)14969-0	http://dx.doi.org/10.1016/S0140-6736(03)14969-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667755				2022-12-28	WOS:000187011600029
J	Siveter, DJ; Sutton, MD; Briggs, DEG; Siveter, DJ				Siveter, DJ; Sutton, MD; Briggs, DEG; Siveter, DJ			An ostracode crustacean with soft parts from the lower silurian	SCIENCE			English	Article							FUNCTIONAL-MORPHOLOGY; HEREFORDSHIRE; ARTHROPOD; ENGLAND; MYODOCOPES; APPENDAGES	An exceptionally well-preserved ostracode from the Silurian of Herefordshire, United Kingdom, provides a rare view of the fossilized soft-part anatomy of this important group of living crustaceans and confirms that Ostracoda were extant in the Paleozoic. The fossil has striking similarity to the extant myodocopid family Cylindroleberididae, to which it is assigned, and demonstrates remarkable evolutionary stasis over 425 million years. The fossil is identified as a male on the basis of its copulatory organ.	Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; Univ Museum Nat Hist, Geol Collect, Oxford OX1 3PW, England	University of Leicester; University of Oxford; Yale University; University of Oxford	Siveter, DJ (corresponding author), Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England.	djs@leicester.ac.uk	Sutton, Mark/A-4189-2010					Briggs DEG, 1996, NATURE, V382, P248, DOI 10.1038/382248a0; Gabbott SE, 2003, LETHAIA, V36, P151, DOI 10.1080/00241160310004620; HIRUTA S, 1979, J FS HOKKAIDO U, V22, P9; Horne DJ, 2002, GEOPH MONOG SERIES, V131, P5; Hou XG, 1996, PHILOS T ROY SOC B, V351, P1131; KORNICKER LS, 1981, SMITHSON CONTRIB ZOO, V319, P1548; Muller K. J, 1979, P 7 INT S OSTR BEOGR, P5; Orr PJ, 2000, J GEOL SOC LONDON, V157, P173, DOI 10.1144/jgs.157.1.173; Parker AR, 1997, J MAR BIOL ASSOC UK, V77, P1223, DOI 10.1017/S002531540003873X; Parker AR, 1997, J CRUSTACEAN BIOL, V17, P632, DOI 10.2307/1549366; Siveter D.J., 1991, Journal of Micropalaeontology, V10, P151; SIVETER D. J, 1989, NATL MUSEUM WALES GE, V9, P252; SIVETER DJ, 1990, T ROY SOC EDIN-EARTH, V81, P45, DOI 10.1017/S0263593300005125; Smith RJ, 2000, PALAEONTOLOGY, V43, P63, DOI 10.1111/1475-4983.00119; Sutton MD, 2002, P ROY SOC B-BIOL SCI, V269, P1195, DOI 10.1098/rspb.2002.1986; Sutton MD, 2001, P ROY SOC B-BIOL SCI, V268, P2355, DOI 10.1098/rspb.2001.1788; Sutton MD, 2001, NATURE, V410, P461, DOI 10.1038/35068549; SUTTON MD, 2001, PALEONTOL ELECT, V4; Vannier J, 1998, MAR BIOL, V132, P391, DOI 10.1007/s002270050406; Vannier J, 1996, J CRUSTACEAN BIOL, V16, P453, DOI 10.2307/1548735; Walossek Dieter, 1993, Fossils and Strata, V32, P1; Yamaguchi S, 2003, MAR BIOL, V143, P23, DOI 10.1007/s00227-003-1062-3	22	106	115	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1749	1751		10.1126/science.1091376	http://dx.doi.org/10.1126/science.1091376			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657495				2022-12-28	WOS:000186970100043
J	Shibata, S; Miyakawa, H; Shimizu, S; Uchida, S				Shibata, S; Miyakawa, H; Shimizu, S; Uchida, S			Fever and anuria	LANCET			English	Editorial Material							CANDIDIASIS		Showa Gen Hosp, Dept Nephrol, Tokyo, Japan; Showa Gen Hosp, Dept Pathol, Tokyo, Japan; Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 1878510, Japan	Teikyo University	Miyakawa, H (corresponding author), Showa Gen Hosp, Dept Nephrol, Tokyo, Japan.	hmiyakaw@dc4.so-net.ne.jp		Shibata, Shigeru/0000-0002-6868-0626				LEHNER T, 1964, LANCET, V1, P1414; RAMSAY AG, 1985, CLIN NEPHROL, V24, P310; Rex JH, 2000, CLIN INFECT DIS, V30, P662, DOI 10.1086/313749; REX JH, 1994, NEW ENGL J MED, V331, P1325, DOI 10.1056/NEJM199411173312001; Uzun O, 1996, CLIN INFECT DIS, V22, pS95, DOI 10.1093/clinids/22.Supplement_2.S95	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1806	1806		10.1016/S0140-6736(03)14900-8	http://dx.doi.org/10.1016/S0140-6736(03)14900-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654319				2022-12-28	WOS:000186872900012
J	Seddon, N; Bearpark, T				Seddon, N; Bearpark, T			Observation of the inverse Doppler effect	SCIENCE			English	Article							ELECTROMAGNETIC SHOCK; OSCILLATIONS; GENERATION	We report experimental observation of an inverse Doppler shift, in which the frequency of a wave is increased on reflection from a receding boundary. This counterintuitive effect has been produced by reflecting a wave from a moving discontinuity in an electrical transmission line. Doppler shifts produced by this system can be varied in a reproducible manner by electronic control of the transmission line and are typically five orders of magnitude greater than those produced by solid objects with kinematic velocities. Potential applications include the development of tunable and multifrequency radiation sources.	BAE Syst, Ctr Adv Technol, Opt & Laser Technol Dept, Bristol BS34 7QW, Avon, England	Bae Systems	Seddon, N (corresponding author), BAE Syst, Ctr Adv Technol, Opt & Laser Technol Dept, POB 5, Bristol BS34 7QW, Avon, England.	nigel.seddon@baesystems.com						BARSUKOV KA, 1962, SOV PHYS-TECH PHYS, V7, P112; BARSUKOV KA, 1960, SOV PHYS-TECH PHYS, V4, P868; Belyantsev A. M., 1995, Technical Physics, V40, P820; Belyantsev AM, 2000, TECH PHYS+, V45, P747, DOI 10.1134/1.1259714; Belyantsev AM, 1998, INT J INFRARED MILLI, V19, P1571, DOI 10.1023/A:1022615411450; Belyantsev AM, 2002, TECH PHYS+, V47, P1477, DOI 10.1134/1.1522123; Ben-Shimol Y, 1998, RADIO SCI, V33, P463, DOI 10.1029/98RS00033; DAUME EY, 1963, SOV PHYS JETP-USSR, V16, P778; Doppler C., 1842, ABHANDLUNGEN KONIGLI, V2, P465; Eleftheriades GV, 2002, IEEE T MICROW THEORY, V50, P2702, DOI 10.1109/TMTT.2002.805197; ENGHETA N, 1980, IEEE T ANTENN PROPAG, V28, P519, DOI 10.1109/TAP.1980.1142368; ENGHETA N, 1990, RECENT ADV ELECTROMA; Frank IM, 1943, J PHYS-USSR, V7, P49; FREIDMAN GI, 1963, IZV VUZ RADIOFIZ, V6, P536; Iyer AK, 2002, IEEE MTT S INT MICR, P1067, DOI 10.1109/MWSYM.2002.1011823; Kataev I.G., 1963, ELECTROMAGNETIC SHOC; LEE KSH, 1963, J MATH PHYS CAMB, V42, P189, DOI 10.1002/sapm1963421189; LEE KSH, 1968, RADIO SCI, V3, P1098, DOI 10.1002/rds19683111098; Papas C. H., 1965, THEORY ELECTROMAGNET; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Reed EJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.133901; Reed EJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.203904; Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184; SOROKIN MY, 1993, RADIOPHYS QUANTUM EL, V36, P410; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699	25	269	300	9	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1537	1540		10.1126/science.1089342	http://dx.doi.org/10.1126/science.1089342			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645840				2022-12-28	WOS:000186802200034
J	Ariyo, AA; Thach, C; Tracy, R				Ariyo, AA; Thach, C; Tracy, R		Cardiovascular Hlth Study Investig	Lp(a) lipoprotein, vascular disease, and mortality in the elderly	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; INDEPENDENT RISK-FACTOR; ELEVATED LIPOPROTEIN(A); ATHEROTHROMBOTIC DISEASE; CEREBROVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; CEREBRAL INFARCTION; MEN; WOMEN; JAPANESE	Background: As compared with what is known about predictors of vascular events in middle-aged persons, less is known about these events in the elderly. Lp(a) lipoprotein, which plays an important part in atherothrombogenesis, has been associated with an increased risk of vascular disease. We investigated this relation among older U.S. adults. Methods: In a prospective study of 5888 community-dwelling older adults (65 years of age or older) in the United States, 2375 women and 1597 men who were free of vascular disease provided base-line serum samples for analysis for levels of Lp(a) lipoprotein. These 3972 subjects were followed for a median of 7.4 years to evaluate the development of stroke and to track deaths from vascular causes and all causes. The men and women were divided into quintile groups according to the Lp(a) lipoprotein level at base line. Results: Using Cox proportional-hazards models, we determined the risk associated with each quintile level of Lp(a) lipoprotein, with the lowest quintile serving as the reference group. As compared with those in the lowest quintile, men in the highest quintile had three times the unadjusted risk of stroke (relative risk, 3.00; 95 percent confidence interval, 1.59 to 5.65), almost three times the risk of death associated with vascular events (relative risk, 2.54; 95 percent confidence interval, 1.59 to 4.08), and nearly twice the risk of death from all causes (relative risk, 1.76; 95 percent confidence interval, 1.31 to 2.36). Adjustment for age; sex; the levels of total cholesterol, low-density lipoprotein cholesterol, and triglycerides; carotid-wall thickness; smoking status; the presence or absence of diabetes and systolic and diastolic hypertension; body-mass index; and other traditional risk factors had little effect on the final assessments. Similar analyses for women, which also included adjustment for estrogen use or nonuse, revealed no such relation. Conclusions: Among older adults in the United States, an elevated level of Lp(a) lipoprotein is an independent predictor of stroke, death from vascular disease, and death from any cause in men but not in women. These data support the use of Lp(a) lipoprotein levels in predicting the risk of these events in older men.	HeartMasters, Ctr Cardiovasc Dis Prevent & Intervent, Dallas, TX 75212 USA; Johns Hopkins Univ Hosp, Div Cardiol, Baltimore, MD 21287 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Vermont, Dept Pathol, Burlington, VT 05405 USA	Johns Hopkins University; Johns Hopkins Medicine; University of Washington; University of Washington Seattle; University of Vermont	Ariyo, AA (corresponding author), HeartMasters, Ctr Cardiovasc Dis Prevent & Intervent, 2411 Poinciana Pl, Dallas, TX 75212 USA.				DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC015103] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-850079-85086, N01-HC-15103] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ariyo A, 1998, J Cardiovasc Risk, V5, P273, DOI 10.1097/00043798-199808000-00010; Assmann G, 1996, AM J CARDIOL, V77, P1179, DOI 10.1016/S0002-9149(96)00159-2; Bostom AG, 1996, JAMA-J AM MED ASSOC, V276, P544, DOI 10.1001/jama.276.7.544; BOSTOM AG, 1994, CIRCULATION, V90, P1688, DOI 10.1161/01.CIR.90.4.1688; CAMBILLAU M, 1992, ARTERIOSCLER THROMB, V12, P1346, DOI 10.1161/01.ATV.12.11.1346; Cantin B, 1998, J AM COLL CARDIOL, V31, P519, DOI 10.1016/S0735-1097(97)00528-7; COLEMAN MP, 1992, ATHEROSCLEROSIS, V92, P177, DOI 10.1016/0021-9150(92)90276-M; COX DR, 1972, J R STAT SOC B, V34, P187; Craig WY, 1998, CLIN CHEM, V44, P2301; Dahlen GH, 1998, J INTERN MED, V244, P425; Dangas G, 1998, J AM COLL CARDIOL, V32, P2035, DOI 10.1016/S0735-1097(98)00469-0; *DEP HLTH HHS, 1980, DHHS PUBL PHS; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; GAUBATZ JW, 1983, J BIOL CHEM, V258, P4582; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; KANNEL WB, 1986, CORONARY HEART DISEA, P60; Kario K, 1996, ARTERIOSCL THROM VAS, V16, P734, DOI 10.1161/01.ATV.16.6.734; KARIO K, 1994, AM J CARDIOL, V73, P1187, DOI 10.1016/0002-9149(94)90179-1; Klausen IC, 1997, ATHEROSCLEROSIS, V132, P77, DOI 10.1016/S0021-9150(97)00071-3; LOSCALZO J, 1990, ARTERIOSCLEROSIS, V10, P672, DOI 10.1161/01.ATV.10.5.672; *MATHS, 1998, S PLUS WIND SYST REL; Nguyen TT, 1997, CIRCULATION, V96, P1390, DOI 10.1161/01.CIR.96.5.1390; RIDKER PM, 1993, JAMA-J AM MED ASSOC, V270, P2195, DOI 10.1001/jama.270.18.2195; RIDKER PM, 1995, JAMA-J AM MED ASSOC, V273, P1269, DOI 10.1001/jama.273.16.1269; *SAS I, 1996, SAS WIND SYST REL 6; SCHAEFER EJ, 1994, JAMA-J AM MED ASSOC, V271, P999, DOI 10.1001/jama.271.13.999; Schlaich MP, 1998, J AM COLL CARDIOL, V31, P359, DOI 10.1016/S0735-1097(97)00497-X; SHINTANI S, 1993, STROKE, V24, P965, DOI 10.1161/01.STR.24.7.965; SPENCER G, 1989, CURRENT POPULATI P25, V1018; Sunayama S, 1996, CIRCULATION, V94, P1263, DOI 10.1161/01.CIR.94.6.1263; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9; Wild SH, 1997, ARTERIOSCL THROM VAS, V17, P239, DOI 10.1161/01.ATV.17.2.239; Wild SH, 1997, ARTERIOSCL THROM VAS, V17, P1010, DOI 10.1161/01.ATV.17.5.1010; WONG WLT, 1990, CLIN CHEM, V36, P192; ZENKER G, 1986, STROKE, V17, P942, DOI 10.1161/01.STR.17.5.942	36	181	194	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2003	349	22					2108	2115		10.1056/NEJMoa001066	http://dx.doi.org/10.1056/NEJMoa001066			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746ZV	14645638				2022-12-28	WOS:000186779700005
J	Birkmeyer, JD; Stukel, TA; Siewers, AE; Goodney, PP; Wennberg, DE; Lucas, FL				Birkmeyer, JD; Stukel, TA; Siewers, AE; Goodney, PP; Wennberg, DE; Lucas, FL			Surgeon volume and operative mortality in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITAL VOLUME; OUTCOMES; CARE; MORBIDITY; QUALITY; IMPACT	Background: Although the relation between hospital volume and surgical mortality is well established, for most procedures, the relative importance of the experience of the operating surgeon is uncertain. Methods: Using information from the national Medicare claims data base for 1998 through 1999, we examined mortality among all 474,108 patients who underwent one of eight cardiovascular procedures or cancer resections. Using nested regression models, we examined the relations between operative mortality and surgeon volume and hospital volume (each in terms of total procedures performed per year), with adjustment for characteristics of the patients and other characteristics of the providers. Results: Surgeon volume was inversely related to operative mortality for all eight procedures (P=0.003 for lung resection, P<0.001 for all other procedures). The adjusted odds ratio for operative death (for patients with a low-volume surgeon vs. those with a high-volume surgeon) varied widely according to the procedure - from 1.24 for lung resection to 3.61 for pancreatic resection. Surgeon volume accounted for a large proportion of the apparent effect of the hospital volume, to an extent that varied according to the procedure: it accounted for 100 percent of the effect for aortic-valve replacement, 57 percent for elective repair of an abdominal aortic aneurysm, 55 percent for pancreatic resection, 49 percent for coronary-artery bypass grafting, 46 percent for esophagectomy, 39 percent for cystectomy, and 24 percent for lung resection. For most procedures, the mortality rate was higher among patients of low-volume surgeons than among those of high-volume surgeons, regardless of the surgical volume of the hospital in which they practiced. Conclusions: For many procedures, the observed associations between hospital volume and operative mortality are largely mediated by surgeon volume. Patients can often improve their chances of survival substantially, even at high-volume hospitals, by selecting surgeons who perform the operations frequently.	Dartmouth Hitchcock Med Ctr, Sect Gen Surg, Dept Surg, Lebanon, NH 03756 USA; Vet Affairs Med Ctr, Vet Affairs Outcomes Grp, White River Jct, VT USA; Inst Clin Evaluat Sci, Toronto, ON, Canada; Maine Med Ctr, Ctr Outcomes Res & Evaluat, Portland, ME 04102 USA	Dartmouth College; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Toronto; Maine Medical Center	Birkmeyer, JD (corresponding author), Dartmouth Hitchcock Med Ctr, Sect Gen Surg, Dept Surg, Lebanon, NH 03756 USA.	john.birkmeyer@hitchcock.org	Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213; Stukel, Therese/0000-0002-2951-1360	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010141] Funding Source: NIH RePORTER; AHRQ HHS [R01 HS10141-01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Begg CB, 2002, NEW ENGL J MED, V346, P1138, DOI 10.1056/NEJMsa011788; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Finlayson E V, 2001, Eff Clin Pract, V4, P172; FINLAYSON EVA, 2001, EFF CLIN PRACT, V4, P235; FISHER ES, 1992, AM J PUBLIC HEALTH, V82, P243, DOI 10.2105/AJPH.82.2.243; Goldstein H., 1998, USERS GUIDE MLWIN; Goodney PP, 2002, J AM COLL SURGEONS, V195, P219, DOI 10.1016/S1072-7515(02)01228-0; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hannan EL, 1998, STROKE, V29, P2292, DOI 10.1161/01.STR.29.11.2292; Hannan EL, 2002, SURGERY, V131, P6, DOI 10.1067/msy.2002.120238; HANNAN EL, 1995, JAMA-J AM MED ASSOC, V273, P209, DOI 10.1001/jama.273.3.209; Hannan EL, 2001, STROKE, V32, P2890, DOI 10.1161/hs1201.099637; Harmon JW, 1999, ANN SURG, V230, P404, DOI 10.1097/00000658-199909000-00013; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; IEZZONI LI, 1992, JAMA-J AM MED ASSOC, V267, P2197, DOI 10.1001/jama.267.16.2197; *LEAPFR GROUP, 2003, PAT SAF EV BAS HOSP; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Miller ME, 1996, MED CARE, V34, P455, DOI 10.1097/00005650-199605000-00007; Schrag D, 2002, ANN SURG, V236, P583, DOI 10.1097/00000658-200211000-00008; Sosa JA, 1998, ANN SURG, V228, P429, DOI 10.1097/00000658-199809000-00016; Taylor DH, 1999, NEW ENGL J MED, V340, P293, DOI 10.1056/NEJM199901283400408	25	2313	2334	2	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2003	349	22					2117	2127		10.1056/NEJMsa035205	http://dx.doi.org/10.1056/NEJMsa035205			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746ZV	14645640				2022-12-28	WOS:000186779700008
J	Akai, J; Storey, K				Akai, J; Storey, K			Brain or brawn: How FGF signaling gives us both	CELL			English	Editorial Material							NEURAL INDUCTION; CELLS; REGION; GENE	How does FGIF (fibroblast growth factor) signaling induce both neural and mesodermal cell fates in the early embryo? Two papers address this fundamental question in this issue of Cell. Bertrand et al. show in the ascidian that a GATA factor determines the neural response of animal cells to FGF signaling, while in the chick, Sheng et al. demonstrate that the slow induction by FGF of a new transcription factor (Churchill) in the neural plate in turn induces expression of Sip1 (Smad interacting protein-1), which inhibits mesodermal genes and sensitizes cells to later neural inducing factors.	Univ Dundee, Fac Life Sci, Div Cell & Dev Biol, Dundee DD1 5EH, Scotland	University of Dundee	Akai, J (corresponding author), Univ Dundee, Fac Life Sci, Div Cell & Dev Biol, Dundee DD1 5EH, Scotland.			Storey, Kate/0000-0003-3506-1287				Bertrand V, 2003, CELL, V115, P615, DOI 10.1016/S0092-8674(03)00928-0; BRIVANIOU AH, 1997, CELL, V88, P13; Brown JM, 2000, CURR BIOL, V10, P869, DOI 10.1016/S0960-9822(00)00601-1; Cebria F, 2002, NATURE, V419, P620, DOI 10.1038/nature01042; Hardcastle Z, 2000, CURR BIOL, V10, P1511, DOI 10.1016/S0960-9822(00)00825-3; Hudson C, 2003, DEVELOPMENT, V130, P147, DOI 10.1242/dev.00200; Sheng GJ, 2003, CELL, V115, P603, DOI 10.1016/S0092-8674(03)00927-9; Streit A, 1998, DEVELOPMENT, V125, P507; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Van de Putte T, 2003, AM J HUM GENET, V72, P465, DOI 10.1086/346092; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	12	12	12	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 26	2003	115	5					510	512		10.1016/S0092-8674(03)00936-X	http://dx.doi.org/10.1016/S0092-8674(03)00936-X			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651843	Bronze			2022-12-28	WOS:000186885600003
J	Varma, JK; Greene, KD; Reller, ME; DeLong, SM; Trottier, J; Nowicki, SF; DiOrio, M; Koch, EM; Bannerman, TL; York, ST; Lambert-Fair, MA; Wells, JG; Mead, PS				Varma, JK; Greene, KD; Reller, ME; DeLong, SM; Trottier, J; Nowicki, SF; DiOrio, M; Koch, EM; Bannerman, TL; York, ST; Lambert-Fair, MA; Wells, JG; Mead, PS			An outbreak of Escherichia coli O157 infection following exposure to a contaminated building	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DAIRY FARM FAMILIES; UNITED-STATES; RISK-FACTORS; SURVIVAL; CONTACT	Context Infection with Escherichia coli O157 causes an estimated 70000 diarrheal illnesses per year in the United States and can result in hemolytic-uremic syndrome and death. Environmental contamination with E coli O157 may be a public health problem. Objectives To determine risk factors for E coli O157 infection during an outbreak investigation at a county fair and to evaluate environmental contamination as a possible cause of the outbreak. Design, Setting, and Participants Case-control study of 23 patients (median age, 15 years) and 53 age-matched controls who had attended the Lorain County, Ohio, fair between August 20 and August 26, 2001. Case-patients had laboratory-confirmed E coli O157 infection, hemolytic-uremic syndrome, or bloody diarrhea within 7 days of attending the fair; controls attended the fair and did not have diarrhea. Main Outcome Measures Risk factors for infection and isolates of E coli O157 from environmental specimens. Results Six (26%) case-patients were hospitalized and 2 (9%) developed hemolyticuremic syndrome. Case-patients were more likely than controls to have visited building A (a multipurpose community facility on the fairgrounds; matched odds ratio [MOR], 21.4 [95% confidence interval {CI), 2.7-170.7]). Among visitors to building A, illness was independently associated with attending a dance in the building (MOR, 7.5; 95% CI, 1.4-41.2), handling sawdust from the floor (MOR, 4.6; 95% CI, 1.1-20.0), or eating and/or drinking in the building (MOR, 4.5; 95% CI, 1.2-16.6). Twenty-four (44%) of 54 specimens collected from building A 6 weeks after the fair grew Shiga toxin-producing E coli O157. Isolates from sawdust, the rafters, and other surfaces were identical by molecular fingerprinting to patient isolates. Sawdust specimens collected 42 weeks after the fair also grew the same E coli O157 strain. Conclusions Absence of evidence implicating specific food or beverage sources and the recovery of E coli O157 from the rafters suggest that airborne dispersion of bacteria contributed to the contamination. Because E coli O157 can survive in the environment for more than 10 months, humans may be at risk of infection long after an environment is initially contaminated.	Ctr Dis Control & Prevent, Food & Diarrheal Dis Branch, Div Bacterial & Mycot Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Atlanta, GA USA; Ohio Dept Hlth, Elyria, OH USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Varma, JK (corresponding author), CDC HIV, TB Prevent & Control Sect, Box 68,Amer Embassy, APO, AP 96546 USA.		Bannerman, Tammy/E-2694-2011					Browning N.D., 2000, REV ADV MATER SCI, V1, P1; *CDCP, 2000, STAND MOL SUBT FOODB; *CDCP, 2000, FOODB DIS ACT SURV N, P19; Crampin M, 1999, EUR J CLIN MICROBIOL, V18, P286, DOI 10.1007/s100960050278; Crump JA, 2002, NEW ENGL J MED, V347, P555, DOI 10.1056/NEJMoa020524; CRUMP JA, IN PRESS EPIDEMIOL I; DOYLE MP, 1987, APPL ENVIRON MICROB, V53, P2394, DOI 10.1128/AEM.53.10.2394-2396.1987; Fields PI, 1997, J CLIN MICROBIOL, V35, P1066, DOI 10.1128/JCM.35.5.1066-1070.1997; Kudva IT, 1998, APPL ENVIRON MICROB, V64, P3166; Locking ME, 2001, EPIDEMIOL INFECT, V127, P215, DOI 10.1017/S0950268801006045; Mead PS, 1997, ARCH INTERN MED, V157, P204, DOI 10.1001/archinte.157.2.204; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; O'Brien SJ, 2001, EMERG INFECT DIS, V7, P1049, DOI 10.3201/eid0706.010626; Ogden ID, 2002, LETT APPL MICROBIOL, V34, P100, DOI 10.1046/j.1472-765x.2002.01052.x; OLSVIK O, 1991, MOL CELL PROBE, V5, P429, DOI 10.1016/S0890-8508(05)80014-3; Rahn K, 1998, J INFECT DIS, V177, P1139, DOI 10.1086/517394; Reymond D, 1996, J CLIN MICROBIOL, V34, P2053, DOI 10.1128/JCM.34.9.2053-2057.1996; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; WELLS JG, 1999, 99 GEN M AM SOC MICR; Wilson JB, 1996, J INFECT DIS, V174, P1021, DOI 10.1093/infdis/174.5.1021; 2001, MMWR MORB MORTAL WKL, V50, P293	22	112	122	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2003	290	20					2709	2712		10.1001/jama.290.20.2709	http://dx.doi.org/10.1001/jama.290.20.2709			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747CR	14645313	Bronze			2022-12-28	WOS:000186788100023
J	Perkin, MR				Perkin, MR			Football position and atopy - both subject to the birth order effect?	BRITISH MEDICAL JOURNAL			English	Article									St George Hosp, Sch Med, Dept Child Hlth, London SW17 0RE, England	St Georges University London	Perkin, MR (corresponding author), St George Hosp, Sch Med, Dept Child Hlth, London SW17 0RE, England.		Perkin, Michael/AID-7491-2022	Perkin, Michael/0000-0001-9272-2585				Strachan David P., 2000, Thorax, V55, pS2, DOI 10.1136/thorax.55.suppl_1.S2; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259	2	2	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1473	1474		10.1136/bmj.327.7429.1473	http://dx.doi.org/10.1136/bmj.327.7429.1473			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684654	Green Published			2022-12-28	WOS:000187562700025
J	Beaugrand, G; Brander, KM; Lindley, JA; Souissi, S; Reid, PC				Beaugrand, G; Brander, KM; Lindley, JA; Souissi, S; Reid, PC			Plankton effect on cod recruitment in the North Sea	NATURE			English	Article							MATCH MISMATCH HYPOTHESIS; LARVAL FISH; GADUS-MORHUA; ATLANTIC COD; DEPENDENT MORTALITY; GROWTH; VARIABILITY; ZOOPLANKTON; ABUNDANCE; SURVIVAL	The Atlantic cod ( Gadus morhua L.) has been overexploited in the North Sea since the late 1960s and great concern has been expressed about the decline in cod biomass and recruitment(1). Here we show that, in addition to the effects of overfishing(1), fluctuations in plankton have resulted in long- term changes in cod recruitment in the North Sea ( bottom- up control). Survival of larval cod is shown to depend on three key biological parameters of their prey: the mean size of prey, seasonal timing and abundance. We suggest a mechanism, involving the match/ mismatch hypothesis(2), by which variability in temperature affects larval cod survival and conclude that rising temperature since the mid- 1980s has modified the plankton ecosystem in a way that reduces the survival of young cod.	Univ Sci & Technol Lille, Stn Marine, CNRS, UMR ELICO 8013, F-62930 Wimereux, France; Sir Alister Hardy Fdn Ocean Sci, The Lab, Plymouth PL1 2PB, Devon, England; ICES, DK-1261 Copenhagen, Denmark	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Beaugrand, G (corresponding author), Univ Sci & Technol Lille, Stn Marine, CNRS, UMR ELICO 8013, BP 80, F-62930 Wimereux, France.		Souissi, Sami/C-5146-2018; Brander, Keith/AAN-6278-2021	Souissi, Sami/0000-0002-6720-0096; BEAUGRAND, GREGORY/0000-0002-0712-5223				Beaugrand G, 2003, GLOBAL CHANGE BIOL, V9, P801, DOI 10.1046/j.1365-2486.2003.00632.x; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; BOLLENS SM, 1992, J PLANKTON RES, V14, P1279, DOI 10.1093/plankt/14.9.1279; Brander K, 2000, OCEANOL ACTA, V23, P485, DOI 10.1016/S0399-1784(00)00133-X; Cook RM, 1997, NATURE, V385, P521, DOI 10.1038/385521a0; CUSHING DH, 1984, J CONSEIL, V41, P159; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; CUSHING DH, 1997, SCI RECR FISH POP; Gallego A, 1997, J FISH BIOL, V51, P121, DOI 10.1111/j.1095-8649.1997.tb06096.x; Gotceitas V, 1996, MAR ECOL PROG SER, V130, P29, DOI 10.3354/meps130029; *ICES COOP RES REP, 2001, WORKSH GAD STOCKS N; *ICES COOP RES REP, 2002, REP ICES ADV COMM FI; Letcher BH, 1996, CAN J FISH AQUAT SCI, V53, P787, DOI 10.1139/cjfas-53-4-787; Mauchline J, 1969, Adv. mar. Biol., V7, P1; Mauchline J, 1998, BIOL CALANOID COPEPO; Munk P, 1997, J FISH BIOL, V51, P340, DOI 10.1111/j.1095-8649.1997.tb06107.x; Myers RA, 1996, MAR ECOL PROG SER, V138, P293, DOI 10.3354/meps138293; Otterlei E, 1999, CAN J FISH AQUAT SCI, V56, P2099, DOI 10.1139/cjfas-56-11-2099; PEPIN P, 1993, CAN J FISH AQUAT SCI, V50, P2166, DOI 10.1139/f93-242; PETERS H, 1983, BIOL IMPLICATION BOD; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Pope JG, 1996, ICES J MAR SCI, V53, P1157, DOI 10.1006/jmsc.1996.0141; Reid PC, 2001, FISH RES, V50, P163, DOI 10.1016/S0165-7836(00)00249-6; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Rothschild BJ, 1998, J PLANKTON RES, V20, P1721, DOI 10.1093/plankt/20.9.1721; Shepherd JG, 1999, ICES J MAR SCI, V56, P584, DOI 10.1006/jmsc.1999.0498; Swain DP, 2003, FISH RES, V59, P327, DOI 10.1016/S0165-7836(02)00027-9; THORISSON K, 1989, RAP PROCES, V191, P264; VAUTARD R, 1992, PHYSICA D, V58, P95, DOI 10.1016/0167-2789(92)90103-T; WARNER AJ, 1994, PROG OCEANOGR, V34, P237, DOI 10.1016/0079-6611(94)90011-6	30	901	928	7	358	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					661	664		10.1038/nature02164	http://dx.doi.org/10.1038/nature02164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668864				2022-12-28	WOS:000187132800041
J	Ishii, H; Kataura, H; Shiozawa, H; Yoshioka, H; Otsubo, H; Takayama, Y; Miyahara, T; Suzuki, S; Achiba, Y; Nakatake, M; Narimura, T; Higashiguchi, M; Shimada, K; Namatame, H; Taniguchi, M				Ishii, H; Kataura, H; Shiozawa, H; Yoshioka, H; Otsubo, H; Takayama, Y; Miyahara, T; Suzuki, S; Achiba, Y; Nakatake, M; Narimura, T; Higashiguchi, M; Shimada, K; Namatame, H; Taniguchi, M			Direct observation of Tomonaga-Luttinger-liquid state in carbon nanotubes at low temperatures	NATURE			English	Article							ELECTRONIC-STRUCTURE; FERMI-LIQUID; BEHAVIOR; TRANSPORT	The electronic transport properties of conventional three-dimensional metals are successfully described by Fermi-liquid theory. But when the dimensionality of such a system is reduced to one, the Fermi-liquid state becomes unstable to Coulomb interactions, and the conduction electrons should instead behave according to Tomonaga-Luttinger-liquid (TLL) theory. Such a state reveals itself through interaction-dependent anomalous exponents in the correlation functions, density of states and momentum distribution of the electrons(1-3). Metallic single-walled carbon nanotubes (SWNTs) are considered to be ideal one-dimensional systems for realizing TLL states(4-6). Indeed, the results of transport measurements on metal - SWNT and SWNT - SWNT junctions have been attributed(7-9) to the effects of tunnelling into or between TLLs, although there remains some ambiguity in these interpretations(10). Direct observations of the electronic states in SWNTs are therefore needed to resolve these uncertainties. Here we report angle-integrated photoemission measurements of SWNTs. Our results reveal an oscillation in the pi-electron density of states owing to one-dimensional van Hove singularities, confirming the one-dimensional nature of the valence band. The spectral function and intensities at the Fermi level both exhibit power-law behaviour ( with almost identical exponents) in good agreement with theoretical predictions for the TLL state in SWNTs.	Tokyo Metropolitan Univ, Grad Sch Sci, Tokyo 1920397, Japan; Nara Womens Univ, Dept Phys, Nara 6308506, Japan; High Energy Accelerator Res Org, Photon Factory, Tsukuba, Ibaraki 3050801, Japan; Hiroshima Univ, Grad Sch Sci, Higashihiroshima 7398526, Japan; Hiroshima Univ, Dept Phys Sci, Higashihiroshima 7398526, Japan; Hiroshima Univ, Hiroshima Synchrotron Radiat Ctr, Higashihiroshima 7398526, Japan	Tokyo Metropolitan University; Nara Womens University; High Energy Accelerator Research Organization (KEK); Hiroshima University; Hiroshima University; Hiroshima University	Kataura, H (corresponding author), Tokyo Metropolitan Univ, Grad Sch Sci, Minami Ohsawa 1-1, Tokyo 1920397, Japan.	kataura@phys.metro-u.ac.jp	Shiozawa, Hidetsugu/A-5206-2017; Shimada, Kenya/G-5080-2016; Shimada, Kenya/ABG-8603-2021; Kataura, Hiromichi/L-8667-2016	Shiozawa, Hidetsugu/0000-0003-0603-2508; Shimada, Kenya/0000-0002-1945-2352; Shimada, Kenya/0000-0002-1945-2352; Kataura, Hiromichi/0000-0002-4777-0622				Abe M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.041405; Bockrath M, 1999, NATURE, V397, P598, DOI 10.1038/17569; Chen P, 1999, PHYS REV LETT, V82, P2548, DOI 10.1103/PhysRevLett.82.2548; Denlinger JD, 1999, PHYS REV LETT, V82, P2540, DOI 10.1103/PhysRevLett.82.2540; Egger R, 1998, EUR PHYS J B, V3, P281, DOI 10.1007/s100510050315; Egger R, 1997, PHYS REV LETT, V79, P5082, DOI 10.1103/PhysRevLett.79.5082; GRIONI M, 2000, ELECT SPECTROSCOPIES, P209; Gweon GH, 1996, J PHYS-CONDENS MAT, V8, P9923, DOI 10.1088/0953-8984/8/48/017; Ichida M, 1999, J PHYS SOC JPN, V68, P3131, DOI 10.1143/JPSJ.68.3131; Joynt R, 1999, SCIENCE, V284, P777, DOI 10.1126/science.284.5415.777; Kane C, 1997, PHYS REV LETT, V79, P5086, DOI 10.1103/PhysRevLett.79.5086; Kataura H, 1999, SYNTHETIC MET, V103, P2555, DOI 10.1016/S0379-6779(98)00278-1; Kwon YK, 1998, PHYS REV B, V58, P13314, DOI 10.1103/PhysRevB.58.R13314; Liu X, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.045419; Maarouf AA, 2000, PHYS REV B, V61, P11156, DOI 10.1103/PhysRevB.61.11156; Mattsson AE, 1997, PHYS REV B, V56, P15615, DOI 10.1103/PhysRevB.56.15615; Odintsov AA, 1999, PHYS REV B, V59, P10457, DOI 10.1103/PhysRevB.59.R10457; Ouyang M, 2001, SCIENCE, V292, P702, DOI 10.1126/science.1058853; Postma HWC, 2000, PHYS REV B, V62, P10653, DOI 10.1103/PhysRevB.62.R10653; Saito R., 1998, PHYS PROPERTIES CARB; SEKIYAMA A, 1995, PHYS REV B, V51, P13899, DOI 10.1103/PhysRevB.51.13899; Sonin EB, 2003, PHYSICA E, V18, P331, DOI 10.1016/S1386-9477(02)01073-1; SUZUKI S, 2001, PHYS REV B, V63; Vavro J, 2002, APPL PHYS LETT, V80, P1450, DOI 10.1063/1.1452788; Voit J, 2000, SCIENCE, V290, P501, DOI 10.1126/science.290.5491.501; VOIT J, 1995, REP PROG PHYS, V58, P977, DOI 10.1088/0034-4885/58/9/002; Wakabayashi T, 1997, Z PHYS D ATOM MOL CL, V40, P414, DOI 10.1007/s004600050240; Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139; Yao Z, 1999, NATURE, V402, P273, DOI 10.1038/46241; Yoshioka H, 2003, PHYSICA E, V18, P212, DOI 10.1016/S1386-9477(02)00970-0; Zwick F, 1998, PHYS REV LETT, V81, P2974, DOI 10.1103/PhysRevLett.81.2974	32	410	414	1	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					540	544		10.1038/nature02074	http://dx.doi.org/10.1038/nature02074			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654836				2022-12-28	WOS:000186944300034
J	Loewe, L; Textor, V; Scherer, S				Loewe, L; Textor, V; Scherer, S			High deleterious genomic mutation rate in stationary phase of Escherichia coli	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; ENVIRONMENTAL-STRESS; ADAPTIVE MUTATION; FITNESS; DNA; POPULATIONS; EVOLUTION; BACTERIA; RECOMBINATION; HYPERMUTATION	In natural habitats, bacteria spend most of their time in some form of growth arrest. Little is known about deleterious mutations in such stages, and consequently there is limited understanding of what evolutionary events occur. In a deleterious mutation accumulation experiment in prolonged stationary phase of Escherichia coli, about 0.03 slightly deleterious mutations were observed per genome per day. This is over an order of magnitude higher than extrapolations from fast-growing cells, but in line with inferences from observations in adaptive stationary phase mutation experiments. These findings may affect understanding of bacterial evolution and the emergence of bacterial pathogenicity.	Tech Univ Munich, Dept Biosci, Microbial Ecol Grp, D-85354 Freising Weihenstephan, Germany	Technical University of Munich	Loewe, L (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, Ashworth Labs, Kings Bldg,W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.		Scherer, Siegfried/I-1320-2013	Scherer, Siegfried/0000-0002-0394-9890				Andersson DI, 1996, P NATL ACAD SCI USA, V93, P906, DOI 10.1073/pnas.93.2.906; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Bull HJ, 2000, GENETICS, V156, P925; Bull HJ, 2000, GENETICS, V154, P1427; Bull HJ, 2001, P NATL ACAD SCI USA, V98, P8334, DOI 10.1073/pnas.151009798; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; Domingo E, 2000, VIROLOGY, V270, P251, DOI 10.1006/viro.2000.0320; Drake JW, 1998, GENETICS, V148, P1667; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Finkel SE, 2000, BACTERIAL STRESS RESPONSES, P231; Finkel SE, 1999, P NATL ACAD SCI USA, V96, P4023, DOI 10.1073/pnas.96.7.4023; Funchain P, 2000, GENETICS, V154, P959; Hacker J, 2003, SCIENCE, V301, P790, DOI 10.1126/science.1086802; Keightley PD, 1998, GENETICS, V150, P1283; Keightley PD, 1999, GENETICS, V153, P515; Kibota TT, 1996, NATURE, V381, P694, DOI 10.1038/381694a0; Kivisaar M, 2003, ENVIRON MICROBIOL, V5, P814, DOI 10.1046/j.1462-2920.2003.00488.x; Lynch M, 1999, EVOLUTION, V53, P645, DOI 10.1111/j.1558-5646.1999.tb05361.x; MATIN A, 1989, ANNU REV MICROBIOL, V43, P293, DOI 10.1146/annurev.mi.43.100189.001453; Morita RY, 1997, BACTERIA OLIGOTROPHI; MUKAI T, 1964, GENETICS, V50, P1; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Rosche WA, 1999, P NATL ACAD SCI USA, V96, P6862, DOI 10.1073/pnas.96.12.6862; Rosenberg SM, 1998, GENETICS, V148, P1559; RYAN FJ, 1963, J GEN MICROBIOL, V30, P193, DOI 10.1099/00221287-30-2-193; RYAN FJ, 1961, Z VEREBUNGSL, V92, P38, DOI 10.1007/BF01854099; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Szafraniec K, 2001, P NATL ACAD SCI USA, V98, P1107, DOI 10.1073/pnas.021390798; Torkelson J, 1997, EMBO J, V16, P3303, DOI 10.1093/emboj/16.11.3303; Townsend JP, 2003, GENETICS, V164, P13; Yeiser B, 2002, P NATL ACAD SCI USA, V99, P8737, DOI 10.1073/pnas.092269199; Zeyl C, 2001, GENETICS, V157, P53	32	60	62	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1558	1560		10.1126/science.1087911	http://dx.doi.org/10.1126/science.1087911			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645846	Green Submitted			2022-12-28	WOS:000186802200041
J	Levison, HF; Morbidelli, A				Levison, HF; Morbidelli, A			The formation of the Kuiper belt by the outward transport of bodies during Neptune's migration	NATURE			English	Article							INCLINATION DISTRIBUTION; ACCRETION; ORIGIN; OBJECT	The 'dynamically cold Kuiper belt' consists of objects on low-inclination orbits between similar to40 and similar to50 AU from the Sun. It currently contains material totalling less than a tenth the mass of the Earth(1,2), which is surprisingly low because, according to accretion models(3,4), the objects would not have grown to their present size unless the cold Kuiper belt originally contained tens of Earth masses of solids. Although several mechanisms have been proposed to produce the observed mass depletion, they all have significant limitations(5). Here we show that the objects currently observed in the dynamically cold Kuiper belt were most probably formed within similar to35 AU and were subsequently pushed outward by Neptune's 1:2 mean motion resonance during its final phase of migration. Combining our mechanism with previous work(6,7), we conclude that the entire Kuiper belt formed closer to the Sun and was transported outward during the final stages of planet formation.	SW Res Inst, Boulder, CO 80302 USA; Observ Cote Azur, F-06304 Nice 4, France	UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur	Levison, HF (corresponding author), SW Res Inst, Boulder, CO 80302 USA.	hal@boulder.swri.edu						Allen RL, 2002, ASTRON J, V124, P2949, DOI 10.1086/343773; Brown ME, 2001, ASTRON J, V121, P2804, DOI 10.1086/320391; Duncan MJ, 1997, SCIENCE, V276, P1670, DOI 10.1126/science.276.5319.1670; Duncan MJ, 1998, ASTRON J, V116, P2067, DOI 10.1086/300541; Fernandez JA, 1996, PLANET SPACE SCI, V44, P431, DOI 10.1016/0032-0633(95)00142-5; Gomes RS, 2003, ICARUS, V161, P404, DOI 10.1016/S0019-1035(02)00056-8; GOMES RS, UNPUB ICARUS; Hahn JM, 1999, ASTRON J, V117, P3041, DOI 10.1086/300891; HOLLENBACH D, IN PRESS DEBRIS DISK; Ida S, 2000, ASTROPHYS J, V528, P351, DOI 10.1086/308179; JEWITT D, 1993, NATURE, V362, P730, DOI 10.1038/362730a0; Kenyon SJ, 1998, ASTRON J, V115, P2136, DOI 10.1086/300331; Levison HF, 2001, ASTRON J, V121, P1730, DOI 10.1086/319420; Luu J, 1997, NATURE, V387, P573, DOI 10.1038/42413; MALHOTRA R, 1995, ASTRON J, V110, P420, DOI 10.1086/117532; Morbidelli A, 2003, NATURE, V422, P30, DOI 10.1038/422030a; MORBIDELLI A, IN PRESS COMETS, V2; Stern SA, 1997, ASTRON J, V114, P841, DOI 10.1086/118518; Stone K, 1998, GLQ-J LESBIAN GAY ST, V4, P589; Trujillo CA, 2002, ASTROPHYS J, V566, pL125, DOI 10.1086/339437; Trujillo CA, 2001, ASTRON J, V122, P457, DOI 10.1086/321117; Trujillo CA, 2001, ASTROPHYS J, V554, pL95, DOI 10.1086/320917; WEIDENSCHILLING S, IN PRESS COMETS, V2	25	175	178	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2003	426	6965					419	421		10.1038/nature02120	http://dx.doi.org/10.1038/nature02120			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647375				2022-12-28	WOS:000186800800031
J	Rosenheck, R; Perlick, D; Bingham, S; Liu-Mares, W; Collins, J; Warren, S; Leslie, D; Allan, E; Campbell, EC; Caroff, S; Corwin, J; Davis, L; Douyon, R; Dunn, L; Evans, D; Frecska, E; Grabowski, J; Graeber, D; Herz, L; Kwon, K; Lawson, W; Mena, F; Sheikh, J; Smelson, D; Smith-Gamble, V				Rosenheck, R; Perlick, D; Bingham, S; Liu-Mares, W; Collins, J; Warren, S; Leslie, D; Allan, E; Campbell, EC; Caroff, S; Corwin, J; Davis, L; Douyon, R; Dunn, L; Evans, D; Frecska, E; Grabowski, J; Graeber, D; Herz, L; Kwon, K; Lawson, W; Mena, F; Sheikh, J; Smelson, D; Smith-Gamble, V		Dept Vet Affairs Cooperative Study	Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; ATYPICAL ANTIPSYCHOTICS; REFRACTORY SCHIZOPHRENIA; CLINICAL-TRIAL; RATING-SCALE; CLOZAPINE; OUTCOMES; CARE; IMPROVEMENT; MEDICATION	Context Although olanzapine has been widely adopted as a treatment of choice for schizophrenia, its long-term effectiveness and costs have not been evaluated in a controlled trial in comparison with a standard antipsychotic drug. Objective To evaluate the effectiveness and cost impact of olanzapine compared with haloperidol in the treatment of schizophrenia. Design and Setting Double-blind, randomized controlled trial with randomization conducted between June 1998 and June 2000 at 17 US Department of Veterans Affairs medical centers. Participants Three hundred nine patients with a Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition diagnosis of schizophrenia or schizoaffective disorder, serious symptoms, and serious dysfunction for the previous 2 years. Fifty-nine percent fully completed and 36% partially completed follow-up assessments. Interventions Patients were randomly assigned to receive flexibly dosed olanzapine, 5 to 20 mg/d, with prophylactic benztropine, 1 to 4 mg/d (n=159); or haloperidol, 5 to 20 mg/d (n=150), for 12 months. Main Outcome Measures 'Standardized measures of symptoms, quality of life, neurocognitive status, and adverse effects of medication. Veterans Affairs administrative data and interviews concerning non-VA service use were used to estimate costs from the perspective of the VA health care system and society as a whole (ie, consumption of all resources on behalf of these patients). Results There were no significant differences between groups in study retention; positive, negative, or total symptoms of schizophrenia; quality of life; or extrapyramidal symptoms. Olanzapine was associated with reduced akathisia in the intention-to-treat analysis (P<.001) and with lower symptoms of tardive dyskinesia in a secondary analysis including only observations during blinded treatment with study drug. Small but significant advantages were also observed on measures of memory and motor function. Olanzapine was also associated with more frequent reports of weight gain and significantly greater VA costs, ranging from $3000 to $9000 annually. Differences in societal costs were somewhat smaller and were not significant. Conclusion Olanzapine does not demonstrate advantages compared with haloperidol (in combination with prophylactic benztropine) in compliance, symptoms, extrapyramidal symptoms, or overall quality of life, and its benefits in reducing akathisia and improving cognition must be balanced with the problems of weight gain and higher cost.	Dept Vet Affairs Med Ctr, West Haven, CT USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; Dept Vet Affairs, Cooperat Studies Program, Coordinating Ctr, Perry Point, MD USA; Dept Vet Affairs Med Ctr, Albuquerque, NM USA; Dept Vet Affairs, Cooperat Studies Program, Clin Res Pharm Coordinating Ctr, Albuquerque, NM USA; Dept Vet Affairs Med Ctr, Montrose, NY USA; Dept Vet Affairs Med Ctr, Philadelphia, PA 19104 USA; Dept Vet Affairs Med Ctr, New York, NY USA; Dept Vet Affairs Med Ctr, Tuscaloosa, AL USA; Dept Vet Affairs Med Ctr, Miami, FL USA; Dept Vet Affairs Med Ctr, Durham, NC USA; Dept Vet Affairs Med Ctr, Augusta, GA USA; Dept Vet Affairs Med Ctr, Bay Pines, FL USA; Dept Vet Affairs Med Ctr, Detroit, MI USA; Dept Vet Affairs Med Ctr, Bedford, MA USA; Dept Vet Affairs Med Ctr, Brecksville, OH USA; Howard Univ, Sch Med, Washington, DC 20059 USA; Dept Vet Affairs Med Ctr, Tuskegee, AL USA; Dept Vet Affairs Med Ctr, Palo Alto, CA USA; Dept Vet Affairs Med Ctr, Lyons, NJ USA; Dept Vet Affairs Med Ctr, Indianapolis, IN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Howard University	Rosenheck, R (corresponding author), VA Connecticut Hlth Care Syst, NE Program Evaluat Ctr 182, 950 Campbell Ave, West Haven, CT 06516 USA.		; Lawson, William/O-9758-2017	Leslie, Douglas/0000-0001-6145-4610; Sheikh, Javaid/0000-0002-5762-4186; Lawson, William/0000-0002-9324-7090	NATIONAL CANCER INSTITUTE [R25CA092049] Funding Source: NIH RePORTER; NCI NIH HHS [R25 CA092049] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1981, MANUAL WISCONSIN CAR; BARNES TRE, 1989, BRIT J PSYCHIAT, V154, P672, DOI 10.1192/bjp.154.5.672; Barnett PG, 1999, MED CARE, V37, pAS9, DOI 10.1097/00005650-199904002-00003; Beasley CM, 1997, EUR NEUROPSYCHOPHARM, V7, P125, DOI 10.1016/S0924-977X(96)00392-6; Beasley CM, 1996, NEUROPSYCHOPHARMACOL, V14, P111, DOI 10.1016/0893-133X(95)00069-P; Benton A, 1978, PSYCHOL ASSESSMENT R; BROMET EJ, 1996, TXB PSYCHIAT EPIDEMI; Buchanan RW, 2002, AM J PSYCHIAT, V159, P1035, DOI 10.1176/appi.ajp.159.6.1035; Casey DE, 2001, J CLIN PSYCHIAT, V62, P4; Citrome L, 2002, HARVARD REV PSYCHIAT, V10, P280, DOI 10.1080/10673220216279; Conley RR, 1998, AM J PSYCHIAT, V155, P914, DOI 10.1176/ajp.155.7.914; Cramer J, 2001, SCHIZOPHRENIA BULL, V27, P227, DOI 10.1093/oxfordjournals.schbul.a006869; Dewan M, 1999, AM J PSYCHIAT, V156, P324; DUGGAN L, 2002, COCHRANE DATABASE SY, V2, DOI UNSP CD001359; Essock SM, 2000, ARCH GEN PSYCHIAT, V57, P987, DOI 10.1001/archpsyc.57.10.987; First M.B., 2014, STRUCTURED CLIN INTE; Frisman L, 1996, ADM POLICY MENT HLTH, V23, P533, DOI 10.1007/BF02108689; Geddes J, 2000, BRIT MED J, V321, P1371, DOI 10.1136/bmj.321.7273.1371; GIBBONS RD, 1993, ARCH GEN PSYCHIAT, V50, P739; Gold MR, 1996, COST EFFECTIVENESS H; Green MF, 1996, AM J PSYCHIAT, V153, P321; Guy W, 1976, PUBLICATION ADM, P217; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Hamilton SH, 1998, NEUROPSYCHOPHARMACOL, V18, P41; Hamilton SH, 2000, INT CLIN PSYCHOPHARM, V15, P245, DOI 10.1097/00004850-200015050-00001; Hamilton SH, 1999, PHARMACOECONOMICS, V15, P469, DOI 10.2165/00019053-199915050-00005; HEINRICHS DW, 1984, SCHIZOPHRENIA BULL, V10, P388, DOI 10.1093/schbul/10.3.388; Jastak S., 1984, WIDE RANGE ACHIEVEME; JEWELL M, ZYPREXA TAKES PROZAC; Kane JM, 1996, NEW ENGL J MED, V334, P34, DOI 10.1056/NEJM199601043340109; KASPROW WJ, 1999, HLTH CARE HOMELESS V; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; KEEPERS GA, 1983, ARCH GEN PSYCHIAT, V40, P1113; KERWIN RW, 1994, BRIT J PSYCHIAT, V164, P141, DOI 10.1192/bjp.164.2.141; KLEIN DF, 1969, DIAGNOSIS DRUG TREAT, P165; Leslie DL, 1999, AM J PSYCHIAT, V156, P1250; Lindenmayer JP, 2001, J CLIN PSYCHIAT, V62, P30; MAGUIRE K, 1991, SOURCEBOOK CRIMINAL; *MED EC CO, 1999, DRUG TOP RED BOOK; Melkersson KI, 2000, J CLIN PSYCHIAT, V61, P742, DOI 10.4088/JCP.v61n1006; Meyer JM, 2001, J CLIN PSYCHOPHARM, V21, P369, DOI 10.1097/00004714-200108000-00003; NEALE M, 1999, INTENSIVE PSYCHIAT C; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Pyne JM, 2003, MED CARE, V41, P208, DOI 10.1097/00005650-200302000-00003; RANDOLPH C, 1997, REPEATABLE BATTERY A; Reitan RM., 1979, TRAIL MAKING TEST MA; Revicki DA, 1999, QUAL LIFE RES, V8, P417, DOI 10.1023/A:1008958925848; Rice DP, 1996, HDB MENTAL HLTH EC H; Rosenheck R, 2003, SCHIZOPHRENIA BULL, V29, P81, DOI 10.1093/oxfordjournals.schbul.a006994; Rosenheck R, 1998, HEALTH SERV RES, V33, P1237; Rosenheck R, 1998, ARCH GEN PSYCHIAT, V55, P618, DOI 10.1001/archpsyc.55.7.618; Rosenheck R, 1997, NEW ENGL J MED, V337, P809, DOI 10.1056/NEJM199709183371202; Rosenheck R, 2003, ARCH GEN PSYCHIAT, V60, P940, DOI 10.1001/archpsyc.60.9.940; Rosenheck R, 2001, MED CARE, V39, P302, DOI 10.1097/00005650-200103000-00010; SCHOBEL BD, 1981, SOC SECUR BULL, V44, P21; Sernyak MJ, 2002, AM J PSYCHIAT, V159, P561, DOI 10.1176/appi.ajp.159.4.561; Simpson G M, 1970, Acta Psychiatr Scand Suppl, V212, P11; Tollefson GD, 1997, AM J PSYCHIAT, V154, P457; *US BUR JUST STAT, 1991, JUST EXP EMPL US 198; WAGNER TH, 2001, HERCS INPATIENT AVER; Ware J. E., 1993, SF36 HLTH SURVEY MAN; Weisner C, 2001, JAMA-J AM MED ASSOC, V286, P1715, DOI 10.1001/jama.286.14.1715	62	266	281	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2003	290	20					2693	2702		10.1001/jama.290.20.2693	http://dx.doi.org/10.1001/jama.290.20.2693			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	747CR	14645311				2022-12-28	WOS:000186788100021
J	Anderson, G; Aagaard, B; Hudnut, K				Anderson, G; Aagaard, B; Hudnut, K			Fault interactions and large complex earthquakes in the Los Angeles area	SCIENCE			English	Article							SAN-ANDREAS FAULT; CALIFORNIA	Faults in complex tectonic environments interact in various ways, including triggered rupture of one fault by another, that may increase seismic hazard in the surrounding region. We model static and dynamic fault interactions between the strike-slip and thrust fault systems in southern California. We find that rupture of the Sierra Madre-Cucamonga thrust fault system is unlikely to trigger rupture of the San Andreas or San Jacinto strike-slip faults. However, a large northern San Jacinto fault earthquake could trigger a cascading rupture of the Sierra Madre-Cucamonga system, potentially causing a moment magnitude 7.5 to 7.8 earthquake on the edge of the Los Angeles metropolitan region.	US Geol Survey, Pasadena, CA 91106 USA	United States Department of the Interior; United States Geological Survey	Anderson, G (corresponding author), UNAVCO, 6350 Nautilus Dr, Boulder, CO 80301 USA.	anderson@unavco.org	Hudnut, Kenneth W/AAB-4549-2020; Hudnut, Kenneth W/B-1945-2009	Hudnut, Kenneth W/0000-0002-3168-4797; Hudnut, Kenneth W/0000-0002-3168-4797; Aagaard, Brad/0000-0002-8795-9833				Aagaard BT, 2001, B SEISMOL SOC AM, V91, P1765, DOI 10.1785/0120000257; AAGAARD BT, 1999, 9903 CALTECH EARTHQ; AAGAARD BT, IN PRESS B SEISMOL S; Anderson G, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016724; Eberhart-Phillips D, 2003, SCIENCE, V300, P1113, DOI 10.1126/science.1082703; Fumal TE, 2002, B SEISMOL SOC AM, V92, P2726, DOI 10.1785/0120000608; Harris RA, 1998, J GEOPHYS RES-SOL EA, V103, P24347, DOI 10.1029/98JB01576; King GCP, 2001, ADV GEOPHYS, V44, P1, DOI 10.1016/S0065-2687(00)80006-0; Kurushin R.A., 1997, 320 GEOL SOC AM; LIN J, IN PRESS J GEOPHYS R; Parsons T, 1999, J GEOPHYS RES-SOL EA, V104, P20183, DOI 10.1029/1999JB900056; PLESCH A, 2002, EOS T AGU, V83; POLLITZ FF, 1992, B SEISMOL SOC AM, V82, P454; Rubin CM, 1998, SCIENCE, V281, P398, DOI 10.1126/science.281.5375.398; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; Toppozada TR, 2002, B SEISMOL SOC AM, V92, P2555, DOI 10.1785/0120000614	16	46	45	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1946	1949		10.1126/science.1090747	http://dx.doi.org/10.1126/science.1090747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671298				2022-12-28	WOS:000187174000055
J	Benton, R; St Johnston, D				Benton, R; St Johnston, D			Drosophila PAR-1 and 14-3-3 inhibit Bazooka/PAR-3 to establish complementary cortical domains in polarized cells	CELL			English	Article							EPITHELIAL TIGHT JUNCTION; PROTEIN-KINASE-C; CAENORHABDITIS-ELEGANS; AXIS FORMATION; OOCYTE DIFFERENTIATION; LOCALIZATION; MAINTENANCE; NEUROBLASTS; TUMOR; STARDUST	PAR-1 kinases are required for polarity in diverse cell types, such as epithelial cells, where they localize laterally. PAR-1 activity is believed to be transduced by binding of 14-3-3 proteins to its phosphorylated substrates, but the relevant targets are unknown. We show that PAR-1 phosphorylates Bazooka/PAR-3 on two conserved serines to generate 14-3-3 binding sites. This inhibits formation of the Bazooka/PAR-6/ aPKC complex by blocking Bazooka oligomerization and binding to aPKC. In epithelia, this complex localizes apically and defines the apical membrane, whereas Bazooka lacking PAR-1 phosphorylation/14-3-3 binding sites forms ectopic lateral complexes. Lateral exclusion by PAR-1/14-3-3 cooperates with apical anchoring by Crumbs/Stardust to restrict Bazooka localization, and loss of both pathways disrupts epithelial polarity. PAR-1 also excludes Bazooka from the posterior of the oocyte, and disruption of this regulation causes anterior-posterior polarity defects. Thus, antagonism of Bazooka by PAR-1/14-3-3 may represent a general mechanism for establishing complementary cortical domains in polarized cells.	Univ Cambridge, Wellcome Trust Canc Res UK Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge	St Johnston, D (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Inst, Cambridge CB2 1QR, England.		St Johnston, Daniel/C-9568-2009	St Johnston, Daniel/0000-0001-5582-3301				Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Benton R, 2003, CURR BIOL, V13, P1330, DOI 10.1016/S0960-9822(03)00508-6; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Cox DN, 2001, CURR BIOL, V11, P75, DOI 10.1016/S0960-9822(01)00027-6; Cox DN, 2001, P NATL ACAD SCI USA, V98, P14475, DOI 10.1073/pnas.261565198; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Doerflinger H, 2003, DEVELOPMENT, V130, P3965, DOI 10.1242/dev.00616; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Goldstein B, 1996, DEVELOPMENT, V122, P1467; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; Hausser A, 1999, J BIOL CHEM, V274, P9258, DOI 10.1074/jbc.274.14.9258; Hirose T, 2002, J CELL SCI, V115, P2485; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; HURD TW, 2003, IN PRESS CURR BIOL; Huynh JR, 2001, DEVELOPMENT, V128, P1201; Huynh JR, 2001, CURR BIOL, V11, P901, DOI 10.1016/S0960-9822(01)00244-5; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; James P, 1996, GENETICS, V144, P1425; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lyczak R, 2002, DEV CELL, V3, P157, DOI 10.1016/S1534-5807(02)00226-5; Mizuno K, 2003, J BIOL CHEM, V278, P31240, DOI 10.1074/jbc.M303593200; Morton DG, 2002, DEV BIOL, V241, P47, DOI 10.1006/dbio.2001.0489; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; Nagai-Tamai Y, 2002, GENES CELLS, V7, P1161, DOI 10.1046/j.1365-2443.2002.00590.x; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Pielage J, 2003, DEV CELL, V5, P841, DOI 10.1016/S1534-5807(03)00358-7; Riechmann V, 2001, CURR OPIN GENET DEV, V11, P374, DOI 10.1016/S0959-437X(00)00207-0; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; Rose LS, 1998, ANNU REV GENET, V32, P521, DOI 10.1146/annurev.genet.32.1.521; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Tomancak P, 2000, NAT CELL BIOL, V2, P458, DOI 10.1038/35017101; Vaccari T, 2002, CURR BIOL, V12, P1524, DOI 10.1016/S0960-9822(02)01079-5; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; XU T, 1993, DEVELOPMENT, V117, P1223; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4	53	319	320	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 12	2003	115	6					691	704		10.1016/S0092-8674(03)00938-3	http://dx.doi.org/10.1016/S0092-8674(03)00938-3			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675534	Bronze			2022-12-28	WOS:000187366100009
J	Gross, JD; Moerke, NJ; von der Haar, T; Lugovskoy, AA; Sachs, AB; McCarthy, JEG; Wagner, G				Gross, JD; Moerke, NJ; von der Haar, T; Lugovskoy, AA; Sachs, AB; McCarthy, JEG; Wagner, G			Ribosome loading onto the mRNA cap is driven by conformational coupling between eIF4G and eIF4E	CELL			English	Article							DEPENDENT TRANSLATION INITIATION; FACTOR 4G EIF4G; PROTEIN-SYNTHESIS; BINDING-PROTEIN; POLY(A)-BINDING PROTEIN; FACTOR EIF-4E; 4E BINDING; FACTOR 4F; YEAST; PHOSPHORYLATION	The eukaryotic initiation factor 4G (eIF4G) is the core of a multicomponent switch controlling gene expression at the level of translation initiation. It interacts with the small ribosomal subunit interacting protein eIF3, and the eIF4E/cap-mRNA complex in order to load the ribosome onto mRNA during cap-dependent translation. We describe the solution structure of the complex between yeast eIF4E/cap and eIF4G (393490). Binding triggers a coupled folding transition of eIF4G (393-490) and the eIF4E N terminus resulting in a molecular bracelet whereby eIF4G (393-490) forms a right-handed helical ring that wraps around the N terminus of eIF4E. Cofolding allosterically enhances association of eIF4E with the cap and is required for maintenance of optimal growth and polysome distributions in vivo. Our data explain how mRNA, eIF4E, and eIF4G exists as a stable mRNP that may facilitate multiple rounds of ribosomal loading during translation initiation, a key determinant in the overall rate of protein synthesis.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Grad Program Biol & Biomed Sci, Boston, MA 02115 USA; Univ Manchester, Inst Sci & Technol, Posttranscript Control Grp, Dept Biomol Sci, Manchester M60 1QD, Lancs, England; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Manchester; University of California System; University of California Berkeley	Wagner, G (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	gerhard_wagner@hms.harvard.edu		von der Haar, Tobias/0000-0002-6031-9254	NATIONAL CANCER INSTITUTE [R01CA068262] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER; NCI NIH HHS [CA68262] Funding Source: Medline; NCRR NIH HHS [RR00995] Funding Source: Medline; NIGMS NIH HHS [GM47467, P01 GM047467] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; ALTMANN M, 1987, MOL CELL BIOL, V7, P998, DOI 10.1128/MCB.7.3.998; Asano K, 2001, EMBO J, V20, P2326, DOI 10.1093/emboj/20.9.2326; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; BENNE R, 1976, P NATL ACAD SCI USA, V73, P3005, DOI 10.1073/pnas.73.9.3005; Berset C, 2003, RNA, V9, P871, DOI 10.1261/rna.5380903; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BRUNGER AT, 1996, X PLOR VERSION 3 851; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P1624, DOI 10.1021/bi00220a026; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; ETCHISON D, 1982, J BIOL CHEM, V257, P4806; Fletcher CM, 1998, BIOCHEMISTRY-US, V37, P9, DOI 10.1021/bi972494r; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Haghighat A, 1997, J BIOL CHEM, V272, P21677, DOI 10.1074/jbc.272.35.21677; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; He H, 2003, MOL CELL BIOL, V23, P5431, DOI 10.1128/MCB.23.15.5431-5445.2003; Hentze MW, 1997, SCIENCE, V275, P500, DOI 10.1126/science.275.5299.500; Hershey J. W. B., 2000, TRANSLATIONAL CONTRO; Hershey PEC, 1999, J BIOL CHEM, V274, P21297, DOI 10.1074/jbc.274.30.21297; IIZUKA N, 1994, MOL CELL BIOL, V14, P7322, DOI 10.1128/MCB.14.11.7322; Jacobson A, 1996, TRANSLATIONAL CONTRO; Karim MM, 2001, J BIOL CHEM, V276, P20750, DOI 10.1074/jbc.M011068200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE KAW, 1982, P NATL ACAD SCI-BIOL, V79, P3447, DOI 10.1073/pnas.79.11.3447; Luo YJ, 2001, J BIOL CHEM, V276, P43083, DOI 10.1074/jbc.M104970200; MADER S, 1995, MOL CELL BIOL, V15, P4990; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Ohlmann T, 1997, EMBO J, V16, P844, DOI 10.1093/emboj/16.4.844; OLIVEIRA CC, 1993, MOL MICROBIOL, V9, P521, DOI 10.1111/j.1365-2958.1993.tb01713.x; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pestova TV, 1996, MOL CELL BIOL, V16, P6870; Prevot D, 2003, BIOL CELL, V95, P141, DOI 10.1016/S0248-4900(03)00031-5; Ptushkina M, 1999, EMBO J, V18, P4068, DOI 10.1093/emboj/18.14.4068; Ptushkina M, 1998, EMBO J, V17, P4798, DOI 10.1093/emboj/17.16.4798; RAUGHT B, 2000, TRANSLATIONAL CONTRO; Richter JD, 2000, COLD SPRING HARBOR M, V39, P785; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; SHA M, 1995, J BIOL CHEM, V270, P29904; Tarun SZ, 1997, MOL CELL BIOL, V17, P6876, DOI 10.1128/MCB.17.12.6876; Uchida N, 2002, J BIOL CHEM, V277, P50286, DOI 10.1074/jbc.M203029200; Vasilescu S, 1996, J BIOL CHEM, V271, P7030, DOI 10.1074/jbc.271.12.7030; von der Haar T, 2000, J BIOL CHEM, V275, P30551, DOI 10.1074/jbc.M004565200; von der Haar T, 2002, MOL MICROBIOL, V46, P531, DOI 10.1046/j.1365-2958.2002.03172.x; Wei CC, 1998, BIOCHEMISTRY-US, V37, P1910, DOI 10.1021/bi9724570; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7	56	269	273	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2003	115	6					739	750		10.1016/S0092-8674(03)00975-9	http://dx.doi.org/10.1016/S0092-8674(03)00975-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675538	Bronze			2022-12-28	WOS:000187366100013
J	Karl, TR; Trenberth, KE				Karl, TR; Trenberth, KE			Modern global climate change	SCIENCE			English	Article							PRECIPITATION; UNCERTAINTIES; CIRCULATION; ENERGY; IMPACT	Modern climate change is dominated by human influences, which are now large enough to exceed the bounds of natural variability. The main source of global climate change is human-induced changes in atmospheric composition. These perturbations primarily result from emissions associated with energy use, but on local and regional scales, urbanization and land use changes are also important. Although there has been progress in monitoring and understanding climate change, there remain many scientific, technical, and institutional impediments to precisely planning for, adapting to, and mitigating the effects of climate change. There is still considerable uncertainty about the rates of change that can be expected, but it is clear that these changes will be increasingly manifested in important and tangible ways, such as changes in extremes of temperature and precipitation, decreases in seasonal and perennial snow and ice extent, and sea level rise. Anthropogenic climate change is now likely to continue for many centuries. We are venturing into the unknown with climate, and its associated impacts could be quite disruptive.	NOAA, Natl Climat Data Ctr, Satellite & Informat Serv, Asheville, NC 28801 USA; Natl Ctr Atmospher Res, Boulder, CO 80307 USA	National Center Atmospheric Research (NCAR) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Center Atmospheric Research (NCAR) - USA	Karl, TR (corresponding author), NOAA, Natl Climat Data Ctr, Satellite & Informat Serv, 151 Patton Ave, Asheville, NC 28801 USA.	Thomas.R.Karl@noaa.gov	Trenberth, Kevin Edward/A-5683-2012	Trenberth, Kevin Edward/0000-0002-1445-1000				Bonan GB, 1999, ECOL APPL, V9, P1305, DOI 10.1890/1051-0761(1999)009[1305:FFTPIO]2.0.CO;2; Broecker WS, 1997, SCIENCE, V278, P1582, DOI 10.1126/science.278.5343.1582; CHARNEY JG, 1975, Q J ROY METEOR SOC, V101, P193, DOI 10.1002/qj.49710142802; Cicerone RJ, 2000, P NATL ACAD SCI USA, V97, P10304, DOI 10.1073/pnas.97.19.10304; COAKLEY J, COMMUNICATION; Coakley JA, 2002, J ATMOS SCI, V59, P668, DOI 10.1175/1520-0469(2002)059<0668:LTTAIR>2.0.CO;2; Colman R, 2003, CLIM DYNAM, V20, P865, DOI 10.1007/s00382-003-0310-z; Dolman A. J., 2003, GLOBAL ENV CHANGE LA; Forest CE, 2002, SCIENCE, V295, P113, DOI 10.1126/science.1064419; GCOS, 2003, GCOS82; GROISMAN PY, 1994, SCIENCE, V263, P198, DOI 10.1126/science.263.5144.198; Groisman PY, 1999, CLIMATIC CHANGE, V42, P243, DOI 10.1023/A:1005432803188; Hahmann AN, 1997, J CLIMATE, V10, P1944, DOI 10.1175/1520-0442(1997)010<1944:RBMOTS>2.0.CO;2; Hoerling MP, 2001, SCIENCE, V292, P90, DOI 10.1126/science.1058582; Hoffert MI, 2002, SCIENCE, V298, P981, DOI 10.1126/science.1072357; Houghton J. T., 2001, CLIMATE CHANGE 2001; Karl TR, 1997, B AM METEOROL SOC, V78, P1107, DOI 10.1175/1520-0477(1997)078<1107:TCHWHL>2.0.CO;2; Karl TR, 1999, SCI AM, V281, P100, DOI 10.1038/scientificamerican1299-100; Katz RW, 1999, ADV WATER RESOUR, V23, P133, DOI 10.1016/S0309-1708(99)00017-2; Kiehl JT, 1997, B AM METEOROL SOC, V78, P197, DOI 10.1175/1520-0477(1997)078<0197:EAGMEB>2.0.CO;2; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; MARLAND G, 2002, TRENDS COMPENDIUM DA; NOBRE C, 2000, IN PRESS VEGETATION; Santer BD, 2003, SCIENCE, V300, P1280, DOI 10.1126/science.1082393; Sato M, 2003, P NATL ACAD SCI USA, V100, P6319, DOI 10.1073/pnas.0731897100; Saunders MA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016832; Stocker TF, 2000, P NATL ACAD SCI USA, V97, P1362, DOI 10.1073/pnas.97.4.1362; Trenberth KE, 2002, B AM METEOROL SOC, V83, P1593, DOI 10.1175/BAMS-83-11-1593(2002)083<1593:TNFASA>2.3.CO;2; Trenberth KE, 1997, GEOPHYS RES LETT, V24, P3057, DOI 10.1029/97GL03092; Trenberth KE, 2003, B AM METEOROL SOC, V84, P1205, DOI 10.1175/BAMS-84-9-1205; United States Department of State, 2002, US CLIM ACT REP 2002; *US NAT RES COUNC, 2001, CLIM CHANG SCI AN SO; Wigley TML, 2001, SCIENCE, V293, P451, DOI 10.1126/science.1061604	33	1163	1254	19	691	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2003	302	5651					1719	1723		10.1126/science.1090228	http://dx.doi.org/10.1126/science.1090228			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657489	Green Published			2022-12-28	WOS:000186970100036
J	McGuire, SE; Le, PT; Osborn, AJ; Matsumoto, K; Davis, RL				McGuire, SE; Le, PT; Osborn, AJ; Matsumoto, K; Davis, RL			Spatiotemporal rescue of memory dysfunction in Drosophila	SCIENCE			English	Article							MUSHROOM BODIES; ADENYLATE-CYCLASE; EXPRESSION; ACQUISITION; RUTABAGA; GENE	We have developed a method for temporal and regional gene expression targeting (TARGET) in Drosophila and show the simultaneous spatial and temporal rescue of a memory defect. The transient expression of the rutabaga-encoded adenylyl cyclase in the mushroom bodies of the adult brain was necessary and sufficient to rescue the rutabaga memory deficit, which rules out a developmental brain defect in the etiology of this deficit and demonstrates an acute role for rutabaga in memory formation in these neurons. The TARGET system offers general utility in simultaneously addressing issues of when and where gene products are required.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648602, Japan	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Nagoya University	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	rdavis@bcm.tmc.edu	Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608	NIGMS NIH HHS [GM63929] Funding Source: Medline; NINDS NIH HHS [NS19904] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019904] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdel-Majid RM, 1998, NAT GENET, V19, P289, DOI 10.1038/980; Armstrong JD, 1998, LEARN MEMORY, V5, P102; BALLING A, 1987, J NEUROGENET, V4, P65, DOI 10.3109/01677068709102334; Barth M, 1997, LEARN MEMORY, V4, P219, DOI 10.1101/lm.4.2.219; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; BRAND AH, 1993, DEVELOPMENT, V118, P401; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; DUDAI Y, 1988, J COMP PHYSIOL A, V162, P101, DOI 10.1007/BF01342707; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; Hitier R, 1998, NEUROREPORT, V9, P2717, DOI 10.1097/00001756-199808240-00006; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Poser S, 2001, INT J DEV NEUROSCI, V19, P387, DOI 10.1016/S0736-5748(00)00094-0; Roman G, 2001, BIOESSAYS, V23, P571, DOI 10.1002/bies.1083; Waddell S, 2001, ANNU REV NEUROSCI, V24, P1283, DOI 10.1146/annurev.neuro.24.1.1283; Welker E, 1996, SCIENCE, V271, P1864, DOI 10.1126/science.271.5257.1864; YANG MY, 1995, NEURON, V15, P45; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	19	918	932	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2003	302	5651					1765	1768		10.1126/science.1089035	http://dx.doi.org/10.1126/science.1089035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657498				2022-12-28	WOS:000186970100048
J	Zuber, MT				Zuber, MT			Planetary science - Learning to think like Martians	SCIENCE			English	Editorial Material							CARBON-DIOXIDE; BEHAVIOR; MARS/; TES		MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Zuber, MT (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.							BOYNTON WV, 2003, 3 INT C MARS POL SCI; FELDMAN WC, 2003, 3 INT C MARS POL SCI; Haberle R.M, 2003, 3 INT C MARS POL SCI; Kieffer HH, 2000, J GEOPHYS RES-PLANET, V105, P9653, DOI 10.1029/1999JE001136; KIEFFER HH, 2003, 3 INT C MARS POL SCI; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; LITVAK ML, 2003, 3 INT C MARS POL SCI; LONGHI J, 2003, 3 INT C MARS POL SCI; Malin MC, 2001, SCIENCE, V294, P2146, DOI 10.1126/science.1066416; Smith DE, 2001, SCIENCE, V294, P2141, DOI 10.1126/science.1066556; SMITH DE, 2003, 3 INT C MARS POL SCI; Titus TN, 2001, J GEOPHYS RES-PLANET, V106, P23181, DOI 10.1029/2000JE001284; ZUBER MT, 2003, 3 INT C MAR POL SCI; 2003, 3 INT C MARS POL SCI	14	8	8	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1694	1695		10.1126/science.1090517	http://dx.doi.org/10.1126/science.1090517			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657483				2022-12-28	WOS:000186970100030
J	Findler, M; Garfunkel, AA				Findler, M; Garfunkel, AA			Oral lichen planus as a clinical sign of graft-versus-host disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hadassah Univ Hosp, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Findler, M (corresponding author), Hadassah Univ Hosp, IL-91120 Jerusalem, Israel.								0	0	1	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2003	349	23					2223	2223		10.1056/NEJMicm010397	http://dx.doi.org/10.1056/NEJMicm010397			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LH	14657429				2022-12-28	WOS:000186921700008
J	Lorenz, K; Lohse, MJ; Quitterer, U				Lorenz, K; Lohse, MJ; Quitterer, U			Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2	NATURE			English	Article							ADRENERGIC-RECEPTOR KINASE; BETA-GAMMA-SUBUNITS; PHOSPHORYLATION; DESENSITIZATION; HETERODIMERS; SUPPRESSION; ACTIVATION; TERMINUS; BINDING	Feedback inhibition is a fundamental principle in signal transduction allowing rapid adaptation to different stimuli. In mammalian cells, the major feedback inhibitor for G-protein-coupled receptors (GPCR) is G-protein-coupled receptor kinase 2 (GRK-2), which phosphorylates activated receptors, uncouples them from G proteins and initiates their internalization(1,2). The functions of GRK-2 are indispensable and need to be tightly controlled(3). Dysregulation promotes disorders such as hypertension(4) or heart failure(5). In our search for a control mechanism for this vital kinase, here we show that the Raf kinase inhibitor protein(6-8) (RKIP) is a physiological inhibitor of GRK-2. After stimulation of GPCR, RKIP dissociates from its known target, Raf-1 (refs 6 - 8), to associate with GRK-2 and block its activity. This switch is triggered by protein kinase C (PKC)- dependent phosphorylation of the RKIP on serine 153. The data delineate a new principle in signal transduction: by activating PKC, the incoming receptor signal is enhanced both by removing an inhibitor from Raf-1 and by blocking receptor internalization. A physiological role for this mechanism is shown in cardiomyocytes in which the downregulation of RKIP restrains beta-adrenergic signalling and contractile activity.	Inst Pharmakol & Toxikol, D-97078 Wurzburg, Germany	University of Wurzburg	Quitterer, U (corresponding author), Inst Pharmakol & Toxikol, Versbacher Str 9, D-97078 Wurzburg, Germany.	toph029@rzbox.uni-wuerzburg.de	Lohse, Martin J/A-7160-2012; Lorenz, Kristina/F-3522-2016	Lohse, Martin J/0000-0002-0599-3510; Lorenz, Kristina/0000-0002-5747-2207				AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Dicker F, 1999, P NATL ACAD SCI USA, V96, P5476, DOI 10.1073/pnas.96.10.5476; Diviani D, 1996, J BIOL CHEM, V271, P5049; Dunigan CD, 2000, METH MOL B, V136, P329; Eichmann T, 2003, J BIOL CHEM, V278, P8052, DOI 10.1074/jbc.M204795200; Gros R, 1997, J CLIN INVEST, V99, P2087, DOI 10.1172/JCI119381; Hasuwa H, 2002, FEBS LETT, V532, P227, DOI 10.1016/S0014-5793(02)03680-3; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; Kallal L, 1998, J BIOL CHEM, V273, P322, DOI 10.1074/jbc.273.1.322; Krasel C, 2001, J BIOL CHEM, V276, P1911, DOI 10.1074/jbc.M008773200; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lefkowitz R J, 1998, Adv Pharmacol, V42, P416; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Ritter O, 2002, FASEB J, V16, P283, DOI 10.1096/fj.02-0321fje; Slupsky JR, 1999, CURR BIOL, V9, P971, DOI 10.1016/S0960-9822(99)80426-6; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Wu JC, 2003, J CELL BIOCHEM, V88, P823, DOI 10.1002/jcb.10390; Yeung K, 2000, MOL CELL BIOL, V20, P3079, DOI 10.1128/MCB.20.9.3079-3085.2000; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686; Yu QM, 1999, J NEUROCHEM, V73, P1222, DOI 10.1046/j.1471-4159.1999.0731222.x	27	284	326	1	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					574	579		10.1038/nature02158	http://dx.doi.org/10.1038/nature02158			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654844				2022-12-28	WOS:000186944300043
J	MacDonald, MP; Spalding, GC; Dholakia, K				MacDonald, MP; Spalding, GC; Dholakia, K			Microfluidic sorting in an optical lattice	NATURE			English	Article							SEPARATION; DNA; MACROMOLECULES; ARRAY; TRAP	The response of a microscopic dielectric object to an applied light field can profoundly affect its kinetic motion(1). A classic example of this is an optical trap, which can hold a particle in a tightly focused light beam(2). Optical fields can also be used to arrange, guide or deflect particles in appropriate light-field geometries(3,4). Here we demonstrate an optical sorter for microscopic particles that exploits the interaction of particles-biological or otherwise-with an extended, interlinked, dynamically reconfigurable, three-dimensional optical lattice. The strength of this interaction with the lattice sites depends on the optical polarizability of the particles, giving tunable selection criteria. We demonstrate both sorting by size (of protein microcapsule drug delivery agents) and sorting by refractive index (of other colloidal particle streams). The sorting efficiency of this method approaches 100%, with values of 96% or more observed even for concentrated solutions with throughputs exceeding those reported for fluorescence-activated cell sorting(5). This powerful, non-invasive technique is suited to sorting and fractionation within integrated ('lab-on-a-chip') microfluidic systems, and can be applied in colloidal, molecular and biological research.	Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; Illinois Wesleyan Univ, Dept Phys, Bloomington, IL 61702 USA	University of St Andrews; Illinois Wesleyan University	MacDonald, MP (corresponding author), Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.		Dholakia, Kishan/C-9873-2009; MacDonald, Michael P/F-5880-2011; Spalding, Gabriel C/C-8246-2009	MacDonald, Michael P/0000-0003-4415-5437; Spalding, Gabriel C/0000-0003-1126-3968; Dholakia, Kishan/0000-0001-6534-9009				ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Athanasopoulou A, 1996, INSTRUM SCI TECHNOL, V24, P79, DOI 10.1080/10739149608000470; BURNS MM, 1990, SCIENCE, V249, P749, DOI 10.1126/science.249.4970.749; Chou CF, 2002, BIOPHYS J, V83, P2170, DOI 10.1016/S0006-3495(02)73977-5; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Dholakia K, 2002, PHYS WORLD, V15, P31, DOI 10.1088/2058-7058/15/10/37; Duke TAJ, 1998, PHYS REV LETT, V80, P1552, DOI 10.1103/PhysRevLett.80.1552; Ertas D, 1998, PHYS REV LETT, V80, P1548, DOI 10.1103/PhysRevLett.80.1548; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095; Galbraith DW, 1999, METHOD CELL BIOL, V58, P315; Han J, 2000, SCIENCE, V288, P1026, DOI 10.1126/science.288.5468.1026; IMASAKA T, 1995, ANAL CHEM, V67, P1763, DOI 10.1021/ac00107a003; Korda PT, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.128301; Korda PT, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.024504; MacDonald MP, 2002, SCIENCE, V296, P1101, DOI 10.1126/science.1069571; MACDONALD MP, UNPUB PHYS REV LETT; Marmottant P, 2003, NATURE, V423, P153, DOI 10.1038/nature01613; Nykypanchuk D, 2002, SCIENCE, V297, P987, DOI 10.1126/science.1073277; Tatarkova SA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.038101	20	1069	1110	9	394	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					421	424		10.1038/nature02144	http://dx.doi.org/10.1038/nature02144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647376				2022-12-28	WOS:000186800800032
J	Burls, A; Sandercock, J				Burls, A; Sandercock, J			How to make a compelling submission to NICE: tips for sponsoring organisations	BRITISH MEDICAL JOURNAL			English	Article									Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Burls, A (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England.		Burls, Amanda J.E./D-7641-2011	Burls, Amanda/0000-0001-9540-622X; Sandercock, Josie/0000-0001-7337-8635					0	9	9	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1446	1448		10.1136/bmj.327.7429.1446	http://dx.doi.org/10.1136/bmj.327.7429.1446			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684641	Green Published			2022-12-28	WOS:000187562700012
J	Russell, TG; Russell, TM				Russell, TG; Russell, TM			Medicine in Egypt at the time of Napoleon Bonaparte	BRITISH MEDICAL JOURNAL			English	Article									Ipswich Hosp, Dept Anaesthet, Ipswich IP4 5PD, Suffolk, England; Univ Edinburgh, Sch Arts Culture & Environm, Edinburgh EH1 1JZ, Midlothian, Scotland	Ipswich Hospital NHS Trust; Ipswich Hospital; University of Edinburgh	Russell, TM (corresponding author), Ipswich Hosp, Dept Anaesthet, Ipswich IP4 5PD, Suffolk, England.							EDME J, 1921, DESCRIPTION EGYPTE, P1; LEBARON LM, 1823, DESCRIPTION EGYPTE, V13, P29; NAPOLEON GRAND, 1821, DESCRIPTION EGYPTE; ROUYER M, 1822, DESCRIPTION EGYPTE, V11, P429; Russell Terence M, 2001, NAPOLEONIC SURVEY EG	5	7	7	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1461	1464		10.1136/bmj.327.7429.1461	http://dx.doi.org/10.1136/bmj.327.7429.1461			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684650	Green Published			2022-12-28	WOS:000187562700021
J	Gobert, V; Gottar, M; Matskevich, AA; Rutschmann, S; Royet, J; Belvin, M; Hoffmann, JA; Ferrandon, D				Gobert, V; Gottar, M; Matskevich, AA; Rutschmann, S; Royet, J; Belvin, M; Hoffmann, JA; Ferrandon, D			Dual activation of the Drosophila Toll pathway by two pattern recognition receptors	SCIENCE			English	Article							GRAM-NEGATIVE BACTERIA; GENOME-WIDE ANALYSIS; IMMUNE-RESPONSE; BINDING PROTEIN; SERINE-PROTEASE; HOST-DEFENSE; BOMBYX-MORI; BETA-1,3-GLUCAN; ANTIFUNGAL; MICROORGANISMS	The Toll-dependent defense against Gram-positive bacterial infections in Drosophila is mediated through the peptidoglycan recognition protein SA(PGRP-SA). A mutation termed osiris disrupts the Gram-negative binding protein 1 (GNBP1) gene and leads to compromised survival of mutant flies after Gram-positive infections, but not after fungal or Gram-negative bacterial challenge. Our results demonstrate that GNBP1 and PGRP-SA can jointly activate the Toll pathway. The potential for a combination of distinct proteins to mediate detection of infectious nonself in the fly will refine the concept of pattern recognition in insects.	CNRS, Inst Biol Mol & Cellulaire, Unite Propre Rech 9022, F-67084 Strasbourg, France; Exelixis Inc, San Francisco, CA 94083 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Exelixis, Inc.	Ferrandon, D (corresponding author), CNRS, Inst Biol Mol & Cellulaire, Unite Propre Rech 9022, 15 Rue Rene Descartes, F-67084 Strasbourg, France.			FERRANDON, Dominique/0000-0001-7680-7773; Rutschmann, Sophie/0000-0003-3932-1162				Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; GOBERT V, UNPUB; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Lee WJ, 1996, P NATL ACAD SCI USA, V93, P7888, DOI 10.1073/pnas.93.15.7888; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Meng XJ, 1999, GENE DEV, V13, P792, DOI 10.1101/gad.13.7.792; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; WEBER AN, 2003, NATURE IMMUNOL, V4, P494; YOSHIDA H, 1986, BIOCHEM BIOPH RES CO, V141, P1177, DOI 10.1016/S0006-291X(86)80168-1; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200	26	290	305	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2126	2130		10.1126/science.1085432	http://dx.doi.org/10.1126/science.1085432			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684822				2022-12-28	WOS:000187385200046
J	Johnson, JM; Castle, J; Garrett-Engele, P; Kan, ZY; Loerch, PM; Armour, CD; Santos, R; Schadt, EE; Stoughton, R; Shoemaker, DD				Johnson, JM; Castle, J; Garrett-Engele, P; Kan, ZY; Loerch, PM; Armour, CD; Santos, R; Schadt, EE; Stoughton, R; Shoemaker, DD			Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays	SCIENCE			English	Article							HUMAN GENES; TRANSCRIPTOME; EXPRESSION; DIVERSITY; BIOLOGY; ARRAYS	Alternative pre-messenger RNA (pre-mRNA) splicing plays important roles in development, physiology, and disease, and more than half of human genes are alternatively spliced. To understand the biological roles and regulation of alternative splicing across different tissues and stages of development, systematic methods are needed. Here, we demonstrate the use of microarrays to monitor splicing at every exon-exon junction in more than 10,000 multi-exon human genes in 52 tissues and cell lines. These genome-wide data provide experimental evidence and tissue distributions for thousands of known and novel alternative splicing events. Adding to previous studies, the results indicate that at least 74% of human multi-exon genes are alternatively spliced.	Merck & Co Inc, Rosetta Inpharmat LLC, Kirkland, WA 98034 USA	Merck & Company	Johnson, JM (corresponding author), Merck & Co Inc, Rosetta Inpharmat LLC, 115th Ave NE, Kirkland, WA 98034 USA.	jason_johnson@merck.com; shoemakd@stanfordalumni.org						Aboushadi N, 2000, BIOCHEMISTRY-US, V39, P237, DOI 10.1021/bi9916325; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Camargo AA, 2001, P NATL ACAD SCI USA, V98, P12103, DOI 10.1073/pnas.201182798; Castle J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r66; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Egan J.P., 1975, SIGNAL DETECTION THE; Hu GK, 2001, GENOME RES, V11, P1237, DOI 10.1101/gr.165501; Kan ZY, 2002, GENOME RES, V12, P1837, DOI 10.1101/gr.764102; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850; Nussbaum RL, 1997, HUM GENET, V99, P145, DOI 10.1007/s004390050329; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455; Wang H, 2003, BIOINFORMATICS, V19, pi315, DOI 10.1093/bioinformatics/btg1044; Yeakley JM, 2002, NAT BIOTECHNOL, V20, P353, DOI 10.1038/nbt0402-353; Zavolan M, 2003, GENOME RES, V13, P1290, DOI 10.1101/gr.1017303	20	1124	1208	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2141	2144		10.1126/science.1090100	http://dx.doi.org/10.1126/science.1090100			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684825				2022-12-28	WOS:000187385200050
J	Paz, JP				Paz, JP			Randomness in quantum computation	SCIENCE			English	Editorial Material									Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Paz, JP (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA.	jpaz@lanl.gov	Paz, Juan Pablo/C-5947-2008					BENNETT CH, 2003, QUANTPH0307100; Emerson J, 2003, SCIENCE, V302, P2098, DOI 10.1126/science.1090790; HAYDEN P, 2003, QUANTPH0307104; Miquel C, 2002, NATURE, V418, P59, DOI 10.1038/nature00801; NIELSEN M, 2000, QUANTUM INFORMATION; Papadimitrou CH, 1994, COMPUTATIONAL COMPLE; Paz JP, 2001, LES HOUCH S, V72, P535	7	2	2	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2076	2077		10.1126/science.1092977	http://dx.doi.org/10.1126/science.1092977			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684809				2022-12-28	WOS:000187385200029
J	Imperiale, TF; Wagner, DR; Lin, CY; Larkin, GN; Rogge, JD; Ransohoff, DF				Imperiale, TF; Wagner, DR; Lin, CY; Larkin, GN; Rogge, JD; Ransohoff, DF			Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer	ANNALS OF INTERNAL MEDICINE			English	Article							FLEXIBLE SIGMOIDOSCOPY; ASYMPTOMATIC ADULTS; SOCIETY GUIDELINES; COLONOSCOPY; ADENOMAS; RECOMMENDATIONS; PREVENTION; POLYPS; UPDATE	Background: Colonoscopic screening for colorectal cancer has been suggested because sigmoidoscopy misses nearly half of persons with advanced proximal neoplasia. Objective: To create a clinical index to stratify risk for advanced proximal neoplasia and to identify a subgroup with very low risk in which screening sigmoidoscopy alone might suffice. Design: Cross-sectional study. Setting: A company-based program of screening colonoscopy for colorectal cancer. Patients: Consecutive persons 50 years of age or older undergoing first-time screening colonoscopy between September 1995 and June 2001. Measurements: A clinical index with 3 variables was created from information on the first 1994 persons. Points were assigned to categories of age, sex, and distal findings. Risk for advanced proximal neoplasia (defined as an adenoma 1 cm or larger or one with villous histology, severe dysplasia, or cancer) was measured for each score. The index was tested on the next 1031 persons from the same screening program. Results: Of 1994 persons, 67 (3.4%) had advanced proximal neoplasia. A low-risk subgroup comprising 37% of the cohort had scores of 0 or 1 and a risk of 0.68% (95% CI, 0.22% to 1.57%). Among the validation group of 1031 persons, risk for advanced proximal neoplasia in the low-risk subgroup (comprising 47% of the cohort) was 0.4% (upper confidence limit of 1.49%). Application of this index detected 92% of persons with advanced proximal neoplasms and, if applied following screening sigmoidoscopy, could reduce the need for colonoscopy by 40%. The marginal benefit of colonoscopy among low-risk persons was small: To detect 7 additional persons with advanced proximal neoplasia, 1217 additional colonoscopies would be required. Conclusions: This clinical index stratifies the risk for advanced proximal neoplasia and identifies a subgroup at very low risk. If it is validated in other cohorts or groups, the index could be used to tailor endoscopic screening for colorectal cancer.	Regenstrief Inst Hlth Care, Indianapolis, IN 46202 USA; Univ N Carolina, Chapel Hill, NC USA; Eli Lilly & Co, Indianapolis, IN 46285 USA; Indianapolis Gastroenterol Res Fdn, Indianapolis, IN 46285 USA; Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; University of North Carolina; University of North Carolina Chapel Hill; Eli Lilly; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis	Imperiale, TF (corresponding author), Regenstrief Inst Hlth Care, 1050 Wishard Blvd, Indianapolis, IN 46202 USA.			Imperiale, Thomas/0000-0001-7586-1073	NIDDK NIH HHS [K24 DK 02756] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002756] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATKIN WS, 1993, LANCET, V341, P736, DOI 10.1016/0140-6736(93)90499-7; Atkin WS, 2000, JNCI-J NATL CANCER I, V92, P513, DOI 10.1093/jnci/92.7.513; Braitman LE, 1996, ANN INTERN MED, V125, P406, DOI 10.7326/0003-4819-125-5-199609010-00008; Byers T, 1997, CA-CANCER J CLIN, V47, P154, DOI 10.3322/canjclin.47.3.154; Detsky AS, 2001, NEW ENGL J MED, V345, P607, DOI 10.1056/NEJM200108233450809; Fletcher RH, 1999, GASTROENTEROLOGY, V117, P486, DOI 10.1053/gast.1999.0029900486; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL FE, 1985, CANCER TREAT REP, V69, P1071; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; KONISHI F, 1982, J CLIN PATHOL, V35, P830, DOI 10.1136/jcp.35.8.830; Levin Theodore R, 2002, Gastrointest Endosc Clin N Am, V12, P23, DOI 10.1016/S1052-5157(03)00055-2; Levin TR, 1999, JAMA-J AM MED ASSOC, V281, P1611, DOI 10.1001/jama.281.17.1611; Lewis JD, 1999, ANN INTERN MED, V130, P525, DOI 10.7326/0003-4819-130-6-199903160-00017; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Pignone M, 2002, ANN INTERN MED, V137, P132, DOI 10.7326/0003-4819-137-2-200207160-00015; Podolsky DK, 2000, NEW ENGL J MED, V343, P207, DOI 10.1056/NEJM200007203430309; Ransohoff DF, 2002, NEW ENGL J MED, V346, P40, DOI 10.1056/NEJMcp010886; Read TE, 1997, NEW ENGL J MED, V336, P8, DOI 10.1056/NEJM199701023360102; Rex DK, 2001, GASTROINTEST ENDOSC, V54, P662, DOI 10.1067/mge.2001.117594; Rex DK, 2000, AM J GASTROENTEROL, V95, P868, DOI 10.1111/j.1572-0241.2000.02059.x; RUTTIMANN UE, 1994, CRIT CARE CLIN, V10, P19, DOI 10.1016/S0749-0704(18)30142-8; Schoen RE, 1998, GASTROENTEROLOGY, V115, P533, DOI 10.1016/S0016-5085(98)70132-5; SELBY JV, 1994, GASTROENTEROLOGY, V106, P1702, DOI 10.1016/0016-5085(94)90429-4; Sherrick RC, 2000, NEW ENGL J MED, V343, P1651; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; Wallace MB, 1998, ANN INTERN MED, V129, P273, DOI 10.7326/0003-4819-129-4-199808150-00002; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; ZARCHY TM, 1994, GASTROENTEROLOGY, V106, P1501, DOI 10.1016/0016-5085(94)90403-0	29	132	139	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2003	139	12					959	965		10.7326/0003-4819-139-12-200312160-00005	http://dx.doi.org/10.7326/0003-4819-139-12-200312160-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756AG	14678915				2022-12-28	WOS:000187443200001
J	Boucek, M				Boucek, M			Paediatric acute heart failure - from deck chairs to lifeboats	LANCET			English	Editorial Material							MYOCARDITIS; CHILDREN		Childrens Hosp, Cardiol Sect, Denver, CO 80218 USA	Children's Hospital Colorado	Boucek, M (corresponding author), Childrens Hosp, Cardiol Sect, Denver, CO 80218 USA.	Boucek.Mark@tchden.org						Baboonian C, 2003, J AM COLL CARDIOL, V42, P473, DOI 10.1016/S0735-1097(03)00655-7; Boucek MM, 2003, J HEART LUNG TRANSPL, V22, P636, DOI 10.1016/S1053-2498(03)00184-0; Colombani PM, 2003, AM J TRANSPLANT, V3, P53, DOI 10.1034/j.1600-6143.3.s4.6.x; DRUCKER NA, 1994, CIRCULATION, V89, P252, DOI 10.1161/01.CIR.89.1.252; Ibrahim AE, 2000, ANN THORAC SURG, V69, P186, DOI 10.1016/S0003-4975(99)01194-7; Kleinert S, 1997, J HEART LUNG TRANSPL, V16, P1248; Kulik TJ, 1996, CIRCULATION, V94, P63; LEWIS AB, 1991, AM J CARDIOL, V68, P365, DOI 10.1016/0002-9149(91)90833-7; Stiller B, 2003, J HEART LUNG TRANSPL, V22, P1201, DOI 10.1016/S1053-2498(02)01233-0	9	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2003	362	9400					1948	1949		10.1016/S0140-6736(03)15081-7	http://dx.doi.org/10.1016/S0140-6736(03)15081-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683649				2022-12-28	WOS:000187210700002
J	Rigotti, NA				Rigotti, NA			Commentary: Putting the research into practice	BRITISH MEDICAL JOURNAL			English	Editorial Material							SMOKING CESSATION; PATCH; TRIAL		Harvard Univ, Sch Med, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA	Harvard University; Harvard Medical School	Rigotti, NA (corresponding author), Harvard Univ, Sch Med, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA.							Burke BL, 2003, J CONSULT CLIN PSYCH, V71, P843, DOI 10.1037/0022-006X.71.5.843; FIORE MC, 2000, TREATING TOBACCO USE; Hajek P, 1999, ARCH INTERN MED, V159, P2033, DOI 10.1001/archinte.159.17.2033; Jorenby DE, 1999, NEW ENGL J MED, V340, P685, DOI 10.1056/NEJM199903043400903; Lancaster T, 2000, BRIT MED J, V321, P355, DOI 10.1136/bmj.321.7257.355; Rigotti NA, 2002, NEW ENGL J MED, V346, P506, DOI 10.1056/NEJMcp012279; US Department of Health and Human Services, 1990, DHHS PUBL; West R, 2000, THORAX, V55, P987, DOI 10.1136/thorax.55.12.987	8	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1395	1396		10.1136/bmj.327.7428.1395	http://dx.doi.org/10.1136/bmj.327.7428.1395			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670890	Green Published			2022-12-28	WOS:000187417900028
J	Gewin, V				Gewin, V			In search of the elite	NATURE			English	Article																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					713	717		10.1038/426713	http://dx.doi.org/10.1038/426713			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668879	Bronze			2022-12-28	WOS:000187132800056
J	McLean-Tooke, APC; Bethune, CA; Fay, AC; Spickett, GP				McLean-Tooke, APC; Bethune, CA; Fay, AC; Spickett, GP			Adrenaline in the treatment of anaphylaxis: what is the evidence?	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MANAGEMENT; EPINEPHRINE; CHILDREN; ETIOLOGY; ALLERGY; FOOD		Royal Victoria Infirm, Reg Dept Immunol & Allergy, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK	McLean-Tooke, APC (corresponding author), Royal Victoria Infirm, Reg Dept Immunol & Allergy, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.	andrew.mclean-tooke@nuth.nordiy.nhs.uk	McLean-Tooke, Andrew/AAF-2568-2021	McLean-Tooke, Andrew/0000-0003-4307-0837				*AM ASS ALL ASTHM, MED RES POS STAT 26; [Anonymous], 2003, Drug Ther Bull, V41, P21; Brown AFT, 1998, J ACCID EMERG MED, V15, P89; Ellis AK, 2003, CURR ALLERGY ASTHM R, V3, P11, DOI 10.1007/s11882-003-0004-y; Estelle F, 2001, J ALLERGY CLIN IMMUN, V108, P871, DOI 10.1067/mai.2001.119409; FISCHER M, 1995, BMJ-BRIT MED J, V311, P731; Gold MS, 2000, J ALLERGY CLIN IMMUN, V106, P171, DOI 10.1067/mai.2000.106041; Goldberg A, 2000, J ALLERGY CLIN IMMUN, V106, P1184, DOI 10.1067/mai.2000.110927; Johnston SL, 2003, BRIT MED J, V326, P589, DOI 10.1136/bmj.326.7389.589; KLEIN JS, 1995, J ALLERGY CLIN IMMUN, V95, P637, DOI 10.1016/S0091-6749(95)70329-2; LANG DM, 1995, DRUG SAFETY, V12, P299, DOI 10.2165/00002018-199512050-00002; Macdougall CF, 2002, ARCH DIS CHILD, V86, P236, DOI 10.1136/adc.86.4.236; MONERETVAUTRIN DA, 1993, REV MED INTERNE, V14, P107, DOI 10.1016/S0248-8663(05)81260-3; MONTANARO A, 2002, J INVEST CLIN IMMUNO, V2, P2; Neugut AI, 2001, ARCH INTERN MED, V161, P15, DOI 10.1001/archinte.161.1.15; *PROJ TEAM RES COU, 2002, EM MED TREATM AN REA; Pumphrey RSH, 2000, CLIN EXP ALLERGY, V30, P1144, DOI 10.1046/j.1365-2222.2000.00864.x; SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603; Sicherer SH, 2001, ANN ALLERG ASTHMA IM, V86, P597, DOI 10.1016/S1081-1206(10)62284-3; Simons FER, 1998, J ALLERGY CLIN IMMUN, V101, P33, DOI 10.1016/S0091-6749(98)70190-3; SOREIDE E, 1988, ACTA ANAESTH SCAND, V32, P339; Stewart AG, 1996, QJM-MON J ASSOC PHYS, V89, P859, DOI 10.1093/qjmed/89.11.859; Unsworth DJ, 2001, ARCH DIS CHILD, V84, P410, DOI 10.1136/adc.84.5.410; Yocum MW, 1999, J ALLERGY CLIN IMMUN, V104, P452, DOI 10.1016/S0091-6749(99)70392-1; ZIMMERMAN B, 2001, CAN J ALLERGY CLIN I, V6, P159	25	158	170	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 6	2003	327	7427					1332	1335		10.1136/bmj.327.7427.1332	http://dx.doi.org/10.1136/bmj.327.7427.1332			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752DE	14656845	Green Published			2022-12-28	WOS:000187131100023
J	Wu, ZC; Viisainen, K; Wang, Y; Hemminki, E				Wu, ZC; Viisainen, K; Wang, Y; Hemminki, E			Perinatal mortality in rural China: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							RISK	Objectives To explore the use of local civil registration data to assess die perinatal mortality in a typical rural county in a less developed province in China, 1999-2000. Design Retrospective cohort study. Pregnancies in a cohort of women followed from registration of pregnancy to outcome of infant seven days after birth. Setting Routine family planning records in 20 rural townships in eastern China. Subjects 3697 pregnancies registered by the local family planning system during 1999. Main outcome measures Abortions, stillbirths, early neonatal mortality, perinatal mortality. Results Only three cases were lost to follow up. The average age of the women at pregnancy was 25.9 years. Three hundred and twelve pregnancies were aborted and 240 ended in miscarriage (total 552, 15%). The perinatal mortality rate was 69 per 1000 births, the rate of stillbirth was 24 per 1000 births, and the early neonatal mortality was 46 per 1000 live births. The early neonatal mortality was 29 in boys and 69 in girls per 1000 live births. The perinatal mortality rate increased notably with parity and was higher in townships having lower income per capita. Conclusions The family planning system at the most local level is a useful data source for studying perinatal mortality in rural China. The perinatal mortality rate in the study county was higher than previously reported for both rural and urban areas in China. The results by parity and sex of the infant raise concern over the impact of the one child policy.	Fudan Univ, Sch Publ Hlth, Shanghai 200032, Peoples R China; Natl Res & Dev Ctr Welf & Hlth, Helsinki 00531, Finland	Fudan University	Wu, ZC (corresponding author), Fudan Univ, Sch Publ Hlth, 138 Yi Xue Yuan Rd, Shanghai 200032, Peoples R China.							Banister J., 1987, CHINAS CHANGING POPU; Chu JH, 2001, POPUL DEV REV, V27, P259; Kane R, 1999, BRIT MED J, V319, P992, DOI 10.1136/bmj.319.7215.992; Kulmala T, 2000, PAEDIATR PERINAT EP, V14, P219, DOI 10.1046/j.1365-3016.2000.00270.x; LI XT, 1995, ZHONG GUO FU YOU BAO, V10, P246; Liu Y, 2001, WORLD J MICROB BIOT, V17, P111, DOI 10.1023/A:1016625209839; MU L, 1995, ZHONG GUO CHU JI WEI, V9, P34; RAYMOND EG, 1994, BRIT J OBSTET GYNAEC, V101, P301, DOI 10.1111/j.1471-0528.1994.tb13614.x; Shah D, 2000, INT J GYNECOL OBSTET, V71, P209, DOI 10.1016/S0020-7292(00)00215-0; Shah NM, 2000, SOC SCI MED, V51, P539, DOI 10.1016/S0277-9536(99)00485-2; WEI YZ, 1992, GUI YANG YI XUE YUAN, V17, P42; XU BZ, 1995, PERINATAL MORTALITY; Yao J S, 1991, Zhonghua Fu Chan Ke Za Zhi, V26, P224; ZHANG J, 1991, INT J EPIDEMIOL, V20, P958, DOI 10.1093/ije/20.4.958; ZHU XL, 1996, XIN JIANG YI XUE YUA, V19, P83	15	35	37	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 6	2003	327	7427					1319	1322		10.1136/bmj.327.7427.1319	http://dx.doi.org/10.1136/bmj.327.7427.1319			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752DE	14656839	Bronze, Green Published			2022-12-28	WOS:000187131100017
J	Ceci, M; Gaviraghi, C; Gorrini, C; Sala, LA; Offenhauser, N; Marchisio, PC; Biffo, S				Ceci, M; Gaviraghi, C; Gorrini, C; Sala, LA; Offenhauser, N; Marchisio, PC; Biffo, S			Release of eIF6 (p27(BBP)) from the 60S subunit allows 80S ribosome assembly	NATURE			English	Article							TRANSLATION INITIATION-FACTOR; PROTEIN-KINASE-C; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; CLONING; RACK1; RECEPTOR; HOMOLOG; BINDING; CELLS	The assembly of 80S ribosomes requires joining of the 40S and 60S subunits, which is triggered by the formation of an initiation complex on the 40S subunit(1). This event is rate-limiting for translation(2), and depends on external stimuli(3) and the status of the cell(4). Here we show that 60S subunits are activated by release of eIF6 (also termed p27(BBP))(5,6). In the cytoplasm, eIF6 is bound to free 60S but not to 80S. Furthermore, eIF6 interacts in the cytoplasm with RACK1(7), a receptor for activated protein kinase C (PKC). RACK1 is a major component of translating ribosomes, which harbour significant amounts of PKC. Loading 60S subunits with eIF6 caused a dose-dependent translational block and impairment of 80S formation, which were reversed by expression of RACK1 and stimulation of PKC in vivo and in vitro. PKC stimulation led to eIF6 phosphorylation, and mutation of a serine residue in the carboxy terminus of eIF6 impaired RACK1/PKC-mediated translational rescue. We propose that eIF6 release regulates subunit joining, and that RACK1 provides a physical and functional link between PKC signalling and ribosome activation.	DIBIT HSR, Mol Histol Unit, I-20132 Milan, Italy; Univ Vita Salute San Raffaele, Sch Med, I-20132 Milan, Italy; Firc Inst Mol Oncol, I-20100 Milan, Italy; Univ Eastern Piedmont Amedeo Avogadro, Dept Sci & Adv Technol, I-15100 Alessandria, Italy	Vita-Salute San Raffaele University; IFOM - FIRC Institute of Molecular Oncology; University of Eastern Piedmont Amedeo Avogadro	Biffo, S (corresponding author), DIBIT HSR, Mol Histol Unit, I-20132 Milan, Italy.	biffo.stefano@hsr.it		Gorrini, Chiara/0000-0002-5239-6671; Ceci, Marcello/0000-0002-5066-1590; Offenhauser, Nina/0000-0002-3316-3047; biffo, stefano/0000-0002-3780-1050				Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Biffo S, 1997, J BIOL CHEM, V272, P30314, DOI 10.1074/jbc.272.48.30314; Chantrel Y, 1998, GENETICS, V148, P559; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Groft CM, 2000, NAT STRUCT BIOL, V7, P1156; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Ho JHN, 2000, RNA, V6, P1625, DOI 10.1017/S1355838200001291; MOCHLYROSEN D, 1995, BIOCHEM SOC T, V23, P596, DOI 10.1042/bst0230596; Nadano D, 2000, JPN J CANCER RES, V91, P802, DOI 10.1111/j.1349-7006.2000.tb01017.x; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Peterson RT, 1998, CURR BIOL, V8, pR248, DOI 10.1016/S0960-9822(98)70152-6; Proud CG, 2001, BIOCHEM SOC T, V29, P541, DOI 10.1042/BST0290541; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Rhoads RE, 1999, J BIOL CHEM, V274, P30337, DOI 10.1074/jbc.274.43.30337; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8; Si K, 1997, P NATL ACAD SCI USA, V94, P14285, DOI 10.1073/pnas.94.26.14285; Si K, 1999, MOL CELL BIOL, V19, P1416; SPROTT SC, 1991, ANAL BIOCHEM, V194, P407, DOI 10.1016/0003-2697(91)90249-S; VALENZUELA DM, 1982, J BIOL CHEM, V257, P7712; Wood LC, 1999, J BIOL CHEM, V274, P11653, DOI 10.1074/jbc.274.17.11653	27	318	329	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					579	584		10.1038/nature02160	http://dx.doi.org/10.1038/nature02160			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654845				2022-12-28	WOS:000186944300044
J	Pierluissi, E; Fischer, MA; Campbell, AR; Landefeld, CS				Pierluissi, E; Fischer, MA; Campbell, AR; Landefeld, CS			Discussion of medical errors in morbidity and mortality conferences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MISTAKES; PHYSICIANS; QUALITY; IMPACT; CARE	Context Morbidity and mortality conferences in residency programs are intended to discuss adverse events and errors with a goal to improve patient care. Little is known about whether residency training programs are accomplishing this goal, Objective To determine the frequency at-which morbidity and mortality conference case presentations include adverse events and errors and whether the errors are discussed and attributed to a particular cause. Design, Setting, and Participants Prospective survey conducted by trained physician observers from July 2000 through April 2001 on 332 morbidity and mortality conference case presentations and discussions in internal medicine (n = 100) and surgery (n =232) at 4 US academic hospitals. Main Outcome Measures Frequencies of presentation of adverse events and errors, discussion of errors, and attribution of errors. Results In internal medicine morbidity and mortality conferences, case presentations and discussions were 3 times longer than in surgery conferences (34.1 minutes vs 11.7 minutes; P=.001), more time was spent listening to invited speakers (43.1% vs 0%; P<.001), and less time was spent in audience discussion (15.2% vs 36.6% P<.001). Fewer internal medicine case presentations included adverse events (37 [37%] vs 166 surgery case presentations [72%]; P<.001) or errors causing an adverse event (18 [18%] vs 98 [42%], respectively; P=.001). When an error caused an adverse event, the error was discussed as an error less often in internal medicine (10 errors [48%] vs 85 errors in surgery (77%]; P=.02). Errors were attributed to a particular cause less often in medicine than in surgery conferences (8 [38%] of 21 medicine errors vs 88 [79%] of 112 surgery errors; P<.001). In discussions of cases with errors, conference leaders in both internal medicine and surgery infrequently used explicit language to signal that an error was being discussed and infrequently acknowledged having made an error. Conclusions Our findings call into question whether adverse events and errors are routinely discussed in internal medicine training programs. Although adverse events and errors were discussed frequently in surgery cases, teachers in both surgery and internal medicine missed opportunities to model recognition of error and to use explicit language in error discussion by acknowledging their personal experiences with error.	Univ Calif San Francisco, Sch Med, San Francisco Vet Affairs Med Ctr, San Francisco, CA USA; Univ Calif San Francisco, Sch Med, San Francisco Gen Hosp, San Francisco, CA USA; Univ Calif San Francisco, Sch Med, Dept Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Stanford Univ, Palo Alto Vet Affairs Med Ctr, Palo Alto, CA 94304 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Pierluissi, E (corresponding author), San Mateo Med Ctr, 222 W 39th St, San Mateo, CA 94403 USA.				NIA NIH HHS [K-07 AG00912] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K07AG000912] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*AM MED ASS, 2002, GRAD MED ED DIR 2002; Becher EC, 2002, ACAD MED, V77, P953, DOI 10.1097/00001888-200210000-00005; BLUMENTHAL D, 1994, JAMA-J AM MED ASSOC, V272, P1867, DOI 10.1001/jama.272.23.1867; BOODMAN SG, 2002, WASHINGTON POST 1203; Bosk CL, 1979, FORGIVE REMEMBER MAN, DOI DOI 10.7208/CHICAGO/9780226924687.001.0001; Bransford JD., 2000, PEOPLE LEARN; Brennan TA, 2002, ACAD MED, V77, P973, DOI 10.1097/00001888-200210000-00008; CHRISTENSEN JF, 1992, J GEN INTERN MED, V7, P424, DOI 10.1007/BF02599161; Croskerry P, 2000, ACAD EMERG MED, V7, P1232, DOI 10.1111/j.1553-2712.2000.tb00468.x; Gallagher TH, 2003, JAMA-J AM MED ASSOC, V289, P1001, DOI 10.1001/jama.289.8.1001; Gordon L, 1994, GORDONS GUIDE SURG M; Harbison SP, 1999, AM J SURG, V177, P136, DOI 10.1016/S0002-9610(98)00319-5; HILFIKER D, 1984, NEW ENGL J MED, V310, P118, DOI 10.1056/NEJM198401123100211; *I MED, 1999, ERR HUM BUILD SAF HL; Knowles MS, 1998, ADULT LEARNER DEFINI; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; MIZRAHI T, 1984, SOC SCI MED, V19, P135, DOI 10.1016/0277-9536(84)90280-6; Newman MC, 1996, ARCH FAM MED, V5, P71, DOI 10.1001/archfami.5.2.71; Orlander JD, 2002, ACAD MED, V77, P1001, DOI 10.1097/00001888-200210000-00011; PERKINSON HJ, 1979, ET CETERA, V36, P37; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Smith ML, 2000, CAMB Q HEALTHC ETHIC, V9, P38, DOI 10.1017/S0963180100901051; STELLING J, 1973, SOC SCI MED, V7, P661, DOI 10.1016/0037-7856(73)90001-2; Volpp KGM, 2003, NEW ENGL J MED, V348, P851, DOI 10.1056/NEJMsb021667; WU AW, 1991, JAMA-J AM MED ASSOC, V265, P2089, DOI 10.1001/jama.265.16.2089; Wu AW, 2000, BRIT MED J, V320, P726, DOI 10.1136/bmj.320.7237.726	27	192	193	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2838	2842		10.1001/jama.290.21.2838	http://dx.doi.org/10.1001/jama.290.21.2838			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QP	14657068	Bronze			2022-12-28	WOS:000186872800026
J	Wikramanayake, AH; Hong, M; Lee, PN; Pang, K; Byrum, CA; Bince, JM; Xu, RH; Martindale, MQ				Wikramanayake, AH; Hong, M; Lee, PN; Pang, K; Byrum, CA; Bince, JM; Xu, RH; Martindale, MQ			An ancient role for nuclear beta-catenin in the evolution of axial polarity and germ layer segregation	NATURE			English	Article							SIGNAL-TRANSDUCTION; XENOPUS EMBRYOS; CELL FATES; SPECIFICATION; ENDODERM; LOCALIZATION; HYPOTHESES; INDUCTION; LITHIUM	The human oncogene beta-catenin is a bifunctional protein with critical roles in both cell adhesion and transcriptional regulation in the Wnt pathway(1-3). Wnt/beta-catenin signalling has been implicated in developmental processes as diverse as elaboration of embryonic polarity(2-6), formation of germ layers(4-8), neural patterning, spindle orientation and gap junction communication(2), but the ancestral function of beta-catenin remains unclear. In many animal embryos, activation of beta-catenin signalling occurs in blastomeres that mark the site of gastrulation and endomesoderm formation(5-10), raising the possibility that asymmetric activation of beta-catenin signalling specified embryonic polarity and segregated germ layers in the common ancestor of bilaterally symmetrical animals. To test whether nuclear translocation of beta-catenin is involved in axial identity and/or germ layer formation in 'pre-bilaterians', we examined the in vivo distribution, stability and function of beta-catenin protein in embryos of the sea anemone Nematostella vectensis (Cnidaria, Anthozoa). Here we show that N. vectensis beta-catenin is differentially stabilized along the oral-aboral axis, translocated into nuclei in cells at the site of gastrulation and used to specify entoderm, indicating an evolutionarily ancient role for this protein in early pattern formation.	Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA; Univ Hawaii, Pacific Biomed Res Ctr, Kewalo Marine Lab, Honolulu, HI 96813 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System	Wikramanayake, AH (corresponding author), Univ Hawaii Manoa, Dept Zool, 2538 McCarthy Mall, Honolulu, HI 96822 USA.	athula@hawaii.edu; mqmartin@hawaii.edu		Byrum, Christine/0000-0002-6653-7922				Collins AG, 1998, P NATL ACAD SCI USA, V95, P15458, DOI 10.1073/pnas.95.26.15458; Ding YN, 2002, TRENDS BIOCHEM SCI, V27, P327, DOI 10.1016/S0968-0004(02)02137-0; FREEMAN G, 1982, DEV BIOL, V94, P142, DOI 10.1016/0012-1606(82)90077-X; Goldstein B, 1997, BIOESSAYS, V19, P105, DOI 10.1002/bies.950190205; HAND C, 1992, BIOL BULL, V182, P169, DOI 10.2307/1542110; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Imai K, 2000, DEVELOPMENT, V127, P3009; Kao KR, 1998, BIOL CELL, V90, P585, DOI 10.1016/S0248-4900(99)80016-1; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; KLYMKOWSKY MW, 1991, METHOD CELL BIOL, V36, P419; Knoll AH, 1999, SCIENCE, V284, P2129, DOI 10.1126/science.284.5423.2129; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Logan CY, 1999, DEVELOPMENT, V126, P345; Mao CA, 1996, DEVELOPMENT, V122, P1489; MCCREA PD, 1993, J CELL BIOL, V123, P477, DOI 10.1083/jcb.123.2.477; Medina M, 2001, P NATL ACAD SCI USA, V98, P9707, DOI 10.1073/pnas.171316998; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Miller JR, 1997, J CELL BIOL, V139, P229, DOI 10.1083/jcb.139.1.229; Miyawaki K, 2003, DEV GROWTH DIFFER, V45, P121; Montross WT, 2000, J CELL SCI, V113, P1759; Polakis P, 2000, GENE DEV, V14, P1837; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Schneider SQ, 2003, J EXP ZOOL PART B, V295B, P25, DOI 10.1002/jez.b.00006; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Weitzel HE, 2002, DEV BIOL, V247, P479; Wikramanayake AH, 1998, P NATL ACAD SCI USA, V95, P9343, DOI 10.1073/pnas.95.16.9343; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	30	238	243	1	25	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 27	2003	426	6965					446	450		10.1038/nature02113	http://dx.doi.org/10.1038/nature02113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647383				2022-12-28	WOS:000186800800039
J	Arnold, P				Arnold, P			Why running is not for people	BRITISH MEDICAL JOURNAL			English	Article											Arnold, P (corresponding author), 202-170 Ocean St, Sydney, NSW 2027, Australia.							PORTER R, 2002, BLOOD GUTS SHORT HIS, P4	1	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1476	1476		10.1136/bmj.327.7429.1476	http://dx.doi.org/10.1136/bmj.327.7429.1476			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684658	Green Published			2022-12-28	WOS:000187562700029
J	Cline, JS				Cline, JS			How to concentrate copper	SCIENCE			English	Editorial Material							DEPOSITS		Univ Nevada, Dept Geosci, Las Vegas, NV 89154 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Cline, JS (corresponding author), Univ Nevada, Dept Geosci, Las Vegas, NV 89154 USA.							Bodnar RJ, 1995, MINERALOGICAL ASS CA, V23, P139; Burnham C., 1979, GEOCHEMISTRY HYDROTH, P71; Burnham CW, 1997, GEOCHEMISTRY HYDROTH, V3, P63; Harris AC, 2003, SCIENCE, V302, P2109, DOI 10.1126/science.1089927; HEDENQUIST JW, 1994, NATURE, V370, P519, DOI 10.1038/370519a0; SINGER DA, 1995, ECON GEOL BULL SOC, V90, P88, DOI 10.2113/gsecongeo.90.1.88; STRINGHAM B, 1966, GEOLOGY PORPHYRY COP, P35; Ulrich T, 2001, ECON GEOL BULL SOC, V96, P1719	8	41	53	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2075	2076		10.1126/science.1093202	http://dx.doi.org/10.1126/science.1093202			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684808				2022-12-28	WOS:000187385200028
J	Shann, F				Shann, F			Hypothermia for traumatic brain injury: how soon, how cold, and how long?	LANCET			English	Editorial Material							LOW INTRACRANIAL-PRESSURE; SEVERE HEAD-INJURY; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; THERAPEUTIC HYPOTHERMIA; CARDIAC-ARREST; HYPERTENSION		Royal Childrens Hosp, Intens Care Unit, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne	Shann, F (corresponding author), Royal Childrens Hosp, Intens Care Unit, Flemington Rd, Parkville, Vic 3052, Australia.		Shann, Frank/C-9510-2011					Aibiki M, 2000, CRIT CARE MED, V28, P3902, DOI 10.1097/00003246-200012000-00029; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1992, J NEUROTRAUM, V9, pS487; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Colbourne F, 1998, STROKE, V29, P1967, DOI 10.1161/01.STR.29.9.1967; Colbourne F, 1997, MOL NEUROBIOL, V14, P171, DOI 10.1007/BF02740655; Colbourne F, 1999, J CEREBR BLOOD F MET, V19, P742, DOI 10.1097/00004647-199907000-00003; GADKARY CA, 2003, COCHRANE LIB; Gunn AJ, 2000, CURR OPIN PEDIATR, V12, P111, DOI 10.1097/00008480-200004000-00004; HIRAYAMA T, 1994, INTRACRANIAL PRESSUR, V9; Holzer M, 2002, NEW ENGL J MED, V346, P549; Iida K, 2003, J NEUROSURG, V98, P793, DOI 10.3171/jns.2003.98.4.0793; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; LEROUX PD, 1991, CHILD NERV SYST, V7, P34, DOI 10.1007/BF00263831; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MEISSNER W, 1998, CRITICAL CARE MED S1, V26, pA82; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; SCHUBERT A, 1995, J NEUROSURG ANESTH, V7, P139, DOI 10.1097/00008506-199504000-00021; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Teasdale GM, 1998, NEUROSURGERY, V43, P723, DOI 10.1097/00006123-199810000-00001; Yan Y, 2001, Chin J Traumatol, V4, P8; Zhang K, 2000, INNER MONGOLIA MED J, V32, P4	27	33	36	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					1950	1951		10.1016/S0140-6736(03)15083-0	http://dx.doi.org/10.1016/S0140-6736(03)15083-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683651				2022-12-28	WOS:000187210700004
J	Davies, AG; Pierce-Shimomura, JT; Kim, H; VanHoven, MK; Thiele, TR; Bonci, A; Bargmann, CI; McIntire, SL				Davies, AG; Pierce-Shimomura, JT; Kim, H; VanHoven, MK; Thiele, TR; Bonci, A; Bargmann, CI; McIntire, SL			A central role of the BK potassium channel in behavioral responses to ethanol in C-elegans	CELL			English	Article							CA2+-ACTIVATED K+ CHANNELS; CAENORHABDITIS-ELEGANS; SYNAPTIC-TRANSMISSION; LARGE-CONDUCTANCE; MULTIPLE ASPECTS; GENE; NEURONS; SENSITIVITY; SEROTONIN; CURRENTS	The activities of many neuronal proteins are modulated by ethanol, but the fundamental mechanisms underlying behavioral effects of ethanol remain unclear. To identify mechanisms responsible for intoxication, we screened for Caenorhabditis elegans mutants with altered behavioral responses to ethanol. We found that slo-1 mutants, which were previously recognized as having slightly uncoordinated movement, are highly resistant to ethanol in two behavioral assays. Numerous loss-of-function slo-1 alleles emerged from our screens, indicating that slo-1 has a central role in ethanol responses. slo-1 encodes the BK potassium channel. Electrophysiological analysis shows that ethanol activates the channel in vivo, which would inhibit neuronal activity. Moreover, behaviors of slo-1 gain-of-function mutants resemble those of ethanol-intoxicated animals. These results demonstrate that selective activation of BK channels is responsible for acute intoxicating effects of ethanol in C. elegans. BK channel activation may explain a variety of behavioral responses to ethanol in invertebrate and vertebrate systems.	Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA 94608 USA; Univ Calif San Francisco, Res Ctr, Dept Neurol, Program Neurosci, Emeryville, CA 94608 USA; Univ Calif San Francisco, Res Ctr, Dept Neurol, Program Biomed Sci, Emeryville, CA 94608 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	McIntire, SL (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin, Emeryville, CA 94608 USA.	slm@itsa.ucsf.edu	Davies, Andrew G/AAY-3567-2020	VanHoven, Miri/0000-0001-7714-1555; Kim, Hongkyun/0000-0002-4879-7122; Bargmann, Cornelia/0000-0002-8484-0618; Thiele, Tod/0000-0003-2628-8359				ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Chu BS, 1998, MOL PHARMACOL, V54, P397, DOI 10.1124/mol.54.2.397; Diamond I, 1997, PHYSIOL REV, V77, P1, DOI 10.1152/physrev.1997.77.1.1; DIAMOND IF, 2002, DIS NERVOUS SYSTEM C, P1814; Dopico AM, 1996, MOL PHARMACOL, V49, P40; Dopico AM, 1999, J PHYSIOL-LONDON, V519, P101, DOI 10.1111/j.1469-7793.1999.0101o.x; Dopico AM, 1998, J PHARMACOL EXP THER, V284, P258; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Gruss M, 2001, EUR J NEUROSCI, V14, P1246, DOI 10.1046/j.0953-816x.2001.01754.x; Hajdu-Cronin YM, 1999, GENE DEV, V13, P1780, DOI 10.1101/gad.13.14.1780; Hallam S, 2000, DEVELOPMENT, V127, P4239; Harris RA, 1999, ALCOHOL CLIN EXP RES, V23, P1563, DOI 10.1097/00000374-199910000-00001; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Hodge CW, 1999, NAT NEUROSCI, V2, P997, DOI 10.1038/14795; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Jakab M, 1997, J MEMBRANE BIOL, V157, P237, DOI 10.1007/PL00005895; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; Jin YS, 1999, J NEUROSCI, V19, P539; Jospin M, 2002, J PHYSIOL-LONDON, V544, P373, DOI 10.1113/jphysiol.2002.022293; Lees-Miller JP, 2000, MOL PHARMACOL, V57, P367; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; Mello C, 1995, METHOD CELL BIOL, V48, P451; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Nickell WT, 2002, J MEMBRANE BIOL, V189, P55, DOI 10.1007/s00232-002-1004-x; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Phillips TJ, 1998, NAT NEUROSCI, V1, P610, DOI 10.1038/2843; Rubinstein M, 1997, CELL, V90, P991, DOI 10.1016/S0092-8674(00)80365-7; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Shioi G, 2001, GENETICS, V157, P1611; Spanagel R, 2002, J NEUROSCI, V22, P8676; Thiele TE, 1998, NATURE, V396, P366, DOI 10.1038/24614; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Walters FS, 2000, AM J PHYSIOL-CELL PH, V279, pC1107, DOI 10.1152/ajpcell.2000.279.4.C1107; Wang ZW, 2001, NEURON, V32, P867, DOI 10.1016/S0896-6273(01)00522-0; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; Yuan A, 2003, NEURON, V37, P765, DOI 10.1016/S0896-6273(03)00096-5	44	260	272	4	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2003	115	6					655	666		10.1016/S0092-8674(03)00979-6	http://dx.doi.org/10.1016/S0092-8674(03)00979-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675531	Bronze			2022-12-28	WOS:000187366100006
J	Li, MY; Brooks, CL; Wu-Baer, F; Chen, DL; Baer, R; Gu, W				Li, MY; Brooks, CL; Wu-Baer, F; Chen, DL; Baer, R; Gu, W			Mono-versus polyubiquitination: Differential control of p53 fate by Mdm2	SCIENCE			English	Article							UBIQUITIN-PROTEIN LIGASE; RING-FINGER DOMAIN; NUCLEAR EXPORT; MDM2-DEPENDENT UBIQUITINATION; DEGRADATION; STABILITY; PROMOTES	Although Mdm2-mediated ubiquitination is essential for both degradation and nuclear export of p53, the molecular basis for the differential effects of Mdm2 remains unknown. Here we show that low levels of Mdm2 activity induce monoubiquitination and nuclear export of p53, whereas high levels promote p53's polyubiquitination and nuclear degradation. A p53-ubiquitin fusion protein that mimics monoubiquitinated p53 was found to accumulate in the cytoplasm in an Mdm2-independent manner, indicating that monoubiquitination is critical for p53 trafficking. These results clarify the nature of ubiquitination-mediated p53 regulation and suggest that distinct mechanisms regulate p53 function in accordance with the levels of Mdm2 activity.	Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Inst Canc Genet, 1150 St Nicholas Ave, New York, NY 10032 USA.			Brooks, Christopher/0000-0003-3487-6644				Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Blattner C, 2002, MOL CELL BIOL, V22, P6170, DOI 10.1128/MCB.22.17.6170-6182.2002; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Gu JJ, 2001, MOL CELL BIOL, V21, P8533, DOI 10.1128/MCB.21.24.8533-8546.2001; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Li M., UNPUB; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Midgley CA, 2000, ONCOGENE, V19, P2312, DOI 10.1038/sj.onc.1203593; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Okamoto K, 2002, MOL CELL, V9, P761, DOI 10.1016/S1097-2765(02)00504-X; Parant JM, 2003, HUM MUTAT, V21, P321, DOI 10.1002/humu.10186; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Shirangi TR, 2002, FASEB J, V16, P420, DOI 10.1096/fj.01-0617fje; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980	31	609	622	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1972	1975		10.1126/science.1091362	http://dx.doi.org/10.1126/science.1091362			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671306				2022-12-28	WOS:000187174000063
J	Mascie-Taylor, CGN; Karim, E				Mascie-Taylor, CGN; Karim, E			The burden of chronic disease	SCIENCE			English	Article							HUMAN HOOKWORM INFECTIONS; PUBLIC-HEALTH IMPORTANCE; RESISTANCE; PYRANTEL; REGION	The shift from acute infectious and deficiency diseases to chronic noncommunicable diseases is not a simple transition but a complex and dynamic epidemiological process, with some diseases disappearing and others appearing or reemerging. The unabated pandemic of childhood and adulthood obesity and concomitant comorbidities are affecting both rich and poor nations, while infectious diseases remain an important public health problem, particularly in developing countries. More attention should be given to the high burden of disease associated with soil-transmitted helminths and schistosomiasis, which until recently was not considered a priority even though regular drug treatment is obtainable at relatively little cost. In developing countries, the pressing requirement is to provide an accessible and good quality health-care system, whereas industrialized countries have a major need for greater public health education and the promotion of healthy life-styles.	Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 3DZ, England; Hlth & Life Sci Partnership, London EC1V 9HL, England	University of Cambridge	Mascie-Taylor, CGN (corresponding author), Univ Cambridge, Dept Biol Anthropol, Cambridge CB2 3DZ, England.	nmt1@cam.ac.uk						*CDCP, 2003, MMWR-MORBID MORTAL W, V52, P881; Chan MS, 1997, PARASITOL TODAY, V13, P438, DOI 10.1016/S0169-4758(97)01144-7; Cioli D, 2000, CURR OPIN INFECT DIS, V13, P659, DOI 10.1097/00001432-200012000-00014; COOPER E, 1991, T ROY SOC TROP MED H, V85, P168, DOI 10.1016/0035-9203(91)90009-N; Crompton DWT, 2000, PARASITOLOGY, V121, pS39, DOI 10.1017/S0031182000006454; Geerts S, 2001, TROP MED INT HEALTH, V6, P915, DOI 10.1046/j.1365-3156.2001.00774.x; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Guyatt H, 2002, WORLD CL PARASITES, V2, P75; Horton J, 2003, TRENDS PARASITOL, V19, P405, DOI 10.1016/S1471-4922(03)00171-5; MONTRESSOR A, 2002, HELMINTH CONTROL SCH; Murray C. J. L., 1996, GLOBAL BURDEN DIS; O'Lorcain P, 2000, PARASITOLOGY, V121, pS51, DOI 10.1017/S0031182000006442; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Reynoldson JA, 1997, ACTA TROP, V68, P301, DOI 10.1016/S0001-706X(97)00106-X; *RI DEP HLTH, OB CONTR PROGR; Sacko M, 1999, T ROY SOC TROP MED H, V93, P195, DOI 10.1016/S0035-9203(99)90306-1; SAVIOLI L, 2002, T R SOC TROP MED HYG, V86, P353; Smith RD, 2003, B WORLD HEALTH ORGAN, V81, P475; Stephenson LS, 2000, PARASITOLOGY, V121, pS23, DOI 10.1017/S0031182000006491; STOLL NR, 1947, J PARASITOL, V33, P1; United Nations Development Programme, HUM DEV REP; *WHO, HLTH ALL 21 CENT; Yokogawa M., 1985, Ascariasis and its public health significance, P265	23	73	81	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1921	1922		10.1126/science.1092488	http://dx.doi.org/10.1126/science.1092488			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671291				2022-12-28	WOS:000187174000046
J	Potuschak, T; Lechner, E; Parmentier, Y; Yanagisawa, S; Grava, S; Koncz, C; Genschik, P				Potuschak, T; Lechner, E; Parmentier, Y; Yanagisawa, S; Grava, S; Koncz, C; Genschik, P			EIN3-dependent regulation of plant ethylene hormone signaling by two Arabidopsis F box proteins: EBF1 and EBF2	CELL			English	Article							SCF UBIQUITIN-LIGASE; RESPONSE PATHWAY; AUX/IAA PROTEINS; AUXIN RESPONSE; DEGRADATION; TRANSDUCTION; THALIANA; ETHYLENE-INSENSITIVE3; IDENTIFICATION; PROTEOLYSIS	The plant hormone ethylene regulates a wide range of developmental processes and the response of plants to stress and pathogens. Genetic studies in Arabidopsis led to a partial elucidation of the mechanisms of ethylene action. Ethylene signal transduction initiates with ethylene binding at a family of ethylene receptors and terminates in a transcription cascade involving the EIN3/EIL and ERF families of plant-specific transcription factors. Here, we identify two Arabidopsis F box proteins called EBF1 and EBF2 that interact physically with EIN3/EIL transcription factors. EBF1 overexpression results in plants insensitive to ethylene. In contrast, plants carrying the ebf1 and ebf2 mutations display a constitutive ethylene response and accumulate the EIN3 protein in the absence of the hormone. Our work places EBF1 and EBF2 within the genetic framework of the ethylene-response pathway and supports a model in which ethylene action depends on EIN3 protein stabilization.	CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; Okayama Univ, Res Inst Bioresources, Kurashiki, Okayama 7100046, Japan; Max Planck Inst Zuchtungsforsch, D-50829 Cologne, Germany	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Okayama University; Max Planck Society	Genschik, P (corresponding author), CNRS, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.			Potuschak, Thomas/0000-0002-2632-4981; GENSCHIK, Pascal/0000-0002-4107-5071				Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; [Anonymous], 2002, ARABIDOPSIS BOOK; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dill A, 2001, P NATL ACAD SCI USA, V98, P14162, DOI 10.1073/pnas.251534098; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Farras R, 2001, EMBO J, V20, P2742, DOI 10.1093/emboj/20.11.2742; Ferrando A, 2000, PLANT J, V22, P553, DOI 10.1046/j.1365-313x.2000.00763.x; Frugis G, 2002, TRENDS CELL BIOL, V12, P308, DOI 10.1016/S0962-8924(02)02308-5; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hsiung YG, 2001, MOL CELL BIOL, V21, P2506, DOI 10.1128/MCB.21.7.2506-2520.2001; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Johnson PR, 1998, ANNU REV GENET, V32, P227, DOI 10.1146/annurev.genet.32.1.227; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; KIPREOS ET, 2000, IN PRESS GENOME BIOL; Lechner E, 2002, J BIOL CHEM, V277, P50069, DOI 10.1074/jbc.M204254200; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; Rios G, 2002, PLANT J, V32, P243, DOI 10.1046/j.1365-313X.2002.01416.x; ROMAN G, 1995, GENETICS, V139, P1393; Ruegger M, 1998, GENE DEV, V12, P198, DOI 10.1101/gad.12.2.198; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Shen WH, 2002, MOL BIOL CELL, V13, P1916, DOI 10.1091/mbc.E02-02-0077; Smalle J, 1997, P NATL ACAD SCI USA, V94, P2756, DOI 10.1073/pnas.94.6.2756; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Xiao WY, 2000, TRENDS PLANT SCI, V5, P454, DOI 10.1016/S1360-1385(00)01769-6; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2002, PLANT CELL, V14, P1919, DOI 10.1105/tpc.003368; Yanagisawa S, 2003, NATURE, V425, P521, DOI 10.1038/nature01984; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; ZUO J, 2002, PLANT J, V24, P265	41	518	576	9	116	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 12	2003	115	6					679	689		10.1016/S0092-8674(03)00968-1	http://dx.doi.org/10.1016/S0092-8674(03)00968-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675533	Bronze			2022-12-28	WOS:000187366100008
J	Bajcsy, M; Zibrov, AS; Lukin, MD				Bajcsy, M; Zibrov, AS; Lukin, MD			Stationary pulses of light in an atomic medium	NATURE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; NONLINEAR OPTICS; ULTRASLOW; ENTANGLEMENT; COHERENCE; STORAGE; PHOTONS; GAS	Physical processes that could facilitate coherent control of light propagation are under active exploration(1-5). In addition to their fundamental interest, these efforts are stimulated by practical possibilities, such as the development of a quantum memory for photonic states(6 - 8). Controlled localization and storage of photonic pulses may also allow novel approaches to manipulating of light via enhanced nonlinear optical processes(9). Recently, electromagnetically induced transparency(10) was used to reduce the group velocity of propagating light pulses(11,12) and to reversibly map propagating light pulses into stationary spin excitations in atomic media(13 - 16). Here we describe and experimentally demonstrate a technique in which light propagating in a medium of Rb atoms is converted into an excitation with localized, stationary electromagnetic energy, which can be held and released after a controllable interval. Our method creates pulses of light with stationary envelopes bound to an atomic spin coherence, offering new possibilities for photon state manipulation and nonlinear optical processes at low light levels.	Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; PN Lebedev Phys Inst, Moscow 117924, Russia	Harvard University; Harvard University; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.		Zibrov, Alexander S/G-7419-2014					Andre A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.143602; BOLLER KJ, 1991, PHYS REV LETT, V66, P2593, DOI 10.1103/PhysRevLett.66.2593; Boyd R. W., 2003, NONLINEAR OPTICS; Cao H, 1999, PHYS REV LETT, V82, P2278, DOI 10.1103/PhysRevLett.82.2278; Cirac JI, 1997, PHYS REV LETT, V78, P3221, DOI 10.1103/PhysRevLett.78.3221; Fleischhauer M, 2000, PHYS REV LETT, V84, P5094, DOI 10.1103/PhysRevLett.84.5094; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; HARRIS SE, 1993, PHYS REV LETT, V70, P552, DOI 10.1103/PhysRevLett.70.552; Harris SE, 1999, PHYS REV LETT, V82, P4611, DOI 10.1103/PhysRevLett.82.4611; HARRIS SE, 1990, PHYS REV LETT, V64, P1107, DOI 10.1103/PhysRevLett.64.1107; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; HEMMER PR, 1995, OPT LETT, V20, P982, DOI 10.1364/OL.20.000982; Kash MM, 1999, PHYS REV LETT, V82, P5229, DOI 10.1103/PhysRevLett.82.5229; Kocharovskaya O, 2001, PHYS REV LETT, V86, P628, DOI 10.1103/PhysRevLett.86.628; KOGELNIK H, 1972, J APPL PHYS, V43, P2327, DOI 10.1063/1.1661499; Kuzmich A, 2003, NATURE, V423, P731, DOI 10.1038/nature01714; Liu C, 2001, NATURE, V409, P490, DOI 10.1038/35054017; Lukin MD, 2001, NATURE, V413, P273, DOI 10.1038/35095000; Lukin MD, 2000, PHYS REV LETT, V84, P1419, DOI 10.1103/PhysRevLett.84.1419; Mabuchi H, 2002, SCIENCE, V298, P1372, DOI 10.1126/science.1078446; Matsko AB, 2001, ADV ATOM MOL OPT PHY, V46, P191, DOI 10.1016/S1049-250X(01)80064-1; Ottaviani C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.197902; Petrosyan D, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.033833; Phillips DF, 2001, PHYS REV LETT, V86, P783, DOI 10.1103/PhysRevLett.86.783; Schmidt H, 1996, OPT LETT, V21, P1936, DOI 10.1364/OL.21.001936; Scully M.O., 1997, QUANTUM OPT; SLUSHER D, 2003, NONLINEAR PHOTONIC C; van der Wal CH, 2003, SCIENCE, V301, P196, DOI 10.1126/science.1085946; YABLONOVITCH E, 1991, PHYS REV LETT, V67, P3380, DOI 10.1103/PhysRevLett.67.3380; Zibrov AS, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.103601	30	489	507	4	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					638	641		10.1038/nature02176	http://dx.doi.org/10.1038/nature02176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668857	Green Submitted			2022-12-28	WOS:000187132800034
J	Niiler, E				Niiler, E			Good neighbours	NATURE			English	Article									KPBS Radio, San Diego, CA 92182 USA		Niiler, E (corresponding author), KPBS Radio, San Diego, CA 92182 USA.								0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					690	694		10.1038/426690	http://dx.doi.org/10.1038/426690			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668872	Bronze			2022-12-28	WOS:000187132800049
J	Tanaka, M; Vitek, CR; Pascual, FB; Bisgard, KM; Tate, JE; Murphy, TV				Tanaka, M; Vitek, CR; Pascual, FB; Bisgard, KM; Tate, JE; Murphy, TV			Trends in pertussis among infants in the United States, 1980-1999	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							YOUNG INFANTS; EPIDEMIOLOGIC FEATURES; CHANGING EPIDEMIOLOGY; NEONATAL PERTUSSIS; VACCINE; ADULTS; IMMUNIZATION; DIAGNOSIS; CHILDREN	Context Reported cases of pertussis among adolescents and adults have increased since the 1980s, despite increasingly high rates of vaccination among infants and children. However, severe pertussis morbidity and mortality occur primarily among infants. Objective To describe the trends and characteristics of reported cases of pertussis among infants younger than 12 months in the United States from 1980 to 1999. Design, Setting, and Participants Cases of pertussis in infants younger than 12 months in the United States reported to the National Notifiable Disease Surveillance System of the Centers for Disease Control and Prevention between 1980 and 1999, and detailed case data from the Supplementary Pertussis Surveillance System. Main Outcome Measures incidence and demographic and clinical characteristics of cases. Results The incidence of reported cases of pertussis among infants increased 49% in the 1990s compared with the incidence in the 1980s (19798 vs 12550 cases reported; 51.1 cases vs 34.2 cases per 100000 infant population, respectively), increases in the incidence of cases and the number of deaths among infants during the 1990s primarily were among those aged 4 months or younger, contrasting with a stable incidence of cases among infants aged 5 months or older. The proportion of cases confirmed by bacterial culture was higher in the 1990s than in the 1980s (50% and 33%, respectively); the proportion of hospitalized cases was unchanged (67% vs 68%, respectively). Receipt of fewer doses of vaccine was associated with hospitalization, when,cases were stratified by age in months. Conclusions The incidence of reported cases of pertussis among infants increased in the 1990s compared with the 1980s. The limited age group affected, the increased rate of bacteriologic confirmation, and the unchanged severity of illness suggest that an increase in infant pertussis has occurred apart from any change in reporting. Strategies are needed to prevent the morbidity and mortality from pertussis among infants too young to be fully vaccinated, according to the current recommended schedules of vaccination in the United States.	Ctr Dis Control & Prevent MS 61, Bacterial Vaccine Preventable Dis Branch, Epidemiol & Surveillance Div, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of North Carolina; University of North Carolina Chapel Hill	Tanaka, M (corresponding author), Ctr Dis Control & Prevent MS 61, Bacterial Vaccine Preventable Dis Branch, Epidemiol & Surveillance Div, Natl Immunizat Program, 1600 Clifton Rd, Atlanta, GA 30333 USA.							Baron S, 1998, PEDIATR INFECT DIS J, V17, P412, DOI 10.1097/00006454-199805000-00013; BASS JW, 1989, PEDIATR INFECT DIS J, V8, P352, DOI 10.1097/00006454-198906000-00004; BEITER A, 1993, OBSTET GYNECOL, V82, P691; BISGARD K, 2002, MANUAL SURVEILLANCE; Bisgard Kristine M., 2001, Pediatric Research, V49, p110A; BROOKSALER F, 1967, AM J DIS CHILD, V114, P389, DOI 10.1001/archpedi.1967.02090250087005; *CDCP, 1992, MMWR-MORBID MORTAL W, V41, P11; *CDCP, NAT IMM PROGR IMM CO; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P73; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P1; CHRISTIE CDC, 1989, AM J DIS CHILD, V143, P1199, DOI 10.1001/archpedi.1989.02150220097027; De Serres G, 2000, Can Commun Dis Rep, V26, P1; EDWARDS KM, 1993, JAMA-J AM MED ASSOC, V269, P53, DOI 10.1001/jama.269.1.53; FARIZO KM, 1992, CLIN INFECT DIS, V14, P708, DOI 10.1093/clinids/14.3.708; FEIGIN RD, 1992, TXB PEDIAT INFECT DI, P1208; FINE PEM, 1986, INT J EPIDEMIOL, V15, P237, DOI 10.1093/ije/15.2.237; GAN VN, 1990, AM J DIS CHILD, V144, P1130, DOI 10.1001/archpedi.1990.02150340076027; Grimprel E, 1999, LANCET, V354, P1699, DOI 10.1016/S0140-6736(99)01576-7; Guris D, 1999, CLIN INFECT DIS, V28, P1230, DOI 10.1086/514776; Halperin SA, 1999, CLIN INFECT DIS, V28, P1238, DOI 10.1086/514792; HEININGER U, 1992, EUR J PEDIATR, V151, P342, DOI 10.1007/BF02113254; Hoppe JE, 2000, PEDIATR INFECT DIS J, V19, P244, DOI 10.1097/00006454-200003000-00014; Izurieta HS, 1996, CLIN INFECT DIS, V22, P503, DOI 10.1093/clinids/22.3.503; Juretzko P, 2002, CLIN INFECT DIS, V35, P162, DOI 10.1086/341027; KAUFMAN S, 1960, AMA J DIS CHILD, V99, P417, DOI 10.1001/archpedi.1960.02070030419003; Keitel WA, 1999, CLIN INFECT DIS, V28, pS118, DOI 10.1086/515064; Muller FMC, 1997, J CLIN MICROBIOL, V35, P2435; *NAT BUR CENS, ANN TIM SER STAT POP; NELSON JD, 1978, AM J DIS CHILD, V132, P371, DOI 10.1001/archpedi.1978.02120290043006; ONORATO IM, 1992, JAMA-J AM MED ASSOC, V267, P2745, DOI 10.1001/jama.267.20.2745; Simpson DM, 2001, AM J PREV MED, V20, P6, DOI 10.1016/S0749-3797(01)00286-0; SOTOMAYOR J, 1985, AM J DIS CHILD, V139, P724, DOI 10.1001/archpedi.1985.02140090086039; SUTTER RW, 1992, JAMA-J AM MED ASSOC, V267, P386, DOI 10.1001/jama.267.3.386; Sweden Ad Hoc Group for the Study of Pertussis Vaccines, 1988, Lancet, Vi, P955; *US DHHS, 2000, HLTH PEOPL 2010, V1, pCH14; *US PHS, ANN REP SURG GEN PUB; *US PHS, 1953, REP INC SEL NOT DIS, P240; Vitek CR, 2003, PEDIATR INFECT DIS J, V22, P628, DOI 10.1097/00006454-200307000-00012; Wharton M, 1990, MMWR Recomm Rep, V39, P1; WHARTON M, 2002, MANUAL SURVEILLANCE	40	262	272	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2003	290	22					2968	2975		10.1001/jama.290.22.2968	http://dx.doi.org/10.1001/jama.290.22.2968			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751WH	14665658	Bronze			2022-12-28	WOS:000187112700028
J	Lim, E; Ali, Z; Ali, A; Routledge, T; Edmonds, L; Altman, DG; Large, S				Lim, E; Ali, Z; Ali, A; Routledge, T; Edmonds, L; Altman, DG; Large, S			Indirect comparison meta-analysis of aspirin therapy after coronary surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-DOSE ASPIRIN; ARTERY-BYPASS-SURGERY; VEIN-GRAFT PATENCY; PLACEBO-CONTROLLED TRIAL; AORTOCORONARY BYPASS; ACETYLSALICYLIC-ACID; ANTIPLATELET THERAPY; ANTITHROMBOTIC THERAPY; POSTOPERATIVE ASPIRIN; ANTICOAGULANT-THERAPY	Objectives To evaluate the efficacy of low and medium dose aspirin therapy after coronary surgery by using an indirect comparison meta-analysis. Data sources Systematic literature search of Medline, Embase, Cochrane controlled trials register, and trial register sites on the internet. Study selection Outcome was evaluated by angiography and reported as graft occlusion and rate of events in patients. Trials that did not include aspirin as the sole therapy or did not have a placebo control arm were excluded. Articles were assessed for eligibility and quality and grouped according to dosage. The estimated difference in effect of low and medium dose aspirin on graft occlusion was obtained by combining the estimated log relative risks of low dose with placebo and medium dose with placebo. Results For graft occlusion, the medium dose trials yielded a relative risk reduction of 45% compared with 26% for the low dose trials. The greater effect in the medium dose trials is summarised by a relative risk ratio of 0.74 (95% confidence interval 0.52 to 1.06; P = 0.10) for graft occlusion and 0.81 (0.57 to 1.16; P = 0.25) for events in patients. Conclusions Medium dose aspirin may more successfully reduce graft occlusion than low dose regimens within the first year after coronary surgery.	Papworth Hosp, Dept Cardiothorac Surg, Cambridge CB3 8RE, England; Papworth Hosp, Clin Lib Serv, Cambridge CB3 8RE, England; Inst Hlth Serv, Canc Res UK NHS Ctr Stat Med, Oxford OX3 7LF, England	Papworth Hospital; Papworth Hospital; Cancer Research UK; University of Oxford	Lim, E (corresponding author), Royal Brompton Hosp, Dept Cardiothorac Surg, London SW3 6NP, England.	eric.lim2@cvsnet.org	Large, Stephen/AAW-4872-2021	Large, Stephen/0000-0002-3201-6344; Lim, Eric/0000-0002-9078-3226				AGNEW TM, 1992, AUST NZ J MED, V22, P665, DOI 10.1111/j.1445-5994.1992.tb04868.x; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; BROOKS N, 1985, BRIT HEART J, V53, P201; BROWN BG, 1985, CIRCULATION, V72, P138, DOI 10.1161/01.CIR.72.1.138; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Cataldo G, 1998, CORONARY ARTERY DIS, V9, P217, DOI 10.1097/00019501-199809040-00007; CHESEBRO JH, 1982, NEW ENGL J MED, V307, P73, DOI 10.1056/NEJM198207083070201; CHESEBRO JH, 1984, NEW ENGL J MED, V310, P209, DOI 10.1056/NEJM198401263100401; Collaboration AT, 1994, BMJ-BRIT MED J, V308, P159, DOI [10.1136/bmj.308.6922.159, DOI 10.1136/BMJ.308.6922.159]; Cooper GJ, 1996, EUR J CARDIO-THORAC, V10, P129, DOI 10.1016/S1010-7940(96)80135-7; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Ellis SG, 1997, AM J CARDIOL, V79, P1460, DOI 10.1016/S0002-9149(97)00171-9; Fisher LD, 2001, AM HEART J, V141, P26, DOI 10.1067/mhj.2001.111262; FREMES SE, 1993, EUR J CARDIO-THORAC, V7, P169, DOI 10.1016/1010-7940(93)90155-5; FUSTER V, 1986, CIRCULATION, V73, P227, DOI 10.1161/01.CIR.73.2.227; GAVAGHAN TP, 1991, CIRCULATION, V83, P1526, DOI 10.1161/01.CIR.83.5.1526; GERSHLICK AH, 1988, BRIT HEART J, V60, P111; GOLDMAN S, 1989, CIRCULATION, V80, P1190, DOI 10.1161/01.CIR.80.5.1190; GOLDMAN S, 1994, CIRCULATION, V89, P1138, DOI 10.1161/01.CIR.89.3.1138; GOLDMAN S, 1988, CIRCULATION, V77, P1324, DOI 10.1161/01.CIR.77.6.1324; GUITERAS P, 1989, EUR HEART J, V10, P159, DOI 10.1093/oxfordjournals.eurheartj.a059456; HENDERSON WG, 1989, ANN INTERN MED, V111, P743, DOI 10.7326/0003-4819-111-9-743; HENDERSON WG, 1988, CONTROL CLIN TRIALS, V9, P189, DOI 10.1016/0197-2456(88)90060-8; HOCKINGS BEF, 1993, MED J AUSTRALIA, V159, P376, DOI 10.5694/j.1326-5377.1993.tb137909.x; Keogh BE, 2001, NATL ADULT CARDIAC S; LORENZ RL, 1984, LANCET, V1, P1261; Mangano DT, 2002, NEW ENGL J MED, V347, P1309, DOI 10.1056/NEJMoa020798; MAYER JE, 1981, ANN THORAC SURG, V31, P204, DOI 10.1016/S0003-4975(10)60927-7; MCENANY MT, 1982, J THORAC CARDIOV SUR, V83, P81; MEISTER W, 1984, BRIT J CLIN PHARMACO, V17, P703, DOI 10.1111/j.1365-2125.1984.tb02407.x; Packer M, 2001, AM HEART J, V141, P899, DOI 10.1067/mhj.2001.115584; PANTELY GA, 1979, NEW ENGL J MED, V301, P962, DOI 10.1056/NEJM197911013011803; Patrono C, 2001, CHEST, V119, p39S, DOI 10.1378/chest.119.1_suppl.39S; PFISTERER M, 1989, LANCET, V2, P1; PIRK J, 1986, ANN THORAC SURG, V42, P312, DOI 10.1016/S0003-4975(10)62742-7; PIRK J, 1986, COR VASA, V28, P177; RAJAH SM, 1994, J THORAC CARDIOV SUR, V107, P1146, DOI 10.1016/S0022-5223(94)70392-2; RAJAH SM, 1985, J THORAC CARDIOV SUR, V90, P373; Rohn V., 1993, Cor et Vasa, V35, P162; ROVELLI F, 1990, CIRCULATION, V82, P507; SANZ G, 1990, CIRCULATION, V82, P765, DOI 10.1161/01.CIR.82.3.765; SHARMA GVRK, 1983, CIRCULATION, V68, P218; Smith GD, 2001, SYSTEMATIC REV HLTH, P143; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Song FJ, 2000, CONTROL CLIN TRIALS, V21, P488, DOI 10.1016/S0197-2456(00)00055-6; Stein PD, 1998, CHEST, V114, p658S, DOI 10.1378/chest.114.5_Supplement.658S; THAULOW E, 1987, SCAND J THORAC CARD, V21, P215, DOI 10.3109/14017438709106027; VERSTRAETE M, 1986, EUR HEART J, V7, P4, DOI 10.1093/oxfordjournals.eurheartj.a061955; WEBER MAJ, 1990, AM J CARDIOL, V66, P1464, DOI 10.1016/0002-9149(90)90535-9; WEKSLER BB, 1983, NEW ENGL J MED, V308, P800, DOI 10.1056/NEJM198304073081402; Yamaguchi A, 1992, Nihon Kyobu Geka Gakkai Zasshi, V40, P485; YLIMAYRY S, 1992, EUR HEART J, V13, P1259, DOI 10.1093/oxfordjournals.eurheartj.a060346; Zimmermann N, 2001, J THORAC CARDIOV SUR, V121, P982, DOI 10.1067/mtc.2001.111416	54	56	59	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 6	2003	327	7427					1309	1311		10.1136/bmj.327.7427.1309	http://dx.doi.org/10.1136/bmj.327.7427.1309			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752DE	14656836	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000187131100014
J	Kempermann, G; Neumann, H				Kempermann, G; Neumann, H			Neuroscience - Microglia: The enemy within?	SCIENCE			English	Editorial Material							NEUROGENESIS		Max Delbruck Ctr Mol Med, Neuronal Stem Cells Res Grp, D-13125 Berlin, Germany; European Neurosci Inst Gottingen, Neuroimmunol Unit, D-37073 Gottingen, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Kempermann, G (corresponding author), Max Delbruck Ctr Mol Med, Neuronal Stem Cells Res Grp, D-13125 Berlin, Germany.		Neumann, Harald/A-9718-2010; Kempermann, Gerd/F-5416-2010	Neumann, Harald/0000-0002-5071-5202; Kempermann, Gerd/0000-0002-5304-4061				Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; MEHLER MF, 1993, NATURE, V362, P62, DOI 10.1038/362062a0; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328	7	111	115	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1689	1690		10.1126/science.1092864	http://dx.doi.org/10.1126/science.1092864			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657479				2022-12-28	WOS:000186970100026
J	Calsbeek, R; Smith, TB				Calsbeek, R; Smith, TB			Ocean currents mediate evolution in island lizards	NATURE			English	Article							LOCOMOTOR PERFORMANCE; ANOLIS; SPECIATION; RADIATIONS; MORPHOLOGY	Islands are considered to be natural laboratories in which to examine evolution because of the implicit assumption that limited gene flow allows tests of evolutionary processes in isolated replicates(1). Here we show that this well-accepted idea requires re-examination. Island inundation during hurricanes can have devastating effects on lizard populations in the Bahamas(2,3). After severe storms, islands may be recolonized by overwater dispersal of lizards from neighbouring islands(3). High levels of gene flow may homogenize genes responsible for divergence, and are widely viewed as a constraining force on evolution(4,5). Ultimately, the magnitude of gene flow determines the extent to which populations diverge from one another, and whether or not they eventually form new species(6,7). We show that patterns of gene flow among island populations of Anolis lizards are best explained by prevailing ocean currents, and that over-water dispersal has evolutionary consequences. Across islands, divergence in fitness-related morphology decreases with increasing gene flow(5). Results suggest that over-water dispersal after hurricanes constrains adaptive diversification in Anolis lizards, and that it may have an important but previously undocumented role in this classical example of adaptive radiation.	Univ Calif Los Angeles, Inst Environm, Ctr Trop Res, Los Angeles, CA 90065 USA	University of California System; University of California Los Angeles	Calsbeek, R (corresponding author), Univ Calif Los Angeles, Inst Environm, Ctr Trop Res, Los Angeles, CA 90065 USA.	calsbeek@ucla.edu		Calsbeek, Ryan/0000-0002-9236-4092				BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; Batchelet E., 1981, CIRCULAR STAT BIOL, V1st; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; CALSBEEK R, UNPUB AM NAT; CASGRAIN P, 2001, R PACKAGE MULTIVARIA; Endler J.A., 1977, Monographs in Population Biology, pi; Georges TM, 1996, NATURE, V379, P434, DOI 10.1038/379434a0; Irschick DJ, 1998, EVOLUTION, V52, P219, DOI 10.1111/j.1558-5646.1998.tb05155.x; Irschick DJ, 1997, ECOLOGY, V78, P2191, DOI 10.2307/2265955; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1111/j.1095-8312.1996.tb01451.x; Jackman TR, 1999, SYST BIOL, V48, P254, DOI 10.1080/106351599260283; KINDER TH, 1985, MAR GEOL, V68, P25, DOI 10.1016/0025-3227(85)90004-0; Lee TN, 1996, J PHYS OCEANOGR, V26, P962, DOI 10.1175/1520-0485(1996)026<0962:MOOWBC>2.0.CO;2; LIGHTY RG, 1979, NATURE, V278, P281, DOI 10.1038/278281b0; LOSOS JB, 1990, ECOL MONOGR, V60, P369, DOI 10.2307/1943062; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; LOSOS JB, 1989, J EXP BIOL, V145, P23; LOSOS JB, 1990, EVOLUTION, V44, P1189, DOI 10.1111/j.1558-5646.1990.tb05225.x; Losos JB, 2000, EVOLUTION, V54, P301, DOI 10.1111/j.0014-3820.2000.tb00032.x; Mayr E., 1963, ANIMAL SPECIES EVOLU; Ogden R, 2002, P NATL ACAD SCI USA, V99, P13612, DOI 10.1073/pnas.212248499; RICE WR, 1993, EVOLUTION, V47, P1637, DOI [10.2307/2410209, 10.1111/j.1558-5646.1993.tb01257.x]; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCHOENER A, 1984, OECOLOGIA, V63, P289, DOI 10.1007/BF00390655; Schoener T.W., 1983, P491; Schoener TW, 2001, SCIENCE, V294, P1525, DOI 10.1126/science.1064396; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Smith TB, 1997, SCIENCE, V276, P1855, DOI 10.1126/science.276.5320.1855; Spiller DA, 1998, SCIENCE, V281, P695, DOI 10.1126/science.281.5377.695; Williams E.E., 1983, LIZARD ECOLOGY STUDI, P326, DOI DOI 10.4159/HARVARD.9780674183384.C18	30	109	112	0	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					552	555		10.1038/nature02143	http://dx.doi.org/10.1038/nature02143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654839				2022-12-28	WOS:000186944300037
J	Zuger, A				Zuger, A			R-x: Canadian drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*PAT MED PRIC REV, 2002, PMPRB 2002 ANN REP; Rawson NSB, 2003, ANN PHARMACOTHER, V37, P1403, DOI 10.1345/aph.1D110; SIMON B, 2003, NY TIMES        1030, pW1	3	8	8	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2003	349	23					2188	2190		10.1056/NEJMp038196	http://dx.doi.org/10.1056/NEJMp038196			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LH	14657425				2022-12-28	WOS:000186921700004
J	Maglen, K				Maglen, K			Politics of quarantine in the 19th century	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Univ Oxford, Oxford, England	University of Oxford	Maglen, K (corresponding author), Univ Oxford, Oxford, England.							Fidler D. P, 1999, INT LAW INFECT DIS; HOWARDJONES N, 1974, WHO CHRON, V28, P495; Maglen K., 2001, THESIS U GLASGOW GLA THESIS U GLASGOW GLA; 1879, NATL BOARD HLTH B, P3; 1881, P INT SAN C PROV JOI, P16	5	9	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2873	2873		10.1001/jama.290.21.2873	http://dx.doi.org/10.1001/jama.290.21.2873			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QP	14657074				2022-12-28	WOS:000186872800032
J	Conboy, IM; Conboy, MJ; Smythe, GM; Rando, TA				Conboy, IM; Conboy, MJ; Smythe, GM; Rando, TA			Notch-mediated restoration of regenerative potential to aged muscle	SCIENCE			English	Article							SKELETAL-MUSCLE; SATELLITE CELLS; DIFFERENTIATION; MYOGENESIS; NUMBERS; FIBERS	A hallmark of aging is diminished regenerative potential of tissues, but the mechanism of this decline is unknown. Analysis of injured muscle revealed that, with age, resident precursor cells ( satellite cells) had a markedly impaired propensity to proliferate and to produce myoblasts necessary for muscle regeneration. This was due to insufficient up-regulation of the Notch ligand Delta and, thus, diminished activation of Notch in aged, regenerating muscle. Inhibition of Notch impaired regeneration of young muscle, whereas forced activation of Notch restored regenerative potential to old muscle. Thus, Notch signaling is a key determinant of muscle regenerative potential that declines with age.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; VA Palo Alto Hlth Care Syst, GRECC, Palo Alto, CA 94304 USA; VA Palo Alto Hlth Care Syst, Serv Neurol, Palo Alto, CA 94304 USA	Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.			Rando, Thomas/0000-0001-5843-8564; Smythe, Gayle/0000-0002-4967-209X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [F31NR005902] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS36409] Funding Source: Medline; NINR NIH HHS [NRSA-AG05902] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bockhold KJ, 1998, MUSCLE NERVE, V21, P173, DOI 10.1002/(SICI)1097-4598(199802)21:2<173::AID-MUS4>3.0.CO;2-8; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Cossu G, 1996, TRENDS GENET, V12, P218, DOI 10.1016/0168-9525(96)10025-1; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Goldring K, 2002, J PATHOL, V197, P457, DOI 10.1002/path.1157; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263; Kojika S, 2001, EXP HEMATOL, V29, P1041, DOI 10.1016/S0301-472X(01)00676-2; Nnodim JO, 2000, MECH AGEING DEV, V112, P99, DOI 10.1016/S0047-6374(99)00076-7; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Partridge TA, 2002, GENE THER, V9, P752, DOI 10.1038/sj.gt.3301764; Roth SM, 2000, ANAT REC, V260, P351, DOI 10.1002/1097-0185(200012)260:4<350::AID-AR30>3.0.CO;2-6; SCHULTZ E, 1982, MECH AGEING DEV, V20, P377, DOI 10.1016/0047-6374(82)90105-1; Shawber C, 1996, DEVELOPMENT, V122, P3765; Welle S, 2002, CAN J APPL PHYSIOL, V27, P19, DOI 10.1139/h02-002; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653	21	777	815	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1575	1577		10.1126/science.1087573	http://dx.doi.org/10.1126/science.1087573			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645852				2022-12-28	WOS:000186802200047
J	Boyd, PA; Tondi, F; Hicks, NR; Chamberlain, PF				Boyd, PA; Tondi, F; Hicks, NR; Chamberlain, PF			Autopsy after termination of pregnancy for fetal anomaly: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							PRENATAL-DIAGNOSIS	Objective To study trends in termination of pregnancy for fetal anomaly over 10 years and to assess the contribution of autopsy to the final diagnosis and counselling after termination. Design Retrospective study with cases from a congenital anomaly register and a defined unselected population. Data sources Pregnancies resulting in termination for fetal anomaly identified from the Oxford congenital anomaly register. Details about the prenatal diagnosis and autopsy findings were retrieved from case notes. Results Of the 57 258 deliveries, 309 (0.5%) were terminated because of prenatally diagnosed abnormality. There Were 129/29 086 (0.4%) terminations for fetal anomaly carried out in 1991-5 and 180/28 172 (0.6%) in 1996-2000. The percentage of fetuses that underwent autopsy fell from 84% to 67%. Autopsy was performed in 132 cases identified by ultrasound scan, with no evidence for abnormal karyotype. In 95 (72%) the autopsy confirmed the suspected diagnosis and did not add important further information, two cases were not classified, and in 35 (27%) the autopsy added information that led to a refinement of the risk of recurrence (reduced in 17, increased in 18); in I I of these 18 cases it was increased to a one in four risk. Conclusions Though there has been an increase in the rate of terminations of pregnancy for fetal anomaly, there has been a decline in the autopsy rate. When a prenatal diagnosis was based on the results of a scan only, the addition of information from a autopsy by a specialist paediatric pathologist provided important information that changed the estimated risk of recurrence in 27% of cases and in 8% this was to a higher (one in four) risk.	Inst Hlth Sci, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; Univ Florence, Fac Med & Chirurg, Dept Ginecol Perinatol & Riprod Umana, Florence, Italy; Univ Oxford, Dept Publ Hlth & Primary Care, Inst Hlth Sci, Oxford OX3 7LF, England; Oxford Radcliffe NHS Trust, Prenatal Diag Unit, Oxford OX3 9DU, England	University of Oxford; University of Florence; University of Oxford	Boyd, PA (corresponding author), Inst Hlth Sci, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England.	Patricia.boyd@orh.nhs.uk						Bauchner H, 2001, BMJ-BRIT MED J, V322, P309, DOI 10.1136/bmj.322.7282.309; Boyd PA, 1998, LANCET, V352, P1577, DOI 10.1016/S0140-6736(98)03202-4; Bricker L, 2000, HEALTH TECHNOL ASSES, V4, P1; Brodlie M, 2002, BRIT MED J, V324, P761, DOI 10.1136/bmj.324.7340.761; Gaffney G, 1998, PRENATAL DIAG, V18, P357, DOI 10.1002/(SICI)1097-0223(199804)18:4<357::AID-PD276>3.0.CO;2-0; Hunter M, 2001, BRIT MED J, V322, P255, DOI 10.1136/bmj.322.7281.255; Khong TY, 2002, BRIT MED J, V324, P749, DOI 10.1136/bmj.324.7340.749; Laussel-Riera A, 2000, ANN PATHOL, V20, P549; Morris JK, 1999, PRENATAL DIAG, V19, P142, DOI 10.1002/(SICI)1097-0223(199902)19:2<142::AID-PD486>3.3.CO;2-Z; *NAT PER EP UN, 2003, REP OXF CONG AN REG; Redfern Michael, 2001, ROYAL LIVERPOOL CHIL; *ROYAL COLL OBST G, 1997, ULTR SCANN FET ABN R; Wald NJ, 1998, HEALTH TECHNOL ASSES, V2, P1, DOI DOI 10.3310/HTA2010; 2002, BMJ, V325, P1121	14	115	116	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 17	2004	328	7432					137	140		10.1136/bmj.37939.570104.EE	http://dx.doi.org/10.1136/bmj.37939.570104.EE			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	765CQ	14662522	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000188249900017
J	Chen, CZ; Li, L; Lodish, HF; Bartel, DP				Chen, CZ; Li, L; Lodish, HF; Bartel, DP			MicroRNAs modulate hematopoietic lineage differentiation	SCIENCE			English	Article							EXPRESSION; RNAS; IDENTIFICATION; CONSERVATION; SEQUENCE; ENCODES; DEATH; FAT	MicroRNAs (miRNAs) are an abundant class of similar to22-nucleotide regulatory RNAs found in plants and animals. Some miRNAs of plants, Caenorhabditis elegans, and Drosophila play important gene-regulatory roles during development by pairing to target mRNAs to specify posttranscriptional repression of these messages. We identify three miRNAs that are specifically expressed in hematopoietic cells and show that their expression is dynamically regulated during early hematopoiesis and lineage commitment. One of these miRNAs, miR-181, was preferentially expressed in the B-lymphoid cells of mouse bone marrow, and its ectopic expression in hematopoietic stem/progenitor cells led to an increased fraction of B-lineage cells in both tissue-culture differentiation assays and adult mice. Our results indicate that microRNAs are components of the molecular circuitry that controls mouse hematopoiesis and suggest that other microRNAs have similar regulatory roles during other facets of vertebrate development.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Lodish, HF (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lodish@wi.mit.edu; dbartel@wi.mit.edu	Li, Ling/A-2008-2010; Huang, H/E-9490-2010	Chen, Chang-Zheng/0000-0002-1620-242X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081612] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL081612, R01 HL081612-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; COLLINS LS, 1987, J IMMUNOL, V138, P1082; Dostie J, 2003, RNA, V9, P631; Enver T, 1998, CELL, V94, P9, DOI 10.1016/S0092-8674(00)81215-5; GAUWERKY CE, 1989, P NATL ACAD SCI USA, V86, P8867, DOI 10.1073/pnas.86.22.8867; HANTZOPOULOS PA, 1989, P NATL ACAD SCI USA, V86, P3519, DOI 10.1073/pnas.86.10.3519; Kawasaki H, 2003, NATURE, V423, P838, DOI 10.1038/nature01730; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503	27	2633	2946	3	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 2	2004	303	5654					83	86		10.1126/science.1091903	http://dx.doi.org/10.1126/science.1091903			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YU	14657504	Green Submitted			2022-12-28	WOS:000187710600038
J	Pitches, D; Burls, A; Fry-Smith, A				Pitches, D; Burls, A; Fry-Smith, A			How to make a silk purse from a sow's ear - a comprehensive review of strategies to optimise data for corrupt managers and incompetent clinicians	BRITISH MEDICAL JOURNAL			English	Article							SURGICAL MORTALITY; REPORT CARDS; SURGEONS; DISEASE		Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT2, W Midlands, England	University of Birmingham	Pitches, D (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT2, W Midlands, England.		Burls, Amanda J.E./D-7641-2011	Burls, Amanda/0000-0001-9540-622X				*AUD GEN AUD SCOTL, 2002, REV MAN WAIT LISTS S; *BBC NEWS, 2002, STROK STAFF LOC NEWS; *BBC NEWS, 2003, PAN FIDDL FIG; *BMA, 2003, BMA SURV A E WAIT TI; BUCHER HC, 1994, BRIT MED J, V309, P761, DOI 10.1136/bmj.309.6957.761; Burack JH, 1999, ANN THORAC SURG, V68, P1195, DOI 10.1016/S0003-4975(99)00907-8; Cutrone M, 2001, PEDIATR DERMATOL, V18, P523, DOI 10.1046/j.1525-1470.2001.1862009.x; FAHEY T, 1995, BRIT MED J, V311, P1056, DOI 10.1136/bmj.311.7012.1056; FARTHING M, 2001, FRAUD MISCONDUCT BIO; GREEN J, 1995, NEW ENGL J MED, V332, P1229, DOI 10.1056/NEJM199505043321812; Gulland A, 2003, BRIT MED J, V327, P179, DOI 10.1136/bmj.327.7408.179; *HC COMM PUBL ACC, 2002, IN ADJ NHS WAIT LIST; Helmy Mohamed Ahmed, 2000, Journal of the Egyptian Society of Parasitology, V30, P951; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Hyman DA, 2001, J LEGAL STUD, V30, P531, DOI 10.1086/324674; Iezzoni LI, 1997, JAMA-J AM MED ASSOC, V278, P1600, DOI 10.1001/jama.278.19.1600; JONES RH, 1989, CIRCULATION, V79, P132; KALB PE, 1999, JAMA-J AM MED ASSOC, V282, P1183; Mehigan BJ, 2000, LANCET, V355, P782, DOI 10.1016/S0140-6736(99)08362-2; Nightingale F., 1863, NOTES ON HOSP; REVILL J, 2003, OBSERVER        0511; SIMBORG DW, 1981, NEW ENGL J MED, V304, P1602, DOI 10.1056/NEJM198106253042611; *WORLD BANK I, FLAGSH PROGR HLTH SE; Wynia MK, 2000, JAMA-J AM MED ASSOC, V283, P1858, DOI 10.1001/jama.283.14.1858; 2002, BBC NEWS        1007	25	20	20	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1436	1439		10.1136/bmj.327.7429.1436	http://dx.doi.org/10.1136/bmj.327.7429.1436			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684638	Green Published			2022-12-28	WOS:000187562700009
J	Berry, KL; Bulow, HE; Hall, DH; Hobert, O				Berry, KL; Bulow, HE; Hall, DH; Hobert, O			A C-elegans CLIC-like protein required for intracellular tube formation and maintenance	SCIENCE			English	Article							CHLORIDE-ION CHANNEL; SECRETORY-EXCRETORY SYSTEM; CAENORHABDITIS-ELEGANS; MOLECULAR-CLONING; ANION CHANNEL; CELL; NCC27; EXPRESSION; FAMILY; P64H1	The Caenorhabditis elegans excretory canal is composed of a single elongated and branched cell that is tunneled by an inner lumen of apical character. Loss of the exc-4 gene causes a cystic enlargement of this intracellular tube. exc-4 encodes a member of the chloride intracellular channel (CLIC) family of proteins. EXC-4 protein localizes to various tubular membranes in distinct cell types, including the lumenal membrane of the excretory tubes. A conserved 55 - amino acid domain enables EXC-4 translocation from the cytosol to the lumenal membrane. The tubular architecture of this membrane requires EXC-4 for both its formation and maintenance.	Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA; Yeshiva Univ Albert Einstein Coll Med, Ctr C Elegans Anat, Dept Neurosci, Bronx, NY 10461 USA	Columbia University; Yeshiva University; Albert Einstein College of Medicine	Hobert, O (corresponding author), Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA.			Hobert, Oliver/0000-0002-7634-2854; Berry, Katherine/0000-0002-2311-0734	NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR012596] Funding Source: NIH RePORTER; NCRR NIH HHS [R24 RR012596] Funding Source: Medline; NIH HHS [R24 OD010943] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Ashley RH, 2003, MOL MEMBR BIOL, V20, P1, DOI 10.1080/09687680210042746; Buechner M, 1999, DEV BIOL, V214, P227, DOI 10.1006/dbio.1999.9398; Buechner M, 2002, TRENDS CELL BIOL, V12, P479, DOI 10.1016/S0962-8924(02)02364-4; Cromer BA, 2002, EUR BIOPHYS J BIOPHY, V31, P356, DOI 10.1007/s00249-002-0219-1; Duncan RR, 1997, J BIOL CHEM, V272, P23880, DOI 10.1074/jbc.272.38.23880; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Harrop SJ, 2001, J BIOL CHEM, V276, P44993, DOI 10.1074/jbc.M107804200; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; LANDRY DW, 1989, SCIENCE, V244, P1469, DOI 10.1126/science.2472007; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; NELSON FK, 1984, J EXP ZOOL, V231, P45, DOI 10.1002/jez.1402310107; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishizawa T, 2000, J BIOL CHEM, V275, P11164, DOI 10.1074/jbc.275.15.11164; Proutski I, 2002, BIOCHEM BIOPH RES CO, V297, P317, DOI 10.1016/S0006-291X(02)02199-X; Tonini R, 2000, FASEB J, V14, P1171, DOI 10.1096/fasebj.14.9.1171; Tulk BM, 2000, J BIOL CHEM, V275, P26986; Tulk BM, 2002, AM J PHYSIOL-CELL PH, V282, pC1103, DOI 10.1152/ajpcell.00402.2001; Valenzuela SM, 2000, J PHYSIOL-LONDON, V529, P541, DOI 10.1111/j.1469-7793.2000.00541.x; Valenzuela SM, 1997, J BIOL CHEM, V272, P12575, DOI 10.1074/jbc.272.19.12575; Warton K, 2002, J BIOL CHEM, V277, P26003, DOI 10.1074/jbc.M203666200	23	124	129	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2134	2137		10.1126/science.1087667	http://dx.doi.org/10.1126/science.1087667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684823				2022-12-28	WOS:000187385200048
J	Low, DE; McGeer, A				Low, DE; McGeer, A			SARS - One year later	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Toronto, Toronto, ON, Canada; Mt Sinai Hosp, Dept Microbiol, Univ Hlth Network, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University Health Network Toronto	Low, DE (corresponding author), Mt Sinai Hosp, Dept Microbiol, Univ Hlth Network, Toronto, ON M5G 1X5, Canada.		mcgeer, allison/H-7747-2014; Low, Donald/B-1726-2012; McGeer, Allison/AAB-6885-2020	mcgeer, allison/0000-0001-5647-6137; McGeer, Allison/0000-0001-5647-6137				[Anonymous], 2003, MMWR MORB MORTAL WKL, V52, P986; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; JERNIGAN JA, IN PRESS EMERG INFEC	3	25	25	0	8	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					2381	2382		10.1056/NEJMp038203	http://dx.doi.org/10.1056/NEJMp038203			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681502				2022-12-28	WOS:000187326200002
J	Adams, WM; Brockington, D; Dyson, J; Vira, B				Adams, WM; Brockington, D; Dyson, J; Vira, B			Managing tragedies: Understanding conflict over common pool resources	SCIENCE			English	Article							NONEQUILIBRIUM	Conflicts over the management of common pool resources are not simply material. They also depend on the perceptions of the protagonists. Policy to improve management often assumes that problems are self-evident, but in fact careful and transparent consideration of the ways different stakeholders understand management problems is essential to effective dialogue.	Univ Cambridge, Dept Geog, Cambridge CB2 3EN, England; Univ Oxford, Sch Geog & Environm, Oxford OX1 3TB, England	University of Cambridge; University of Oxford	Adams, WM (corresponding author), Univ Cambridge, Dept Geog, Downing Pl, Cambridge CB2 3EN, England.	wa12@cam.ac.uk	/ADO-3246-2022; Brockington, Dan/AAK-9065-2021	Brockington, Dan/0000-0001-5692-0154; DYSON, JANE/0000-0003-4868-3229				Agrawal A, 2001, WORLD DEV, V29, P1649, DOI 10.1016/S0305-750X(01)00063-8; Arnold J. E. M., 1997, FARMS TREES FARMERS; BEHNKE RH, 1993, RANGE ECOLOGY AT DISEQUILIBRIUM, P1; Bobbitt P., 1978, TRAGIC CHOICES; Brown K, 2001, ECOL ECON, V37, P417, DOI 10.1016/S0921-8009(00)00293-7; Dryzek J.S., 2017, POLITICS EARTH ENV D, V3rd, DOI 10.1093/hepl/9780199696000.001.0001; Edwards VM, 1998, J THEOR POLIT, V10, P347, DOI 10.1177/0951692898010003008; Illius AW, 1999, ECOL APPL, V9, P798, DOI 10.1890/1051-0761(1999)009[0798:OTRONC]2.0.CO;2; Leach G., 1988, WOODFUEL CRISIS PEOP; Leach M., 1996, The lie of the land: challenging received wisdom on the African environment., P1; Oakerson R. J., 1992, Making the commons work: theory, practice, and policy., P41; Oakerson Ronald, 1986, P C COMM PROP RES MA, P13; OSTROM E, 1990, GOVT COMMONS EVOLUTI; ROE EM, 1991, WORLD DEV, V19, P287, DOI 10.1016/0305-750X(91)90177-J; SINCLAIR ARE, 1985, CAN J ZOOL, V63, P987, DOI 10.1139/z85-147; Sullivan S, 2002, J BIOGEOGR, V29, P1595, DOI 10.1046/j.1365-2699.2002.00799.x; Thomson J. T., 1992, Making the commons work: theory, practice, and policy., P129; Wilson James, 2002, DRAMA COMMONS, P327; Wollenberg E., 2001, International Journal of Agricultural Resources, Governance and Ecology, V1, P199, DOI 10.1504/IJARGE.2001.000012	19	205	214	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1915	1916		10.1126/science.1087771	http://dx.doi.org/10.1126/science.1087771			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671288	Green Submitted			2022-12-28	WOS:000187174000043
J	Elioff, MS; Valentini, JJ; Chandler, DW				Elioff, MS; Valentini, JJ; Chandler, DW			Subkelvin cooling NO molecules via "billiard-like" collisions with argon	SCIENCE			English	Article							BOSE-EINSTEIN CONDENSATION; DIFFERENTIAL CROSS-SECTIONS; GAS; PHOTOASSOCIATION; CESIUM; ATOMS	We report the cooling of nitric oxide using a single collision between an argon atom and a molecule of NO. We have produced significant numbers (10(8) to 10(9) molecules per cubic centimeter per quantum state) of translationally cold NO molecules in a specific quantum state with an upper-limit root mean square laboratory velocity of 15 plus or minus 1 meters per second, corresponding to a 406 plus or minus 23 millikelvin upper limit of temperature, in a crossed molecular beam apparatus. The technique, which relies on a kinematic collapse of the velocity distributions of the molecular beams for the scattering events that produce cold molecules, is general and independent of the energy of the colliding partner.	Sandia Natl Labs, Combust Res Facil, Livermore, CA 94550 USA; Columbia Univ, Dept Chem, New York, NY 10027 USA	United States Department of Energy (DOE); Sandia National Laboratories; Columbia University	Elioff, MS (corresponding author), Sandia Natl Labs, Combust Res Facil, Livermore, CA 94550 USA.							Alexander MH, 1999, J CHEM PHYS, V111, P7426, DOI 10.1063/1.480066; ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Bahns JT, 2000, ADV ATOM MOL OPT PHY, V42, P171, DOI 10.1016/S1049-250X(08)60187-1; Bethlem HL, 2000, PHYS REV LETT, V84, P5744, DOI 10.1103/PhysRevLett.84.5744; Bethlem HL, 2000, NATURE, V406, P491, DOI 10.1038/35020030; Bethlem HL, 2003, INT REV PHYS CHEM, V22, P73, DOI 10.1080/0144235021000046422; BRADLEY CC, 1995, PHYS REV LETT, V75, P1687, DOI 10.1103/PhysRevLett.75.1687; Burnett K, 2002, NATURE, V416, P225, DOI 10.1038/416225a; Chandler D. W., 1999, ADV PHOTOCHEMISTRY, V25; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; Diddams SA, 2001, SCIENCE, V293, P825, DOI 10.1126/science.1061171; Donley EA, 2002, NATURE, V417, P529, DOI 10.1038/417529a; Elioff MS, 2002, J CHEM PHYS, V117, P6455, DOI 10.1063/1.1505440; Eppink ATJB, 1997, REV SCI INSTRUM, V68, P3477, DOI 10.1063/1.1148310; Gupta M, 1999, J PHYS CHEM A, V103, P10670, DOI 10.1021/jp993560x; Kerman AJ, 2000, PHYS REV LETT, V84, P439, DOI 10.1103/PhysRevLett.84.439; Ketterle W, 2002, INT J MOD PHYS B, V16, P4537, DOI 10.1142/S0217979202014668; Kim JH, 1997, PHYS REV LETT, V78, P3665, DOI 10.1103/PhysRevLett.78.3665; LUQUE J, 1999, MP99109 SRI INT; Masnou-Seeuws F, 2001, ADV ATOM MOL OPT PHY, V47, P53; MILLER JD, 1993, PHYS REV LETT, V71, P2204, DOI 10.1103/PhysRevLett.71.2204; MONROE C, 1990, PHYS REV LETT, V65, P1571, DOI 10.1103/PhysRevLett.65.1571; Regal CA, 2003, NATURE, V424, P47, DOI 10.1038/nature01738; Rolston SL, 2002, NATURE, V416, P219, DOI 10.1038/416219a; Shaffer JP, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.021401; Takekoshi T, 1998, PHYS REV LETT, V81, P5105, DOI 10.1103/PhysRevLett.81.5105; THORSHEIM HR, 1987, PHYS REV LETT, V58, P2420, DOI 10.1103/PhysRevLett.58.2420; Weinstein JD, 1998, NATURE, V395, P148, DOI 10.1038/25949; Westley MS, 2001, J CHEM PHYS, V114, P2669, DOI 10.1063/1.1338528; Wieman CE, 1999, REV MOD PHYS, V71, pS253, DOI 10.1103/RevModPhys.71.S253	30	154	156	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1940	1943		10.1126/science.1090679	http://dx.doi.org/10.1126/science.1090679			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671296				2022-12-28	WOS:000187174000053
J	Guo, HW; Ecker, JR				Guo, HW; Ecker, JR			Plant responses to ethylene gas are mediated by SCF (EBF1/EBF2)-dependent proteolysis of EIN3 transcription factor	CELL			English	Article							RECEPTOR GENE FAMILY; F-BOX SUBUNIT; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; PROTEIN-DEGRADATION; UBIQUITIN-LIGASE; PATHWAY; COMPLEX; MUTANT; KINASE	Plants use ethylene gas as a signal to regulate myriad developmental processes and stress responses. The Arabidopsis EIN3 protein is a key transcription factor mediating ethylene-regulated gene expression and morphological responses. Here, we report that EIN3 protein levels rapidly increase in response to ethylene and this response requires several ethylene-signaling pathway components including the ethylene receptors (ETR1 and EIN4), CTR1, EIN2, EIN5, and EIN6. In the absence of ethylene, EIN3 is quickly degraded through a ubiquitin/proteasome pathway mediated by two F box proteins, EBF1 and EBF2. Plants containing mutations in either gene show enhanced ethylene response by stabilizing EIN3, whereas efb1 efb2 double mutants show constitutive ethylene phenotypes. Plants over-expressing either F box gene display ethylene insensitivity and destabilization of EIN3 protein. These results reveal that a ubiquitin/proteasome pathway negatively regulates ethylene responses by targeting EIN3 for degradation, and pinpoint EIN3 regulation as the key step in the response to ethylene.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ecker@salk.edu	Ecker, Joseph R/B-9144-2008	Ecker, Joseph R/0000-0001-5799-5895	NIGMS NIH HHS [1F32GM66639] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM066639] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abeles F, 1992, ETHYLENE PLANT BIOL; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bechtold N, 1998, METH MOL B, V82, P259; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chao QM, 1997, CELL, V89, P1133, DOI 10.1016/S0092-8674(00)80300-1; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; Frugis G, 2002, TRENDS CELL BIOL, V12, P308, DOI 10.1016/S0962-8924(02)02308-5; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gray WM, 1999, GENE DEV, V13, P1678, DOI 10.1101/gad.13.13.1678; Guo HW, 2001, SCIENCE, V291, P487, DOI 10.1126/science.291.5503.487; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; Hellmann H, 2002, SCIENCE, V297, P793, DOI 10.1126/science.1072831; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hua J, 1998, PLANT CELL, V10, P1321, DOI 10.1105/tpc.10.8.1321; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Larsen PB, 2001, PLANT PHYSIOL, V125, P1061, DOI 10.1104/pp.125.2.1061; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; LIN C, 1995, P NATL ACAD SCI USA, V92, P8423, DOI 10.1073/pnas.92.18.8423; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; Ouaked F, 2003, EMBO J, V22, P1282, DOI 10.1093/emboj/cdg131; Potuschak T, 2003, CELL, V115, P679, DOI 10.1016/S0092-8674(03)00968-1; ROMAN G, 1995, GENETICS, V139, P1393; Sakai H, 1998, P NATL ACAD SCI USA, V95, P5812, DOI 10.1073/pnas.95.10.5812; Sasaki A, 2003, SCIENCE, V299, P1896, DOI 10.1126/science.1081077; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Stepanova AN, 2000, CURR OPIN PLANT BIOL, V3, P353, DOI 10.1016/S1369-5266(00)00096-0; Vierstra RD, 2003, TRENDS PLANT SCI, V8, P135, DOI 10.1016/S1360-1385(03)00014-1; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Xiao WY, 2000, TRENDS PLANT SCI, V5, P454, DOI 10.1016/S1360-1385(00)01769-6; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yin YH, 2002, CELL, V109, P181, DOI 10.1016/S0092-8674(02)00721-3	43	620	687	15	138	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2003	115	6					667	677		10.1016/S0092-8674(03)00969-3	http://dx.doi.org/10.1016/S0092-8674(03)00969-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675532	Bronze			2022-12-28	WOS:000187366100007
J	Faupl, P; Richter, W; Urbanek, C				Faupl, P; Richter, W; Urbanek, C			Geochronology - Dating of the herto hominin fossils	NATURE			English	Editorial Material							PLEISTOCENE HOMO-SAPIENS; MIDDLE AWASH; ETHIOPIA		Univ Vienna, Dept Geol Sci, A-1090 Vienna, Austria	University of Vienna	Faupl, P (corresponding author), Univ Vienna, Dept Geol Sci, Waehringer Guertel 18, A-1090 Vienna, Austria.							Chernet T, 1998, J VOLCANOL GEOTH RES, V80, P267, DOI 10.1016/S0377-0273(97)00035-8; Clark JD, 2003, NATURE, V423, P747, DOI 10.1038/nature01670; Stringer C, 2003, NATURE, V423, P692, DOI 10.1038/423692a; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669	4	6	6	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					621	622		10.1038/426621a	http://dx.doi.org/10.1038/426621a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668852				2022-12-28	WOS:000187132800029
J	Heistad, DD				Heistad, DD			Unstable coronary-artery plaques	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ATHEROSCLEROSIS		Univ Iowa, Carver Coll Med, Iowa City, IA 52242 USA; Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Heistad, DD (corresponding author), Univ Iowa, Carver Coll Med, Iowa City, IA 52242 USA.							Azumi H, 2002, ARTERIOSCL THROM VAS, V22, P1838, DOI 10.1161/01.ATV.0000037101.40667.62; Kockx MM, 2003, ARTERIOSCL THROM VAS, V23, P440, DOI 10.1161/01.ATV.0000057807.28754.7F; WILLIAMS JK, 1988, CIRC RES, V62, P515, DOI 10.1161/01.RES.62.3.515	3	42	45	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					2285	2287		10.1056/NEJMp038161	http://dx.doi.org/10.1056/NEJMp038161			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668452				2022-12-28	WOS:000187125000002
J	Opferman, JT; Letai, A; Beard, C; Sorcinelli, MD; Ong, CC; Korsmeyer, SJ				Opferman, JT; Letai, A; Beard, C; Sorcinelli, MD; Ong, CC; Korsmeyer, SJ			Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1	NATURE			English	Article							HEMATOPOIETIC-CELLS; DEFICIENT MICE; BCL-2 FAMILY; APOPTOSIS; DEATH; SURVIVAL; HOMEOSTASIS; LACKING; MEMBER; IL-7	Regulated apoptosis is essential for both the development and the subsequent maintenance of the immune system(1,2). Interleukins, including IL- 2, IL- 4, IL- 7 and IL- 15, heavily influence lymphocyte survival during the vulnerable stages of VDJ rearrangement and later in ensuring cellular homeostasis, but the genes specifically responsible for the development and maintenance of lymphocytes have not been identified(3 - 8). The antiapoptotic protein MCL- 1 is an attractive candidate, as it is highly regulated(9), appears to enhance short- term survival(10) and functions at an apical step in genotoxic deaths(11). However, Mcl- 1 deficiency results in peri- implantation lethality(12). Here we show that mice conditional for Mcl- 1 display a profound reduction in B and T lymphocytes when MCL- 1 is removed. Deletion of Mcl- 1 during early lymphocyte differentiation increased apoptosis and arrested the development at pro- B- cell and double- negative T- cell stages. Induced deletion of Mcl- 1 in peripheral B- and T- cell populations resulted in their rapid loss. Moreover, IL- 7 both induced and required MCL- 1 to mediate lymphocyte survival. Thus, MCL- 1, which selectively inhibits the proapoptotic protein BIM, is essential both early in lymphoid development and later on in the maintenance of mature lymphocytes.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst,Dept Pathol & Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Korsmeyer, SJ (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst,Dept Pathol & Med, Boston, MA 02115 USA.	stanley_korsmeyer@dfci.harvard.edu	Opferman, Joseph T/M-5331-2018	Opferman, Joseph T/0000-0002-1147-5621				Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Datta SR, 2002, DEV CELL, V3, P631, DOI 10.1016/S1534-5807(02)00326-X; GODFREY DI, 1993, J IMMUNOL, V150, P4244; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee PD., 2001, J LIGHT MET, V1, P15; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; MA A, 1995, P NATL ACAD SCI USA, V92, P4763, DOI 10.1073/pnas.92.11.4763; Maraskovsky E, 1997, CELL, V89, P1011, DOI 10.1016/S0092-8674(00)80289-5; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Ranger AM, 2003, P NATL ACAD SCI USA, V100, P9324, DOI 10.1073/pnas.1533446100; Rathmell JC, 1999, ANNU REV IMMUNOL, V17, P781, DOI 10.1146/annurev.immunol.17.1.781; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rinkenberger JL, 2000, GENE DEV, V14, P23; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Vella AT, 1998, P NATL ACAD SCI USA, V95, P3810, DOI 10.1073/pnas.95.7.3810; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yang T, 1996, J CELL PHYSIOL, V166, P523, DOI 10.1002/(SICI)1097-4652(199603)166:3<523::AID-JCP7>3.0.CO;2-R; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zhou P, 1997, BLOOD, V89, P630, DOI 10.1182/blood.V89.2.630	30	644	676	0	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					671	676		10.1038/nature02067	http://dx.doi.org/10.1038/nature02067			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668867				2022-12-28	WOS:000187132800044
J	Curtis, JP; Wang, YF; Portnay, EL; Masoudi, FA; Havranek, EP; Krumholz, HM				Curtis, JP; Wang, YF; Portnay, EL; Masoudi, FA; Havranek, EP; Krumholz, HM			Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article									Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Dis, New Haven, CT 06520 USA; Denver Hlth Med Ctr, Div Cardiol, Denver, CO 80204 USA	Yale University; Denver Health Medical Center	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Dis, Room I-456 SHM,333 Cedar St,POB 208088, New Haven, CT 06520 USA.		, Harlan/AAI-2875-2020; Masoudi, Frederick/Q-7467-2019		NATIONAL INSTITUTE ON AGING [K08AG001011] Funding Source: NIH RePORTER; NIA NIH HHS [K08-AG01011] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		FitzGerald GA, 2003, LANCET, V361, P542, DOI 10.1016/S0140-6736(03)12560-3; FLEMING C, 1992, MED CARE, V30, P377, DOI 10.1097/00005650-199205000-00001; MacDonald TM, 2003, LANCET, V361, P573, DOI 10.1016/S0140-6736(03)12509-3; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; 2003, US TODAY        0213, pD1	5	62	63	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 6	2003	327	7427					1322	1323		10.1136/bmj.327.7427.1322	http://dx.doi.org/10.1136/bmj.327.7427.1322			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752DE	14656840	Green Published, Bronze			2022-12-28	WOS:000187131100018
J	van Alem, AP; Vrenken, RH; de Vos, R; Tijssen, JGP; Koster, RW				van Alem, AP; Vrenken, RH; de Vos, R; Tijssen, JGP; Koster, RW			Use of automated external defibrillator by first responders in out of hospital cardiac arrest: prospective controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOPULMONARY-RESUSCITATION; VENTRICULAR-FIBRILLATION; POLICE OFFICERS; SURVIVAL	Objective To test the hypothesis that the use of an automated external defibrillator by police and fire fighters results in higher discharge rates for out of hospital cardiac arrest. Design Controlled clinical trial with initial random allocation of automated external defibrillators to first responders in four of the eight participating regions; each region switched from control to experimental, and vice versa, every four months. Setting Amsterdam and surroundings, the Netherlands. Participants Patients with witnessed out of hospital cardiac arrests, identified by the emergency medical system between January 2000 and January 2002. Main outcomes measures Survival to hospital discharge; return of spontaneous circulation; admission to hospital. Results 243 patients (65% in ventricular fibrillation) were included in the experimental area and 226 patients (67% in ventricular fibrillation) in the control area. The median time interval between collapse and first shock was 668 seconds in the experimental area and 769 seconds in the control area (P < 0.001). 44 (18%) patients in the experimental area versus 33 (15%) patients in the control area were discharged (odds ratio 1.3 (95% confidence interval 0.8 to 2.2), P = 0.33), 139 (57%) experimental versus 108 (48%) control patients had return of spontaneous circulation (1.5 (1.0 to 2.2), P = 0.05), and 103 (42%) experimental versus 74 (33%) control patients were admitted (1.5 (1.1 to 1.6), P = 0.02). The median delay from receipt of call to dispatch of the ambulance was 120 seconds, and the delay to dispatch of the first responder was 180 seconds. Conclusions Use of automated external defibrillators by first responders did not significantly increase survival to discharge from hospital, although it did improve return of spontaneous circulation and admission to hospital. Improved dispatch procedures should increase the success of programmes of first responders using external defibrillators.	Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; Municipal Hlth Serv, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Alem, AP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Cardiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.p.vanalem@amc.uva.nl	de Vos, Rien/AAN-7053-2020					[Anonymous], 2000, Resuscitation, V46, P73; Capucci A, 2002, CIRCULATION, V106, P1065, DOI 10.1161/01.CIR.0000028148.62305.69; Cobb LA, 1999, JAMA-J AM MED ASSOC, V281, P1182, DOI 10.1001/jama.281.13.1182; CUMMINS RO, 1984, LANCET, V2, P318; CUMMINS RO, 1986, CIRCULATION, V73, P381, DOI 10.1161/01.CIR.73.3.381; Davies CS, 2002, RESUSCITATION, V52, P13; Diggle PJ, 1994, ANAL LONGITUDINAL DA; EISENBERG MS, 1986, AM J EMERG MED, V4, P299, DOI 10.1016/0735-6757(86)90297-4; Groh WJ, 2001, ACAD EMERG MED, V8, P324, DOI 10.1111/j.1553-2712.2001.tb02109.x; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Jaffe A, 2001, NEW ENGL J MED, V344, P771; Mosesso VN, 1998, ANN EMERG MED, V32, P200, DOI 10.1016/S0196-0644(98)70137-4; Myerburg RJ, 2002, CIRCULATION, V106, P1058, DOI 10.1161/01.CIR.0000028147.92190.A7; ORNATO JP, 1999, PREHOSP EMERG CARE, V3, P298; Ross P, 2001, RESUSCITATION, V50, P141, DOI 10.1016/S0300-9572(01)00343-4; Valenzuela TD, 1997, CIRCULATION, V96, P3308; Waalewijn RA, 1998, RESUSCITATION, V38, P157, DOI 10.1016/S0300-9572(98)00102-6; Waalewijn RA, 2002, RESUSCITATION, V54, P31, DOI 10.1016/S0300-9572(02)00047-3; Waalewijn RA, 2001, RESUSCITATION, V51, P113, DOI 10.1016/S0300-9572(01)00407-5; White RD, 1996, ANN EMERG MED, V28, P480, DOI 10.1016/S0196-0644(96)70109-9; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	21	139	142	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 6	2003	327	7427					1312	1315		10.1136/bmj.327.7427.1312	http://dx.doi.org/10.1136/bmj.327.7427.1312			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752DE	14656837	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000187131100015
J	von Kries, R; Ihme, N; Oberle, D; Lorani, A; Stark, R; Altenhofen, L; Niethard, FU				von Kries, R; Ihme, N; Oberle, D; Lorani, A; Stark, R; Altenhofen, L; Niethard, FU			Effect of ultrasound screening on the rate of first operative procedures for developmental hip dysplasia in Germany	LANCET			English	Article							CONGENITAL DISLOCATION; NEWBORN-INFANTS; DIAGNOSIS; INSTABILITY; ULTRASONOGRAPHY; CHILDREN; TRIAL; UK	Background Ultrasound screening for developmental hip dysplasia and early conservative treatment might prevent later hip operations. A national hip ultrasound-screening programme, undertaken during the first 6 weeks of life, was introduced across Germany in 1996 and was continued for 5 years. We assessed the rate of first operation on the hip during this programme. Methods A national active surveillance programme of initial operations for developmental hip dysplasia was started in 1997 and continued for 5 years. Screening participation was assessed by a random digit dialling telephone survey. Cases were children aged between 10 weeks and 5 years at first operation, who had had no underlying disease leading to developmental hip dysplasia. Completeness of case ascertainment was validated with a capture-recapture study in a representative subsample. Calculated incidences were compared with previously established rates. Findings About 90% of all children were screened. 147 cases in the first year, and between 81 and 105 for subsequent years were reported. Treatment included closed reductions 353 (66%), open reductions 61 (11%), and osteotomies 121 (23%). Developmental hip dysplasia was diagnosed by ultrasound before 6 weeks of age in 272 (55%) of cases, 64 (13%) were screened at the recommended time but had normal findings, 70 (14%) had delayed screening, and 89 (18%) were not screened. Capture-recapture estimates suggested that 52% of cases were reported. The corrected incidence for first operation was 0.26 per 1000 livebirths (95% CI 0.22-0.32). Interpretation Ultrasound screening seems to prevent many, but not all, operations for developmental hip dysplasia. Rates of timely screening (ie, before 6 weeks of age) and training of doctors in ultrasound screening need to be improved.	Univ Munich, Inst Social Paediat & Adolescent Med, Dept Paediat Epidemiol, D-81377 Munich, Germany; Univ Aachen, Dept Orthopaed, Aachen, Germany; Cent Res Inst Ambulatory Hlth Care Germany, Cologne, Germany	University of Munich; RWTH Aachen University	von Kries, R (corresponding author), Univ Munich, Inst Social Paediat & Adolescent Med, Dept Paediat Epidemiol, Heiglhofstr 63, D-81377 Munich, Germany.	AG.EPI@LRZ.uni-muenchen.de	Stark, Renée/B-6733-2013	Stark, Renée/0000-0002-6612-292X				Altenhofen L, 1996, DEUT ARZTEBLATT, V93, pA; Andersson JE, 2002, ACTA PAEDIATR, V91, P926, DOI 10.1080/080352502760148658; BARLOW TG, 1962, J BONE JOINT SURG BR, V44, P292, DOI 10.1302/0301-620X.44B2.292; Chan A, 1999, LANCET, V354, P1514, DOI 10.1016/S0140-6736(98)12469-8; Duppe H, 2002, J BONE JOINT SURG BR, V84B, P878, DOI 10.1302/0301-620X.84B6.12326; Eastwood DM, 2003, LANCET, V361, P595, DOI 10.1016/S0140-6736(03)12519-6; Elbourne D, 2002, LANCET, V360, P2009, DOI 10.1016/S0140-6736(02)12024-1; Godward S, 1998, LANCET, V351, P1149, DOI 10.1016/S0140-6736(97)10466-4; GRAF R, 1983, J PEDIATR ORTHOPED, V3, P354, DOI 10.1097/01241398-198307000-00015; Holen KJ, 2002, J BONE JOINT SURG BR, V84B, P886, DOI 10.1302/0301-620X.84B6.12093; Hook EB, 1995, EPIDEMIOL REV, V17, P243, DOI 10.1093/oxfordjournals.epirev.a036192; KATTHAGEN BD, 1988, Z ORTHOP GRENZGEB, V126, P475, DOI 10.1055/s-2008-1044470; Laubereau B, 2001, MONATSSCHR KINDERH, V149, P367, DOI 10.1007/s001120050777; MARKS DS, 1994, J BONE JOINT SURG BR, V76B, P534, DOI 10.1302/0301-620X.76B4.8027134; Maxwell SL, 2002, BMJ-BRIT MED J, V324, P1031, DOI 10.1136/bmj.324.7344.1031; NIETHARD FU, 2000, DTSCH ARZTEBLATT, V97, P1593; Ortolani M., 1937, PEDIATRIA NAPOLI, V45, P129; Pauwels F, 1976, BIOMECHANICS NORMAL; ROSENDAHL K, 1992, ACTA PAEDIATR, V81, P177, DOI 10.1111/j.1651-2227.1992.tb12198.x; ROSENDAHL K, 1994, PEDIATRICS, V94, P47; von Kries R, 2001, MONATSSCHR KINDERH, V149, P1191, DOI 10.1007/s001120170044; VON ROSEN S, 1956, Acta Orthop Scand, V26, P136; WEIDTMAN V, 1984, HUFTGELENKSVERANDERU; *ZENTR, 1991, HINW DURCHF FRUH KIN	24	101	103	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2003	362	9399					1883	1887		10.1016/S0140-6736(03)14957-4	http://dx.doi.org/10.1016/S0140-6736(03)14957-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667743				2022-12-28	WOS:000187011600008
J	Aldrich, R; Kemp, L; Williams, JS; Harris, E; Simpson, S; Wilson, A; McGill, K; Byles, J; Lowe, J; Jackson, T				Aldrich, R; Kemp, L; Williams, JS; Harris, E; Simpson, S; Wilson, A; McGill, K; Byles, J; Lowe, J; Jackson, T			Using socioeconomic evidence in clinical practice guidelines	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMPLEX INTERVENTIONS; CARE; SEARCH		Newcastle Inst Publ Hlth, Newcastle, NSW 2300, Australia; Univ New S Wales, Sch Publ Hlth & Community Med, Ctr Hlth Equity Training Res & Evaluat, Sydney, NSW 2052, Australia; Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia; La Trobe Univ, Sch Publ Hlth, Bundoora, Vic 3086, Australia; John Hunter Hosp, Hunter Area Hlth Serv, Hunter Region Mail Ctr, NSW 2310, Australia	University of New South Wales Sydney; University of Newcastle; La Trobe University; John Hunter Hospital	Aldrich, R (corresponding author), Newcastle Inst Publ Hlth, POB 664J, Newcastle, NSW 2300, Australia.	raldrich@mail.newcastle.edu.au	Byles, Julie E/C-5062-2008	Byles, Julie E/0000-0002-3984-6877; Kemp, Lynn/0000-0002-0348-1837; Simpson, Sarah/0000-0003-1896-5145; Wilson, Amanda/0000-0001-5681-9611; Jackson, Terri/0000-0001-6351-2773				Acheson D., 1998, INDEPENDENT INQUIRY; Barton S, 2000, BRIT MED J, V321, P255, DOI 10.1136/bmj.321.7256.255; Bradley F, 1999, BMJ-BRIT MED J, V318, P711; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Britton A, 1998, BRIT MED J, V316, P703, DOI 10.1136/bmj.316.7132.703a; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; COUZOS S, 2001, SYST REV EX EV PRIM; Furler JS, 2002, MED J AUSTRALIA, V177, P80, DOI 10.5694/j.1326-5377.2002.tb04673.x; Greenhalgh T, 1999, BMJ-BRIT MED J, V318, P323, DOI 10.1136/bmj.318.7179.323; Harbour R, 2001, BRIT MED J, V323, P334, DOI 10.1136/bmj.323.7308.334; HARRIS E, 1999, PERSPECTIVES HLTH IN; Harris MF, 2002, MED J AUSTRALIA, V177, P250, DOI 10.5694/j.1326-5377.2002.tb04757.x; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Kidd KE, 2000, CONTROL CLIN TRIALS, V21, p184S, DOI 10.1016/S0197-2456(00)00076-3; Mason S, 2003, BRIT MED J, V326, P1244, DOI 10.1136/bmj.326.7401.1244; *NAT HLTH MED RES, 2003, US SOC EV CLIN PRACT, P95; *NAT HLTH MED RES, 2000, COMP COST BEN EV EC; National Health and Medical Research Council, 1998, GUID DEV IMPL EV CLI; *NZ GUID GROUP, 2002, BEST PRACT EV BAS GU, P163; Shaw M., 2002, HLTH PLACE SOC; Speller V, 1997, BRIT MED J, V315, P361; Turrell G., 1999, SOCIOECONOMIC DETERM; Whitehead M, 1990, CONCEPTS PRINCIPLES; WILKINSON R, 1998, SOCIAL DETERMINANTS, P308	24	44	48	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 29	2003	327	7426					1283	1285		10.1136/bmj.327.7426.1283	http://dx.doi.org/10.1136/bmj.327.7426.1283			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749VD	14644976	Green Published, Green Submitted			2022-12-28	WOS:000186948800025
J	Muller, UK				Muller, UK			Fish 'n flag	SCIENCE			English	Editorial Material							FLIGHT; WIND; WAVE		Univ Wageningen & Res Ctr, Dept Expt Zool, NL-6700 HB Wageningen, Netherlands	Wageningen University & Research	Muller, UK (corresponding author), Univ Wageningen & Res Ctr, Dept Expt Zool, NL-6700 HB Wageningen, Netherlands.							Birch JM, 2003, J EXP BIOL, V206, P2257, DOI 10.1242/jeb.00381; Liao JC, 2003, SCIENCE, V302, P1566, DOI 10.1126/science.1088295; Liao JC, 2003, J EXP BIOL, V206, P1059, DOI 10.1242/jeb.00209; MCHENRY MJ, 1995, J EXP BIOL, V198, P2293; Muller UK, 2002, INTEGR COMP BIOL, V42, P981, DOI 10.1093/icb/42.5.981; PRANDTL L, 1952, ESSENTIALS FLUID MEC; Spedding GR, 2003, J EXP BIOL, V206, P2313, DOI 10.1242/jeb.00423; Zhang J, 2000, NATURE, V408, P835, DOI 10.1038/35048530	8	38	39	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1511	1512		10.1126/science.1092367	http://dx.doi.org/10.1126/science.1092367			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645830				2022-12-28	WOS:000186802200023
J	Kelsey, PB; Chen, S; Lauwers, GY; McCluskey, RT; Bazari, H; Chan, A; Pratt, J				Kelsey, PB; Chen, S; Lauwers, GY; McCluskey, RT; Bazari, H; Chan, A; Pratt, J			Case 37-2003: A 79-year-old man with coronary artery disease, peripheral vascular disease, end-stage renal disease, and abdominal pain and distention - Colonic necrosis with perforation due to sodium polystyrene sulfonate in sorbitol. Ischemic colitis, healed	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DIALYSIS-RELATED AMYLOIDOSIS; GASTROINTESTINAL-TRACT; KAYEXALATE-SORBITOL; INTESTINAL NECROSIS; SMALL-BOWEL; ENEMAS; EMBOLIZATION; INVOLVEMENT; INFARCTION		Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Kelsey, PB (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Abraham SC, 2001, AM J SURG PATHOL, V25, P637, DOI 10.1097/00000478-200105000-00011; ARORA RR, 1993, AM HEART J, V126, P225, DOI 10.1016/S0002-8703(07)80034-2; Bailey M, 1998, GASTROENTEROL CLIN N, V27, P747, DOI 10.1016/S0889-8553(05)70032-7; Bennett LN, 1996, AM J PERINAT, V13, P167, DOI 10.1055/s-2007-994318; BLAIR NP, 1995, CAN J SURG, V38, P281; CAMPISTOL JM, 1990, AM J NEPHROL, V10, P389, DOI 10.1159/000168154; Dardik A, 2000, SOUTH MED J, V93, P511; FINE MJ, 1987, ANGIOLOGY, V38, P769, DOI 10.1177/000331978703801007; Fujiyama A, 1999, INTERNAL MED, V38, P580, DOI 10.2169/internalmedicine.38.580; GERSTMAN BB, 1992, AM J KIDNEY DIS, V20, P159, DOI 10.1016/S0272-6386(12)80544-0; HENDEL RC, 1989, ARCH INTERN MED, V149, P2371, DOI 10.1001/archinte.149.10.2371; IKEGAYA N, 1995, AM J KIDNEY DIS, V25, P807, DOI 10.1016/0272-6386(95)90559-6; LILLEMOE KD, 1987, SURGERY, V101, P267; MATOS C, 1986, GASTROINTEST RADIOL, V11, P322, DOI 10.1007/BF02035100; Rashid A, 1997, AM J SURG PATHOL, V21, P60, DOI 10.1097/00000478-199701000-00007; REILLY PM, 1993, CRIT CARE MED, V21, pS55, DOI 10.1097/00003246-199302001-00011; RoyChaudhury P, 1997, AM J KIDNEY DIS, V30, P120, DOI 10.1016/S0272-6386(97)90574-6; SCOTT TR, 1993, DIS COLON RECTUM, V36, P607, DOI 10.1007/BF02049870; TAKAHASHI S, 1988, CLIN NEPHROL, V30, P168; THADHANI RI, 1995, MEDICINE, V74, P350, DOI 10.1097/00005792-199511000-00005; WOOTTON FT, 1989, ANN INTERN MED, V111, P947, DOI 10.7326/0003-4819-111-11-947; ZIJLSTRA FJ, 1981, LANCET, V2, P815	22	19	20	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2003	349	22					2147	2155		10.1056/NEJMcpc030031	http://dx.doi.org/10.1056/NEJMcpc030031			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746ZV	14645643				2022-12-28	WOS:000186779700011
J	Birkmeyer, JD; Siewers, AE; Marth, NJ; Goodman, DC				Birkmeyer, JD; Siewers, AE; Marth, NJ; Goodman, DC			Regionalization of high-risk surgery and implications for patient travel times	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HOSPITAL VOLUME; CARDIAC-SURGERY; UNITED-STATES; MORTALITY; PANCREATICODUODENECTOMY; DISTANCE; IMPACT; CHOICE; CARE	Context Given the strong volume-outcome relationships observed with many surgical procedures, restricting some procedures to hospitals exceeding a minimum volume standard is advocated. However, such regionalization policies might cause unreasonable travel burdens for surgical patients. Objective To estimate how minimum volume standards for esophagectomy and pancreatic resection would affect how long patients must travel for these procedures. Design, Setting, and Patients Simulated trial based on Medicare claims and US road network data. All US hospitals in the 48 continental states were in the study if their surgical procedures included esophagectomy and pancreatic resection. Data from Medicare patients (N=15796) undergoing these 2 procedures for cancer between 1994 and 1999 were used. Main Outcome Measure Additional travel time for patients required to change to higher-volume centers as a result of alternative hospital volume standards (procedures per year). Results With low-volume standards (1 /year for pancreatectomy; 2/year for esophagectomy), approximately 15% of patients would change to higher-volume centers, with negligible effect on their travel times. Most patients would need to travel less than 30 additional minutes (74% pancreatectomy; 76% esophagectomy). Many patients already lived closer to a higher-volume hospital (25% pancreatectomy; 26% esophagectomy). Conversely, with very high-volume standards (>16/year for pancreatectomy; >19/year for esophagectomy), approximately 80% of patients would change to higher-volume centers. More than 50% of these patients would increase their travel time by more than 60 minutes. Travel times would increase most for patients living in rural areas. Conclusions Many patients travel pasta higher-volume center to undergo surgery at a low-volume hospital. If not set too high, hospital volume standards could be implemented for selected operations without imposing unreasonable travel burdens on patients.	Dartmouth Hitchcock Med Ctr, Sect Gen Surg, Dept Surg, Lebanon, NH 03756 USA; Dartmouth Hitchcock Med Ctr, Dept Pediat, Lebanon, NH 03756 USA; Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci, Hanover, NH USA; Maine Med Ctr, Ctr Outcomes Res & Evaluat, Portland, ME 04102 USA	Dartmouth College; Dartmouth College; Dartmouth College; Maine Medical Center	Birkmeyer, JD (corresponding author), Dartmouth Hitchcock Med Ctr, Sect Gen Surg, Dept Surg, Lebanon, NH 03756 USA.		Goodman, David/AAG-7497-2020		AHRQ HHS [R01 HS10141-01] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS010141] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Birkmeyer JD, 2002, ANN SURG ONCOL, V9, P826, DOI 10.1007/BF02557516; Birkmeyer JD, 1999, SURGERY, V125, P250, DOI 10.1067/msy.1999.95211; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Chang RKR, 2002, PEDIATRICS, V109, P173, DOI 10.1542/peds.109.2.173; Daley J, 2002, SURGERY, V131, P16, DOI 10.1067/msy.2002.120237; Epstein AM, 2002, NEW ENGL J MED, V346, P1161, DOI 10.1056/NEJM200204113461512; Goodman DC, 1997, AM J PUBLIC HEALTH, V87, P1144, DOI 10.2105/AJPH.87.7.1144; GREENBERG ER, 1988, NEW ENGL J MED, V318, P612, DOI 10.1056/NEJM198803103181006; GRUMBACH K, 1995, JAMA-J AM MED ASSOC, V274, P1282, DOI 10.1001/jama.274.16.1282; HEWITT M, 2001, NATL CANC POLICY BOA; Khuri SF, 2001, SURGERY, V130, P429, DOI 10.1067/msy.2001.117138; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; MCGUIRK MA, 1984, INQUIRY-J HEALTH CAR, V21, P84; Patti M G, 1998, J Gastrointest Surg, V2, P186, DOI 10.1016/S1091-255X(98)80011-5	15	245	246	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2003	290	20					2703	2708		10.1001/jama.290.20.2703	http://dx.doi.org/10.1001/jama.290.20.2703			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747CR	14645312	Bronze			2022-12-28	WOS:000186788100022
J	Amorim, MR; Castilla, EE; Orioli, IM				Amorim, MR; Castilla, EE; Orioli, IM			Is there a familial link between Down's syndrome and neural tube defects? Population and familial survey	BRITISH MEDICAL JOURNAL			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE GENE; ABNORMAL FOLATE METABOLISM; MATERNAL RISK-FACTORS; POLYMORPHISM; MUTATION; PREGNANCIES; PREVENTION; ETIOLOGY; VITAMIN	Objective To verify whether Down's syndrome and neural tube defects arise more often in the same family than expected by chance. Design Population and familial survey. Setting Network of maternity hospitals in the Latin American collaborative study of congenital malformations (ECLAMC) in Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay, and Venezuela between 1982 and 2000. Probands 2421 cases of neural tube defects, 952 of hydrocephalus, and 3095 of Down's Syndrome registered from a total of 1583 838 live births and stillbirths. Main outcome measures Observed number of cases of Down's syndrome among siblings of probands with a neural tube defect or hydrocephalus and number expected on the basis of maternal age; observed number of cases of neural tube defects or hydrocephalus among siblings of probands with Down's syndrome and number expected according to the prevalence in the same population. Results Five cases of Down's syndrome occurred among 5404 pregnancies previous to a case of neural tube defect or hydrocephalus, compared with 5.13 expected after adjustment by maternal age. Twelve cases of neural tube defect or hydrocephalus occurred among 8066 pregnancies previous to a case of Down's syndrome, compared with 17.18 expected on the basis of the birth prevalence for neural tube defects plus hydrocephalus in the same population. Conclusion No association occur-red between families at risk of neural tube defects and those at risk of Down's syndrome.	Univ Fed Rio de Janeiro, ECLAMC, Dept Genet, BR-21944970 Rio De Janeiro, Brazil; Inst Oswaldo Cruz, ECLAMC, Dept Genet, BR-20001970 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Orioli, IM (corresponding author), Univ Fed Rio de Janeiro, ECLAMC, Dept Genet, Caixa Postal 68 011, BR-21944970 Rio De Janeiro, Brazil.		Amorim, Marcia R./GWZ-3228-2022; Amorim, Marcia R/D-3010-2013	Amorim, Marcia R/0000-0002-0528-0377				Al-Gazali LI, 2001, AM J MED GENET, V103, P128, DOI 10.1002/ajmg.1509; Barkai G, 2003, LANCET, V361, P1331, DOI 10.1016/S0140-6736(03)13080-2; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Castilla E. E., 1990, ADV MUTAGEN RES, P191; Chadefaux-Vekemans B, 2002, PEDIATR RES, V51, P766, DOI 10.1203/01.PDR.0000017484.64723.43; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Hassold TJ, 2001, AM J HUM GENET, V69, P434, DOI 10.1086/321971; Hobbs CA, 2000, AM J HUM GENET, V67, P623, DOI 10.1086/303055; James SJ, 1999, AM J CLIN NUTR, V70, P495; JAQUES PF, 1996, CIRCULATION, V93, P7; Kallen B, 1996, AM J MED GENET, V65, P160; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; O'Leary VB, 2002, AM J MED GENET, V107, P151, DOI 10.1002/ajmg.10121; Petersen MB, 2000, AM J HUM GENET, V67, P141; RISCH N, 1990, AM J HUM GENET, V46, P222; Stuppia L, 2002, EUR J HUM GENET, V10, P388, DOI 10.1038/sj.ejhg.5200819; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; WALD N, 1991, LANCET, V338, P131; Yanamandra K, 2003, EUR J HUM GENET, V11, P5, DOI 10.1038/sj.ejhg.5200928	19	10	10	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 10	2004	328	7431					84	87		10.1136/bmj.37945.610914.EE	http://dx.doi.org/10.1136/bmj.37945.610914.EE			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	762MP	14662523	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000187976400016
J	Aronson, J				Aronson, J			Commentary: Signs of love, not a love potion	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Oxford, Radcliffe Infirm, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford	Aronson, J (corresponding author), Univ Oxford, Radcliffe Infirm, Oxford OX2 6HE, England.								0	1	1	1	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1471	1472		10.1136/bmj.327.7429.1471	http://dx.doi.org/10.1136/bmj.327.7429.1471			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684653	Green Published			2022-12-28	WOS:000187562700024
J	Barker, D				Barker, D			The midwife, the coincidence, and the hypothesis	BRITISH MEDICAL JOURNAL			English	Article									Univ Southampton, Princess Anne Hosp, Dev Origins Hlth & Dis Ctr, Southampton SO16 5YA, Hants, England	University of Southampton	Barker, D (corresponding author), Univ Southampton, Princess Anne Hosp, Dev Origins Hlth & Dis Ctr, Southampton SO16 5YA, Hants, England.		Barker, David JP/A-5671-2013						0	43	46	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1428	1430		10.1136/bmj.327.7429.1428	http://dx.doi.org/10.1136/bmj.327.7429.1428			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684636	Green Published			2022-12-28	WOS:000187562700007
J	Gale, RP; Gale, CP; Roper, TA; Mulley, GP				Gale, RP; Gale, CP; Roper, TA; Mulley, GP			Depiction of elderly and disabled people on road traffic signs: international comparison	BRITISH MEDICAL JOURNAL			English	Article									York Hosp, Dept Ophthalmol, York YO31 8HE, N Yorkshire, England; York Hosp, Dept Cardiol, York YO31 8HE, N Yorkshire, England; Gen Infirm Leeds, Dept Med, Leeds LS1 3EX, W Yorkshire, England; St James Univ Hosp, Dept Elderly Med, Leeds LS9 7TF, W Yorkshire, England	Leeds General Infirmary; Saint James's University Hospital	Gale, RP (corresponding author), York Hosp, Dept Ophthalmol, York YO31 8HE, N Yorkshire, England.			Gale, Chris/0000-0003-4732-382X				*DEP TRANSP LOC GO, 1999, HIST BRIT TRAFF SIGN; *GREAT BRIT FOR CO, 2000, DIPL SERV LIST 2001, P21	2	2	2	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1456	1457		10.1136/bmj.327.7429.1456	http://dx.doi.org/10.1136/bmj.327.7429.1456			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684647	Green Published			2022-12-28	WOS:000187562700018
J	Peres, CA; Baider, C; Zuidema, PA; Wadt, LHO; Kainer, KA; Gomes-Silva, DAP; Salomao, RP; Simoes, LL; Franciosi, ERN; Valverde, FC; Gribel, R; Shepard, GH; Kanashiro, M; Coventry, P; Yu, DW; Watkinson, AR; Freckleton, RP				Peres, CA; Baider, C; Zuidema, PA; Wadt, LHO; Kainer, KA; Gomes-Silva, DAP; Salomao, RP; Simoes, LL; Franciosi, ERN; Valverde, FC; Gribel, R; Shepard, GH; Kanashiro, M; Coventry, P; Yu, DW; Watkinson, AR; Freckleton, RP			Demographic threats to the sustainability of Brazil nut exploitation	SCIENCE			English	Article							BERTHOLLETIA-EXCELSA; POPULATION-DYNAMICS; DENSITY-DEPENDENCE; TROPICAL PALM; EXTRACTION; TREE	A comparative analysis of 23 populations of the Brazil nut tree ( Bertholletia excelsa) across the Brazilian, Peruvian, and Bolivian Amazon shows that the history and intensity of Brazil nut exploitation are major determinants of population size structure. Populations subjected to persistent levels of harvest lack juvenile trees less than 60 centimeters in diameter at breast height; only populations with a history of either light or recent exploitation contain large numbers of juvenile trees. A harvesting model confirms that intensive exploitation levels over the past century are such that juvenile recruitment is insufficient to maintain populations over the long term. Without management, intensively harvested populations will succumb to a process of senescence and demographic collapse, threatening this cornerstone of the Amazonian extractive economy.	Univ E Anglia, Ctr Ecol Evolut & Conservat, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; Univ Sao Paulo, Dept Ecol, BR-05508900 Sao Paulo, Brazil; PROMAB, Riberalta, Beni, Bolivia; Univ Utrecht, Dept Plant Ecol, NL-3508 TB Utrecht, Netherlands; EMBRAPA, Ctr Pesquisa Agroflorestal Acre, BR-69908970 Rio Branco, Acre, Brazil; Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; Univ Florida, Trop Conservat & Dev Program, Gainesville, FL 32611 USA; Museu Paraense Emilio Goeldi, Dept Bot, BR-66040170 Belem, Para, Brazil; ACCA, Proyecto Conservando Castanales, Puerto Maldonado, Madre De Dios, Peru; INPA, Dept Bot, BR-69083000 Manaus, Amazonas, Brazil; Embrapa Amazonia Oriental DFID, Projeto Dendrogene, BR-69095100 Belem, Para, Brazil; Mauritius Herbarium, MSIRI, Reduit, Mauritius	University of East Anglia; University of East Anglia; Universidade de Sao Paulo; Utrecht University; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); State University System of Florida; University of Florida; State University System of Florida; University of Florida; Museu Paraense Emilio Goeldi; Institute Nacional de Pesquisas da Amazonia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Peres, CA (corresponding author), Univ E Anglia, Ctr Ecol Evolut & Conservat, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England.		Watkinson, Andrew R/N-1649-2013; Freckleton, Rob P/B-6455-2013; Zuidema, Pieter A/C-8951-2009; Wadt, Lucia HO/M-1703-2013; Peres, Carlos Augusto/N-8275-2019; Baider, Claudia/C-2570-2009; Shepard, Glenn H./C-3667-2014; Shepard, Glenn/AAS-4059-2021; Peres, Carlos A./B-1276-2013; Yu, Douglas W./D-2536-2009; Gribel, Rogerio/C-5392-2013; SALOMÃO, RAFAEL/AAU-1306-2020; Peres, Carlos A./ABE-8361-2020	Zuidema, Pieter A/0000-0001-8100-1168; Baider, Claudia/0000-0002-2203-2076; Shepard, Glenn H./0000-0003-3195-8230; Shepard, Glenn/0000-0003-3195-8230; Peres, Carlos A./0000-0002-1588-8765; Yu, Douglas W./0000-0001-8551-5609; Gribel, Rogerio/0000-0002-0850-5578; SALOMÃO, RAFAEL/0000-0003-0947-0132; Peres, Carlos A./0000-0002-1588-8765; Wadt, Lucia/0000-0002-5018-7550; Freckleton, Robert/0000-0002-8338-864X				[Anonymous], FLORESTA AMAZONICA D; BAIDER C, 2000, DEMOGRAFIA ECOLOGIA; BOOT RGA, 1995, ECOL APPL, V5, P896, DOI 10.2307/2269340; CLAY JW, 1997, HARVESTING WILD SPEC, P246; Freckleton RP, 2003, J APPL ECOL, V40, P846, DOI 10.1046/j.1365-2664.2003.00842.x; HUBER J, 1910, B MUS PARAENSE HIST, V6, P781; *I BRAS GEOGR EST, 2002, PROD EXTR VEG SILV; *I NAC PESQ ESP, 2003, MON BRAZ AM FOR SAT; Matos DMS, 1999, ECOLOGY, V80, P2635, DOI 10.2307/177246; Nepstad D. C., 1992, Advances in Economic Botany, V9, P1; Peres CA, 1997, J TROP ECOL, V13, P69, DOI 10.1017/S0266467400010269; Peres CA, 1997, J TROP ECOL, V13, P595, DOI 10.1017/S0266467400010749; Peters C.M., 1994, SUSTAINABLE HARVEST; Pires JM, 1984, AMAZON LIMNOLOGY LAN, P581, DOI DOI 10.1007/978-94-009-6542-3; Zuidema PA, 2002, J TROP ECOL, V18, P1, DOI 10.1017/S0266467402002018; ZUIDEMA PA, 2003, ECOLOGY MANAGEMENT B, V6	16	208	216	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2112	2114		10.1126/science.1091698	http://dx.doi.org/10.1126/science.1091698			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684819				2022-12-28	WOS:000187385200041
J	Yuan, HQ; Grosche, FM; Deppe, M; Geibel, C; Sparn, G; Steglich, F				Yuan, HQ; Grosche, FM; Deppe, M; Geibel, C; Sparn, G; Steglich, F			Observation of two distinct superconducting phases in CeCu2Si2	SCIENCE			English	Article							HYDROSTATIC-PRESSURE; TRANSITION; TEMPERATURE; MAGNETISM; CECU2GE2; HELIUM	We report the presence of two disconnected superconducting domes in the pressure-temperature phase diagram of partially germanium- substituted CeCu2Si2. The lower density superconducting dome lies on the threshold of antiferromagnetic order, indicating magnetically mediated pairing, whereas the higher density superconducting regime straddles a weakly first-order volume collapse, suggesting a pairing interaction based on spatially extended density fluctuations. Two distinct pairing mechanisms thus appear to operate in the single, wide, superconducting range of stoichiometric CeCu2Si2, both of which might apply more generally to other classes of correlated electron systems.	Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany; Xiangtan Univ, Dept Phys, Xiangtan 411105, Peoples R China; Univ London Royal Holloway & Bedford New Coll, Dept Phys, Egham TW20 0EX, Surrey, England	Max Planck Society; Xiangtan University; University of London; Royal Holloway University London	Yuan, HQ (corresponding author), Max Planck Inst Chem Phys Solids, Nothnitzer Str 40, D-01187 Dresden, Germany.		Grosche, Malte/A-7117-2012; Sparn, Guenter/F-5120-2013; Grosche, Friedrich Malte/AAP-1734-2020	Grosche, Malte/0000-0002-3912-9819; Grosche, Friedrich Malte/0000-0002-3912-9819				ALLEN JW, 1982, PHYS REV LETT, V49, P1106, DOI 10.1103/PhysRevLett.49.1106; BELLARBI B, 1984, PHYS REV B, V30, P1182, DOI 10.1103/PhysRevB.30.1182; Gegenwart P, 1998, PHYS REV LETT, V81, P1501, DOI 10.1103/PhysRevLett.81.1501; Hegger H, 2000, PHYS REV LETT, V84, P4986, DOI 10.1103/PhysRevLett.84.4986; Holmes A. T., UNPUB; Holmes AT, 2003, ACTA PHYS POL B, V34, P567; Jaccard D, 1999, PHYSICA B, V259-61, P1, DOI 10.1016/S0921-4526(98)01069-2; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; MONTHOUX P, UNPUB; Movshovich R, 1996, PHYS REV B, V53, P8241, DOI 10.1103/PhysRevB.53.8241; Onishi Y, 2000, J PHYS SOC JPN, V69, P3955, DOI 10.1143/JPSJ.69.3955; Onodera A, 2002, SOLID STATE COMMUN, V123, P113, DOI 10.1016/S0038-1098(02)00245-4; STEGLICH F, 1979, PHYS REV LETT, V43, P1892, DOI 10.1103/PhysRevLett.43.1892; Stockert O, 2003, ACTA PHYS POL B, V34, P963; THOMAS F, 1993, PHYSICA B, V186-88, P303, DOI 10.1016/0921-4526(93)90561-J; Thomasson J, 1998, SOLID STATE COMMUN, V106, P637, DOI 10.1016/S0038-1098(98)00087-8; Vargoz E, 1998, SOLID STATE COMMUN, V106, P631, DOI 10.1016/S0038-1098(98)00086-6; Yuan HQ, 2003, ACTA PHYS POL B, V34, P533; YUAN HQ, UNPUB	19	335	340	3	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2104	2107		10.1126/science.1091648	http://dx.doi.org/10.1126/science.1091648			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684816				2022-12-28	WOS:000187385200038
J	Doran, T; Drever, F; Whitehead, M				Doran, T; Drever, F; Whitehead, M			Health of young and elderly informal carers: analysis of UK census data	BRITISH MEDICAL JOURNAL			English	Article									Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England	University of Liverpool	Doran, T (corresponding author), Univ Liverpool, Dept Publ Hlth, Liverpool L69 3GB, Merseyside, England.							Banks P, 2001, DISABIL SOC, V16, P797, DOI 10.1080/09687590120083967; *GEN REG OFF SCOTL, SCOTL CENS; MAHER J, 2002, CAREERS 2000; *NO IR STAT RES AG, 2001, NO IR CENS 2001 OUTP; *ONS, 2003, CENS 2001 S	5	44	44	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1388	1388		10.1136/bmj.327.7428.1388	http://dx.doi.org/10.1136/bmj.327.7428.1388			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755PL	14670886	Bronze, Green Published			2022-12-28	WOS:000187417900025
J	Kallianpur, AR				Kallianpur, AR			Medical consensus and informed consent: the patient needs more time	LANCET			English	Editorial Material									Vanderbilt Univ, Med Ctr, Dept Gen Internal Med, Nashville, TN 37232 USA	Vanderbilt University	Kallianpur, AR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Gen Internal Med, Nashville, TN 37232 USA.								0	2	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					2011	2011		10.1016/S0140-6736(03)15023-4	http://dx.doi.org/10.1016/S0140-6736(03)15023-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683663				2022-12-28	WOS:000187210700025
J	Khaldeeva, N; Hillis, SD; Voronin, E; Rakhmanova, A; Yakovlev, A; Jamieson, DJ; Ryder, RW				Khaldeeva, N; Hillis, SD; Voronin, E; Rakhmanova, A; Yakovlev, A; Jamieson, DJ; Ryder, RW			HIV-1 seroprevalence rates in women and relinquishment of infants to the state in St Petersburg, Russia, 2002	LANCET			English	Article								The effectiveness of rapid HIV-1 testing and nevirapine prophylaxis for HIV-Infected mothers without prenatal care has been shown. We found that from 1998 to 2002, HIV-1 seroprevalence in women giving birth in St Petersburg, Russia increased 100-fold: from 0.013% to 1.3% (p<0.0001). HIV-1 seroprevalence was 8% (114 of 1466) in women without prenatal care and 1% (376 of 37 645) in those with prenatal care (p<0.0001). All 376 HIV-1-infected women with, and 41% (47 of 114) of HIV-1-infected women without prenatal care received intrapartum antiretroviral therapy (p<0.0001). In women who were HIV-1 positive, 26% (30 of 114) of those without prenatal care and 4% (13 of 371) of those with prenatal care relinquished their infants to the custody of the state, compared with 10% (354 of 37 621) of HIV-1-negative women (p<0.0001).	Ctr Dis Control & Prevent, Atlanta, GA 30341 USA; St Petersburg Glaser Pediat AIDS Fdn Planning Gra, St Petersburg, Russia; City AIDS Ctr, St Petersburg, Russia; Republ Hosp Infect Dis, Clin AIDS Ctr, St Petersburg, Russia; City Hlth Comm, St Petersburg, Russia; Botkin Hosp, St Petersburg, Russia; Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA	Centers for Disease Control & Prevention - USA; University of North Carolina; University of North Carolina Chapel Hill	Hillis, SD (corresponding author), Ctr Dis Control & Prevent, Mailstop K-34,4770 Buford Hwy NE, Atlanta, GA 30341 USA.		Yakovlev, Alexey/H-2748-2015	Yakovlev, Alexey/0000-0003-4163-5769; Jamieson, Denise/0000-0003-2597-1201				*ALL RUSS CTR PUBL, 1998, WOM REPR HLTH SURV 1; Hamers FF, 2003, LANCET, V361, P1035, DOI 10.1016/S0140-6736(03)12831-0; *MENT DIS RIGHTS I, 1999, CHILDR RUSS I HUM RI; *UNAIDS JOINT UN P, 2002, CHILDR BRINK 2002 JO; *UNAIDS JOINT UN P, 2002, REP GLOB HIV AIDS EP	5	16	18	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					1981	1982		10.1016/S0140-6736(03)15019-2	http://dx.doi.org/10.1016/S0140-6736(03)15019-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683660				2022-12-28	WOS:000187210700013
J	Freeman, KC				Freeman, KC			The hunt for dark matter in galaxies	SCIENCE			English	Editorial Material							ROTATION CURVES; MASS		Australian Natl Univ, Mt Stromlo Observ, Weston, ACT 2611, Australia	Australian National University	Freeman, KC (corresponding author), Australian Natl Univ, Mt Stromlo Observ, Weston, ACT 2611, Australia.	kcf@mso.anu.edu.au		Freeman, Kenneth/0000-0001-6280-1207				BEGEMAN KG, 1989, ASTRON ASTROPHYS, V223, P47; de Blok WJG, 2002, ASTRON ASTROPHYS, V385, P816, DOI 10.1051/0004-6361:20020080; Moore B, 1999, ASTROPHYS J, V524, pL19, DOI 10.1086/312287; Navarro JF, 1996, ASTROPHYS J, V462, P563, DOI 10.1086/177173; Shapiro PR, 2002, ASTROPHYS J, V565, pL1, DOI 10.1086/339243; Wilkinson MI, 1999, MON NOT R ASTRON SOC, V310, P645, DOI 10.1046/j.1365-8711.1999.02964.x; 2003, INT ASTR UN S SYDN A, V220	7	3	3	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1902	1903		10.1126/science.1091466	http://dx.doi.org/10.1126/science.1091466			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671282				2022-12-28	WOS:000187174000037
J	Ganel, T; Goodale, MA				Ganel, T; Goodale, MA			Visual control of action but not perception requires analytical processing of object shape	NATURE			English	Article							SELECTIVE ATTENTION; RECOGNITION; INFORMATION; VIEWPOINT; PATHWAYS; FEATURES	The visual perception of object shape depends on ' holistic'(1 - 4) processing in which a given dimension cannot be perceptually isolated from the other dimensions of the object. The visual control of action ( such as grasping an object), however, which is mediated by cortical areas that are largely independent of those mediating conscious perception(5 - 8), must take into account only the most action- relevant dimension of an object without being misled by other non- relevant object features. Here we report the results of two experiments showing that vision for perception and vision for action deal with objects in a fundamentally different manner. We tested participants' ability to make perceptual judgements of the width of different rectangular objects or to grasp them across their width, while in both cases ignoring length(9,10). Participants could not ignore length when making perceptual judgements of width but they could completely ignore length when grasping the same objects. These results suggest that in situations in which the elementary dimensions of an object's shape are perceived in a holistic manner, the same dimensions are treated analytically when a visually guided action is directed at that same object.	Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6A 5C2, Canada	Western University (University of Western Ontario)	Ganel, T (corresponding author), Univ Western Ontario, Dept Psychol, CIHR Grp Act & Percept, London, ON N6A 5C2, Canada.	tganel@uwo.ca	Ganel, Tzvi/B-9344-2011; Goodale, Melvyn A/M-5907-2013	Ganel, Tzvi/0000-0003-0658-0598; Goodale, Melvyn A/0000-0001-6748-0561				Bar M, 2001, J COGNITIVE NEUROSCI, V13, P793, DOI 10.1162/08989290152541458; DUNCAN J, 1984, J EXP PSYCHOL GEN, V113, P501, DOI 10.1037/0096-3445.113.4.501; DYKES JR, 1978, PERCEPT PSYCHOPHYS, V23, P36, DOI 10.3758/BF03214292; Edelman S, 1997, PHILOS T R SOC B, V352, P1191, DOI 10.1098/rstb.1997.0102; FELFOLDY GL, 1974, PERCEPT PSYCHOPHYS, V15, P453, DOI 10.3758/BF03199285; Ganel T, 2002, J EXP PSYCHOL HUMAN, V28, P854, DOI 10.1037//0096-1523.28.4.854; GARNER WR, 1978, J EXP PSYCHOL GEN, V107, P287, DOI 10.1037/0096-3445.107.3.287; GARNER WR, 1974, PROCESSING INFORMATI; Goodale MA, 1998, COGNITION, V67, P181, DOI 10.1016/S0010-0277(98)00017-1; GOODALE MA, 1994, CURR BIOL, V4, P604, DOI 10.1016/S0960-9822(00)00132-9; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1994, NEUROPSYCHOLOGIA, V32, P1159, DOI 10.1016/0028-3932(94)90100-7; Goodale MA, 1996, ADV MOTOR LEARNING C, P87; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; HUMPHREY GK, 1994, PERCEPTION, V23, P1457, DOI 10.1068/p231457; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Koffka K, 1935, PRINCIPLES GESTALT P; Kwok RM, 2003, NEUROPSYCHOLOGIA, V41, P932, DOI 10.1016/S0028-3932(02)00324-X; Law MB, 2002, PERCEPT PSYCHOPHYS, V64, P1017, DOI 10.3758/BF03194753; Macmillan NA, 1998, PERCEPT PSYCHOPHYS, V60, P250, DOI 10.3758/BF03206034; Maddox W. T., 1992, MULTIDIMENSIONAL MOD, P147; MARR D, 1980, PHILOS T ROY SOC B, V290, P199, DOI 10.1098/rstb.1980.0091; NATSOULAS T, 1983, AM J PSYCHOL, V96, P435, DOI 10.2307/1422567; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; POMERANTZ JR, 1989, J EXP PSYCHOL HUMAN, V15, P635, DOI 10.1037/0096-1523.15.4.635; Shalev L, 2000, J EXP PSYCHOL HUMAN, V26, P997, DOI 10.1037/0096-1523.26.3.997; Swinnen SP, 2002, J COGNITIVE NEUROSCI, V14, P463, DOI 10.1162/089892902317361976	29	151	156	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					664	667		10.1038/nature02156	http://dx.doi.org/10.1038/nature02156			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752DY	14668865				2022-12-28	WOS:000187132800042
J	Chesley, SR; Ostro, SJ; Vokrouhlicky, D; Capek, D; Giorgini, JD; Nolan, MC; Margot, JL; Hine, AA; Benner, LAM; Chamberlin, AB				Chesley, SR; Ostro, SJ; Vokrouhlicky, D; Capek, D; Giorgini, JD; Nolan, MC; Margot, JL; Hine, AA; Benner, LAM; Chamberlin, AB			Direct detection of the Yarkovsky effect by radar ranging to asteroid 6489 Golevka	SCIENCE			English	Article							EARTH; RADIATION; EVOLUTION; DELIVERY; MOBILITY; MODEL	Radar ranging from Arecibo, Puerto Rico, to the 0.5-kilometer near-Earth asteroid 6489 Golevka unambiguously reveals a small nongravitational acceleration caused by the anisotropic thermal emission of absorbed sunlight. The magnitude of this perturbation, known as the Yarkovsky effect, is a function of the asteroid's mass and surface thermal characteristics. Direct detection of the Yarkovsky effect on asteroids will help constrain their physical properties, such as bulk density, and refine their orbital paths. Based on the strength of the detected perturbation, we estimate the bulk density of Golevka to be 2.7(-0.6)(+0.4) grams per cubic centimeter.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Charles Univ Prague, Astron Inst, CZ-18000 Prague, Czech Republic; Natl Astron & Ionosphere Ctr, Arecibo Observ, Arecibo, PR 00612 USA; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Charles University Prague; National Aeronautics & Space Administration (NASA); University of California System; University of California Los Angeles	Chesley, SR (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	steven.chesley@jpl.nasa.gov	Vokrouhlický, David/Q-4359-2017; Nolan, Michael C/H-4980-2012; Margot, Jean-Luc/A-6154-2012	Vokrouhlický, David/0000-0002-6034-5452; Nolan, Michael C/0000-0001-8316-0680; Margot, Jean-Luc/0000-0001-9798-1797				Bottke W. F., 2002, ASTEROIDS, P395; Bottke WF, 2000, ICARUS, V145, P301, DOI 10.1006/icar.2000.6361; Bottke WF, 2001, SCIENCE, V294, P1693, DOI 10.1126/science.1066760; BRITT DT, 2003, ASTEROIDS, P485; Bus SJ, 2002, ICARUS, V158, P146, DOI 10.1006/icar.2002.6856; Consolmagno GJ, 1998, METEORIT PLANET SCI, V33, P1221, DOI 10.1111/j.1945-5100.1998.tb01307.x; Farinella P, 1999, SCIENCE, V283, P1507, DOI 10.1126/science.283.5407.1507; Farinella P, 1998, ICARUS, V132, P378, DOI 10.1006/icar.1997.5872; Giorgini JD, 2002, SCIENCE, V296, P132, DOI 10.1126/science.1068191; HARRIS AW, 2003, ASTEROIDS, V3, P205; Hudson RS, 2000, ICARUS, V148, P37, DOI 10.1006/icar.2000.6483; LANGSETH MG, 1972, THERMAL CHARACTERIST, P169; Margot JL, 2002, SCIENCE, V296, P1445, DOI 10.1126/science.1072094; Morbidelli A, 2003, ICARUS, V163, P120, DOI 10.1016/S0019-1035(03)00047-2; OSTRO SJ, 1991, B AM ASTRON SOC, V23, P11444; Rubincam DP, 1998, J GEOPHYS RES-PLANET, V103, P1725, DOI 10.1029/97JE03034; RUBINCAM DP, 1995, J GEOPHYS RES-PLANET, V100, P1585, DOI 10.1029/94JE02411; RUBINCAM DP, 1987, J GEOPHYS RES-SOLID, V92, P1287, DOI 10.1029/JB092iB02p01287; Vokrouhlicky D, 2000, NATURE, V407, P606, DOI 10.1038/35036528; Vokrouhlicky D, 2001, CELEST MECH DYN ASTR, V81, P149, DOI 10.1023/A:1013375524103; Vokrouhlicky D, 1998, ASTRON ASTROPHYS, V335, P1093; Vokrouhlicky D, 1999, ASTRON ASTROPHYS, V344, P362; Vokrouhlicky D, 2000, ICARUS, V148, P118, DOI 10.1006/icar.2000.6469; Wechsler A.E., 1972, THERMAL CHARACTERIST, P215; YEOMANS DK, 1987, ASTRON J, V94, P189, DOI 10.1086/114463; YOMOGIDA K, 1983, J GEOPHYS RES, V88, P9513, DOI 10.1029/JB088iB11p09513	26	133	136	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 5	2003	302	5651					1739	1742		10.1126/science.1091452	http://dx.doi.org/10.1126/science.1091452			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657492				2022-12-28	WOS:000186970100040
J	Tonkin, LA; Bass, BL				Tonkin, LA; Bass, BL			Mutations in RNAi rescue aberrant chemotaxis of ADAR mutants	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; ADENOSINE DEAMINASES; MESSENGER-RNA; C-ELEGANS; RDE-1; GENE; INTERFERENCE; HAIRPINS; ACT		Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Bass, BL (corresponding author), Univ Utah, Dept Biochem, 20 North 1900 East, Salt Lake City, UT 84132 USA.				NIGMS NIH HHS [R01 GM044073, GM44073] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044073] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Morse DP, 1999, P NATL ACAD SCI USA, V96, P6048, DOI 10.1073/pnas.96.11.6048; Morse DP, 2002, P NATL ACAD SCI USA, V99, P7906, DOI 10.1073/pnas.112704299; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; Parrish S, 2001, RNA, V7, P1397; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tonkin LA, 2002, EMBO J, V21, P6025, DOI 10.1093/emboj/cdf607; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808	12	120	133	0	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1725	1725		10.1126/science.1091340	http://dx.doi.org/10.1126/science.1091340			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657490	Green Accepted			2022-12-28	WOS:000186970100037
J	Frey, HU; Phan, TD; Fuselier, SA; Mende, SB				Frey, HU; Phan, TD; Fuselier, SA; Mende, SB			Continuous magnetic reconnection at Earth's magnetopause	NATURE			English	Article							MOVING AURORAL FORMS; FIELD; SIGNATURES; CONVECTION; FLOW	The most important process that allows solar-wind plasma to cross the magnetopause and enter Earth's magnetosphere is the merging between solar-wind and terrestrial magnetic fields of opposite sense - magnetic reconnection(1). It is at present not known whether reconnection can happen in a continuous fashion or whether it is always intermittent. Solar flares(2) and magnetospheric substorms(3) - two phenomena believed to be initiated by reconnection - are highly burst-like occurrences, raising the possibility that the reconnection process is intrinsically intermittent, storing and releasing magnetic energy in an explosive and uncontrolled manner. Here we show that reconnection at Earth's high-latitude magnetopause is driven directly by the solar wind, and can be continuous and even quasi-steady over an extended period of time. The dayside proton auroral spot in the ionosphere - the remote signature of high-latitude magnetopause reconnection(4) - is present continuously for many hours. We infer that reconnection is not intrinsically intermittent; its steadiness depends on the way that the process is driven.	Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Lockheed Martin Adv Technol Ctr, Palo Alto, CA 94304 USA	University of California System; University of California Berkeley; Lockheed Martin	Frey, HU (corresponding author), Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA.			Frey, Harald/0000-0001-8955-3282				ANGELOPOULOS V, 1994, J GEOPHYS RES-SPACE, V99, P21257, DOI 10.1029/94JA01263; Cowley S. W. H., 1984, GEOPHYS MONOGR SER, V30, P375, DOI DOI 10.1029/GM030P0375; COWLEY SWH, 1989, PLANET SPACE SCI, V37, P1461, DOI 10.1016/0032-0633(89)90116-5; Farrugia CJ, 1998, J GEOPHYS RES-SPACE, V103, P9309, DOI 10.1029/97JA02882; FREY HU, 2002, J GEOPHYS RES, V107; FREY HU, 2003, J GEOPHYS RES A, V108; FUSELIER SA, 2002, J GEOPHYS RES, V107; *GODD SPAC FLIGHT, 1999, NASATM2000209883 GOD; HUDSON H, 1995, ANNU REV ASTRON ASTR, V33, P239, DOI 10.1146/annurev.aa.33.090195.001323; Lockwood M, 2003, ANN GEOPHYS-GERMANY, V21, P955, DOI 10.5194/angeo-21-955-2003; Lockwood M, 2001, J GEOPHYS RES-SPACE, V106, P29555, DOI 10.1029/2000JA900175; Lockwood M, 1998, GEOPHYS RES LETT, V25, P591, DOI 10.1029/98GL00185; Mende SB, 2000, SPACE SCI REV, V91, P287, DOI 10.1023/A:1005292301251; MENDE SB, 1990, GEOPHYS RES LETT, V17, P131, DOI 10.1029/GL017i002p00131; Milan SE, 1999, ANN GEOPHYS-ATM HYDR, V17, P1166, DOI 10.1007/s00585-999-1166-2; NEWELL PT, 1995, REV GEOPHYS, V33, P665, DOI 10.1029/95RG00182; NEWELL PT, 1989, J GEOPHYS RES, V94, P8921, DOI 10.1029/JA094iA07p08921; PHAN T, 2003, GEOPHYS RES LETT, V30; Phan TD, 2000, NATURE, V404, P848, DOI 10.1038/35009050; Sandholt PE, 2000, J GEOPHYS RES-SPACE, V105, P12869, DOI 10.1029/2000JA900025; SANDHOLT PE, 1988, ADV SPACE RES, V8, P21; SCHOLER M, 1988, GEOPHYS RES LETT, V15, P291, DOI 10.1029/GL015i004p00291	22	120	120	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2003	426	6966					533	537		10.1038/nature02084	http://dx.doi.org/10.1038/nature02084			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654835				2022-12-28	WOS:000186944300032
J	Pickhardt, PJ; Choi, JR; Hwang, I; Butler, JA; Puckett, ML; Hildebrandt, HA; Wong, RK; Nugent, PA; Mysliwiec, PA; Schindler, WR				Pickhardt, PJ; Choi, JR; Hwang, I; Butler, JA; Puckett, ML; Hildebrandt, HA; Wong, RK; Nugent, PA; Mysliwiec, PA; Schindler, WR			Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CT COLONOGRAPHY; PERFORMANCE-CHARACTERISTICS; CANCER; POLYPS; SIZE	BACKGROUND: We evaluated the performance characteristics of computed tomographic (CT) virtual colonoscopy for the detection of colorectal neoplasia in an average-risk screening population. METHODS: A total of 1233 asymptomatic adults (mean age, 57.8 years) underwent same-day virtual and optical colonoscopy. Radiologists used the three-dimensional endoluminal display for the initial detection of polyps on CT virtual colonoscopy. For the initial examination of each colonic segment, the colonoscopists were unaware of the findings on virtual colonoscopy, which were revealed to them before any subsequent reexamination. The sensitivity and specificity of virtual colonoscopy and the sensitivity of optical colonoscopy were calculated with the use of the findings of the final, unblinded optical colonoscopy as the reference standard. RESULTS: The sensitivity of virtual colonoscopy for adenomatous polyps was 93.8 percent for polyps at least 10 mm in diameter, 93.9 percent for polyps at least 8 mm in diameter, and 88.7 percent for polyps at least 6 mm in diameter. The sensitivity of optical colonoscopy for adenomatous polyps was 87.5 percent, 91.5 percent, and 92.3 percent for the three sizes of polyps, respectively. The specificity of virtual colonoscopy for adenomatous polyps was 96.0 percent for polyps at least 10 mm in diameter, 92.2 percent for polyps at least 8 mm in diameter, and 79.6 percent for polyps at least 6 mm in diameter. Two polyps were malignant; both were detected on virtual colonoscopy, and one of them was missed on optical colonoscopy before the results on virtual colonoscopy were revealed. CONCLUSIONS: CT virtual colonoscopy with the use of a three-dimensional approach is an accurate screening method for the detection of colorectal neoplasia in asymptomatic average-risk adults and compares favorably with optical colonoscopy in terms of the detection of clinically relevant lesions.	Natl Naval Med Ctr, Dept Radiol, Bethesda, MD USA; Natl Naval Med Ctr, Dept Gastroenterol, Bethesda, MD USA; Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Radiol, Bethesda, MD 20814 USA; NCI, Div Canc Prevent, Bethesda, MD 20892 USA; Walter Reed Army Med Ctr, Dept Radiol, Washington, DC 20307 USA; Walter Reed Army Med Ctr, Dept Gastroenterol, Washington, DC 20307 USA; Naval Med Ctr, Dept Radiol, San Diego, CA USA; Naval Med Ctr, Dept Gastroenterol, San Diego, CA USA	Walter Reed National Military Medical Center; Walter Reed National Military Medical Center; Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Defense; United States Army; Walter Reed National Military Medical Center; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; United States Department of Defense; United States Navy; Naval Medical Center San Diego; United States Department of Defense; United States Navy; Naval Medical Center San Diego	Pickhardt, PJ (corresponding author), Univ Wisconsin, Sch Med, Dept Radiol, E3-311 Clin Sci Ctr,600 Highland Ave, Madison, WI 53792 USA.	ppickhardt@mail.radiology.wisc.edu						Bond J H, 2000, Semin Gastrointest Dis, V11, P176; Bond JH, 1999, NEW ENGL J MED, V341, P1540, DOI 10.1056/NEJM199911113412010; Bond JH, 2001, ENDOSCOPY, V33, P454, DOI 10.1055/s-2001-14266; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P193; Cotton PB, 2003, GASTROINTEST ENDOSC, V57, pAB174; Dachman AH, 2003, RADIOL CLIN N AM, V41, P377, DOI 10.1016/S0033-8389(02)00124-0; Dachman AH, 1998, AM J ROENTGENOL, V171, P989, DOI 10.2214/ajr.171.4.9762982; Durkalski VL, 2002, CONTROL CLIN TRIALS, V23, P570, DOI 10.1016/S0197-2456(02)00232-5; Fenlon HM, 1999, NEW ENGL J MED, V341, P1496, DOI 10.1056/NEJM199911113412003; FENLON HM, 2000, NEW ENGL J MED, V342, P524; Gluecker TM, 2003, GASTROENTEROLOGY, V124, P911, DOI 10.1053/gast.2003.50158; Gopalswamy N, 1997, GASTROINTEST ENDOSC, V46, P497, DOI 10.1016/S0016-5107(97)70003-8; Hara AK, 2000, RADIOLOGY, V215, P353, DOI 10.1148/radiology.215.2.r00ap33353; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Johnson CD, 2000, RADIOLOGY, V216, P331, DOI 10.1148/radiology.216.2.r00au47331; Johnson CD, 2003, GASTROENTEROLOGY, V125, P311, DOI 10.1016/S0016-5085(03)00894-1; Kulling D, 2001, ENDOSCOPY, V33, P428, DOI 10.1055/s-2001-14271; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Macari M, 2000, AM J ROENTGENOL, V174, P1543, DOI 10.2214/ajr.174.6.1741543; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V329, P672; McFarland EG, 2002, ABDOM IMAGING, V27, P275, DOI 10.1007/s00261-001-0169-6; Pickhardt PJ, 2003, AM J ROENTGENOL, V181, P799, DOI 10.2214/ajr.181.3.1810799; Pickhardt PJ, 2003, AM J ROENTGENOL, V181, P1599, DOI 10.2214/ajr.181.6.1811599; Pickhardt PJ, 2003, RADIOLOGY, V229, P291, DOI 10.1148/radiol.2291030503; Rex DK, 2002, GASTROINTEST ENDOSC, V55, pS33, DOI 10.1067/mge.2002.124747; REX DK, 1993, AM J GASTROENTEROL, V88, P825; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Smith RA, 2003, CA-CANCER J CLIN, V53, P27, DOI 10.3322/canjclin.53.1.27; Winawer Sidney J, 2002, Gastrointest Endosc Clin N Am, V12, P1, DOI 10.1016/S1052-5157(03)00053-9; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Yee J, 2001, RADIOLOGY, V219, P685, DOI 10.1148/radiology.219.3.r01jn40685	32	1472	1532	1	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2003	349	23					2191	2200		10.1056/NEJMoa031618	http://dx.doi.org/10.1056/NEJMoa031618			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LH	14657426				2022-12-28	WOS:000186921700005
J	Li, MO; Sarkisian, MR; Mehal, WZ; Rakic, P; Flavell, RA				Li, MO; Sarkisian, MR; Mehal, WZ; Rakic, P; Flavell, RA			Phosphatidylserine receptor is required for clearance of apoptotic cells	SCIENCE			English	Article							MEMBRANE PHOSPHATIDYLSERINE; LUNG DEVELOPMENT; DEATH; PHAGOCYTOSIS; MICE; RECOGNITION; ENGULFMENT; BRAIN; REDISTRIBUTION; MACROPHAGES	Cells undergoing apoptosis during development are removed by phagocytes, but the underlying mechanisms of this process are not fully understood. Phagocytes lacking the phosphatidylserine receptor (PSR) were defective in removing apoptotic cells. Consequently, in PSR-deficient mice, dead cells accumulated in the lung and brain, causing abnormal development and leading to neonatal lethality. A fraction of PSR knockout mice manifested a hyperplasic brain phenotype resembling that of mice deficient in the cell death - associated genes encoding Apaf-1, caspase-3, and caspase-9, which suggests that phagocytes may also be involved in promoting apoptosis. These data demonstrate a critical role for PSR in early stages of mammalian organogenesis and suggest that this receptor may be involved in respiratory distress syndromes and congenital brain malformations.	Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Digest Dis, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Flavell, RA (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.			li, ming/0000-0002-1383-0535				Arur S, 2003, DEV CELL, V4, P587, DOI 10.1016/S1534-5807(03)00090-X; Balasubramanian K, 1997, J BIOL CHEM, V272, P31113, DOI 10.1074/jbc.272.49.31113; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Cole FS, 2001, PEDIATR RES, V50, P157, DOI 10.1203/00006450-200108000-00001; De Paepe ME, 1999, J PEDIATR SURG, V34, P863, DOI 10.1016/S0022-3468(99)90389-5; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 2001, SEMIN IMMUNOL, V13, P365, DOI 10.1006/smim.2001.0333; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hamon Y, 2000, NAT CELL BIOL, V2, P399, DOI 10.1038/35017029; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Kresch MJ, 1998, PEDIATR RES, V43, P426, DOI 10.1203/00006450-199803000-00020; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Leonard JR, 2002, J NEUROPATH EXP NEUR, V61, P673, DOI 10.1093/jnen/61.8.673; Manfredi AA, 2002, APOPTOSIS, V7, P153, DOI 10.1023/A:1014366531885; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; SAMBRANO GR, 1995, P NATL ACAD SCI USA, V92, P1396, DOI 10.1073/pnas.92.5.1396; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; Scavo LM, 1998, AM J RESP CELL MOL, V18, P21, DOI 10.1165/ajrcmb.18.1.2744; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X	28	305	318	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1560	1563		10.1126/science.1087621	http://dx.doi.org/10.1126/science.1087621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645847				2022-12-28	WOS:000186802200042
J	Weigel, LM; Clewell, DB; Gill, SR; Clark, NC; McDougal, LK; Flannagan, SE; Kolonay, JF; Shetty, J; Killgore, GE; Tenover, FC				Weigel, LM; Clewell, DB; Gill, SR; Clark, NC; McDougal, LK; Flannagan, SE; Kolonay, JF; Shetty, J; Killgore, GE; Tenover, FC			Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus	SCIENCE			English	Article							GLYCOPEPTIDE RESISTANCE; UNITED-STATES; CELL-WALL; ENTEROCOCCI; EVOLUTION; SEQUENCE	Vancomycin is usually reserved for treatment of serious infections, including those caused by multidrug-resistant Staphylococcus aureus. A clinical isolate of S. aureus with high-level resistance to vancomycin ( minimal inhibitory concentration = 1024 mug/ml) was isolated in June 2002. This isolate harbored a 57.9-kilobase multiresistance conjugative plasmid within which Tn1546 (vanA) was integrated. Additional elements on the plasmid encoded resistance to trimethoprim (dfrA), beta-lactams (blaZ), aminoglycosides (aacA-aphD), and disinfectants ( qacC). Genetic analyses suggest that the long-anticipated transfer of vancomycin resistance to a methicillin-resistant S. aureus occurred in vivo by interspecies transfer of Tn1546 from a co-isolate of Enterococcus faecalis.	Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA; Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; Inst Genom Res, Rockville, MD 20850 USA; J Craig Center Sci Fdn Joint Technol Ctr, Rockville, MD 20850 USA	Centers for Disease Control & Prevention - USA; University of Michigan System; University of Michigan; J. Craig Venter Institute	Weigel, LM (corresponding author), Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA 30333 USA.	lweigel@cdc.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095359] Funding Source: NIH RePORTER; NIAID NIH HHS [N01-AI-95359] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARTHUR M, 1993, J BACTERIOL, V175, P117, DOI 10.1128/JB.175.1.117-127.1993; Berg T, 1998, J BACTERIOL, V180, P4350, DOI 10.1128/JB.180.17.4350-4359.1998; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007; BYRNE ME, 1990, ANTIMICROB AGENTS CH, V34, P2106, DOI 10.1128/AAC.34.11.2106; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P902; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; CLARK NC, 1993, ANTIMICROB AGENTS CH, V37, P2311, DOI 10.1128/AAC.37.11.2311; Cui LZ, 2000, ANTIMICROB AGENTS CH, V44, P2276, DOI 10.1128/AAC.44.9.2276-2285.2000; DUTKAMALEN S, 1995, J CLIN MICROBIOL, V33, P24, DOI 10.1128/JCM.33.1.24-27.1995; Firth N, 2000, GRAM-POSITIVE PATHOGENS, P326; FLANNAGAN SE, IN PRESS ANTIMICROB; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; MORTON TM, 1993, J BACTERIOL, V175, P4436, DOI 10.1128/JB.175.14.4436-4447.1993; NOBLE WC, 1992, FEMS MICROBIOL LETT, V93, P195; Oliveira DC, 2002, LANCET INFECT DIS, V2, P180, DOI 10.1016/S1473-3099(02)00227-X; Roberts RB, 1998, J INFECT DIS, V178, P164, DOI 10.1086/515610; Sieradzki K, 1999, J BACTERIOL, V181, P7566, DOI 10.1128/JB.181.24.7566-7570.1999; Sieradzki R, 1999, J BIOL CHEM, V274, P18942, DOI 10.1074/jbc.274.27.18942; Walsh C, 1999, SCIENCE, V284, P442, DOI 10.1126/science.284.5413.442	21	647	702	4	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1569	1571		10.1126/science.1090956	http://dx.doi.org/10.1126/science.1090956			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645850				2022-12-28	WOS:000186802200045
J	Gonzalez-Leon, JA; Acar, MH; Ryu, SW; Ruzette, AVG; Mayes, AM				Gonzalez-Leon, JA; Acar, MH; Ryu, SW; Ruzette, AVG; Mayes, AM			Low-temperature processing of 'baroplastics' by pressure-induced flow	NATURE			English	Article							CRITICAL ORDERING TRANSITION; PHASE-BEHAVIOR; DISORDER TRANSITION; DIBLOCK COPOLYMER; ACRYLATE; FLUCTUATIONS; DEPENDENCE; STYRENE; MODEL	The manufacturing of plastics traditionally involves melt processing at temperatures typically greater than 200degreesC - to enable extrusion or moulding under pressure into desired forms followed by solidification. This process consumes energy and can cause substantial degradation of polymers and additives (such as flame retardants and ultraviolet stabilizers), limiting plastics performance and recyclability(1). It was recently reported that the application of pressure could induce melt-like behaviour in the block copolymer polystyrene-block-poly(n-butyl methacrylate) (PS-b-PBMA)(2), and this behaviour has now been demonstrated in a range of other block copolymer systems(3-8). These polymers have been termed baroplastics(2-5). However, in each case, the order-to-disorder transition, which gives rise to the accompanying change in rheology from soft solid to melt(9,10), was observed at temperatures far exceeding the glass transition temperatures (T-g) of both components. Here we show that baroplastic systems containing nanophase domains of one high-T-g and one low-T-g component can exhibit melt-like flow under pressure at ambient temperature through an apparent semi-solid partial mixing mechanism that substantially preserves the high-T-g phase. These systems were shredded and remoulded ten times with no evident property degradation. Baroplastics with low-temperature formability promise lower energy consumption in manufacture and processing, reduced use of additives, faster production and improved recyclability, and also provide potential alternatives to current thermoplastic elastomers, rubber-modified plastics, and semi-crystalline polymers(11,12).	MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Mayes, AM (corresponding author), MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	amayes@mit.edu	Acar, Metin Hayri/N-3246-2014; Acar, Metin/GYA-3922-2022	Acar, Metin Hayri/0000-0001-8953-1905; 				Cassebras M, 1999, MACROMOL RAPID COMM, V20, P261, DOI 10.1002/(SICI)1521-3927(19990501)20:5<261::AID-MARC261>3.3.CO;2-Q; Dos Santos FD, 2003, J POLYM SCI POL PHYS, V41, P224, DOI 10.1002/polb.10379; EHRENSTEIN GH, 2001, POLYM MAT, P63; FLEMINGS MC, 1991, METALL TRANS B, V22, P269, DOI 10.1007/BF02651227; Frielinghaus H, 1996, MACROMOLECULES, V29, P3263, DOI 10.1021/ma950998w; Gonzalez-Leon JA, 2003, MACROMOLECULES, V36, P2508, DOI 10.1021/ma0209803; Ha JW, 2002, MACROMOLECULES, V35, P6811, DOI 10.1021/ma011692u; HAJDUK DA, 1995, MACROMOLECULES, V28, P7148, DOI 10.1021/ma00125a017; Hajduk DA, 1996, MACROMOLECULES, V29, P1473, DOI 10.1021/ma950643c; Hasegawa H, 1999, J PHYS CHEM SOLIDS, V60, P1307, DOI 10.1016/S0022-3697(99)00109-2; HERBST H, 1997, FRONTIERS SCI TECHNO, P73; Hillmyer M, 1999, CURR OPIN SOLID ST M, V4, P559, DOI 10.1016/S1359-0286(00)00006-1; HOLDEN G, 1996, THERMOPLASTIC ELASTO, P573; Keddie JL, 1997, MAT SCI ENG R, V21, P101, DOI 10.1016/S0927-796X(97)00011-9; Lovell PA, 1997, EMULSION POLYM EMULS, P657; Malmstrom EE, 1998, MACROMOL CHEM PHYSIC, V199, P923; Migler KB, 1998, MACROMOLECULES, V31, P360, DOI 10.1021/ma971295c; Patten TE, 1998, ADV MATER, V10, P901, DOI 10.1002/(SICI)1521-4095(199808)10:12<901::AID-ADMA901>3.0.CO;2-B; Pollard M, 1998, MACROMOLECULES, V31, P6493, DOI 10.1021/ma980316f; RUSSELL TP, 1994, NATURE, V368, P729, DOI 10.1038/368729a0; Ruzette AVG, 2003, MACROMOLECULES, V36, P3351, DOI 10.1021/ma021394c; Ruzette AVG, 2001, MACROMOLECULES, V34, P1894, DOI 10.1021/ma000712+; Ruzette AVG, 2001, J CHEM PHYS, V114, P8205, DOI 10.1063/1.1361072; Ruzette AVG, 1998, MACROMOLECULES, V31, P8509, DOI 10.1021/ma981055c; Ryu DY, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.235501; Ryu DY, 2002, NAT MATER, V1, P114, DOI 10.1038/nmat724; Schwahn D, 1996, PHYS REV LETT, V77, P3153, DOI 10.1103/PhysRevLett.77.3153; Shipp DA, 1998, MACROMOLECULES, V31, P8005, DOI 10.1021/ma981033q; Steinhoff B, 1998, MACROMOLECULES, V31, P36, DOI 10.1021/ma970659y	29	94	102	6	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2003	426	6965					424	428		10.1038/nature02140	http://dx.doi.org/10.1038/nature02140			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647377				2022-12-28	WOS:000186800800033
J	Li, WH; Moore, MJ; Vasilieva, N; Sui, JH; Wong, SK; Berne, MA; Somasundaran, M; Sullivan, JL; Luzuriaga, K; Greenough, TC; Choe, H; Farzan, M				Li, WH; Moore, MJ; Vasilieva, N; Sui, JH; Wong, SK; Berne, MA; Somasundaran, M; Sullivan, JL; Luzuriaga, K; Greenough, TC; Choe, H; Farzan, M			Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus	NATURE			English	Article							MESSENGER-RNA EXPRESSION; AMINOPEPTIDASE-N; LOCALIZATION; HOMOLOG; CLONING; DOMAIN; SITE	Spike (S) proteins of coronaviruses, including the coronavirus that causes severe acute respiratory syndrome (SARS), associate with cellular receptors to mediate infection of their target cells(1,2). Here we identify a metallopeptidase, angiotensin-converting enzyme 2 (ACE2)(3,4), isolated from SARS coronavirus (SARS-CoV)permissive Vero E6 cells, that efficiently binds the S1 domain of the SARS-CoV S protein. We found that a soluble form of ACE2, but not of the related enzyme ACE1, blocked association of the S1 domain with Vero E6 cells. 293T cells transfected with ACE2, but not those transfected with human immunodeficiency virus-1 receptors, formed multinucleated syncytia with cells expressing S protein. Furthermore, SARS-CoV replicated efficiently on ACE2-transfected but not mock-transfected 293T cells. Finally, anti-ACE2 but not anti-ACE1 antibody blocked viral replication on Vero E6 cells. Together our data indicate that ACE2 is a functional receptor for SARS-CoV.	Harvard Univ, Sch Med, Childrens Hosp, Perlmutter Lab,Pulm Div,Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Dept Med Microbiol & Mol Genet, Brigham & Womens Hosp, Partners AIDS Res Ctr,Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; Tufts Univ, Sch Med, Tufts Univ Core Facil, Boston, MA 02111 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Tufts University; University of Massachusetts System; University of Massachusetts Worcester	Choe, H (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Perlmutter Lab,Pulm Div,Dept Pediat, Boston, MA 02115 USA.	hyeryun.choe@tch.harvard.edu; farzan@mbcrr.harvard.edu		SUI, JIANHUA/0000-0002-1272-9662; Farzan, Michael/0000-0002-2990-5319; Li, Wenhui/0000-0003-1305-7404				Bonavia A, 2003, J VIROL, V77, P2530, DOI 10.1128/JVI.77.4.2530-2538.2003; Breslin JJ, 2003, J VIROL, V77, P4435, DOI 10.1128/JVI.77.7.4435-4438.2003; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Dales NA, 2002, J AM CHEM SOC, V124, P11852, DOI 10.1021/ja0277226; DELMAS B, 1994, J VIROL, V68, P5216, DOI 10.1128/JVI.68.8.5216-5224.1994; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; DVEKSLER GS, 1993, J VIROL, V67, P1; Fouchier RAM, 2003, NATURE, V423, P240, DOI 10.1038/423240a; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Harmer D, 2002, FEBS LETT, V532, P107, DOI 10.1016/S0014-5793(02)03640-2; Holmes KV, 2003, NEW ENGL J MED, V348, P1948, DOI 10.1056/NEJMp030078; HOLMES KV, 1993, ADV EXP MED BIOL, V342, P261; Huang LL, 2003, J BIOL CHEM, V278, P15532, DOI 10.1074/jbc.M212934200; Jackwood MW, 2001, AVIAN DIS, V45, P366, DOI 10.2307/1592976; Komatsu T, 2002, DNA SEQUENCE, V13, P217, DOI 10.1080/1042517021000021608; KUBO H, 1994, J VIROL, V68, P5403, DOI 10.1128/JVI.68.9.5403-5410.1994; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Leung WK, 2003, GASTROENTEROLOGY, V125, P1011, DOI [10.1016/j.gastro.2003.08.001, 10.1053/S0016-5085(03)01215-0]; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939; Sturman L S, 1984, Adv Exp Med Biol, V173, P25; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Tresnan DB, 1998, ADV EXP MED BIOL, V440, P69; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0	30	3664	3966	17	336	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2003	426	6965					450	454		10.1038/nature02145	http://dx.doi.org/10.1038/nature02145			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647384	Green Published, Bronze			2022-12-28	WOS:000186800800040
J	Weitz, G				Weitz, G			Love and death in Wagner's Tristan und Isolde - an epic anticholinergic crisis	BRITISH MEDICAL JOURNAL			English	Article							NIGHTSHADE; INGESTION		Med Univ Schleswig Holstein, Dept Internal Med 1, D-23538 Lubeck, Germany	University of Kiel; Schleswig Holstein University Hospital	Weitz, G (corresponding author), Med Univ Schleswig Holstein, Dept Internal Med 1, Campus Lubeck,Ratzeburger Allee 160, D-23538 Lubeck, Germany.							BETZ P, 1991, Archiv fuer Kriminologie, V188, P175; Carter AJ, 1996, BRIT MED J, V313, P1630, DOI 10.1136/bmj.313.7072.1630; Chessick RD, 1990, PSYCHOANALYTIC EXPLO, P465; COSMAN MP, 1983, ANNU REV NUTR, V3, P1, DOI 10.1146/annurev.nu.03.070183.000245; FUHNER H, 1926, ARCH EXP PATHOL PH, V111, P281; GEDIMAN HK, 1981, J AM PSYCHOANAL ASS, V29, P607, DOI 10.1177/000306518102900306; GOLDSMITH SR, 1968, J AMER MED ASSOC, V204, P169, DOI 10.1001/jama.204.2.169; GOWDY JM, 1972, J AMER MED ASSOC, V221, P585, DOI 10.1001/jama.221.6.585; HAULE J, 1990, DIVINE MADNESS ARCHE; HILL C, 1984, MUSIC REV, V45, P7; JACKSON S W, 1972, Journal of the History of Medicine and Allied Sciences, V27, P262; Karras DJ, 1996, AM J EMERG MED, V14, P478, DOI 10.1016/S0735-6757(96)90158-8; KNAPP R, 1984, MUS REV, V45, P10; MIKOLICH JR, 1975, ANN INTERN MED, V83, P321, DOI 10.7326/0003-4819-83-3-321; Muller JL, 1998, J TOXICOL-CLIN TOXIC, V36, P617, DOI 10.3109/15563659809028060; OBER PC, 1965, MONATSHEFTE DEUTSCHU, V57, P321; PAHLEN K, 1983, R WAGNER TRISTAN ISO; PIOMELLI D, 1994, HIST PHIL LIFE SCI, V16, P241; RICHEY J, 1994, MUS REV, V55, P97; SHAMPO MA, 1992, MAYO CLIN PROC, V67, P477, DOI 10.1016/S0025-6196(12)60396-6; Shannon M, 1999, J TOXICOL-CLIN TOXIC, V37, P709, DOI 10.1081/CLT-100102448; Volger Gisela, 1982, RAUSCH REALITAT DROG	22	7	7	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1469	1471		10.1136/bmj.327.7429.1469	http://dx.doi.org/10.1136/bmj.327.7429.1469			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684652	Green Published			2022-12-28	WOS:000187562700023
J	Peiris, JSM; Yuen, KY; Osterhaus, ADME; Stohr, K				Peiris, JSM; Yuen, KY; Osterhaus, ADME; Stohr, K			Current concepts: The severe acute respiratory syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							THIN-SECTION CT; SYNDROME SARS; TRANSMISSION DYNAMICS; CLINICAL-FEATURES; GENOME SEQUENCE; LUNG PATHOLOGY; X-RAY; CORONAVIRUS; OUTBREAK; TORONTO		WHO, Geneva, Switzerland; Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Div Infect Dis, Hong Kong, Hong Kong, Peoples R China; Erasmus MC, Rotterdam, Netherlands	World Health Organization; University of Hong Kong; University of Hong Kong; Erasmus University Rotterdam; Erasmus MC	Stohr, K (corresponding author), WHO, 40 Ave Appia, Geneva, Switzerland.	stohrk@who.int	Yuen, Kwok Yung/C-4465-2009	Osterhaus, Albert/0000-0002-6074-1172; Yuen, Kwok-yung/0000-0002-2083-1552				Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P100; Antonio GE, 2003, RADIOLOGY, V228, P810, DOI 10.1148/radiol.2283030726; Antonio GE, 2003, AM J ROENTGENOL, V181, P11, DOI 10.2214/ajr.181.1.1810011; Avendano M, 2003, CAN MED ASSOC J, V168, P1649; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Booth CM, 2003, JAMA-J AM MED ASSOC, V290, P334; Breiman RF, 2003, EMERG INFECT DIS, V9, P1037; *CDCP, 2003, SEV AC RESP SYNDR SA; Chan JWM, 2003, THORAX, V58, P686, DOI 10.1136/thorax.58.8.686; CHAN KH, IN PRESS EMERG INFEC; Chan KS, 2003, RESPIROLOGY, V8, pS36, DOI 10.1046/j.1440-1843.2003.00522.x; Chan PKS, 2003, EMERG INFECT DIS, V9, P1058; CHAN PKS, IN PRESS EMERG INFEC; Chiu Wa-keung, 2003, Pediatr Crit Care Med, V4, P279, DOI 10.1097/01.PCC.0000077079.42302.81; Cinatl J, 2003, LANCET, V362, P293, DOI 10.1016/S0140-6736(03)13973-6; Cinatl J, 2003, LANCET, V362, P748; Cinatl J, 2003, LANCET, V361, P2045, DOI 10.1016/S0140-6736(03)13615-X; Donnelly CA, 2003, LANCET, V361, P1832; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Dye C, 2003, SCIENCE, V300, P1884, DOI 10.1126/science.1086925; FARCAS GA, 2003, 43 INT C ANT AG CHEM; Franks TJ, 2003, HUM PATHOL, V34, P743, DOI 10.1016/S0046-8177(03)00367-8; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Grinblat L, 2003, RADIOLOGY, V228, P802, DOI 10.1148/radiol.2283030671; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; GUAN Y, IN PRESS LANCET; HO JC, IN PRESS AM J RESP C; HO LC, 2003, SARS CLIN MAN WORKSH; Holmes KV, 2003, SCIENCE, V300, P1377, DOI 10.1126/science.1086418; Hon KLE, 2003, LANCET, V361, P1701, DOI 10.1016/S0140-6736(03)13364-8; *HONG KONG SPEC AD, 2003, OUTBR SEV AC RESP SY; Hong Tao, 2003, Zhonghua Yi Xue Za Zhi, V83, P632; Hsu LY, 2003, EMERG INFECT DIS, V9, P713; Jia W, 2003, PHYTOTHER RES, V17, P840, DOI 10.1002/ptr.1397; Kuiken T, 2003, LANCET, V362, P263, DOI 10.1016/S0140-6736(03)13967-0; Kumar D, 2003, AM J TRANSPLANT, V3, P977, DOI 10.1034/j.1600-6143.2003.00197.x; LEE HKK, IN PRESS EMERG INFEC; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Lew TWK, 2003, JAMA-J AM MED ASSOC, V290, P374, DOI 10.1001/jama.290.3.374; LIM W, 2003, WHO GLOB C SEV AC RE; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; LOUTFY MR, 2003, 43 INT C ANT AG CHEM; Lu PX, 2003, CHINESE MED J-PEKING, V116, P972; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Martina BEE, 2003, NATURE, V425, P915, DOI 10.1038/425915a; MCGEER A, 2003, TORONTO OUTBREAK; MULLER MP, 2003, 43 INT C ANT AG CHEM; Muller NL, 2003, AM J ROENTGENOL, V181, P3, DOI 10.2214/ajr.181.1.1810003; Nakajima N, 2003, JPN J INFECT DIS, V56, P139; Ng SKC, 2003, LANCET, V362, P570, DOI 10.1016/S0140-6736(03)14121-9; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Nicolaou S, 2003, NEW ENGL J MED, V348, P2006, DOI 10.1056/NEJMicm030360; Nicolaou S, 2003, AM J ROENTGENOL, V180, P1247, DOI 10.2214/ajr.180.5.1801247; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Poon LLM, 2003, J CLIN VIROL, V28, P233, DOI 10.1016/j.jcv.2003.08.004; Poutanen SM, 2003, NEW ENGL J MED, V348, P1995, DOI 10.1056/NEJMoa030634; Rainer TH, 2003, BRIT MED J, V326, P1354, DOI 10.1136/bmj.326.7403.1354; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Ruan YJ, 2003, LANCET, V361, P1779, DOI 10.1016/S0140-6736(03)13414-9; Ruan YJ, 2003, LANCET, V361, P1832; Scales DC, 2003, EMERG INFECT DIS, V9, P1205, DOI 10.3201/eid0910.030525; Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6; SINGH K, IN PRESS EMERG INFEC; So LKY, 2003, LANCET, V361, P1615, DOI 10.1016/S0140-6736(03)13265-5; Stohr K, 2003, LANCET, V361, P1730, DOI 10.1016/S0140-6736(03)13376-4; STYRA R, 2003, 43 INT C ANT AG CHEM; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; TSOU IY, IN PRESS PEDIAT RADI; Tsou J., 2003, ARCHITECTURAL STUDIE; Tsui PT, 2003, EMERG INFECT DIS, V9, P1064; Tsui SKW, 2003, NEW ENGL J MED, V349, P187, DOI 10.1056/NEJM200307103490216; Varia M, 2003, CAN MED ASSOC J, V169, P285; WHO, 2003, 1 DAT STAB RES SARS; *WHO, 2003, WHO GUID; Wong KC, 2003, J BONE JOINT SURG AM, V85A, P1339, DOI 10.2106/00004623-200307000-00022; Wong KT, 2003, RADIOLOGY, V228, P395, DOI 10.1148/radiol.2283030541; Wong KT, 2003, RADIOLOGY, V228, P401, DOI 10.1148/radiol.2282030593; Wong RSM, 2003, BRIT MED J, V326, P1358, DOI 10.1136/bmj.326.7403.1358; Wong V. W. S., 2003, Hong Kong Medical Journal, V9, P199; World Health Organization, 2003, CONS DOC EP SEV AC R; Wu W, 2003, CHINESE MED J-PEKING, V116, P811; Yassi A, 2003, BRIT MED J, V326, P1394, DOI 10.1136/bmj.326.7403.1394-b; Zhao DW, 2003, CHINESE MED J-PEKING, V116, P823; Zhao Z, 2003, J MED MICROBIOL, V52, P715, DOI 10.1099/jmm.0.05320-0; Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2; 2003, MMWR MORB MORTAL WKL, V52, P284; 2003, BIOSAFETY SARS INCID; 2003, MMWR MORB MORTAL WKL, V52, P241; 2003, MMWR MORB MORTAL WKL, V52, P433	94	835	885	0	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					2431	2441		10.1056/NEJMra032498	http://dx.doi.org/10.1056/NEJMra032498			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681510	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000187326200011
J	Hendrikson, CA; Howell, EE; Bush, DE; Miles, JS; Meininger, GR; Friedlander, T; Bushnell, AC; Chandra-Strobos, N				Hendrikson, CA; Howell, EE; Bush, DE; Miles, JS; Meininger, GR; Friedlander, T; Bushnell, AC; Chandra-Strobos, N			Chest pain relief by nitroglycerin does not predict active coronary artery disease	ANNALS OF INTERNAL MEDICINE			English	Article							ASSOCIATION TASK-FORCE; PRACTICE GUIDELINES COMMITTEE; RANDOMIZED-TRIAL; AMERICAN-COLLEGE; MYOCARDIAL-INFARCTION; EMERGENCY-DEPARTMENT; ACC/AHA GUIDELINES; UNSTABLE ANGINA; DIAGNOSIS; MANAGEMENT	Background: The belief that chest pain relief with nitroglycerin Indicates the presence of active coronary artery disease is common. However, this hypothesis has not been tested. Objective: To define the diagnostic and prognostic value of chest pain relief with nitroglycerin. Design: Prospective observational cohort study. Setting: urban community teaching hospital. Patients: 459 consecutive patients with chest pain admitted through the emergency department who received nitroglycerin from emergency services personnel or an emergency department nurse. Follow-up was obtained by telephone contact at 4 months. Measurements: Chest pain relief was defined as a decrease of at least 50% in patients' self-reported pain within 5 minutes of the Initial dose of sublingual or spray nitroglycerin. Active coronary artery disease was defined as any elevated serum enzyme levels, coronary angiography demonstrating a 70% or greater stenosis, or a positive exercise test result. Results: Nitroglycerin relieved chest pain in 39% of patients (181 of 459). In patients with active coronary artery disease as the likely cause of their chest pain, 35% (49 of 141) had chest pain relief with nitroglycerin. In contrast, in patients without active coronary artery disease, 41% (113 of 275) had chest pain relief (P > 0.2). Four-month clinical outcomes were similar in patients with or without chest pain relief with nitroglycerin (P > 0.2). Conclusions: These data suggest that, in a general population admitted for chest pain, relief of pain after nitroglycerin treatment does not predict active coronary artery disease and should not be used to guide diagnosis.	Johns Hopkins Bayview Med Ctr, Div Cardiol, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	Chandra-Strobos, N (corresponding author), Johns Hopkins Bayview Med Ctr, Div Cardiol, 4940 Eastern Ave, Baltimore, MD 21224 USA.	nchandra@jhmi.edu	Friedlander, Tracy/AFK-5288-2022; Friedlander, Tracy/AAG-3839-2022		NHLBI NIH HHS [T32-HLO7227-26] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007227] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		*AG HLTH CAR POL R, 1992, CLIN PRACT GUID AC P; *AM HEART ASS, 2001, HEART STROK STAT UPD; *AM HEART ASS, 2002, WHAT IS ANG; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; Braunwald E, 2000, CIRCULATION, V102, P1193, DOI 10.1161/01.CIR.102.10.1193; CALIFF RM, 2003, ACUTE CORONARY SYNDR; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Decker WW, 2003, ANN EMERG MED, V41, P342, DOI 10.1067/mem.2003.78; DIAMOND GA, 1980, J CLIN INVEST, V65, P1210, DOI 10.1172/JCI109776; DIAMOND GA, 1983, J AM COLL CARDIOL, V1, P474; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Engelberg S, 2000, Prehosp Emerg Care, V4, P290, DOI 10.1080/10903120090940967; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; GOLDMAN L, 1982, NEW ENGL J MED, V307, P588, DOI 10.1056/NEJM198209023071004; Goodacre S, 2002, ACAD EMERG MED, V9, P203; Goodman SG, 2000, J AM COLL CARDIOL, V36, P693, DOI 10.1016/S0735-1097(00)00808-1; Goyal RK, 1996, ANN INTERN MED, V124, P1008, DOI 10.7326/0003-4819-124-11-199606010-00010; KAUL S, 1994, ANN INTERN MED, V121, P976, DOI 10.7326/0003-4819-121-12-199412150-00013; LEE TH, 2001, HARRISONS PRINCIPLES, P60; Mathew V, 2001, J AM COLL CARDIOL, V37, P2053, DOI 10.1016/S0735-1097(01)01291-8; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; Shry EA, 2002, AM J CARDIOL, V90, P1264, DOI 10.1016/S0002-9149(02)02850-3; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Simoons ML, 2001, LANCET, V357, P1915; SOX HC, 1981, ANN INTERN MED, V95, P680, DOI 10.7326/0003-4819-95-6-680; Storrow AB, 2000, ANN EMERG MED, V35, P449, DOI 10.1067/mem.2000.105601; Wallentin L, 2000, LANCET, V356, P9, DOI 10.1016/S0140-6736(00)02427-2; WEINER DA, 1979, NEW ENGL J MED, V301, P230, DOI 10.1056/NEJM197908023010502; Zarich SW, 2002, CLIN CHIM ACTA, V326, P185, DOI 10.1016/S0009-8981(02)00303-0	31	66	67	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 16	2003	139	12					979	986		10.7326/0003-4819-139-12-200312160-00007	http://dx.doi.org/10.7326/0003-4819-139-12-200312160-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	756AG	14678917				2022-12-28	WOS:000187443200003
J	Ito, A; Nakao, M; Wandra, T				Ito, A; Nakao, M; Wandra, T			Human taeniasis and cysticercosis in Asia	LANCET			English	Review							IRIAN-JAYA; PHYLOGENETIC HYPOTHESIS; SOLIUM; INDONESIA; PAPUA; TAENIASIS/CYSTICERCOSIS; JAYAWIJAYA; TAPEWORMS; DIAGNOSIS; GENOTYPES	Context Human taeniasis caused by the pork, Taenia solium, or beef, T saginata, tapeworm arises after eating pork or beef contaminated with metacestodes, the larval stage of these parasites. Taeniasis with T solium can lead to neurocysticercosis and threaten others by accidental ingestion of eggs released from asymptomatic taeniasis patients. The 2003 World Health Assembly declared that T solium is of worldwide public-health importance, and that it is an eradicable parasitic disease worldwide. Adult taeniid tapeworms expelled from people in almost all Asian countries appeared to be T saginata (the so-called Asian Taenia), even though they ate pork. The organism is now named T asiatica, and has been found in Taiwan, Korea, China, Vietnam, and Indonesia. But it has been difficult to differentiate T saginata from beef and Asian Taenia from pork. Starting point Marshall Lightowlers and colleagues (Int J Parasitol 2003; 33: 1207-17) recently demonstrated that recombinant oncosphere vaccines against several taeniid cestodes, including T ovis, T saginata, T solium, and Echinococcus granulosus, are highly effective. Protection was almost 100%, in the laboratory and in the field. These researchers found several common features, including a predicted secretory signal sequence, and one or two copies of a fibronectin type III domain, each encoded by separate exons within the associated gene. Where next? Molecular and immunological techniques, including vaccine research and development of animal models for differentiation of taeniid species in humans, have greatly advanced over the past decade. The clinical importance of infections by these taeniids, including T asiatica, in humans, and the potential for cysticercosis attributable to T asiatica in humans, needs further study.	Asahikawa Med Coll, Dept Parasitol, Asahikawa, Hokkaido 0788510, Japan; Minist Hlth, Directorate Gen Communicable Dis Control & Enviro, Jakarta, Indonesia	Asahikawa Medical College; Ministry of Health - Indonesia	Ito, A (corresponding author), Asahikawa Med Coll, Dept Parasitol, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan.	akiraito@asahikawa-med.ac.jp	WANDRA, TONI/AAD-5736-2021; Ito, A./E-9377-2014	Ito, A./0000-0002-5070-9187; Wandra, Toni/0000-0002-4606-5411				[Anonymous], [No title captured]; de Queiroz A, 1998, J PARASITOL, V84, P379, DOI 10.2307/3284501; Eom Keeseon S., 1993, Korean Journal of Parasitology, V31, P1, DOI 10.3347/kjp.1993.31.1.1; Eom KS, 2002, J PARASITOL, V88, P758, DOI 10.1645/0022-3395(2002)088[0758:IOTAIC]2.0.CO;2; FAN PC, 1988, PARASITOL TODAY, V4, P86, DOI 10.1016/0169-4758(88)90204-9; Gonzalez AE, 2003, ACTA TROP, V87, P103, DOI 10.1016/S0001-706X(03)00025-1; GUJDUSEK DC, 1978, PNG MED J, V21, P329; Hoberg EP, 2002, MICROBES INFECT, V4, P859, DOI 10.1016/S1286-4579(02)01606-4; Hoberg EP, 2001, P ROY SOC B-BIOL SCI, V268, P781, DOI 10.1098/rspb.2000.1579; Hoberg EP, 2000, J PARASITOL, V86, P89, DOI 10.1645/0022-3395(2000)086[0089:APHFSO]2.0.CO;2; Ito A, 2001, Southeast Asian J Trop Med Public Health, V32 Suppl 2, P85; Ito A, 2003, ACTA TROP, V87, P95, DOI 10.1016/S0001-706X(03)00024-X; Ito A, 2003, TRENDS PARASITOL, V19, P377, DOI 10.1016/S1471-4922(03)00200-9; Ito A, 2003, ACTA TROP, V86, P3, DOI 10.1016/S0001-706X(02)00269-3; Ito A, 2002, J HELMINTHOL, V76, P311, DOI 10.1079/JOH2002128; ITO A, 1992, PARASITOL TODAY, V8, P182, DOI 10.1016/0169-4758(92)90259-5; Lightowlers MW, 2003, INT J PARASITOL, V33, P1207, DOI 10.1016/S0020-7519(03)00174-7; Margono SS, 2003, J HELMINTHOL, V77, P39, DOI 10.1079/JOH2002146; Nakao M, 2002, MITOCHONDRION, V1, P497, DOI 10.1016/S1567-7249(02)00040-5; Nakao M, 2002, PARASITOLOGY, V124, P657, DOI 10.1017/S0031182002001725; Nakao M, 2000, MOL BIOCHEM PARASIT, V111, P415, DOI 10.1016/S0166-6851(00)00334-0; Nakao M, 2003, INFECT GENET EVOL, V3, P159, DOI 10.1016/S1567-1348(03)00070-4; Pawlowski Zbigniew S., 2002, P1, DOI 10.1079/9780851996288.0001; RAJSHEKHAR V, 2000, SOLITARY CYSTICERCUS; Schantz PM, 1998, EMERG INFECT DIS, V2, P213, DOI [10.1128/9781555816957.ch12, DOI 10.1128/9781555816957.CH12]; Simanjuntak GM, 1997, PARASITOL TODAY, V13, P321, DOI 10.1016/S0169-4758(97)01104-6; Singh Gagandeep, 2002, P111, DOI 10.1079/9780851996288.0111; Subahar R, 2001, T ROY SOC TROP MED H, V95, P388, DOI 10.1016/S0035-9203(01)90190-7; Sutisna IP, 1999, TROP MED INT HEALTH, V4, P288, DOI 10.1046/j.1365-3156.1999.00394.x; Wandra T, 2000, T ROY SOC TROP MED H, V94, P46, DOI 10.1016/S0035-9203(00)90433-4; Wandra T, 2003, EMERG INFECT DIS, V9, P884; Willingham A Lee 3rd, 2003, Southeast Asian J Trop Med Public Health, V34 Suppl 1, P35; Yamasaki H, 2002, J CLIN MICROBIOL, V40, P3818, DOI 10.1128/JCM.40.10.3818-3821.2002; YAMASAKI H, IN PRESS J CLIN MICR	34	118	122	1	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2003	362	9399					1918	1920		10.1016/S0140-6736(03)14965-3	http://dx.doi.org/10.1016/S0140-6736(03)14965-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667751	Green Submitted			2022-12-28	WOS:000187011600025
J	Willingham, S; Outeiro, TF; DeVit, MJ; Lindquist, SL; Muchowski, PJ				Willingham, S; Outeiro, TF; DeVit, MJ; Lindquist, SL; Muchowski, PJ			Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; PARKINSONS-DISEASE; DROSOPHILA MODEL; SCA1 MICE; NEURODEGENERATION; MUTATION; SUPPRESSION; EXPRESSION; PROTEINS; HSP70	Genome-wide screens were performed in yeast to identify genes that enhance the toxicity of a mutant huntingtin fragment or of alpha-synuclein. Of 4850 haploid mutants containing deletions of nonessential genes, 52 were identified that were sensitive to a mutant huntingtin fragment, 86 that were sensitive to alpha-synuclein, and only one mutant that was sensitive to both. Genes that enhanced toxicity of the mutant huntingtin fragment clustered in the functionally related cellular processes of response to stress, protein folding, and ubiquitin-dependent protein catabolism, whereas genes that modified alpha-synuclein toxicity clustered in the processes of lipid metabolism and vesicle-mediated transport. Genes with human orthologs were overrepresented in our screens, suggesting that we may have discovered conserved and nonoverlapping sets of cell-autonomous genes and pathways that are relevant to Huntington's disease and Parkinson's disease.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Muchowski, PJ (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.		Outeiro, Tiago F/C-1067-2008; Outeiro, Tiago/L-7351-2019; Outeiro, Tiago/M-8106-2019	Outeiro, Tiago F/0000-0003-1679-1727; Outeiro, Tiago/0000-0003-1679-1727; 				Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Botstein D, 1997, SCIENCE, V277, P1259, DOI 10.1126/science.277.5330.1259; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Scherzer CR, 2003, HUM MOL GENET, V12, P2457, DOI 10.1093/hmg/ddg265; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	30	324	341	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1769	1772		10.1126/science.1090389	http://dx.doi.org/10.1126/science.1090389			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657499				2022-12-28	WOS:000186970100049
J	Rosenfeld, RG				Rosenfeld, RG			Insulin-like growth factors and the basis of growth	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Lucile Packard Fdn Childrens Hlth, Palo Alto, CA 94304 USA; Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR USA	Stanford University; Oregon Health & Science University	Rosenfeld, RG (corresponding author), Stanford Univ, Lucile Packard Fdn Childrens Hlth, Palo Alto, CA 94304 USA.								0	102	107	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2003	349	23					2184	2186		10.1056/NEJMp038156	http://dx.doi.org/10.1056/NEJMp038156			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LH	14657423				2022-12-28	WOS:000186921700002
J	Topol, EJ; Lauer, MS				Topol, EJ; Lauer, MS			The rudimentary phase of personalised medicine: coronary risk scores	LANCET			English	Editorial Material							CARDIOVASCULAR-DISEASE; PREDICTION		Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Topol, EJ (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.		Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177; Topol, Eric/0000-0002-1478-4729				Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; *NAT CHOL ED PROGR, RISK ASS TOOL EST 10; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	7	26	26	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 29	2003	362	9398					1776	1777		10.1016/S0140-6736(03)14941-0	http://dx.doi.org/10.1016/S0140-6736(03)14941-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654312				2022-12-28	WOS:000186872900005
J	Zheng, M; Jagota, A; Strano, MS; Santos, AP; Barone, P; Chou, SG; Diner, BA; Dresselhaus, MS; McLean, RS; Onoa, GB; Samsonidze, GG; Semke, ED; Usrey, M; Walls, DJ				Zheng, M; Jagota, A; Strano, MS; Santos, AP; Barone, P; Chou, SG; Diner, BA; Dresselhaus, MS; McLean, RS; Onoa, GB; Samsonidze, GG; Semke, ED; Usrey, M; Walls, DJ			Structure-based carbon nanotube sorting by sequence-dependent DNA assembly	SCIENCE			English	Article							SEPARATION	Wrapping of carbon nanotubes (CNTs) by single-stranded DNA (ssDNA) was found to be sequence-dependent. A systematic search of the ssDNA library selected a sequence d(GT) n, n = 10 to 45 that self-assembles into a helical structure around individual nanotubes in such a way that the electrostatics of the DNA-CNT hybrid depends on tube diameter and electronic properties, enabling nanotube separation by anion exchange chromatography. Optical absorption and Raman spectroscopy show that early fractions are enriched in the smaller diameter and metallic tubes, whereas late fractions are enriched in the larger diameter and semiconducting tubes.	DuPont Co Inc, Cent Res & Dev, Expt Stn, Wilmington, DE 19880 USA; Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; MIT, Dept Phys Elect Engn & Comp Sci, Cambridge, MA 02139 USA; CDTN, CNEN, Ctr Desenvolvimento Tecnol Nucl, BR-30123970 Belo Horizonte, MG, Brazil	DuPont; University of Illinois System; University of Illinois Urbana-Champaign; Massachusetts Institute of Technology (MIT); Centro de Desenvolvimento da Tecnologia Nuclear (CDTN); Comissao Nacional de Energia Nuclear (CNEN)	Zheng, M (corresponding author), DuPont Co Inc, Cent Res & Dev, Expt Stn, Wilmington, DE 19880 USA.		Samsonidze, Georgy/G-3613-2016; Santos, Adelina/V-3087-2019	Samsonidze, Georgy/0000-0002-3759-1794; 				Avouris P, 2002, ACCOUNTS CHEM RES, V35, P1026, DOI 10.1021/ar010152e; Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; BENEDICT LX, 1995, PHYS REV B, V52, P8541, DOI 10.1103/PhysRevB.52.8541; Chattopadhyay D, 2003, J AM CHEM SOC, V125, P3370, DOI 10.1021/ja028599l; Chattopadhyay D, 2002, J AM CHEM SOC, V124, P728, DOI 10.1021/ja0172159; Dai HJ, 2002, ACCOUNTS CHEM RES, V35, P1035, DOI 10.1021/ar0101640; Doorn SK, 2002, J AM CHEM SOC, V124, P3169, DOI 10.1021/ja012364c; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; Jackson J.D., 1999, CLASSICAL ELECTRODYN; Krupke R, 2003, SCIENCE, V301, P344, DOI 10.1126/science.1086534; Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253; Manning GS, 2002, BIOPHYS CHEM, V101, P461, DOI 10.1016/S0301-4622(02)00162-X; MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031; MARSH TC, 1995, NUCLEIC ACIDS RES, V23, P696, DOI 10.1093/nar/23.4.696; Niyogi S, 2002, ACCOUNTS CHEM RES, V35, P1105, DOI 10.1021/ar010155r; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; Saito R., 1998, PHYS PROPERTIES CARB; Sauvajol JL, 2002, CARBON, V40, P1697, DOI 10.1016/S0008-6223(02)00010-6; Strano MS, 2003, NANO LETT, V3, P1091, DOI 10.1021/nl034196n; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877	21	1429	1498	5	498	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1545	1548		10.1126/science.1091911	http://dx.doi.org/10.1126/science.1091911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645843				2022-12-28	WOS:000186802200037
J	Forastiere, AA; Goepfert, H; Maor, M; Pajak, TF; Weber, R; Morrison, W; Glisson, B; Trotti, A; Ridge, JA; Chao, C; Peters, G; Lee, DJ; Leaf, A; Ensley, J; Cooper, J				Forastiere, AA; Goepfert, H; Maor, M; Pajak, TF; Weber, R; Morrison, W; Glisson, B; Trotti, A; Ridge, JA; Chao, C; Peters, G; Lee, DJ; Leaf, A; Ensley, J; Cooper, J			Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NECK-CANCER; HEAD	Background: Induction chemotherapy with cisplatin plus fluorouracil followed by radiotherapy is the standard alternative to total laryngectomy for patients with locally advanced laryngeal cancer. The value of adding chemotherapy to radiotherapy and the optimal timing of chemotherapy are unknown. Methods: We randomly assigned patients with locally advanced cancer of the larynx to one of three treatments: induction cisplatin plus fluorouracil followed by radiotherapy, radiotherapy with concurrent administration of cisplatin, or radiotherapy alone. The primary end point was preservation of the larynx. Results: A total of 547 patients were randomly assigned to one of the three study groups. The median follow-up period was 3.8 years. At two years, the proportion of patients who had an intact larynx after radiotherapy with concurrent cisplatin (88 percent) differed significantly from the proportions in the groups given induction chemotherapy followed by radiotherapy (75 percent, P=0.005) or radiotherapy alone (70 percent, P<0.001). The rate of locoregional control was also significantly better with radiotherapy and concurrent cisplatin (78 percent, vs. 61 percent with induction cisplatin plus fluorouracil followed by radiotherapy and 56 percent with radiotherapy alone). Both of the chemotherapy-based regimens suppressed distant metastases and resulted in better disease-free survival than radiotherapy alone. However, overall survival rates were similar in all three groups. The rate of high-grade toxic effects was greater with the chemotherapy-based regimens (81 percent with induction cisplatin plus fluorouracil followed by radiotherapy and 82 percent with radiotherapy with concurrent cisplatin, vs. 61 percent with radiotherapy alone). The mucosal toxicity of concurrent radiotherapy and cisplatin was nearly twice as frequent as the mucosal toxicity of the other two treatments during radiotherapy. Conclusions: In patients with laryngeal cancer, radiotherapy with concurrent administration of cisplatin is superior to induction chemotherapy followed by radiotherapy or radiotherapy alone for laryngeal preservation and locoregional control.	Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Radiat Therapy Oncol Grp Headquarters, Philadelphia, PA USA; Univ S Florida, H Lee Moffit Canc Ctr & Res Inst, Tampa, FL USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL USA; New York Harbor Healthcare Syst, Dept Vet Affairs, Brooklyn, NY USA; Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI USA; NYU, Med Ctr, Dept Radiat Oncol, New York, NY 10016 USA	Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; UTMD Anderson Cancer Center; Radiation Therapy Oncology Group (RTOG); State University System of Florida; University of South Florida; Fox Chase Cancer Center; University of Alabama System; University of Alabama Birmingham; Barbara Ann Karmanos Cancer Institute; Wayne State University; New York University	Forastiere, AA (corresponding author), Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, 1650 Orleans St,Suite G90, Baltimore, MD 21231 USA.	af@jhmi.edu			NCI NIH HHS [CA06294, CA21661, CA37422, CA32115, CA49957, CA-46282, CA-32102, CA-20319] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U10CA021661, U10CA032115, U10CA046282, U10CA049957, U10CA032102, U10CA037422, P01CA006294, U10CA020319] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRISTOL DR, 1989, CONTROL CLIN TRIALS, V10, P142, DOI 10.1016/0197-2456(89)90027-5; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; HONG WK, 1993, CANCER RES, V53, P5113; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; List MA, 1996, CANCER-AM CANCER SOC, V77, P2294, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2294::AID-CNCR17>3.0.CO;2-S; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Weymuller EA, 2001, ARCH OTOLARYNGOL, V127, P489; WOLF GT, 1991, NEW ENGL J MED, V324, P1685, DOI 10.1056/nejm199106133242402; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0	11	2123	2196	2	92	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2003	349	22					2091	2098		10.1056/NEJMoa031317	http://dx.doi.org/10.1056/NEJMoa031317			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746ZV	14645636	Bronze			2022-12-28	WOS:000186779700003
J	Zheng, NF; Bu, XH; Feng, PY				Zheng, NF; Bu, XH; Feng, PY			Synthetic design of crystalline inorganic chalcogenides exhibiting fast-ion conductivity	NATURE			English	Article							SULFIDE; SILICA; SIZE	Natural porous solids such as zeolites are invariably formed with inorganic cations such as Na+ and K+ (refs 1, 2). However, current research on new porous materials is mainly focused on the use of organic species as either structure-directing or structure-building units; purely inorganic systems have received relatively little attention in exploratory synthetic work(3-9). Here we report the synthesis of a series of three-dimensional sulphides and selenides containing highly mobile alkali metal cations as charge-balancing extra-framework cations. Such crystalline inorganic chalcogenides integrate zeolite-like architecture with high anionic framework polarizability and high concentrations of mobile cations. Such structural features are particularly desirable for the development of fast-ion conductors(10). These materials demonstrate high ionic conductivity (up to 1.8 x 10(-2) ohm(-1) cm(-1)) at room temperature and moderate to high humidity. This synthetic methodology, together with novel structural, physical and chemical properties, may lead to the development of new microporous and open-framework materials with potential applications in areas such as batteries, fuel cells, electrochemical sensors and photocatalysis.	Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; Univ Calif Santa Barbara, Dept Chem, Santa Barbara, CA 93106 USA	University of California System; University of California Riverside; University of California System; University of California Santa Barbara	Feng, PY (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.		Bu, Xianhui/L-9403-2013; Zheng, Nanfeng/G-4613-2010	Bu, Xianhui/0000-0002-2994-4051; Zheng, Nanfeng/0000-0001-9879-4790				BEDARD RL, 1989, ZEOLITES FACTS FIGUR, P375; Breck D.W., 1974, ZEOLITE MOL SIEVES; Bu XH, 2002, J AM CHEM SOC, V124, P12646, DOI 10.1021/ja021009z; Cahill CL, 2000, J CHEM SOC DALTON, P1475, DOI 10.1039/a909005c; Cheetham AK, 1999, ANGEW CHEM INT EDIT, V38, P3268, DOI 10.1002/(SICI)1521-3773(19991115)38:22<3268::AID-ANIE3268>3.0.CO;2-U; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; DHINGRA S, 1992, SCIENCE, V258, P1769, DOI 10.1126/science.258.5089.1769; Feng PY, 1997, NATURE, V388, P735, DOI 10.1038/41937; Flanigen E. M., 1991, INTRO ZEOLITE SCI PR, P13; HOPPE R, 1961, Z ANORG ALLG CHEM, V309, P49, DOI 10.1002/zaac.19613090105; HUO QS, 1995, SCIENCE, V268, P1324, DOI 10.1126/science.268.5215.1324; Johnson SA, 1999, SCIENCE, V283, P963, DOI 10.1126/science.283.5404.963; Li HL, 1999, SCIENCE, V283, P1145, DOI 10.1126/science.283.5405.1145; Scott RWJ, 1999, CURR OPIN SOLID ST M, V4, P113, DOI 10.1016/S1359-0286(99)00014-5; Wehmschulte RJ, 1997, J AM CHEM SOC, V119, P9566, DOI 10.1021/ja972111c; West A. R, 1992, SOLID STATE CHEM ITS; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548; Zheng NF, 2002, SCIENCE, V298, P2366, DOI 10.1126/science.1078663	18	347	357	14	506	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					428	432		10.1038/nature02159	http://dx.doi.org/10.1038/nature02159			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647378				2022-12-28	WOS:000186800800034
J	Geijsen, N; Horoschak, M; Kim, K; Gribnau, J; Eggan, K; Daley, GQ				Geijsen, N; Horoschak, M; Kim, K; Gribnau, J; Eggan, K; Daley, GQ			Derivation of embryonic germ cells and male gametes from embryonic stem cells	NATURE			English	Article							MALE-STERILITY GENE; RET FINGER PROTEIN; IN-VITRO; YOLK-SAC; MOUSE; EXPRESSION; DAZ; DIFFERENTIATION; SPERMATOGENESIS; PROLIFERATION	Egg and sperm cells ( gametes) of the mouse are derived from a founder population of primordial germ cells that are set aside early in embryogenesis. Primordial germ cells arise from the proximal epiblast, a region of the early mouse embryo that also contributes to the first blood lineages of the embryonic yolk sac(1). Embryonic stem cells differentiate in vitro into cystic structures called embryoid bodies consisting of tissue lineages typical of the early mouse embryo(2,3). Because embryoid bodies sustain blood development, we reasoned that they might also support primordial germ cell formation. Here we isolate primordial germ cells from embryoid bodies, and derive continuously growing lines of embryonic germ cells. Embryonic germ cells show erasure of the methylation markers ( imprints) of the Igf2r and H19 genes, a property characteristic of the germlineage. We show that embryoid bodies support maturation of the primordial germ cells into haploid male gametes, which when injected into oocytes restore the somatic diploid chromosome complement and develop into blastocysts. Our ability to derive germ cells from embryonic stem cells provides an accessible in vitro model system for studies of germline epigenetic modification and mammalian gametogenesis.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Ctr Regenerat Med & Technol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University	Daley, GQ (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	george.daley@childrens.harvard.edu	Eggan, Kevin/P-7119-2018					BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Cao TY, 1996, DEV GENET, V19, P309, DOI 10.1002/(SICI)1520-6408(1996)19:4<309::AID-DVG4>3.3.CO;2-1; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; FENDERSON BA, 1984, DEV BIOL, V103, P117, DOI 10.1016/0012-1606(84)90013-7; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; KOSHIMIZU U, 1995, DEV BIOL, V168, P683, DOI 10.1006/dbio.1995.1113; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lawson KA, 1994, CIBA F SYMP, V182, P84; Leahy A, 1999, J EXP ZOOL, V284, P67, DOI 10.1002/(SICI)1097-010X(19990615)284:1&lt;67::AID-JEZ10&gt;3.0.CO;2-O; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Moore FL, 2003, P NATL ACAD SCI USA, V100, P538, DOI 10.1073/pnas.0234478100; Ogawa S, 1998, BIOCHEM BIOPH RES CO, V251, P515, DOI 10.1006/bbrc.1998.9502; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Seboun E, 1997, GENOMICS, V41, P227, DOI 10.1006/geno.1997.4635; SELIG S, 1992, EMBO J, V11, P1217, DOI 10.1002/j.1460-2075.1992.tb05162.x; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; Tezel G, 2002, PATHOL INT, V52, P623, DOI 10.1046/j.1440-1827.2002.01401.x; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; WASSARMAN PM, 1992, BIOL REPROD, V46, P186, DOI 10.1095/biolreprod46.2.186; Zandstra PW, 2000, BIOTECHNOL BIOENG, V69, P607, DOI 10.1002/1097-0290(20000920)69:6<607::AID-BIT4>3.3.CO;2-6	31	615	703	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 8	2004	427	6970					148	154		10.1038/nature02247	http://dx.doi.org/10.1038/nature02247			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	760YY	14668819				2022-12-28	WOS:000187863900034
J	Newman, TB				Newman, TB			The power of stories over statistics	BRITISH MEDICAL JOURNAL			English	Article							FULL-TERM INFANTS; PRACTICE PARAMETER; NEONATAL JAUNDICE; HYPERBILIRUBINEMIA; KERNICTERUS; MANAGEMENT; GUIDELINES; AIRPLANES; NEWBORN		Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Newman, TB (corresponding author), Univ Calif San Francisco, UCSF Box 0560, San Francisco, CA 94143 USA.							APPLEBY J, 2000, US TODAY        0204, P1; BERGMAN DA, 1994, PEDIATRICS, V94, P558; Bishai D, 2003, ARCH PEDIAT ADOL MED, V157, P953, DOI 10.1001/archpedi.157.10.953; BROWN AK, 1996, YB NEONATAL PERINATA, pR17; Bull MJ, 2001, PEDIATRICS, V108, P1218; Carter K, 2001, JAMA-J AM MED ASSOC, V286, P299; Dawes RM, 1999, J ECON BEHAV ORGAN, V39, P29, DOI 10.1016/S0167-2681(99)00024-4; Ebbesen F, 2000, ACTA PAEDIATR, V89, P1213, DOI 10.1080/080352500750027592; Johnson L, 1998, CLIN PERINATOL, V25, P555, DOI 10.1016/S0095-5108(18)30097-6; Joint Commission on Accreditation of Healthcare Organizations, 2001, SENTINEL EVENT ALERT; NEWMAN TB, 1993, PEDIATRICS, V92, P651; NEWMAN TB, 1990, CLIN PERINATOL, V17, P331, DOI 10.1016/S0095-5108(18)30571-2; Newman TB, 2000, PEDIATRICS, V105, P242; Newman TB, 2003, ARCH PEDIAT ADOL MED, V157, P969, DOI 10.1001/archpedi.157.10.969; NEWMAN TB, 1992, PEDIATRICS, V89, P809; Seidman DS, 2001, ACTA PAEDIATR, V90, P292, DOI 10.1080/080352501300067613; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; WATCHKO JF, 1983, PEDIATRICS, V71, P660	18	47	47	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1424	1427		10.1136/bmj.327.7429.1424	http://dx.doi.org/10.1136/bmj.327.7429.1424			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684635	Green Published			2022-12-28	WOS:000187562700006
J	Olshansky, B; Dossey, L				Olshansky, B; Dossey, L			Retroactive prayer: a preposterous hypothesis?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTERCESSORY PRAYER; COMPLEMENTARY MEDICINE; BELL INEQUALITIES; OUTCOMES; THERAPY; SCIENCE; DISEASE; REMOTE		Univ Iowa Hosp, Iowa City, IA 52242 USA; Alternat Therapies Hlth & Med, Santa Fe, NM USA	University of Iowa	Olshansky, B (corresponding author), Univ Iowa Hosp, Iowa City, IA 52242 USA.	brian-olshansky@uiowa.edu	Olshansky, Brian/S-3671-2016	Olshansky, Brian/0000-0002-6044-045X; Dossey, Larry/0000-0002-8190-2625				Abbot NC, 2000, J ALTERN COMPLEM MED, V6, P159, DOI 10.1089/acm.2000.6.159; Anick D, 2000, ALTERN THER HEALTH M, V6, P23; ANICK D, 2000, ALTERN THER HEALTH M, V6, P119; ASPECT A, 1982, PHYS REV LETT, V49, P1804, DOI 10.1103/PhysRevLett.49.1804; Astin JA, 2000, ANN INTERN MED, V132, P903, DOI 10.7326/0003-4819-132-11-200006060-00009; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Benor DJ, 2002, SUBTLE ENERGIES ENER, V11, P249; Bierman DJ, 1997, PERCEPT MOTOR SKILL, V84, P689, DOI 10.2466/pms.1997.84.2.689; BIERMAN DJ, 1999, SCI CONSCIOUSNESS, P367; BOSLOUGH J, 1985, S HAWKING; BOSLOUGH J, 1990, NATL GEOGR, V177, P109; Braud W, 2000, ALTERN THER HEALTH M, V6, P37; BRAUD WG, 1989, J SCI EXPLORATION, V3, P43; BYRD RC, 1988, SOUTHERN MED J, V81, P826, DOI 10.1097/00007611-198807000-00005; Chibnall JT, 2001, ARCH INTERN MED, V161, P2529, DOI 10.1001/archinte.161.21.2529; DOSSEY L, 1989, RECOVERING SOUL, P123; Dossey L, 1999, REINVENTING MED, P37; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Freedman W, 2003, AM SCI, V91, P36, DOI 10.1511/2003.11.840; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; Green M.B., 1988, SUPERSTRING THEORY; GURALNIK DB, 1986, WEBSTERS NEW WORLD D, P302; Harris WS, 1999, ARCH INTERN MED, V159, P2273, DOI 10.1001/archinte.159.19.2273; Jonas WB, 2003, ALTERN THER HEALTH M, V9, P56; Krucoff MW, 2001, AM HEART J, V142, P760, DOI 10.1067/mhj.2001.119138; Leibovici L, 2000, BRIT MED J, V320, P1145; Leibovici L, 1999, BMJ-BRIT MED J, V319, P1629, DOI 10.1136/bmj.319.7225.1629; Leibovici L, 2001, BRIT MED J, V323, P1450, DOI 10.1136/bmj.323.7327.1450; Maddox J, 1999, SCI AM, V281, P62; MEAD M, 1994, SUN, V228, P40; MERMIN ND, 1990, PHYS REV LETT, V65, P1838, DOI 10.1103/PhysRevLett.65.1838; MINKEL JR, 2002, SCI AM; NADEAU R, 1999, NONLOCAL UNIVERSE, P67; PRIESTLEY JB, 1978, MAN TIME, P245; RADIN DI, 1989, FOUND PHYS, V19, P1499, DOI 10.1007/BF00732509; ROBERTS L, 2001, COCHRANE DATABASE SY; SAGAN C, 1995, DEMON HAUNTED WORD, P302; SCHLITZ W, 1997, ALTERNATIVE THER, V3, P62; SCHMIDT H, 1982, FOUND PHYS, V12, P565, DOI 10.1007/BF00731929; SCHMIDT H, 1993, J PARAPSYCHOL, V57, P331; SCHWARZ P, SPACE TIME STRING TH; SEARLE J, 1995, J CONSCIOUSNESS STUD, V2; Sicher F, 1998, WESTERN J MED, V169, P356; STAPP H, 2001, RES NEWS OPPORTUN SC, V1, P8; STAPP HP, 1988, WORLD VIEW CONT PHYS, P40; Targ R, 1977, MIND REACH SCI LOOK, P169; Tittel W, 1998, PHYS REV LETT, V81, P3563, DOI 10.1103/PhysRevLett.81.3563; TUCKER MC, 1994, ELLINGTON READER, P371; WEBER R, 1986, DIALOGUES SCI SAGES, P41; [No title captured]; 1995, FUNDAMENTAL WISDOM M, P50	51	9	9	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 20	2003	327	7429					1465	1468B		10.1136/bmj.327.7429.1465	http://dx.doi.org/10.1136/bmj.327.7429.1465			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684651	Green Published			2022-12-28	WOS:000187562700022
J	Asbury, CL; Fehr, AN; Block, SM				Asbury, CL; Fehr, AN; Block, SM			Kinesin moves by an asymmetric hand-over-hand mechanism	SCIENCE			English	Article							OPTICAL FORCE CLAMP; COILED-COIL; 8-NM STEP; MICROTUBULES; MOLECULES; MOVEMENT; ATP; HYDROLYZES; REGION	Kinesin is a double-headed motor protein that moves along microtubules in 8-nanometer steps. Two broad classes of model have been invoked to explain kinesin movement: hand-over-hand and inchworm. In hand-over-hand models, the heads exchange leading and trailing roles with every step, whereas no such exchange is postulated for inchworm models, where one head always leads. By measuring the stepwise motion of individual enzymes, we find that some kinesin molecules exhibit a marked alternation in the dwell times between sequential steps, causing these motors to "limp" along the microtubule. Limping implies that kinesin molecules strictly alternate between two different conformations as they step, indicative of an asymmetric, hand-over-hand mechanism.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University	Block, SM (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051453] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM051453] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERLINER E, 1995, NATURE, V373, P718, DOI 10.1038/373718a0; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Coy DL, 1999, J BIOL CHEM, V274, P3667, DOI 10.1074/jbc.274.6.3667; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; Howard J, 1996, ANNU REV PHYSIOL, V58, P703, DOI 10.1146/annurev.ph.58.030196.003415; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Kojima H, 1997, BIOPHYS J, V73, P2012, DOI 10.1016/S0006-3495(97)78231-6; Lang MJ, 2002, BIOPHYS J, V83, P491, DOI 10.1016/S0006-3495(02)75185-0; Li Y, 2003, NATURE, V424, P341, DOI 10.1038/nature01801; MANLY BFJ, 2001, RANDOMIZATION BOOTST, P34; MEYHOFER E, 1995, P NATL ACAD SCI USA, V92, P574, DOI 10.1073/pnas.92.2.574; Misura KMS, 2001, J BIOL CHEM, V276, P13273, DOI 10.1074/jbc.M009636200; RAY S, 1993, J CELL BIOL, V121, P1083, DOI 10.1083/jcb.121.5.1083; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; SONG YH, 1993, P NATL ACAD SCI USA, V90, P1671, DOI 10.1073/pnas.90.5.1671; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; SVOBODA K, 1995, BIOPHYS J, V68, pS69; Tripet B, 1997, J BIOL CHEM, V272, P8946; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; Visscher K, 1998, METHOD ENZYMOL, V298, P460, DOI 10.1016/S0076-6879(98)98040-5; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	28	419	435	5	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2130	2134		10.1126/science.1092985	http://dx.doi.org/10.1126/science.1092985			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14657506	Green Submitted, Green Accepted			2022-12-28	WOS:000187385200047
J	Brake, JM; Daschner, MK; Luk, YY; Abbott, NL				Brake, JM; Daschner, MK; Luk, YY; Abbott, NL			Biomolecular interactions at phospholipid-decorated surfaces of liquid crystals	SCIENCE			English	Article							PORCINE PANCREAS; KINETIC-ANALYSIS; MONOLAYERS; MEMBRANES; STREPTAVIDIN; RECOGNITION; INTERFACE; CATALYSIS; BILAYERS; ZYMOGEN	The spontaneous assembly of phospholipids at planar interfaces between thermotropic liquid crystals and aqueous phases gives rise to patterned orientations of the liquid crystals that reflect the spatial and temporal organization of the phospholipids. Strong and weak specific-binding events involving proteins at these interfaces drive the reorganization of the phospholipids and trigger orientational transitions in the liquid crystals. Because these interfaces are fluid, processes involving the lateral organization of proteins ( such as the formation of protein- and phospholipid-rich domains) are also readily imaged by the orientational response of the liquid crystal, as are stereospecific enzymatic events. These results provide principles for label-free monitoring of aqueous streams for molecular and biomolecular species without the need for complex instrumentation.	Univ Wisconsin, Dept Biol & Chem Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Abbott, NL (corresponding author), Univ Wisconsin, Dept Biol & Chem Engn, 1415 Engn Dr, Madison, WI 53706 USA.							BLANKENBURG R, 1989, BIOCHEMISTRY-US, V28, P8214, DOI 10.1021/bi00446a037; BONSEN PPM, 1972, BIOCHIM BIOPHYS ACTA, V270, P364, DOI 10.1016/0005-2760(72)90200-7; CHARYCH DH, 1993, SCIENCE, V261, P585, DOI 10.1126/science.8342021; DAHMENLEVISON U, 1998, THIN SOLID FILMS, V616, P327; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; DEHAAS GH, 1971, BIOCHIM BIOPHYS ACTA, V239, P252, DOI 10.1016/0005-2760(71)90171-8; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Gast AP, 1999, BIOMOL ENG, V16, P21, DOI 10.1016/S1050-3862(99)00045-5; GRAINGER DW, 1992, J CONTROL RELEASE, V19, P201, DOI 10.1016/0168-3659(92)90077-5; Grant LM, 2002, BIOPHYS J, V82, P1373, DOI 10.1016/S0006-3495(02)75492-1; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Gupta VK, 1998, SCIENCE, V279, P2077, DOI 10.1126/science.279.5359.2077; HILTROP K, 1981, BER BUNSEN PHYS CHEM, V85, P582, DOI 10.1002/bbpc.19810850712; Hubbard JB, 1998, BIOPHYS CHEM, V75, P163, DOI 10.1016/S0301-4622(98)00199-9; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1002, P127, DOI 10.1016/0005-2760(89)90281-6; KALB E, 1992, BIOCHIM BIOPHYS ACTA, V1103, P307, DOI 10.1016/0005-2736(92)90101-Q; Ransac S, 1997, METHOD ENZYMOL, V286, P263; Rao NM, 1997, BIOPHYS J, V73, P3066, DOI 10.1016/S0006-3495(97)78334-6; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43; Song XD, 1999, ANAL CHEM, V71, P2097, DOI 10.1021/ac981145f; Stahelin RV, 2001, BIOCHEM J, V359, P679, DOI 10.1042/0264-6021:3590679; Tanaka K, 2000, LANGMUIR, V16, P2665, DOI 10.1021/la9909244; Walker RA, 1997, LANGMUIR, V13, P3070, DOI 10.1021/la961007q; Yang TL, 2001, ANAL CHEM, V73, P165, DOI 10.1021/ac000997o; ZOGRAFI G, 1971, CHEM PHYS LIPIDS, V7, P185, DOI 10.1016/0009-3084(71)90001-6	25	522	541	11	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2094	2097		10.1126/science.1091749	http://dx.doi.org/10.1126/science.1091749			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684814				2022-12-28	WOS:000187385200035
J	Kethu, SR; Rich, HG				Kethu, SR; Rich, HG			Bleeding colonic diverticulum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brown Med Sch, Providence, RI 02912 USA	Brown University	Kethu, SR (corresponding author), Brown Med Sch, Providence, RI 02912 USA.								0	5	5	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					2423	2423		10.1056/NEJMicm030395	http://dx.doi.org/10.1056/NEJMicm030395			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681508				2022-12-28	WOS:000187326200008
J	Olsen, SJ; Chang, H; Cheung, TY; Tang, AF; Fisk, TL; Ooi, SP; Kuo, H; Jiang, DD; Chen, K; Lando, J; Hsu, K; Chen, T; Dowell, SF				Olsen, SJ; Chang, H; Cheung, TY; Tang, AF; Fisk, TL; Ooi, SP; Kuo, H; Jiang, DD; Chen, K; Lando, J; Hsu, K; Chen, T; Dowell, SF			Transmission of the severe acute respiratory syndrome on aircraft	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-FEATURES; SYNDROME SARS	BACKGROUND: The severe acute respiratory syndrome (SARS) spread rapidly around the world, largely because persons infected with the SARS-associated coronavirus (SARS-CoV) traveled on aircraft to distant cities. Although many infected persons traveled on commercial aircraft, the risk, if any, of in-flight transmission is unknown. METHODS: We attempted to interview passengers and crew members at least 10 days after they had taken one of three flights that transported a patient or patients with SARS. All index patients met the criteria of the World Health Organization for a probable case of SARS, and index or secondary cases were confirmed to be positive for SARS-CoV on reverse-transcriptase polymerase chain reaction or serologic testing. RESULTS: After one flight carrying a symptomatic person and 119 other persons, laboratory-confirmed SARS developed in 16 persons, 2 others were given diagnoses of probable SARS, and 4 were reported to have SARS but could not be interviewed. Among the 22 persons with illness, the mean time from the flight to the onset of symptoms was four days (range, two to eight), and there were no recognized exposures to patients with SARS before or after the flight. Illness in passengers was related to the physical proximity to the index patient, with illness reported in 8 of the 23 persons who were seated in the three rows in front of the index patient, as compared with 10 of the 88 persons who were seated elsewhere (relative risk, 3.1; 95 percent confidence interval, 1.4 to 6.9). In contrast, another flight carrying four symptomatic persons resulted in transmission to at most one other person, and no illness was documented in passengers on the flight that carried a person who had presymptomatic SARS. CONCLUSIONS: Transmission of SARS may occur on an aircraft when infected persons fly during the symptomatic phase of illness. Measures to reduce the risk of transmission are warranted.	Ctr Dis Control & Prevent, Int Emerging Infect Program, Nonthaburi, Thailand; Taiwan Ctr Dis Control, Dept Hlth, Taipei, Taiwan; Dept Hlth, Hong Kong, Hong Kong, Peoples R China; Emory Univ, Sch Med, Atlanta, GA USA; Minist Hlth, Epidemiol & Dis Control Div, Singapore, Singapore; Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA	Emory University; Ministry of Health-Singapore; Centers for Disease Control & Prevention - USA	Olsen, SJ (corresponding author), Ctr Dis Control & Prevent, Int Emerging Infect Program, Box 68,Amer Embassy, APO, AP 96546 USA.							[Anonymous], 2003, WKLY EPIDEMIOL REC, V78, P97; [Anonymous], 1995, MMWR-MORBID MORTAL W, V44, P137; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Booth CM, 2003, JAMA-J AM MED ASSOC, V290, P334; *CDCP, 2003, INT GUID CLEAN COMM; *CDCP, 2003, INT GUID SEV AC RESP; Demers RR, 2001, CHEST, V120, P1377, DOI 10.1378/chest.120.4.1377; GARNER JS, 1997, GUIDELINE ISOLATION; Hsu LY, 2003, EMERG INFECT DIS, V9, P713; *IATA, 2003, DID YOU KNOW FACTS I; KAHN J, 2003, INT HERALD TRIBUNE T, V1, P4; Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501; LAKSHMANAN IAR, 2003, BOSTON GLOBE    0518; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Musher DM, 2003, NEW ENGL J MED, V348, P1256, DOI 10.1056/NEJMra021771; Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6; Wenzel RP, 1996, NEW ENGL J MED, V334, P981, DOI 10.1056/NEJM199604113341509; *WHO, 2003, UPD 59 REP GUANGX CH; *WHO, 2003, UPD 62 MOR 8000 CAS; World Health Organization, 2003, CAS DEF SURV SEV AC; World Health Organization, 2003, UPD 11 WHO REC NEW M; World Health Organization (WHO), 2003, SUMM PROB SARS CAS O; 2003, MMWR MORB MORTAL WKL, V52, P248; 2003, MMWR MORB MORTAL WKL, V52, P284; 2003, MMWR MORB MORTAL WKL, V52, P241; 1995, MMWR MORB MORTAL WKL, V44, P175; 2003, MMWR MORB MORTAL WKL, V52, P405	28	402	421	0	33	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					2416	2422		10.1056/NEJMoa031349	http://dx.doi.org/10.1056/NEJMoa031349			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681507	Bronze			2022-12-28	WOS:000187326200007
J	Hagen, T; Taylor, CT; Lam, F; Moncada, S				Hagen, T; Taylor, CT; Lam, F; Moncada, S			Redistribution of intracellular oxygen in hypoxia by nitric oxide: Effect on HIF1 alpha	SCIENCE			English	Article							INDUCIBLE FACTOR 1-ALPHA; COMPLEX-III; HEART-MITOCHONDRIA; ALPHA-SUBUNIT; HIF; TRANSCRIPTION; EXPRESSION; FACTOR-1-ALPHA; STABILIZATION; ACTIVATION	Cells exposed to low oxygen concentrations respond by initiating defense mechanisms, including the stabilization of hypoxia-inducible factor (HIF) 1alpha, a transcription factor that upregulates genes such as those involved in glycolysis and angiogenesis. Nitric oxide and other inhibitors of mitochondrial respiration prevent the stabilization of HIF1alpha during hypoxia. In studies of cultured cells, we show that this effect is a result of an increase in prolyl hydroxylase dependent degradation of HIF1alpha. With the use of Renilla luciferase to detect intracellular oxygen concentrations, we also demonstrate that, upon inhibition of mitochondrial respiration in hypoxia, oxygen is redistributed toward non-respiratory oxygen-dependent targets such as prolyl hydroxylases so that they do not register hypoxia. Thus, the signaling consequences of hypoxia may be profoundly modified by nitric oxide.	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; Natl Univ Ireland Univ Coll Dublin, Conway Inst Biomed & Biochem Res, Dublin 4, Ireland	University of London; University College London; University College Dublin	Moncada, S (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	s.moncada@ucl.ac.uk		Taylor, Cormac/0000-0002-0946-1247				Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; FANDREY J, 1994, BIOCHEM J, V303, P507, DOI 10.1042/bj3030507; Gnaiger E, 2002, BIOCHEM SOC T, V30, P252, DOI 10.1042/bst0300252; HAGEN T, UNPUB; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Mateo J, 2003, BIOCHEM J, V376, P537, DOI 10.1042/BJ20031155; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; Poderoso JJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P85, DOI 10.1006/abbi.1996.0146; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Safran M, 2003, J CLIN INVEST, V111, P779, DOI 10.1172/JCI200318181; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Semenza GL, 2000, BIOCHEM PHARMACOL, V59, P47, DOI 10.1016/S0006-2952(99)00292-0; Trimmer BA, 2001, SCIENCE, V292, P2486, DOI 10.1126/science.1059833; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Waypa GB, 2002, CIRC RES, V91, P719, DOI 10.1161/01.RES.0000036751.04896.F1; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Yang ZZ, 2003, AM J PHYSIOL-RENAL, V284, pF1207, DOI 10.1152/ajprenal.00017.2002	24	600	623	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1975	1978		10.1126/science.1088805	http://dx.doi.org/10.1126/science.1088805			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671307				2022-12-28	WOS:000187174000064
J	Silver, RA; Lubke, J; Sakmann, B; Feldmeyer, D				Silver, RA; Lubke, J; Sakmann, B; Feldmeyer, D			High-probability uniquantal transmission at excitatory synapses in barrel cortex	SCIENCE			English	Article							PYRAMIDAL CELLS; SYNAPTIC CONNECTIONS; NEURONS; RELEASE; SINGLE; INFORMATION; LAYER-4; HIPPOCAMPUS; POTENTIALS; PLASTICITY	The number of vesicles released at excitatory synapses and the number of release sites per synaptic connection are key determinants of information processing in the cortex, yet they remain uncertain. Here we show that the number of functional release sites and the number of anatomically identified synaptic contacts are equal at connections between spiny stellate and pyramidal cells in rat barrel cortex. Moreover, our results indicate that the amount of transmitter released per synaptic contact is independent of release probability and the intrinsic release probability is high. These properties suggest that connections between layer 4 and layer 2/3 are tuned for reliable transmission of spatially distributed, timing-based signals.	UCL, Dept Physiol, London WC1E 6BT, England; Forschungszentrum Julich, Inst Med, D-52425 Julich, Germany; Max Planck Inst Med Res, Zellphysiol Abt, D-69120 Heidelberg, Germany	University of London; University College London; Helmholtz Association; Research Center Julich; Max Planck Society	Silver, RA (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	a.silver@ucl.ac.uk	Feldmeyer, Dirk/H-5940-2013; Lubke, Joachim/H-8762-2013	Feldmeyer, Dirk/0000-0002-1716-8972; Lubke, Joachim/0000-0002-4086-3199; Silver, Robin/0000-0002-5480-6638				Bekkers JM, 1999, J PHYSIOL-LONDON, V516, P227, DOI 10.1111/j.1469-7793.1999.227aa.x; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; CastroAlamancos MA, 1997, P NATL ACAD SCI USA, V94, P4161, DOI 10.1073/pnas.94.8.4161; Clements JD, 2000, TRENDS NEUROSCI, V23, P105, DOI 10.1016/S0166-2236(99)01520-9; Diamond JS, 1997, J NEUROSCI, V17, P4672; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Foster KA, 2002, NEURON, V36, P1115, DOI 10.1016/S0896-6273(02)01106-6; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; JACK JJB, 1981, J PHYSIOL-LONDON, V321, P65, DOI 10.1113/jphysiol.1981.sp013972; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Katz B., 1969, RELEASE NEURAL TRANS; KORN H, 1981, SCIENCE, V213, P898, DOI 10.1126/science.6266015; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; London M, 2002, NAT NEUROSCI, V5, P332, DOI 10.1038/nn826; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Reid CA, 1999, J PHYSIOL-LONDON, V518, P121, DOI 10.1111/j.1469-7793.1999.0121r.x; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; SILVER RA, 1998, CENTRAL SYNAPSES QUA, P130; VEREJONE.D, 1966, AUST J STAT, V8, P53, DOI 10.1111/j.1467-842X.1966.tb00164.x; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219	26	164	166	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1981	1984		10.1126/science.1087160	http://dx.doi.org/10.1126/science.1087160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671309				2022-12-28	WOS:000187174000066
J	Kehlet, H; Dahl, JB				Kehlet, H; Dahl, JB			Anaesthesia, surgery, and challenges in postoperative recovery	LANCET			English	Review							INGUINAL-HERNIA REPAIRS; EPIDURAL-ANESTHESIA; NITROUS-OXIDE; PAIN RELIEF; PATIENT SATISFACTION; MORPHINE CONSUMPTION; GENERAL-ANESTHESIA; SYSTEMATIC REVIEWS; SPINAL-ANESTHESIA; COLONIC RESECTION	Surgical injury can be followed by pain, nausea, vomiting and ileus, stress-induced catabolism, impaired pulmonary function, increased cardiac demands, and risk of thromboembolism. These problems can lead to complications, need for treatment in hospital, postoperative fatigue, and delayed convalescence. Development of safe and short-acting anaesthetics, improved pain relief by early intervention with multimodal analgesia, and stress reduction by regional anaesthetic techniques, beta-blockade, or glucocorticoids have provided important possibilities for enhanced recovery. When these techniques are combined with a change in perioperative care a pronounced enhancement of recovery and decrease in hospital stay can be achieved, even in major operations. The anaesthetist has an important role in facilitating early postoperative recovery by provision of minimally-invasive anaesthesia and pain relief, and by collaborating with surgeons, surgical nurses, and physiotherapists to reduce risk and pain.	Glostrup Univ Hosp, Dept Anaesthesia, DK-2600 Glostrup, Denmark; Hvidovre Univ Hosp, Dept Surg Gastroenterol, DK-2650 Hvidovre, Denmark	University of Copenhagen; University of Copenhagen	Kehlet, H (corresponding author), Hvidovre Univ Hosp, Dept Surg Gastroenterol, DK-2650 Hvidovre, Denmark.	henrik.kehlet@hh.hosp.dk						Apfelbaum JL, 2002, ANESTHESIOLOGY, V97, P66, DOI 10.1097/00000542-200207000-00010; Armand S, 1998, BRIT J ANAESTH, V81, P126, DOI 10.1093/bja/81.2.126; Auerbach AD, 2002, JAMA-J AM MED ASSOC, V287, P1435, DOI 10.1001/jama.287.11.1435; Austrup ML, 1999, SURG CLIN N AM, V79, P253, DOI 10.1016/S0039-6109(05)70382-0; Barden Jodie, 2002, BMC Anesthesiol, V2, P4, DOI 10.1186/1471-2253-2-4; Bardram L, 2000, BRIT J SURG, V87, P1540, DOI 10.1046/j.1365-2168.2000.01559.x; Barton SF, 2002, ANESTHESIOLOGY, V97, P306, DOI 10.1097/00000542-200208000-00004; Basse L, 2000, ANN SURG, V232, P51, DOI 10.1097/00000658-200007000-00008; Basse L, 2002, DIS COLON RECTUM, V45, P1661, DOI 10.1007/s10350-004-7255-0; Basse L, 2002, BRIT J SURG, V89, P446, DOI 10.1046/j.0007-1323.2001.02044.x; Bisgaard T, 2002, SURGERY, V132, P817, DOI 10.1067/msy.2002.127682; Bisgaard T, 1999, J CLIN MONIT COMPUT, V15, P1, DOI 10.1023/A:1009930026753; Bisgaard T, 2001, ARCH SURG-CHICAGO, V136, P917, DOI 10.1001/archsurg.136.8.917; Blanshard HJ, 2001, ANESTH ANALG, V92, P89; Bundred N, 1998, BRIT MED J, V317, P1275, DOI 10.1136/bmj.317.7168.1275; Callesen T, 2001, ANESTH ANALG, V93, P1373, DOI 10.1097/00000539-200112000-00004; Carli F, 2002, ANESTHESIOLOGY, V97, P540, DOI 10.1097/00000542-200209000-00005; Carr DB, 1999, LANCET, V353, P2051, DOI 10.1016/S0140-6736(99)03313-9; Carroll D, 1996, BRIT J ANAESTH, V77, P798, DOI 10.1093/bja/77.6.798; COLLINS SL, 2002, COCHRANE LIB; Coveney E, 1998, ANN SURG, V227, P496, DOI 10.1097/00000658-199804000-00008; Dahl JB, 1999, ANESTHESIOLOGY, V91, P1919, DOI 10.1097/00000542-199912000-00045; Dahl JB, 2002, ACTA ANAESTH SCAND, V46, P121, DOI 10.1034/j.1399-6576.2002.460201.x; Delaney CP, 2001, BRIT J SURG, V88, P1533, DOI 10.1046/j.0007-1323.2001.01905.x; DEXTER F, 1995, ANESTHESIOLOGY, V83, P77; Dirks J, 2002, ANESTHESIOLOGY, V97, P560, DOI 10.1097/00000542-200209000-00007; Divatia JV, 1996, ANESTHESIOLOGY, V85, P1055, DOI 10.1097/00000542-199611000-00014; Dolin SJ, 2002, BRIT J ANAESTH, V89, P409, DOI 10.1093/bja/aef207; Dooley WC, 2002, AM J SURG, V184, P545, DOI 10.1016/S0002-9610(02)01051-6; ESERHART LHJ, 2000, ACTA ANAESTH SCAND, V44, P1252; Fassoulaki A, 2002, ANESTH ANALG, V95, P985, DOI 10.1097/00000539-200210000-00036; Garcia-Miguel FJ, 2003, LANCET, V362, P1749, DOI 10.1016/S0140-6736(03)14857-X; Grantcharov TP, 2001, EUR J SURG, V167, P260; Greif R, 2000, NEW ENGL J MED, V342, P161, DOI 10.1056/NEJM200001203420303; Gupta A, 2001, BRIT J SURG, V88, P1296, DOI 10.1046/j.0007-1323.2001.01860.x; Hall GM, 2002, ANESTH ANALG, V95, P1446, DOI 10.1097/00000539-200211000-00064; Hart DW, 2002, ANN SURG, V236, P450, DOI 10.1097/00000658-200210000-00007; Hartung J, 1996, ANESTH ANALG, V83, P114, DOI 10.1097/00000539-199607000-00020; Hogue SL, 2000, ANESTH ANALG, V91, P97, DOI 10.1097/00000539-200007000-00019; Holte K, 2002, BRIT J ANAESTH, V89, P622, DOI 10.1093/bja/aef220; Holte K, 2002, DRUGS, V62, P2603, DOI 10.2165/00003495-200262180-00004; Holte K, 2002, J AM COLL SURGEONS, V195, P694, DOI 10.1016/S1072-7515(02)01491-6; Holte K, 2002, ACTA ANAESTH SCAND, V46, P1089, DOI 10.1034/j.1399-6576.2002.460906.x; Hyllested M, 2002, BRIT J ANAESTH, V88, P199, DOI 10.1093/bja/88.2.199; Ilfeld BM, 2002, ANESTHESIOLOGY, V96, P1297, DOI 10.1097/00000542-200206000-00006; Jin FL, 2001, J CLIN ANESTH, V13, P524, DOI 10.1016/S0952-8180(01)00320-8; JORGENSEN H, 2001, COCHRANE LIB; Kalso E, 2002, PAIN, V98, P269, DOI 10.1016/S0304-3959(02)00019-2; Kark AE, 1998, J AM COLL SURGEONS, V186, P447, DOI 10.1016/S1072-7515(98)00057-X; Kehlet H, 1999, WORLD J SURG, V23, P801, DOI 10.1007/s002689900583; Kehlet H, 2002, AM J SURG, V183, P630, DOI 10.1016/S0002-9610(02)00866-8; Kehlet H, 2001, BRIT J ANAESTH, V87, P62, DOI 10.1093/bja/87.1.62; Kehlet H, 1999, DRUGS, V58, P793, DOI 10.2165/00003495-199958050-00002; KEHLET H, 1998, NEURAL BLOCKADE CLIN, P129; KEHLET H, 2002, AM COLL SURG ACS PRI, V4, P1; KEHLET H, IN PRESS FECAL URINA; Keulemans Y, 1998, ANN SURG, V228, P734, DOI 10.1097/00000658-199812000-00003; Kimmins MH, 2001, DIS COLON RECTUM, V44, P565, DOI 10.1007/BF02234330; Kirsh EJ, 2000, UROLOGY, V56, P101, DOI 10.1016/S0090-4295(00)00594-X; Knight MK, 2002, J UROLOGY, V167, P2368, DOI 10.1016/S0022-5347(05)64986-5; Kremer C, 2000, BRIT MED J, V320, P279, DOI 10.1136/bmj.320.7230.279; Kuo PC, 2000, ANN SURG, V231, P772, DOI 10.1097/00000658-200005000-00018; Lau H, 2001, ARCH SURG-CHICAGO, V136, P1150, DOI 10.1001/archsurg.136.10.1150; Lauretti GR, 1998, ANESTHESIOLOGY, V89, P913, DOI 10.1097/00000542-199810000-00016; Lewis SJ, 2001, BRIT MED J, V323, P773, DOI 10.1136/bmj.323.7316.773; Ljungqvist O, 2000, SURGERY, V128, P757, DOI 10.1067/msy.2000.107166; Lobo DN, 2002, LANCET, V359, P1812, DOI 10.1016/S0140-6736(02)08711-1; Macario A, 1999, ANESTH ANALG, V89, P652, DOI 10.1097/00000539-199909000-00022; MAJEED AW, 1995, BRIT MED J, V311, P296, DOI 10.1136/bmj.311.7000.296; McCrory CR, 2002, ANESTH ANALG, V95, P169, DOI 10.1097/00000539-200207000-00030; Miller Ronald D, 2002, Best Pract Res Clin Anaesthesiol, V16, P353, DOI 10.1053/bean.2002.0247; Moiniche S, 2000, ANESTH ANALG, V90, P899; Moiniche S, 2003, ANESTH ANALG, V96, P68, DOI 10.1213/01.ANE.0000040583.65135.57; Moiniche S, 2002, ANESTHESIOLOGY, V96, P725, DOI 10.1097/00000542-200203000-00032; Moiniche S, 1998, BRIT J ANAESTH, V81, P377, DOI 10.1093/bja/81.3.377; Moller C, 2001, EUR J OBSTET GYN R B, V98, P18, DOI 10.1016/S0301-2115(01)00342-6; Myles PS, 1999, ANESTH ANALG, V88, P83, DOI 10.1097/00000539-199901000-00016; Norris EJ, 2001, ANESTHESIOLOGY, V95, P1054, DOI 10.1097/00000542-200111000-00006; Noveck RJ, 2001, CLIN DRUG INVEST, V21, P465, DOI 10.2165/00044011-200121070-00002; Park WY, 2001, ANN SURG, V234, P560; Perkins FM, 2000, ANESTHESIOLOGY, V93, P1123, DOI 10.1097/00000542-200010000-00038; Podore PC, 1999, J VASC SURG, V29, P787, DOI 10.1016/S0741-5214(99)70204-1; Power I, 1999, SURG CLIN N AM, V79, P275, DOI 10.1016/S0039-6109(05)70383-2; Rawal N, 2002, ANESTHESIOLOGY, V96, P1290, DOI 10.1097/00000542-200206000-00005; Rigg JRA, 2002, LANCET, V359, P1276, DOI 10.1016/S0140-6736(02)08266-1; Robinson BJ, 1999, ACTA ANAESTH SCAND, V43, P185, DOI 10.1034/j.1399-6576.1999.430211.x; Rodgers A, 2000, BMJ-BRIT MED J, V321, P1493, DOI 10.1136/bmj.321.7275.1493; Romsing J, 2002, BRIT J ANAESTH, V88, P215, DOI 10.1093/bja/88.2.215; Rowlingson JC, 2001, ANESTH ANALG, V92, P3; Rubin GJ, 2002, BRIT J SURG, V89, P971, DOI 10.1046/j.1365-2168.2002.02138.x; Rygnestad T, 1997, ACTA ANAESTH SCAND, V41, P868, DOI 10.1111/j.1399-6576.1997.tb04802.x; Schmid RL, 1999, PAIN, V82, P111, DOI 10.1016/S0304-3959(99)00044-5; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; Seale AK, 1999, ARCH SURG-CHICAGO, V134, P308, DOI 10.1001/archsurg.134.3.308; Senagore AJ, 2001, SURGERY, V129, P672, DOI 10.1067/msy.2001.114648; Sessler DI, 1997, NEW ENGL J MED, V336, P1730, DOI 10.1056/NEJM199706123362407; Sneyd JR, 1998, EUR J ANAESTH, V15, P433, DOI 10.1097/00003643-199807000-00009; Stoltz RR, 2002, AM J GASTROENTEROL, V97, P65; SUMMITT RL, 1992, OBSTET GYNECOL, V80, P895; Taguchi A, 2001, NEW ENGL J MED, V345, P935, DOI 10.1056/NEJMoa010564; Tovar EA, 2001, EUR J CARDIO-THORAC, V20, P449, DOI 10.1016/S1010-7940(01)00835-1; Tramer M, 1997, BRIT J ANAESTH, V78, P247, DOI 10.1093/bja/78.3.247; Tramer M, 1996, BRIT J ANAESTH, V76, P186, DOI 10.1093/bja/76.2.186; Tramer MR, 2001, ACTA ANAESTH SCAND, V45, P4, DOI 10.1034/j.1399-6576.2001.450102.x; Tramer MR, 2001, ACTA ANAESTH SCAND, V45, P14, DOI 10.1034/j.1399-6576.2001.450103.x; Udelsman R, 2000, ANN SURG, V232, P331, DOI 10.1097/00000658-200009000-00005; Voitk AJ, 1997, CAN J SURG, V40, P284; Walder B, 2001, ACTA ANAESTH SCAND, V45, P795, DOI 10.1034/j.1399-6576.2001.045007795.x; Walker SM, 2002, ANESTH ANALG, V95, P674, DOI 10.1213/01.ANE.0000023209.14008.5B; Warren JL, 1998, J NATL CANCER I, V90, P833, DOI 10.1093/jnci/90.11.833; Weinbroum AA, 2002, CANCER-AM CANCER SOC, V95, P1164, DOI 10.1002/cncr.10784; Werner MU, 2002, ANESTH ANALG, V95, P1361, DOI 10.1097/00000539-200211000-00049; Wheatley RG, 2001, BRIT J ANAESTH, V87, P47, DOI 10.1093/bja/87.1.47; Wilmore DW, 2002, ANN SURG, V236, P643, DOI 10.1097/00000658-200211000-00015; Woolf CJ, 2001, ANESTHESIOLOGY, V95, P241, DOI 10.1097/00000542-200107000-00034; Wray CJ, 2002, NUTRITION, V18, P971, DOI 10.1016/S0899-9007(02)00985-1; Wu CL, 2002, ANESTHESIOLOGY, V96, P994, DOI 10.1097/00000542-200204000-00030	117	884	942	7	94	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2003	362	9399					1921	1928		10.1016/S0140-6736(03)14966-5	http://dx.doi.org/10.1016/S0140-6736(03)14966-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667752				2022-12-28	WOS:000187011600026
J	Smidt, N; Green, S				Smidt, N; Green, S			Is the diagnosis important for the treatment of patients with shoulder complaints?	LANCET			English	Editorial Material							CORTICOSTEROID INJECTION; GENERAL-PRACTICE; PRIMARY-CARE; PHYSIOTHERAPY; DISORDERS; TRIAL; PAIN		VU Med Ctr, Inst Res Extramural Med, NL-1081 BT Amsterdam, Netherlands; Monash Med Ctr, Australian Cochrane Ctr, Monash Inst Hlth Serv Res, Clayton, Vic 3168, Australia	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Monash University	Smidt, N (corresponding author), VU Med Ctr, Inst Res Extramural Med, NL-1081 BT Amsterdam, Netherlands.			Green, Sally Elizabeth/0000-0002-9564-9050				Buchbinder R, 2003, COCHRANE LIB; CHAKRAVARTY KK, 1990, BRIT MED J, V300, P848, DOI 10.1136/bmj.300.6728.848-a; CHARD MD, 1991, ARTHRITIS RHEUM-US, V34, P766, DOI 10.1002/art.1780340619; CROFT P, 1993, EPIDEMIOLOGY RHEUMAT, P375; CYRIAX J, 1981, TXB ORTHOPAEDIC MED, P193; de Winter AF, 1999, ANN RHEUM DIS, V58, P272, DOI 10.1136/ard.58.5.272; GREEN S, 2003, COCHRANE LIB; Hay EM, 2003, ANN RHEUM DIS, V62, P394, DOI 10.1136/ard.62.5.394; Knottnerus JA, 2002, EVIDENCE BASE CLIN D; LIESDEK C, 1997, PHYSIOTHERAPY, V83, P12; van der Windt DAWM, 2003, ANN RHEUM DIS, V62, P385, DOI 10.1136/ard.62.5.385; van der Windt DAWM, 1998, BRIT MED J, V317, P1292, DOI 10.1136/bmj.317.7168.1292; VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959; Winters JC, 1997, BRIT MED J, V314, P1320, DOI 10.1136/bmj.314.7090.1320	14	11	11	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1867	1868		10.1016/S0140-6736(03)14997-5	http://dx.doi.org/10.1016/S0140-6736(03)14997-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667738				2022-12-28	WOS:000187011600003
J	Tintillier, M; Coche, E; Malaise, J; Goffin, E				Tintillier, M; Coche, E; Malaise, J; Goffin, E			Peritoneal dialysis and an inguinal hernia	LANCET			English	Editorial Material									Clin Univ St Luc, Dept Nephrol, B-1200 Brussels, Belgium; Clin Univ St Luc, Dept Radiol, B-1200 Brussels, Belgium; Clin Univ St Luc, Dept Surg, B-1200 Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Tintillier, M (corresponding author), Clin Univ St Luc, Dept Nephrol, B-1200 Brussels, Belgium.								0	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1893	1893		10.1016/S0140-6736(03)14960-4	http://dx.doi.org/10.1016/S0140-6736(03)14960-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667746				2022-12-28	WOS:000187011600010
J	Naeyaert, JM; Brochez, L				Naeyaert, JM; Brochez, L			Dysplastic nevi	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; ATYPICAL-MOLE SYNDROME; BENIGN MELANOCYTIC NEVI; PIGMENTED SKIN-LESIONS; RISK FACTOR; HISTOLOGIC ASSOCIATION; FAMILIAL MELANOMA; SELF-EXAMINATION; OCULAR MELANOMA; PRONE FAMILIES		State Univ Ghent Hosp, Dept Dermatol, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital	Naeyaert, JM (corresponding author), State Univ Ghent Hosp, Dept Dermatol, De Pintelaan 185, B-9000 Ghent, Belgium.							Argenziano G, 1998, ARCH DERMATOL, V134, P1563, DOI 10.1001/archderm.134.12.1563; AUGUSTSSON A, 1991, ACTA DERM-VENEREOL, V71, P518; Autier P, 2000, ARCH DERMATOL, V136, P423, DOI 10.1001/archderm.136.3.423; Autier P, 1998, JNCI-J NATL CANCER I, V90, P1873, DOI 10.1093/jnci/90.24.1873; BATAILLE V, 1995, INT J CANCER, V60, P622, DOI 10.1002/ijc.2910600509; Bataille V, 1998, BRIT J CANCER, V77, P505, DOI 10.1038/bjc.1998.81; Bergman W, 1997, Ned Tijdschr Geneeskd, V141, P2010; Berwick M, 1996, J NATL CANCER I, V88, P17, DOI 10.1093/jnci/88.1.17; Bishop JAN, 2000, J INVEST DERMATOL, V114, P28, DOI 10.1046/j.1523-1747.2000.00823.x; Bishop JAN, 2000, BRIT J DERMATOL, V142, P331; Brochez L, 2002, J PATHOL, V196, P459, DOI 10.1002/path.1061; Burden AD, 1999, ARCH DERMATOL, V135, P261, DOI 10.1001/archderm.135.3.261; CAREY WP, 1994, CANCER, V74, P3118, DOI 10.1002/1097-0142(19941215)74:12<3118::AID-CNCR2820741210>3.0.CO;2-7; Carli P, 2003, ARCH DERMATOL, V139, P607, DOI 10.1001/archderm.139.5.607; CLARK WH, 1978, ARCH DERMATOL, V114, P732, DOI 10.1001/archderm.114.5.732; CLARK WH, 1984, HUM PATHOL, V15, P1147, DOI 10.1016/S0046-8177(84)80310-X; CLEMENTE C, 1991, HUM PATHOL, V22, P313, DOI 10.1016/0046-8177(91)90078-4; CRIJNS MB, 1991, ARCH DERMATOL, V127, P1346, DOI 10.1001/archderm.127.9.1346; CRIJNS MB, 1992, ARCH DERMATOL, V128, P513; Dal Pozzo V, 1999, EUR J DERMATOL, V9, P303; DEWIT PEJ, 1993, EUR J CANCER, V29A, P831, DOI 10.1016/S0959-8049(05)80419-8; DUNCAN LM, 1993, J INVEST DERMATOL, V100, pS318, DOI 10.1111/1523-1747.ep12470215; DURAY PH, 1992, J AM ACAD DERMATOL, V27, P741, DOI 10.1016/0190-9622(92)70248-E; ELDER DE, 1980, CANCER, V46, P1787, DOI 10.1002/1097-0142(19801015)46:8<1787::AID-CNCR2820460816>3.0.CO;2-S; Gallagher RDP, 2000, JAMA-J AM MED ASSOC, V283, P2955, DOI 10.1001/jama.283.22.2955; GARBE C, 1994, J INVEST DERMATOL, V102, P695, DOI 10.1111/1523-1747.ep12374280; GROB JJ, 1990, CANCER, V66, P387, DOI 10.1002/1097-0142(19900715)66:2<387::AID-CNCR2820660232>3.0.CO;2-J; GROB JJ, 1988, BRIT J DERMATOL, V118, P745, DOI 10.1111/j.1365-2133.1988.tb02591.x; HALL WH, 1992, JAMA-J AM MED ASSOC, V268, P1314, DOI 10.1001/jama.1992.03490100112037; HALPERN AC, 1993, J INVEST DERMATOL, V100, pS346, DOI 10.1038/jid.1993.61; HALPERN AC, 1993, J AM ACAD DERMATOL, V29, P51, DOI 10.1016/0190-9622(93)70151-I; HALPERN AC, 1991, ARCH DERMATOL, V127, P995, DOI 10.1001/archderm.127.7.995; HOLLY EA, 1987, J AM ACAD DERMATOL, V17, P459, DOI 10.1016/S0190-9622(87)70230-8; KANG SW, 1994, ARCH DERMATOL, V130, P999, DOI 10.1001/archderm.130.8.999; Kefford RF, 1999, J CLIN ONCOL, V17, P3245, DOI 10.1200/JCO.1999.17.10.3245; KLEIN LJ, 1990, J AM ACAD DERMATOL, V22, P275, DOI 10.1016/0190-9622(90)70037-I; KOPF AW, 1990, J AM ACAD DERMATOL, V22, P117, DOI 10.1016/S0190-9622(08)80006-0; MACKIE RM, 1993, LANCET, V341, P1618, DOI 10.1016/0140-6736(93)90758-9; MARGHOOB AA, 1994, ARCH DERMATOL, V130, P993, DOI 10.1001/archderm.130.8.993; MASRI GD, 1990, J AM ACAD DERMATOL, V22, P1042, DOI 10.1016/0190-9622(90)70149-C; Menzies SW, 1996, ARCH DERMATOL, V132, P1178, DOI 10.1001/archderm.132.10.1178; Pehamberger H, 1993, J INVEST DERMATOL, V100, P356; PIEPKORN M, 1989, J AM ACAD DERMATOL, V20, P407, DOI 10.1016/S0190-9622(89)70050-5; PIEPKORN MW, 1994, J AM ACAD DERMATOL, V30, P707, DOI 10.1016/S0190-9622(08)81499-5; RHODES AR, 1983, J AM ACAD DERMATOL, V9, P563, DOI 10.1016/S0190-9622(83)70171-4; Rhodes AR, 1998, J AM ACAD DERMATOL, V39, P262, DOI 10.1016/S0190-9622(98)70086-6; RICHARD MA, 1993, ARCH DERMATOL, V129, P1280, DOI 10.1001/archderm.129.10.1280; RIGEL DS, 1989, CANCER, V63, P386, DOI 10.1002/1097-0142(19890115)63:2<386::AID-CNCR2820630231>3.0.CO;2-6; SAGEBIEL RW, 1993, J INVEST DERMATOL, V100, pS322, DOI 10.1111/1523-1747.ep12470218; STEIJLEN PM, 1988, HISTOPATHOLOGY, V12, P289, DOI 10.1111/j.1365-2559.1988.tb01943.x; Stolz W, 2003, SEMIN CUTAN MED SURG, V22, P9, DOI 10.1053/sder.2003.50001; SWERDLOW AJ, 1986, BRIT MED J, V292, P1555, DOI 10.1136/bmj.292.6535.1555; TAYLOR MR, 1984, AM J OPHTHALMOL, V98, P478, DOI 10.1016/0002-9394(84)90135-1; TIERSTEN AD, 1991, J DERMATOL SURG ONC, V17, P44, DOI 10.1111/j.1524-4725.1991.tb01592.x; TSAO H, 2003, FITZPATRICKS DERMATO, P906; TUCKER MA, 1983, J PEDIATR-US, V103, P65, DOI 10.1016/S0022-3476(83)80777-X; TUCKER MA, 1993, J INVEST DERMATOL, V100, pS350, DOI 10.1111/1523-1747.ep12470264; Tucker MA, 1997, JAMA-J AM MED ASSOC, V277, P1439, DOI 10.1001/jama.277.18.1439; VINK J, 1990, J AM ACAD DERMATOL, V23, P858, DOI 10.1016/0190-9622(90)70304-Z	59	66	69	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2003	349	23					2233	2240		10.1056/NEJMcp023017	http://dx.doi.org/10.1056/NEJMcp023017			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LH	14657431				2022-12-28	WOS:000186921700011
J	Wu, XC; Li, Z; Zhou, BC; Dong, ZM				Wu, XC; Li, Z; Zhou, BC; Dong, ZM			A polydactylous amniote from the Triassic period	NATURE			English	Editorial Material							TETRAPOD LIMB; EVOLUTION		Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada; Shanghai Sci & Technol Museum, Shanghai 200127, Peoples R China; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Wu, XC (corresponding author), Canadian Museum Nat, POB 3443 Stn D, Ottawa, ON K1P 6P4, Canada.							Clack JA., 2012, GAINING GROUND ORIGI; COATES MI, 1990, NATURE, V347, P66, DOI 10.1038/347066a0; DANFORTH CH, 1947, AM J ANAT, V80, P143, DOI 10.1002/aja.1000800202; EDWARDS JL, 1989, AM ZOOL, V29, P235; GOULD SJ, 1991, NAT HIST, V1, P22; LEBEDEV OA, 1984, DOKL AKAD NAUK SSSR+, V278, P1470; Li Jin-Ling, 2002, Vertebrata Palasiatica, V40, P241; Motani R, 1999, J VERTEBR PALEONTOL, V19, P28, DOI 10.1080/02724634.1999.10011120; Radhakrishna U, 1999, AM J HUM GENET, V65, P645, DOI 10.1086/302557; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; SHUBIN NH, 1986, EVOL BIOL, V20, P319	11	21	25	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2003	426	6966					516	516		10.1038/426516a	http://dx.doi.org/10.1038/426516a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654831	Bronze			2022-12-28	WOS:000186944300028
J	Ryan, EA				Ryan, EA			Hormones and insulin resistance during pregnancy	LANCET			English	Editorial Material							SKELETAL-MUSCLE; OBESE WOMEN; PHOSPHORYLATION; EXPRESSION; ALPHA		Univ Alberta, Heritage Med Res Ctr, Dept Endocrinol & Metab, Edmonton, AB T6G 2S2, Canada	University of Alberta	Ryan, EA (corresponding author), Univ Alberta, Heritage Med Res Ctr, Dept Endocrinol & Metab, Edmonton, AB T6G 2S2, Canada.	Edmond.Ryan@UAlberta.ca						Catalano PM, 2002, AM J PHYSIOL-ENDOC M, V282, pE522, DOI 10.1152/ajpendo.00124.2001; Friedman JE, 1999, DIABETES, V48, P1807, DOI 10.2337/diabetes.48.9.1807; Kirwan JP, 2002, DIABETES, V51, P2207, DOI 10.2337/diabetes.51.7.2207; McTernan PG, 2002, J CLIN ENDOCR METAB, V87, P2407, DOI 10.1210/jc.87.5.2407; Melczer Z, 2003, ACTA OBSTET GYN SCAN, V82, P432; Nagaev I, 2001, BIOCHEM BIOPH RES CO, V285, P561, DOI 10.1006/bbrc.2001.5173; Shao JH, 2000, DIABETES, V49, P603, DOI 10.2337/diabetes.49.4.603; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sugden MC, 2003, ENDOCRINOLOGY, V144, P146, DOI 10.1210/en.2002-220811; Yura S, 2003, J CLIN ENDOCR METAB, V88, P1394, DOI 10.1210/jc.2002-011926	10	70	72	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1777	1778		10.1016/S0140-6736(03)14942-2	http://dx.doi.org/10.1016/S0140-6736(03)14942-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654313				2022-12-28	WOS:000186872900006
J	Dandonneau, Y; Vega, A; Loisel, H; du Penhoat, Y; Menkes, C				Dandonneau, Y; Vega, A; Loisel, H; du Penhoat, Y; Menkes, C			Oceanic Rossby waves acting as a "hay rake" for ecosystem floating by-products	SCIENCE			English	Article							SEA-SURFACE; PACIFIC; FLUXES; LIGHT; PHYTOPLANKTON; VARIABILITY; ATTENUATION; ABSORPTION; NUTRIENTS; WATERS	Recent satellite observations of Rossby waves and chlorophyll anomalies propagating in subtropical gyres have suggested that wave-induced upwelling could stimulate photosynthesis. Instead, we show that chlorophyll maxima are located in abnormally warm water, in Rossby wave - induced convergences. This excludes inputs of nutrients from deeper water. We argue that the sea color anomalies are not caused by chlorophyll but by floating particles evolved from the ecosystem and accumulated by Rossby waves, acting as "marine hay rakes," in convergence zones. Such processes may be determinant for the distribution of living organisms in oligotrophic areas.	IRD, IPSL, Lab Oceanog Dynam & Climatol, F-75252 Paris 05, France; IRD, Lab Etud Geophys & Oceanog Spatiale, Toulouse, France; Univ Littoral Cote dOpale, MREN, UMR 8013, Wimereux, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; Universite du Littoral-Cote-d'Opale	Dandonneau, Y (corresponding author), IRD, IPSL, Lab Oceanog Dynam & Climatol, F-75252 Paris 05, France.	yd@lodyc.jussieu.fr	menkes, christophe/H-9085-2016; menkes, christophe/X-6073-2019	menkes, christophe/0000-0002-1457-9696; menkes, christophe/0000-0002-1457-9696				Aufdenkampe AK, 2001, GLOBAL BIOGEOCHEM CY, V15, P101, DOI 10.1029/2000GB001268; Bricaud A, 1998, J GEOPHYS RES-OCEANS, V103, P31033, DOI 10.1029/98JC02712; BRICAUD A, 1995, J GEOPHYS RES-OCEANS, V100, P13321, DOI 10.1029/95JC00463; CARDER KL, 1989, LIMNOL OCEANOGR, V34, P68, DOI 10.4319/lo.1989.34.1.0068; Christian JR, 1997, J GEOPHYS RES-OCEANS, V102, P15667, DOI 10.1029/97JC00369; Cipollini P, 2001, GEOPHYS RES LETT, V28, P323, DOI 10.1029/1999GL011231; Claustre H, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014056; Claustre H, 1999, J GEOPHYS RES-OCEANS, V104, P3401, DOI 10.1029/98JC01334; CULLEN JJ, 1995, J GEOPHYS RES-OCEANS, V100, P13255, DOI 10.1029/95JC00454; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Gill AE, 1982, ATMOSPHERE OCEAN DYN; HAURY LR, 1994, DEEP-SEA RES PT I, V41, P1191, DOI 10.1016/0967-0637(94)90040-X; Legendre L, 1998, J GEOPHYS RES-OCEANS, V103, P2897, DOI 10.1029/97JC02706; McGillicuddy DJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001987; McNeil JD, 1999, J GEOPHYS RES-OCEANS, V104, P15537, DOI 10.1029/1999JC900137; Mobley C.D., 1998, HYDROLIGHT 4 0 USERS; Neuer S, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015393; O'Reilly JE, 1998, J GEOPHYS RES-OCEANS, V103, P24937, DOI 10.1029/98JC02160; Petzold T. J., 1972, 7278 SCRIPPS I OC; Romano JC, 1996, DEEP-SEA RES PT I, V43, P411, DOI 10.1016/0967-0637(96)00024-6; Siegel DA, 1996, DEEP-SEA RES PT II, V43, P321, DOI 10.1016/0967-0645(96)00088-4; Siegel DA, 2001, NATURE, V409, P576, DOI 10.1038/35054659; SMITH KL, 1989, NATURE, V337, P724, DOI 10.1038/337724a0; Uz BM, 2001, NATURE, V409, P597, DOI 10.1038/35054527; Vega A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015886; Villareal TA, 1996, J PLANKTON RES, V18, P1103, DOI 10.1093/plankt/18.7.1103; Wallace BB, 1999, LIMNOL OCEANOGR, V44, P273, DOI 10.4319/lo.1999.44.2.0273; YODER JA, 1994, NATURE, V371, P689, DOI 10.1038/371689a0; Zhang XD, 1998, APPL OPTICS, V37, P6525, DOI 10.1364/AO.37.006525	29	59	59	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1548	1551		10.1126/science.1090729	http://dx.doi.org/10.1126/science.1090729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645844	Green Submitted			2022-12-28	WOS:000186802200038
J	Stewart, M				Stewart, M			Nuclear trafficking	SCIENCE			English	Editorial Material							IMPORTIN-BETA; STRUCTURAL BASIS; PORE COMPLEX		MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Stewart, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ms@mrc-lmb.cam.ac.uk						Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Bednenko J, 2003, J CELL BIOL, V162, P391, DOI 10.1083/jcb.200303085; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; FUKUHARA N, 2003, J BIOL CHEM; Harel A, 2003, MOL BIOL CELL, V14, P4387, DOI 10.1091/mbc.E03-05-0275; Koerner C, 2003, J BIOL CHEM, V278, P16216, DOI 10.1074/jbc.M301137200; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; WELS K, 2003, CELL, V112, P441; Zhang CM, 2002, CURR BIOL, V12, P498, DOI 10.1016/S0960-9822(02)00714-5	17	23	24	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1513	1514		10.1126/science.1092863	http://dx.doi.org/10.1126/science.1092863			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645832				2022-12-28	WOS:000186802200025
J	Peter, BJ; Kent, HM; Mills, IG; Vallis, Y; Butler, PJG; Evans, PR; McMahon, HT				Peter, BJ; Kent, HM; Mills, IG; Vallis, Y; Butler, PJG; Evans, PR; McMahon, HT			BAR domains as sensors of membrane curvature: The amphiphysin BAR structure	SCIENCE			English	Article							GTPASE-ACTIVATING PROTEIN; SYNAPTIC VESICLE ENDOCYTOSIS; CLATHRIN-MEDIATED ENDOCYTOSIS; ADP-RIBOSYLATION FACTORS; ACTIN CYTOSKELETON; DROSOPHILA AMPHIPHYSIN; LYSOPHOSPHATIDIC ACID; TERMINAL DOMAIN; SH3 DOMAIN; BINDING	The BAR (Bin/amphiphysin/Rvs) domain is the most conserved feature in amphiphysins from yeast to human and is also found in endophilins and nadrins. We solved the structure of the Drosophila amphiphysin BAR domain. It is a crescent-shaped dimer that binds preferentially to highly curved negatively charged membranes. With its N-terminal amphipathic helix and BAR domain (N-BAR), amphiphysin can drive membrane curvature in vitro and in vivo. The structure is similar to that of arfaptin2, which we find also binds and tubulates membranes. From this, we predict that BAR domains are in many protein families, including sorting nexins, centaurins, and oligophrenins. The universal and minimal BAR domain is a dimerization, membrane-binding, and curvature-sensing module.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Evans, PR (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	pre@mrc-lmb.cam.ac.uk; hmm@mrc-lmb.cam.ac.uk	Peter, Brian/AAZ-7323-2020; Mills, Ian/AAK-9292-2020	Mills, Ian/0000-0001-5347-5083				Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Billuart P, 1998, PATHOL BIOL, V46, P678; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Drake MT, 2001, J BIOL CHEM, V276, P28700, DOI 10.1074/jbc.M104226200; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fauchereau F, 2003, MOL CELL NEUROSCI, V23, P574, DOI 10.1016/S1044-7431(03)00078-2; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Ge K, 2000, GENOMICS, V67, P210, DOI 10.1006/geno.2000.6216; Greiner J, 2003, INT J CANCER, V106, P224, DOI 10.1002/ijc.11200; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Harada A, 2000, J BIOL CHEM, V275, P36885, DOI 10.1074/jbc.M004069200; Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Leventis PA, 2001, TRAFFIC, V2, P839; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; McMahon HT, 1997, FEBS LETT, V413, P319, DOI 10.1016/S0014-5793(97)00928-9; Modregger J, 2003, J BIOL CHEM, V278, P4160, DOI 10.1074/jbc.M208568200; Nie ZZ, 2002, J BIOL CHEM, V277, P48965, DOI 10.1074/jbc.M202969200; PETER BJ, UNPUB; Pilon M, 2000, MOL BIOL CELL, V11, P3277, DOI 10.1091/mbc.11.10.3277; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Reinhard C, 2003, P NATL ACAD SCI USA, V100, P8253, DOI 10.1073/pnas.1432391100; Ren XR, 2001, J CELL BIOL, V152, P971, DOI 10.1083/jcb.152.5.971; Richnau N, 2001, J BIOL CHEM, V276, P35060, DOI 10.1074/jbc.M103540200; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; Schmidt A, 1999, NATURE, V401, P133, DOI 10.1038/43613; Shin OH, 2001, BIOCHEM BIOPH RES CO, V285, P1267, DOI 10.1006/bbrc.2001.5330; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Slepnev VI, 2000, J BIOL CHEM, V275, P17583, DOI 10.1074/jbc.M910430199; Spitzenberger F, 2003, J BIOL CHEM, V278, P26166, DOI 10.1074/jbc.M213222200; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wigge P, 1997, CURR BIOL, V7, P554, DOI 10.1016/S0960-9822(06)00254-5; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zelhof AC, 2001, DEVELOPMENT, V128, P5005; Zhang B, 2002, TRAFFIC, V3, P452, DOI 10.1034/j.1600-0854.2002.30702.x	46	1272	1306	0	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 23	2004	303	5657					495	499		10.1126/science.1092586	http://dx.doi.org/10.1126/science.1092586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765XM	14645856				2022-12-28	WOS:000188316400030
J	Buckling, A; Wills, MA; Colegrave, N				Buckling, A; Wills, MA; Colegrave, N			Adaptation limits diversification of experimental bacterial populations	SCIENCE			English	Article							EXPERIMENTAL EVOLUTION; GENETIC-POLYMORPHISM; PEAKS; DIVERSITY; FITNESS	Adaptation to a specific niche theoretically constrains a population's ability to subsequently diversify into other niches. We tested this theory using the bacterium Pseudomonas fluorescens, which diversifies into niche specialists when propagated in laboratory microcosms. Numerically dominant genotypes were allowed to diversify in isolation. As predicted, populations increased in fitness through time but showed a greatly decreased ability to diversify. Subsequent experiments demonstrated that niche generalists and reductions in intrinsic evolvability were not responsible for our data. These results show that niche specialization may come with a cost of reduced potential to diversify.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland	University of Bath; University of Edinburgh	Buckling, A (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssagjb@bath.ac.uk	Wills, Matthew Albion/AAE-1790-2019; Colegrave, Nick/F-3916-2010	Buckling, Angus/0000-0003-1170-4604; Wills, Matthew/0000-0002-7344-7749				Ayala F.J., 1974, Annual Rev Ecol Syst, V5, P115, DOI 10.1146/annurev.es.05.110174.000555; BELL G, 1997, SELECTION MECH EVOLU; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; Buckling A, 2000, NATURE, V408, P961, DOI 10.1038/35050080; FOBZHANSKY T, 1937, GENETICS ORIGIN SPEC; HEDRICK PW, 1976, ANNU REV ECOL SYST, V7, P1, DOI 10.1146/annurev.es.07.110176.000245; HEDRICK PW, 1986, ANNU REV ECOL SYST, V17, P535; Kassen R, 2000, NATURE, V406, P508, DOI 10.1038/35020060; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; KORONA R, 1994, P NATL ACAD SCI USA, V91, P9037, DOI 10.1073/pnas.91.19.9037; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; Muller HJ, 1939, BIOL REV CAMB PHILOS, V14, P261, DOI 10.1111/j.1469-185X.1939.tb00934.x; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rainey PB, 1996, MOL MICROBIOL, V19, P521, DOI 10.1046/j.1365-2958.1996.391926.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROSENZWEIG RF, 1994, GENETICS, V137, P903; Rozen DE, 2000, AM NAT, V155, P24, DOI 10.1086/303299; Schluter D, 2000, AM NAT, V156, pS4, DOI 10.1086/303412; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Templeton A., 2000, EPISTASIS EVOLUTIONA; Vamosi SM, 2002, P ROY SOC B-BIOL SCI, V269, P923, DOI 10.1098/rspb.2001.1946; Wade Michael J., 2000, P213; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; Wright S, 1931, GENETICS, V16, P0097	24	82	87	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2107	2109		10.1126/science.1088848	http://dx.doi.org/10.1126/science.1088848			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684817	Green Submitted			2022-12-28	WOS:000187385200039
J	Blumenthal, D				Blumenthal, D			Health policy report: Academic-industrial relationships in the life sciences	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CONFLICTS-OF-INTEREST; UNIVERSITY; FACULTY		Massachusetts Gen Hosp Partners Hlth Care Syst, Inst Hlth Policy, Boston, MA USA	Harvard University; Massachusetts General Hospital; Partners Healthcare System	Blumenthal, D (corresponding author), Massachusetts Gen Hosp Partners Hlth Care Syst, Inst Hlth Policy, Boston, MA USA.							Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Blumenthal D, 1996, NEW ENGL J MED, V334, P368, DOI 10.1056/NEJM199602083340606; Blumenthal D, 1996, NEW ENGL J MED, V335, P1734, DOI 10.1056/NEJM199612053352305; BLUMENTHAL D, 1986, SCIENCE, V232, P1361, DOI 10.1126/science.3715452; BLUMENTHAL D, 1992, JAMA-J AM MED ASSOC, V268, P3344, DOI 10.1001/jama.268.23.3344; BLUMENTHAL D, 2000, ENCY ETHICAL LEGAL P; Bok D., 2003, U MARKETPLACE COMMER; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; CAMPBELL EG, IN PRESS HLTH AFF MI; Cho MK, 2000, JAMA-J AM MED ASSOC, V284, P2203, DOI 10.1001/jama.284.17.2203; COHEN W, 1994, U IND RES CTR US; *COMM FUND TASK FO, 1999, BENCH BEDS PRES RES; *COMM GOV OP US HO, 1990, ARE SCI MISC CONFL I; Culliton Barbara J., 1982, SCIENCE, V216, P158; CULLITON BJ, 1982, SCIENCE, V216, P155, DOI 10.1126/science.11643731; CULLITON BJ, 1982, SCIENCE, V216, P960, DOI 10.1126/science.11643748; Dickson David., 1984, NEW POLITICS SCI; DORFMAN NS, 1983, RES POLICY, V12, P299, DOI 10.1016/0048-7333(83)90009-4; ETZKOWITZ H, RISE ENTREPRENEURIAL; EVELAND JD, 1982, DEV U IND COOPERATIV; FRIST W, 2000, GENE THERAPY IS THER; *GEN ACC OFF, 2001, GAO0289; *GEN ACC OFF, 1998, GAO PUBL; GORE A, 1983, PARTNERS RES ENTERPR, P121; *GOV U IND RES ROU, 1986, NEW ALL PARTN AM SCI; GROBSTEIN C, 1985, SCI TECHNOL HUM VAL, P55, DOI 10.1177/016224398501000209; JAFFE AB, 1993, Q J ECON, V108, P577, DOI 10.2307/2118401; KEYWORTH GA, 1983, SCIENCE, V220, P1122, DOI 10.1126/science.220.4602.1122; LANFITT TW, 1983, PARTNERS RES ENTERPR; LEONHARDT D, 2002, NY TIMES        0624, pA1; LEVINE J, 1990, J HOPKINS MAGAZI AUG, P14; Nathan DG, 2002, NEW ENGL J MED, V347, P1368, DOI 10.1056/NEJMsb020394; NEWMAN M, 2003, NY TIMES        0409, pC6; PETERS LS, 1982, CURRENT US U IND RES; PRAGER DJ, 1980, SCIENCE, V207, P379, DOI 10.1126/science.7350670; PRESSMAN L, 2000, AUTM LICENSING SURVE; Rennie D, 1997, JAMA-J AM MED ASSOC, V277, P1762; Strickland S. P., 1972, POLITICS SCI DREAD D; Swann John, 1988, ACAD SCI PHARM IND C; *TASK FORC FIN CON, 2001, PROT SUBJ PRES TRUST; *TASK FORC FIN CON, 2002, PROT SUBJ PRES TRUST, V2; *TASK FORC RES ACC, 2000, REP U PROT HUM BEING; Vogel G, 2000, SCIENCE, V290, P2049; WYNGAARDEN JB, 1983, PARTNERS RES ENTERPR, P128; 2003, FED REG, V68, P15456	45	90	92	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					2452	2459		10.1056/NEJMhpr035460	http://dx.doi.org/10.1056/NEJMhpr035460			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681513				2022-12-28	WOS:000187326200014
J	Hugot, JP; Alberti, C; Berrebi, D; Bingen, E; Cezard, JP				Hugot, JP; Alberti, C; Berrebi, D; Bingen, E; Cezard, JP			Crohn's disease: the cold chain hypothesis	LANCET			English	Article							INFLAMMATORY-BOWEL-DISEASE; LISTERIA-MONOCYTOGENES; YERSINIA EFFECTOR; ESCHERICHIA-COLI; ANTIGENS; PROTEIN; PATHOGENESIS; PREVALENCE; CITY	Crohn's disease is the result of an abnormal immune response of the gut mucosa triggered by one or more environmental risk factors in people with predisposing gene variations, including CARD15 mutations. Epidemiological data allow assessment of familial environmental risk factors related to western lifestyle, diet, bacteria, and domestic hygiene. All findings point to refrigeration as a potential risk factor for Crohn's disease. Furthermore, cold-chain development paralleled the outbreak of Crohn's disease during the 20th century. The cold chain hypothesis suggests that psychrotrophic bacteria such as Yersinia spp and Listeria spp contribute to the disease. These bacteria have been identified in Crohn's disease lesions and we discuss their pathogenic properties with respect to our knowledge of the disease. From a molecular perspective, we postulate that the disease is a result of a defect in host recognition by pathogenic bacterial components that usually escape the immune response (eg, Yop molecules), which results in an excessive host response to these bacteria.	Hop Robert Debre, Assistance Publ Hop Paris, Dept Microbiol, EA 3105, F-75019 Paris, France; Hop Robert Debre, Assistance Publ Hop Paris, Dept Paediat Gastroenterol, F-75019 Paris, France; Hop Robert Debre, Assistance Publ Hop Paris, Dept Publ Hlth, Clin Epidemiol Unit, F-75019 Paris, France; Hop Robert Debre, Assistance Publ Hop Paris, Dept Pathol, EA 3102, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Hugot, JP (corresponding author), Hop Robert Debre, Serv Gastroenterol, 48 Blvd Serurier, F-75019 Paris, France.	jean-pierre.hugot@rdb.ap-hop-paris.fr	Hugot, Jean-Pierre/F-6594-2012	Hugot, Jean-Pierre/0000-0002-8446-6056				Andus T, 2000, HEPATO-GASTROENTEROL, V47, P29; Arnold GL, 2002, INFLAMM BOWEL DIS, V8, P10, DOI 10.1097/00054725-200201000-00002; BLASER MJ, 1984, GASTROENTEROLOGY, V87, P888; BRAHME F, 1975, GASTROENTEROLOGY, V69, P342; Chamaillard M, 2003, P NATL ACAD SCI USA, V100, P3455, DOI 10.1073/pnas.0530276100; CHAMPAGNE CP, 1994, CRIT REV FOOD SCI, V34, P1, DOI 10.1080/10408399409527648; Chen WX, 2000, J GASTROEN HEPATOL, V15, P1145, DOI 10.1046/j.1440-1746.2000.02331.x; Chiba M, 1998, SCAND J GASTROENTERO, V33, P430; FELLOWS IW, 1990, GUT, V31, P1262, DOI 10.1136/gut.31.11.1262; Fujimura Y, 1996, GUT, V38, P724, DOI 10.1136/gut.38.5.724; GENT AE, 1994, LANCET, V343, P766, DOI 10.1016/S0140-6736(94)91841-4; GLEASON TH, 1982, AM J SURG PATHOL, V6, P347, DOI 10.1097/00000478-198206000-00007; Greenwood MH, 1995, CONTRIB TO MICROBIOL, V13, P74; Hellers G, 1979, Acta Chir Scand Suppl, V490, P1; Hugot JP, 2003, EUR J HUM GENET, V11, P179, DOI 10.1038/sj.ejhg.5200932; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kallinowski F, 1998, HEPATO-GASTROENTEROL, V45, P1552; Karlinger K, 2000, EUR J RADIOL, V35, P154, DOI 10.1016/S0720-048X(00)00238-2; Lamps LW, 2003, AM J SURG PATHOL, V27, P220, DOI 10.1097/00000478-200302000-00011; LIU Y, 1995, GASTROENTEROLOGY, V108, P1396, DOI 10.1016/0016-5085(95)90687-8; Loftus EV, 1998, GASTROENTEROLOGY, V114, P1161, DOI 10.1016/S0016-5085(98)70421-4; MAYBERRY JF, 1984, GUT, V25, P886, DOI 10.1136/gut.25.8.886; McCormick P, 2001, Ir Med J, V94, P203; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Mollaret HH, 1995, CONTRIB TO MICROBIOL, V13, P1; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Polito JM, 1996, GASTROENTEROLOGY, V111, P580, DOI 10.1053/gast.1996.v111.pm8780560; ROSE JDR, 1988, GUT, V29, P346, DOI 10.1136/gut.29.3.346; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; Shivananda S, 1996, GUT, V39, P690, DOI 10.1136/gut.39.5.690; SONNENBERG A, 1991, GASTROENTEROLOGY, V100, P143, DOI 10.1016/0016-5085(91)90594-B; Sukegawa Y, 2000, SCAND J GASTROENTERO, V35, P1188; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Thevenot R, 1978, ESSAI HIST FROID ART; VanKruiningen HJ, 1997, J CLIN GASTROENTEROL, V25, P470, DOI 10.1097/00004836-199709000-00017; Walmsley RS, 1998, J CLIN PATHOL, V51, P657, DOI 10.1136/jcp.51.9.657; Zeng L, 1996, SCAND J GASTROENTERO, V31, P79, DOI 10.3109/00365529609031631	40	126	126	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2003	362	9400					2012	2015		10.1016/S0140-6736(03)15024-6	http://dx.doi.org/10.1016/S0140-6736(03)15024-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683664				2022-12-28	WOS:000187210700026
J	McMichael, AJ; Butler, CD; Folke, C				McMichael, AJ; Butler, CD; Folke, C			New visions for addressing sustainability	SCIENCE			English	Article							POPULATION; GROWTH	Attaining sustainability will require concerted interactive efforts among disciplines, many of which have not yet recognized, and internalized, the relevance of environmental issues to their main intellectual discourse. The inability of key scientific disciplines to engage interactively is an obstacle to the actual attainment of sustainability. For example, in the list of Millennium Development Goals from the United Nations World Summit on Sustainable Development, Johannesburg, 2002, the seventh of the eight goals, to "ensure environmental sustainability," is presented separately from the parallel goals of reducing fertility and poverty, improving gains in equity, improving material conditions, and enhancing population health. A more integrated and consilient approach to sustainability is urgently needed.	Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden	Australian National University; Stockholm University	McMichael, AJ (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia.	tony.mcmichael@anu.edu.au	Folke, Carl/Z-1545-2019	Folke, Carl/0000-0002-4050-3281; Butler, Colin/0000-0002-2942-5294				ABERNETHY V, 1993, POPULATION POLITICS; Aguirre A.A., 2002, CONSERVATION MED ECO; Andre C, 1998, J ECON BEHAV ORGAN, V34, P1, DOI 10.1016/S0167-2681(97)00045-0; [Anonymous], 2001, PANARCHY UNDERSTANDI; ARROW K, 1995, SCIENCE, V268, P520, DOI 10.1126/science.268.5210.520; Arthur WB, 1999, SCIENCE, V284, P107, DOI 10.1126/science.284.5411.107; Berkes F., 2003, NAVIGATING SOCIAL EC, V1, P30; BERKMAN LF, 2001, SOCIAL EPIDEMIOLOGY; Butler C, 2000, ECOSYST HEALTH, V6, P171, DOI 10.1046/j.1526-0992.2000.006003171.x; Butler CD, 2000, GLOBAL CHANGE HUMAN, V1, P156, DOI DOI 10.1023/A:1010029222095; COHEN JE, 1995, SCIENCE, V269, P341, DOI 10.1126/science.7618100; COSTANZA R, 1997, DEV ECOLOGICAL EC; DAILY GC, 1992, BIOSCIENCE, V42, P761, DOI 10.2307/1311995; DEMENY P, 1988, POPUL DEV REV, V14, P213, DOI 10.2307/2808097; EASTERLIN RA, 1971, AM ECON REV, V61, P399; Levin S., 1999, FRAGILE DOMINION; Lubchenco J, 1998, SCIENCE, V279, P491, DOI 10.1126/science.279.5350.491; Maler KG, 2000, EUR ECON REV, V44, P645, DOI 10.1016/S0014-2921(00)00043-X; MCINTOSH RJ, 2000, WAY WIND BLOWS; McMichael AJ, 2000, LANCET, V356, P495, DOI 10.1016/S0140-6736(00)02564-2; McMichael AJ, 1999, AM J EPIDEMIOL, V149, P887; National Research Council, 1999, OUR COMM JOURN TRANS; Ostrom E., 2002, DRAMA COMMONS; Rapport DJ, 1998, TRENDS ECOL EVOL, V13, P397, DOI 10.1016/S0169-5347(98)01449-9; Raven PH, 2002, SCIENCE, V297, P954, DOI 10.1126/science.297.5583.954; Redman C.L., 1999, HUMAN IMPACT ANCIENT; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; STERN PC, 1993, SCIENCE, V260, P1897, DOI 10.1126/science.260.5116.1897; WHITE L, 1967, SCIENCE, V155, P1203, DOI 10.1126/science.155.3767.1203	29	136	144	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1919	1920						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752NL	14671290				2022-12-28	WOS:000187174000045
J	Suit, HD; Willers, H				Suit, HD; Willers, H			Comment on "Tumor response to radiotherapy regulated by endothelial cell apoptosis" (I)	SCIENCE			English	Editorial Material							MULTICELLULAR SPHEROIDS; RADIATION RESPONSE; SENSITIVITY; FRACTION; MICE		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Suit, HD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02114 USA.							BUDACH W, 1992, CANCER RES, V52, P6292; BUDACH W, 1993, J NATL CANCER I, V85, P988, DOI 10.1093/jnci/85.12.988; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; GERWECK LE, 1994, INT J RADIAT ONCOL, V29, P57, DOI 10.1016/0360-3016(94)90226-7; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; PUCK TT, 1956, J EXP MED, V103, P653, DOI 10.1084/jem.103.5.653; ROFSTAD EK, 1986, INT J RADIAT ONCOL, V12, P975, DOI 10.1016/0360-3016(86)90394-9; STUSCHKE M, 1992, INT J RADIAT ONCOL, V23, P69, DOI 10.1016/0360-3016(92)90545-S	8	23	23	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652												1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671277				2022-12-28	WOS:000187174000028
J	Shafer, RW; Smeaton, LM; Robbins, GK; De Gruttola, V; Snyder, SW; D'Aquila, RT; Johnson, VA; Morse, GD; Nokta, MA; Martinez, AI; Gripshover, BM; Kaul, P; Haubrich, R; Swingle, M; McCarty, SD; Vella, S; Hirsch, MS; Merigan, TC; Fischl, M; Pollard, R; Dube, M; Pettinelli, C; Delapenha, R; Putnam, B; Klebert, M; Testa, M; Chiesi, A; Tomino, C; Deeks, S; Nevin, T; Levin, J; French, V; Fennell, O; Stevens, M; Grosso, R; Dusak, B; Hodder, S; Tolson, J; Brothers, C; Leavitt, R; Manion, D; Ruiz, N; Morrisey, K; Becker, M; Quart, B; Jennings, C; Gedeon, L; Dascomb, S; Cooper, M; Murphy, M; Blakelock, K; Doolan, A				Shafer, RW; Smeaton, LM; Robbins, GK; De Gruttola, V; Snyder, SW; D'Aquila, RT; Johnson, VA; Morse, GD; Nokta, MA; Martinez, AI; Gripshover, BM; Kaul, P; Haubrich, R; Swingle, M; McCarty, SD; Vella, S; Hirsch, MS; Merigan, TC; Fischl, M; Pollard, R; Dube, M; Pettinelli, C; Delapenha, R; Putnam, B; Klebert, M; Testa, M; Chiesi, A; Tomino, C; Deeks, S; Nevin, T; Levin, J; French, V; Fennell, O; Stevens, M; Grosso, R; Dusak, B; Hodder, S; Tolson, J; Brothers, C; Leavitt, R; Manion, D; Ruiz, N; Morrisey, K; Becker, M; Quart, B; Jennings, C; Gedeon, L; Dascomb, S; Cooper, M; Murphy, M; Blakelock, K; Doolan, A		AIDS Clin Trials Grp 384 Team	Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; CLINICAL-TRIALS; NUCLEOSIDE; RESISTANCE; ZIDOVUDINE; LAMIVUDINE; EFAVIRENZ; ADHERENCE; TOXICITY	BACKGROUND: It is unclear whether therapy for human immunodeficiency virus type 1 (HIV-1) should be initiated with a four-drug or two sequential three-drug regimens. METHODS: In this multicenter trial we compared initial therapy involving four-drug regimens containing efavirenz and nelfinavir in combination with either didanosine and stavudine or zidovudine and lamivudine with therapy involving two consecutive three-drug regimens the first of which contained either efavirenz or nelfinavir. RESULTS: A total of 980 subjects were followed for a median of 2.3 years. There was no significant difference in the occurrence of regimen failures between the group that received the four-drug regimen containing didanosine, stavudine, nelfinavir, and efavirenz and the groups that received the three-drug regimens beginning with didanosine, stavudine, and nelfinavir (hazard ratio for regimen failure, 1.24) or didanosine, stavudine, and efavirenz (hazard ratio, 1.01). There was no significant difference between the group that received the four-drug regimen containing zidovudine, lamivudine, nelfinavir, and efavirenz and the groups that received the three-drug regimens beginning with zidovudine, lamivudine, and nelfinavir (hazard ratio, 1.06) or zidovudine, lamivudine, and efavirenz (hazard ratio, 1.45). A four-drug regimen was associated with a longer time to the first regimen failure than the three-drug regimens containing didanosine, stavudine, and nelfinavir (hazard ratio for a first regimen failure, 0.55); didanosine, stavudine, and efavirenz (hazard ratio, 0.63); or zidovudine, lamivudine, and nelfinavir (hazard ratio, 0.49), but not the three-drug regimen containing zidovudine, lamivudine, and efavirenz (hazard ratio, 1.21). CONCLUSIONS: There was no significant difference in the duration of successful HIV-1 treatment between a single four-drug regimen and two consecutive three-drug regimens. Among these treatment strategies, initiating therapy with the three-drug regimen of zidovudine, lamivudine, and efavirenz is the optimal choice.	Stanford Univ, Med Ctr, Stanford, CA 94305 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Social & Sci Syst, Silver Spring, MD USA; Vanderbilt Univ, Med Ctr, Nashville, TN USA; Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; SUNY Buffalo, Buffalo, NY 14260 USA; Univ Texas, Med Branch, Galveston, TX 77550 USA; NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Univ Cincinnati, Coll Med, Cincinnati, OH USA; Univ Calif San Diego, San Diego, CA 92103 USA; Bristol Myers Squibb Co, Plainsboro, NJ USA; GlaxoSmithKline, Res Triangle Pk, NC USA; Ist Super Sanita, I-00161 Rome, Italy	Stanford University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Social & Scientific Systems; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Texas System; University of Texas Medical Branch Galveston; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Case Western Reserve University; University System of Ohio; University of Cincinnati; University of California System; University of California San Diego; Bristol-Myers Squibb; GlaxoSmithKline; Istituto Superiore di Sanita (ISS)	Robbins, GK (corresponding author), Massachusetts Gen Hosp, Infect Dis Unit, 55 Fruit St, Boston, MA 02114 USA.	grobbins@partners.org	Merigan, Thomas/AGQ-7464-2022; VELLA, STEFANO/ABI-3368-2020; Testa, Marianna/L-9768-2019; Vella, Stefano/GZM-0519-2022; Tomino, Carlo/AAA-7478-2021; Johnson, Victoria/GVU-7127-2022; VELLA, STEFANO/V-8440-2019; Robbins, Gregory/F-7988-2011	VELLA, STEFANO/0000-0003-2347-5984; Robbins, Gregory/0000-0001-7545-5817	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052, M01RR005096, M01RR000044, M01RR000070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI038855, R01AI046148, U01AI038858] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR005096, RR00044, M01 RR000044, M01 RR000070, RR00070, RR00052, M01 RR000052, RR05096] Funding Source: Medline; NIAID NIH HHS [AI38858, AI38855, U01 AI038858, U01 AI038855, R01 AI046148] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bacheler L, 2001, J VIROL, V75, P4999, DOI 10.1128/JVI.75.11.4999-5008.2001; BOUCHER CAB, 1993, ANTIMICROB AGENTS CH, V37, P2231, DOI 10.1128/AAC.37.10.2231; Brinkman K, 1999, LANCET, V354, P1112, DOI 10.1016/S0140-6736(99)06102-4; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; Cote HCF, 2002, NEW ENGL J MED, V346, P811, DOI 10.1056/NEJMoa012035; COX DR, 1984, ANAL SURVIVAL DATA, P97; Descamps D, 2000, JAMA-J AM MED ASSOC, V283, P205, DOI 10.1001/jama.283.2.205; Dube MP, 2002, ANTIVIR THER, V7, pL18; Gallego O, 2001, AIDS, V15, P1701, DOI 10.1097/00002030-200109070-00014; Grabar S, 2000, AIDS, V14, P141, DOI 10.1097/00002030-200001280-00009; Havlir DV, 2000, JAMA-J AM MED ASSOC, V283, P229, DOI 10.1001/jama.283.2.229; Ickovics JR, 2002, ANTIVIR THER, V7, P185; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Murphy RL, 1999, J INFECT DIS, V179, P808, DOI 10.1086/314668; *NAT I ALL INF DIS, 1992, DIV AIDS TABL GRAD S; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Paredes R, 2000, ARCH INTERN MED, V160, P1123, DOI 10.1001/archinte.160.8.1123; Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264; Squires KE, 2001, ANTIVIR THER, V6, P1; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222	20	186	192	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					2304	2315		10.1056/NEJMoa030265	http://dx.doi.org/10.1056/NEJMoa030265			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668456	Green Accepted, Bronze			2022-12-28	WOS:000187125000006
J	Franco, EL				Franco, EL			Are we ready for a paradigm change in cervical cancer screening?	LANCET			English	Editorial Material							CYTOLOGIC ABNORMALITIES; PAPANICOLAOU TEST		McGill Univ, Dept Epidemiol, Montreal, PQ H2W 1S6, Canada; McGill Univ, Dept Oncol, Montreal, PQ H2W 1S6, Canada	McGill University; McGill University	Franco, EL (corresponding author), McGill Univ, Dept Epidemiol, Montreal, PQ H2W 1S6, Canada.	eduardo.franco@mcgill.ca	Franco, Eduardo/C-6445-2014	Franco, Eduardo/0000-0002-4409-8084				Franco Eduardo L, 2003, J Natl Cancer Inst Monogr, P89; Little J, 2001, BRIT MED J, V323, P109; Lytwyn A, 2000, CAN MED ASSOC J, V163, P701; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; Schiffman M, 2003, ARCH PATHOL LAB MED, V127, P946; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1393, DOI 10.1067/mob.2003.462; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1383, DOI 10.1067/mob.2003.457; SOLOMON D, 1991, INT J GYNECOL PATHOL, V10, P323, DOI 10.1097/00004347-199110000-00003; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F	10	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2003	362	9399					1866	1867		10.1016/S0140-6736(03)14996-3	http://dx.doi.org/10.1016/S0140-6736(03)14996-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667737				2022-12-28	WOS:000187011600002
J	Little, P				Little, P			Commentary: More valid criteria may be needed	BRITISH MEDICAL JOURNAL			English	Editorial Material							HEMOLYTIC STREPTOCOCCAL PHARYNGITIS; PENICILLIN; IMMEDIATE		Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 55T, Hants, England	University of Southampton	Little, P (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 55T, Hants, England.			Little, Paul/0000-0003-3664-1873				DELMAR C, 1992, MED J AUSTRALIA, V156, P572, DOI 10.5694/j.1326-5377.1992.tb121422.x; DELMAR CB, 2000, COCHRANE DATABASE SY; ELDAHER NT, 1991, PEDIATR INFECT DIS J, V10, P126, DOI 10.1097/00006454-199102000-00010; GERBER MA, 1990, J PEDIATR-US, V117, P853, DOI 10.1016/S0022-3476(05)80121-0; PICHICHERO ME, 1987, PEDIATR INFECT DIS J, V6, P635, DOI 10.1097/00006454-198707000-00004; Roos K, 1996, SCAND J INFECT DIS, V28, P459, DOI 10.3109/00365549609037940; Zwart S, 2003, BRIT MED J, V327, P1324, DOI 10.1136/bmj.327.7427.1324	7	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 6	2003	327	7427					1327	1327		10.1136/bmj.327.7427.1327	http://dx.doi.org/10.1136/bmj.327.7427.1327			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752DE	14656842	Green Published			2022-12-28	WOS:000187131100020
J	McCune, CA; Ravine, D; Worwood, M; Jackson, HA; Evans, HM; Hutton, D				McCune, CA; Ravine, D; Worwood, M; Jackson, HA; Evans, HM; Hutton, D			Screening for hereditary haemochromatosis within families and beyond	LANCET			English	Article							OVERLOAD	Screening programmes for haemochromatosis that include follow-up identification of relatives are claimed to be cost effective. We assessed uptake of screening by first-degree relatives of two groups of index cases: people homozygous for the C282Y mutation ascertained by genetic screening of blood donors; and patients presenting clinically with haemochromatosis. Only 40 (24%) of 165 relatives of blood donors had been tested. By contrast, testing uptake in 121 relatives of patients diagnosed clinically was more than double that (53%), despite unstructured provision of genetic information. A substantial number of untested relatives had undiagnosed iron overload. Overall efficacy of population screening for haemochromatosis is undermined by these observations.	Univ Wales Coll Med, Dept Haematol, Cardiff CF14 4XN, S Glam, Wales; Univ Western Australia, Sch Med & Pharmacol, Western Australian Inst Med Res, Perth, WA 6009, Australia; Royal Gwent Hosp, Dept Haematol, Newport NPT 2VB, Gwent, Wales; Univ Durham, John Snow Coll, Thornaby, Stockton Tees, England; Welsh Blood Serv, Pontyclun, Wales	Cardiff University; University of Western Australia; Royal Gwent Hospital; Durham University	McCune, CA (corresponding author), Univ Wales Coll Med, Dept Haematol, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.		Ravine, David/A-6797-2008					Ajioka RS, 2003, BLOOD, V101, P3351, DOI 10.1182/blood-2002-11-3453; Beutler E, 2003, BLOOD, V101, P3347, DOI 10.1182/blood-2002-06-1747; Cappuccio J, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P525; Jackson HA, 2001, BRIT J HAEMATOL, V114, P474, DOI 10.1046/j.1365-2141.2001.02949.x; McCune CA, 2002, HUM GENET, V111, P538, DOI 10.1007/s00439-002-0824-1	5	18	18	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1897	1898		10.1016/S0140-6736(03)14963-X	http://dx.doi.org/10.1016/S0140-6736(03)14963-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667749				2022-12-28	WOS:000187011600013
J	Greenberg, AJ; Moran, JR; Coyne, JA; Wu, CI				Greenberg, AJ; Moran, JR; Coyne, JA; Wu, CI			Ecological adaptation during incipient speciation revealed by precise gene replacement	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; SEXUAL ISOLATION; HYDROCARBON POLYMORPHISM; REPRODUCTIVE ISOLATION; DESATURASE GENE; COLD TOLERANCE; EVOLUTION; TEMPERATURE; POPULATIONS; STARVATION	To understand the role of adaptation in speciation, one must characterize the ecologically relevant phenotypic effects of naturally occurring alleles at loci potentially causing reproductive isolation. The desaturase2 gene of Drosophila melanogaster is such a locus. Two geographically differentiated ds2 alleles underlie a pheromonal difference between the Zimbabwe and Cosmopolitan races. We used a site-directed gene replacement technique to introduce an allele of ds2 from the Zimbabwe population into Cosmopolitan flies. We show that the Cosmopolitan allele confers resistance to cold as well as susceptibility to starvation when the entire genetic background is otherwise identical. We conclude that ecological adaptation likely accompanies sexual isolation between the two behavioral races of D. melanogaster.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Wu, CI (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57th St, Chicago, IL 60637 USA.			Greenberg, Anthony/0000-0003-3296-5811				Cossins AR, 1994, TEMPERATURE ADAPTATI; Coyne JA, 1996, GENETICS, V143, P353; COYNE JA, 1983, EVOLUTION, V37, P1101, DOI 10.1111/j.1558-5646.1983.tb00225.x; Coyne JA, 1999, GENET RES, V73, P189, DOI 10.1017/S0016672398003723; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Dallerac R, 2000, P NATL ACAD SCI USA, V97, P9449, DOI 10.1073/pnas.150243997; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; Doi M, 2001, P NATL ACAD SCI USA, V98, P6714, DOI 10.1073/pnas.091421598; Fang S, 2002, GENETICS, V162, P781; Gibert P, 2001, PHYSIOL BIOCHEM ZOOL, V74, P429, DOI 10.1086/320429; Gibert P, 2001, EVOLUTION, V55, P1063, DOI 10.1554/0014-3820(2001)055[1063:CCTAMC]2.0.CO;2; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Hoffmann AA, 2001, EVOLUTION, V55, P1621, DOI 10.1111/j.0014-3820.2001.tb00681.x; Hollocher H, 1997, EVOLUTION, V51, P1175, DOI 10.1111/j.1558-5646.1997.tb03965.x; Hollocher H, 1997, GENETICS, V147, P1191; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Karan D, 2000, J THERM BIOL, V25, P345, DOI 10.1016/S0306-4565(99)00106-0; KIMURA MT, 1988, EVOLUTION, V42, P1288, DOI 10.1111/j.1558-5646.1988.tb04188.x; Knipple DC, 2002, GENETICS, V162, P1737; LAURIEAHLBERG CC, 1987, GENETICS, V115, P129; LOCKEY KH, 1988, COMP BIOCHEM PHYS B, V89, P595, DOI 10.1016/0305-0491(88)90305-7; Ohtsu T, 1998, EUR J BIOCHEM, V252, P608, DOI 10.1046/j.1432-1327.1998.2520608.x; Parkash R, 2000, EVOL ECOL RES, V2, P685; PARTRIDGE L, 1994, EVOLUTION, V48, P1269, DOI 10.1111/j.1558-5646.1994.tb05311.x; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rong YS, 2001, GENETICS, V157, P1307; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Takahashi A, 2001, P NATL ACAD SCI USA, V98, P3920, DOI 10.1073/pnas.061465098; Tiku PE, 1996, SCIENCE, V271, P815, DOI 10.1126/science.271.5250.815; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; Ting CT, 2001, P NATL ACAD SCI USA, V98, P6709, DOI 10.1073/pnas.121418898; WU CI, 1995, P NATL ACAD SCI USA, V92, P2519, DOI 10.1073/pnas.92.7.2519; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x	37	132	136	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1754	1757		10.1126/science.1090432	http://dx.doi.org/10.1126/science.1090432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657496				2022-12-28	WOS:000186970100045
J	Outeiro, TF; Lindquist, S				Outeiro, TF; Lindquist, S			Yeast cells provide insight into alpha-synuclein biology and pathobiology	SCIENCE			English	Article							PARKINSONS-DISEASE; PHOSPHOLIPASE-D; MEMBRANE INTERACTIONS; PROTEIN AGGREGATION; BINDING PROTEINS; FATTY-ACIDS; MUTATIONS; SYSTEM; NEURODEGENERATION; OLIGOMERIZATION	Alpha-synuclein is implicated in several neurodegenerative disorders, such as Parkinson's disease and multiple system atrophy, yet its functions remain obscure. When expressed in yeast, alpha-synuclein associated with the plasma membrane in a highly selective manner, before forming cytoplasmic inclusions through a concentration-dependent, nucleated process. Alpha-synuclein inhibited phospholipase D, induced lipid droplet accumulation, and affected vesicle trafficking. This readily manipulable system provides an opportunity to dissect the molecular pathways underlying normal alpha-synuclein biology and the pathogenic consequences of its misfolding.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.		Outeiro, Tiago/M-8106-2019; Outeiro, Tiago/L-7351-2019; Outeiro, Tiago F/C-1067-2008	Outeiro, Tiago/0000-0003-1679-1727; Outeiro, Tiago F/0000-0003-1679-1727	NINDS NIH HHS [NS044829-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS044829] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Berke SJS, 2003, CURR OPIN GENET DEV, V13, P253, DOI 10.1016/S0959-437X(03)00053-4; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Dawson TM, 2003, J CLIN INVEST, V111, P145, DOI 10.1172/JCI200317575; Gasser T, 2001, J NEUROL, V248, P833, DOI 10.1007/s004150170066; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Jo EJ, 2002, J MOL BIOL, V315, P799, DOI 10.1006/jmbi.2001.5269; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; Muchowskil PJ, 2002, NEURON, V35, P9, DOI 10.1016/S0896-6273(02)00761-4; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rudge SA, 2001, GENETICS, V158, P1431; Sampathu DM, 2003, AM J PATHOL, V163, P91, DOI 10.1016/S0002-9440(10)63633-4; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sreenivas A, 1998, J BIOL CHEM, V273, P16635, DOI 10.1074/jbc.273.27.16635; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389	30	587	608	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1772	1775		10.1126/science.1090439	http://dx.doi.org/10.1126/science.1090439			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657500	Green Accepted			2022-12-28	WOS:000186970100050
J	Bigay, J; Gounon, P; Robineau, S; Antonny, B				Bigay, J; Gounon, P; Robineau, S; Antonny, B			Lipid packing sensed by ArfGAP1 couples COPI coat disassembly to membrane bilayer curvature	NATURE			English	Article							ADP-RIBOSYLATION FACTOR; GTPASE-ACTIVATING PROTEIN; GOLGI MEMBRANES; BINDING PROTEIN; VESICLES; COMPLEX; LIPOSOMES; FACTOR-1; NUCLEOTIDE; TRANSPORT	Protein coats deform flat lipid membranes into buds and capture membrane proteins to form transport vesicles(1-3). The assembly/ disassembly cycle of the COPI coat on Golgi membranes is coupled to the GTP/GDP cycle of the small G protein Arf1. At the heart of this coupling is the specific interaction of membrane-bound Arf1 - GTP with coatomer, a complex of seven proteins that forms the building unit of the COPI coat(4-7). Although COPI coat disassembly requires the catalysis of GTP hydrolysis in Arf1 by a specific GTPase-activating protein (ArfGAP1)(8-10), the precise timing of this reaction during COPI vesicle formation is not known. Using time-resolved assays for COPI dynamics on liposomes of controlled size, we show that the rate of ArfGAP1-catalysed GTP hydrolysis in Arf1 and the rate of COPI disassembly increase over two orders of magnitude as the curvature of the lipid bilayer increases and approaches that of a typical transport vesicle. This leads to a model for COPI dynamics in which GTP hydrolysis in Arf1 is organized temporally and spatially according to the changes in lipid packing induced by the coat.	CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; Univ Nice, Ctr Commun Microscopie Appl, F-06103 Nice 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Antonny, B (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.		Antonny, Bruno/ABH-7434-2020	Antonny, Bruno/0000-0002-9166-8668; Joelle, BIGAY/0000-0002-7487-3416				Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Antonny B, 2003, EMBO REP, V4, P419, DOI 10.1038/sj.embor.embor812; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; FINAZZI D, 1994, J BIOL CHEM, V269, P13325; FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337; Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Matsuoka K, 2000, METHODS, V20, P417, DOI 10.1006/meth.2000.0955; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Nickel W, 2001, METHOD ENZYMOL, V329, P388; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Reinhard C, 2003, P NATL ACAD SCI USA, V100, P8253, DOI 10.1073/pnas.1432391100; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Stamnes M, 1998, P NATL ACAD SCI USA, V95, P13676, DOI 10.1073/pnas.95.23.13676; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; Yanagisawa LL, 2002, MOL BIOL CELL, V13, P2193, DOI 10.1091/mbc.01-11-0563; YANG NC, 1969, MOL PHOTOCHEM, V1, P159; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418; Zhu YX, 1998, MOL BIOL CELL, V9, P1323, DOI 10.1091/mbc.9.6.1323	30	250	254	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2003	426	6966					563	566		10.1038/nature02108	http://dx.doi.org/10.1038/nature02108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654841				2022-12-28	WOS:000186944300040
J	Kappelman, J; Rasmussen, DT; Sanders, WJ; Feseha, M; Bown, T; Copeland, P; Crabaugh, J; Fleagle, J; Glantz, M; Gordon, A; Jacobs, B; Maga, M; Muldoon, K; Pan, A; Pyne, L; Richmond, B; Ryan, T; Seiffert, ER; Sen, S; Todd, L; Wiemann, MC; Winkler, A				Kappelman, J; Rasmussen, DT; Sanders, WJ; Feseha, M; Bown, T; Copeland, P; Crabaugh, J; Fleagle, J; Glantz, M; Gordon, A; Jacobs, B; Maga, M; Muldoon, K; Pan, A; Pyne, L; Richmond, B; Ryan, T; Seiffert, ER; Sen, S; Todd, L; Wiemann, MC; Winkler, A			Oligocene mammals from Ethiopia and faunal exchange between Afro-Arabia and Eurasia	NATURE			English	Article							FLOOD VOLCANISM; MIOCENE; PROBOSCIDEANS; HIGHLANDS; MOROCCO; YEMEN	Afro-Arabian mammalian communities underwent a marked transition near the Oligocene/Miocene boundary at approximately 24 million years (Myr) ago. Although it is well documented that the endemic paenungulate taxa were replaced by migrants from the Northern Hemisphere, the timing and evolutionary dynamics of this transition have long been a mystery because faunas from about 32 to 24 Myr ago are largely unknown(1). Here we report a late Oligocene fossil assemblage from Ethiopia, which constrains the migration to postdate 27 Myr ago, and yields new insight into the indigenous faunal dynamics that preceded this event. The fauna is composed of large paenungulate herbivores and reveals not only which earlier taxa persisted into the late Oligocene epoch but also demonstrates that one group, the Proboscidea, underwent a marked diversification. When Eurasian immigrants entered Afro-Arabia, a pattern of winners and losers among the endemics emerged: less diverse taxa such as arsinoitheres became extinct, moderately species-rich groups such as hyracoids continued into the Miocene with reduced diversity, whereas the proboscideans successfully carried their adaptive radiation out of Afro-Arabia and across the world.	Univ Texas, Dept Anthropol, Austin, TX 78712 USA; Univ Texas, Dept Geol Sci, Austin, TX 78712 USA; Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; Univ Houston, Dept Geosci, Houston, TX 77204 USA; Univ Wyoming, Dept Geol & Geophys, Laramie, WY 82071 USA; SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; Colorado State Univ, Dept Anthropol, Ft Collins, CO 80523 USA; So Methodist Univ, Dept Geol Sci, Dallas, TX 75275 USA; George Washington Univ, Dept Anthropol, Washington, DC 20052 USA; Duke Univ, Dept Biol Anthropol & Anat, Durham, NC 27708 USA; Museum Natl Hist Nat, Lab Paleontol, F-75005 Paris, France; Forest Serv, Ctr Wood Anat Res, USDA, Forest Prod Lab, Madison, WI 53705 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Washington University (WUSTL); University of Michigan System; University of Michigan; University of Houston System; University of Houston; University of Wyoming; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Colorado State University; Southern Methodist University; George Washington University; Duke University; Museum National d'Histoire Naturelle (MNHN); United States Department of Agriculture (USDA); United States Forest Service; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Kappelman, J (corresponding author), Univ Texas, Dept Anthropol, Austin, TX 78712 USA.		Gordon, Adam/AAB-9006-2019; Copeland, Pete/A-9823-2008	Gordon, Adam/0000-0002-1807-4644; Maga, A. Murat/0000-0002-7921-9018; PAN, AARON/0000-0002-3286-3105				Andrews CW, 1906, DESCRIPTIVE CATALOGU, P1; Baker J, 1996, EARTH PLANET SC LETT, V138, P39, DOI 10.1016/0012-821X(95)00229-6; BOSCHETTO HB, 1992, J HUM EVOL, V22, P47, DOI 10.1016/0047-2484(92)90029-9; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Coppens Y., 1978, P336; Court N, 1995, J VERTEBR PALEONTOL, V15, P650, DOI 10.1080/02724634.1995.10011254; FESEHA M, 2001, SEQUENCE STRATIGRAPH; Gheerbrant E, 2002, ACTA PALAEONTOL POL, V47, P493; Gheerbrant E, 1996, NATURE, V383, P68, DOI 10.1038/383068a0; Harris J.M., 1978, P315; Hofmann C, 1997, NATURE, V389, P838, DOI 10.1038/39853; Maglio V.J., 1978, P603; MURDOCK TG, 1944, MINERAL INVESTIGATIO, V19; PICKFORD M, 1986, COMPTES RENDUS ACD S, V19, P1305; Pickford M., 1986, MUNCHNER GEOWISS ABH, V8, P1; Rasmussen D.T., 1988, Journal of Vertebrate Paleontology, V8, P67; RASMUSSEN DT, 1989, EVOLUTION PERISSODAC, P57; Rochette P, 1998, EARTH PLANET SC LETT, V164, P497, DOI 10.1016/S0012-821X(98)00241-6; Sanders WJ, 2002, J VERTEBR PALEONTOL, V22, P388, DOI 10.1671/0272-4634(2002)022[0388:NPFTEM]2.0.CO;2; SHOSHANI J, 2001, 8 INT THER C JOH, P128; Spell TL, 1996, GEOL SOC AM BULL, V108, P1549, DOI 10.1130/0016-7606(1996)108<1549:CTRJVF>2.3.CO;2; Tanner L.G., 1978, P279; TASSY P, 1985, MEMOIRES SCI TERRE U, V8534, P1; Thomas H, 1999, FOSSIL VERTEBRATES OF ARABIA, P430; Ukstins IA, 2002, EARTH PLANET SC LETT, V198, P289, DOI 10.1016/S0012-821X(02)00525-3; Wight A.W.R., 1980, GEOLOGY LIBYA, P309; YEMANE K, 1987, J AFR EARTH SCI, V6, P91, DOI 10.1016/0899-5362(87)90110-2; YEMANE K, 1987, PALAEOGEOGR PALAEOCL, V60, P123, DOI 10.1016/0031-0182(87)90028-9; YEMANE K, 1985, NATURE, V318, P653, DOI 10.1038/318653a0	29	105	112	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2003	426	6966					549	552		10.1038/nature02102	http://dx.doi.org/10.1038/nature02102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654838	Green Published			2022-12-28	WOS:000186944300036
J	Lin, M; Storer, B; Martin, PJ; Tseng, L; Gooley, T; Chen, P; Hansen, JA				Lin, M; Storer, B; Martin, PJ; Tseng, L; Gooley, T; Chen, P; Hansen, JA			Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic cell transplantation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW-TRANSPLANTATION; SINGLE NUCLEOTIDE POLYMORPHISMS; GENE POLYMORPHISMS; TNF-ALPHA; INTERFERON-GAMMA; IL-10 PRODUCTION; T-CELLS; CD4(+); ASSOCIATE; SIBLINGS	BACKGROUND: Polymorphisms in cytokine genes can influence immune responses, inflammation, and tissue injury and may affect the outcome of hematopoietic stem-cell transplantation. METHODS: We analyzed single-nucleotide polymorphisms in the genes for interleukin-1(beta), interleukin-1-receptor antagonist, interleukin-6, interleukin-10 (IL10), and tumor necrosis factor (alpha) in 570 transplant recipients and their HLA-identical sibling donors. Genotypes were tested for an association with graft-versus-host disease (GVHD) by multivariable analysis. A second cohort of 423 transplant recipients was independently analyzed for the genotype associations identified in the first cohort. RESULTS: The recipient's IL10 promoter region genotype was significantly associated with the risk of acute GVHD in the first cohort. Analysis of all 993 transplant recipients showed that, as compared with the C/C genotype, the IL10 -592A/A genotype was associated with a decreased risk of grade III or IV acute GVHD (hazard ratio, 0.4; 95 percent confidence interval, 0.2 to 0.9; P=0.02) and death in remission (hazard ratio, 0.6; 95 percent confidence interval, 0.3 to 1.0; P=0.05). A haplotype analysis showed that the IL10 -592A allele was a specific marker for a promoter haplotype, T-C-A-T-A, defined by five polymorphisms at positions -3575, -2763, -1082, -819, and -592, respectively. CONCLUSIONS: Among recipients of hematopoietic cells from an HLA-identical sibling, the IL10 -592A allele is a marker of a favorable outcome after transplantation.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Sch Med, Seattle, WA USA; Natl Taiwan Univ Hosp, Dept Med Genet, Taipei, Taiwan; Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; Natl Taiwan Univ, Canc Res Ctr, Taipei 10764, Taiwan	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Hansen, JA (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,D2-100,POB 19024, Seattle, WA 98109 USA.			Chen, Pei-Jer/0000-0001-8316-3785; TSENG, LI-HUI/0000-0002-8308-6772	NCI NIH HHS [CA15704, CA18221, CA18029] Funding Source: Medline; NIAID NIH HHS [AI33484, AI49213] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA018221, P30CA015704, P01CA018029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI033484] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andersen P. K., 2012, STAT MODELS BASED CO; BACCHETTA R, 1994, J EXP MED, V179, P493, DOI 10.1084/jem.179.2.493; BEATTY PG, 1985, NEW ENGL J MED, V313, P765, DOI 10.1056/NEJM198509263131301; Bidwell J, 1999, GENES IMMUN, V1, P3, DOI 10.1038/sj.gene.6363645; Blazar BR, 1998, TRANSPLANTATION, V66, P1220, DOI 10.1097/00007890-199811150-00018; BLAZAR BR, 1995, BLOOD, V85, P842, DOI 10.1182/blood.V85.3.842.bloodjournal853842; Cavet J, 1999, BLOOD, V94, P3941, DOI 10.1182/blood.V94.11.3941.423k10_3941_3946; Cavet J, 2001, BLOOD, V98, P1594, DOI 10.1182/blood.V98.5.1594; Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y; Cullup H, 2001, BRIT J HAEMATOL, V113, P807, DOI 10.1046/j.1365-2141.2001.02811.x; DING L, 1993, J IMMUNOL, V151, P1224; FERRARA JLM, 1991, NEW ENGL J MED, V324, P667; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibson AW, 2001, J IMMUNOL, V166, P3915, DOI 10.4049/jimmunol.166.6.3915; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; HANSEN JA, 1992, MANUAL CLIN LAB IMMU, P850; HARTL DL, 1997, PRINCIPLES POPULATIO, P71; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Holler E, 2000, BONE MARROW TRANSPL, V25, P237, DOI 10.1038/sj.bmt.1702126; Keijsers Vivian, 1997, Arthritis and Rheumatism, V40, pS179; Koss K, 2000, GENES IMMUN, V1, P185, DOI 10.1038/sj.gene.6363657; Krenger W, 1997, TRANSPLANTATION, V64, P553, DOI 10.1097/00007890-199708270-00001; Levings MK, 2001, J IMMUNOL, V166, P5530, DOI 10.4049/jimmunol.166.9.5530; Lin MT, 2001, BLOOD, V98, P3172, DOI 10.1182/blood.V98.10.3172; MORISHIMA Y, 1989, BLOOD, V74, P2252, DOI 10.1182/blood.V74.6.2252.2252; PERREAULT C, 1990, BLOOD, V76, P1269; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Sasazuki T, 1999, NEW ENGL J MED, V340, P402; SMITH SR, 1995, TRANSPLANTATION, V59, P890, DOI 10.1097/00007890-199503270-00016; Socie G, 2001, TRANSPLANTATION, V72, P699, DOI 10.1097/00007890-200108270-00024; SULLIVAN KM, 1991, SEMIN HEMATOL, V28, P250; Takahashi H, 2000, BONE MARROW TRANSPL, V26, P1317, DOI 10.1038/sj.bmt.1702724; Taylor PA, 2002, BLOOD, V99, P3493, DOI 10.1182/blood.V99.10.3493; Tegoshi H, 2002, HUM IMMUNOL, V63, P121, DOI 10.1016/S0198-8859(01)00363-9; Tseng LH, 2002, J IMMUNOL METHODS, V267, P151, DOI 10.1016/S0022-1759(02)00165-5; Tseng LH, 2002, TISSUE ANTIGENS, V59, P280, DOI 10.1034/j.1399-0039.2002.590405.x; Tseng LH, 2001, TISSUE ANTIGENS, V57, P318, DOI 10.1034/j.1399-0039.2001.057004318.x; Turner DM, 1997, EUR J IMMUNOGENET, V24, P1, DOI 10.1111/j.1365-2370.1997.tb00001.x; Zeller JC, 1999, J IMMUNOL, V163, P3684	40	298	317	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2003	349	23					2201	2210		10.1056/NEJMoa022060	http://dx.doi.org/10.1056/NEJMoa022060			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LH	14657427	Bronze			2022-12-28	WOS:000186921700006
J	Chunilal, SD; Eikelboom, JW; Attia, J; Miniati, M; Panju, AA; Simel, DL; Ginsberg, JS				Chunilal, SD; Eikelboom, JW; Attia, J; Miniati, M; Panju, AA; Simel, DL; Ginsberg, JS			Does this patient have pulmonary embolism?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEEP-VEIN THROMBOSIS; CLINICAL-PREDICTION RULES; D-DIMER ASSAYS; VENOUS THROMBOEMBOLISM; DIAGNOSTIC STRATEGY; PROBABILITY; MANAGEMENT; MODEL; EMERGENCY; RISK	Context Experienced clinicians' gestalt is useful in estimating the pretest probability for pulmonary embolism and is complementary to diagnostic testing, such as lung scanning. However, it is unclear whether recently developed clinical prediction rules, using explicit features of clinical examination, are comparable with clinicians' gestalt. If so, clinical prediction rules would be powerful tools because they could be used by less-experienced health care professionals to simplify the diagnosis of pulmonary embolism. Recent studies have shown that the combination of a low pretest probability (using a clinical prediction rule) and a normal result of a D-dimer test reliably excludes pulmonary,embolism without the need for further testing. Objective To evaluate and demonstrate the accuracy of pretest probability assessment for pulmonary embolism using clinical gestalt vs clinical prediction rules. Data Sources The MEDLINE database was searched for relevant articles published between 1966 and March 2003. Bibliographies of pertinent articles also were scanned for suitable articles. Study Selection To be included in the analysis, studies were required to have consecutive, unselected patients enrolled; participating physicians in the studies, blinded to the results of diagnostic testing, had to estimate pretest probability of pulmonary embolism; and validated diagnostic methods had to be used to confirm or exclude pulmonary embolism. Data Extraction Three reviewers independently scanned titles and abstracts for inclusion of studies. An initial MEDLINE search identified 1709 studies, of which 16 involving 8306 patients were included in the final analysis. Data Synthesis A clinical gestalt strategy was used in 7 studies, and in the low, moderate, and high pretest categories, the rates of pulmonary embolism ranged from 8% to 19%, 26% to 47%, and 46% to 91%, respectively. Clinical prediction rules were used in 10 studies, and 3% to 28%, 16% to 46%, and 38% to 98% in the low, moderate, and high pretest probability groups, respectively, had pulmonary embolism. Conclusions The clinical gestalt of experienced clinicians and the clinical prediction rules used by physicians of varying experience have shown similar accuracy in discriminating among patients who have a low, moderate, or high pretest probability of pulmonary embolism. We advocate the use of a clinical prediction rule because it has shown to be accurate and can be used by less-experienced clinicians.	McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; Queen Elisabeth Hosp, Dept Haematol, Woodville, SA, Australia; Royal Perth Hosp, Dept Haematol, Perth, WA, Australia; Univ Newcastle, Ctr Clin Epidemiol & Biostat, Newcastle, NSW, Australia; Natl Res Council Italy, Inst Clin Physiol, Pisa, Italy; Hamilton Hlth Sci Corp, Henderson Div, Hamilton, ON, Canada; Duke Univ, Vet Affairs Med Ctr, Durham, NC USA; Duke Univ, Dept Med, Durham, NC USA	McMaster University; Royal Perth Hospital; University of Western Australia; University of Newcastle; Consiglio Nazionale delle Ricerche (CNR); McMaster University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University	Ginsberg, JS (corresponding author), McMaster Univ, Dept Med, HSC 3X28,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	ginsbrgj@mcmaster.ca	ginsberg, jeffrey s/ABC-1065-2020; Attia, John R/F-5376-2013; Eikelboom, John/AAG-6117-2019	Attia, John R/0000-0001-9800-1308; Eikelboom, John/0000-0003-4126-1285; Miniati, Massimo/0000-0002-6977-8916				Anand SS, 1998, JAMA-J AM MED ASSOC, V279, P1094, DOI 10.1001/jama.279.14.1094; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; BARRITT DW, 1960, LANCET, V1, P1309; Bates SM, 2003, ANN INTERN MED, V138, P787, DOI 10.7326/0003-4819-138-10-200305200-00006; Bates SM, 2001, ARCH INTERN MED, V161, P447, DOI 10.1001/archinte.161.3.447; Becker DM, 1996, ARCH INTERN MED, V156, P939, DOI 10.1001/archinte.156.9.939; Chagnon I, 2002, AM J MED, V113, P269, DOI 10.1016/S0002-9343(02)01212-3; de Moerloose P, 2000, THROMB HAEMOSTASIS, V83, P180; Douketis JD, 1997, ARCH INTERN MED, V157, P1522, DOI 10.1001/archinte.157.14.1522; Eddy DM., 1992, META ANAL CONFIDENCE; EDDY DM, 1992, FAST PRO V1 8 SOFTWA; GARDNER S, 1989, CONFIDENCE INTERVAL; Ginsberg JS, 1998, ANN INTERN MED, V129, P1006, DOI 10.7326/0003-4819-129-12-199812150-00003; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Goldhaber SZ, 1998, NEW ENGL J MED, V339, P93, DOI 10.1056/NEJM199807093390207; Grady D, 2000, ANN INTERN MED, V132, P689, DOI 10.7326/0003-4819-132-9-200005020-00002; Hampson N B, 1995, Semin Respir Infect, V10, P123; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; HOELLERICH VL, 1986, ARCH INTERN MED, V146, P1699, DOI 10.1001/archinte.146.9.1699; HULL RD, 1994, ARCH INTERN MED, V154, P289, DOI 10.1001/archinte.154.3.289; HULL RD, 1983, ANN INTERN MED, V98, P891, DOI 10.7326/0003-4819-98-6-891; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kearon C, 2001, ANN INTERN MED, V135, P108, DOI 10.7326/0003-4819-135-2-200107170-00011; Kline JA, 2002, ANN EMERG MED, V39, P144, DOI 10.1067/mem.2002.121398; Kruip MJHA, 2002, ARCH INTERN MED, V162, P1631, DOI 10.1001/archinte.162.14.1631; KRUIT WHJ, 1991, J INTERN MED, V230, P333, DOI 10.1111/j.1365-2796.1991.tb00453.x; Miniati M, 2003, AM J MED, V114, P173, DOI 10.1016/S0002-9343(02)01478-X; Miniati M, 1999, AM J RESP CRIT CARE, V159, P864, DOI 10.1164/ajrccm.159.3.9806130; Miniati M, 1996, AM J RESP CRIT CARE, V154, P1387, DOI 10.1164/ajrccm.154.5.8912753; MOSER KM, 1994, JAMA-J AM MED ASSOC, V271, P223, DOI 10.1001/jama.271.3.223; Musset D, 2002, LANCET, V360, P1914, DOI 10.1016/S0140-6736(02)11914-3; Perrier A, 1996, ARCH INTERN MED, V156, P531, DOI 10.1001/archinte.156.5.531; Perrier A, 1997, AM J RESP CRIT CARE, V156, P492, DOI 10.1164/ajrccm.156.2.9702032; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Sanson BJ, 2000, THROMB HAEMOSTASIS, V83, P199; Sijens PE, 2000, THROMB HAEMOSTASIS, V84, P156; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; STEIN PD, 1981, AM J CARDIOL, V47, P218, DOI 10.1016/0002-9149(81)90388-X; STEIN PD, 1992, CIRCULATION, V85, P462, DOI 10.1161/01.CIR.85.2.462; SUSKIN D, 1990, METASTAT VERSION 1; VANBEEK EJR, 1993, THROMB HAEMOSTASIS, V70, P408; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; WELLS PS, 1995, LANCET, V345, P1326, DOI 10.1016/S0140-6736(95)92535-X; Wells PS, 2001, ANN INTERN MED, V135, P98, DOI 10.7326/0003-4819-135-2-200107170-00010; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Wicki J, 2001, ARCH INTERN MED, V161, P92, DOI 10.1001/archinte.161.1.92	48	118	123	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2849	2858		10.1001/jama.290.21.2849	http://dx.doi.org/10.1001/jama.290.21.2849			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QP	14657070	Green Published			2022-12-28	WOS:000186872800028
J	Hansen, H; Groce, N				Hansen, H; Groce, N			Human immunodeficiency virus and quarantine in Cuba	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AIDS; HIV		Yale Univ, Sch Med, New Haven, CT 06520 USA	Yale University	Hansen, H (corresponding author), Yale Univ, Sch Med, 333 Cedar St, New Haven, CT 06520 USA.		Chesters, Heather/C-6089-2009	Groce, Nora/0000-0002-7885-7042				Avila JP, 1996, BIOMED PHARMACOTHER, V50, P216, DOI 10.1016/0753-3322(96)87661-X; BAYER R, 1989, NEW ENGL J MED, V320, P1022, DOI 10.1056/NEJM198904133201529; Burr C, 1997, LANCET, V350, P647, DOI 10.1016/S0140-6736(05)63342-9; CASTILLO OG, 2003, TOURISM DEV LOCOMOTI; Farmer P, 1996, EMERG INFECT DIS, V2, P259, DOI 10.3201/eid0204.960402; FEINSILVER JM, 1989, LAT AM RES REV, V24, P1; Hansen H, 2001, Med Anthropol, V19, P259; KEYS S, 1997, AIDS WKLY PLUS  0901, P21; PEREZSTABLE EJ, 1991, AM J PUBLIC HEALTH, V81, P563, DOI 10.2105/AJPH.81.5.563; SANTANA S, 1991, INT J HEALTH SERV, V21, P511, DOI 10.2190/PPF0-X27G-LF4X-XEYC; SCHEPERHUGHES N, 1994, SOC SCI MED, V39, P991, DOI 10.1016/0277-9536(94)90210-0; SCHEPERHUGHES N, 1993, LANCET, V342, P965, DOI 10.1016/0140-6736(93)92006-F; Swanson J M, 1995, J Assoc Nurses AIDS Care, V6, P33, DOI 10.1016/S1055-3290(05)80027-5; *UNAIDS, 2003, FACT SHEET CUB; Waitzkin H, 1997, J FAM PRACTICE, V45, P250	15	16	16	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2875	2875		10.1001/jama.290.21.2875	http://dx.doi.org/10.1001/jama.290.21.2875			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	748QP	14657076	Bronze			2022-12-28	WOS:000186872800034
J	Pepine, CJ; Handberg, EM; Cooper-Dehoff, RM; Marks, RG; Kowey, P; Messerli, FH; Mancia, G; Cangiano, JL; Garcia-Barreto, D; Keltai, M; Erdine, S; Bristol, HA; Kolb, HR; Bakris, GL; Cohen, JD; Parmley, WW				Pepine, CJ; Handberg, EM; Cooper-Dehoff, RM; Marks, RG; Kowey, P; Messerli, FH; Mancia, G; Cangiano, JL; Garcia-Barreto, D; Keltai, M; Erdine, S; Bristol, HA; Kolb, HR; Bakris, GL; Cohen, JD; Parmley, WW		INVEST Investigators	A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease - The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR MORBIDITY; BLOOD-PRESSURE; ANTIHYPERTENSIVE DRUGS; BETA-BLOCKERS; MORTALITY; OUTCOMES; THERAPY; PREVENTION; INTERVENTION; METAANALYSIS	Context Despite evidence of efficacy of anti hypertensive agents in treating hypertensive patients, safety and efficacy of anti hypertensive agents for coronary artery disease (CAD) have been discerned only from subgroup analyses in large trials. Objective To compare mortality and morbidity outcomes in patients with hypertension and CAD treated with a calcium antagonist strategy (CAS) or a non-calcium antagonist strategy (NCAS). Design, Setting, and Participants Randomized, open label, blinded end point study of 22576 hypertensive CAD patients aged 50 years or older, which was conducted September 1997 to February 2003 at 862 sites in 14 countries. Interventions Patients were randomly assigned to either CAS (verapamil sustained release) or NCAS (atenolol). Strategies specified dose and additional drug regimens. Trandolapril and/or hydrochlorothiazide was administered to achieve blood pressure goals according to guidelines from the sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) of less than 140 mm Hg (systolic) and less than 90 mm Hg (diastolic); and less than 130 mm Hg (systolic) and less than 85 mm Hg (diastolic) if diabetes or renal impairment was present. Trandolapril was also recommended for patients with heart failure, diabetes, or renal impairment. Main Outcome Measures Primary: first occurrence of death (all cause), nonfatal myocardial infarction, or nonfatal stroke; other: cardiovascular death, angina, adverse experiences,, hospitalizations, and blood pressure control at 24 months. Results At 24 months, in the CAS group, 6391 patients (81.5%) were taking verapamil sustained release; 4934 (62.9%) were taking trandolapril; and 3430 (43.7%) were taking hydrochlorothiazide. In the NCAS group, 6083 patients (77.5%) were taking atenolol; 4733 (60.3%) were taking hydrochlorothiazide; and 4113 (52.4%) were taking trandolapril. After a follow-up of 61835 patient-years (mean, 2.7 years per patient), 2269 patients had a primary outcome event with no statistically significant difference between treatment strategies (9.93% in CAS and 10.17% in NCAS; relative risk [RR],0.98; 95% confidence interval [CI], 0.90-1.06). Two-year blood pressure control was similar between groups. The JNC VI blood pressure goals were achieved by 65.0% (systolic) and 88.5% (diastolic) of CAS and 64.0% (systolic) and 88.1% (diastolic) of NCAS patients. A total of 71.7% of CAS and 70.7% of,NCAS patients achieved a systolic blood pressure of less than 140 mm Hg And diastolic blood pressure of less than 90 mm HA. Conclusion The verapamil-trandolapril-based strategy was as clinically effective as the atenolol-hydrochlorothiazide-based strategy in hypertensive CAD patients.	Univ Florida, Coll Med, Dept Med, Div Cardiovasc Med, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Stat, Div Cardiovasc Med, Gainesville, FL 32610 USA; Lankenau Hosp, Dept Med, Wynnewood, PA USA; Ochsner Clin & Alton Ochsner Med Fdn, Dept Med, New Orleans, LA USA; Univ Studi, Dept Med, Monza, Italy; Clin Las Amer, Hato Rey, PR USA; Inst Cardiol & Cirugia Cardiovasc, Havana, Cuba; Semmelweis Univ, Dept Cardiol, Budapest, Hungary; Istanbul Univ, Inst Cardiol, Istanbul, Turkey; Rush Univ, Dept Prevent Med, Chicago, IL 60612 USA; St Louis Univ, Dept Med, St Louis, MO 63103 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Lankenau Medical Center; Ochsner Health System; Semmelweis University; Istanbul University; Rush University; Saint Louis University; University of California System; University of California San Francisco	Pepine, CJ (corresponding author), Univ Florida, Coll Med, Dept Med, Div Cardiovasc Med, 1600 SW Archer Rd, Gainesville, FL 32610 USA.		Messerli, Franz/AAR-4783-2021	Handberg, Eileen/0000-0002-7805-9577; Patt, Mitchell/0000-0001-9696-4477	DIVISION OF HEART AND VASCULAR DISEASES [N01HV068163] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL064924] Funding Source: NIH RePORTER	DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alderman M, 1997, J HYPERTENS, V15, P105; *AM HEART ASS, 2002, HEART DIS STROK STA; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1993, ARCH INTERN MED, V153, P154, DOI DOI 10.1001/archinte.1993.00410020010002; Bakris GL, 2000, AM J KIDNEY DIS, V36, P646, DOI 10.1053/ajkd.2000.16225; BENGTSSON C, 1992, J INTERN MED, V231, P583, DOI 10.1111/j.1365-2796.1992.tb01243.x; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; Chalmers J, 1999, CLIN EXP HYPERTENS, V21, P1009; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COOPERDEHOFF R, 2003, CIRCULATION, V108, P750; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Epstein M, 1997, AM J CARDIOL, V79, P9, DOI 10.1016/S0002-9149(97)00266-X; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; FURBERG CD, 1995, CIRCULATION, V92, P1326, DOI 10.1161/01.CIR.92.5.1326; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hennekens CH, 1996, NEW ENGL J MED, V335, P1660, DOI 10.1056/NEJM199611283352207; Hjalmarson A, 1999, LANCET, V353, P2001; Holzgreve H, 2003, AM J HYPERTENS, V16, P381, DOI 10.1016/S0895-7061(03)00062-1; Joint National Committee on Prevention Detection evaluation and treatment of high blood pressure, 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005; Karlberg BE, 2000, BLOOD PRESSURE, V9, P140, DOI 10.1080/080370500453483; Lechat P, 1999, LANCET, V353, P9; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Messerli FH, 1998, JAMA-J AM MED ASSOC, V279, P1903, DOI 10.1001/jama.279.23.1903; Neal B, 2000, LANCET, V356, P1955; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Pahor M, 2000, LANCET, V356, P1949, DOI 10.1016/S0140-6736(00)03306-7; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Pepine CJ, 1998, J AM COLL CARDIOL, V32, P1228, DOI 10.1016/S0735-1097(98)00423-9; Pepine CJ, 1998, CLIN CARDIOL, V21, P633, DOI 10.1002/clc.4960210906; PEPINE CJ, 1995, EUR HEART J, V16, P19, DOI 10.1093/eurheartj/16.suppl_H.19; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; Ruilope LM, 2002, J HYPERTENS, V20, P729; Ruilope LM, 1999, J HYPERTENS, V17, P1917, DOI 10.1097/00004872-199917121-00022; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; WRIGHT J, 2003, JAMA-J AM MED ASSOC, V289, P2067; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Yusuf S, 2000, NEW ENGL J MED, V342, P145	43	935	1003	1	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2805	2816		10.1001/jama.290.21.2805	http://dx.doi.org/10.1001/jama.290.21.2805			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QP	14657064	Bronze			2022-12-28	WOS:000186872800022
J	Morris, S; Stacey, M				Morris, S; Stacey, M			ABC of resuscitation - Resuscitation in pregnancy	BRITISH MEDICAL JOURNAL			English	Review							PERIMORTEM CESAREAN-SECTION		Cardiff & Vale NHS Trust, Cardiff, S Glam, Wales	Cardiff University	Morris, S (corresponding author), Cardiff & Vale NHS Trust, Cardiff, S Glam, Wales.							Department of Health, 2001, REP CONF ENQ MAT DEA; European Resuscitation Council, 2000, RESUSCITATION, V46, P293; GOODWIN APL, 1992, ANAESTHESIA, V47, P433, DOI 10.1111/j.1365-2044.1992.tb02228.x; Page-Rodriguez A, 1999, ACAD EMERG MED, V6, P1072, DOI 10.1111/j.1553-2712.1999.tb01199.x; Whitten M, 2000, J ROY SOC MED, V93, P6, DOI 10.1177/014107680009300103	5	66	75	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 29	2003	327	7426					1277	1279		10.1136/bmj.327.7426.1277	http://dx.doi.org/10.1136/bmj.327.7426.1277			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749VD	14644974	Green Published			2022-12-28	WOS:000186948800023
J	Courchamp, F; Woodroffe, R; Roemer, G				Courchamp, F; Woodroffe, R; Roemer, G			Removing protected populations to save endangered species	SCIENCE			English	Article									New Mexico State Univ, Dept Fishery & Wildlife Sci, Las Cruces, NM 88003 USA; Univ Paris 11, F-91405 Orsay, France; Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	New Mexico State University; UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Davis	Roemer, G (corresponding author), New Mexico State Univ, Dept Fishery & Wildlife Sci, Las Cruces, NM 88003 USA.		burke, daniel/D-3668-2009; Courchamp, Franck/ABE-7204-2020	Courchamp, Franck/0000-0001-7605-4548				COONAN T, 2003, ISLAND FOX CAPTIVE B; ROEMER G, IN PRESS FOXES JACKA; Roemer GW, 2002, P NATL ACAD SCI USA, V99, P791, DOI 10.1073/pnas.012422499; *US NAT PARK SERV, 2003, SANT CRUZ ISL PRIM R	4	75	77	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1532	1532		10.1126/science.1089492	http://dx.doi.org/10.1126/science.1089492			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645839				2022-12-28	WOS:000186802200032
J	Dick, HJB; Lin, J; Schouten, H				Dick, HJB; Lin, J; Schouten, H			An ultraslow-spreading class of ocean ridge	NATURE			English	Article							SOUTHWEST INDIAN RIDGE; GRAVITY-ANOMALIES; CRUSTAL THICKNESS; MELT GENERATION; GAKKEL RIDGE; BASALT; MANTLE; ATLANTIC; MORB	New investigations of the Southwest Indian and Arctic ridges reveal an ultraslow-spreading class of ocean ridge that is characterized by intermittent volcanism and a lack of transform faults. We find that the mantle beneath such ridges is emplaced continuously to the seafloor over large regions. The differences between ultraslow- and slow-spreading ridges are as great as those between slow- and fast-spreading ridges. The ultraslow- spreading ridges usually form at full spreading rates less than about 12 mm yr(-1), though their characteristics are commonly found at rates up to approximately 20 mm yr(-1). The ultraslow-spreading ridges consist of linked magmatic and amagmatic accretionary ridge segments. The amagmatic segments are a previously unrecognized class of accretionary plate boundary structure and can assume any orientation, with angles relative to the spreading direction ranging from orthogonal to acute. These amagmatic segments sometimes coexist with magmatic ridge segments for millions of years to form stable plate boundaries, or may displace or be displaced by transforms and magmatic ridge segments as spreading rate, mantle thermal structure and ridge geometry change.	Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Dick, HJB (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	hdick@whoi.edu		Lin, Jian/0000-0002-6831-2014				BOWN JW, 1994, EARTH PLANET SC LETT, V121, P435, DOI 10.1016/0012-821X(94)90082-5; Brozena JM, 2003, GEOLOGY, V31, P825, DOI 10.1130/G19528.1; CLAY KR, 1995, MAR PETROL GEOL, V12, P137; Coakley BJ, 1998, EARTH PLANET SC LETT, V162, P81, DOI 10.1016/S0012-821X(98)00158-7; Cochran JR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001830; COCHRAN JR, 1998, EOS T AGU, V79, pF854; COCHRAN JR, 1991, EOS, V260, P88; DAUTEUIL O, 1993, NATURE, V361, P145, DOI 10.1038/361145a0; DEMETS C, 1990, GEOPHYS J INT, V101, P425, DOI 10.1111/j.1365-246X.1990.tb06579.x; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; DICK HJB, 1996, SCI RESULTS, P103; DICK HJB, 1998, EOS, pF919; DUCKWORTH GL, 1982, TECTONOPHYSICS, V89, P173, DOI 10.1016/0040-1951(82)90038-5; Edwards MH, 2001, NATURE, V409, P808, DOI 10.1038/35057258; FEDEN RH, 1979, EARTH PLANET SC LETT, V44, P18, DOI 10.1016/0012-821X(79)90004-9; Fornari DJ, 1998, J GEOPHYS RES-SOL EA, V103, P9827, DOI 10.1029/98JB00028; FORSYTH DW, 1992, GEOPH MONOG SERIES, V71, P1; Georgen JE, 2001, EARTH PLANET SC LETT, V187, P283, DOI 10.1016/S0012-821X(01)00293-X; Grindlay NR, 1998, EARTH PLANET SC LETT, V161, P243, DOI 10.1016/S0012-821X(98)00154-X; HEEZEN BC, 1960, SCI AM, V203, P98, DOI 10.1038/scientificamerican1060-98; JACKSON HR, 1982, J GEOPHYS RES, V87, P1773, DOI 10.1029/JB087iB03p01773; JACKSON HR, 1983, EARTH PLANET SC LETT, V63, P368, DOI 10.1016/0012-821X(83)90110-3; Jokat W, 2003, NATURE, V423, P962, DOI 10.1038/nature01706; KLEIN EM, 1987, J GEOPHYS RES-SOLID, V92, P8089, DOI 10.1029/JB092iB08p08089; KUO BY, 1988, MAR GEOPHYS RES, V10, P205, DOI 10.1007/BF00310065; LEROEX AP, 1992, CONTRIB MINERAL PETR, V110, P253, DOI 10.1007/BF00310742; LIN J, 1992, GEOPHYS RES LETT, V19, P13, DOI 10.1029/91GL03041; MACDONALD KC, 1993, GSA TODAY, V3, P1; MACDONALD KC, 1986, W N ATLANTIC REGION, P51; MACNAB R, 2003, GEOPH RES ABSTR, V5, P10909; Magde LS, 1997, J GEOPHYS RES-SOL EA, V102, P20571, DOI 10.1029/97JB01278; MAHONEY J, 1992, J GEOPHYS RES-SOL EA, V97, P19771, DOI 10.1029/92JB01424; Michael PJ, 2003, NATURE, V423, P956, DOI 10.1038/nature01704; MICHAEL PJ, 2001, EOS, V82, pF1097; MORGAN JP, 1993, NATURE, V364, P706, DOI 10.1038/364706a0; Okino K, 2002, EARTH PLANET SC LETT, V202, P275, DOI 10.1016/S0012-821X(02)00790-2; Pertermann M, 2003, J PETROL, V44, P2173, DOI 10.1093/petrology/egg074; PHIPPSMORGAN J, 1987, J GEOPHYS RES, V92, P12823; Poliakov ANB, 1998, GEOPH MONOG SERIES, V106, P305; REID I, 1981, MAR GEOPHYS RES, V5, P165; Salters VJM, 2002, NATURE, V418, P68, DOI 10.1038/nature00798; Sandwell DT, 1997, J GEOPHYS RES-SOL EA, V102, P10039, DOI 10.1029/96JB03223; Sauter D, 2001, EARTH PLANET SC LETT, V192, P303, DOI 10.1016/S0012-821X(01)00455-1; SMALL C, 1989, J GEOPHYS RES-SOLID, V94, P17383, DOI 10.1029/JB094iB12p17383; Small C, 1998, GEOPH MONOG SERIES, V106, P1; SOLOMON S, 1989, P73; SOTIN C, 1989, GEOPHYS RES LETT, V16, P835, DOI 10.1029/GL016i008p00835; STANDISH J, 2002, EOS, V83, pF1331; TOLSTOY M, 1993, SCIENCE, V262, P726, DOI 10.1126/science.262.5134.726; VOGT P, 1989, J GEOPHYS RES, V84, P1071; White RS, 2001, J PETROL, V42, P1171, DOI 10.1093/petrology/42.6.1171	51	691	766	7	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2003	426	6965					405	412		10.1038/nature02128	http://dx.doi.org/10.1038/nature02128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647373				2022-12-28	WOS:000186800800029
J	Planz, O; Seiler, P; Hengartner, H; Zinkernagel, RM				Planz, O; Seiler, P; Hengartner, H; Zinkernagel, RM			Specific cytotoxic T cells eliminate cells producing neutralizing antibodies (vol 382, pg 726, 1996)	NATURE			English	Correction							MICE											Hangartner L, 2003, P NATL ACAD SCI USA, V100, P12883, DOI 10.1073/pnas.2135542100; Planz O, 1996, NATURE, V382, P726, DOI 10.1038/382726a0; Seiler P, 1998, J VIROL, V72, P2253, DOI 10.1128/JVI.72.3.2253-2258.1998	3	7	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					474	474		10.1038/nature02146	http://dx.doi.org/10.1038/nature02146			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647387	Bronze			2022-12-28	WOS:000186800800045
J	Bertrand, V; Hudson, C; Caillol, D; Popovici, C; Lemaire, P				Bertrand, V; Hudson, C; Caillol, D; Popovici, C; Lemaire, P			Neural tissue in ascidian embryos is induced by FGF9/16/20, acting via a combination of maternal GATA and Ets transcription factors	CELL			English	Article							CHORDATE CIONA-INTESTINALIS; FIBROBLAST-GROWTH-FACTOR; XENOPUS EMBRYOS; NERVOUS-SYSTEM; HOMEOBOX GENE; CELL FATE; EXPRESSION; INDUCTION; SPECIFICATION; NOTOCHORD	In chordates, formation of neural tissue from ectodermal cells requires an induction. The molecular nature of the inducer remains controversial in vertebrates. Here, using the early neural marker Otx as an entry point, we dissected the neural induction pathway in the simple embryos of Ciona intestinalis. We first isolated the regulatory element driving Otx expression in the prospective neural tissue, showed that this element directly responds to FGF signaling and that FGF9/16/20 acts as an endogenous neural inducer. Binding site analysis and gene loss of function established that FGF9/16/20 induces neural tissue in the ectoderm via a synergy between two maternal response factors. Ets1/2 mediates general FGF responsiveness, while the restricted activity of GATAa targets the neural program to the ectoderm. Thus, our study identifies an endogenous FGF neural inducer and its early downstream gene cascade. It also reveals a role for GATA factors in FGF signaling.	Univ Mediterranee, AP Marseille, CNRS, INSERM,Lab Genet & Physiol Dev,IBDM, F-13288 Marseille 9, France; CNRS, UPMC, Stn Zool, Unite Biol Dev,UMR 7009, F-06230 Villefranche Sur Mer, France; INSERM, Mol Oncol Lab, U119, IFR 57, F-13009 Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bertrand, V (corresponding author), Univ Mediterranee, AP Marseille, CNRS, INSERM,Lab Genet & Physiol Dev,IBDM, Parc Sci Luminy,Case 907, F-13288 Marseille 9, France.		Lemaire, Patrick/P-8228-2019; Lemaire, Patrick/B-5560-2012; Hudson, Clare/X-7618-2019; Lemaire, Patrick/D-4237-2009; POPOVICI, Cornel/A-2027-2009	Lemaire, Patrick/0000-0003-4925-2009; Lemaire, Patrick/0000-0003-4925-2009; Hudson, Clare/0000-0003-1585-8328; POPOVICI, Cornel/0000-0001-8226-3127; Bertrand, Vincent/0000-0002-9036-2544				Akanuma T, 2002, DEV GENES EVOL, V212, P459, DOI 10.1007/s00427-002-0264-x; Corbo JC, 1998, DEV BIOL, V203, P358, DOI 10.1006/dbio.1998.9067; Corbo JC, 1997, DEVELOPMENT, V124, P589; D'Ambrosio P, 2003, DEV DYNAM, V226, P145, DOI 10.1002/dvdy.10216; Darras S, 2001, DEV BIOL, V236, P271, DOI 10.1006/dbio.2001.0339; Darras S, 1997, DEVELOPMENT, V124, P4275; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Erives A, 1998, DEV BIOL, V194, P213, DOI 10.1006/dbio.1997.8810; Garcia-Garcia MJ, 1999, DEVELOPMENT, V126, P3523; Hardcastle Z, 2000, CURR BIOL, V10, P1511, DOI 10.1016/S0960-9822(00)00825-3; Harland R, 2000, CURR OPIN GENET DEV, V10, P357, DOI 10.1016/S0959-437X(00)00096-4; HemmatiBrivanlou A, 1997, CELL, V88, P13, DOI 10.1016/S0092-8674(00)81853-X; HIKOSAKA A, 1994, DEV BIOL, V166, P763, DOI 10.1006/dbio.1994.1354; Hongo I, 1999, DEV BIOL, V216, P561, DOI 10.1006/dbio.1999.9515; Hudson C, 2003, DEVELOPMENT, V130, P147, DOI 10.1242/dev.00200; Hudson C, 2001, MECH DEVELOP, V100, P189, DOI 10.1016/S0925-4773(00)00528-1; Imai KS, 2002, DEVELOPMENT, V129, P1729; Inazawa T, 1998, J PHYSIOL-LONDON, V511, P347, DOI 10.1111/j.1469-7793.1998.347bh.x; Jiang YM, 1996, DEV BIOL, V174, P258, DOI 10.1006/dbio.1996.0071; Kawachi K, 2003, J BIOL CHEM, V278, P5473, DOI 10.1074/jbc.M211054200; KELLEY C, 1994, DEV BIOL, V165, P193, DOI 10.1006/dbio.1994.1246; Koga C, 1999, BIOCHEM BIOPH RES CO, V261, P756, DOI 10.1006/bbrc.1999.1039; Launay C, 1996, DEVELOPMENT, V122, P869; Lemaire P, 2002, DEV BIOL, V252, P151, DOI 10.1006/dbio.2002.0861; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; Locascio A, 1999, DEVELOPMENT, V126, P4737; Miya T, 2003, DEV BIOL, V261, P25, DOI 10.1016/S0012-1606(03)00246-X; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; NEAVE B, 1995, MECH DEVELOP, V51, P169, DOI 10.1016/0925-4773(95)00351-7; Nishida H, 2002, BIOESSAYS, V24, P613, DOI 10.1002/bies.10099; NISHIDA H, 1987, DEV BIOL, V121, P526, DOI 10.1016/0012-1606(87)90188-6; Oishi I, 1999, GENES CELLS, V4, P41, DOI 10.1046/j.1365-2443.1999.00234.x; Partington GA, 1997, DEV BIOL, V181, P144, DOI 10.1006/dbio.1996.8432; Ristoratore F, 1999, DEVELOPMENT, V126, P5149; Satou Y, 2002, DEV GENES EVOL, V212, P432, DOI 10.1007/s00427-002-0266-8; Satou Y, 2002, GENESIS, V33, P153, DOI 10.1002/gene.10119; Satou Y, 2001, GENESIS, V30, P103, DOI 10.1002/gene.1040; Sheng GJ, 1999, MECH DEVELOP, V87, P213, DOI 10.1016/S0925-4773(99)00150-1; Shibata K, 1998, BIOCHEM BIOPH RES CO, V252, P241, DOI 10.1006/bbrc.1998.9490; Song JW, 1996, DEV DYNAM, V206, P427, DOI 10.1002/(SICI)1097-0177(199608)206:4<427::AID-AJA8>3.0.CO;2-K; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Streit A, 1999, TRENDS GENET, V15, P20, DOI 10.1016/S0168-9525(98)01620-5; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Wada S, 1996, MECH DEVELOP, V60, P59, DOI 10.1016/S0925-4773(96)00600-4; Wada S, 2002, DEV DYNAM, V225, P46, DOI 10.1002/dvdy.10135; Wada S, 1999, MECH DEVELOP, V82, P67, DOI 10.1016/S0925-4773(99)00012-X; WHITTAKER JR, 1973, P NATL ACAD SCI USA, V70, P2096, DOI 10.1073/pnas.70.7.2096; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; Xu RH, 1997, MOL CELL BIOL, V17, P436, DOI 10.1128/MCB.17.1.436; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; ZON LI, 1991, P NATL ACAD SCI USA, V88, P10642, DOI 10.1073/pnas.88.23.10642	53	203	204	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 26	2003	115	5					615	627		10.1016/S0092-8674(03)00928-0	http://dx.doi.org/10.1016/S0092-8674(03)00928-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651852	Bronze			2022-12-28	WOS:000186885600011
J	Emerson, J; Weinstein, YS; Saraceno, M; Lloyd, S; Cory, DG				Emerson, J; Weinstein, YS; Saraceno, M; Lloyd, S; Cory, DG			Pseudo-random unitary operators for quantum information processing	SCIENCE			English	Article							ENTANGLEMENT; SYSTEMS; CHAOS	In close analogy to the fundamental role of random numbers in classical information theory, random operators are a basic component of quantum information theory. Unfortunately, the implementation of random unitary operators on a quantum processor is exponentially hard. Here we introduce a method for generating pseudo-random unitary operators that can reproduce those statistical properties of random unitary operators most relevant to quantum information tasks. This method requires exponentially fewer resources, and hence enables the practical application of random unitary operators in quantum communication and information processing protocols. Using a nuclear magnetic resonance quantum processor, we were able to realize pseudo-random unitary operators that reproduce the expected random distribution of matrix elements.	MIT, Dept Nucl Engn, Cambridge, MA 02139 USA; MIT, Dept Mech Engn, Cambridge, MA 02139 USA; Comis Nacl Energia Atom, Unidad Actividad Fis Tandar, RA-1429 Buenos Aires, DF, Argentina	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Comision Nacional de Energia Atomica (CNEA)	Emerson, J (corresponding author), Perimeter Inst Theoret Phys, 35 King St N, Waterloo, ON N2J 2W9, Canada.		Weinstein, Yaakov/A-3513-2013	Saraceno, Marcos/0000-0003-2569-7927				Beenakker CWJ, 1997, REV MOD PHYS, V69, P731, DOI 10.1103/RevModPhys.69.731; Benenti G, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.227901; Bianucci P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.046226; Brennen GK, 2003, QUANTUM INF COMPUT, V3, P619; Cory DG, 1997, P NATL ACAD SCI USA, V94, P1634, DOI 10.1073/pnas.94.5.1634; Emerson J, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.284102; Fortunato EM, 2002, J CHEM PHYS, V116, P7599, DOI 10.1063/1.1465412; Georgeot B, 2001, PHYS REV LETT, V86, P2890, DOI 10.1103/PhysRevLett.86.2890; Gershenfeld NA, 1997, SCIENCE, V275, P350, DOI 10.1126/science.275.5298.350; Haake F., 2010, QUANTUM SIGNATURES C, DOI [10.1007/978-3-642-05428-0, DOI 10.1007/978-3-642-05428-0]; Jacquod P, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.055203; Mehta M.L., 1991, RANDOM MATRICES; Meyer DA, 2002, J MATH PHYS, V43, P4273, DOI 10.1063/1.1497700; NIELSEN MA, 2001, QUANTUM COMPUTATION; Porter C.E., 1965, STAT THEORY SPECTRA; Pozniak M, 1998, J PHYS A-MATH GEN, V31, P1059, DOI 10.1088/0305-4470/31/3/016; Schack R, 1998, PHYS REV A, V57, P1634, DOI 10.1103/PhysRevA.57.1634; Scott AJ, 2003, J PHYS A-MATH GEN, V36, P9553, DOI 10.1088/0305-4470/36/36/308; STERNBERG S, 1994, GROUP THEORY PHYSICS; Viola L, 2001, SCIENCE, V293, P2059, DOI 10.1126/science.1064460	23	157	159	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2098	2100		10.1126/science.1090790	http://dx.doi.org/10.1126/science.1090790			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684815	Green Submitted			2022-12-28	WOS:000187385200036
J	Macfarlane, GJ; Biggs, AM; Maconochie, N; Hotopf, M; Doyle, P; Lunt, M				Macfarlane, GJ; Biggs, AM; Maconochie, N; Hotopf, M; Doyle, P; Lunt, M			Incidence of cancer among UK Gulf War veterans: cohort study	BRITISH MEDICAL JOURNAL			English	Article							HEALTH; MORTALITY	Objectives To determine whether incidence rates of cancer are higher in UK service personnel who were deployed in the Gulf war than in those not deployed and whether any increased risk of cancer is related to self reported exposures to potentially hazardous material during the period of deployment. Design A cohort study with follow up from 1 April 1991 (the end of the Gulf war) to 31 July 2002. Participants 51721 Gulf war veterans and 50 755 service personnel matched for age, sex, rank, service, and level of fitness who were not deployed in the Gulf (the Era cohort). Main outcome measures Incident cancers, identified on the NHS central register. Results There were 270 incident cancers among the Gulf cohort and 269 among the Era cohort (incidence rate ratio 0.99, 95% confidence interval 0.83 to 1.17). There was no excess in site specific cancers among the Gulf cohort. Adjustment for lifestyle factors (smoking and alcohol consumption) did not alter these results. In the Gulf cohort, risk of cancer was not related to multiple vaccinations or exposure to pesticides or depleted uranium during deployment. Conclusion There is no current excess risk of cancer overall nor of site specific cancers in Gulf war veterans. Specific exposures during deployment have not resulted in a subsequent increased risk of cancer. The long latent period for cancer, however, necessitates the continued follow up of these cohorts.	Univ Manchester, Sch Epidemiol & Hlth Sci, Unit Chron Dis Epidemiol & Hlth Sci, Manchester M13 9PT, Lancs, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Guys Kings & St Thomass Sch Med, Dept Psychol Med, Gulf War Illnesses Res Unit, London SE5 8AZ, England; Univ Manchester, Sch Epidemiol & Hlth Sci, Epidemiol Unit, Arthrit Res Campaign, Manchester M13 9PL, Lancs, England	University of Manchester; University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London; University of Manchester	Macfarlane, GJ (corresponding author), Univ Manchester, Sch Epidemiol & Hlth Sci, Unit Chron Dis Epidemiol & Hlth Sci, Manchester M13 9PT, Lancs, England.		Lunt, Mark/A-7132-2014; Lunt, Mark/N-3413-2019; Hotopf, Matthew/E-4971-2010; Macfarlane, Gary J/I-9521-2014	Lunt, Mark/0000-0002-2391-5575; Lunt, Mark/0000-0002-2391-5575; Macfarlane, Gary J/0000-0003-2322-3314; Hotopf, Matthew/0000-0002-3980-4466				Cherry N, 2001, OCCUP ENVIRON MED, V58, P291, DOI 10.1136/oem.58.5.291; Everitt B, 2002, PSYCHOL MED, V32, P1371, DOI 10.1017/S0033291702006311; Kang HK, 2001, AM J EPIDEMIOL, V154, P399, DOI 10.1093/aje/154.5.399; Knoke JD, 1998, EPIDEMIOLOGY, V9, P648, DOI 10.1097/00001648-199811000-00015; Macfarlane GJ, 2000, LANCET, V356, P17, DOI 10.1016/S0140-6736(00)02428-4; Maconochie N, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-4; *ROYAL SOC, 2002, HLTH EFF DEPL UR M 1; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7	8	30	30	1	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1373	1375		10.1136/bmj.327.7428.1373	http://dx.doi.org/10.1136/bmj.327.7428.1373			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670879	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000187417900016
J	Knight, J				Knight, J			Tomorrow's world	NATURE			English	Article																			0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					709	711		10.1038/426709	http://dx.doi.org/10.1038/426709			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668877	Bronze			2022-12-28	WOS:000187132800054
J	Veltman, C				Veltman, C			Genesis of a high-tech hub	NATURE			English	Article																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					700	704		10.1038/426700	http://dx.doi.org/10.1038/426700			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668874	Bronze			2022-12-28	WOS:000187132800051
J	Utzinger, J; Bergquist, R; Xiao, SH; Singer, BH; Tanner, M				Utzinger, J; Bergquist, R; Xiao, SH; Singer, BH; Tanner, M			Sustainable schistosomiasis control - the way forward	LANCET			English	Editorial Material							SUB-SAHARAN AFRICA; HELMINTH INFECTIONS; SANITATION; EFFICACY		Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA; WHO, UNDP, World Bank, Special Programme Res & Training Trop Dis, CH-1211 Geneva, Switzerland; Chinese Ctr Dis Control & Prevent, Inst Parasit Dis, Shanghai, Peoples R China; Swiss Trop Inst, CH-4002 Basel, Switzerland	Princeton University; The World Bank; World Health Organization; Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention; University of Basel; Swiss Tropical & Public Health Institute	Utzinger, J (corresponding author), Princeton Univ, Off Populat Res, Princeton, NJ 08544 USA.							Asaolu SO, 2003, ACTA TROP, V86, P283, DOI 10.1016/S0001-706X(03)00060-3; Bergquist NR, 2002, TRENDS PARASITOL, V18, P309, DOI 10.1016/S1471-4922(02)02301-2; Brooker S, 2000, ADV PARASIT, V47, P245, DOI 10.1016/S0065-308X(00)47011-9; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; El Khoby T, 1998, PARASITOL TODAY, V14, P92, DOI 10.1016/S0169-4758(97)01206-4; Engels D, 2002, ACTA TROP, V82, P139, DOI 10.1016/S0001-706X(02)00045-1; Fincham JE, 2003, ACTA TROP, V86, P315, DOI 10.1016/S0001-706X(03)00063-9; Guyatt HL, 2001, B WORLD HEALTH ORGAN, V79, P695; Katz N, 1998, MEM I OSWALDO CRUZ, V93, P33, DOI 10.1590/S0074-02761998000700005; Lengeler C, 2002, B WORLD HEALTH ORGAN, V80, P235; N'Goran EK, 2003, ANN TROP MED PARASIT, V97, P37, DOI 10.1179/000349803125002553; Savioli L, 1999, MONITORING HELMINTH; Utzinger J, 2003, ANTIMICROB AGENTS CH, V47, P1487, DOI 10.1128/AAC.47.5.1487-1495.2003; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Watts J, 2003, LANCET, V361, P1022, DOI 10.1016/S0140-6736(03)12849-8; WEHAB Working Group, 2002, FRAM ACT WAT SAN; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; WHO, 2002, WHO TECH REP SER; *WHO, 2002, GLOB PLAN STOP TUB; 2002, WORLD BANK LOAN PROG	20	153	157	1	15	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1932	1934		10.1016/S0140-6736(03)14968-9	http://dx.doi.org/10.1016/S0140-6736(03)14968-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667754				2022-12-28	WOS:000187011600028
J	Burgay, M; D'Amico, N; Possenti, A; Manchester, RN; Lyne, AG; Joshi, BC; McLaughlin, MA; Kramer, M; Sarkissian, JM; Camilo, F; Kalogera, V; Kim, C; Lorimer, DR				Burgay, M; D'Amico, N; Possenti, A; Manchester, RN; Lyne, AG; Joshi, BC; McLaughlin, MA; Kramer, M; Sarkissian, JM; Camilo, F; Kalogera, V; Kim, C; Lorimer, DR			An increased estimate of the merger rate of double neutron stars from observations of a highly relativistic system	NATURE			English	Article							BINARY PULSAR; MASSES	The merger(1) of close binary systems containing two neutron stars should produce a burst of gravitational waves, as predicted by the theory of general relativity(2). A reliable estimate of the double-neutron-star merger rate in the Galaxy is crucial in order to predict whether current gravity wave detectors will be successful in detecting such bursts. Present estimates of this rate are rather low(3-7), because we know of only a few double-neutron-star binaries with merger times less than the age of the Universe. Here we report the discovery of a 22-ms pulsar, PSR J0737 - 3039, which is a member of a highly relativistic double-neutron-star binary with an orbital period of 2.4 hours. This system will merge in about 85 Myr, a time much shorter than for any other known neutron-star binary. Together with the relatively low radio luminosity of PSR J0737 - 3039, this timescale implies an order-of-magnitude increase in the predicted merger rate for double-neutron-star systems in our Galaxy (and in the rest of the Universe).	Univ Cagliari, Dipartimento Fis, I-09042 Monserrato, Italy; Univ Bologna, Dipartimento Astron, I-40127 Bologna, Italy; Osservatorio Astron Cagliari, INAF, I-09012 Capoterra, Italy; Osservatorio Astron Bologna, INAF, I-40127 Bologna, Italy; CSIRO, Australia Telescope Natl Facil, Epping, NSW 2121, Australia; Univ Manchester, Jodrell Bank Observ, Macclesfield SK11 9DL, Cheshire, England; Natl Ctr Radio Astrophys, Pune 411007, Maharashtra, India; Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA	University of Cagliari; University of Bologna; Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Manchester; Jodrell Bank Centre for Astrophysics; Tata Institute of Fundamental Research (TIFR); National Centre for Radio Astrophysics (NCRA), Pune; Columbia University; Northwestern University	D'Amico, N (corresponding author), Univ Cagliari, Dipartimento Fis, SP Monserrato Sestu Km 0-7, I-09042 Monserrato, Italy.	damico@ca.astro.it	D'Amico, Nichi/A-5715-2009; Lorimer, Duncan/ABH-7909-2020	Kramer, Michael/0000-0002-4175-2271; Burgay, Marta/0000-0002-8265-4344; McLaughlin, Maura/0000-0001-7697-7422; Joshi, Bhal Chandra/0000-0002-0863-7781				ABRAMOVICI A, 1992, SCIENCE, V256, P325, DOI 10.1126/science.256.5055.325; Arzoumanian Z, 1999, ASTROPHYS J, V520, P696, DOI 10.1086/307482; BRADASCHIA C, 1991, GRAVITATIONAL ASTRONOMY : INSTRUMENT DESIGN AND ASTROPHYSICAL PROSPECTS, P110; CURRAN SJ, 1995, MON NOT R ASTRON SOC, V276, P347; DAMOUR T, 1991, ASTROPHYS J, V366, P501, DOI 10.1086/169585; DAMOUR T, 1986, ANN I H POINCARE-PHY, V44, P263; Danzmann K., 1995, 1 E AM C GRAV WAV EX, P100; Kalogera V, 2001, ASTROPHYS J, V556, P340, DOI 10.1086/321583; Kim C, 2003, ASTROPHYS J, V584, P985, DOI 10.1086/345740; Manchester RN, 2001, MON NOT R ASTRON SOC, V328, P17, DOI 10.1046/j.1365-8711.2001.04751.x; MANCHESTER RN, 1977, PULSARS, pCH9; Misner C.W., 1973, GRAVITATION; PETERS PC, 1963, PHYS REV, V131, P435, DOI 10.1103/PhysRev.131.435; PHINNEY ES, 1991, ASTROPHYS J, V380, pL17, DOI 10.1086/186163; ROBERTS DH, 1976, ASTROPHYS J, V203, P196, DOI 10.1086/154065; SHAPIRO II, 1964, PHYS REV LETT, V13, P789, DOI 10.1103/PhysRevLett.13.789; SMARR LL, 1976, ASTROPHYS J, V207, P574, DOI 10.1086/154524; SRINIVASAN G, 1982, ASTRON ASTROPHYS, V108, P143; StaveleySmith L, 1996, PUBL ASTRON SOC AUST, V13, P243, DOI 10.1017/S1323358000020919; TAYLOR JH, 1979, NATURE, V277, P437, DOI 10.1038/277437a0; TAYLOR JH, 1994, REV MOD PHYS, V66, P711, DOI 10.1103/RevModPhys.66.711; TAYLOR JH, 1992, PHILOS T ROY SOC A, V341, P117, DOI 10.1098/rsta.1992.0088; TAYLOR JH, 1993, ASTROPHYS J, V411, P674, DOI 10.1086/172870; Thorsett SE, 1999, ASTROPHYS J, V512, P288, DOI 10.1086/306742; vandenHeuvel EPJ, 1996, MON NOT R ASTRON SOC, V283, pL37, DOI 10.1093/mnras/283.2.L37; Wex N, 1998, MON NOT R ASTRON SOC, V298, P67, DOI 10.1046/j.1365-8711.1998.01570.x	27	643	651	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					531	533		10.1038/nature02124	http://dx.doi.org/10.1038/nature02124			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654834				2022-12-28	WOS:000186944300031
J	Claustre, H; Maritorena, S				Claustre, H; Maritorena, S			The many shades of ocean blue	SCIENCE			English	Editorial Material							CHLOROPHYLL; REFLECTANCE; ALGORITHMS; SATELLITE; SEAWIFS; WATERS		CNRS, INSU, Observ Oceanol Villefranche, Lab Oceanog Villefranche, F-06238 Villefranche Sur Mer, France; Univ Calif Santa Barbara, Inst Computat Earth Syst Sci, Santa Barbara, CA 93106 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; University of California System; University of California Santa Barbara	Claustre, H (corresponding author), CNRS, INSU, Observ Oceanol Villefranche, Lab Oceanog Villefranche, F-06238 Villefranche Sur Mer, France.		Peters, Steef w.m./A-7433-2011; CLAUSTRE, Herve/E-6877-2011	CLAUSTRE, Herve/0000-0001-6243-0258; Maritorena, Stephane/0000-0002-5508-8391				Antoine D, 1996, GLOBAL BIOGEOCHEM CY, V10, P57, DOI 10.1029/95GB02832; BALCH WM, 2004, ASLO TOS OC RES C HO; Bishop JKB, 2002, SCIENCE, V298, P817, DOI 10.1126/science.1074961; CLAUSTRE H, 2002, GEOPHYS RES LETT, V29; Dandonneau Y, 2003, SCIENCE, V302, P1548, DOI 10.1126/science.1090729; Dierssen HM, 2000, J GEOPHYS RES-OCEANS, V105, P26301, DOI 10.1029/1999JC000296; GREGG MC, 2002, GEOPHYS RES LETT, V29; HOLLIGAN PM, 1983, NATURE, V304, P339, DOI 10.1038/304339a0; Loisel H, 2000, APPL OPTICS, V39, P3001, DOI 10.1364/AO.39.003001; O'Reilly JE, 1998, J GEOPHYS RES-OCEANS, V103, P24937, DOI 10.1029/98JC02160; Siegel DA, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000965; Stramski D, 2001, J GEOPHYS RES-OCEANS, V106, P31345, DOI 10.1029/2000JC000461; Subramaniam A, 2001, DEEP-SEA RES PT II, V49, P107	13	83	84	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1514	1515		10.1126/science.1092704	http://dx.doi.org/10.1126/science.1092704			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645833				2022-12-28	WOS:000186802200026
J	Gleick, PH				Gleick, PH			Global freshwater resources: Soft-path solutions for the 21st century	SCIENCE			English	Article								Twentieth-century water policies relied on the construction of massive infrastructure in the form of dams, aqueducts, pipelines, and complex centralized treatment plants to meet human demands. These facilities brought tremendous benefits to billions of people, but they also had serious and often unanticipated social, economical, and ecological costs. Many unsolved water problems remain, and past approaches no longer seem sufficient. A transition is under way to a "soft path" that complements centralized physical infrastructure with lower cost community-scale systems, decentralized and open decision-making, water markets and equitable pricing, application of efficient technology, and environmental protection.	Pacific Inst Studies Dev Environm & Secur, Oakland, CA 94612 USA		Gleick, PH (corresponding author), Pacific Inst Studies Dev Environm & Secur, Oakland, CA 94612 USA.		Gleick, Peter H/E-5528-2015	Gleick, Peter H/0000-0001-7232-9284				ALLEN S, 1999, SEMICONDUCTOR WASTEW; [Anonymous], 2002, REP GLOB HIV AIDS EP; [Anonymous], 2001, INT TECHNOLOGY ROADM; [Anonymous], 2000, GROUNDWATER SOC RESO; Avakyan A. B., 1998, Lakes Reservoirs Research and Management, V3, P45, DOI 10.1111/j.1440-1770.1998.tb00031.x; BROOKS DB, 2003, ANOTHER PATH NOT TAK; Cohen M., 2001, MISSING WATER USES F; COSGROVE W, 2000, WATER SECURE WORLD R, pCH4; Gleick P.H., 2002, DIRTY WATER ESTIMATE; Gleick PH, 2002, NATURE, V418, P373, DOI 10.1038/418373a; GLEICK PH, IN PRESS WASTE NOT W; GLEICK PH, IN PRESS ANN REV ENV; Gleick PH, 2000, WORLDS WATER 2000 20, P39; Intergovernmental Panel on Climate Change, 2001, CLIM CHANG 2001 IMP; Jin L., 2001, WATER POLICY, V3, P215, DOI [DOI 10.1016/S1366-7017(01)00015-0, 10.1016/S1366-7017(01)00015-0]; Lovins A, 1979, SOFT ENERGY PATHS DU; *NC DIV POLL PREV, 1998, WAT EFF MAN; Nixon SW, 2003, AMBIO, V32, P30, DOI 10.1639/0044-7447(2003)032[0030:RTNAAN]2.0.CO;2; *ORG EC COOP DEV C, 2002, AID ACT WAT SECT 199; Postel S., 1999, PILLAR SAND CAN IRRI; Postel SL, 2001, FOREIGN POLICY, P60, DOI 10.2307/3183260; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Shiklomanov IA, 1998, ASSESSMENT WATER RES; SOLLEY WB, 1998, 1200 USGS; United Nations, 1966, WORLD POP PROSP ASS; Vickers A., 2001, HDB WATER USE CONSER; Vorosmarty C., 2001, EOS T AM GEOPHYS UN, V82, P54, DOI [DOI 10.1029/01EO00031, 10.1029/01EO00031, 10.1029/01-o00031]; VOROSMARTY CJ, 2003, VEGETATION WATER HUM, P408; *WAT SUPPL SAN COL, 2000, VIS 21 SHAR VIS HYG; WHO, GLOB WAT SUPPL SAN A; Wolff Gary, 2002, WORLDS WATER 2002 20, P1; World Commission of Dams Dams and Development, 2000, NEW FRAM DEC MAK	32	806	831	12	314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1524	1528		10.1126/science.1089967	http://dx.doi.org/10.1126/science.1089967			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645837	Green Submitted			2022-12-28	WOS:000186802200030
J	Savill, J; Gregory, C; Haslett, C				Savill, J; Gregory, C; Haslett, C			Eat me or die	SCIENCE			English	Editorial Material							APOPTOTIC CELLS; CLEARANCE; RELEASE		Univ Edinburgh, Coll Med & Vet Med, MRC, Ctr Inflammat Res, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh	Savill, J (corresponding author), Univ Edinburgh, Coll Med & Vet Med, MRC, Ctr Inflammat Res, Edinburgh EH8 9AG, Midlothian, Scotland.							Brown SB, 1999, J IMMUNOL, V162, P480; Clissold PM, 2001, TRENDS BIOCHEM SCI, V26, P7, DOI 10.1016/S0968-0004(00)01700-X; Fadok VA, 2001, J CLIN INVEST, V108, P957, DOI 10.1172/JCI14122; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; GLEADLE JM, COMMUNICATION; Hengartner MO, 2001, CELL, V104, P325, DOI 10.1016/S0092-8674(01)00219-7; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Wang XC, 2003, SCIENCE, V302, P1563, DOI 10.1126/science.1087641	11	69	78	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1516	1517		10.1126/science.1092533	http://dx.doi.org/10.1126/science.1092533			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645835	Green Submitted			2022-12-28	WOS:000186802200028
J	Parimi, PV; Lu, WTT; Vodo, P; Sridhar, S				Parimi, PV; Lu, WTT; Vodo, P; Sridhar, S			Photonic crystals - Imaging by flat lens using negative refraction	NATURE			English	Editorial Material							VERIFICATION; INDEX		Northeastern Univ, Dept Phys, Boston, MA 02115 USA; Northeastern Univ, Elect Mat Res Inst, Boston, MA 02115 USA	Northeastern University; Northeastern University	Parimi, PV (corresponding author), Northeastern Univ, Dept Phys, Boston, MA 02115 USA.	s.sridhar@neu.edu	Sridhar, Srinivas/A-3688-2012					Houck AA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.137401; Iyer AK, 2003, OPT EXPRESS, V11, P696, DOI 10.1364/OE.11.000696; Luo C, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.201104; Notomi M, 2000, PHYS REV B, V62, P10696, DOI 10.1103/PhysRevB.62.10696; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; W E, 2003, PHYS REV B, V67	7	508	529	3	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					404	404		10.1038/426404a	http://dx.doi.org/10.1038/426404a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647372	Bronze			2022-12-28	WOS:000186800800028
J	Quivy, JP; Almouzni, G				Quivy, JP; Almouzni, G			Rad53: A controller ensuring the fine-tuning of histone levels	CELL			English	Editorial Material							ASSEMBLY FACTOR-I; DNA-DAMAGE; REPLICATION; PROTEINS; ASF1; PCNA	Checkpoint proteins are activated in response to genotoxic insults or replication stress to maintain genome integrity. Their function is believed to depend largely on the detection of the DNA damage or defects occurring during replication fork progression.	Inst Curie, CNRS, Res Sect, UMR 218, F-75218 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Quivy, JP (corresponding author), Inst Curie, CNRS, Res Sect, UMR 218, F-75218 Paris 05, France.		Almouzni, Genevieve/ABG-1029-2021	Almouzni, Genevieve/0000-0001-5570-0723; quivy, jean-pierre/0000-0001-6557-7204				Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	11	3	3	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 26	2003	115	5					508	510		10.1016/S0092-8674(03)00931-0	http://dx.doi.org/10.1016/S0092-8674(03)00931-0			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651842	Bronze			2022-12-28	WOS:000186885600002
J	Rainville, S; Thompson, JK; Pritchard, DE				Rainville, S; Thompson, JK; Pritchard, DE			An ion balance for ultra-high-precision atomic mass measurements	SCIENCE			English	Article							FINE-STRUCTURE CONSTANT; PENNING TRAP; SPECTROSCOPY	We have developed the analog of a double-pan balance for determining the masses of single molecular ions from the ratio of their two cyclotron frequencies. By con. ning two different ions on the same magnetron orbit in a Penning trap, we balance out many sources of noise and error ( such as fluctuations of the magnetic field). To minimize the systematic error associated with the Coulomb interaction between the two ions, they are kept about 1 millimeter apart from each other, resulting in fractional uncertainty below 1 x 10(-11). Such precision opens the door to numerous applications of mass spectrometry, including metrology, fundamental physics, and weighing chemical bonds.	MIT, MIT Harvard Ctr Ultracold Atoms, Elect Res Lab, Cambridge, MA 02139 USA; MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Rainville, S (corresponding author), Harvard Univ, 100 Edwin H Land Blvd, Cambridge, MA 02142 USA.	rainville@alum.mit.edu		Thompson, James/0000-0003-1160-5112; Rainville, Simon/0000-0001-7087-5943				BELER T, 2002, PHYS REV LETT, V88; Bergstrom I, 2002, NUCL INSTRUM METH A, V487, P618, DOI 10.1016/S0168-9002(01)02178-7; Bradley MP, 1999, PHYS REV LETT, V83, P4510, DOI 10.1103/PhysRevLett.83.4510; BROWN LS, 1986, REV MOD PHYS, V58, P233, DOI 10.1103/RevModPhys.58.233; Chase MW, 1998, J PHYS CHEM REF DATA, V9, DOI [10.18434/T42S31, DOI 10.18434/T42S31]; CORNELL EA, 1990, PHYS REV A, V41, P312, DOI 10.1103/PhysRevA.41.312; CORNELL EA, 1992, PHYS REV A, V45, P3049, DOI 10.1103/PhysRevA.45.3049; DIFILIPPO F, 1994, PHYS REV LETT, V73, P1481, DOI 10.1103/PhysRevLett.73.1481; Fogelberg B, 1999, PHYS REV LETT, V82, P1823, DOI 10.1103/PhysRevLett.82.1823; Gabrielse G, 1999, PHYS REV LETT, V82, P3198, DOI 10.1103/PhysRevLett.82.3198; GREENE GL, 1991, PHYS REV D, V44, pR2216, DOI 10.1103/PhysRevD.44.R2216; JAGOD MF, 1992, J CHEM PHYS, V97, P7111, DOI 10.1063/1.463536; Kruger E, 1998, METROLOGIA, V35, P203, DOI 10.1088/0026-1394/35/3/9; Linstrom P.J., 2003, NIST CHEM WEBBOOK; Lobashev VM, 2003, NUCL PHYS A, V719, p153C, DOI 10.1016/S0375-9474(03)00985-0; Marshall AG, 1998, MASS SPECTROM REV, V17, P1, DOI 10.1002/(SICI)1098-2787(1998)17:1<1::AID-MAS1>3.0.CO;2-K; NATARAJAN V, 1995, PHYS REV LETT, V74, P2855, DOI 10.1103/PhysRevLett.74.2855; Rainville S, 2001, HYPERFINE INTERACT, V132, P177, DOI 10.1023/A:1011922529114; RAINVILLE S, 2003, THESIS MIT CAMBRIDGE; SLUZDAK G, 2003, EXPANDING ROLE MASS; Thompson J. O. F., UNPUB; THOMPSON JK, THESIS MIT CAMBRIDGE; Van Dyck RS, 2001, HYPERFINE INTERACT, V132, P163, DOI 10.1023/A:1011914310458; Van Dyck RS, 1999, REV SCI INSTRUM, V70, P1665, DOI 10.1063/1.1149649; Wicht A, 2002, PHYS SCRIPTA, VT102, P82, DOI 10.1238/Physica.Topical.102a00082	25	101	104	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2004	303	5656					334	338		10.1126/science.1092320	http://dx.doi.org/10.1126/science.1092320			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14671311				2022-12-28	WOS:000188111800033
J	van den Berg, B; Clemons, WM; Collinson, I; Modis, Y; Hartmann, E; Harrison, SC; Rapoport, TA				van den Berg, B; Clemons, WM; Collinson, I; Modis, Y; Hartmann, E; Harrison, SC; Rapoport, TA			X-ray structure of a protein-conducting channel	NATURE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL SEQUENCE RECOGNITION; ESCHERICHIA-COLI; ER MEMBRANE; CROSS-LINKING; PREPROTEIN TRANSLOCATION; SEC PROTEINS; COMPLEX; TRANSPORT; ANGSTROM	A conserved heterotrimeric membrane protein complex, the Sec61 or SecY complex, forms a protein-conducting channel, allowing polypeptides to be transferred across or integrated into membranes. We report the crystal structure of the complex from Methanococcus jannaschii at a resolution of 3.2 Angstrom. The structure suggests that one copy of the heterotrimer serves as a functional translocation channel. The alpha-subunit has two linked halves, transmembrane segments 1-5 and 6-10, clamped together by the gamma-subunit. A cytoplasmic funnel leading into the channel is plugged by a short helix. Plug displacement can open the channel into an 'hourglass' with a ring of hydrophobic residues at its constriction. This ring may form a seal around the translocating polypeptide, hindering the permeation of other molecules. The structure also suggests mechanisms for signal-sequence recognition and for the lateral exit of transmembrane segments of nascent membrane proteins into lipid, and indicates binding sites for partners that provide the driving force for translocation.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Max Planck Inst Biophys, D-60439 Frankfurt, Germany; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Med Univ Lubeck, Inst Biol, D-23538 Lubeck, Germany	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Max Planck Society; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; University of Lubeck	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	tom_rapoport@hms.harvard.edu	Clemons, William M/D-1026-2009; Hartmann, Enno/C-5687-2013	Clemons, William M/0000-0002-0021-889X; van den Berg, Bert/0000-0003-1966-8804; Collinson, Ian/0000-0002-3931-0503; Modis, Yorgo/0000-0002-6084-0429				Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; BIEKER KL, 1990, J BIOENERG BIOMEMBR, V22, P291, DOI 10.1007/BF00763169; Breyton C, 2002, NATURE, V418, P662, DOI 10.1038/nature00827; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; DERMAN AI, 1993, EMBO J, V12, P879, DOI 10.1002/j.1460-2075.1993.tb05728.x; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Duong F, 2003, EMBO J, V22, P4375, DOI 10.1093/emboj/cdg418; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; FLOWER AM, 1995, EMBO J, V14, P884, DOI 10.1002/j.1460-2075.1995.tb07070.x; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Hanein D, 1996, CELL, V87, P721, DOI 10.1016/S0092-8674(00)81391-4; Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Heritage D, 2001, J BIOL CHEM, V276, P22655, DOI 10.1074/jbc.M102409200; Irihimovitch V, 2003, J BIOL CHEM, V278, P12881, DOI 10.1074/jbc.M210762200; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; KIM YJ, 1994, CELL, V78, P845; Kowarik M, 2002, MOL CELL, V10, P769, DOI 10.1016/S1097-2765(02)00685-8; KURZCHALIA TV, 1988, EUR J BIOCHEM, V172, P663, DOI 10.1111/j.1432-1033.1988.tb13940.x; Manting EH, 2000, EMBO J, V19, P852, DOI 10.1093/emboj/19.5.852; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0; Mingarro I, 2000, BMC Cell Biol, V1, P3, DOI 10.1186/1471-2121-1-3; Morgan DG, 2002, J MOL BIOL, V324, P871, DOI 10.1016/S0022-2836(02)01111-7; Mori H, 2003, J BIOL CHEM, V278, P14257, DOI 10.1074/jbc.M300230200; Mori H, 2001, TRENDS MICROBIOL, V9, P494, DOI 10.1016/S0966-842X(01)02174-6; MOTHES W, 1994, EMBO J, V13, P3973, DOI 10.1002/j.1460-2075.1994.tb06713.x; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; MURPHY CK, 1994, P NATL ACAD SCI USA, V91, P2557, DOI 10.1073/pnas.91.7.2557; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; PLATH K, IN PRESS MOL BIOL CE; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Raden D, 2000, J CELL BIOL, V150, P53, DOI 10.1083/jcb.150.1.53; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Satoh Y, 2003, BIOCHEMISTRY-US, V42, P7442, DOI 10.1021/bi034333v; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; TANI K, 1990, J BIOL CHEM, V265, P17341; van der Sluis EO, 2002, FEBS LETT, V527, P159, DOI 10.1016/S0014-5793(02)03202-7; Veenendaal AKJ, 2001, J BIOL CHEM, V276, P32559, DOI 10.1074/jbc.M103912200; Yahr TL, 2000, EMBO J, V19, P4393, DOI 10.1093/emboj/19.16.4393	50	954	976	1	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 1	2004	427	6969					36	44		10.1038/nature02218	http://dx.doi.org/10.1038/nature02218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YP	14661030				2022-12-28	WOS:000187710000026
J	Smith, GCS; Pell, JP				Smith, GCS; Pell, JP			Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials	BRITISH MEDICAL JOURNAL			English	Article							INJURIES; QUALITY	Objectives To determine whether parachutes are effective in preventing major trauma related to gravitational challenge. Design Systematic review of randomised controlled trials. Data sources: Medline, Web of Science, Embase, and the Cochrane Library databases; appropriate internet sites and citation lists. Study selection: Studies showing the effects of using a parachute during free fall. Main outcome measure Death or major trauma, defined as an injury severity score > 15. Results We were unable to identify any randomiscd controlled trials of parachute intervention. Conclusions As with many interventions intended to prevent ill health, the effectiveness of parachutes has not been subjected to rigorous evaluation by using randomised controlled trials. Advocates of evidence based medicine have criticised the adoption of interventions evaluated by using only observational data. We think that everyone might benefit if the most radical protagonists of evidence based medicine organised and participated in a double blind, randomised, placebo controlled, crossover trial of the parachute.	Univ Cambridge, Dept Obstet & Gynaecol, Cambridge CB2 2QQ, England; Greater Glasgow NHS Board, Dept Publ Hlth, Glasgow G3 8YU, Lanark, Scotland	University of Cambridge	Smith, GCS (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Cambridge CB2 2QQ, England.		Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997; Pell, Jill/0000-0002-8898-7035				Belmont PJ, 2001, J TRAUMA, V50, P855; Bricknell MCM, 1999, OCCUP MED-OXFORD, V49, P17, DOI 10.1093/occmed/49.1.17; CUNNINGHAM A, 2002, GUINNESS WORLDS RECO; Lasczkowski G, 2002, FORENSIC SCI INT, V125, P250, DOI 10.1016/S0379-0738(02)00002-6; Lee CT, 1999, INJURY, V30, P283, DOI 10.1016/S0020-1383(99)00083-2; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lossius HM, 2001, RESUSCITATION, V50, P263, DOI 10.1016/S0300-9572(01)00361-6; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Pines A, 1997, EUR J OBSTET GYN R B, V71, P193, DOI 10.1016/S0301-2115(96)02634-6; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Smith GD, 2002, BMJ-BRIT MED J, V325, P1437	11	727	735	1	105	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1459	1461		10.1136/bmj.327.7429.1459	http://dx.doi.org/10.1136/bmj.327.7429.1459			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684649	Green Published			2022-12-28	WOS:000187562700020
J	Huynh, KD; Lee, JT				Huynh, KD; Lee, JT			Inheritance of a pre-inactivated paternal X chromosome in early mouse embryos	NATURE			English	Article							XIST RNA ACCUMULATION; GENE-EXPRESSION; STAGE	In mammals, dosage compensation ensures equal X-chromosome expression between males (XY) and females (XX) by transcriptionally silencing one X chromosome in XX embryos(1). In the prevailing view, the XX zygote inherits two active X chromosomes, one each from the mother and father, and X inactivation does not occur until after implantation(2-6). Here, we report evidence to the contrary in mice. We find that one X chromosome is already silent at zygotic gene activation (2-cell stage). This X chromosome is paternal in origin and exhibits a gradient of silencing. Genes close to the X-inactivation centre show the greatest degree of inactivation, whereas more distal genes show variable inactivation and can partially escape silencing. After implantation, imprinted silencing in extraembryonic tissues becomes globalized and more complete on a gene-by-gene basis. These results argue that the XX embryo is in fact dosage compensated at conception along much of the X chromosome. We propose that imprinted X inactivation results from inheritance of a pre-inactivated X chromosome from the paternal germ line.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Lee, JT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Mol Biol,Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@frodo.mgh.harvard.edu						ADLER DA, 1977, NATURE, V267, P838, DOI 10.1038/267838a0; Carrel L, 1996, HUM MOL GENET, V5, P391, DOI 10.1093/hmg/5.3.391; Chadwick BP, 2003, DEV CELL, V4, P445, DOI 10.1016/S1534-5807(03)00097-2; Duthie SM, 1999, HUM MOL GENET, V8, P195, DOI 10.1093/hmg/8.2.195; EPSTEIN CJ, 1978, NATURE, V274, P500, DOI 10.1038/274500a0; Graves JAM, 1996, ANNU REV GENET, V30, P233, DOI 10.1146/annurev.genet.30.1.233; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Hartshorn C, 2003, MOL REPROD DEV, V64, P41, DOI 10.1002/mrd.10223; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Huynh KD, 2001, CURR OPIN CELL BIOL, V13, P690, DOI 10.1016/S0955-0674(00)00272-6; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; KRATZER PG, 1978, NATURE, V274, P503, DOI 10.1038/274503a0; KRIETSCH WKG, 1982, DIFFERENTIATION, V23, P141, DOI 10.1111/j.1432-0436.1982.tb01276.x; Latham KE, 2000, BIOL REPROD, V63, P64, DOI 10.1095/biolreprod63.1.64; Lee JT, 2003, CURR BIOL, V13, pR242, DOI 10.1016/S0960-9822(03)00162-3; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; LYON MF, 1999, RESULTS PROBLEMS CEL, P73; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Matsui J, 2001, HUM MOL GENET, V10, P1393, DOI 10.1093/hmg/10.13.1393; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MUKHERJEE AB, 1976, P NATL ACAD SCI USA, V73, P1608, DOI 10.1073/pnas.73.5.1608; NOTHIAS JY, 1995, J BIOL CHEM, V270, P22077, DOI 10.1074/jbc.270.38.22077; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8	30	293	301	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 18	2003	426	6968					857	862		10.1038/nature02222	http://dx.doi.org/10.1038/nature02222			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	754QM	14661031				2022-12-28	WOS:000187342000063
J	Carnethon, MR; Gidding, SS; Nehgme, R; Sidney, S; Jacobs, DR; Liu, K				Carnethon, MR; Gidding, SS; Nehgme, R; Sidney, S; Jacobs, DR; Liu, K			Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALL-CAUSE MORTALITY; PHYSICAL-ACTIVITY; FOLLOW-UP; EXERCISE; HYPERTENSION; MEN; WEIGHT; OVERWEIGHT; PREVENTION; GLUCOSE	Context Low cardiorespiratory fitness is an established risk factor for cardiovascular and total mortality; however, mechanisms responsible for these associations are uncertain. Objective To test whether low fitness, estimated by short duration on a maximal treadmill test, predicted the development of cardiovascular disease risk factors and whether improving fitness (increase in treadmill test duration between examinations) was associated with risk reduction. Design, Setting, and Participants Population-based longitudinal cohort study of men and women 18 to 30 years of age in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Participants who completed the treadmill examination according to the Balke protocol at baseline were followed up from 1985-1986 to 2000-2001. A subset of participants (n=2478) repeated the exercise test in 1992-1993. Main Outcome Measures Incident type 2 diabetes, hypertension, the metabolic syndrome (defined according to National Cholesterol Education Program Adult-Treatment Panel 111), and hypercholesterolemia (low-density lipoprotein cholesterol greater than or equal to160 mg/dL [4.14 mmol/L]). Results During the 15-year study period, the rates of incident diabetes, hypertension, the metabolic syndrome, and hypercholesterolemia were 2.8, 13.0, 10.2, and 11.7 per 1000 person-years, respectively. After adjustment for age, race, sex, smoking, and family history of diabetes, hypertension, or premature myocardial infarction, participants with low fitness (<20th percentile) were 3- to 6-fold more likely to develop diabetes, hypertension, and the metabolic syndrome than participants with high fitness ( >= 60th percentile), all P<.001. Adjusting for baseline body mass index diminished the strength of these associations to 2-fold (all P<.001). In contrast, the association between low fitness and hypercholesterolemia was modest (hazard ratio [HR], 1.4; 95% confidence interval [CI], 1.1-1.7; P=.02) and attenuated to marginal significance after body mass index adjustment (P=13). Improved fitness over 7 years was associated with a reduced risk of developing diabetes (HR, 0.4; 95% Cl, 0.2-1.0; P=.04) and the metabolic syndrome (HR, 0.5; 95% Cl, 0.3-0.7; P<.001), but the strength and significance of these associations was reduced after accounting for changes in weight. Conclusions Poor fitness in young adults is associated with the development of cardiovascular disease risk factors. These associations involve obesity and may be modified by improving fitness.	Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Thomas Jefferson Univ, Nemours Cardiac Ctr, Wilmington, DE USA; Thomas Jefferson Univ, Dept Pediat, Wilmington, DE USA; Kaiser Permanente Med Care Program, Div Res, Oakland, CA 94611 USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA	Northwestern University; Feinberg School of Medicine; Jefferson University; Jefferson University; Kaiser Permanente; University of Minnesota System; University of Minnesota Twin Cities	Carnethon, MR (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, 680 N Lake Shore Dr,Suite 1102, Chicago, IL 60611 USA.	carnethon@northwestern.edu		Jacobs, David/0000-0002-7232-0543; Gidding, Samuel/0000-0002-8557-7225	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095095, N01HC048047, N01HC048050, N01HC048048, N01HC048049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL073249] Funding Source: NIH RePORTER	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARIAS E, 2003, DEATHS PRELIMINARY D; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BLAIR SN, 1984, JAMA-J AM MED ASSOC, V252, P487, DOI 10.1001/jama.252.4.487; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Borg G A, 1974, Exerc Sport Sci Rev, V2, P131; Caspersen CJ, 2000, MED SCI SPORT EXER, V32, P1601; Centers for Disease Control and Prevention, 1996, PHYS ACT HLTH REP SU; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Durstine J L, 1994, Exerc Sport Sci Rev, V22, P477; EKELUND LG, 1988, NEW ENGL J MED, V319, P1379, DOI 10.1056/NEJM198811243192104; Fagard RH, 1999, MED SCI SPORT EXER, V31, pS624, DOI 10.1097/00005768-199911001-00022; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Gulati M, 2003, CIRCULATION, V108, P1554, DOI 10.1161/01.CIR.0000091080.57509.E9; Jacobs David R Jr, 1989, J Cardiopulm Rehabil, V9, P448, DOI 10.1097/00008483-198911000-00003; Juhaeri, 2002, INT J OBESITY, V26, P58, DOI 10.1038/sj.ijo.0801846; Kraus WE, 2002, NEW ENGL J MED, V347, P1483, DOI [DOI 10.1056/NEJMoa020194, DOI 10.1056/NEJMOA020194, 10.1056/NEJMoa020194]; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; Lee CD, 2002, MED SCI SPORT EXER, V34, P592; Lee CD, 2002, MED SCI SPORT EXER, V34, P735; Melanson EL, 2001, EUR J APPL PHYSIOL, V85, P442, DOI 10.1007/s004210100479; Mora S, 2003, JAMA-J AM MED ASSOC, V290, P1600, DOI 10.1001/jama.290.12.1600; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Perseghin G, 1996, NEW ENGL J MED, V335, P1357, DOI 10.1056/NEJM199610313351804; Petrella RJ, 2003, AM J PREV MED, V24, P316, DOI 10.1016/S0749-3797(03)00022-9; POLLOCK ML, 1976, AM HEART J, V92, P39, DOI 10.1016/S0002-8703(76)80401-2; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Sidney S, 1998, MED SCI SPORT EXER, V30, P427, DOI 10.1097/00005768-199803000-00014; SIDNEY S, 1992, MED SCI SPORT EXER, V24, P177; STAMLER R, 1978, JAMA-J AM MED ASSOC, V240, P1607, DOI 10.1001/jama.240.15.1607; STEFANICK ML, 1984, PHYSICAL ACTIVITY FI, P417; Sternfeld B, 1999, ANN EPIDEMIOL, V9, P25, DOI 10.1016/S1047-2797(98)00030-1; WARNICK GR, 1982, CLIN CHEM, V28, P1379; Wei M, 1999, ANN INTERN MED, V130, P89, DOI 10.7326/0003-4819-130-2-199901190-00002; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547	38	425	436	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2003	290	23					3092	3100		10.1001/jama.290.23.3092	http://dx.doi.org/10.1001/jama.290.23.3092			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753ZB	14679272	Bronze			2022-12-28	WOS:000187277300028
J	Ruchkin, V; Schwab-Stone, M				Ruchkin, V; Schwab-Stone, M			What can we learn from developmental studies of psychiatric disorders?	LANCET			English	Editorial Material							14-YEAR FOLLOW-UP; ADULTHOOD; PSYCHOPATHOLOGY; COMORBIDITY; PREVALENCE; CONTINUITY; DIAGNOSES		Yale Univ, Sch Med, Yale Child Ctudy Ctr, New Haven, CT 06520 USA	Yale University	Ruchkin, V (corresponding author), Yale Univ, Sch Med, Yale Child Ctudy Ctr, 333 Cedar St, New Haven, CT 06520 USA.	vladislav.ruchkin@yale.edu		Ruchkin, Vladislav/0000-0002-2510-6798				CICCHETTI D, 1992, DEV PSYCHOPATHOL, V4, P489, DOI 10.1017/S0954579400004831; Costello EJ, 2003, ARCH GEN PSYCHIAT, V60, P837, DOI 10.1001/archpsyc.60.8.837; Costello EJ, 2002, BIOL PSYCHIAT, V52, P529, DOI 10.1016/S0006-3223(02)01372-0; FERDINAND RF, 1995, AM J PSYCHIAT, V152, P1586; FERGUSSON DM, 1993, J AM ACAD CHILD PSY, V32, P1127, DOI 10.1097/00004583-199311000-00004; Hofstra MB, 2002, J AM ACAD CHILD PSY, V41, P182, DOI 10.1097/00004583-200202000-00012; Hofstra MB, 2000, J AM ACAD CHILD PSY, V39, P850, DOI 10.1097/00004583-200007000-00013; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kim-Cohen J, 2003, ARCH GEN PSYCHIAT, V60, P709, DOI 10.1001/archpsyc.60.7.709; Lewinsohn PM, 1999, J AM ACAD CHILD PSY, V38, P56, DOI 10.1097/00004583-199901000-00020; Widiger TA, 2000, PSYCHOL BULL, V126, P946, DOI 10.1037//0033-2909.126.6.946	11	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2003	362	9400					1951	1952		10.1016/S0140-6736(03)15084-2	http://dx.doi.org/10.1016/S0140-6736(03)15084-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	753BC	14683652				2022-12-28	WOS:000187210700005
J	Tingay, DG; Tsimnadis, P; Basnyat, B				Tingay, DG; Tsimnadis, P; Basnyat, B			A blurred view from Everest	LANCET			English	Editorial Material							HIGH-ALTITUDE RETINOPATHY		Royal Childrens Hosp, Dept Neonatol, Melbourne, Vic 3052, Australia; Nepal Int Clin & Himalayan Rescue Assoc, Kathmandu, Nepal; Wentworth Area Hlth Serv, Penrith, NSW, Australia	Royal Children's Hospital Melbourne	Tingay, DG (corresponding author), Royal Childrens Hosp, Dept Neonatol, Flemington Rd, Melbourne, Vic 3052, Australia.	david.tingay@rch.org.au	Tingay, David/ABA-9706-2020	Tingay, David/0000-0003-1522-4691				Basnyat B, 2000, High Alt Med Biol, V1, P167; HACKETT PH, 1979, AM J MED, V67, P214, DOI 10.1016/0002-9343(79)90393-0; MCFADDEN DM, 1981, JAMA-J AM MED ASSOC, V245, P581, DOI 10.1001/jama.245.6.581; RENNIE D, 1975, ARCH OPHTHALMOL-CHIC, V93, P395; Wiedman M, 1999, OPHTHALMOLOGY, V106, P1924, DOI 10.1016/S0161-6420(99)90402-5	5	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2003	362	9400					1978	1978		10.1016/S0140-6736(03)15017-9	http://dx.doi.org/10.1016/S0140-6736(03)15017-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683658				2022-12-28	WOS:000187210700011
J	Chatterjee, S; Callaway, EM				Chatterjee, S; Callaway, EM			Parallel colour-opponent pathways to primary visual cortex	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; S-CONE; GANGLION-CELLS; OLD-WORLD; MORPHOLOGY; RETINA; ORGANIZATION; MECHANISMS; LAMINAE; AXONS	The trichromatic primate retina parses the colour content of a visual scene into ' red/ green' and ` blue/ yellow' representations(1 - 2). Cortical circuits must combine the information encoded in these colour- opponent signals to reconstruct the full range of perceived colours(3). Red/ green and blue/ yellow inputs are relayed by the lateral geniculate nucleus ( LGN) of thalamus to primary visual cortex ( V1), so understanding how cortical circuits transform these signals requires understanding how LGN inputs to V1 are organized. Here we report direct recordings from LGN afferent axons in muscimol- inactivated V1. We found that blue/ yellow afferents terminated exclusively in superficial cortical layers 3B and 4A, whereas red/ green afferents were encountered only in deeper cortex, in lower layer 4C. We also describe a distinct cortical target for ' blue- OFF' cells, whose afferents terminated in layer 4A and seemed patchy in organization. The more common ` blue- ON' afferents were found in 4A as well as lower layer 2/ 3. Chromatic information is thus conveyed to V1 by parallel, anatomically segregated colour- opponent systems, to be combined at a later stage of the colour circuit.	Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA; Univ Calif San Diego, Neurosci Program, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Chatterjee, S (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	sochatte@ucsd.edu	Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267				Ahmad KM, 2003, VISUAL NEUROSCI, V20, P189, DOI 10.1017/S0952523803202091; BLASDEL GG, 1984, J NEUROSCI, V4, P880; BLASDEL GG, 1983, J NEUROSCI, V3, P1389; Calkins DJ, 1999, NEURON, V24, P313, DOI 10.1016/S0896-6273(00)80846-6; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chatterjee S, 2002, NEURON, V35, P1135, DOI 10.1016/S0896-6273(02)00874-7; Chichilnisky EJ, 1999, NAT NEUROSCI, V2, P889, DOI 10.1038/13189; CONLEY M, 1989, VISUAL NEUROSCI, V2, P287, DOI 10.1017/S0952523800001206; Dacey DM, 2000, ANNU REV NEUROSCI, V23, P743, DOI 10.1146/annurev.neuro.23.1.743; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Dacey DM, 2003, NEURON, V37, P15, DOI 10.1016/S0896-6273(02)01143-1; De Valois RL, 2000, P NATL ACAD SCI USA, V97, P4997, DOI 10.1073/pnas.97.9.4997; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; HENDRICKSON AE, 1978, J COMP NEUROL, V182, P123, DOI 10.1002/cne.901820108; Hendry SHC, 2000, ANNU REV NEUROSCI, V23, P127, DOI 10.1146/annurev.neuro.23.1.127; HENDRY SHC, 1994, SCIENCE, V264, P575, DOI 10.1126/science.8160015; HUBEL DH, 1972, J COMP NEUROL, V146, P421, DOI 10.1002/cne.901460402; Klug K, 2003, J NEUROSCI, V23, P9881; LENNIE P, 1988, CRIT REV NEUROBIOL, V3, P333; LEVENTHAL AG, 1981, SCIENCE, V213, P1139, DOI 10.1126/science.7268423; Martin PR, 1997, EUR J NEUROSCI, V9, P1536, DOI 10.1111/j.1460-9568.1997.tb01509.x; MICHAEL CR, 1988, P NATL ACAD SCI USA, V85, P4914, DOI 10.1073/pnas.85.13.4914; Reid RC, 2002, J NEUROSCI, V22, P6158; Ringach DL, 1997, VISION RES, V37, P2455, DOI 10.1016/S0042-6989(96)00247-7; RODIECK RW, 1993, J COMP NEUROL, V338, P289, DOI 10.1002/cne.903380211; SCHILLER PH, 1978, J NEUROPHYSIOL, V41, P788, DOI 10.1152/jn.1978.41.3.788; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; VALBERG A, 1986, VISION RES, V26, P1061, DOI 10.1016/0042-6989(86)90040-4; Wandell B. A., 1995, FDN VISION, P413; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115	30	147	153	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					668	671		10.1038/nature02167	http://dx.doi.org/10.1038/nature02167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668866				2022-12-28	WOS:000187132800043
J	White, MF				White, MF			Insulin signaling in health and disease	SCIENCE			English	Article							STIMULATES TYROSINE PHOSPHORYLATION; RECEPTOR SUBSTRATE-2; RESISTANCE; GROWTH; CELLS; PROTEIN; OBESITY	The signaling pathways used by insulin have been identified [M. White, Insulin Signaling Pathway, Sci. STKE (Connections Map, as seen November 2003), http://stke.sciencemag. org/cgi/cm/cmp_12069]. Now our challenge is to understand how the failure of these signals is associated with obesity and the progressive failure of pancreatic beta cells that leads to diabetes. Whether better management of chronic inflammation can improve insulin action is an important area of investigation. Drugs that stimulate IRS2 (insulin receptor substrate protein 2) synthesis or signaling might be a good starting point. This knowledge will lead to rational strategies that prevent or cure diabetes.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Howard Hughes Med Inst, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Howard Hughes Medical Institute	White, MF (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Howard Hughes Med Inst, 1 Joslin Pl, Boston, MA 02215 USA.							Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Bliss M., 1982, DISCOVERY INSULIN; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; KASUGA M, 1982, NATURE, V298, P667, DOI 10.1038/298667a0; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; KREBS DL, 2003, SCI STKE, pE6; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Schubert M, 2003, J NEUROSCI, V23, P7084, DOI 10.1523/JNEUROSCI.23-18-07084.2003; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; WHITE MF, 1985, NATURE, V318, P183, DOI 10.1038/318183a0; WHITE MF, 2003, SCI STKE; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	21	490	529	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1710	1711		10.1126/science.1092952	http://dx.doi.org/10.1126/science.1092952			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657487	Green Submitted			2022-12-28	WOS:000186970100034
J	Cheng, AC; Lowe, M; Stephens, DP; Currie, B				Cheng, AC; Lowe, M; Stephens, DP; Currie, B			Ethical problems of evaluating a new treatment for melioidosis	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; COLONY-STIMULATING FACTOR; HOSPITALIZED-PATIENTS; FILGRASTIM; PNEUMONIA; CSF; FAILURE	When mortality from melioidosis fell sharply after multiple changes in management at an Australian hospital, doctors wanted to identify whether a new drug was responsible. But designing a trial that was ethically acceptable proved impossible.	Flinders Univ S Australia, Menzies Sch Hlth Res, Darwin, NT 0811, Australia; Flinders Univ S Australia, No Terr Clin Sch, Darwin, NT 0811, Australia; Royal Darwin Hosp, Div Med, Darwin, NT 0811, Australia; Royal Darwin Hosp, Intens Care Unit, Darwin, NT 0811, Australia	Charles Darwin University; Menzies School of Health Research; Flinders University South Australia; Flinders University South Australia; Northern Territory Government	Cheng, AC (corresponding author), Flinders Univ S Australia, Menzies Sch Hlth Res, POB 41096, Darwin, NT 0811, Australia.		Cheng, Allen/A-1403-2008	Stephens, Dianne/0000-0002-3785-6828; Cheng, Allen/0000-0003-3152-116X				BARTLETT RH, 1985, PEDIATRICS, V76, P479; Brody BA, 1997, CONTROL CLIN TRIALS, V18, P602, DOI 10.1016/S0197-2456(97)00006-8; Brody BA, 1997, CONTROL CLIN TRIALS, V18, P661; Currie BJ, 2000, CLIN INFECT DIS, V31, P981, DOI 10.1086/318116; DANCE DAB, 1991, CLIN MICROBIOL REV, V4, P52, DOI 10.1128/CMR.4.1.52-60.1991; Jones AL, 1996, INFECT IMMUN, V64, P782, DOI 10.1128/IAI.64.3.782-790.1996; MARHOFFER W, 1993, DIABETES RES CLIN PR, V19, P183, DOI 10.1016/0168-8227(93)90112-I; MONTANER JSG, 1990, ANN INTERN MED, V113, P14, DOI 10.7326/0003-4819-113-1-14; NELSON S, 1991, J INFECT DIS, V164, P901, DOI 10.1093/infdis/164.5.901; Nelson S, 1998, J INFECT DIS, V178, P1075, DOI 10.1086/515694; Nelson S, 2000, J INFECT DIS, V182, P970, DOI 10.1086/315775; PETO R, 1995, J CLIN EPIDEMIOL, V48, P23, DOI 10.1016/0895-4356(94)00150-O; Powell K, 2003, FEMS MICROBIOL LETT, V224, P315, DOI 10.1016/S0378-1097(03)00473-7; Root RK, 2003, CRIT CARE MED, V31, P367, DOI 10.1097/01.CCM.0000048629.32625.5D; Royall Richard M, 1991, Stat Sci, V6, P52, DOI 10.1214/ss/1177011934; SALANT DJ, 1976, J LAB CLIN MED, V88, P536; SERUSHAGO BA, 1992, IMMUNOLOGY, V75, P475; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; Stephens DP, 2002, INTERN MED J, V32, P143, DOI 10.1046/j.1445-5994.2002.00195.x; WEI LJ, 1978, J AM STAT ASSOC, V73, P840; Welte K, 1996, BLOOD, V88, P1907, DOI 10.1182/blood.V88.6.1907.bloodjournal8861907; 2001, SUNDAY TERRITOR 0923	22	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 29	2003	327	7426					1280	1282		10.1136/bmj.327.7426.1280	http://dx.doi.org/10.1136/bmj.327.7426.1280			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749VD	14644975	Green Published			2022-12-28	WOS:000186948800024
J	Gray, RD; Atkinson, QD				Gray, RD; Atkinson, QD			Language-tree divergence times support the Anatolian theory of Indo-European origin	NATURE			English	Article							BAYESIAN-INFERENCE; CLASSIFICATION; PHYLOGENY	Languages, like genes, provide vital clues about human history(1,2). The origin of the Indo-European language family is "the most intensively studied, yet still most recalcitrant, problem of historical linguistics"(3). Numerous genetic studies of Indo-European origins have also produced inconclusive results(4,5,6). Here we analyse linguistic data using computational methods derived from evolutionary biology. We test two theories of Indo-European origin: the 'Kurgan expansion' and the 'Anatolian farming' hypotheses. The Kurgan theory centres on possible archaeological evidence for an expansion into Europe and the Near East by Kurgan horsemen beginning in the sixth millennium BP7,8. In contrast, the Anatolian theory claims that Indo-European languages expanded with the spread of agriculture from Anatolia around 8,000-9,500 years BP9. In striking agreement with the Anatolian hypothesis, our analysis of a matrix of 87 languages with 2,449 lexical items produced an estimated age range for the initial Indo-European divergence of between 7,800 and 9,800 years BP. These results were robust to changes in coding procedures, calibration points, rooting of the trees and priors in the bayesian analysis.	Univ Auckland, Dept Psychol, Auckland 1020, New Zealand	University of Auckland	Gray, RD (corresponding author), Univ Auckland, Dept Psychol, Private Bag 92019, Auckland 1020, New Zealand.		Gray, Russell/H-2078-2015	Gray, Russell/0000-0002-9858-0191; Atkinson, Quentin/0000-0002-8499-7535				Barbrook AC, 1998, NATURE, V394, P839, DOI 10.1038/29667; BERGSLAND K, 1962, CURR ANTHROPOL, V3, P115, DOI 10.1086/200264; BLUST R, 2000, TIME DEPTH HIST LING, P311; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Diamond J, 2003, SCIENCE, V300, P597, DOI 10.1126/science.1078208; DIXON RMW, 1997, RISE FALL LANGUAGE; Dyen I., 1997, FILE IE DATA1; GAMKRELIDZE TV, 1995, TRENDS LINGUISTICS 8; Gimbutas, 1973, J INDOEUROPEAN STUDI, V1, P163; Gkiasta M, 2003, ANTIQUITY, V77, P45, DOI 10.1017/S0003598X00061330; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; Holden CJ, 2002, P ROY SOC B-BIOL SCI, V269, P793, DOI 10.1098/rspb.2002.1955; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Mallory JP., 1989, SEARCH INDO EUROPEAN, DOI DOI 10.1038/nature11698; McMahon A, 2003, T PHILOL SOC, V101, P7, DOI 10.1111/1467-968X.00108; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Pagel M., 2000, TIME DEPTH HIST LING; RENFREW C, 2000, TIME DEPTH HIST LING, P413; Rexova K, 2003, CLADISTICS, V19, P120, DOI 10.1016/S0748-3007(02)00147-0; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Ringe D, 2002, T PHILOL SOC, V100, P59, DOI 10.1111/1467-968X.00091; Sandberg C, 2002, IEEE IND APPL MAG, V8, P50, DOI 10.1109/2943.999613; SANDERSON MJ, 1989, EVOLUTION, V43, P1781, DOI 10.1111/j.1558-5646.1989.tb02626.x; SEMONI O, 2000, SCIENCE, V290, P1155; STEEL MA, 1988, NATURE, V333, P494; SWADESH M, 1952, P AM PHILOS SOC, V96, P453; Swofford David L., 1996, P407	30	477	489	4	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					435	439		10.1038/nature02029	http://dx.doi.org/10.1038/nature02029			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	747JE	14647380	Green Submitted			2022-12-28	WOS:000186800800036
J	Go, AS; Hylek, EM; Chang, YC; Phillips, KA; Henault, LE; Capra, AM; Jensvold, NG; Selby, JV; Singer, DE				Go, AS; Hylek, EM; Chang, YC; Phillips, KA; Henault, LE; Capra, AM; Jensvold, NG; Selby, JV; Singer, DE			Anticoagulation therapy for stroke prevention in atrial fibrillation - How well do randomized trials translate into clinical practice?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; ORAL ANTICOAGULATION; ANTITHROMBOTIC THERAPY; PREDICTING STROKE; RHYTHM CONTROL; INTENSITY; WARFARIN; VALIDATION; MORTALITY; EFFICACY	Context Warfarin has been shown to be highly efficacious for preventing thromboembolism in atrial fibrillation in randomized trials, but its effectiveness and safety in clinical practice is less clear. Objective To evaluate the effect of warfarin on risk of thromboembolism, hemorrhage, and death in atrial fibrillation within a usual care setting. Design Cohort study assembled between July 1, 1996, and December 31,1997, and followed up through August 31, 1999. Setting Large integrated health care system in Northern California. Patients Of 13559 adults with nonvalvular atrial fibrillation, 11526 were studied, 43% of whom were women, mean age 71 years, with no known contraindications to anticoagulation at baseline. Main Outcomes Ischemic stroke, peripheral embolism, hemorrhage, and death according to warfarin use and comorbidity status, as determined by automated databases, review of medical records, and state mortality files. Results Among 11526 patients, 397 incident thromboembolic events (372 ischemic strokes, 25 peripheral embolism) occurred during 25341 person-years of follow-up, and warfarin therapy was associated with a 51% (95% confidence interval [CI], 39%-60%) lower risk of thromboembolism compared with no warfarin therapy (either no antithrombotic therapy or aspirin) after adjusting for potential confounders and likelihood of receiving warfarin. Warfarin was effective in reducing thromboembolic risk in the presence or absence of risk factors for stroke. A nested case-control analysis estimated a 64% reduction in odds of thromboembolism with warfarin compared with no antithrombotic therapy. Warfarin was also associated with a reduced risk of all-cause mortality. (adjusted hazard ratio, 0.69; 95% CI, 0.61-0.77). Intracranial hemorrhage was uncommon, but the rate was moderately higher among those taking vs those not taking warfarin (0.46 vs 0.23 per 100 person-years, respectively; P=.003, adjusted hazard ratio, 1.97; 95% CI, 1.24-3.13). However, warfarin therapy was not associated with an increased adjusted risk of nonintracranial major hemorrhage. The effects of warfarin were similar when patients with contraindications at baseline were analyzed separately or combined with those without contraindications (total cohort of 13559). Conclusions Warfarin is very effective for preventing ischemic stroke inpatients with atrial fibrillation in clinical practice while the absolute increase in the risk of intracranial hemorrhage is small. Results of randomized trials of anticoagulation translate well into clinical care for patients with atrial fibrillation.	Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Massachusetts Gen Hosp, Dept Med, Div Gen Med, Clin Epidemiol Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Go, AS (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway St,3rd Floor, Oakland, CA 94612 USA.	Alan.S.Go@kp.org	Go, Alan S./AAE-7745-2019	Hylek, Elaine/0000-0001-8263-8304	NIA NIH HHS [AG15478] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG015478] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Albers GW, 2001, CHEST, V119, p194S, DOI 10.1378/chest.119.1_suppl.194S; [Anonymous], 1997, ARCH INTERN MED, V157, P1237; Ansell JE, 1997, ANN PHARMACOTHER, V31, P604, DOI 10.1177/106002809703100516; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; Aronow WS, 1999, J AM GERIATR SOC, V47, P366, DOI 10.1111/j.1532-5415.1999.tb03004.x; Blackshear JL, 1996, LANCET, V348, P633; Caro JJ, 2000, CAN MED ASSOC J, V162, P973; Caro JJ, 1999, CAN MED ASSOC J, V161, P493; CARO JJ, 1999, CMAJ, V161, P533; CONNOLLY SJ, 1991, J AM COLL CARDIOL, V18, P349, DOI 10.1016/0735-1097(91)90585-W; Diggle PJ, 1994, ANAL LONGITUDINAL DA; ERNSTER VL, 1994, PREV MED, V23, P587, DOI 10.1006/pmed.1994.1093; Evans A, 2001, ARCH INTERN MED, V161, P1443, DOI 10.1001/archinte.161.11.1443; Evans A, 2001, STROKE, V32, P2828, DOI 10.1161/hs1201.099520; Evans A, 2000, STROKE, V31, P2106, DOI 10.1161/01.STR.31.9.2106; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; EZEKOWITZ MD, 1993, NEW ENGL J MED, V328, P148; Fisher LD, 1999, ANNU REV PUBL HEALTH, V20, P145, DOI 10.1146/annurev.publhealth.20.1.145; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Frost L, 2002, J INTERN MED, V252, P64, DOI 10.1046/j.1365-2796.2002.01009.x; Gage BF, 2000, STROKE, V31, P822, DOI 10.1161/01.STR.31.4.822; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Go AS, 2000, CIRCULATION, V102, P11, DOI 10.1161/01.CIR.102.1.11; Goldenberg GM, 1999, CLIN DRUG INVEST, V17, P483, DOI 10.2165/00044011-199917060-00009; GOTTLIEB LK, 1994, ARCH INTERN MED, V154, P1945, DOI 10.1001/archinte.154.17.1945; Greenland S, 2001, ANNU REV PUBL HEALTH, V22, P189, DOI 10.1146/annurev.publhealth.22.1.189; Hart RG, 2000, CEREBROVASC DIS, V10, P39, DOI 10.1159/000016023; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Hylek EM, 1996, NEW ENGL J MED, V335, P540, DOI 10.1056/NEJM199608223350802; Kalra L, 2000, BMJ-BRIT MED J, V320, P1236, DOI 10.1136/bmj.320.7244.1236; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; Kleinbaum D. G., 1998, APPL REGRESSION ANAL; KOPECKY SL, 1987, NEW ENGL J MED, V317, P669, DOI 10.1056/NEJM198709103171104; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Schlesselman JJ, 1982, CASE CONTROL STUDIES; SELBY JV, 1994, EPIDEMIOL REV, V16, P90, DOI 10.1093/oxfordjournals.epirev.a036148; Stokes ME, 2000, CATEGORICAL DATA ANA; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441; Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	49	570	592	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2003	290	20					2685	2692		10.1001/jama.290.20.2685	http://dx.doi.org/10.1001/jama.290.20.2685			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747CR	14645310	Bronze			2022-12-28	WOS:000186788100020
J	Hughes-Davies, L; Huntsman, D; Ruas, M; Fuks, F; Bye, J; Chin, SF; Milner, J; Brown, LA; Hsu, F; Gilks, B; Nielsen, T; Schulzer, M; Chia, S; Ragaz, J; Cahn, A; Linger, L; Ozdag, H; Cattaneo, E; Jordanova, ES; Schuuring, E; Yu, DS; Venkitaraman, A; Ponder, B; Doherty, A; Aparicio, S; Bentley, D; Theillet, C; Ponting, CP; Caldas, C; Kouzarides, T				Hughes-Davies, L; Huntsman, D; Ruas, M; Fuks, F; Bye, J; Chin, SF; Milner, J; Brown, LA; Hsu, F; Gilks, B; Nielsen, T; Schulzer, M; Chia, S; Ragaz, J; Cahn, A; Linger, L; Ozdag, H; Cattaneo, E; Jordanova, ES; Schuuring, E; Yu, DS; Venkitaraman, A; Ponder, B; Doherty, A; Aparicio, S; Bentley, D; Theillet, C; Ponting, CP; Caldas, C; Kouzarides, T			EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer	CELL			English	Article							HISTONE H3; LYSINE 9; DOMAIN; METHYLATION; PROTEINS; CHROMO; GENE; METHYLTRANSFERASE; SUSCEPTIBILITY; EXPRESSION	The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated in DNA repair and transcriptional regulation. Here we identify a protein, EMSY, which binds BRCA2 within a region (exon 3) deleted in cancer. EMSY is capable of silencing the activation potential of BRCA2 exon 3, associates with chromatin regulators HP1beta and BS69, and localizes to sites of repair following DNA damage. EMSY maps to chromosome 11q13.5, a region known to be involved in breast and ovarian cancer. We show that the EMSY gene is amplified almost exclusively in sporadic breast cancer (13%) and higher-grade ovarian cancer (17%). In addition, EMSY amplification is associated with worse survival, particularly in node-negative breast cancer, suggesting that it may be of prognostic value. The remarkable clinical overlap between sporadic EMSY amplification and familial BRCA2 deletion implicates a BRCA2 pathway in sporadic breast and ovarian cancer.	Canc Res UK, Wellcome Trust Inst, Cambridge CB2 1QR, England; Canc Res UK, Dept Pathol, Cambridge CB2 1QR, England; Univ Cambridge, Dept Oncol, MRC, Res Ctr, Cambridge CB2 2XZ, England; Vancouver Gen Hosp, Dept Pathol, Genet Pathol Evaluat Ctr, Vancouver, BC V6H 3Z6, Canada; Vancouver Gen Hosp, Prostate Ctr, Vancouver, BC V6H 3Z6, Canada; British Columbia Canc Agcy, Dept Pathol, Vancouver, BC V6H 3Z6, Canada; Univ British Columbia, Vancouver, BC V6H 3Z6, Canada; Wellcome Trust Sanger Inst Hinxton, Cambridge CB10 1SA, England; Univ British Columbia, Dept Stat & Med, Vancouver, BC V6T 2B5, Canada; British Columbia Canc Agcy, Dept Med Oncol, Vancouver, BC V5Z 4E6, Canada; Leiden Univ, Ctr Med, Dept Pathol, NL-2300 RC Leiden, Netherlands; Univ Groningen Hosp, Dept Pathol, NL-9700 RB Groningen, Netherlands; MRC, Canc Cell Unit, Res Ctr, Cambridge CB2 2XZ, England; Cambridge Inst Med Res, Cambridge CB2 2XZ, England; Ctr Val Aurelle, INSERM, EMI 229, Montpellier, France; Univ Oxford, MRC, Funct Genet Unit, Oxford OX1 3QX, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; Wellcome Trust Sanger Institute; University of British Columbia; British Columbia Cancer Agency; Leiden University; Leiden University - Excl LUMC; University of Groningen; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); University of Oxford	Hughes-Davies, L (corresponding author), Canc Res UK, Wellcome Trust Inst, Tennsi Court Rd, Cambridge CB2 1QR, England.	lh205@cus.cam.ac.uk; cc234@cam.ac.uk; tkl06@mole.bio.cam.ac.uk	Caldas, Carlos/U-7250-2019; Huntsman, David/ABE-6082-2020; Theillet, Charles/O-7634-2018; Ponting, Chris/AAV-2621-2021; Özdag, Hilal/C-9929-2009; Caldas, Carlos/A-7543-2008	Caldas, Carlos/0000-0003-3547-1489; Özdag, Hilal/0000-0001-7940-2499; Jordanova, Ekaterina/0000-0003-3890-7102; Ponting, Chris/0000-0003-0202-7816; chin, suet-feung/0000-0001-5697-1082; Aparicio, Samuel/0000-0002-0487-9599; Doherty, Aidan/0000-0002-6370-1109; Kouzarides, Tony/0000-0002-8918-4162; Brown, Lindsay/0000-0002-2790-5112; Theillet, Charles/0000-0001-5555-2759; Ruas, Margarida/0000-0002-4872-7618; Jordanova, Ekaterina S./0000-0002-8121-1322; CATTANEO, ELENA/0000-0002-0755-4917				Ansieau S, 2002, J BIOL CHEM, V277, P4906, DOI 10.1074/jbc.M110078200; Bachman KE, 2001, J BIOL CHEM, V276, P32282, DOI 10.1074/jbc.M104661200; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bekri S, 1997, CYTOGENET CELL GENET, V79, P125, DOI 10.1159/000134699; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bornemann D, 1998, GENETICS, V150, P675; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; Collins N, 1997, BRIT J CANCER, V76, P1150, DOI 10.1038/bjc.1997.526; Courjal F, 1997, CANCER RES, V57, P4360; COX DR, 1972, J R STAT SOC B, V34, P187; Dobrovic A, 1997, CANCER RES, V57, P3347; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; Gayther SA, 1998, J MAMMARY GLAND BIOL, V3, P365, DOI 10.1023/A:1018779830743; Hakimi MA, 2002, P NATL ACAD SCI USA, V99, P7420, DOI 10.1073/pnas.112008599; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Milner J, 1997, NATURE, V386, P772, DOI 10.1038/386772a0; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Nordling M, 1998, CANCER RES, V58, P1372; Ormandy CJ, 2003, BREAST CANCER RES TR, V78, P323, DOI 10.1023/A:1023033708204; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pilch DR, 2003, BIOCHEM CELL BIOL, V81, P123, DOI 10.1139/o03-042; Risch HA, 2001, AM J HUM GENET, V68, P700, DOI 10.1086/318787; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shin S, 2003, P NATL ACAD SCI USA, V100, P7201, DOI 10.1073/pnas.1132020100; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Yang L, 2003, BIOCHEM J, V369, P651, DOI 10.1042/BJ20020854; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049	37	341	366	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 26	2003	115	5					523	535		10.1016/S0092-8674(03)00930-9	http://dx.doi.org/10.1016/S0092-8674(03)00930-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651845	Bronze			2022-12-28	WOS:000186885600004
J	Tumbar, T; Guasch, G; Greco, V; Blanpain, C; Lowry, WE; Rendl, M; Fuchs, E				Tumbar, T; Guasch, G; Greco, V; Blanpain, C; Lowry, WE; Rendl, M; Fuchs, E			Defining the epithelial stem cell niche in skin	SCIENCE			English	Article							GROWTH-FACTOR-BETA; LABEL-RETAINING CELLS; HAIR FOLLICLE BULGE; SELF-RENEWAL; WNT; GENE; EXPRESSION; EPIDERMIS; MICE; PROLIFERATION	Many adult regenerative cells divide infrequently but have high proliferative capacity. We developed a strategy to fluorescently label slow-cycling cells in a cell type-specific fashion. We used this method to purify the label-retaining cells (LRCs) that mark the skin stem cell (SC) niche. We found that these cells rarely divide within their niche but change properties abruptly when stimulated to exit. We determined their transcriptional pro. le, which, when compared to progeny and other SCs, defines the niche. Many of the > 100 messenger RNAs preferentially expressed in the niche encode surface receptors and secreted proteins, enabling LRCs to signal and respond to their environment.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Blanpain, Cedric/ABD-8392-2021; Fuchs, Elaine/G-1565-2016; Tumbar, Tudorita/A-1916-2014	Guasch, Geraldine/0000-0001-7362-9318; Rendl, Michael/0000-0001-6326-620X; Tumbar, Tudorita/0000-0002-2273-1889	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063663, R01AR050452] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR063663, R01 AR050452, R01 AR050452-04] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Botchkarev VA, 2003, J INVEST DERMATOL, V120, P168, DOI 10.1046/j.1523-1747.2003.12003.x; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Garcion E, 2001, DEVELOPMENT, V128, P2485; Hocevar BA, 2003, EMBO J, V22, P3084, DOI 10.1093/emboj/cdg286; Iavarone A, 1999, MOL CELL BIOL, V19, P916; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Ito M, 2001, J INVEST DERMATOL, V116, P956, DOI 10.1046/j.0022-202x.2001.01369.x; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; JONES PH, 1995, CELL, V80, P83, DOI 10.1016/0092-8674(95)90453-0; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lyle S, 1999, J INVEST DERM SYMP P, V4, P296, DOI 10.1038/sj.jidsp.5640233; Mackenzie IC, 1997, J INVEST DERMATOL, V109, P377, DOI 10.1111/1523-1747.ep12336255; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; POTTEN CS, 1988, J CELL SCI, P45; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Sander G, 2000, J INVEST DERMATOL, V115, P753, DOI 10.1046/j.1523-1747.2000.00122.x; Sette C, 2000, INT J DEV BIOL, V44, P599; Soma Y, 2002, ARCH DERMATOL RES, V293, P609, DOI 10.1007/s00403-001-0279-6; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100	33	1496	1581	5	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 16	2004	303	5656					359	363		10.1126/science.1092436	http://dx.doi.org/10.1126/science.1092436			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14671312	Green Accepted			2022-12-28	WOS:000188111800040
J	Smith, R				Smith, R			Thoughts for new medical students at a new medical school	BRITISH MEDICAL JOURNAL			English	Article									BMJ, London WC1H 9JR, England		Smith, R (corresponding author), BMJ, London WC1H 9JR, England.							Smith R, 2001, BMJ-BRIT MED J, V322, P1073, DOI 10.1136/bmj.322.7294.1073	1	32	33	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1430	1433		10.1136/bmj.327.7429.1430	http://dx.doi.org/10.1136/bmj.327.7429.1430			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684637	Green Published			2022-12-28	WOS:000187562700008
J	Paul, SM; Beitel, GJ				Paul, SM; Beitel, GJ			Tubulogenesis CLICs into place	SCIENCE			English	Editorial Material							EXCRETORY CELL; ELEGANS; TUBES		Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Paul, SM (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.		Paul, Steve/ABE-5400-2020					Ashley RH, 2003, MOL MEMBR BIOL, V20, P1, DOI 10.1080/09687680210042746; Berry KL, 2003, SCIENCE, V302, P2134, DOI 10.1126/science.1087667; Boletta A, 2003, TRENDS CELL BIOL, V13, P484, DOI 10.1016/S0962-8924(03)00169-7; Buechner M, 1999, DEV BIOL, V214, P227, DOI 10.1006/dbio.1999.9398; Buechner M, 2002, TRENDS CELL BIOL, V12, P479, DOI 10.1016/S0962-8924(02)02364-4; Davis GE, 2003, MICROCIRCULATION, V10, P27, DOI 10.1038/sj.mn.7800175; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Wilk R, 2000, DEV BIOL, V219, P183, DOI 10.1006/dbio.2000.9619	9	9	9	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2077	2078		10.1126/science.1093203	http://dx.doi.org/10.1126/science.1093203			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684810				2022-12-28	WOS:000187385200030
J	Gordon, KB; Papp, KA; Hamilton, TK; Walicke, PA; Dummer, W; Li, N; Bresnahan, BW; Menter, A				Gordon, KB; Papp, KA; Hamilton, TK; Walicke, PA; Dummer, W; Li, N; Bresnahan, BW; Menter, A		Efalizumab Study Grp	Efalizumab for patients with moderate to severe plaque psoriasis - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; MONOCLONAL-ANTIBODY; LYMPHOCYTE ADHESION; DISEASE SEVERITY; SKIN-DISEASE; LFA-1; RECEPTORS; MOLECULES; PRURITUS; IMPACT	Context Because T-cell interactions are involved in the pathophysiology of psoriasis, therapy with a T-cell modulator may have beneficial effects on psoriasis severity and health-related quality of life (HRQL). Objective To assess the efficacy and safety of efalizumab, a T-cell modulator, in patients with plaque psoriasis. Design, Setting, and Patients Phase 3 randomized, double-blind, parallel-group, placebo-controlled trial involving 556 adult patients with stable, moderate to severe plaque psoriasis and conducted at 30 study centers in the United States and Canada between January and July 2002. Interventions Patients were randomly assigned in a 2:1 ratio to receive 12 weekly doses of subcutaneous efalizumab, 1 mg/kg (n=369), or placebo equivalent (n = 187). Main Outcome Measures At least 75% improvement on the Psoriasis Area and Severity Index (PASI-75); improvement on the overall Dermatology Life Quality Index (DLQI), Itching Visual Analog Scale (VAS), and Psoriasis Symptom Assessment (PSA) at week 12 vs baseline. Results Efalizumab-treated patients experienced significantly greater improvement on all end points than placebo-treated patients. Twenty-seven percent of efalizumab-treated patients achieved PASI-75 vs 4% of the placebo group (P<.001). Efalizumab-treated patients exhibited significantly greater mean percentage improvement than placebo-treated patients on the overall DLQI (47% vs 14%; P<.001), Itching VAS (38% vs -0.2%; P<.001), and PSA frequency and severity subscales (48% vs 18% and 47% vs 17%, respectively; P<.001 for both) at the first assessment point. Efalizumab was safe and well tolerated, with primarily mild to moderate adverse events. Conclusion In this 12-week study, efalizumab resulted in significant improvements in clinical end points, including physician-assessed and dermatology-specific patient-reported HRQL measures, in patients with moderate to severe plaque psoriasis.	Loyola Univ, Med Ctr, Maywood, IL 60153 USA; Atlanta Dermatol Vein & Res Ctr LLC, Atlanta, GA USA; Genentech Inc, San Francisco, CA 94080 USA; Baylor Univ, Med Ctr, Dallas, TX USA; Prob Med Res, Waterloo, ON, Canada	Loyola University Chicago; Roche Holding; Genentech; Baylor University; Baylor University Medical Center	Gordon, KB (corresponding author), Loyola Univ, Med Ctr, 2160 S 1st Ave,Bldg 112,Room 342, Maywood, IL 60153 USA.	kgordon@lumc.edu	menter md, alan/A-8250-2009	Papp, Kim A./0000-0001-9557-3642				Ashcroft DM, 1999, BRIT J DERMATOL, V141, P185; Bos JD, 1999, IMMUNOL TODAY, V20, P40, DOI 10.1016/S0167-5699(98)01381-4; Chren MM, 1996, J INVEST DERMATOL, V107, P707, DOI 10.1111/1523-1747.ep12365600; Chren MM, 1997, ARCH DERMATOL, V133, P1433, DOI 10.1001/archderm.133.11.1433; CHRISTOPHERS E, 1995, BRIT J DERMATOL, V132, P236; DUSTIN ML, 1988, J CELL BIOL, V107, P321, DOI 10.1083/jcb.107.1.321; DUSTIN ML, 1991, ANNU REV IMMUNOL, V9, P27, DOI 10.1146/annurev.iy.09.040191.000331; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Gilhar A, 1997, J INVEST DERMATOL, V109, P283, DOI 10.1111/1523-1747.ep12335758; Gottlieb A, 2000, J AM ACAD DERMATOL, V42, P428, DOI 10.1016/S0190-9622(00)90214-7; Gottlieb AB, 2002, ARCH DERMATOL, V138, P591, DOI 10.1001/archderm.138.5.591; GOTTLIEB AB, 1998, DIS MANAGE CLIN OUTC, V1, P195; GOTTLIEB SL, 1995, NAT MED, V1, P442, DOI 10.1038/nm0595-442; GREAVES MW, 1995, NEW ENGL J MED, V332, P581, DOI 10.1056/NEJM199503023320907; Gupta MA, 1998, BRIT J DERMATOL, V139, P846; GUPTA MA, 1988, ARCH DERMATOL, V124, P1052, DOI 10.1001/archderm.124.7.1052; GUPTA MA, 1995, ACTA DERM-VENEREOL, V75, P240; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Krueger G, 2001, ARCH DERMATOL, V137, P280; Krueger GG, 2000, J AM ACAD DERMATOL, V43, P281, DOI 10.1067/mjd.2000.106374; Krueger J, 2000, J INVEST DERMATOL, V115, P333, DOI 10.1046/j.1523-1747.2000.00abs-8.x; Krueger JG, 2002, J AM ACAD DERMATOL, V46, P1, DOI 10.1067/mjd.2002.120568; KUYPERS TW, 1989, RES IMMUNOL, V140, P461, DOI 10.1016/0923-2494(89)90114-4; Leary MR, 1998, HEALTH PSYCHOL, V17, P530, DOI 10.1037/0278-6133.17.6.530; Lebwohl M, 2003, NEW ENGL J MED, V349, P2004, DOI 10.1056/NEJMoa030002; McKenna KE, 1997, J AM ACAD DERMATOL, V36, P388, DOI 10.1016/S0190-9622(97)80214-9; Menter MA, 2003, J AM ACAD DERMATOL, V49, pS39, DOI 10.1016/mjd.2003.545; NICKOLOFF BJ, 1990, J INVEST DERMATOL, V94, pS151, DOI 10.1111/1523-1747.ep12876134; PAPADOPOULUS E, 2003, 1250750 STN BL US FD; Papp K, 2001, J AM ACAD DERMATOL, V45, P665, DOI 10.1067/mjd.2001.117850; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; SHIKIAR R, 2002, VALIDITY PATIENT REP, P1; SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; Wahl A, 2000, J AM ACAD DERMATOL, V43, P803, DOI 10.1067/mjd.2000.107501; Weiss SC, 2002, J AM ACAD DERMATOL, V47, P512, DOI 10.1067/mjd.2002.122755; Werther WA, 1996, J IMMUNOL, V157, P4986; Yosipovitch G, 2000, BRIT J DERMATOL, V143, P969, DOI 10.1046/j.1365-2133.2000.03829.x	37	299	311	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2003	290	23					3073	3080		10.1001/jama.290.23.3073	http://dx.doi.org/10.1001/jama.290.23.3073			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753ZB	14679270				2022-12-28	WOS:000187277300026
J	Metivier, R; Penot, G; Hubner, MR; Reid, G; Brand, H; Kos, M; Gannon, F				Metivier, R; Penot, G; Hubner, MR; Reid, G; Brand, H; Kos, M; Gannon, F			Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter	CELL			English	Article							RNA-POLYMERASE-II; IN-VIVO; TRANSCRIPTIONAL ACTIVATION; GLUCOCORTICOID-RECEPTOR; COACTIVATOR COMPLEXES; HISTONE MODIFICATIONS; CHROMATIN STRUCTURE; DISTINCT PATTERNS; NUCLEAR RECEPTORS; GENE-EXPRESSION	Transcriptional activation of a gene involves an orchestrated recruitment of components of the basal transcription machinery and intermediate factors, concomitant with an alteration in local chromatin structure generated by posttranslational modifications of histone tails and nucleosome remodeling. We provide here a comprehensive picture of events resulting in transcriptional activation of a gene, through evaluating the estrogen receptor-alpha (NR3A1) target pS2 gene promoter in MCF-7 cells. This description integrates chromatin remodeling with a kinetic evaluation of cyclical networks of association of 46 transcription factors with the promoter, as determined by chromatin immunoprecipitation assays. We define the concept of a "transcriptional clock" that directs and achieves the sequential and combinatorial assembly of a transcriptionally productive complex on a promoter. Furthermore, the unanticipated findings of key roles for histone deacetylases and nucleosome-remodeling complexes in limiting transcription implies that transcriptional activation is a cyclical process that requires both activating and repressive epigenetic processes.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Metivier, R (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	raphael.metivier@embl-heidelberg.de; frank.gannon@embo.org	jia, xu/A-8386-2016; Kos, Martin/E-2534-2011; Gannon, Frank/G-1194-2015	Kos, Martin/0000-0002-3337-9681; Reid, George/0000-0002-0298-693X				Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Alvarez M, 2003, GENE, V313, P43, DOI 10.1016/S0378-1119(03)00627-9; Belandia B, 2003, CELL, V114, P277, DOI 10.1016/S0092-8674(03)00599-3; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Berk AJ, 1999, CURR OPIN CELL BIOL, V11, P330, DOI 10.1016/S0955-0674(99)80045-3; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Burakov D, 2002, J BIOL CHEM, V277, P14359, DOI 10.1074/jbc.C200099200; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; Emerson BM, 2002, CELL, V109, P267, DOI 10.1016/S0092-8674(02)00740-7; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Feigelson HS, 1996, CARCINOGENESIS, V17, P2279, DOI 10.1093/carcin/17.11.2279; Ferdous A, 2002, BIOCHEMISTRY-US, V41, P12798, DOI 10.1021/bi020425t; Fletcher TM, 2002, MOL CELL BIOL, V22, P3255, DOI 10.1128/MCB.22.10.3255-3263.2002; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; Guermah M, 2001, MOL CELL BIOL, V21, P6882, DOI 10.1128/MCB.21.20.6882-6894.2001; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jepsen K, 2002, J CELL SCI, V115, P689; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kassabov SR, 2003, MOL CELL, V11, P391, DOI 10.1016/S1097-2765(03)00039-X; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Klinge CM, 2000, STEROIDS, V65, P227, DOI 10.1016/S0039-128X(99)00107-5; Kraus WL, 1998, GENE DEV, V12, P331, DOI 10.1101/gad.12.3.331; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lee JW, 2001, CELL MOL LIFE SCI, V58, P289, DOI 10.1007/PL00000856; Li XT, 2003, MOL CELL BIOL, V23, P3763, DOI 10.1128/MCB.23.11.3763-3773.2003; Liu Z, 2001, P NATL ACAD SCI USA, V98, P12426, DOI 10.1073/pnas.231474798; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Marmorstein R, 2001, NAT REV MOL CELL BIO, V2, P422, DOI 10.1038/35073047; Martens JHA, 2003, MOL CELL BIOL, V23, P1808, DOI 10.1128/MCB.23.5.1808-1816.2003; MASIAKOWSKI P, 1982, NUCLEIC ACIDS RES, V10, P7895, DOI 10.1093/nar/10.24.7895; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nilsson S, 2001, PHYSIOL REV, V81, P1535, DOI 10.1152/physrev.2001.81.4.1535; Nye AC, 2002, MOL CELL BIOL, V22, P3437, DOI 10.1128/MCB.22.10.3437-3449.2002; Ogbourne S, 1998, BIOCHEM J, V331, P1; ONATE SA, 1995, SCIENCE, V270, P1354; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Perissi V, 1999, P NATL ACAD SCI USA, V96, P3652, DOI 10.1073/pnas.96.7.3652; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Sabbah M, 1998, BIOCHEM J, V336, P639, DOI 10.1042/bj3360639; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Sewack GF, 1997, J BIOL CHEM, V272, P31118, DOI 10.1074/jbc.272.49.31118; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sharma VM, 2003, GENE DEV, V17, P502, DOI 10.1101/gad.1039503; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; Vermeulen W, 2002, MOL CELL, V10, P1264, DOI 10.1016/S1097-2765(02)00795-5; VILLALOBOS M, 1995, ENVIRON HEALTH PERSP, V103, P844, DOI 10.2307/3432398; WAMMACK A, 2001, J BIOL CHEM, V276, P45939; Wang CG, 2001, J BIOL CHEM, V276, P18375, DOI 10.1074/jbc.M100800200; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; WOLFFE A, 1992, CHROMATIN STRUCTURE; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3; Wu SY, 1999, J BIOL CHEM, V274, P23480, DOI 10.1074/jbc.274.33.23480; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961	74	1207	1239	0	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 12	2003	115	6					751	763		10.1016/S0092-8674(03)00934-6	http://dx.doi.org/10.1016/S0092-8674(03)00934-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675539	Bronze			2022-12-28	WOS:000187366100014
J	Povich, MS; Raymond, JC; Jones, GH; Uzzo, M; Ko, YK; Feldman, PD; Smith, PL; Marsden, BG; Woods, TN				Povich, MS; Raymond, JC; Jones, GH; Uzzo, M; Ko, YK; Feldman, PD; Smith, PL; Marsden, BG; Woods, TN			Doubly ionized carbon observed in the plasma tail of comet Kudo-Fujikawa	SCIENCE			English	Article							BETA-PICTORIS; SOLAR; DUST; CO	Comet C/2002 X5 (Kudo-Fujikawa) was observed near its perihelion of 0.19 astronomical unit by the Ultraviolet Coronagraph Spectrometer aboard the Solar and Heliospheric Observatory spacecraft. Images of the comet reconstructed from high-resolution spectra reveal a quasi-spherical cloud of neutral hydrogen and a variable tail of C+ and C2+ that disconnects from the comet and subsequently regenerates. The high abundance of C2+ and C+, at least 24% relative to water, cannot be explained by photodissociation of carbon monoxide and is instead attributed to the evaporation and subsequent photoionization of atomic carbon from organic refractory compounds present in the cometary dust grains. This result serves to strengthen the connection between comets and the material from which the Solar System formed.	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Johns Hopkins University; University of Colorado System; University of Colorado Boulder	Povich, MS (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.		Jones, Geraint H./C-1682-2008	Jones, Geraint H./0000-0002-5859-1136				ALFVEN H, 1957, TELLUS, V9, P92, DOI 10.1111/j.2153-3490.1957.tb01855.x; Bouret JC, 2002, ASTRON ASTROPHYS, V390, P1049, DOI 10.1051/0004-6361:20020741; BOUT M, 2003, B AM ASTRON SOC, V35, P988; Brandt JC, 2000, ICARUS, V148, P52, DOI 10.1006/icar.2000.6484; COMBI MR, 1988, ASTROPHYS J, V327, P1026, DOI 10.1086/166260; Curdt W, 2001, ASTRON ASTROPHYS, V375, P591, DOI 10.1051/0004-6361:20010364; DiSanti MA, 2001, ICARUS, V153, P361, DOI 10.1006/icar.2001.6695; Feldman PD, 2002, ASTROPHYS J, V576, pL91, DOI 10.1086/343089; GOMBOSI TI, 1996, J GEOPHYS RES, V101, P15223; Greenberg JM, 1999, SPACE SCI REV, V90, P149, DOI 10.1023/A:1005298014670; HUEBNER WF, 1992, ASTROPHYS SPACE SCI, V195, P1, DOI 10.1007/BF00644558; Kohl JL, 1995, SOL PHYS, V162, P313, DOI 10.1007/BF00733433; LAMY PL, 1988, ICARUS, V76, P100, DOI 10.1016/0019-1035(88)90142-X; NAKANO S, 2002, 8032 INT ASTR UN; Raymond JC, 2002, ASTROPHYS J, V564, P1054, DOI 10.1086/324545; Sheeley NR, 1999, J GEOPHYS RES-SPACE, V104, P24739, DOI 10.1029/1999JA900308; Verner DA, 1996, ASTROPHYS J, V465, P487, DOI 10.1086/177435; Vidal-Madjar A, 1998, PLANET SPACE SCI, V46, P629, DOI 10.1016/S0032-0633(97)00192-X; WATANABE J, 2002, 8033 INT ASTR UN; Woods TN, 1998, P SOC PHOTO-OPT INS, V3442, P180, DOI 10.1117/12.330255; Yi Y, 1996, J GEOPHYS RES-SPACE, V101, P27585, DOI 10.1029/96JA02235	21	24	24	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1949	1952		10.1126/science.1092142	http://dx.doi.org/10.1126/science.1092142			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671299				2022-12-28	WOS:000187174000056
J	Coltman, DW; O'Donoghue, P; Jorgenson, JT; Hogg, JT; Strobeck, C; Festa-Bianchet, M				Coltman, DW; O'Donoghue, P; Jorgenson, JT; Hogg, JT; Strobeck, C; Festa-Bianchet, M			Undesirable evolutionary consequences of trophy hunting	NATURE			English	Article							DEER CERVUS-ELAPHUS; POPULATION-DYNAMICS; BIGHORN SHEEP; CONSERVATION; REPRODUCTION; MANAGEMENT; SELECTION; SIZE; RAMS	Phenotype- based selective harvests, including trophy hunting, can have important implications for sustainable wildlife management if they target heritable traits(1 - 3). Here we show that in an evolutionary response to sport hunting of bighorn trophy rams ( Ovis canadensis) body weight and horn size have declined significantly over time. We used quantitative genetic analyses, based on a partly genetically reconstructed pedigree from a 30- year study of a wild population in which trophy hunting targeted rams with rapidly growing horns(4), to explore the evolutionary response to hunter selection on ram weight and horn size. Both traits were highly heritable, and trophy- harvested rams were of significantly higher genetic ' breeding value' for weight and horn size than rams that were not harvested. Rams of high breeding value were also shot at an early age, and thus did not achieve high reproductive success(5). Declines in mean breeding values for weight and horn size therefore occurred in response to unrestricted trophy hunting, resulting in the production of smaller- horned, lighter rams, and fewer trophies.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; Alberta Dept Sustainable Dev, Fish & Wildlife Div, Canmore, AB T0L 0M0, Canada; Montana Conservat Sci Inst, Missoula, MT 59803 USA; Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada	University of Sheffield; University of Alberta; University of Sherbrooke	Coltman, DW (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.		Coltman, David W/A-4453-2012; Strobeck, Curtis/E-9998-2011	Coltman, David W/0000-0002-1268-2307; Festa-Bianchet, Marco/0000-0002-2352-3379				Ashley MV, 2003, BIOL CONSERV, V111, P115, DOI 10.1016/S0006-3207(02)00279-3; Clutton-Brock TH, 2002, NATURE, V415, P633, DOI 10.1038/415633a; Coltman DW, 2001, EVOLUTION, V55, P2116, DOI 10.1111/j.0014-3820.2001.tb01326.x; Coltman DW, 2002, P ROY SOC B-BIOL SCI, V269, P165, DOI 10.1098/rspb.2001.1851; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; CRAWFORD AM, 1995, GENETICS, V140, P703; Festa-Bianchet M, 2003, ANIMAL BEHAVIOR AND WILDLIFE CONSERVATION, P191; FestaBianchet M, 1996, CAN J ZOOL, V74, P330, DOI 10.1139/z96-041; FESTABIANCHET M, IN PRESS BEHAV ECOL; GINSBERG JR, 1994, CONSERV BIOL, V8, P157, DOI 10.1046/j.1523-1739.1994.08010157.x; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; GROENEVELD E, 1992, ARCH ANIM BREED, V15, P399; GROENEVELD E, 1995, USERS GUIDE REML VCE; Harris RB, 2002, WILDLIFE SOC B, V30, P634; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Hogg JT, 1997, BEHAV ECOL SOCIOBIOL, V41, P33, DOI 10.1007/s002650050361; JACHMANN H, 1995, AFR J ECOL, V33, P230, DOI 10.1111/j.1365-2028.1995.tb00800.x; JORGENSON JT, 1993, J WILDLIFE MANAGE, V57, P429, DOI 10.2307/3809267; Jorgenson JT, 1998, J WILDLIFE MANAGE, V62, P1011, DOI 10.2307/3802554; Langvatn R, 1999, WILDLIFE BIOL, V5, P213; Laurian C, 2000, J APPL ECOL, V37, P515, DOI 10.1046/j.1365-2664.2000.00520.x; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; Lynch M., 1998, GENETICS ANAL QUANTI; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Merila J, 2001, NATURE, V412, P76, DOI 10.1038/35083580; Milner-Gulland EJ, 2003, NATURE, V422, P135, DOI 10.1038/422135a; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Slate J, 1998, ANIM GENET, V29, P307, DOI 10.1046/j.1365-2052.1998.00347.x; THELEN TH, 1991, J WILDLIFE MANAGE, V55, P243, DOI 10.2307/3809146; [No title captured]	30	545	555	8	609	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					655	658		10.1038/nature02177	http://dx.doi.org/10.1038/nature02177			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668862				2022-12-28	WOS:000187132800039
J	Dadson, SJ; Hovius, N; Chen, HG; Dade, WB; Hsieh, ML; Willett, SD; Hu, JC; Horng, MJ; Chen, MC; Stark, CP; Lague, D; Lin, JC				Dadson, SJ; Hovius, N; Chen, HG; Dade, WB; Hsieh, ML; Willett, SD; Hu, JC; Horng, MJ; Chen, MC; Stark, CP; Lague, D; Lin, JC			Links between erosion, runoff variability and seismicity in the Taiwan orogen	NATURE			English	Article							SEDIMENT; EVOLUTION; INCISION; RANGE; RATES; MODEL	The erosion of mountain belts controls their topographic and structural evolution(1 - 3) and is the main source of sediment delivered to the oceans(4). Mountain erosion rates have been estimated from current relief and precipitation, but a more complete evaluation of the controls on erosion rates requires detailed measurements across a range of timescales. Here we report erosion rates in the Taiwan mountains estimated from modern river sediment loads, Holocene river incision and thermochronometry on a million- year scale. Estimated erosion rates within the actively deforming mountains are high ( 3 - 6 mm yr(-1)) on all timescales, but the pattern of erosion has changed over time in response to the migration of localized tectonic deformation. Modern, decadal- scale erosion rates correlate with historical seismicity and storm- driven runoff variability. The highest erosion rates are found where rapid deformation, high storm frequency and weak substrates coincide, despite low topographic relief.	Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Natl Taiwan Univ, Dept Geosci, Taipei 10764, Taiwan; Natl Taiwan Univ, Dept Geog, Taipei 10764, Taiwan; Dartmouth Coll, Dept Earth Sci, Hanover, NH 03755 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; Minist Econ Affairs, Water Resources Agcy, Taipei, Taiwan; Taroko Natl Pk Headquarters, Fu Su Village 972, Hualien, Taiwan; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	University of Cambridge; National Taiwan University; National Taiwan University; Dartmouth College; University of Washington; University of Washington Seattle; Columbia University	Dadson, SJ (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.	simon00@esc.cam.ac.uk	Lague, Dimitri/C-8870-2011; Hovius, Niels/F-1094-2013; Dadson, Simon J/D-2370-2010; Willett, Sean D/B-1716-2008; Hu, Jyr-Ching/EPS-4687-2022	Dadson, Simon/0000-0002-6144-4639; LIN, JIUN CHUAN/0000-0003-3955-7677; Hu, Jyr-Ching/0000-0001-5044-5225; CHEN, HONGEY/0000-0003-1211-3259; Lague, Dimitri/0000-0002-8980-1415; Hovius, Niels/0000-0002-9158-9871				BEAUMONT C, 1992, THRUST TECTONICS, P1; Carena S, 2002, GEOLOGY, V30, P935, DOI 10.1130/0091-7613(2002)030<0935:ADOTIB>2.0.CO;2; COHN TA, 1995, REV GEOPHYS, V33, P1117, DOI 10.1029/95RG00292; EKSTROM G, 1988, NATURE, V332, P319, DOI 10.1038/332319a0; Finlayson DP, 2002, GEOLOGY, V30, P219, DOI 10.1130/0091-7613(2002)030<0219:SCORIE>2.0.CO;2; Fuller CW, 2003, J GEOL, V111, P71, DOI 10.1086/344665; Hartshorn K, 2002, SCIENCE, V297, P2036, DOI 10.1126/science.1075078; HICKMAN JB, 2002, GEOL S AM S, V358, P75; Ho C. S., 1986, INTRO GEOLOGY TAIWAN; Hovius N, 2000, J GEOL, V108, P73, DOI 10.1086/314387; Hsieh ML, 2001, GEOMORPHOLOGY, V38, P337, DOI 10.1016/S0169-555X(00)00105-7; HSIEH ML, 2002, GEOL S AM S, V358, P55; Kao SJ, 2001, TERR ATMOS OCEAN SCI, V12, P401, DOI 10.3319/TAO.2001.12.2.401(O); KEEFER DK, 1984, GEOL SOC AM BULL, V95, P406, DOI 10.1130/0016-7606(1984)95<406:LCBE>2.0.CO;2; KOONS PO, 1989, AM J SCI, V289, P1041, DOI 10.2475/ajs.289.9.1041; LI YH, 1976, GEOLOGY, V4, P105, DOI 10.1130/0091-7613(1976)4<105:DOTIST>2.0.CO;2; Liew PM, 1998, GLOBAL PLANET CHANGE, V17, P85; LIEW PM, 1993, TECTONOPHYSICS, V222, P55, DOI 10.1016/0040-1951(93)90189-Q; Liu T.-K., 1982, PROCEED GEOL SOC CHI, V25, P22; MILLIMAN JD, 1992, J GEOL, V100, P525, DOI 10.1086/629606; Montgomery DR, 2001, GEOLOGY, V29, P579, DOI 10.1130/0091-7613(2001)029<0579:CTATMO>2.0.CO;2; Shieh SL, 2000, USERS GUIDE TYPHOON; STUIVER M, 1993, RADIOCARBON, V35, P215, DOI 10.1017/S0033822200013904; TENG LS, 1990, TECTONOPHYSICS, V183, P57, DOI 10.1016/0040-1951(90)90188-E; *WAT RES AG, 1970, HYDR YB TAIW REP CHI; Whipple KX, 1999, J GEOPHYS RES-SOL EA, V104, P17661, DOI 10.1029/1999JB900120; Willett SD, 1999, J GEOPHYS RES-SOL EA, V104, P28957, DOI 10.1029/1999JB900248; Willett SD, 2003, GEOLOGY, V31, P945, DOI 10.1130/G19702.1; Yu SB, 1997, TECTONOPHYSICS, V274, P41, DOI 10.1016/S0040-1951(96)00297-1; [No title captured]	30	691	747	7	202	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					648	651		10.1038/nature02150	http://dx.doi.org/10.1038/nature02150			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668860	Green Published			2022-12-28	WOS:000187132800037
J	Howard, K				Howard, K			San Diego	NATURE			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					689	689		10.1038/426689	http://dx.doi.org/10.1038/426689			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668871	Bronze			2022-12-28	WOS:000187132800048
J	Powell, K				Powell, K			High-tech, high society	NATURE			English	Article																			0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					720	721		10.1038/426720	http://dx.doi.org/10.1038/426720			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668880	Bronze			2022-12-28	WOS:000187132800057
J	Schwammle, V; Herrmann, HJ				Schwammle, V; Herrmann, HJ			Geomorphology: Solitary wave behaviour of sand dunes - Colliding dunes appear to traverse through one another and emerge unscathed.	NATURE			English	Editorial Material							MODEL		Univ Stuttgart, D-70569 Stuttgart, Germany	University of Stuttgart	Schwammle, V (corresponding author), Univ Stuttgart, ICA-1, D-70569 Stuttgart, Germany.	veit@ica1.uni-stuttgart.de		Schwammle, Veit/0000-0002-9708-6722				Bagnold R., 1941, PHYS BLOWN SAND DESE; Besler H, 2002, Z GEOMORPHOL, V126, P59; FINKEL HJ, 1959, J GEOL, V67, P614, DOI 10.1086/626622; Hesp PA, 1998, GEOMORPHOLOGY, V22, P193, DOI 10.1016/S0169-555X(97)00070-6; Kroy K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.054301; Lamb G.L., 1980, ELEMENTS SOLITON THE; Sauermann G, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.031305; Sauermann G, 2000, GEOMORPHOLOGY, V36, P47, DOI 10.1016/S0169-555X(00)00047-7; WERNER BT, 1990, J GEOL, V98, P1, DOI 10.1086/629371; WIPPERMANN FK, 1986, BOUND-LAY METEOROL, V36, P319, DOI 10.1007/BF00118335	10	97	101	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					619	620		10.1038/426619a	http://dx.doi.org/10.1038/426619a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668849				2022-12-28	WOS:000187132800026
J	Yokoyama, K; Doi, Y; Yamane, K; Kurokawa, H; Shibata, N; Shibayama, K; Yagi, T; Kato, H; Arakawa, Y				Yokoyama, K; Doi, Y; Yamane, K; Kurokawa, H; Shibata, N; Shibayama, K; Yagi, T; Kato, H; Arakawa, Y			Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa	LANCET			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; AMINOGLYCOSIDE ANTIBIOTICS; MICROMONOSPORA-PURPUREA; GENTAMICIN; ARBEKACIN; BACTERIA; TRENDS; DNA	Background Bacteria develop resistance to aminoglycosides by producing aminoglycoside-modifying enzymes such as acetyltransferase, phosphorylase, and adenyltransferase. These enzymes, however, cannot confer consistent resistance to various aminoglycosides because of their substrate specificity. Notwithstanding, a Pseudomonas aeruginosa strain AR-2 showing high-level resistance (minimum inhibitory concentration >1024 mg/L) to various aminoglycosides was isolated clinically. We aimed to clone and characterise the genetic determinant of this resistance. Methods We used conventional methods for DNA manipulation, susceptibility testing, and gene analyses to clone and characterise the genetic determinant of the resistance seen. PCR detection of the gene was also done on a stock of P aeruginosa strains that were isolated clinically since 1997. Findings An aminoglycoside-resistance gene, designated rmtA, was identified in P aeruginosa AR-2. The Escherichia coli transformant and transconjugant harbouring the rmtA gene showed very high-level resistance to various aminoglycosides, including amikacin, tobramycin, isepamicin, arbekacin, kanamycin, and gentamicin. The 756-bp nucleotide rmtA gene encoded a protein, RmtA. This protein showed considerable similarity to the 16S rRNA methylases of aminoglycoside-producing actinomycetes, which protect bacterial 16S rRNA from intrinsic aminoglycosides by methylation. Incorporation of radiolabelled methyl groups into the 30S ribosome was detected in the presence of RmtA. Of 1113 clinically isolated P aeruginosa strains, nine carried the rmtA gene, as shown by PCR analyses. Interpretation Our findings strongly suggest intergeneric lateral gene transfer of 16S rRNA methylase gene from some aminoglycoside-producing microorganisms to P aeruginosa. Further dissemination of the rmtA gene in nosocomial bacteria could be a matter of concern in the future.	Natl Inst Infect Dis, Dept Bacterial Pathogenesis & Infect Control, Tokyo 2080011, Japan	National Institute of Infectious Diseases (NIID)	Arakawa, Y (corresponding author), Natl Inst Infect Dis, Dept Bacterial Pathogenesis & Infect Control, 4-7-1 Gakuen, Tokyo 2080011, Japan.		Yagi, Tetsuya/J-3303-2012; Arakawa, Yoshichika/P-5997-2015	Doi, Yohei/0000-0002-9620-2525				Arakawa Y, 2000, EMERG INFECT DIS, V6, P572, DOI 10.3201/eid0606.000604; Bootsma HJ, 2000, MOL MICROBIOL, V36, P93, DOI 10.1046/j.1365-2958.2000.01828.x; *DNA DAT BANK JAP, DDBJ HOM SEARCH SYST; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; Gonzalez-Zorn B, 2003, LANCET INFECT DIS, V3, P67, DOI 10.1016/S1473-3099(03)00510-3; INOUE M, 1994, DRUG EXP CLIN RES, V20, P233; Jones AM, 2001, LANCET, V358, P557, DOI 10.1016/S0140-6736(01)05714-2; KELEMEN GH, 1991, GENE, V98, P53, DOI 10.1016/0378-1119(91)90103-I; Kondo S., 1999, J Infect Chemother, V5, P1, DOI 10.1007/s101560050001; Kurokawa H, 1999, LANCET, V354, P955, DOI 10.1016/S0140-6736(05)75707-X; Lipsitch M, 2002, EMERG INFECT DIS, V8, P347, DOI 10.3201/eid0804.010312; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; *NAT COMM CLIN LAB, 2002, M100S12 NCCLS; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; PRICE KE, 1986, AM J MED, V80, P182, DOI 10.1016/0002-9343(86)90499-7; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; SKEGGS PA, 1985, MOL GEN GENET, V200, P415, DOI 10.1007/BF00425725; Tacconelli E, 2002, EMERG INFECT DIS, V8, P220, DOI 10.3201/eid0802.010121; TANAKA N, 1983, ANTIMICROB AGENTS CH, V24, P797, DOI 10.1128/AAC.24.5.797; THOMPSON J, 1985, MOL GEN GENET, V201, P168, DOI 10.1007/BF00425655; THORNSBERRY C, 1980, ANTIMICROB AGENTS CH, V18, P338, DOI 10.1128/AAC.18.2.338; Umezawa H, 1979, Jpn J Antibiot, V32 Suppl, pS1; Watanabe T, 1997, J ANTIMICROB CHEMOTH, V39, P471, DOI 10.1093/jac/39.4.471; Westbrock-Wadman S, 1999, ANTIMICROB AGENTS CH, V43, P2975, DOI 10.1128/AAC.43.12.2975	25	169	243	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1888	1893		10.1016/S0140-6736(03)14959-8	http://dx.doi.org/10.1016/S0140-6736(03)14959-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667745				2022-12-28	WOS:000187011600009
J	Bastow, R; Dean, C				Bastow, R; Dean, C			Plant sciences - Deciding when to flower	SCIENCE			English	Editorial Material							ARABIDOPSIS; GENE; PROTEIN; ENCODES; TIME; REPRESSOR; HISTONE; FCA		John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Bastow, R (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England.							Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; He YH, 2003, SCIENCE, V302, P1751, DOI 10.1126/science.1091109; LEE I, 1994, PLANT CELL, V6, P75, DOI 10.1105/tpc.6.1.75; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Schomburg FM, 2001, PLANT CELL, V13, P1427, DOI 10.1105/tpc.13.6.1427; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Tian L, 2001, P NATL ACAD SCI USA, V98, P200, DOI 10.1073/pnas.011347998	10	14	14	2	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1695	1697		10.1126/science.1092862	http://dx.doi.org/10.1126/science.1092862			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657484				2022-12-28	WOS:000186970100031
J	Shibata, Y; Branicky, R; Landaverde, IO; Hekimi, S				Shibata, Y; Branicky, R; Landaverde, IO; Hekimi, S			Redox regulation of germline and vulval development in Caenorhabditis elegans	SCIENCE			English	Article							LIVED CLK-1 MUTANTS; C-ELEGANS; TRANSFER PROTEIN; GENE; ABETALIPOPROTEINEMIA; MUTATIONS; KINASE	In vitro studies have indicated that reactive oxygen species (ROS) and the oxidation of signaling molecules are important mediators of signal transduction. We have identified two pathways by which the altered redox chemistry of the clk-1 mutants of Caenorhabditis elegans acts in vivo on germline development. One pathway depends on the oxidation of an analog of vertebrate low density lipoprotein (LDL) and acts on the germline through the Ack-related tyrosine kinase (ARK-1) kinase and inositol trisphosphate (IP3) signaling. The other pathway is the oncogenic ras signaling pathway, whose action on germline as well as vulval development appears to be modulated by cytoplasmic ROS.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Hekimi, S (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.		Shibata, Yukimasa/H-8467-2017					ALLEVA R, 1995, P NATL ACAD SCI USA, V92, P9388, DOI 10.1073/pnas.92.20.9388; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; Branicky R, 2001, GENETICS, V159, P997; Clandinin TR, 1998, CELL, V92, P523, DOI 10.1016/S0092-8674(00)80945-9; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Ernster L., 1993, CLIN INVESTIGATOR, V71, P60; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Guo ZM, 2001, ARTERIOSCL THROM VAS, V21, P1131, DOI 10.1161/hq0701.092092; Hihi AK, 2002, J BIOL CHEM, V277, P2202, DOI 10.1074/jbc.M109034200; Hopper NA, 2000, MOL CELL, V6, P65, DOI 10.1016/S1097-2765(00)00008-3; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jacobs D, 1998, GENETICS, V149, P1809; Jonassen T, 2002, J BIOL CHEM, V277, P45020, DOI 10.1074/jbc.M204758200; Jonassen T, 2001, P NATL ACAD SCI USA, V98, P421, DOI 10.1073/pnas.021337498; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Miyadera H, 2002, FEBS LETT, V512, P33, DOI 10.1016/S0014-5793(02)02282-2; Miyadera H, 2001, J BIOL CHEM, V276, P7713, DOI 10.1074/jbc.C000889200; Morey M, 2001, DEV BIOL, V238, P145, DOI 10.1006/dbio.2001.0389; Segrest JP, 2001, J LIPID RES, V42, P1346; SHARP D, 1993, NATURE, V365, P65, DOI 10.1038/365065a0; SHIBATA Y, UNPUB; SPIETH J, 1991, J MOL EVOL, V32, P429, DOI 10.1007/BF02101283; Sternberg PW, 1998, TRENDS GENET, V14, P466, DOI 10.1016/S0168-9525(98)01592-3; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; WONG A, 1995, GENETICS, V139, P1247	26	96	120	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1779	1782		10.1126/science.1087167	http://dx.doi.org/10.1126/science.1087167			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657502				2022-12-28	WOS:000186970100052
J	Wang, HR; Zhang, Y; Ozdamar, B; Ogunjimi, AA; Alexandrova, E; Thomsen, GH; Wrana, JL				Wang, HR; Zhang, Y; Ozdamar, B; Ogunjimi, AA; Alexandrova, E; Thomsen, GH; Wrana, JL			Regulation of cell polarity and protrusion formation by targeting RhoA for degradation	SCIENCE			English	Article							PROTEIN-KINASE-C; E3 UBIQUITIN LIGASE; CAENORHABDITIS-ELEGANS; FAMILY GTPASES; COMPLEX; CDC42; SMURF2; TRANSFORMATION; CYTOSKELETON; ADHESION	The Rho family of small guanosine triphosphatases regulates actin cytoskeleton dynamics that underlie cellular functions such as cell shape changes, migration, and polarity. We found that Smurf1, a HECT domain E3 ubiquitin ligase, regulated cell polarity and protrusive activity and was required to maintain the transformed morphology and motility of a tumor cell. Atypical protein kinase C zeta (PKCzeta), an effector of the Cdc42/Rac1-PAR6 polarity complex, recruited Smurf1 to cellular protrusions, where it controlled the local level of RhoA. Smurf1 thus links the polarity complex to degradation of RhoA in lamellipodia and filopodia to prevent RhoA signaling during dynamic membrane movements.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M56 1X5, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; SUNY Stony Brook, Dept Biochem & Cell Biol, Ctr Dev Genet, Stony Brook, NY 11794 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wrana, JL (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, 600 Univ Ave, Toronto, ON M56 1X5, Canada.		Wrana, Jeffrey/F-8857-2013	Wang, Hong-Rui/0000-0002-2916-8849	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032429] Funding Source: NIH RePORTER; NICHD NIH HHS [HD32429, R01 HD032429-07, R01 HD032429-06, R01 HD032429] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bao J, UNPUB; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bonni S, 2001, NAT CELL BIOL, V3, P587, DOI 10.1038/35078562; Coghlan MP, 2000, MOL CELL BIOL, V20, P2880, DOI 10.1128/MCB.20.8.2880-2889.2000; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gao L, 2002, CURR BIOL, V12, P221, DOI 10.1016/S0960-9822(01)00663-7; Gomes JE, 2002, CURR BIOL, V12, pR444, DOI 10.1016/S0960-9822(02)00939-9; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Hall A, 1999, BRIT J CANCER, V80, P25; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hung TJ, 1999, DEVELOPMENT, V126, P127; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Qiu RG, 1997, MOL CELL BIOL, V17, P3449, DOI 10.1128/MCB.17.6.3449; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Suzuki A, 2002, J CELL SCI, V115, P3565, DOI 10.1242/jcs.00032; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Van Aelst L, 2002, GENE DEV, V16, P1032, DOI 10.1101/gad.978802; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	34	429	443	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1775	1779		10.1126/science.1090772	http://dx.doi.org/10.1126/science.1090772			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657501				2022-12-28	WOS:000186970100051
J	Taylor, JA; Weber, W; Standish, L; Quinn, H; Goesling, J; McGann, M; Calabrese, C				Taylor, JA; Weber, W; Standish, L; Quinn, H; Goesling, J; McGann, M; Calabrese, C			Efficacy and safety of echinacea in treating upper respiratory tract infections in children - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALTERNATIVE MEDICINE USE; ZINC GLUCONATE LOZENGES; COMMON COLD; DOUBLE-BLIND; YOUNG-CHILDREN; COMPLEMENTARY; DURATION; SYMPTOMS	Context Echinacea is a widely used herbal remedy for treatment of upper respiratory tract infections (URls). However, there are few data on the efficacy and safety of echinacea in treating URIs in children. Objectives To determine if Echinacea purpurea is effective in reducing the duration and/or severity of URI symptoms in children and to assess its safety in this population. Design, Setting, and Participants Randomized, double-blind, placebo-controlled trial of healthy children 2 to 11 years old recruited from a regional practice-based network and an alternative medical center in 4-month periods from 2000 through 2002. Interventions Study patients were randomized to receive either echinacea or placebo for up to 3 URIs over a 4-month period. Study medication was begun at the onset of symptoms and continued throughout the URI, for a maximum of 10 days. Main Outcome Measures Primary outcomes were duration and severity of symptoms and adverse events recorded by parents; secondary outcomes included peak severity of symptoms, number of days of peak severity, number of days of fever, and a global assessment of severity of symptoms by parents of study children. Results Data were analyzed on 707 URIs that occurred in 407 children, including 337 URIs treated with echinacea and 370 with placebo. There were 79 children who completed their study period without having a URI. The median duration of URIs was 9 days (95% confidence interval, 8-10 days); there was no difference in duration between URls treated with echinacea or placebo (P=.89). There was also no difference in the overall estimate of severity of URI symptoms between the 2 treatment groups (median, 33 in both groups; P=.69). In addition, there were no statistically significant differences between the 2 groups for peak severity of symptoms (P=.68), number of days of peak symptoms (1.60 in the echinacea group and 1.64 in the placebo group; P=37), number of days of fever (0.81 in the echinacea group vs 0.64 in the placebo group; P=.09), or parental global assessment of severity of the URI (P=.67). Overall, there was no difference in the rate of adverse events reported in the 2 treatment groups; however, rash occurred during 7.1% of the URls treated with echinacea and 2.7% of those treated with placebo (P=.008). Conclusions Echinacea purpurea, as dosed in this study, was not effective in treating URI symptoms in patients 2 to 11 years old, and its use was associated with an increased risk of rash.	Univ Washington, Inst Child Hlth, Seattle, WA 98915 USA; Childrens Hosp & Reg Med Ctr, Seattle, WA USA; Bastyr Univ, Dept Naturopath Med, Kenmore, WA USA; Mercer Isl Pediat Associates, Mercer Isl, WA USA; Natl Coll Naturopath Med, Helfgott Res Inst, Portland, OR USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital	Taylor, JA (corresponding author), Univ Washington, Inst Child Hlth, Box 354920, Seattle, WA 98915 USA.	unclat@u.washington.edu		Calabrese, Carlo/0000-0003-3657-4463	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT000114] Funding Source: NIH RePORTER; NCCIH NIH HHS [AT00114-01] Funding Source: Medline	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)		Aitken M, 1998, ARCH PEDIAT ADOL MED, V152, P244; Barrett B, 1999, J FAM PRACTICE, V48, P628; Barrett BP, 2002, ANN INTERN MED, V137, P939, DOI 10.7326/0003-4819-137-12-200212170-00006; Brinkeborn RM, 1999, PHYTOMEDICINE, V6, P1; CANEDY D, 1998, NY TIMES        0723, pC1; Clemens CJ, 1997, J PEDIATR-US, V130, P463, DOI 10.1016/S0022-3476(97)70211-7; DENNY FW, 1983, PEDIATRICS, V71, P871; Dingle J. H., 1964, ILLNESS HOME STUDY 2, P33; Dorn M., 1997, COMPLEMENT THER MED, V5, P40, DOI [DOI 10.1016/S0965-2299(97)80089-1, 10.1016/S0965-2299(97)80089-1]; FOX JP, 1985, AM J EPIDEMIOL, V122, P830, DOI 10.1093/oxfordjournals.aje.a114166; Henneicke-Von Zepelin HH, 1999, CURR MED RES OPIN, V15, P214, DOI 10.1185/03007999909114094; Hoheisel O., 1997, EUR J CLIN RES, V9, P261; JACKSON GG, 1958, ARCH INTERN MED, V101, P267, DOI 10.1001/archinte.1958.00260140099015; KOGAN MD, 1994, JAMA-J AM MED ASSOC, V272, P1025, DOI 10.1001/jama.272.13.1025; Lindenmuth GF, 2000, J ALTERN COMPLEM MED, V6, P327, DOI 10.1089/10755530050120691; Macknin ML, 1998, JAMA-J AM MED ASSOC, V279, P1962, DOI 10.1001/jama.279.24.1962; Melchart D, 1995, J Altern Complement Med, V1, P145, DOI 10.1089/acm.1995.1.145; Melchart D., 2000, COCHRANE DB SYST REV; Mossad SB, 1996, ANN INTERN MED, V125, P81, DOI 10.7326/0003-4819-125-2-199607150-00001; Mullins RJ, 2002, ANN ALLERG ASTHMA IM, V88, P42, DOI 10.1016/S1081-1206(10)63591-0; Newall CA., 1996, HERBAL MED GUIDE HLT; O'Hara M, 1998, ARCH FAM MED, V7, P523, DOI 10.1001/archfami.7.6.523; Ottolini MC, 2001, AMBUL PEDIATR, V1, P122, DOI 10.1367/1539-4409(2001)001<0122:CAAMUA>2.0.CO;2; Pitetti R, 2001, PEDIATR EMERG CARE, V17, P165, DOI 10.1097/00006565-200106000-00004; Sawni-Sikand A, 2002, AMBUL PEDIATR, V2, P99, DOI 10.1367/1539-4409(2002)002<0099:UOCATA>2.0.CO;2; Schoneberger D, 1992, FORUM IMMUNOL, V8, P2; Schulten B, 2001, ARZNEIMITTELFORSCH, V51, P563; SMITH MBH, 1993, JAMA-J AM MED ASSOC, V269, P2258, DOI 10.1001/jama.269.17.2258; SPIGELBLATT L, 1994, PEDIATRICS, V94, P811; STIMPEL M, 1984, INFECT IMMUN, V46, P845, DOI 10.1128/IAI.46.3.845-849.1984; TAYLOR JA, 1993, J PEDIATR-US, V122, P799, DOI 10.1016/S0022-3476(06)80031-4; WALD ER, 1991, PEDIATRICS, V87, P129; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Zink T, 1998, AM FAM PHYSICIAN, V58, P1133; 2002, MED LETT DRUGS THER, V44, P29	35	103	106	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2824	2830		10.1001/jama.290.21.2824	http://dx.doi.org/10.1001/jama.290.21.2824			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QP	14657066	Bronze			2022-12-28	WOS:000186872800024
J	Chim, SSC; Tsui, SKW; Chan, KCA; Au, TCC; Hung, ECW; Tong, YK; Chiu, RWK; Ng, EKO; Chan, PKS; Chu, CM; Sung, JJY; Tam, JS; Fung, KP; Waye, MMY; Lee, CY; Yuen, KY; Lo, YMD				Chim, SSC; Tsui, SKW; Chan, KCA; Au, TCC; Hung, ECW; Tong, YK; Chiu, RWK; Ng, EKO; Chan, PKS; Chu, CM; Sung, JJY; Tam, JS; Fung, KP; Waye, MMY; Lee, CY; Yuen, KY; Lo, YMD		CUHK Molecular SARS Res Grp	Genomic characterisation of the severe acute respiratory syndrome coronavirus of Amoy Gardens outbreak in Hong Kong	LANCET			English	Article								Severe acute respiratory syndrome (SARS) is a global health concern. In Hong Kong, two major outbreaks, one hospital based and the other in the Amoy Gardens apartments, were identified. The frequency of diarrhoea, admission to intensive care, and mortality differed significantly between the two outbreaks. We did genomic sequencing for viral isolates from five Amoy Gardens patients. The virus sequence was identical in four of these five patients. The sequence data from one hospital case and the four identical community cases had only three nucleotide differences. Alterations in the SARS coronavirus genome are unlikely to have caused the distinctive clinical features of the Amoy Gardens patients, and these results highlight the importance of non-viral genomic factors in this outbreak.	Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Biochem, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Paediat, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; United Christian Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; United Christian Hospital; University of Hong Kong	Lo, YMD (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Room 38023,F Clin Sci Bldg,30-32 Ngan Shing St, Shatin, Hong Kong, Peoples R China.	loym@cuhk.edu.hk	Ng, Enders/T-3881-2019; Chan, K.C. Allen/M-2930-2013; Wong, Chi Hang/C-6909-2015; Wong, Chi Hang/ABE-8673-2021; Chan, Martin/B-3588-2009; Lo, Yuk Ming Dennis/D-4468-2011; Chan, Paul KS/J-9360-2013; Sung, Joseph J. Y./R-3203-2018; 韋妙宜教授, Mary Miu Yee Waye/A-9674-2008; Fung, Kwok Pui/R-9708-2018; Chim, Stephen SC/O-6271-2016; Tsui, Stephen Kwok-Wing/E-4385-2015; Ng, Enders K.O./F-2787-2010	Ng, Enders/0000-0002-6955-0030; Chan, K.C. Allen/0000-0003-1780-1691; Wong, Chi Hang/0000-0003-4157-6287; Wong, Chi Hang/0000-0003-4157-6287; Chan, Martin/0000-0002-1568-1596; Lo, Yuk Ming Dennis/0000-0001-8746-0293; Chan, Paul KS/0000-0002-6360-4608; Sung, Joseph J. Y./0000-0003-3125-5199; 韋妙宜教授, Mary Miu Yee Waye/0000-0002-2582-4917; Fung, Kwok Pui/0000-0001-6214-5123; Chim, Stephen SC/0000-0002-2152-7050; Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Ng, Enders K.O./0000-0002-6955-0030; Yuen, Kwok-yung/0000-0002-2083-1552; Ng, Enders Kai-on/0000-0002-5293-3529; Chan, Anna/0000-0003-2176-5734				Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952	4	41	49	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1807	1808		10.1016/S0140-6736(03)14901-X	http://dx.doi.org/10.1016/S0140-6736(03)14901-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654320	Green Published, Bronze			2022-12-28	WOS:000186872900013
J	Chow, J; Kopp, RJ; Portney, PR				Chow, J; Kopp, RJ; Portney, PR			Energy resources and global development	SCIENCE			English	Article								In order to address the economic and environmental consequences of our global energy system, we consider the availability and consumption of energy resources. Problems arise from our dependence on combustible fuels, the environmental risks associated with their extraction, and the environmental damage caused by their emissions. Yet no primary energy source, be it renewable or nonrenewable, is free of environmental or economic limitations. As developed and developing economies continue to grow, conversion to and adoption of environmentally benign energy technology will depend on political and economic realities.	Resources Future Inc, Washington, DC 20036 USA	Resources for the Future	Chow, J (corresponding author), Resources Future Inc, 1616 P St NW, Washington, DC 20036 USA.		liang, jiwang/A-5334-2009	Chow, Jeffrey/0000-0002-3351-7730				ANDERSON S, 2003, 0268 RES FUT; BLACKMAN A, 1998, 9821 RES FUT; BURTRAW D, 1997, 9731 RES FUT; Burtraw Dallas, 2003, 0315 RES FUT; DAPOTE SL, 1998, BIOMASS ENERGY DATA, P1; DARMSTADTER J, 2002, 0210 RES FUT; *INT AT EN AG, 2001, AN UR SUPPL 2050; IPCC, 2001, ADV CLIM CHANG RES; KRUPNICK A, 1998, 9846 RES FUT; Radler M, 2001, OIL GAS J, V99, P125; *US DEP EN, 2003, INT EN ANN 2001 ED	11	664	681	8	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1528	1531		10.1126/science.1091939	http://dx.doi.org/10.1126/science.1091939			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645838				2022-12-28	WOS:000186802200031
J	Hungate, BA; Dukes, JS; Shaw, MR; Luo, YQ; Field, CB				Hungate, BA; Dukes, JS; Shaw, MR; Luo, YQ; Field, CB			Nitrogen and climate change	SCIENCE			English	Editorial Material							CO2; DEPOSITION; RESPONSES; STORAGE; WORLD		No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA; Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA	Northern Arizona University; Northern Arizona University; Carnegie Institution for Science; University of Oklahoma System; University of Oklahoma - Norman	Hungate, BA (corresponding author), No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA.	bruce.hungate@nau.edu	Dukes, Jeffrey/AAD-8791-2019; Hungate, Bruce/F-8991-2011; Dukes, Jeffrey S/C-9765-2009	Hungate, Bruce/0000-0002-7337-1887; Dukes, Jeffrey S/0000-0001-9482-7743				Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Gill RA, 2002, NATURE, V417, P279, DOI 10.1038/417279a; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Hungate BA, 1999, CARBON DIOXIDE ENV S, P265, DOI DOI 10.1016/B978-012460370-7/50011-5; Kicklighter DW, 1999, TELLUS B, V51, P343, DOI 10.1034/j.1600-0889.1999.00017.x; Lutz W, 2001, NATURE, V412, P543, DOI 10.1038/35087589; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; RASTETTER EB, 1992, WATER AIR SOIL POLL, V64, P327, DOI 10.1007/BF00477109; Schlesinger WH., 1997, BIOGEOCHEMISTRY; Townsend AR, 1996, ECOL APPL, V6, P806, DOI 10.2307/2269486	11	597	657	9	355	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1512	1513		10.1126/science.1091390	http://dx.doi.org/10.1126/science.1091390			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645831				2022-12-28	WOS:000186802200024
J	Stroebel, D; Choquet, Y; Popot, JL; Picot, D				Stroebel, D; Choquet, Y; Popot, JL; Picot, D			An atypical haem in the cytochrome b(6)f complex	NATURE			English	Article							ELECTRON-TRANSFER; BC(1) COMPLEX; CRYSTAL-STRUCTURE; CHLOROPHYLL-A; BF COMPLEX; CHLOROPLAST; PROTEIN; SPINACH; SUBUNIT; DOMAIN	Photosystems I and II ( PSI and II) are reaction centres that capture light energy in order to drive oxygenic photosynthesis; however, they can only do so by interacting with the multisubunit cytochrome b(6)f complex. This complex receives electrons from PSII and passes them to PSI, pumping protons across the membrane and powering the Q-cycle. Unlike the mitochondrial and bacterial homologue cytochrome bc(1), cytochrome b(6)f can switch to a cyclic mode of electron transfer around PSI using an unknown pathway. Here we present the X-ray structure at 3.1 Angstrom of cytochrome b(6)f from the alga Chlamydomonas reinhardtii. The structure bears similarities to cytochrome bc(1) but also exhibits some unique features, such as binding chlorophyll, beta-carotene and an unexpected haem sharing a quinone site. This haem is atypical as it is covalently bound by one thioether linkage and has no axial amino acid ligand. This haem may be the missing link in oxygenic photosynthesis.	Univ Paris 07, CNRS, UMR 7099, Lab Physicochim Mol Membranes Biol, F-75005 Paris, France; Inst Biol Physicochim, CNRS, UPR 1261, Lab Physiol Membranaire & Mol Chloroplaste, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS)	Picot, D (corresponding author), Univ Paris 07, CNRS, UMR 7099, Lab Physicochim Mol Membranes Biol, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	Jean-Luc.Popot@ibpc.fr; Daniel.Picot@ibpc.fr	Choquet, Yves/ABE-3084-2020; Choquet, Yves/M-5533-2019	Choquet, Yves/0000-0003-4760-3397; Picot, Daniel/0000-0002-1375-1490				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Breyton C, 1997, J BIOL CHEM, V272, P21892, DOI 10.1074/jbc.272.35.21892; Breyton C, 2000, BBA-BIOENERGETICS, V1459, P467, DOI 10.1016/S0005-2728(00)00185-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrell CJ, 1997, STRUCTURE, V5, P1613, DOI 10.1016/S0969-2126(97)00309-2; Choquet Y, 2003, PLANT CELL, V15, P1443, DOI 10.1105/tpc.011692; CROFTS AR, 1983, BIOCHIM BIOPHYS ACTA, V726, P149, DOI 10.1016/0304-4173(83)90004-6; Crofts AR, 1999, P NATL ACAD SCI USA, V96, P10021, DOI 10.1073/pnas.96.18.10021; Darrouzet E, 2001, TRENDS BIOCHEM SCI, V26, P445, DOI 10.1016/S0968-0004(01)01897-7; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Finazzi G, 2002, BIOCHEMISTRY-US, V41, P7475, DOI 10.1021/bi025714w; Hart SE, 2003, BIOCHEMISTRY-US, V42, P4829, DOI 10.1021/bi020674h; Hirst J, 2001, BIOCHEMISTRY-US, V40, P1274, DOI 10.1021/bi002090q; HOFLE G, 1984, LIEBIGS ANN CHEM, P1883; HOPE AB, 1993, BIOCHIM BIOPHYS ACTA, V1143, P1, DOI 10.1016/0005-2728(93)90210-7; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; HURT E, 1981, EUR J BIOCHEM, V117, P591; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; JOLIOT P, 1988, BIOCHIM BIOPHYS ACTA, V933, P319, DOI 10.1016/0005-2728(88)90039-4; Joliot P, 1998, BIOCHEMISTRY-US, V37, P10404, DOI 10.1021/bi980546m; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuras R, 1997, J BIOL CHEM, V272, P32427, DOI 10.1074/jbc.272.51.32427; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; LAVERGNE J, 1983, BIOCHIM BIOPHYS ACTA, V725, P25, DOI 10.1016/0005-2728(83)90220-7; MARTINEZ SE, 1994, STRUCTURE, V2, P95, DOI 10.1016/S0969-2126(00)00012-5; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; MUKAI K, 1989, EUR J BIOCHEM, V178, P649, DOI 10.1111/j.1432-1033.1989.tb14494.x; MURAKAMI S, 1970, J CELL BIOL, V47, P332, DOI 10.1083/jcb.47.2.332; NITSCHKE W, 1987, BIOCHIM BIOPHYS ACTA, V892, P314, DOI 10.1016/0005-2728(87)90235-0; Peterman EJG, 1998, BIOPHYS J, V75, P389, DOI 10.1016/S0006-3495(98)77523-X; Pierre Y, 1997, J BIOL CHEM, V272, P21901, DOI 10.1074/jbc.272.35.21901; PIERRE Y, 1995, J BIOL CHEM, V270, P29342, DOI 10.1074/jbc.270.49.29342; Pond AE, 1999, BIOCHEMISTRY-US, V38, P7601, DOI 10.1021/bi9825448; Sainz G, 2000, BIOCHEMISTRY-US, V39, P9164, DOI 10.1021/bi0004596; Sazanov LA, 1998, P NATL ACAD SCI USA, V95, P1319, DOI 10.1073/pnas.95.3.1319; Schoepp B, 2000, J BIOL CHEM, V275, P5275, DOI 10.1074/jbc.275.8.5275; Schutz M, 2000, J MOL BIOL, V300, P663, DOI 10.1006/jmbi.2000.3915; Whitelegge JP, 2002, MOL CELL PROTEOMICS, V1, P816, DOI 10.1074/mcp.M200045-MCP200; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Yan JS, 2001, BBA-BIOENERGETICS, V1506, P182, DOI 10.1016/S0005-2728(01)00212-2; Yu J, 1998, J BIOL CHEM, V273, P8860, DOI 10.1074/jbc.273.15.8860; Zhang HM, 1999, J BIOL CHEM, V274, P1581, DOI 10.1074/jbc.274.3.1581; Zhang HM, 2003, P NATL ACAD SCI USA, V100, P5160, DOI 10.1073/pnas.0931431100; Zhang HM, 2001, J BIOL CHEM, V276, P38159; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zito F, 1998, BIOCHEMISTRY-US, V37, P10395, DOI 10.1021/bi980238o	51	513	549	3	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 27	2003	426	6965					413	418		10.1038/nature02155	http://dx.doi.org/10.1038/nature02155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647374				2022-12-28	WOS:000186800800030
J	Celli, BR				Celli, BR			A 62-year-old woman with chronic obstructive pulmonary disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VOLUME-REDUCTION SURGERY; QUALITY-OF-LIFE; LUNG-TRANSPLANTATION; COPD PATIENTS; INHALED CORTICOSTEROIDS; FLUTICASONE PROPIONATE; ACUTE EXACERBATIONS; NONINVASIVE VENTILATION; ADVANCE DIRECTIVES; SMOKING-CESSATION		Tufts Univ, Medford, MA 02155 USA; Caritas St Elizabeths Med Ctr, Boston, MA USA	Tufts University; St. Elizabeth's Medical Center	Celli, BR (corresponding author), St Elizabeths Med Ctr, 736 cambridge St, Brighton, MA 02135 USA.	bcelli@copdnet.org						Aaron SD, 2003, NEW ENGL J MED, V348, P2618, DOI 10.1056/NEJMoa023161; Altose MD, 2000, NEW ENGL J MED, V343, P1902; American Thoracic Society, 1999, AM J RESP CRIT CARE, V159, P1666; AMOROSO P, 1993, THORAX, V48, P882, DOI 10.1136/thx.48.9.882; [Anonymous], 1980, Ann Intern Med, V93, P391; [Anonymous], 1996, GLOBAL BURDEN DIS CO; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; BANDO K, 1995, J HEART LUNG TRANSPL, V14, P692; BONE R, 1994, CHEST, V105, P1411; BRANTIGAN OC, 1959, AM REV RESPIR DIS, V80, P194; BROCHARD L, 1995, NEW ENGL J MED, V333, P817, DOI 10.1056/NEJM199509283331301; BUIST AS, 1976, AM REV RESPIR DIS, V114, P115; BUIST AS, 1989, AM REV RESPIR DIS, V140, P1494, DOI 10.1164/ajrccm/140.5.1494; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; CALLAHAN CM, 1991, ANN INTERN MED, V114, P216, DOI 10.7326/0003-4819-114-3-216; Casaburi R, 2002, EUR RESPIR J, V19, P217, DOI 10.1183/09031936.02.00269802; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; Celli BR, 1997, CHEST, V112, P902, DOI 10.1378/chest.112.4.902; Chapman KR, 2001, CHEST, V119, P1691, DOI 10.1378/chest.119.6.1691; COOPER JD, 1995, J THORAC CARDIOV SUR, V109, P106, DOI 10.1016/S0022-5223(95)70426-4; Cooper JD, 1996, J THORAC CARDIOV SUR, V112, P1319, DOI 10.1016/S0022-5223(96)70147-2; Criner GJ, 1999, AM J RESP CRIT CARE, V160, P2018, DOI 10.1164/ajrccm.160.6.9902117; Dahl R, 2001, AM J RESP CRIT CARE, V164, P778, DOI 10.1164/ajrccm.164.5.2007006; Daughton D, 1998, ARCH FAM MED, V7, P425, DOI 10.1001/archfami.7.5.425; Dennis RJ, 1996, CHEST, V109, P115, DOI 10.1378/chest.109.1.115; DOMPELING E, 1993, ANN INTERN MED, V118, P770, DOI 10.7326/0003-4819-118-10-199305150-00003; FIORE MC, 2000, TREATING TOBACCO USE; Fishman A, 2003, NEW ENGL J MED, V348, P2059; Fishman A, 2001, NEW ENGL J MED, V345, P1075; Flaherty KR, 2001, CHEST, V119, P1337, DOI 10.1378/chest.119.5.1337; FLENLEY DC, 1981, LANCET, V1, P681; Friedman M, 1999, CHEST, V115, P635, DOI 10.1378/chest.115.3.635; Garcia-Aymerich J, 2001, AM J RESP CRIT CARE, V164, P1002, DOI 10.1164/ajrccm.164.6.2006012; Geddes D, 2000, NEW ENGL J MED, V343, P239, DOI 10.1056/NEJM200007273430402; Glaspole IN, 2000, ANN THORAC SURG, V69, P1711, DOI 10.1016/S0003-4975(00)01270-4; Gorecka D, 2003, CHEST, V123, P1916, DOI 10.1378/chest.123.6.1916; Griffiths TL, 2000, LANCET, V355, P362, DOI 10.1016/S0140-6736(99)07042-7; GROSS CR, 1995, CHEST, V108, P1587, DOI 10.1378/chest.108.6.1587; Heffner JE, 1996, AM J RESP CRIT CARE, V154, P1735, DOI 10.1164/ajrccm.154.6.8970363; Heijdra YF, 2002, CHEST, V121, P1427, DOI 10.1378/chest.121.5.1427; Hosenpud JD, 2001, J HEART LUNG TRANSPL, V20, P805, DOI 10.1016/S1053-2498(01)00323-0; Ingenito EP, 2001, AM J RESP CRIT CARE, V163, P1068, DOI 10.1164/ajrccm.163.5.9911013; Jones PW, 1997, AM J RESP CRIT CARE, V155, P1283, DOI 10.1164/ajrccm.155.4.9105068; KRAMER N, 1995, AM J RESP CRIT CARE, V151, P1799, DOI 10.1164/ajrccm.151.6.7767523; Lacasse Y, 1996, LANCET, V348, P1115, DOI 10.1016/S0140-6736(96)04201-8; Leyenson N, 2000, CHEST, V118, P728, DOI 10.1378/chest.118.3.728; McCrory DC, 2001, CHEST, V119, P1190, DOI 10.1378/chest.119.4.1190; Miravitlles M, 2000, RESPIRATION, V67, P495, DOI 10.1159/000067462; *NAT HEART LUNG BL, 1998, MORB MORT 1998 CHART; Niewoehner DE, 1999, NEW ENGL J MED, V340, P1941, DOI 10.1056/NEJM199906243402502; O'Donnell DE, 1999, AM J RESP CRIT CARE, V160, P542, DOI 10.1164/ajrccm.160.2.9901038; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; ORENS JB, 1995, CHEST, V107, P144, DOI 10.1378/chest.107.1.144; Paggiaro PL, 1998, LANCET, V351, P773, DOI 10.1016/S0140-6736(97)03471-5; PATTERSON GA, 1991, J THORAC CARDIOV SUR, V101, P623; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0; Prochaska J O, 1992, Prog Behav Modif, V28, P183; REARDON J, 1994, CHEST, V105, P1046, DOI 10.1378/chest.105.4.1046; REILLY BM, 1994, ARCH INTERN MED, V154, P2299, DOI 10.1001/archinte.154.20.2299; Rennard S, 2002, EUR RESPIR J, V20, P799, DOI 10.1183/09031936.02.03242002; Rennard SI, 1996, CHEST, V110, P62, DOI 10.1378/chest.110.1.62; Rennard SI, 2001, AM J RESP CRIT CARE, V163, P1087, DOI 10.1164/ajrccm.163.5.9903053; RIES AL, 1995, ANN INTERN MED, V122, P823, DOI 10.7326/0003-4819-122-11-199506010-00003; SAINT S, 1995, JAMA-J AM MED ASSOC, V273, P957, DOI 10.1001/jama.273.12.957; Seemungal TAR, 2000, AM J RESP CRIT CARE, V161, P1608, DOI 10.1164/ajrccm.161.5.9908022; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sin DD, 2001, AM J RESP CRIT CARE, V164, P580, DOI 10.1164/ajrccm.164.4.2009033; Snider GL, 1996, CHEST, V109, P540, DOI 10.1378/chest.109.2.540; Soriano JB, 2000, THORAX, V55, P789, DOI 10.1136/thorax.55.9.789; Soriano JB, 2002, EUR RESPIR J, V20, P819, DOI 10.1183/09031936.02.00301302; SORLIE PD, 1989, AM REV RESPIR DIS, V140, P379, DOI 10.1164/ajrccm/140.2.379; Szekely LA, 1997, CHEST, V111, P550, DOI 10.1378/chest.111.3.550; THOMAS P, 1992, CHEST, V101, P160, DOI 10.1378/chest.101.1.160; Thompson WH, 1996, AM J RESP CRIT CARE, V154, P407, DOI 10.1164/ajrccm.154.2.8756814; Turner MO, 1997, ARCH INTERN MED, V157, P1736, DOI 10.1001/archinte.157.15.1736; ULRIK CS, 1995, THORAX, V50, P750, DOI 10.1136/thx.50.7.750; van der Valk P, 2002, AM J RESP CRIT CARE, V166, P1358, DOI 10.1164/rccm.200206-512OC; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; Vincken W, 2002, EUR RESPIR J, V19, P209, DOI 10.1183/09031936.02.00238702; WILLIAMS TJ, 1990, CLIN CHEST MED, V11, P347; ZuWallack RL, 2001, CHEST, V119, P1661, DOI 10.1378/chest.119.6.1661	84	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2003	290	20					2721	2729		10.1001/jama.290.20.2721	http://dx.doi.org/10.1001/jama.290.20.2721			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747CR	14645315				2022-12-28	WOS:000186788100025
J	Haber, DA				Haber, DA			The BRCA2-EMSY connection: Implications for breast and ovarian tumorigenesis	CELL			English	Editorial Material							DNA-REPAIR; CYCLIN D1; INVOLVEMENT; BRCA1; MICE	In this issue, Hughes-Davies et al. describe a novel gene product, EMSY, which suppresses the transactivational activity of BRCA2. EMSY is located within an amplicon in sporadic breast and ovarian cancers, suggesting that its overexpression may mimic the effects of BRCA2 inactivation. The implications for BRCA2 function are discussed.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Hillsborough 02129, North Ireland		Haber, DA (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Hillsborough 02129, North Ireland.							Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Hughes-Davies L, 2003, CELL, V115, P523, DOI 10.1016/S0092-8674(03)00930-9; Milner J, 1997, NATURE, V386, P772, DOI 10.1038/386772a0; Osin P P, 1999, Breast Cancer Res, V1, P36, DOI 10.1186/bcr11; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; SCHUURING E, 1995, GENE, V159, P83, DOI 10.1016/0378-1119(94)00562-7; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Thai TH, 1998, HUM MOL GENET, V7, P195, DOI 10.1093/hmg/7.2.195; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0	10	11	11	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 26	2003	115	5					507	508		10.1016/S0092-8674(03)00933-4	http://dx.doi.org/10.1016/S0092-8674(03)00933-4			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651841	Bronze			2022-12-28	WOS:000186885600001
J	Richard, C; Warszawski, J; Anguel, N; Deye, N; Combes, A; Barnoud, D; Boulain, T; Lefort, Y; Fartoukh, M; Baud, F; Boyer, A; Brochard, L; Teboul, JL				Richard, C; Warszawski, J; Anguel, N; Deye, N; Combes, A; Barnoud, D; Boulain, T; Lefort, Y; Fartoukh, M; Baud, F; Boyer, A; Brochard, L; Teboul, JL		French Pulmonary Artery Catheter S	Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRITICALLY-ILL PATIENTS; RIGHT HEART CATHETERIZATION; RISK SURGICAL PATIENTS; OXYGEN DELIVERY; SEVERE SEPSIS; COMPLICATIONS; MULTICENTER; MORTALITY; THERAPY; SCORE	Context Many physicians believe that the pulmonary artery catheter (PAC) is useful for the diagnosis and treatment of cardiopulmonary disturbances; however, observational studies suggest that its use may be harmful. Objective To determine the effects on outcome of the early use of a PAC in patients with shock mainly of septic origin, acute respiratory distress syndrome (ARDS), or both. Design, Setting, and Patients A multicenter randomized controlled study of 676 patients aged 18 years or older who fulfilled the standard criteria for shock, ARDS, or both conducted in 36 intensive care units in France from January 30, 1999, to June 29, 2001. Intervention Patients, were randomly assigned to either receive a PAC (n=335) or not (n=341). The treatment was left to the discretion of each individual physician. Main Outcome Measures The primary end point was mortality at 28 days. The principal secondary end points were day 14 and 90 mortality; day 14 organ system, renal support, and vasoactive agents-free days; hospital, intensive care unit, and mechanical ventilation-free days at day 28. Results The 2 groups were similar at baseline. There were no significant differences in mortality with or without the PAC at day 14: 49.9% vs 51.3% (mortality relative risk [RR], 0.97; 95% confidence interval [CI], 0.84-1.13; P=.70); day 28: 59.4% vs 61.0% (RR, 0.97; 95% CI, 0.86-1.10; P=.67); or day 90:70.7% vs 72.0% (RR, 0.98; 95% CI, 0.89-1.08; P-.71). At day 14, the mean (SD) number of days free of organ system failures with or without the PAC (2.3 [3.6] vs 2.4 [3.5]), renal support (7.4 [6.0] vs 7.5 [5.9]), and vasoactive agents (3.8 [4.8] vs 3.9 [4.9]) did not differ. At day 28, mean (SD) days in hospital with or without the PAC (0.9 [3.6] vs 0.9 [3.3]), in the intensive care unit (3.4 [6.8] vs 3.3 [6.9]), or mechanical ventilation use (5.2 [8.5] vs 5.0 [8.5]) did not differ. Conclusion Clinical management involving the early use of a PAC in patients with shock, ARDS, or both did not significantly affect mortality and morbidity.	Univ Paris 11, Assistance Publ Hop Paris, Hop Bicetre, Serv Reanimat Med, F-94275 Le Kremlin Bicetre, France; Univ Paris 11, Assistance Publ Hop Paris, Hop Bicetre, Serv Sante Publ & Epidemiol, F-94275 Le Kremlin Bicetre, France; Univ Paris 06, Assistance Publ Hop Paris, Hop Europeen Georges Pompidou, Serv Reanimat Med, Paris, France; Univ Paris 06, Assistance Publ Hop Paris, Grp Hosp Pitie Salpetriere, Serv Reanimat Med, Paris, France; Univ Paris 06, Assistance Publ Hop Paris, Grp Hosp Pitie Salpetriere, Serv Pneumol & Reanimat, Paris, France; CHU A Michallon, Serv Reanimat Med, Grenoble, France; CHR Orleans La Source, Serv Reanimat, Orleans, France; Univ Paris 12, Hop Henri Mondor, Assistance Publ Hop Paris, Serv Reanimat Med, F-94010 Creteil, France; Univ Paris 07, Assistance Publ Hop Paris, Hop Lariboisiere, Serv Reanimat Med, Paris, France; Univ Paris 07, Assistance Publ Hop Paris, Hop Louis Mourier, Serv Reanimat Med, Colombes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; CHU Grenoble Alpes; Centre Hospitalier Regional d'Orleans; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Richard, C (corresponding author), Univ Paris 11, Assistance Publ Hop Paris, Hop Bicetre, Serv Reanimat Med, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.		Boulain, Thierry/M-3309-2019	Boulain, Thierry/0000-0003-4664-3661; Teboul, Jean-Louis/0000-0002-5748-7820; BOYER, Alexandre/0000-0003-4384-8872				Alia I, 1999, CHEST, V115, P453, DOI 10.1378/chest.115.2.453; Angus D, 2001, BRIT MED J, V322, P446, DOI 10.1136/bmj.322.7284.446; BENNETT D, 1991, INTENS CARE MED, V17, pR1, DOI 10.1007/BF01704735; Bernard GR, 2000, JAMA-J AM MED ASSOC, V283, P2568, DOI 10.1001/jama.283.19.2568; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; BOYD O, 1993, JAMA-J AM MED ASSOC, V270, P2699, DOI 10.1001/jama.270.22.2699; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; CONNORS AF, 1985, CHEST, V88, P567, DOI 10.1378/chest.88.4.567; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; Connors AF, 2002, INTENS CARE MED, V28, P225, DOI 10.1007/s00134-002-1230-9; Dalen JE, 1996, JAMA-J AM MED ASSOC, V276, P916, DOI 10.1001/jama.276.11.916; FAGON JY, 1993, INTENS CARE MED, V19, P137, DOI 10.1007/BF01720528; GATTINONI L, 1995, NEW ENGL J MED, V333, P1025, DOI 10.1056/NEJM199510193331601; Guyatt G, 1991, J Intensive Care Med, V6, P91; HAUCK WW, 1986, STAT MED, V5, P203, DOI 10.1002/sim.4780050302; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; IBERTI TJ, 1990, JAMA-J AM MED ASSOC, V264, P2928, DOI 10.1001/jama.264.22.2928; Ivanov R, 2000, CRIT CARE MED, V28, P615, DOI 10.1097/00003246-200003000-00002; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; MERMEL LA, 1994, AM J RESP CRIT CARE, V149, P1020, DOI 10.1164/ajrccm.149.4.8143037; MIMOZ O, 1994, CRIT CARE MED, V22, P573, DOI 10.1097/00003246-199404000-00011; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Rhodes A, 2002, INTENS CARE MED, V28, P256, DOI 10.1007/s00134-002-1206-9; ROBIN ED, 1987, CHEST, V92, P727, DOI 10.1378/chest.92.4.727; Sandham JD, 2003, NEW ENGL J MED, V348, P5, DOI 10.1056/NEJMoa021108; SHAH KB, 1984, ANESTHESIOLOGY, V61, P271, DOI 10.1097/00000542-198409000-00007; Slama MA, 1996, INTENS CARE MED, V22, P916, DOI 10.1007/BF02044116; Taylor RW, 1997, CRIT CARE MED, V25, P910; Trottier S J, 1997, New Horiz, V5, P201; Vieillard-Baron A, 2000, AM J RESP CRIT CARE, V161, P1597; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156	33	395	412	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2003	290	20					2713	2720		10.1001/jama.290.20.2713	http://dx.doi.org/10.1001/jama.290.20.2713			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747CR	14645314	Bronze			2022-12-28	WOS:000186788100024
J	Furness, S; Connor, J; Robinson, E; Norton, R; Ameratunga, S; Jackson, R				Furness, S; Connor, J; Robinson, E; Norton, R; Ameratunga, S; Jackson, R			Car colour and risk of car crash injury: population based case control study	BRITISH MEDICAL JOURNAL			English	Article							DRIVER SLEEPINESS		Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat Sect, Auckland 1, New Zealand; Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia	University of Auckland; University of Sydney	Furness, S (corresponding author), Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat Sect, Private Bag 92019, Auckland 1, New Zealand.			Connor, Jennie/0000-0002-3209-8693; Jackson, Rod/0000-0001-5914-6934; Ameratunga, Shanthi/0000-0001-8042-2251				Connor J, 2002, BRIT MED J, V324, P1125, DOI 10.1136/bmj.324.7346.1125; Connor J, 2001, SLEEP, V24, P688, DOI 10.1093/sleep/24.6.688; Lardelli-Claret P, 2002, EPIDEMIOLOGY, V13, P721, DOI 10.1097/00001648-200211000-00019; Peden M, 2002, INJURY CHART BOOK GR	5	11	12	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1455	1456		10.1136/bmj.327.7429.1455	http://dx.doi.org/10.1136/bmj.327.7429.1455			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	757LA	14684646	Green Published			2022-12-28	WOS:000187562700017
J	Boulware, LE; Jaar, BG; Tarver-Carr, ME; Brancati, FL; Powe, NR				Boulware, LE; Jaar, BG; Tarver-Carr, ME; Brancati, FL; Powe, NR			Screening for proteinuria in US adults - A cost-effectiveness analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							3RD NATIONAL-HEALTH; PERCUTANEOUS RENAL BIOPSY; BLOOD-PRESSURE CONTROL; CHRONIC KIDNEY-DISEASE; QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; FOLLOW-UP; MULTIFACTORIAL INTERVENTION; MEDICATION ADHERENCE	Context Chronic kidney disease is a growing public health problem. Screening for early identification could improve health but could also lead to unnecessary harms and excess costs. Objective To assess the value of periodic, population-based dipstick screening for early detection of urine protein in adults with neither hypertension nor diabetes and in adults with hypertension. Design, Setting, and Population Cost-effectiveness analysis using a Markov decision analytic model to compare a strategy of annual screening with no screening (usual care) for proteinuria at age 50 years followed by treatment with an angiotensin-converting enzyme (ACE) inhibitor or an angiotensin II-receptor blocker (ARB). Main Outcome Measure Cost per quality-adjusted life-year (QALY). Results For persons with neither hypertension nor diabetes, the cost-effectiveness ratio for screening vs no screening (usual care) was unfavorable ($282 818 per QALY; incremental cost of $616 and a gain of 0.0022 QALYs per person). However, screening such persons beginning at age 60 years yielded a more favorable ratio ($53 372 per QALY). For persons with hypertension, the ratio was highly favorable ($18621 per QALY; incremental cost of $476 and a gain of 0.03 QALYs per person). Cost-effectiveness was mediated by both chronic kidney disease progression and death prevention benefits of ACE inhibitor and ARB therapy. Influential parameters that might make screening for the general population more cost-effective include a greater incidence of proteinuria, age at screening ($53 372 per QALY for persons beginning screening at age 60 years), or lower frequency of screening (every 10 years: $80700 per QALY at age 50 years; $6195 per QALY at age 60 years; and $5486 per QALY at age 70 years). Conclusions Early detection of urine protein to slow progression of chronic kidney disease and decrease mortality is not cost-effective unless selectively directed toward high-risk groups (older persons and persons with hypertension) or conducted at an infrequent interval of 10 years.	Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Boulware, LE (corresponding author), Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, 2024 E Monument St,Suite 2-635, Baltimore, MD 21205 USA.	lboulwa@jhmi.edu	Jaar, Bernard/B-1917-2009	Jaar, Bernard/0000-0003-1210-7115; Boulware, Ebony/0000-0002-8650-4212	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059616] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; American Diabetes Association, 2003, DIABETES CARE, V26, pS80, DOI DOI 10.2337/DIACARE.26.2007.S80; Barat I, 2001, BRIT J CLIN PHARMACO, V51, P615, DOI 10.1046/j.0306-5251.2001.01401.x; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Cabana MD, 2000, ARCH PEDIAT ADOL MED, V154, P685, DOI 10.1001/archpedi.154.7.685; CAREL RS, 1987, CLIN CHEM, V33, P2106; CHANG P, PHARM MARKET SHARE D; CHERRY DK, 2002, NATL AMBULATORY MED; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Ciechanowski PS, 2001, AM J PSYCHIAT, V158, P29, DOI 10.1176/appi.ajp.158.1.29; Clause SL, 2002, ANN PHARMACOTHER, V36, P1505; Coon P, 2002, DIABETES CARE, V25, P2224, DOI 10.2337/diacare.25.12.2224; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; *CTR MED MED SERV, 2003 CLIN DIAGN LAB; *CTR MED MED SERV, 2000 MED PROV AN REV; *CTR MED MED SERV, 2003 NAT PHYS FRE; CUTLER DM, 2001, HEALTH AFFAIR, V20, P11; de Wit GA, 2002, NEPHROL DIAL TRANSPL, V17, P86, DOI 10.1093/ndt/17.1.86; Di Iorio D, 2000, ARCH FAM MED, V9, P1015, DOI 10.1001/archfami.9.10.1015; DiMatteo MR, 2002, MED CARE, V40, P794, DOI 10.1097/01.MLR.0000024612.61915.2D; Erlinger TP, 2000, J AM GERIATR SOC, V48, P1486, DOI 10.1111/jgs.2000.48.11.1486; Farber HJ, 2003, J ASTHMA, V40, P17, DOI 10.1081/JAS-120017203; Friedman RH, 1996, AM J HYPERTENS, V9, P285, DOI 10.1016/0895-7061(95)00353-3; Fuiano G, 2000, AM J KIDNEY DIS, V35, P448, DOI 10.1016/S0272-6386(00)70197-1; Gaede P, 1999, LANCET, V353, P617, DOI 10.1016/S0140-6736(98)07368-1; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gall MA, 1997, BMJ-BRIT MED J, V314, P783, DOI 10.1136/bmj.314.7083.783; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Golan L, 1999, ANN INTERN MED, V131, P660, DOI 10.7326/0003-4819-131-9-199911020-00005; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; Hyman DJ, 2000, ARCH INTERN MED, V160, P2281, DOI 10.1001/archinte.160.15.2281; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; *IMS HLTH, ANG ANT DAT IMPR; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; JAMES GP, 1978, CLIN CHEM, V24, P1934; JEE SH, 2003, 43 ANN C CARD DIS EP; Jones CA, 1998, AM J KIDNEY DIS, V32, P992, DOI 10.1016/S0272-6386(98)70074-5; Kiberd BA, 1995, BRIT MED J, V311, P1595, DOI 10.1136/bmj.311.7020.1595; Kinchen KS, 2002, ANN INTERN MED, V137, P479, DOI 10.7326/0003-4819-137-6-200209170-00007; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; KLEIN R, 1995, DIABETES, V44, P916, DOI 10.2337/diabetes.44.8.916; KUTNER NG, 1991, AM J NEPHROL, V11, P334, DOI 10.1159/000168333; LEBOVITZ HE, 1994, KIDNEY INT, V45, pS150; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Lipscomb J., 1996, COST EFFECTIVENESS H, P214; Lonn E, 2002, J AM COLL CARDIOL, V40, P693, DOI 10.1016/S0735-1097(02)02035-1; Luce BR, 1996, COST EFFECTIVENESS H, P176; MADAIO MP, 1990, KIDNEY INT, V38, P529, DOI 10.1038/ki.1990.236; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Manninen D L, 1991, Clin Transpl, P193; Markell MS, 1997, AM J KIDNEY DIS, V29, P881, DOI 10.1016/S0272-6386(97)90462-5; MARTIN TL, 1995, DIABETES CARE, V18, P1124, DOI 10.2337/diacare.18.8.1124; Marwah DS, 1996, AM J KIDNEY DIS, V28, P47, DOI 10.1016/S0272-6386(96)90129-8; Mattock MB, 1998, DIABETES, V47, P1786, DOI 10.2337/diabetes.47.11.1786; *MED EC CO, 2001, 2001 DRUG TOP RED BO; Mehta SS, 1999, AM J HYPERTENS, V12, P333, DOI 10.1016/S0895-7061(00)86958-7; MENDELSSOHN DC, 1995, AM J KIDNEY DIS, V26, P580, DOI 10.1016/0272-6386(95)90592-8; Merkus MP, 1997, AM J KIDNEY DIS, V29, P584, DOI 10.1016/S0272-6386(97)90342-5; Molitch ME, 2003, DIABETES CARE, V26, pS94, DOI [10.2337/diacare.26.2007.s94, DOI 10.2337/DIACARE.26.2007.S94]; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Murray CJL, 2000, HEALTH ECON, V9, P235, DOI 10.1002/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O; Nass K, 1999, AM J KIDNEY DIS, V34, P955, DOI 10.1016/S0272-6386(99)70058-2; *NAT KIDN FDN, 2000, NAT KIDN FDN CLIN PR; Nelson CR, 2000, HYPERTENSION, V36, P600, DOI 10.1161/01.HYP.36.4.600; Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203; Ni H, 2003, AM HEART J, V146, P121, DOI 10.1016/S0002-8703(02)94800-3; Nosadini R, 2000, DIABETES, V49, P476, DOI 10.2337/diabetes.49.3.476; *OFF AN EP NCHS, CDC WOND 1999 COMPR; Okosun IS, 2000, ANN EPIDEMIOL, V10, P263, DOI 10.1016/S1047-2797(00)00045-4; Palmer AJ, 2000, DIABETOLOGIA, V43, P13, DOI 10.1007/s001250050003; PARRISH AE, 1992, CLIN NEPHROL, V38, P135; Patel RP, 2002, ANN PHARMACOTHER, V36, P40, DOI 10.1345/aph.1A046; Rachmani R, 2000, DIABETES RES CLIN PR, V49, P187, DOI 10.1016/S0168-8227(00)00155-8; Raiz L, 1997, J Health Soc Policy, V8, P67, DOI 10.1300/J045v08n04_05; RALSTON SH, 1988, ANN RHEUM DIS, V47, P759, DOI 10.1136/ard.47.9.759; Ramsey SD, 2001, MED CARE, V39, P979, DOI 10.1097/00005650-200109000-00008; RASGON S, 1993, AM J KIDNEY DIS, V22, P403, DOI 10.1016/S0272-6386(12)70143-9; Renal Physicians Association, 2001, Clin Nephrol, V56, P179; Ruggenenti P, 1998, BRIT MED J, V316, P504, DOI 10.1136/bmj.316.7130.504; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Ruggenenti P, 2000, AM J KIDNEY DIS, V35, P1155, DOI 10.1016/S0272-6386(00)70054-0; Schoenfeld ER, 2001, OPHTHALMOLOGY, V108, P563, DOI 10.1016/S0161-6420(00)00600-X; SHAW ST, 1985, JAMA-J AM MED ASSOC, V253, P1596, DOI 10.1001/jama.253.11.1596; Speirs C, 1998, BRIT J CLIN PHARMACO, V46, P63, DOI 10.1046/j.1365-2125.1998.00031.x; Stratta P, 1996, AM J KIDNEY DIS, V27, P631, DOI 10.1016/S0272-6386(96)90096-7; Tengs TO, 2000, MED CARE, V38, P583, DOI 10.1097/00005650-200006000-00004; Thom DH, 2002, FAM PRACT, V19, P476, DOI 10.1093/fampra/19.5.476; *THOMPS MICR, 2003, MICR HLTH CAR SER, P116; Torffvit O, 2001, J DIABETES COMPLICAT, V15, P307, DOI 10.1016/S1056-8727(01)00176-3; *US DEP HHS, 2000, DET DIS PAT CHRON RE; *US DEP LAB, 2002, NAT COMP SURV 2001; *US REN DAT SYST, USRDS 2002 ANN DAT R; van Manen JG, 2001, PERITON DIALYSIS INT, V21, P595; Vargas CM, 2000, AM J EPIDEMIOL, V152, P272, DOI 10.1093/aje/152.3.272; Vijan S, 2000, JAMA-J AM MED ASSOC, V283, P889, DOI 10.1001/jama.283.7.889; Voyaki SM, 2001, J HYPERTENS, V19, P511, DOI 10.1097/00004872-200103000-00020; Wang PS, 2002, J GEN INTERN MED, V17, P504, DOI 10.1046/j.1525-1497.2002.00406.x; Warram JH, 1996, J AM SOC NEPHROL, V7, P930; WOOLHANDLER S, 1989, JAMA-J AM MED ASSOC, V262, P1214, DOI 10.1001/jama.262.9.1214; Wyatt RJ, 1998, J AM SOC NEPHROL, V9, P853; Yusuf HR, 1998, PREV MED, V27, P1, DOI 10.1006/pmed.1997.0268; Yusuf S, 2000, NEW ENGL J MED, V342, P145	107	279	295	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2003	290	23					3101	3114		10.1001/jama.290.23.3101	http://dx.doi.org/10.1001/jama.290.23.3101			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	753ZB	14679273				2022-12-28	WOS:000187277300029
J	Imondi, R; Thomas, JB				Imondi, R; Thomas, JB			The ups and downs of Wnt signaling	SCIENCE			English	Editorial Material							COMMISSURAL AXONS; SPINAL-CORD; GUIDANCE		Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Imondi, R (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.							BOVALENTA P, 1990, DEVELOPMENT, V109, P435; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	9	9	9	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1903	1904		10.1126/science.1092976	http://dx.doi.org/10.1126/science.1092976			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671283				2022-12-28	WOS:000187174000038
J	Bowman, L				Bowman, L			Different directions?	NATURE			English	Article																			0	0	0	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					712	712		10.1038/426712	http://dx.doi.org/10.1038/426712			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668878	Bronze			2022-12-28	WOS:000187132800055
J	Gallo, RC; Montagnier, L				Gallo, RC; Montagnier, L			Retrospective: The discovery of HIV as the cause of AIDS	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Maryland, Inst Biotechnol, Inst Human Virol, Baltimore, MD 21201 USA; World Fdn AIDS Res & Prevent, Paris, France	University System of Maryland; University of Maryland Baltimore	Gallo, RC (corresponding author), Univ Maryland, Inst Biotechnol, Inst Human Virol, Baltimore, MD 21201 USA.							GALLO RC, 1991, VIRUS HUNTING; MONTAGNIER L, 2000, VIRUS	2	172	181	0	35	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					2283	2285		10.1056/NEJMp038194	http://dx.doi.org/10.1056/NEJMp038194			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668451				2022-12-28	WOS:000187125000001
J	Howard, K				Howard, K			The view from the top	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					696	697		10.1038/426696	http://dx.doi.org/10.1038/426696			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668873	Bronze			2022-12-28	WOS:000187132800050
J	Cooper, RA; Stoflet, SJ; Wartman, SA				Cooper, RA; Stoflet, SJ; Wartman, SA			Perceptions of medical school deans and state medical society executives about physician supply	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTSECONDARY EDUCATION; TRENDS; SECONDARY; IMPACT	Context Physician shortages are appearing, yet controversy about their significance and uncertainty about their remedy exist. Objectives To sample the perceptions of medical school deans and state medical society executives about the adequacy of physician supply, to determine the perceived impact of any shortages on medical schools, and to assess the capacity of medical schools to expand. Design, Setting, and Participants Medical school deans in the United States and Puerto Rico were surveyed by means of a structured questionnaire, and officials of US state medical societies were queried by means of open-ended telephone interviews. Information was obtained from 58% of medical school deans and 86% of state medical society executives. Main Outcome Measure Reported perceptions of shortages or surpluses of physicians by specialty and plans to increase medical school class size. Results Approximately 85% of both deans and medical society respondents perceived shortages of physicians, usually in multiple specialties, while 10% perceived surpluses, usually coexisting with shortages. Among deans reporting shortages, 83 % described a negative impact on their schools. Recent or planned increases in class size were reported by 27% of deans and expansion capacity by another 34%, but 7% noted recent decreases in class size. Applied generally, these changes in class size could yield 7.6% additional matriculants annually. Conclusions Physician shortages are prevalent and they are negatively affecting medical schools. Little capacity exists to alleviate these shortages through class size expansion.	Med Coll Wisconsin, Hlth Policy Inst, Milwaukee, WI 53226 USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA	Medical College of Wisconsin; University of Texas System; University of Texas Health San Antonio	Cooper, RA (corresponding author), Med Coll Wisconsin, Hlth Policy Inst, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	rcooper@mcw.edu						*AM ASS COLL OST M, 1997, 979 ASS AM MED COLL; *ASS AM MED COLL, 2002, POL PHYS WORKF; BALL D, 2002, 2001 SURV NEW MEX PH; Braddock D, 1999, MON LABOR REV, V122, P51; *CAL MED ASS, 2001, THEN NON COM PHYS SU; Cooper RA, 2002, HEALTH AFFAIR, V21, P140, DOI 10.1377/hlthaff.21.1.140; Cooper RA, 2003, ACAD MED, V78, P855, DOI 10.1097/00001888-200309000-00003; Cooper RA, 2003, ACAD MED, V78, P864, DOI 10.1097/00001888-200309000-00004; Cooper RA, 2003, HEALTH AFFAIR, V22, P71, DOI 10.1377/hlthaff.22.4.71; Cooper RA, 2003, HEALTH SERV RES, V38, P675, DOI 10.1111/1475-6773.00139; Cooper RA, 2002, ACAD MED, V77, P761, DOI 10.1097/00001888-200208000-00002; *COUNC GRAD MED ED, 2003, STAT PHYS WORKF; *CTR HLTH WORKF ST, 2003, REASS PHYS WORKF POL; *CTR HLTH WORKF ST, 2003, PHYS SUPPL DEM IND N; Etzioni DA, 2003, ANN SURG, V238, P170, DOI 10.1097/01.SLA.0000081085.98792.3d; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fleming KC, 2003, MAYO CLIN PROC, V78, P1026; Grumbach K, 2002, HEALTH AFFAIR, V21, P13, DOI 10.1377/hlthaff.21.5.13; Grumbach K, 2002, HEALTH AFFAIR, V21, P155, DOI 10.1377/hlthaff.21.1.155; *MASS MED SOC, 2003, PHYS WORKF STUD MAY; *MERR HAWK ASS, SUMM REP 2002 REV PH; Organ CH, 2002, ARCH SURG-CHICAGO, V137, P250, DOI 10.1001/archsurg.137.3.250; Schubert A, 2003, ANESTH ANALG, V96, P207, DOI 10.1097/00000539-200301000-00043; STRUNK BC, 2002, TREADING WATER AM AC; TRUDE S, 2002, GROWING PHYSICIAN AC; WESTFALL C, 2003, GROUP PRACTICE J SEP	26	31	31	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2003	290	22					2992	2995		10.1001/jama.290.22.2992	http://dx.doi.org/10.1001/jama.290.22.2992			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751WH	14665661				2022-12-28	WOS:000187112700031
J	Abuzzahab, MJ; Schneider, A; Goddard, A; Grigorescu, F; Lautier, C; Keller, E; Kiess, W; Klammt, J; Kratzsch, J; Osgood, D; Pfaffle, R; Raile, K; Seidel, B; Smith, RJ; Chernausek, SD; Frank, GR; Kaplowitz, PB; Pescovitz, OH; Smith, EP				Abuzzahab, MJ; Schneider, A; Goddard, A; Grigorescu, F; Lautier, C; Keller, E; Kiess, W; Klammt, J; Kratzsch, J; Osgood, D; Pfaffle, R; Raile, K; Seidel, B; Smith, RJ; Chernausek, SD; Frank, GR; Kaplowitz, PB; Pescovitz, OH; Smith, EP		IUGR Study Grp	IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INSULIN-RESISTANCE; SHORT STATURE; GENE; HORMONE; BINDING; DELETION; CHILDREN; FAILURE; PROTEIN; SYSTEM	BACKGROUND: Approximately 10 percent of infants with intrauterine growth retardation remain small, and the causes of their growth deficits are often unclear. We postulated that mutations in the gene for the insulin-like growth factor I receptor (IGF-IR) might underlie some cases of prenatal and postnatal growth failure. METHODS: We screened two groups of children for abnormalities in the IGF-IR gene. In one group of 42 patients with unexplained intrauterine growth retardation and subsequent short stature, we used single-strand conformation polymorphism analysis, followed by direct DNA sequencing of any abnormalities found. A second cohort consisted of 50 children with short stature who had elevated circulating IGF-I concentrations. Complete sequencing of the IGF-IR gene was performed with DNA from nine children. We also studied a control group of 43 children with normal birth weights. RESULTS: In the first cohort, we identified one girl who was a compound heterozygote for point mutations in exon 2 of the IGF-IR gene that altered the amino acid sequence to Arg108Gln in one allele and Lys115Asn in the other. Fibroblasts cultured from the patient had decreased IGF-I-receptor function, as compared with that in control fibroblasts. No such mutations were found in the 43 controls. In the second group, we identified one boy with a nonsense mutation (Arg59stop) that reduced the number of IGF-I receptors on fibroblasts. Both children had intrauterine growth retardation and poor postnatal growth. CONCLUSIONS: Mutations in the IGF-IR gene that lead to abnormalities in the function or number of IGF-I receptors may also retard intrauterine and subsequent growth in humans.	Childrens Hosp, Med Ctr, Div Endocrinol, Cincinnati, OH 45229 USA; Univ Leipzig, Hosp Children & Adolescents, Leipzig, Germany; Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany; Genentech Inc, San Francisco, CA 94080 USA; Inst Univ Rech Clin, Montpellier, France; Brown Med Sch, Hallett Ctr Diabet & Endocrinol, Providence, RI USA	Cincinnati Children's Hospital Medical Center; Leipzig University; Leipzig University; Roche Holding; Genentech; Universite de Montpellier; Brown University	Chernausek, SD (corresponding author), Childrens Hosp, Med Ctr, Div Endocrinol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	steven.chernausek@cchmc.org	Grigorescu, Florin/Q-3728-2019; GRIGORESCU, FLORIN/C-2238-2013; Lautier, Corinne/P-2701-2018	Grigorescu, Florin/0000-0002-3095-5639; GRIGORESCU, FLORIN/0000-0002-3095-5639; Klammt, Jurgen/0000-0003-2293-9193; Raile, Klemens/0000-0002-0842-1737; Lautier, Corinne/0000-0002-3229-191X; , steven/0000-0003-4538-8793	NCRR NIH HHS [M01RR08084] Funding Source: Medline; NIDDK NIH HHS [DK43038] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR008084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043038] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABBOTT AM, 1992, J BIOL CHEM, V267, P10759; ACCILI D, 1995, DIABETES METAB REV, V11, P47, DOI 10.1002/dmr.5610110105; [Anonymous], 2000, ADV DATA VITAL HLTH; BIERICH JR, 1984, EUR J PEDIATR, V142, P186, DOI 10.1007/BF00442446; Blagitko N, 2000, HUM MOL GENET, V9, P1587, DOI 10.1093/hmg/9.11.1587; Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; DErcole AJ, 1996, MOL NEUROBIOL, V13, P227, DOI 10.1007/BF02740625; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; GEFFNER ME, 1993, BIOCHEM BIOPH RES CO, V193, P1216, DOI 10.1006/bbrc.1993.1755; GLAVAC D, 1993, HUM MUTAT, V2, P404, DOI 10.1002/humu.1380020513; Greulich WW., 1959, CALIF MED, V91, P53; Hattori Y, 1996, J CLIN ENDOCR METAB, V81, P2257, DOI 10.1210/jc.81.6.2257; HEATHMONNIG E, 1987, J CLIN ENDOCR METAB, V64, P501, DOI 10.1210/jcem-64-3-501; HONE J, 1994, J MED GENET, V31, P715, DOI 10.1136/jmg.31.9.715; HOWARD TK, 1993, HUM MOL GENET, V2, P2089, DOI 10.1093/hmg/2.12.2089; JUUL A, 1994, CLIN ENDOCRINOL, V41, P85, DOI 10.1111/j.1365-2265.1994.tb03788.x; Kiess W, 2001, HORM RES, V56, P59, DOI 10.1159/000048137; LARGO RH, 1980, HELV PAEDIATR ACTA, V35, P419; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; MCCUSKER RH, 1990, J CELL PHYSIOL, V144, P244, DOI 10.1002/jcp.1041440210; MOMOI T, 1992, EUR J PEDIATR, V151, P321, DOI 10.1007/BF02113248; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; ORLOWSKI CC, 1989, J CELL PHYSIOL, V139, P469, DOI 10.1002/jcp.1041390304; PEOPLES R, 1995, CYTOGENET CELL GENET, V70, P228, DOI 10.1159/000134040; Prader A, 1989, Helv Paediatr Acta Suppl, V52, P1; ROBACK EW, 1991, AM J MED GENET, V38, P74, DOI 10.1002/ajmg.1320380117; ROSENFELD RG, 1994, ENDOCR REV, V15, P369, DOI 10.1210/er.15.3.369; Sandford AJ, 1997, BIOTECHNIQUES, V23, P890, DOI 10.2144/97235st05; Tritos NA, 1998, J CLIN ENDOCR METAB, V83, P3025, DOI 10.1210/jc.83.9.3025; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; ZADIK Z, 1990, J CLIN ENDOCR METAB, V71, P932, DOI 10.1210/jcem-71-4-932	32	416	440	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2003	349	23					2211	2222		10.1056/NEJMoa010107	http://dx.doi.org/10.1056/NEJMoa010107			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LH	14657428				2022-12-28	WOS:000186921700007
J	Clapham, DE				Clapham, DE			TRP channels as cellular sensors	NATURE			English	Review							NONSELECTIVE CATION CHANNEL; RECEPTOR POTENTIAL CHANNEL; OPERATED CA2+ CURRENT; ION-CHANNEL; CAPSAICIN-RECEPTOR; MICE LACKING; DROSOPHILA PHOTOTRANSDUCTION; CAENORHABDITIS-ELEGANS; MOLECULAR-BASIS; ADP-RIBOSE	TRP channels are the vanguard of our sensory systems, responding to temperature, touch, pain, osmolarity, pheromones, taste and other stimuli. But their role Is much broader than classical sensory transduction. They are an ancient sensory apparatus for the cell, not just the multicellular organism, and they have been adapted to respond to all manner of stimuli, from both within and outside the cell.	Harvard Univ, Childrens Hosp Boston, Sch Med,Dept Neurobiol, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Clapham, DE (corresponding author), Harvard Univ, Childrens Hosp Boston, Sch Med,Dept Neurobiol, Howard Hughes Med Inst, Enders 1309,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; 				Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Benham CD, 2003, CELL CALCIUM, V33, P479, DOI 10.1016/S0143-4160(03)00063-0; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Birnbaumer L, 2003, CELL CALCIUM, V33, P419, DOI 10.1016/S0143-4160(03)00068-X; BLOCK SM, 1992, SOC GEN PHY, V47, P1; Boulter C, 2001, P NATL ACAD SCI USA, V98, P12174, DOI 10.1073/pnas.211191098; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Corey DP, 2003, NEURON, V39, P585, DOI 10.1016/S0896-6273(03)00505-1; Cui J, 2002, J BIOL CHEM, V277, P47175, DOI 10.1074/jbc.M205870200; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; den Dekker E, 2003, CELL CALCIUM, V33, P497, DOI 10.1016/S0143-4160(03)00065-4; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Duncan LM, 1998, CANCER RES, V58, P1515; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Goel M, 2002, J BIOL CHEM, V277, P48303, DOI 10.1074/jbc.M207882200; Greka A, 2003, NAT NEUROSCI, V6, P837, DOI 10.1038/nn1092; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; Guler AD, 2002, J NEUROSCI, V22, P6408; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hardie RC, 2002, NEURON, V36, P689, DOI 10.1016/S0896-6273(02)01048-6; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Heiner I, 2003, CELL CALCIUM, V33, P533, DOI 10.1016/S0143-4160(03)00058-7; Hersh BM, 2002, P NATL ACAD SCI USA, V99, P4355, DOI 10.1073/pnas.062065399; HILLE B, 2001, ION CHANNELS EXCITAB, P663; HLGEMANN DW, 2001, SCI STKE, pRE19; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; HOWARD J, 1988, ANNU REV BIOPHYS BIO, V17, P99; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Iwata Y, 2003, J CELL BIOL, V161, P957, DOI 10.1083/jcb.200301101; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Lee N, 2003, J BIOL CHEM, V278, P20890, DOI 10.1074/jbc.M211232200; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; MINKE B, 1977, BIOPHYS STRUCT MECH, V3, P59, DOI 10.1007/BF00536455; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nagamine K, 1998, GENOMICS, V54, P124, DOI 10.1006/geno.1998.5551; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; NILIUS B, 2003, CELL CALCIUM, V14, P33; Nomura H, 1998, J BIOL CHEM, V273, P25967, DOI 10.1074/jbc.273.40.25967; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Perraud AL, 2003, CELL CALCIUM, V33, P519, DOI 10.1016/S0143-4160(03)00057-5; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Putney JW, 1999, BIOESSAYS, V21, P38; Putney JW, 1999, P NATL ACAD SCI USA, V96, P14669, DOI 10.1073/pnas.96.26.14669; Rafty LA, 2002, J BIOL CHEM, V277, P47114, DOI 10.1074/jbc.M208997200; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Sukharev SI, 1999, J GEN PHYSIOL, V113, P525, DOI 10.1085/jgp.113.4.525; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Vaca L, 2002, J BIOL CHEM, V277, P42178, DOI 10.1074/jbc.M204531200; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Voets T, 2003, J GEN PHYSIOL, V121, P245, DOI 10.1085/jgp.20028752; Voets T, 2001, J BIOL CHEM, V276, P47767, DOI 10.1074/jbc.C100607200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; WES PD, 1995, P NATL ACAD SCI USA, V92, P9652, DOI 10.1073/pnas.92.21.9652; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Xu XZS, 2003, CELL, V114, P285, DOI 10.1016/S0092-8674(03)00565-8; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yue LX, 2001, NATURE, V410, P705, DOI 10.1038/35070596; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhou XL, 2003, P NATL ACAD SCI USA, V100, P7105, DOI 10.1073/pnas.1230540100; Zitt C, 1997, J CELL BIOL, V138, P1333, DOI 10.1083/jcb.138.6.1333	98	1956	2087	9	894	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2003	426	6966					517	524		10.1038/nature02196	http://dx.doi.org/10.1038/nature02196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654832				2022-12-28	WOS:000186944300029
J	Hales, S; Woodward, A				Hales, S; Woodward, A			Climate change will increase demands on malaria control in Africa	LANCET			English	Editorial Material									Wellington Sch Med & Hlth Sci, Wellington, New Zealand	University of Otago	Hales, S (corresponding author), Wellington Sch Med & Hlth Sci, Wellington, New Zealand.	shales@wnmeds.ac.nz	hales, simon/E-5768-2010	Hales, Simon/0000-0002-4529-7595; Woodward, Alistair/0000-0001-5425-6018				[Anonymous], 2003, AFR MAL REP 2003; Githeko A.K., 2001, GLOB CHANGE HUM HLTH, V2, P54, DOI [10.1023/A:1011943131643, DOI 10.1023/A:1011943131643]; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; *INT PAN CLIM CHAN, CLIM CHANG 2001; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; PATZ J, 2002, NATURE, V415, P905; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; WHO, 2003, CLIM CHANG HUM HLTH	8	21	23	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1775	1775		10.1016/S0140-6736(03)14939-2	http://dx.doi.org/10.1016/S0140-6736(03)14939-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654310				2022-12-28	WOS:000186872900003
J	Nosworthy, A				Nosworthy, A			Hypokalemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johannesburg Hosp, ZA-2000 Johannesburg, South Africa	University of Witwatersrand	Nosworthy, A (corresponding author), Johannesburg Hosp, ZA-2000 Johannesburg, South Africa.								0	5	5	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2003	349	22					2116	2116		10.1056/NEJMicm990705	http://dx.doi.org/10.1056/NEJMicm990705			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746ZV	14645639				2022-12-28	WOS:000186779700006
J	Crowther, CA; Hiller, JE; Doyle, LW; Haslam, RR				Crowther, CA; Hiller, JE; Doyle, LW; Haslam, RR		Australasian Collaborative Trial	Effect of magnesium sulfate given for neuroprotection before preterm birth - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CEREBRAL-PALSY; WEIGHT INFANTS; INTRAVENTRICULAR HEMORRHAGE; NEONATAL MORBIDITY; GESTATIONAL-AGE; INTENSIVE-CARE; RISK; CHILDREN; TOCOLYSIS; MORTALITY	Context Prenatal magnesium sulfate may reduce the risk of cerebral palsy or death in very preterm infants. Objective To determine the effectiveness of magnesium sulfate given for neuroprotection to women at risk of preterm birth before 30 weeks' gestation in preventing pediatric mortality and cerebral palsy. Design, Setting, and Patients Randomized controlled trial at 16 tertiary hospitals in Australia and New Zealand with stratification by center and multiple pregnancy. A total of 1062 women with fetuses younger than 30 weeks' gestation for whom birth was planned or expected within 24 hours were enrolled from February 1996 to September 2000 with follow-up of surviving children at a corrected age of 2 years. Interventions Women were randomly assigned to receive a loading infusion of 8 mL (4 g [16 mmol] of 0.5 g/mL of magnesium sulfate solution or isotonic sodium chloride solution [0.9%]) for 20 minutes followed by a maintenance infusion of 2 mL/h for up to 24 hours. Main Outcome Measures Rates of total-pediatric mortality, cerebral palsy, and the combined outcome of death or cerebral palsy at a corrected age of 2 years. Results Data were analyzed for 1047 (99%) 2-year survivors. Total pediatric mortality (13.8% Vs 17.1%; relative risk [RR], 0.83; 95% confidence interval [CI], 0.64-1.09), cerebral palsy in survivors (6.8% vs 8.2%; RR, 0.83; 95% CI, 0.54-1.27), and combined death or cerebral palsy (19.8% Vs 24.0%; RR, 0.83; 95% CI, 0.66-1.03) were less frequent for infants exposed to magnesium sulfate, but none of the differences were statistically significant. Substantial gross motor dysfunction (3.4% vs 6.6%; RR, 0.51; 95% CI, 0.29-0.91) and combined death or substantial gross motor dysfunction (17.0% Vs 22.7%; RR, 0.75; 95% CI, 0.59-0.96) were significantly reduced in the magnesium group. Conclusions Magnesium sulfate given to women immediately before very preterm birth may improve important pediatric outcomes. No serious harmful effects were seen.	Univ Adelaide, Dept Obstet & Gynaecol, Adelaide, SA, Australia; Univ Adelaide, Dept Publ Hlth, Adelaide, SA, Australia; Womens & Childrens Hosp, Dept Neonatal Med, Adelaide, SA, Australia; Univ Melbourne, Royal Womens Hosp, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; Univ Melbourne, Royal Womens Hosp, Dept Paediat, Melbourne, Vic, Australia	University of Adelaide; University of Adelaide; Womens & Childrens Hospital Australia; University of Melbourne; University of Melbourne	Crowther, CA (corresponding author), Univ Adelaide, Womens & Childrens Hosp, Dept Obstet & Gynaecol, King William Rd, Adelaide, SA 5006, Australia.		Doyle, Lex/AAJ-5205-2021; Hiller, Janet E./A-5633-2008; Pritchard, Margo A/G-5188-2010	Doyle, Lex/0000-0002-7667-7312; Hiller, Janet E./0000-0002-8532-4033; Pritchard, Margo A/0000-0002-1058-9117				Bayley N, 1993, BAYLEY SCALES INFANT; Boyle CA, 2000, AM J EPIDEMIOL, V152, P120, DOI 10.1093/aje/152.2.120; Canterino JC, 1999, OBSTET GYNECOL, V93, P396, DOI 10.1016/S0029-7844(98)00455-4; Drummond PM, 2002, PAEDIATR PERINAT EP, V16, P172, DOI 10.1046/j.1365-3016.2002.00408.x; FineSmith RB, 1997, AM J PERINAT, V14, P303, DOI 10.1055/s-2007-994149; FORD GW, 1990, AM J PERINAT, V7, P178, DOI 10.1055/s-2007-999475; Grether JK, 1998, AM J OBSTET GYNECOL, V178, P1, DOI 10.1016/S0002-9378(98)70617-9; Grether JK, 2000, AM J OBSTET GYNECOL, V183, P717, DOI 10.1067/mob.2000.106581; Hagberg B, 2001, ACTA PAEDIATR, V90, P271, DOI 10.1080/080352501300067532; Hauth J. C., 1995, American Journal of Obstetrics and Gynecology, V172, P419; Kimberlin DF, 1998, AM J PERINAT, V15, P635, DOI 10.1055/s-2007-994082; KITCHEN WH, 1987, AM J PERINAT, V4, P29, DOI 10.1055/s-2007-999733; KUBAN KCK, 1992, J CHILD NEUROL, V7, P70, DOI 10.1177/088307389200700113; LEE J, 1994, OCCUP ENVIRON MED, V51, P841, DOI 10.1136/oem.51.12.841; Lorenz JM, 1998, ARCH PEDIAT ADOL MED, V152, P425, DOI 10.1001/archpedi.152.5.425; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Mittendorf R., 2000, American Journal of Obstetrics and Gynecology, V182, pS20; Mittendorf R, 2002, AM J OBSTET GYNECOL, V186, P1111, DOI 10.1067/mob.2002.123544; Mittendorf R, 1997, LANCET, V350, P1517, DOI 10.1016/S0140-6736(97)24047-X; NELSON KB, 1995, PEDIATRICS, V95, P263; O'Shea TM, 1998, AM J EPIDEMIOL, V147, P362; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; PANETH N, 1997, PEDIATRICS, V99, P1; Perlman J., 1994, Pediatric Research, V37, p231A; Pharoah POD, 1998, ARCH DIS CHILD-FETAL, V79, pF21, DOI 10.1136/fn.79.1.F21; ROBERTSON PA, 1992, AM J OBSTET GYNECOL, V166, P1629, DOI 10.1016/0002-9378(92)91551-K; Schendel DE, 1996, JAMA-J AM MED ASSOC, V276, P1805, DOI 10.1001/jama.276.22.1805; STANLEY FJ, 1982, DEV MED CHILD NEUROL, V24, P93; STANLEY FJ, 1992, BRIT MED J, V304, P1658, DOI 10.1136/bmj.304.6843.1658; Vermeulen GM, 2001, EUR J OBSTET GYN R B, V99, P207, DOI 10.1016/S0301-2115(01)00383-9; Vohr B, 1999, SEMIN PERINATOL, V23, P212, DOI 10.1016/S0146-0005(99)80065-2; Weintraub Z, 2001, ARCH DIS CHILD-FETAL, V85, pF13, DOI 10.1136/fn.85.1.F13; Wiswell T. E., 1996, Pediatric Research, V39, p253A	33	343	359	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 26	2003	290	20					2669	2676		10.1001/jama.290.20.2669	http://dx.doi.org/10.1001/jama.290.20.2669			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	747CR	14645308	Bronze			2022-12-28	WOS:000186788100018
J	Inoki, K; Zhu, TQ; Guan, KL				Inoki, K; Zhu, TQ; Guan, KL			TSC2 mediates cellular energy response to control cell growth and survival	CELL			English	Article							ACTIVATED PROTEIN-KINASE; P70 S6 KINASE; TUMOR-SUPPRESSOR GENE; TUBEROUS-SCLEROSIS; MAMMALIAN TARGET; RAPAMYCIN; MTOR; PHOSPHORYLATION; INSULIN; COMPLEX	Mutations in either the TSC1 or TSC2 tumor suppressor gene are responsible for Tuberous Sclerosis Complex. The gene products of TSC1 and TSC2 form a functional complex and inhibit the phosphorylation of S6K and 4EBP1, two key regulators of translation. Here, we describe that TSC2 is regulated by cellular energy levels and plays an essential role in the cellular energy response pathway. Under energy starvation conditions, the AMP-activated protein kinase (AMPK) phosphorylates TSC2 and enhances its activity. Phosphorylation of TSC2 by AMPK is required for translation regulation and cell size control in response to energy deprivation. Furthermore, TSC2 and its phosphorylation by AMPK protect cells from energy deprivation-induced apoptosis. These observations demonstrate a model where TSC2 functions as a key player in regulation of the common mTOR pathway of protein synthesis, cell growth, and viability in response to cellular energy levels.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, KL (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	kunliang@umich.edu	INOKI, KEN/A-1202-2007; Guan, Kun-Liang/ADK-7088-2022		NIDDK NIH HHS [R01 DK124709] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Au KS, 1998, AM J HUM GENET, V62, P286, DOI 10.1086/301705; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1; Jaeschke A, 2002, J CELL BIOL, V159, P217, DOI 10.1083/jcb.jcb.200206108; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Kenerson HL, 2002, CANCER RES, V62, P5645; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Kobayashi T, 2001, P NATL ACAD SCI USA, V98, P8762, DOI 10.1073/pnas.151033798; Krause U, 2002, EUR J BIOCHEM, V269, P3751, DOI 10.1046/j.1432-1033.2002.03074.x; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Onda H, 2002, MOL CELL NEUROSCI, V21, P561, DOI 10.1006/mcne.2002.1184; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Potter CJ, 2001, CURR OPIN GENET DEV, V11, P279, DOI 10.1016/S0959-437X(00)00191-X; Proud CG, 2002, EUR J BIOCHEM, V269, P5338, DOI 10.1046/j.1432-1033.2002.03292.x; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Scott PH, 1998, P NATL ACAD SCI USA, V95, P7772, DOI 10.1073/pnas.95.13.7772; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE715, DOI 10.1152/ajpendo.2000.279.4.E715; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; Yoo LI, 2002, NAT REV CANCER, V2, P529, DOI 10.1038/nrc843; Young J, 1998, MOL MED TODAY, V4, P313, DOI 10.1016/S1357-4310(98)01245-3; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	51	2875	2995	11	222	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 26	2003	115	5					577	590		10.1016/S0092-8674(03)00929-2	http://dx.doi.org/10.1016/S0092-8674(03)00929-2			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651849	Bronze			2022-12-28	WOS:000186885600008
J	Rogers, GC; Rogers, SL; Schwimmer, TA; Ems-McClung, SC; Walczak, CE; Vale, RD; Scholey, JM; Sharp, DJ				Rogers, GC; Rogers, SL; Schwimmer, TA; Ems-McClung, SC; Walczak, CE; Vale, RD; Scholey, JM; Sharp, DJ			Two mitotic kinesins cooperate to drive sister chromatid separation during anaphase	NATURE			English	Article							CENTROMERE-ASSOCIATED KINESIN; MICROTUBULE FLUX; CHROMOSOME MOVEMENT; DYNAMICS; POLEWARD; SPINDLE; KINETOCHORE; PROTEIN; MITOSIS; XKCM1	During anaphase identical sister chromatids separate and move towards opposite poles of the mitotic spindle(1,2). In the spindle, kinetochore microtubules(3) have their plus ends embedded in the kinetochore and their minus ends at the spindle pole. Two models have been proposed to account for the movement of chromatids during anaphase. In the ' Pac- Man' model, kinetochores induce the depolymerization of kinetochore microtubules at their plus ends, which allows chromatids to move towards the pole by ' chewing up' microtubule tracks(4,5). In the 'poleward flux' model, kinetochores anchor kinetochore microtubules and chromatids are pulled towards the poles through the depolymerization of kinetochore microtubules at the minus ends(6). Here, we show that two functionally distinct microtubule- destabilizing KinI kinesin enzymes ( so named because they possess a kinesin- like ATPase domain positioned internally within the polypeptide) are responsible for normal chromatid- to- pole motion in Drosophila. One of them, KLP59C, is required to depolymerize kinetochore microtubules at their kinetochore- associated plus ends, thereby contributing to chromatid motility through a Pac- Man- based mechanism. The other, KLP10A, is required to depolymerize microtubules at their pole- associated minus ends, thereby moving chromatids by means of poleward flux.	Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Indiana Univ, Med Sci Program, Bloomington, IN 47405 USA; Univ Calif Davis, Ctr Genet & Dev, Davis, CA 95616 USA; Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA	Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Indiana University System; Indiana University Bloomington; University of California System; University of California Davis; University of California System; University of California Davis	Sharp, DJ (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA.	dsharp@aecom.yu.edu			NIGMS NIH HHS [R01 GM059618] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059618] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bousbaa H, 1997, J CELL SCI, V110, P1979; Brust-Mascher I, 2002, MOL BIOL CELL, V13, P3967, DOI 10.1091/mbc.02-05-0069; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Garcia MA, 2002, CURR BIOL, V12, P610, DOI 10.1016/S0960-9822(02)00761-3; Goldstein LSB, 2000, J CELL BIOL, V150, pF63, DOI 10.1083/jcb.150.2.F63; GORBSKY GJ, 1987, J CELL BIOL, V104, P9, DOI 10.1083/jcb.104.1.9; Hunter AW, 2000, J CELL SCI, V113, P4379; Kline-Smith SL, 2002, MOL BIOL CELL, V13, P2718, DOI 10.1091/mbc.E01-12-0143; Maddox P, 2002, CURR BIOL, V12, P1670, DOI 10.1016/S0960-9822(02)01183-1; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; McIntosh JR, 2002, ANNU REV CELL DEV BI, V18, P193, DOI 10.1146/annurev.cellbio.18.032002.132412; MITCHISON T, 1986, CELL, V45, P515, DOI 10.1016/0092-8674(86)90283-7; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Mitchison TJ, 2001, NAT CELL BIOL, V3, pE17, DOI 10.1038/35050656; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Sharp DJ, 2000, NAT CELL BIOL, V2, P922, DOI 10.1038/35046574; Sharp DJ, 1999, NAT CELL BIOL, V1, P51, DOI 10.1038/9025; SULLIVAN W, 1995, CURR OPIN CELL BIOL, V7, P18, DOI 10.1016/0955-0674(95)80040-9; SULLIVAN W, 1993, DEVELOPMENT, V118, P1245; Troxell CL, 2001, MOL BIOL CELL, V12, P3476, DOI 10.1091/mbc.12.11.3476; VALDESPEREZ PE, 1995, J THEOR BIOL, V175, P525, DOI 10.1006/jtbi.1995.0160; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Walczak CE, 2002, CURR BIOL, V12, P1885, DOI 10.1016/S0960-9822(02)01227-7; Waterman-Storer CM, 1998, CURR BIOL, V8, P1227, DOI 10.1016/S0960-9822(07)00515-5; Waters JC, 1996, MOL BIOL CELL, V7, P1547, DOI 10.1091/mbc.7.10.1547; West RR, 2002, J CELL SCI, V115, P931; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95	30	262	268	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 22	2004	427	6972					364	370		10.1038/nature02256	http://dx.doi.org/10.1038/nature02256			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765KE	14681690				2022-12-28	WOS:000188266200044
J	Montelli, R; Nolet, G; Dahlen, FA; Masters, G; Engdahl, ER; Hung, SH				Montelli, R; Nolet, G; Dahlen, FA; Masters, G; Engdahl, ER; Hung, SH			Finite-frequency tomography reveals a variety of plumes in the mantle	SCIENCE			English	Article							TRAVEL-TIMES; DEPENDENT VISCOSITY; FRECHET KERNELS; PLATE-TECTONICS; SHEAR VELOCITY; FLOOD BASALTS; EARTHS MANTLE; DEEP MANTLE; CONVECTION; HOTSPOTS	We present tomographic evidence for the existence of deep-mantle thermal convection plumes. P-wave velocity images show at least six well-resolved plumes that extend into the lowermost mantle: Ascension, Azores, Canary, Easter, Samoa, and Tahiti. Other less well-resolved plumes, including Hawaii, may also reach the lowermost mantle. We also see several plumes that are mostly confined to the upper mantle, suggesting that convection may be partially separated into two depth regimes. All of the observed plumes have diameters of several hundred kilometers, indicating that plumes convey a substantial fraction of the internal heat escaping from Earth.	Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; Univ Calif San Diego, Inst Geophys & Planetary Phys, La Jolla, CA 92093 USA; Univ Colorado, Dept Phys, Boulder, CO 80309 USA; Natl Taiwan Univ, Dept Geosci, Taipei 10764, Taiwan	Princeton University; University of California System; University of California San Diego; University of Colorado System; University of Colorado Boulder; National Taiwan University	Montelli, R (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	montelli@princeton.edu	Nolet, Guust/F-3142-2013	Nolet, Guust/0000-0002-2709-1518; HUNG, SHU-HUEI/0000-0002-2701-4635; Engdahl, Eric Robert/0000-0003-4248-4798				Anderson DL, 2001, SCIENCE, V293, P2016, DOI 10.1126/science.1065448; Anderson DL, 2000, GEOPHYS RES LETT, V27, P3623, DOI 10.1029/2000GL011533; Anderson DL, 1998, GEODYNAMICS, V28, P255; Bijwaard H, 1999, EARTH PLANET SC LETT, V166, P121, DOI 10.1016/S0012-821X(99)00004-7; Bijwaard H, 1998, J GEOPHYS RES-SOL EA, V103, P30055, DOI 10.1029/98JB02467; Bolton H, 2001, J GEOPHYS RES-SOL EA, V106, P13527, DOI 10.1029/2000JB900378; Bolton H., 1996, THESIS U CALIFORNIA; Bunge HP, 1997, J GEOPHYS RES-SOL EA, V102, P11991, DOI 10.1029/96JB03806; Courtillot V, 1999, EARTH PLANET SC LETT, V166, P177, DOI 10.1016/S0012-821X(98)00282-9; Courtillot V, 2003, EARTH PLANET SC LETT, V205, P295, DOI 10.1016/S0012-821X(02)01048-8; Cserepes L, 2000, EARTH PLANET SC LETT, V183, P61, DOI 10.1016/S0012-821X(00)00265-X; Dahlen FA, 2000, GEOPHYS J INT, V141, P157, DOI 10.1046/j.1365-246X.2000.00070.x; Davaille A, 2002, EARTH PLANET SC LETT, V203, P621, DOI 10.1016/S0012-821X(02)00897-X; Davaille A, 1999, NATURE, V402, P756, DOI 10.1038/45461; DAVIES GF, 1988, J GEOPHYS RES-SOLID, V93, P10467, DOI 10.1029/JB093iB09p10467; Engdahl ER, 1998, B SEISMOL SOC AM, V88, P722; Foulger GR, 2003, SCIENCE, V300, P921, DOI 10.1126/science.1083376; GRAND SP, 1994, J GEOPHYS RES-SOL EA, V99, P11591, DOI 10.1029/94JB00042; Grand SP., 1997, GSA TODAY, V7, P1; Gu YJ, 2001, J GEOPHYS RES-SOL EA, V106, P11169, DOI 10.1029/2001JB000340; Hung SH, 2001, GEOPHYS J INT, V146, P289, DOI 10.1046/j.1365-246x.2001.01466.x; Hung SH, 2000, GEOPHYS J INT, V141, P175, DOI 10.1046/j.1365-246X.2000.00072.x; KARATO S, 1993, GEOPHYS RES LETT, V20, P1623, DOI 10.1029/93GL01767; Kellogg LH, 1999, SCIENCE, V283, P1881, DOI 10.1126/science.283.5409.1881; Kravtsov Y. A., 1990, GEOMETRICAL OPTICS I; MONTELLI R, IN PRESS GEOPHYS J I; MORELLI A, 1987, SEISMIC TOMOGRAPHY, P251; Morgan W.J., 1972, GEOL SOC AM MEM, V132, P7, DOI [DOI 10.1130/MEM132-P7, 10.1130/MEM132-p7]; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; MORGAN WL, COMMUNICATION; NATAF HC, 1993, NATURE, V364, P115, DOI 10.1038/364115a0; Ni SD, 2002, SCIENCE, V296, P1850, DOI 10.1126/science.1070698; Nolet G, 2000, J GEOPHYS RES-SOL EA, V105, P19043, DOI 10.1029/2000JB900161; Norton I.O., 2000, HIST DYNAMICS GLOBAL, V121, P339, DOI [10.1029/GM121p0339, DOI 10.1029/GM121P0339]; OKEEFE JA, 1959, SCIENCE, V129, P565, DOI 10.1126/science.129.3348.565; RICHARDS MA, 1989, SCIENCE, V246, P103, DOI 10.1126/science.246.4926.103; Ritsema J, 1998, GEOPHYS RES LETT, V25, P4245, DOI 10.1029/1998GL900127; SLEEP N, 2002, GEOCHEM GEOPHYS GEOS, V3; SLEEP NH, 1990, J GEOPHYS RES-SOLID, V95, P6715, DOI 10.1029/JB095iB05p06715; Su WJ, 1997, PHYS EARTH PLANET IN, V100, P135, DOI 10.1016/S0031-9201(96)03236-0; Tackley PJ, 2000, SCIENCE, V288, P2002, DOI 10.1126/science.288.5473.2002; van der Hilst RD, 1999, SCIENCE, V283, P1885, DOI 10.1126/science.283.5409.1885; Van der Voo R, 1999, NATURE, V397, P246, DOI 10.1038/16686; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; vanKeken P, 1997, EARTH PLANET SC LETT, V148, P1, DOI 10.1016/S0012-821X(97)00042-3; Vasco DW, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB000412; Vidale JE, 2001, GEOPHYS RES LETT, V28, P859, DOI 10.1029/2000GL012428; Wegener A., 1924, ORIGIN CONTINENTS OC; WILSON JT, 1963, CAN J PHYS, V41, P863, DOI 10.1139/p63-094; WILSON JT, 1965, PHILOS T R SOC LON A, V258; Wu P, 1999, GEOPHYS J INT, V139, P691, DOI 10.1046/j.1365-246x.1999.00965.x; Zhong SJ, 2000, J GEOPHYS RES-SOL EA, V105, P11063, DOI 10.1029/2000JB900003	52	807	858	3	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 16	2004	303	5656					338	343		10.1126/science.1092485	http://dx.doi.org/10.1126/science.1092485			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	763QK	14657505	Green Published			2022-12-28	WOS:000188111800034
J	Sparen, P; Vagero, D; Shestov, DB; Plavinskaja, S; Parfenova, N; Hoptiar, V; Paturot, D; Galanti, MR				Sparen, P; Vagero, D; Shestov, DB; Plavinskaja, S; Parfenova, N; Hoptiar, V; Paturot, D; Galanti, MR			Long term mortality after severe starvation during the siege of Leningrad: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; WOMEN BORN 1915-29; ANOREXIA-NERVOSA; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; PRENATAL EXPOSURE; EATING-DISORDERS; DUTCH FAMINE; SWEDISH MEN; RISK	Objective To determine whether starvation during periods of increased growth after birth has long term health consequences. Design Analysis of cardiovascular risk factors and mortality in a longitudinal follow up after the 1941-4 siege of Leningrad. Mortality measured from 1975 to the end of 1999. Setting St Petersburg, Russia (formerly Leningrad). Participants 5000 men born 1916-35 who lived in Leningrad, randomly selected to take part in health examinations in 1975-7. Of the 3905 men who participated, a third had experienced the siege. Main outcome measures Relative risk of ischaemic heart disease and mortality from stroke by siege exposure. Odds ratios and means for several cardiovascular risk factors. Results Three to six decades after the siege, in men who experienced the siege around the age of puberty blood pressure was raised (mean difference in systolic 3.3 mm Hg, in diastolic 1.3 mm Hg) as was mortality from ischaemic heart disease (relative risk 1.39, 95% confidence interval 1.07 to 1.79) and stroke (1.67, 1.15 to 2.43), including haemorrhagic stroke (1.71, 0.90 to 3.22). The effect on mortality was partly mediated via blood pressure but not by any other measured biological, behavioural, or social factor. Conclusions Starvation, or accompanying chronic stress, particularly at the onset of or during puberty, may increase vulnerability to later cardiovascular disease.	Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; Stockholm Univ, Karolinska Inst, CHESS, Ctr Hlth Equity Studies, S-10691 Stockholm, Sweden; Russian Acad Med Sci, Inst Expt Med, St Petersburg, Russia; Univ Coll, Sodertorns Hgsk, Huddinge, Sweden; Karolinska Hosp, Dept Med, Clin Epidemiol Unit, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Stockholm University; Institute of Experimental Medicine; Russian Academy of Medical Sciences; Sodertorn University; Karolinska Institutet; Karolinska University Hospital	Sparen, P (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.		Parfenova, Nina/E-6672-2014	Parfenova, Nina/0000-0002-1236-3058; Sparen, Par/0000-0002-5184-8971				ABERNATHY JR, 1988, AM J CARDIOL, V61, P1071, DOI 10.1016/0002-9149(88)90128-2; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; ANTONOV AN, 1947, J PEDIATR, V30, P250, DOI 10.1016/S0022-3476(47)80160-X; Beevor Anthony, 1998, STALINGRAD; Bohlooly-Y M, 2001, ENDOCRINOLOGY, V142, P3317, DOI 10.1210/en.142.8.3317; Breslow NE., 1987, STAT METHODS CANC RE, P81; BROZEK J, 1948, JAMA-J AM MED ASSOC, V137, P1569, DOI 10.1001/jama.1948.02890520001001; Bygren LO, 2000, AM J HUM BIOL, V12, P447, DOI 10.1002/1520-6300(200007/08)12:4&lt;447::AID-AJHB3&gt;3.0.CO;2-M; COOKE RA, 1995, BRIT J HOSP MED, V54, P313; DESIMONE GD, 1994, BRIT HEART J, V71, P287; FORSDAHL A, 1977, BRIT J PREV SOC MED, V31, P91; GARNETT ES, 1969, LANCET, V1, P914; Holdaway I M, 1999, Pituitary, V2, P29, DOI 10.1023/A:1009965803750; Hypponen E, 2001, BRIT MED J, V323, P1033, DOI 10.1136/bmj.323.7320.1033; Kannisto V, 1997, AM J EPIDEMIOL, V145, P987, DOI 10.1093/oxfordjournals.aje.a009067; Kermack WO, 1934, LANCET, V1, P698; Keys A, 1950, BIOL HUMAN STARVATIO; KREIPE RE, 1992, PEDIATR ANN, V21, P760; LEON D, 2001, FETAL ORIGINS CARDIO; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; MARSHALL WA, 1986, HUMAN GROWTH COMPREH, P171; Melamed S, 1999, J PSYCHOSOM RES, V46, P591, DOI 10.1016/S0022-3999(99)00007-0; NELSON MJ, 1992, AM J EPIDEMIOL, V136, P633, DOI 10.1093/oxfordjournals.aje.a116543; PAVLOV DV, 1965, LENINGRAD 1941 BLOCK; PECK AMN, 1989, J EPIDEMIOL COMMUN H, V43, P380, DOI 10.1136/jech.43.4.380; Roseboom TJ, 2000, HEART, V84, P595, DOI 10.1136/heart.84.6.595; Roseboom TJ, 2000, AM J CLIN NUTR, V72, P1101; Rosmond R, 2000, J INTERN MED, V247, P188, DOI 10.1046/j.1365-2796.2000.00603.x; Stanner SA, 1997, BMJ-BRIT MED J, V315, P1342, DOI 10.1136/bmj.315.7119.1342; Stein Z., 1975, FAMINE HUM DEV DUTCH; Stoving RK, 1999, J PSYCHIATR RES, V33, P139, DOI 10.1016/S0022-3956(98)00049-1; Swenne I, 2000, ACTA PAEDIATR, V89, P447, DOI 10.1080/080352500750028177; Zicha J, 1999, PHYSIOL REV, V79, P1227, DOI 10.1152/physrev.1999.79.4.1227	33	93	99	0	17	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 3	2004	328	7430					11	14A		10.1136/bmj.37942.603970.9A	http://dx.doi.org/10.1136/bmj.37942.603970.9A			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	761QG	14660443	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000187919000013
J	DeBusk, RF				DeBusk, RF			Sexual activity in patients with angina	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; ERECTILE DYSFUNCTION; SILDENAFIL CITRATE; PHYSICAL EXERTION; EFFICACY; RISK		Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA	Stanford University	DeBusk, RF (corresponding author), Stanford Univ, Sch Med, Dept Med, 780 Welch Rd,Suite 106, Palo Alto, CA 94304 USA.							*AHCPR, 1994, AHCPR PUBL; Albert CM, 2000, NEW ENGL J MED, V343, P1355, DOI 10.1056/NEJM200011093431902; *AM HEART ASS, 2000, EM CARD CAR ADV CARD; American Heart Association, 2003, HEART DIS STROK STAT; BOHLEN JG, 1984, ARCH INTERN MED, V144, P1745, DOI 10.1001/archinte.144.9.1745; Cheitlin MD, 1999, CIRCULATION, V99, P168, DOI 10.1161/01.CIR.99.1.168; Conti CR, 1999, AM J CARDIOL, V83, p29C; DeBusk R, 2000, AM J CARDIOL, V86, P175, DOI 10.1016/S0002-9149(00)00896-1; DEBUSK RF, 1986, NEW ENGL J MED, V314, P161, DOI 10.1056/NEJM198601163140307; DeBusk RF, 2002, JAMA-J AM MED ASSOC, V287, P2359, DOI 10.1001/jama.287.18.2359; DeBusk RF, 2000, AM J CARDIOL, V86, p51F; FROELICHER VF, 1980, CARDIOLOGY, V66, P223, DOI 10.1159/000170869; Kloner RA, 2003, AM J CARDIOL, V92, p37M, DOI 10.1016/S0002-9149(03)00074-2; LAUMANN EO, 1994, SOCIAL ORG SEXUALITY, P77; MITTLEMAN MA, 1995, CIRCULATION, V92, P1720, DOI 10.1161/01.CIR.92.7.1720; Muller JE, 1996, JAMA-J AM MED ASSOC, V275, P1405, DOI 10.1001/jama.275.18.1405; POLLOCK ML, 1995, HEART DIS REHABILITA; Porst H, 2001, INT J IMPOT RES, V13, P192, DOI 10.1038/sj.ijir.3900713; Webb DJ, 2000, J AM COLL CARDIOL, V36, P25, DOI 10.1016/S0735-1097(00)00705-1	19	26	27	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2003	290	23					3129	3132		10.1001/jama.290.23.3129	http://dx.doi.org/10.1001/jama.290.23.3129			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753ZB	14679276				2022-12-28	WOS:000187277300032
J	Waage, IM; Gedde-Dahl, A				Waage, IM; Gedde-Dahl, A			Drug points - Pulmonary embolism possibly associated with olanzapine treatment	BRITISH MEDICAL JOURNAL			English	Article							VENOUS THROMBOEMBOLISM; CLOZAPINE		Haukeland Univ Hosp, Dept Psychiat, N-5021 Bergen, Norway; Haukeland Univ Hosp, Reg Drug Informat Ctr RELIS Vest, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Waage, IM (corresponding author), Solli Nervesanatorium, Osveien 15, N-5227 Nesttun, Norway.							Hagg S, 2000, LANCET, V355, P1155, DOI 10.1016/S0140-6736(00)02066-3; Hagg S, 2002, CNS DRUGS, V16, P765; Knudson JF, 2000, LANCET, V356, P252, DOI 10.1016/S0140-6736(05)74504-9; Selten JP, 2003, J CLIN PSYCHIAT, V64, P609, DOI 10.4088/JCP.v64n0518a; Walker AM, 1997, EPIDEMIOLOGY, V8, P671, DOI 10.1097/00001648-199710000-00010	5	32	33	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1384	1384		10.1136/bmj.327.7428.1384	http://dx.doi.org/10.1136/bmj.327.7428.1384			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670884	Green Published, Bronze			2022-12-28	WOS:000187417900023
J	Houck, O				Houck, O			Tales from a troubled marriage: Science and law in environmental policy	SCIENCE			English	Article							CLEAN-AIR ACT	Early environmental policy depended on science, with mixed results. Newer approaches continue to rely on science to identify problems and solve them, but use other mechanisms to set standards and legal obligations. Given the important role that science continues to play, however, several cautionary tales are in order concerning "scientific management," "good science," the lure of money, and the tension between objectivity and involvement in important issues of our time.	Tulane Univ, Sch Law, New Orleans, LA 70118 USA	Tulane University	Houck, O (corresponding author), Tulane Univ, Sch Law, 6329 Freret St, New Orleans, LA 70118 USA.							Adler RW, 1999, HARVARD ENVIRON LAW, V23, P203; ADLER RW, 1993, CLEAN WATER ACT 20 Y; BABICH A, 2003, ENV FORUM        MAY, P36; BEAN MJ, 1999, ENV FORUM        JAN, P26; BEEMAN P, 1994, DES MOINES REGI 0307, P1; *BNA, 1990, BNA ENV REP CURR DEV, V21, P1485; *BNA, 1993, BNA ENV REP CURR DEV, V24, P878; Breyer S.G., 1993, BREAKING VICIOUS CIR, V1st ed.; BRIDGES T, 1990, WASHINGTON POST 0624, pH2; COGLIANESE G, SHIFTING SANDS LIMIT; *EPA, 1989, WAT QUAL IMPR STUD; GREER L, 2002, ENV FORUM        JAN, P28; Harr J., 1995, CIVIL ACTION; HOUCK O, 2002, CLEAN WATER ACT TMDL, P173; Houck OA, 1994, MISS LJ, V63, P403; HOUCK OA, 1991, ENV LAW REGIST, V21, P10551; Houck Oliver, 1991, ENV L REP, V21, P10; Houck Oliver A., 1993, U COLO L REV, V64, P277; Houck OliverA., 2002, CLEAN WATER ACT TMDL; HOWARD P, 1990, HOUSTON POST    1024, pA2; JACKSON DZ, 2003, BOSTON GLOBE    0620, pA15; KURLANSKY M, 1997, COD, P122; Lambrecht Bill, 2003, ST LOUIS POST D 1106, pA1; LATIN H, 1991, ENV L, V21, P1647; Limbaugh Rush, 1992, WAY THINGS OUGGHT BE, V160; MILLER H, 2003, NY TIMES        0807; PERCIVAL R, 2003, ENV REGULATION LAW S, P333; REITZE A, 2001, ENVIRON LAW, V21, P1550; REUKIN AC, 2003, NY TIMES        0619, pA1; REVKIN AC, 2003, NY TIMES        0829, pA11; RODGERS WH, 1992, ENV LAW, V1; RODGERS WH, 1992, ENV LAW, V2; SCHOENBROD D, 1983, UCLA LAW REV, V30, P740; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; TYSON JL, 1994, CHRISTIAN SCI M 0314, P11; TYSON JL, 1979, BATON ROUGE MOR 0525, pB1; WAGAR WE, 1995, COLUMBIA LAW REV, V95, P1613; WILL G, 1998, TIMES PICAYUNE  0223, pB7; 2003, BNA DAILY ENV   1030, pA14; 1986, FED REG, V51, P40572	40	33	34	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1926	1929		10.1126/science.1093758	http://dx.doi.org/10.1126/science.1093758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752NL	14671294				2022-12-28	WOS:000187174000049
J	Kawaguchi, Y; Kovacs, JJ; McLaurin, A; Vance, JM; Ito, A; Yao, TP				Kawaguchi, Y; Kovacs, JJ; McLaurin, A; Vance, JM; Ito, A; Yao, TP			The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress	CELL			English	Article							HISTONE DEACETYLASES; IN-VIVO; PROTEASOME; DISEASE; MICROTUBULES; DEGRADATION; INHIBITOR; TUBULIN; BODIES; DOMAIN	The efficient clearance of cytotoxic misfolded protein aggregates is critical for cell survival. Misfolded protein aggregates are transported and removed from the cytoplasm by dynein motors via the microtubule network to a novel organelle termed the aggresome where they are processed. However, the means by which dynein motors recognize misfolded protein cargo, and the cellular factors that regulate aggresome formation, remain unknown. We have discovered that HDAC6, a microtubule-associated deacetylase, is a component of the aggresome. We demonstrate that HDAC6 has the capacity to bind both polyubiquitinated misfolded proteins and dynein motors, thereby acting to recruit misfolded protein cargo to dynein motors for transport to aggresomes. Indeed, cells deficient in HDAC6 fail to clear misfolded protein aggregates from the cytoplasm, cannot form aggresomes properly, and are hypersensitive to the accumulation of misfolded proteins. These findings identify HDAC6 as a crucial player in the cellular management of misfolded protein-induced stress.	Duke Univ, Dept Pharmcol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Dept Med, Durham, NC 27710 USA; Duke Univ, Ctr Human Genet, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Yao, TP (corresponding author), Duke Univ, Dept Pharmcol & Canc Biol, Durham, NC 27710 USA.		Ito, Akihiro/A-6100-2015		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764] Funding Source: NIH RePORTER; NINDS NIH HHS [NS39764] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hook SS, 2002, P NATL ACAD SCI USA, V99, P13425, DOI 10.1073/pnas.172511699; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McNaught KSP, 2002, EUR J NEUROSCI, V16, P2136, DOI 10.1046/j.1460-9568.2002.02301.x; Plemper RK, 1999, TRENDS BIOCHEM SCI, V24, P266, DOI 10.1016/S0968-0004(99)01420-6; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; THOMAS PJ, 1995, TRENDS BIOCHEM SCI, V20, P456, DOI 10.1016/S0968-0004(00)89100-8; Tran PB, 1999, TRENDS NEUROSCI, V22, P194, DOI 10.1016/S0166-2236(99)01409-5; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wojcik C, 1996, EUR J CELL BIOL, V71, P311; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhao X, 2001, J BIOL CHEM, V276, P35042, DOI 10.1074/jbc.M105086200	26	1146	1198	1	72	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 12	2003	115	6					727	738		10.1016/S0092-8674(03)00939-5	http://dx.doi.org/10.1016/S0092-8674(03)00939-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	755AR	14675537	Bronze			2022-12-28	WOS:000187366100012
J	Salter, MG; Franklin, KA; Whitelam, GC				Salter, MG; Franklin, KA; Whitelam, GC			Gating of the rapid shade-avoidance response by the circadian clock in plants	NATURE			English	Article							APRR1/TOC1 QUINTET; PHYTOCHROME-A; ARABIDOPSIS; PERCEPTION; EXPRESSION; SIGNAL; PATTERNS; GENE	The phytochromes are a family of plant photoreceptor proteins that control several adaptive developmental strategies(1,2). For example, the phytochromes perceive far- red light ( wavelengths between 700 and 800 nm) reflected or scattered from the leaves of nearby vegetation. This provides an early warning of potential shading, and triggers a series of ' shade- avoidance' responses, such as a rapid increase in elongation(3), by which the plant attempts to overgrow its neighbours(3). Other, less immediate, responses include accelerated flowering and early production of seeds. However, little is known about the molecular events that connect light perception with increased growth in shade avoidance. Here we show that the circadian clock gates this rapid shade- avoidance response. It is most apparent around dusk and is accompanied by altered expression of several genes. One of these rapidly responsive genes encodes a basic helix - loop - helix protein, PIL1, previously shown to interact with the clock protein TOC1 ( ref. 4). Furthermore PIL1 and TOC1 are both required for the accelerated growth associated with the shade- avoidance response.	Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England	University of Leicester	Whitelam, GC (corresponding author), Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England.	gcw1@le.ac.uk						Botto JF, 2002, PLANT CELL ENVIRON, V25, P53, DOI 10.1046/j.0016-8025.2001.00812.x; Carabelli M, 1996, P NATL ACAD SCI USA, V93, P3530, DOI 10.1073/pnas.93.8.3530; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Franklin KA, 2003, PLANT PHYSIOL, V131, P1340, DOI 10.1104/pp.102.015487; Hall A, 2001, PLANT PHYSIOL, V127, P1808, DOI 10.1104/pp.010294; Halliday KJ, 2003, PLANT J, V33, P875, DOI 10.1046/j.1365-313X.2003.01674.x; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; JOHNSON E, 1994, PLANT PHYSIOL, V105, P141, DOI 10.1104/pp.105.1.141; KENDRICK RE, 1999, PHOTOMORPHOGENESIS P; Makino S, 2002, PLANT CELL PHYSIOL, V43, P58, DOI 10.1093/pcp/pcf005; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; MORGAN DC, 1980, PLANTA, V150, P95, DOI 10.1007/BF00582351; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Sharrock RA, 2002, PLANT PHYSIOL, V130, P442, DOI 10.1104/pp.005389; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Smith H, 1997, PLANT CELL ENVIRON, V20, P840, DOI 10.1046/j.1365-3040.1997.d01-104.x; Tepperman JM, 2001, P NATL ACAD SCI USA, V98, P9437, DOI 10.1073/pnas.161300998; Toth R, 2001, PLANT PHYSIOL, V127, P1607, DOI 10.1104/pp.010467; Yamashino T, 2003, PLANT CELL PHYSIOL, V44, P619, DOI 10.1093/pcp/pcg078	20	236	258	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					680	683		10.1038/nature02174	http://dx.doi.org/10.1038/nature02174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668869				2022-12-28	WOS:000187132800046
J	Sesso, HD; Buring, JE; Rifai, N; Blake, GJ; Gaziano, JM; Ridker, PM				Sesso, HD; Buring, JE; Rifai, N; Blake, GJ; Gaziano, JM; Ridker, PM			C-reactive protein and the risk of developing hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; INFLAMMATION; HEALTH; COHORT; ATHEROSCLEROSIS; INTERLEUKIN-6; ASSOCIATION; EXPRESSION; PREVENTION	Context Although it has been hypothesized that hypertension is in part an inflammatory disorder, clinical data linking inflammation with incident hypertension are scarce. Objective To examine whether C-reactive protein levels, a marker of systemic inflammation, are associated with incident hypertension. Design, Setting, and Participants A prospective cohort study that began in 1992 of 20525 female US health professionals aged 45 years or older who provided baseline blood samples with initially normal levels of blood pressure (BP) (systolic BP <140 mm Hg and diastolic BP <90 mm Hg, and no history of hypertension or antihypertensive medications) and then followed up for a median of 7.8 years for the development of incident hypertension. Plasma C-reactive protein levels were measured and baseline coronary risk factors were collected. Main Outcome Measure Incident hypertension, defined as either a new physician diagnosis, the initiation of anti hypertensive treatment, or self-reported systolic BP of at least 140 mm Hg or a diastolic BP of at least 90 mm Hg. Results During follow-up, 5365 women developed incident hypertension. In crude models, the relative risks (RRs) and 95% confidence intervals (Cis) of developing hypertension from the lowest (referent) to the highest levels of baseline C-reactive protein were 1.00, 1.25 (95% CI, 1.14-1.40)', 1.51 (95% Cl, 1.35-1.68), 1.90 (95% Cl, 1 ' 72-2.11), and 2.50 (95% Cl, 2.27-2.75) (linear trend P<.001). In fully adjusted models for coronary risk factors, the RRs and 95% Cis were 1.00, 1.07 (95% Cl, 0.95-1.20), 1.17 (95% Cl, 1.04-1.31), 1.30 (95% Cl, 1.17-1.45), and 1.52 (95% Cl, 1.36-1.69) (linear trend P<.001). C-reactive protein was significantly associated with an increased risk of developing hypertension in all prespecified subgroups evaluated, including those with very low levels of baseline BP, as well as those with no traditional coronary risk factors. Similar results were found when treating C-reactive protein as a continuous variable and controlling for baseline BP. Conclusion C- reactive protein levels are associated with future development of hypertension, which suggests that hypertension is in part an inflammatory disorder.	Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Dept Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Donald W Reynolds Ctr Cardiovasc Res, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Childrens Hosp, Dept Lab Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital	Sesso, HD (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Dept Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	hsesso@hsph.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL043851] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bautista LE, 2001, J HYPERTENS, V19, P857, DOI 10.1097/00004872-200105000-00004; Bermudez EA, 2002, ARTERIOSCL THROM VAS, V22, P1668, DOI 10.1161/01.ATV.0000029781.31325.66; Brasier AR, 2002, ARTERIOSCL THROM VAS, V22, P1257, DOI 10.1161/01.ATV.0000021412.56621.A2; Chae CU, 2001, HYPERTENSION, V38, P399, DOI 10.1161/01.HYP.38.3.399; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Cushman M, 1999, CIRCULATION, V100, P717, DOI 10.1161/01.CIR.100.7.717; DAWSON S, 1992, ATHEROSCLEROSIS, V95, P105, DOI 10.1016/0021-9150(92)90014-8; Devaraj S, 2003, CIRCULATION, V107, P398, DOI 10.1161/01.CIR.0000052617.91920.FD; Engstrom G, 2002, ARTERIOSCL THROM VAS, V22, P2054, DOI 10.1161/01.ATV.0000041842.43905.F3; Ford ES, 2000, J CLIN EPIDEMIOL, V53, P95, DOI 10.1016/S0895-4356(99)00143-2; GILES WH, 1995, AM J PREV MED, V11, P163, DOI 10.1016/S0749-3797(18)30468-9; Klag M J, 1993, Ann Epidemiol, V3, P442; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Liuzzo G, 2001, Rays, V26, P221; Meier-Ewert HK, 2001, CLIN CHEM, V47, P426; Ockene IS, 2001, CLIN CHEM, V47, P444; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Poli KA, 2000, CIRCULATION, V101, P264, DOI 10.1161/01.CIR.101.3.264; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 1999, CIRCULATION, V100, P713, DOI 10.1161/01.CIR.100.7.713; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rohde LEP, 1999, AM J CARDIOL, V84, P1018, DOI 10.1016/S0002-9149(99)00491-9; Sesso HD, 2000, HYPERTENSION, V36, P801, DOI 10.1161/01.HYP.36.5.801; Skoog T, 2002, EUR HEART J, V23, P376, DOI 10.1053/euhj.2001.2805; Srikumar N, 2002, AM J HYPERTENS, V15, P683, DOI 10.1016/S0895-7061(02)02952-7; TODD ME, 1992, CAN J PHYSIOL PHARM, V70, P536, DOI 10.1139/y92-069; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; Venugopal SK, 2002, CIRCULATION, V106, P1439, DOI 10.1161/01.CIR.0000033116.22237.F9; Verma S, 2001, Cardiol Rev, V9, P250, DOI 10.1097/00045415-200109000-00003; Verma S, 2002, CIRCULATION, V105, P1890, DOI 10.1161/01.CIR.0000015126.83143.B4; Verma S, 2002, CIRCULATION, V106, P913, DOI 10.1161/01.CIR.0000029802.88087.5E; Wang CH, 2003, CIRCULATION, V107, P1783, DOI 10.1161/01.CIR.0000061916.95736.E5; Yamada S, 2001, AM J EPIDEMIOL, V153, P1183, DOI 10.1093/aje/153.12.1183; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	37	753	797	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2003	290	22					2945	2951		10.1001/jama.290.22.2945	http://dx.doi.org/10.1001/jama.290.22.2945			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751WH	14665655	Bronze			2022-12-28	WOS:000187112700025
J	Bainbridge, WS				Bainbridge, WS			Perceptions of science essay - Privacy and property on the Net: Research questions	SCIENCE			English	Editorial Material									Natl Sci Fdn, Div Informat & Intelligenet Syst, Arlington, VA 22230 USA; Natl Sci Fdn, Directorate Comp & Informat Sci & Engn, Arlington, VA 22230 USA	National Science Foundation (NSF); National Science Foundation (NSF); NSF - Directorate for Computer & Information Science & Engineering (CISE)	Bainbridge, WS (corresponding author), Natl Sci Fdn, Div Informat & Intelligenet Syst, 4201 Wilson Blvd, Arlington, VA 22230 USA.							BAINBRIDGE WS, 2000, SOCIAL SCI DIGITAL W; BAINBRIDGE WS, 2003, IN PRESS ENCY COMMUN; BELL D, 1973, COMING POST IND SOC; Computer Science and Telecommunications Board & National Research Council, 2003, WHO GOES THER AUTH L; ELBOGHDADY D, 2002, WASHINGTON POST 1111, pH1; GANZBROWN CA, 1998, J WORLD INTELLECT PR, V1; *IPS INS, 2003, LEG ISS DONT HIND AM; MADDEN M, 2003, MUSIC DOWNLOADING FI; MCCAA R, 2002, SCAND POP STUD, V13; *NAT RES COUNC COM, 2003, INF TECHN COUNT; *NAT RES COUNC COM, 2000, DIG DIL INT PROP INF; Ogburn W.F., 1922, SOCIAL CHANGE; SCHWARTZ B, 1968, AM J SOCIOL, V73	13	4	5	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1686	1687		10.1126/science.1086471	http://dx.doi.org/10.1126/science.1086471			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657478				2022-12-28	WOS:000186970100025
J	De Cock, KM; Marum, E; Mbori-Ngacha, D				De Cock, KM; Marum, E; Mbori-Ngacha, D			A serostatus-based approach to HIV/AIDS prevention and care in Africa	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; SUB-SAHARAN AFRICA; PUBLIC-HEALTH; HIV EPIDEMIC; RURAL UGANDA; TRANSMISSION; TUBERCULOSIS; PREVALENCE; DISEASE; AIDS		Univ Kenya, Nairobi, Kenya; US Ctr Dis Control & Prevent Kenya, Nairobi, Kenya		De Cock, KM (corresponding author), POB 30137, Nairobi, Kenya.		Abrams, William R/A-5782-2008					Ammann AJ, 2003, BRIT MED J, V326, P1342, DOI 10.1136/bmj.326.7403.1342; BRATTEGAARD K, 1993, AIDS, V7, P883, DOI 10.1097/00002030-199306000-00019; Buve A, 2001, AIDS, V15, pS5, DOI 10.1097/00002030-200108004-00002; Cantwell MF, 1997, INT J TUBERC LUNG D, V1, P205; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Clinton WJ, 2003, NEW ENGL J MED, V348, P1800, DOI 10.1056/NEJMsb023052; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; De Cock KM, 2002, LANCET, V360, P67, DOI 10.1016/S0140-6736(02)09337-6; Frankish H, 2003, LANCET, V362, P297, DOI 10.1016/S0140-6736(03)14007-X; Gayle HD, 2003, NEW ENGL J MED, V348, P1802, DOI 10.1056/NEJMsb030352; Grant AD, 2001, AM J TROP MED HYG, V65, P810, DOI 10.4269/ajtmh.2001.65.810; Gruskin S, 2002, LANCET, V360, P1880, DOI 10.1016/S0140-6736(02)11780-6; *HLTH CAN, 2002, TRANSM HIV MOTH CHIL, P2; *I MED, 1999, RED ODDS PREV PER TR; Janssen RS, 2001, AM J PUBLIC HEALTH, V91, P1019, DOI 10.2105/AJPH.91.7.1019; Joesoef MR, 2003, INT J STD AIDS, V14, P193, DOI 10.1258/095646203762869214; Lewis DK, 2003, T ROY SOC TROP MED H, V97, P91, DOI 10.1016/S0035-9203(03)90035-6; Lucas SB, 1996, BRIT MED J, V312, P335, DOI 10.1136/bmj.312.7027.335; MARUM E, 2002, 14 INT AIDS C BARC S; Pisani E, 2003, BRIT MED J, V326, P1384, DOI 10.1136/bmj.326.7403.1384; Robinson NJ, 1999, INT J STD AIDS, V10, P718, DOI 10.1258/0956462991913394; Stetler HC, 1997, AIDS, V11, P369, DOI 10.1097/00002030-199703110-00015; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/00002030-200306130-00012; Stringer EM, 2001, OBSTET GYNECOL, V98, P1104, DOI 10.1016/S0029-7844(01)01631-3; Talbot EA, 2003, INT J TUBERC LUNG D, V7, P710; Temmerman M, 2003, AIDS, V17, P1239, DOI 10.1097/00002030-200305230-00016; *UNAIDS, 2003, FOLL UP 2001 UN SPEC; *US CDCP, 2002, MMWR-MORBID MORTAL W, V51, P1013; *US CDCP, 1998, MMWR-MORBID MORTAL W, V47, pRR12; Vetter KM, 1996, PEDIATR INFECT DIS J, V15, P438, DOI 10.1097/00006454-199605000-00011; World Health Organization (WHO), 2003, RIGHT KNOW NEW APPR; 2003, LANCET, V361, P539; 2003, NY TIMES        0809	33	100	102	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 29	2003	362	9398					1847	1849		10.1016/S0140-6736(03)14906-9	http://dx.doi.org/10.1016/S0140-6736(03)14906-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654325				2022-12-28	WOS:000186872900026
J	Liao, JC; Beal, DN; Lauder, GV; Triantafyllou, MS				Liao, JC; Beal, DN; Lauder, GV; Triantafyllou, MS			Fish exploiting vortices decrease muscle activity	SCIENCE			English	Article							HYDRODYNAMIC FUNCTION; ONCORHYNCHUS-MYKISS; SWIMMING SPEEDS; LOCOMOTION; SCHOOLS; TROUT; PROPULSION; SALMON; SLOW	Fishes moving through turbulent flows or in formation are regularly exposed to vortices. Although animals living in fluid environments commonly capture energy from vortices, experimental data on the hydrodynamics and neural control of interactions between fish and vortices are lacking. We used quantitative flow visualization and electromyography to show that trout will adopt a novel mode of locomotion to slalom in between experimentally generated vortices by activating only their anterior axial muscles. Reduced muscle activity during vortex exploitation compared with the activity of fishes engaged in undulatory swimming suggests a decrease in the cost of locomotion and provides a mechanism to understand the patterns of fish distributions in schools and riverine environments.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; MIT, Dept Ocean Engn, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT)	Liao, JC (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.							ABRAHAMS MV, 1987, ENVIRON BIOL FISH, V20, P79, DOI 10.1007/BF00002028; ALEXANDER RM, 1989, PHYSIOL REV, V69, P1199, DOI 10.1152/physrev.1989.69.4.1199; Anderson J.M, 1996, THESIS MIT; Belyayev V., 1969, PROBLEMS ICHTHYOLOGY, V9, P578; BOSE N, 1990, PROC R SOC SER B-BIO, V240, P591, DOI 10.1098/rspb.1990.0054; BREDER C. M., 1965, ZOOLOGICA NEW YORK, V50, P97; BREDER CM, 1976, FISH B-NOAA, V74, P471; Drucker EG, 1999, J EXP BIOL, V202, P2393; Drucker EG, 2002, INTEGR COMP BIOL, V42, P243, DOI 10.1093/icb/42.2.243; FAUSCH KD, 1993, CAN J FISH AQUAT SCI, V50, P1198, DOI 10.1139/f93-136; GOLPALKRISHNAN R, 1994, J FLUID MECH, V274, P1, DOI DOI 10.1017/S0022112094002016; Hammond L, 1998, J EXP BIOL, V201, P1659; HARTWELL SI, 1978, T AM FISH SOC, V107, P793, DOI 10.1577/1548-8659(1978)107<793:SPOJMB>2.0.CO;2; Herskin J, 1998, J FISH BIOL, V53, P366, DOI 10.1006/jfbi.1998.0708; Hinch SG, 2000, CAN J FISH AQUAT SCI, V57, P2470, DOI 10.1139/cjfas-57-12-2470; JAYNE BC, 1994, J COMP PHYSIOL A, V175, P123; Liao JC, 2003, J EXP BIOL, V206, P1059, DOI 10.1242/jeb.00209; McGlinchey SM, 2001, COMP BIOCHEM PHYS A, V129, P727, DOI 10.1016/S1095-6433(01)00334-8; Nauen JC, 2002, J EXP BIOL, V205, P1709; PARTRIDGE BL, 1979, NATURE, V279, P418, DOI 10.1038/279418a0; Pavlov D.S., 2000, Journal of Ichthyology, V40, pS232; PITCHER TJ, 1976, SCIENCE, V194, P963, DOI 10.1126/science.982056; Streitlien K, 1996, AIAA J, V34, P2315, DOI 10.2514/3.13396; Webb Paul W., 1998, P3; Webb PW, 1998, J EXP BIOL, V201, P2403; WEIHS D, 1973, NATURE, V241, P290, DOI 10.1038/241290a0; WU TY, 1975, SWIMMING FLYING NATU, V2; Zdravkovich M.M., 1997, FLOW CIRCULAR CYLIND, V1	28	545	571	7	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1566	1569		10.1126/science.1088295	http://dx.doi.org/10.1126/science.1088295			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645849				2022-12-28	WOS:000186802200044
J	Wang, LJ; Fan, C; Topol, SE; Topol, EJ; Wang, Q				Wang, LJ; Fan, C; Topol, SE; Topol, EJ; Wang, Q			Mutation of MEF2A in an inherited disorder with features of coronary artery disease	SCIENCE			English	Article							HEART-DISEASE; MOUSE EMBRYOGENESIS; LINKAGE ANALYSIS; EXPRESSION; CHROMOSOME-2; LINEAGES; SUGGESTS; LOCUS; DEATH	The early genetic pathway(s) triggering the pathogenesis of coronary artery disease (CAD) and myocardial infarction (MI) remain largely unknown. Here, we describe an autosomal dominant form of CAD/MI (adCAD1) that is caused by the deletion of seven amino acids in transcription factor MEF2A. The deletion disrupts nuclear localization of MEF2A, reduces MEF2A-mediated transcription activation, and abolishes synergistic activation by MEF2A and by the transcription factor GATA-1 through a dominant-negative mechanism. The MEF2A protein demonstrates strong expression in the endothelium of coronary arteries. These results identify a pathogenic gene for a familial vascular disease with features of CAD and implicate the MEF2A signaling pathway in the pathogenesis of CAD/MI.	Cleveland Clin Fdn, Ctr Cardiovasc Genet, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Lerner Res Inst, Ctr Mol Genet, Dept Mol Cardiol, Cleveland, OH 44195 USA; Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Med, Cleveland, OH 44195 USA; Case Western Reserve Univ, Cleveland Clin Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Topol, EJ (corresponding author), Cleveland Clin Fdn, Ctr Cardiovasc Genet, Dept Cardiovasc Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.			Topol, Eric/0000-0002-1478-4729	NHLBI NIH HHS [R01 HL065630, R01 HL66251, R01 HL65630, R01 HL066251] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066251, R01HL065630] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Black BL, 1998, MOL CELL BIOL, V18, P69, DOI 10.1128/MCB.18.1.69; Borghi S, 2001, J CELL SCI, V114, P4477; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Firulli AB, 1996, CIRC RES, V78, P196, DOI 10.1161/01.RES.78.2.196; Francke S, 2001, HUM MOL GENET, V10, P2751, DOI 10.1093/hmg/10.24.2751; Harrap SB, 2002, ARTERIOSCL THROM VAS, V22, P874, DOI 10.1161/01.ATV.0000016258.40568.F1; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mao ZX, 1996, J BIOL CHEM, V271, P14371, DOI 10.1074/jbc.271.24.14371; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; NORA JJ, 1980, CIRCULATION, V61, P503, DOI 10.1161/01.CIR.61.3.503; Pajukanta P, 2000, AM J HUM GENET, V67, P1481, DOI 10.1086/316902; SCHILDKRAUT JM, 1989, AM J CARDIOL, V64, P555, DOI 10.1016/0002-9149(89)90477-3; Subramanian SV, 1996, MECH DEVELOP, V57, P103, DOI 10.1016/0925-4773(96)00542-4; WANG Q, 2000, TXB CARDIOVASCULAR M, V3, P1	18	265	308	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1578	1581		10.1126/science.1088477	http://dx.doi.org/10.1126/science.1088477			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645853	Green Accepted			2022-12-28	WOS:000186802200048
J	Webby, RJ; Webster, RG				Webby, RJ; Webster, RG			Are we ready for pandemic influenza?	SCIENCE			English	Review							GUILLAIN-BARRE-SYNDROME; A VIRUSES; TRANSMISSION DYNAMICS; HONG-KONG; VACCINE; SWINE; AGENT; CHINA; SARS; H9N2	During the past year, the public has become keenly aware of the threat of emerging infectious diseases with the global spread of severe acute respiratory syndrome (SARS), the continuing threat of bioterrorism, the proliferation of West Nile virus, and the discovery of human cases of monkeypoxin the United States. At the same time, an old foe has again raised its head, reminding us that our worst nightmare may not be a new one. In 2003, highly pathogenic strains of avian influenza virus, including the H5N1 and H7N7 subtypes, again crossed from birds to humans and caused fatal disease. Direct avian-to-human influenza transmission was unknown before 1997. Have we responded to these threats by better preparing for emerging disease agents, or are we continuing to act only as crises arise? Here we consider progress to date in preparedness for an influenza pandemic and review what remains to be done. We conclude by prioritizing the remaining needs and exploring the reasons for our current lack of preparedness for an influenza pandemic.	St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Webster, RG (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, 332 N Lauderdale St, Memphis, TN 38105 USA.	robert.webster@stjude.org	Webby, Richard J/N-5657-2018		NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095357] Funding Source: NIH RePORTER; NCI NIH HHS [CA-21765] Funding Source: Medline; NIAID NIH HHS [AI95357] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbott A, 2003, NATURE, V423, P5, DOI 10.1038/423005b; ABBOTT A, 2003, NATURE, V424, P123; Enserink M, 2003, SCIENCE, V301, P294, DOI 10.1126/science.301.5631.294; Enserink M, 2003, SCIENCE, V300, P718, DOI 10.1126/science.300.5620.718; Fedson DS, 2003, CLIN INFECT DIS, V36, P1552, DOI 10.1086/375056; Ferguson NM, 2003, J ANTIMICROB CHEMOTH, V51, P977, DOI 10.1093/jac/dkg136; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; KOOPMANS M, 2003, EUROSURVEILL WKLY, V7; Krug RM, 2003, ANTIVIR RES, V57, P147, DOI 10.1016/S0166-3542(02)00207-3; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Liu M, 2003, VIROLOGY, V314, P580, DOI 10.1016/S0042-6822(03)00458-6; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Olsen CW, 2002, VIRUS RES, V85, P199, DOI 10.1016/S0168-1702(02)00027-8; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; ROSCELLI JD, 1991, AM J EPIDEMIOL, V133, P952, DOI 10.1093/oxfordjournals.aje.a115974; SAFRANEK TJ, 1991, AM J EPIDEMIOL, V133, P940, DOI 10.1093/oxfordjournals.aje.a115973; Schabas RE, 2001, CAN MED ASSOC J, V164, P36; Schickli JH, 2001, PHILOS T ROY SOC B, V356, P1965, DOI 10.1098/rstb.2001.0979; Sheldon Tony, 2003, BMJ, V326, P952; Smolinsky M.S., 2003, MICROBIAL THREATS HL; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Stohr K, 2003, VACCINE, V21, P1744, DOI 10.1016/S0264-410X(03)00065-3; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; Tumpey TM, 2002, J VIROL, V76, P6344, DOI 10.1128/JVI.76.12.6344-6355.2002; van Kolfschooten F, 2003, LANCET, V361, P1444, DOI 10.1016/S0140-6736(03)13156-X; *WHO GLOB INFL PRO, IN PRESS WKLY EPIDEM; Wood JM, 2001, PHILOS T R SOC B, V356, P1953, DOI 10.1098/rstb.2001.0981; Wood JM., 1998, TXB INFLUENZA, P317; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999; 2003, WHO DIS ALERT   0219; 2003, PROMED DIGEST   0514; 2003, WHO DIS ALERT   0424	37	468	525	8	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 28	2003	302	5650					1519	1522		10.1126/science.1090350	http://dx.doi.org/10.1126/science.1090350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645836				2022-12-28	WOS:000186802200029
J	Relman, DA				Relman, DA			Shedding light on microbial detection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Med Ctr, Stanford, CA 94305 USA	Stanford University	Relman, DA (corresponding author), Stanford Univ, Med Ctr, Stanford, CA 94305 USA.			Relman, David A./0000-0001-8331-1354				Kovacs GTA, 2003, P IEEE, V91, P915, DOI 10.1109/JPROC.2003.813580; McFadden P, 2002, SCIENCE, V297, P2075, DOI 10.1126/science.297.5589.2075; Rider TH, 2003, SCIENCE, V301, P213, DOI 10.1126/science.1084920	3	14	18	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2003	349	22					2162	2163		10.1056/NEJMcibr035737	http://dx.doi.org/10.1056/NEJMcibr035737			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746ZV	14645646				2022-12-28	WOS:000186779700014
J	Hinds, BJ; Chopra, N; Rantell, T; Andrews, R; Gavalas, V; Bachas, LG				Hinds, BJ; Chopra, N; Rantell, T; Andrews, R; Gavalas, V; Bachas, LG			Aligned multiwalled carbon nanotube membranes	SCIENCE			English	Article							ARRAYS	An array of aligned carbon nanotubes (CNTs) was incorporated across a polymer film to form a well-ordered nanoporous membrane structure. This membrane structure was confirmed by electron microscopy, anisotropic electrical conductivity, gas flow, and ionic transport studies. The measured nitrogen permeance was consistent with the flux calculated by Knudsen diffusion through nanometer-scale tubes of the observed microstructure. Data on Ru(NH3)(6)(3+) transport across the membrane in aqueous solution also indicated transport through aligned CNT cores of the observed microstructure. The lengths of the nanotubes within the polymer film were reduced by selective electrochemical oxidation, allowing for tunable pore lengths. Oxidative trimming processes resulted in carboxylate end groups that were readily functionalized at the entrance to each CNT inner core. Membranes with CNT tips that were functionalized with biotin showed a reduction in Ru(NH3)(6)(3+) flux by a factor of 15 when bound with streptavidin, thereby demonstrating the ability to gate molecular transport through CNT cores for potential applications in chemical separations and sensing.	Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA; Univ Kentucky, Dept Chem, Lexington, KY 40506 USA; Univ Kentucky, Ctr Appl Energy Res, Lexington, KY 40511 USA	University of Kentucky; University of Kentucky; University of Kentucky	Hinds, BJ (corresponding author), Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA.		Nitin, Chopra/F-8236-2011; Bachas, Leonidas G/G-2479-2015	Bachas, Leonidas/0000-0002-3308-6264				Ago H, 2000, APPL PHYS LETT, V77, P79, DOI 10.1063/1.126883; Andrews R, 1999, CHEM PHYS LETT, V303, P467, DOI 10.1016/S0009-2614(99)00282-1; Asefa T, 1999, NATURE, V402, P867, DOI 10.1038/47229; Bahr JL, 2001, CHEM MATER, V13, P3823, DOI 10.1021/cm0109903; Casavant MJ, 2003, J APPL PHYS, V93, P2153, DOI 10.1063/1.1536732; Cheung CL, 2002, J PHYS CHEM B, V106, P2429, DOI 10.1021/jp0142278; Hamon MA, 2002, APPL PHYS A-MATER, V74, P333, DOI 10.1007/s003390201281; Huang SM, 2002, J PHYS CHEM B, V106, P3543, DOI 10.1021/jp014047y; Ito T, 2003, ELECTROCHEM SOLID ST, V6, pC4, DOI 10.1149/1.1526779; Jirage KB, 1997, SCIENCE, V278, P655, DOI 10.1126/science.278.5338.655; Kanzow H, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.125402; Klein E, 2000, J MEMBRANE SCI, V179, P1, DOI 10.1016/S0376-7388(00)00514-7; Lee SB, 2002, SCIENCE, V296, P2198, DOI 10.1126/science.1071396; Merkulov VI, 2002, APPL PHYS LETT, V80, P4816, DOI 10.1063/1.1487920; Miller SA, 2002, J ELECTROANAL CHEM, V522, P66, DOI 10.1016/S0022-0728(02)00648-4; Nguyen CV, 2002, NANO LETT, V2, P1079, DOI 10.1021/nl025689f; Pages X, 2001, SEP PURIF TECHNOL, V25, P399, DOI 10.1016/S1383-5866(01)00068-5; Qian D, 2000, APPL PHYS LETT, V76, P2868, DOI 10.1063/1.126500; Ren ZF, 1998, SCIENCE, V282, P1105, DOI 10.1126/science.282.5391.1105; Steinle ED, 2002, ANAL CHEM, V74, P2416, DOI 10.1021/ac020024j; Sun L, 2000, J AM CHEM SOC, V122, P12340, DOI 10.1021/ja002429w; Thurn-Albrecht T, 2000, ADV MATER, V12, P787, DOI 10.1002/(SICI)1521-4095(200006)12:11<787::AID-ADMA787>3.0.CO;2-1; WIPF DO, 1988, ANAL CHEM, V60, P306, DOI 10.1021/ac00155a006; Zhang ZJ, 2000, APPL PHYS LETT, V77, P3764, DOI 10.1063/1.1330751	24	1129	1186	18	836	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 2	2004	303	5654					62	65		10.1126/science.1092048	http://dx.doi.org/10.1126/science.1092048			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	758YU	14645855				2022-12-28	WOS:000187710600031
J	Jefferson, T; Shashok, K; Wager, E				Jefferson, T; Shashok, K; Wager, E			Get peered!	BRITISH MEDICAL JOURNAL			English	Article									C Compositor Ruiz, Granada 18008, Spain		Jefferson, T (corresponding author), Via Adige 28A, I-00061 Sabazia, Italy.								0	2	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1439	1441		10.1136/bmj.327.7429.1439	http://dx.doi.org/10.1136/bmj.327.7429.1439			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684639	Green Published			2022-12-28	WOS:000187562700010
J	File, TM				File, TM			Community-acquired pneumonia	LANCET			English	Review							RESISTANT STREPTOCOCCUS-PNEUMONIAE; POLYMERASE-CHAIN-REACTION; LOW-RISK PATIENTS; RAPID IMMUNOCHROMATOGRAPHIC ASSAY; LOWER RESPIRATORY-INFECTION; LENGTH-OF-STAY; CHLAMYDIA-PNEUMONIAE; MYCOPLASMA-PNEUMONIAE; ANTIMICROBIAL THERAPY; MACROLIDE RESISTANCE	This seminar reviews important features and management issues of community-acquired pneumonia (CAP) that are especially relevant to immunocompetent adults in light of new information about cause, clinical course, diagnostic testing, treatment, and prevention. Streptococcus pneumoniae remains the most important pathogen; however, emerging, resistance of this organism to antimicrobial agents has affected empirical treatment of CAP. Atypical pathogens have been quite commonly identified in several prospective studies. The clinical significance of these pathogens (with the exception of Legionella spp) is not clear, partly because of the lack of rapid, standardised tests. Diagnostic evaluation of CAP is important for appropriate assessment of severity of illness and for establishment of the causative agent in the disease. Until better rapid diagnostic methods are developed, most patients will be treated empirically. Antimicrobials continue to be the mainstay of treatment, and decisions about specific agents are guided by several considerations that include spectrum of activity, and pharmacokinetic and pharmacodynamic principles. Several factors have been shown to be associated with a beneficial clinical outcome in patients with CAP. These factors include administration of antimicrobials in a timely manner, choice of antibiotic therapy, and the use of a critical pneumonia pathway. The appropriate use of vaccines against pneumococcal disease and influenza should be encouraged. Several guidelines for management of CAP have recently been published, the recommendations of which are reviewed.	Summa Hlth Syst, Infect Dis Serv, Akron, OH USA; Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Rootstown, OH 44272 USA	Summa Health System; Northeast Ohio Medical University (NEOMED)	File, TM (corresponding author), 75 Arch St,Suite 105, Akron, OH 44304 USA.	filet@summa-health.org						Amsden GW, 1999, J ANTIMICROB CHEMOTH, V44, P1, DOI 10.1093/jac/44.1.1; Angus DC, 2002, AM J RESP CRIT CARE, V166, P717, DOI 10.1164/rccm.2102084; Arancibia F, 2002, ARCH INTERN MED, V162, P1849, DOI 10.1001/archinte.162.16.1849; Aronsky D, 2001, MED CLIN N AM, V85, P1397, DOI 10.1016/S0025-7125(05)70387-4; Atlas SJ, 1998, ARCH INTERN MED, V158, P1350, DOI 10.1001/archinte.158.12.1350; Auble TE, 1998, INFECT DIS CLIN N AM, V12, P741, DOI 10.1016/S0891-5520(05)70208-7; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; Battleman DS, 2002, ARCH INTERN MED, V162, P682, DOI 10.1001/archinte.162.6.682; Benenson R, 1999, ACAD EMERG MED, V6, P1243, DOI 10.1111/j.1553-2712.1999.tb00140.x; Bishai W, 2002, J ANTIMICROB CHEMOTH, V49, P433, DOI 10.1093/jac/49.3.433; Bochud PY, 2001, MEDICINE, V80, P75, DOI 10.1097/00005792-200103000-00001; BRATZLER DW, 2001, ANN EMERG MED S, V38, pS36; Brown PD, 1998, LANCET, V352, P1295, DOI 10.1016/S0140-6736(98)02239-9; Burel E, 2001, EUR J CLIN MICROBIOL, V20, P840, DOI 10.1007/s100960100614; Campbell GD, 1998, CLIN INFECT DIS, V26, P1188, DOI 10.1086/520286; Campbell SG, 2003, CHEST, V123, P1142, DOI 10.1378/chest.123.4.1142; *CDCP, 2002, MMWR MORB MORTAL WEE, V51; Chan S S, 2001, Eur J Emerg Med, V8, P279, DOI 10.1097/00063110-200112000-00006; Chen DK, 1999, NEW ENGL J MED, V341, P233, DOI 10.1056/NEJM199907223410403; Coley CM, 1996, ARCH INTERN MED, V156, P1565, DOI 10.1001/archinte.156.14.1565; Cornu C, 2001, VACCINE, V19, P4780, DOI 10.1016/S0264-410X(01)00217-1; Davidson R, 2002, NEW ENGL J MED, V346, P747, DOI 10.1056/NEJMoa012122; DEAN NC, 2001, AM J MED, V110, P541; Dedier J, 2001, ARCH INTERN MED, V161, P2099, DOI 10.1001/archinte.161.17.2099; Dobbin CJ, 2001, MED J AUSTRALIA, V174, P333, DOI 10.5694/j.1326-5377.2001.tb143307.x; Doern GV, 2001, ANTIMICROB AGENTS CH, V45, P1721, DOI 10.1128/AAC.45.6.1721-1729.2001; Dominguez J, 2001, CHEST, V119, P243, DOI 10.1378/chest.119.1.243; Dorca J, 1997, Arch Bronconeumol, V33, P240; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Dudas V, 2000, ANN PHARMACOTHER, V34, P446, DOI 10.1345/aph.19174; Ewig S, 2002, CHEST, V121, P1486, DOI 10.1378/chest.121.5.1486; Ewig S, 1998, AM J RESP CRIT CARE, V158, P1102, DOI 10.1164/ajrccm.158.4.9803114; Falguera M, 2001, ARCH INTERN MED, V161, P1866, DOI 10.1001/archinte.161.15.1866; Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223; Felmingham D, 2002, J INFECTION, V44, P3, DOI 10.1053/jinf.2001.0939; File TM, 1999, CLIN INFECT DIS, V29, P426, DOI 10.1086/520227; File TM, 1998, INFECT DIS CLIN N AM, V12, P569, DOI 10.1016/S0891-5520(05)70199-9; File TM, 2003, CLIN INFECT DIS, V36, P396, DOI 10.1086/367545; File TM, 2002, INT J ANTIMICROB AG, V20, P235, DOI 10.1016/S0924-8579(02)00130-9; File TM, 2002, CLIN INFECT DIS, V34, pS17, DOI 10.1086/324526; Fine MJ, 1999, ARCH INTERN MED, V159, P970, DOI 10.1001/archinte.159.9.970; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Fogarty C, 2000, CLIN INFECT DIS, V31, P613, DOI 10.1086/313976; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; Garau J, 2002, LANCET INFECT DIS, V2, P404, DOI 10.1016/S1473-3099(02)00316-X; Gardner P, 2002, CLIN INFECT DIS, V35, P503, DOI 10.1086/341965; Gleason PP, 1999, ARCH INTERN MED, V159, P2562, DOI 10.1001/archinte.159.21.2562; Glerant JC, 1999, RESP MED, V93, P208, DOI 10.1016/S0954-6111(99)90010-0; *GUID INF DIS FREN, 2001, MED MALADIES INFECT, V31, P357; Gutierrez F, 2003, CLIN INFECT DIS, V36, P286, DOI 10.1086/345852; Halm EA, 2002, ARCH INTERN MED, V162, P1278, DOI 10.1001/archinte.162.11.1278; Hedlund J, 2002, SCAND J INFECT DIS, V34, P887, DOI 10.1080/0036554021000026965; Heffelfinger JD, 2000, ARCH INTERN MED, V160, P1399, DOI 10.1001/archinte.160.10.1399; Ho PL, 2001, J ANTIMICROB CHEMOTH, V48, P659, DOI 10.1093/jac/48.5.659; Ho PL, 2001, CLIN INFECT DIS, V32, P701, DOI 10.1086/319222; Hoban DJ, 2001, CLIN INFECT DIS, V32, pS81, DOI 10.1086/320181; Houck PM, 2001, CHEST, V119, P1420, DOI 10.1378/chest.119.5.1420; Hyde TB, 2001, JAMA-J AM MED ASSOC, V286, P1857, DOI 10.1001/jama.286.15.1857; Ishida T, 2001, INTERNAL MED, V40, P873, DOI 10.2169/internalmedicine.40.873; Jacobs MR, 2003, J ANTIMICROB CHEMOTH, V52, P229, DOI 10.1093/jac/dkg321; Jokinen C, 2001, CLIN INFECT DIS, V32, P1141, DOI 10.1086/319746; Kalin M, 2000, J INFECT DIS, V182, P840, DOI 10.1086/315760; Kays MB, 2002, PHARMACOTHERAPY, V22, P395, DOI 10.1592/phco.22.5.395.33185; Kelley MA, 2000, CLIN INFECT DIS, V31, P1008, DOI 10.1086/318157; Kirk O, 2001, DAN MED BULL, V48, P84; Klugman K P, 2001, Lancet Infect Dis, V1, P85, DOI 10.1016/S1473-3099(01)00063-9; Klugman KP, 2001, CURR OPIN INFECT DIS, V14, P173, DOI 10.1097/00001432-200104000-00011; Korsgaard J, 2002, RESP MED, V96, P344, DOI 10.1053/rmed.2001.1262; Leclercq R, 2002, ANTIMICROB AGENTS CH, V46, P2727, DOI 10.1128/AAC.46.9.2727-2734.2002; Leclercq R, 2001, J ANTIMICROB CHEMOTH, V48, P9, DOI 10.1093/jac/48.suppl_2.9; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Lonks JR, 2002, CLIN INFECT DIS, V35, P556, DOI 10.1086/341978; Luna CM, 2001, ARCH BRONCONEUMOL, V37, P340; Luna CM, 2000, CHEST, V118, P1344, DOI 10.1378/chest.118.5.1344; Lynch JP, 2002, CLIN INFECT DIS, V34, pS27, DOI 10.1086/324527; Mandell LA, 2003, CLIN INFECT DIS, V37, P1405, DOI 10.1086/380488; Mandell Lionel A., 2000, Clinical Infectious Diseases, V31, P383, DOI 10.1086/313959; Marras TK, 2000, CHEST, V118, P1339, DOI 10.1378/chest.118.5.1339; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; Martinez JA, 2003, CLIN INFECT DIS, V36, P389, DOI 10.1086/367541; Marx A, 1999, CLIN INFECT DIS, V29, P134, DOI 10.1086/520142; McGee L, 2002, J ANTIMICROB CHEMOTH, V49, P173, DOI 10.1093/jac/49.1.173; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Menendez R, 1999, AM J RESP CRIT CARE, V159, P1868, DOI 10.1164/ajrccm.159.6.9807070; Menendez R, 2002, CHEST, V122, P612, DOI 10.1378/chest.122.2.612; Metersky ML, 2002, CURR OPIN INFECT DIS, V15, P169, DOI 10.1097/00001432-200204000-00012; Metlay JP, 2000, CLIN INFECT DIS, V30, P520, DOI 10.1086/313716; Metlay JP, 1997, JAMA-J AM MED ASSOC, V278, P1440, DOI 10.1001/jama.278.17.1440; Metlay JP, 2003, ANN INTERN MED, V138, P109, DOI 10.7326/0003-4819-138-2-200301210-00012; Metlay JP, 2002, CURR OPIN INFECT DIS, V15, P163, DOI 10.1097/00001432-200204000-00011; Metlay JP, 1998, RESP MED, V92, P1137, DOI 10.1016/S0954-6111(98)90408-5; Miyashita N, 2001, CHEST, V119, P1295, DOI 10.1378/chest.119.4.1295-a; Moroney JF, 2001, CLIN INFECT DIS, V33, P797, DOI 10.1086/322623; Mortensen EM, 2002, ARCH INTERN MED, V162, P1059, DOI 10.1001/archinte.162.9.1059; Murdoch DR, 2001, J CLIN MICROBIOL, V39, P3495, DOI 10.1128/JCM.39.10.3495-3498.2001; Musher DM, 2002, NEW ENGL J MED, V346, P630, DOI 10.1056/NEJM200202213460820; Musher DM, 2001, ARCH INTERN MED, V161, P2538, DOI 10.1001/archinte.161.21.2538; Nathwani D, 2001, CLIN INFECT DIS, V32, P728, DOI 10.1086/319216; Niederman MS, 1998, CLIN THER, V20, P820, DOI 10.1016/S0149-2918(98)80144-6; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Nishijima T, 1999, J ANTIMICROB CHEMOTH, V43, P637, DOI 10.1093/jac/43.5.637; Nuorti JP, 2000, NEW ENGL J MED, V342, P681, DOI 10.1056/NEJM200003093421002; Park DR, 2001, J INFECT DIS, V184, P268, DOI 10.1086/322040; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Ramirez JA, 1996, DIAGN MICR INFEC DIS, V24, P7, DOI 10.1016/0732-8893(95)00254-5; Ramirez JA, 2001, ARCH INTERN MED, V161, P848, DOI 10.1001/archinte.161.6.848; Rhew DC, 1998, CHEST, V113, P142, DOI 10.1378/chest.113.1.142; Rhew DC, 2001, ANN INTERN MED, V135, P736, DOI 10.7326/0003-4819-135-8_Part_2-200110161-00013; Rhew DC, 2001, ARCH INTERN MED, V161, P722, DOI 10.1001/archinte.161.5.722; Richter SS, 2002, CLIN INFECT DIS, V34, P330, DOI 10.1086/338065; Rodvold KA, 1997, ANTIMICROB AGENTS CH, V41, P1399, DOI 10.1128/AAC.41.6.1399; Roson B, 2000, CLIN INFECT DIS, V31, P869, DOI 10.1086/318151; Ruiz-Gonzalez A, 1999, AM J MED, V106, P385, DOI 10.1016/S0002-9343(99)00050-9; Scott JAG, 1999, CHEST, V116, P1716, DOI 10.1378/chest.116.6.1716; Scott JAG, 2000, LANCET, V355, P1225, DOI 10.1016/S0140-6736(00)02089-4; Siegel RE, 1999, CHEST, V116, P535, DOI 10.1378/chest.116.2.535; Stahl JE, 1999, ARCH INTERN MED, V159, P2576, DOI 10.1001/archinte.159.21.2576; Stout JE, 1997, NEW ENGL J MED, V337, P682, DOI 10.1056/NEJM199709043371006; Syrjala H, 1998, CLIN INFECT DIS, V27, P358, DOI 10.1086/514675; Tan MJ, 2002, CLIN INFECT DIS, V35, P533, DOI 10.1086/341771; *TASK FORC CAP, 1998, PPGG ID PHIL SOC MIC, V1; Theerthakarai R, 2001, CHEST, V119, P181, DOI 10.1378/chest.119.1.181; Tong CYW, 1999, J CLIN PATHOL, V52, P257, DOI 10.1136/jcp.52.4.257; Vergis EN, 2000, SEMIN RESP CRIT CARE, V21, P295, DOI 10.1055/s-2000-9934; VOGEL F, 2000, CHEMOTHERAPIE J, V9, P3; Watanabe H, 2000, Respirology, V5, P59, DOI 10.1046/j.1440-1843.2000.00227.x; Waterer GW, 1999, CHEST, V116, P1278, DOI 10.1378/chest.116.5.1278; Waterer GW, 2001, AM J MED, V110, P41, DOI 10.1016/S0002-9343(00)00624-0; Waterer GW, 2001, ARCH INTERN MED, V161, P1837, DOI 10.1001/archinte.161.15.1837; Wattanathum A, 2003, CHEST, V123, P1512, DOI 10.1378/chest.123.5.1512; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Wipf JE, 1999, ARCH INTERN MED, V159, P1082, DOI 10.1001/archinte.159.10.1082; Working Groups of the South African Pulmonology Society, 1996, South African Medical Journal, V86, P1152; Wunderink RG, 2001, CHEST, V119, P5, DOI 10.1378/chest.119.1.5; Yanagihara K, 2001, INT J ANTIMICROB AG, V18, pS45, DOI 10.1016/S0924-8579(01)00402-2; Yu VL, 2002, J INFECT DIS, V186, P127, DOI 10.1086/341087; 2000, THERAPEUTIC GUIDELIE	141	352	370	1	30	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2003	362	9400					1991	2001		10.1016/S0140-6736(03)15021-0	http://dx.doi.org/10.1016/S0140-6736(03)15021-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683661	Green Published, Bronze			2022-12-28	WOS:000187210700023
J	Hotopf, M; David, AS; Hull, L; Nikalaou, V; Unwin, C; Wessely, S				Hotopf, M; David, AS; Hull, L; Nikalaou, V; Unwin, C; Wessely, S			Gulf War illness - better, worse, or just the same? A cohort study	BRITISH MEDICAL JOURNAL			English	Article							HEALTH SURVEY SF-36; SELF-REPORTED SYMPTOMS; VETERANS; EXPOSURES; MORTALITY; TESTS	Objectives Firstly, to describe changes in the health of Gulf war veterans studied in a previous occupational cohort study and to compare outcome with comparable non-deployed military personnel. Secondly, to determine whether differences in prevalence between Gulf veterans and controls at follow up can be explained by greater persistence or greater incidence of disorders. Design Occupational cohort study in the form of a postal survey. Participants Military personnel who served in the 1991 Persian Gulf war; personnel who served on peacekeeping duties to Bosnia; military personnel who were deployed elsewhere ("Era" controls). All participants had responded to a previous survey. Setting United Kingdom. Main outcome measures Self reported fatigue measured on the Chalder fatigue scale; psychological distress measured on the general health questionnaire, physical functioning and health perception on the SF-36; and a count of physical symptoms. Results Gulf war veterans experienced a modest reduction in prevalence of fatigue (48.8% at stage 1, 43.4% at stage 2) and psychological distress (40.0% stage 1, 37.1% stage 2) but a slight worsening of physical functioning on the SF-36 (90.3 stage 1, 88.7 stage 2). Compared with the other cohorts Gulf veterans continued to experience poorer health on all outcomes, although physical functioning also declined in Bosnia veterans. Era controls showed both lower incidence of fatigue than Gulf veterans, and both comparison groups-showed less persistence of fatigue compared with Gulf veterans. Conclusions Gulf war veterans remain a group with many symptoms of ill health. The excess of illness at follow up is explained by both higher incidence and greater persistence of symptoms.	Guys Kings & St Thomass Sch Med, Dept Psychol Med, Gulf War Illnesses Res Unit, London SE5 8AZ, England	University of London; King's College London	Hotopf, M (corresponding author), Guys Kings & St Thomass Sch Med, Dept Psychol Med, Gulf War Illnesses Res Unit, London SE5 8AZ, England.		Wessely, Simon C/A-8713-2008; Hotopf, Matthew/E-4971-2010; David, Anthony/O-1750-2019; David, Anthony S/C-1315-2011	David, Anthony/0000-0003-0967-774X; David, Anthony S/0000-0003-0967-774X; Wessely, Simon Charles/0000-0002-6743-9929; Hotopf, Matthew/0000-0002-3980-4466				CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Cherry N, 2001, OCCUP ENVIRON MED, V58, P291, DOI 10.1136/oem.58.5.291; David AS, 2002, PSYCHOL MED, V32, P1357, DOI 10.1017/S0033291702006359; Fukuda K, 1998, JAMA-J AM MED ASSOC, V280, P981, DOI 10.1001/jama.280.11.981; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Gray GC, 1999, AM J TROP MED HYG, V60, P758, DOI 10.4269/ajtmh.1999.60.758; Gray GC, 2002, AM J EPIDEMIOL, V155, P1033, DOI 10.1093/aje/155.11.1033; Kang HK, 1996, NEW ENGL J MED, V335, P1498, DOI 10.1056/NEJM199611143352006; Macfarlane GJ, 2000, LANCET, V356, P17, DOI 10.1016/S0140-6736(00)02428-4; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Proctor SP, 1998, INT J EPIDEMIOL, V27, P1000, DOI 10.1093/ije/27.6.1000; SCHEFFE H, 1953, BIOMETRIKA, V40, P87, DOI 10.1093/biomet/40.1-2.87; Sharief MK, 2002, NEUROLOGY, V59, P1518, DOI 10.1212/01.WNL.0000032755.27372.FC; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Unwin C, 1999, LANCET, V353, P169, DOI 10.1016/S0140-6736(98)11338-7; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; 1998, HLTH STUDY CANADIAN	18	62	65	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1370	1372A		10.1136/bmj.327.7428.1370	http://dx.doi.org/10.1136/bmj.327.7428.1370			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755PL	14670878	Green Published, Bronze			2022-12-28	WOS:000187417900015
J	Sreenivasan, G				Sreenivasan, G			Does informed consent to research require comprehension?	LANCET			English	Editorial Material							THERAPEUTIC MISCONCEPTION		Univ Toronto, Dept Philosophy, Toronto, ON M5S 1A1, Canada	University of Toronto	Sreenivasan, G (corresponding author), Univ Toronto, Dept Philosophy, Toronto, ON M5S 1A1, Canada.	gopal.sreenivasan@utoronto.ca						30Beauchamp T. L., 2001, PRINCIPLES BIOMEDICA, P77; [Anonymous], 1996, JAMA-J AM MED ASSOC, V276, P1691; [Anonymous], 1979, BELM REP; [Anonymous], 1986, HIST THEORY INFORM C; APPELBAUM PS, 1982, INT J LAW PSYCHIAT, V5, P319, DOI 10.1016/0160-2527(82)90026-7; APPELBAUM PS, 1987, HASTINGS CENT REP, V17, P20, DOI 10.2307/3562038; BENSON PR, 1985, SOC SCI MED, V20, P1331, DOI 10.1016/0277-9536(85)90388-0; BERG JW, 2001, INFORMED CONSENT LEG; BROCK D, 1993, LIFE DEATH PHILOS ES, P21; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; GEUSS R, 1981, IDEA CRITICAL THEORY, pCH2; Griffin James, 1986, WELL BEING; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; Katz J., 1984, SILENT WORLD DOCTOR; LEVINE RJ, 1988, ETHICS REGULATION CL, P95; Lidz CW, 2002, MED CARE, V40, P55, DOI 10.1097/01.MLR.0000023956.25813.18; MILL JS, 1978, ON LIBERTY; Schneider C.E., 1998, PRACTICE AUTONOMY; Sugarman J, 1999, Hastings Cent Rep, V29, pS1, DOI 10.2307/3528546; Truog RD, 1999, NEW ENGL J MED, V340, P804, DOI 10.1056/NEJM199903113401013; *WORLD MED ASS, 2000, JAMA-J AM MED ASSOC, V284, P3044	21	90	90	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 13	2003	362	9400					2016	2018		10.1016/S0140-6736(03)15025-8	http://dx.doi.org/10.1016/S0140-6736(03)15025-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	753BC	14683665				2022-12-28	WOS:000187210700027
J	Lyuksyutova, AI; Lu, CC; Milanesio, N; King, LA; Guo, NN; Wang, YS; Nathans, J; Tessier-Lavigne, M; Zou, YM				Lyuksyutova, AI; Lu, CC; Milanesio, N; King, LA; Guo, NN; Wang, YS; Nathans, J; Tessier-Lavigne, M; Zou, YM			Anterior-posterior guidance of commissural Axons by Wnt-frizzled signaling	SCIENCE			English	Article							SONIC HEDGEHOG; SPINAL-CORD; FLOOR PLATE; CHEMOATTRACTANT; MECHANISMS; NETRIN-1; RECEPTOR	Commissural neurons in the mammalian dorsal spinal cord send axons ventrally toward the floor plate, where they cross the midline and turn anteriorly toward the brain; a gradient of chemoattractant(s) inside the spinal cord controls this turning. In rodents, several Wnt proteins stimulate the extension of commissural axons after midline crossing (postcrossing). We found that Wnt4 messenger RNA is expressed in a decreasing anterior-to-posterior gradient in the floor plate, and that a directed source of Wnt4 protein attracted postcrossing commissural axons. Commissural axons in mice lacking the Wnt receptor Frizzled3 displayed anterior-posterior guidance defects after midline crossing. Thus, Wnt-Frizzled signaling guides commissural axons along the anterior-posterior axis of the spinal cord.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Univ Chicago, Comm Dev Biol, Chicago, IL 60637 USA; Univ Chicago, Comm Neurobiol, Chicago, IL 60637 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Ophthalmol, Baltimore, MD 21205 USA; Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA	University of Chicago; University of Chicago; University of Chicago; Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Stanford University	Zou, YM (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.	yzou@bsd.uchicago.edu		Nathans, Jeremy/0000-0001-8106-5460	NINDS NIH HHS [R01 NS047484] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047484] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Liu AP, 2000, MECH DEVELOP, V91, P409, DOI 10.1016/S0925-4773(99)00308-1; LYUKSYUTOVA AI, UNPUB; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang YS, 2002, J NEUROSCI, V22, P8563; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	16	443	451	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1984	1988		10.1126/science.1089610	http://dx.doi.org/10.1126/science.1089610			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671310				2022-12-28	WOS:000187174000067
J	Robbins, GK; De Gruttola, V; Shafer, RW; Smeaton, LM; Snyder, SW; Pettinelli, C; Dube, MP; Fischl, MA; Pollard, RB; Delapenha, R; Gedeon, L; van der Horst, C; Murphy, RL; Becker, MI; D'Aquila, RT; Vella, S; Merigan, TC; Hirsch, MS; Nokta, M; Johnson, V; Morse, G; Putnam, B; Klebert, M; Martinez, A; Chiesi, A; Tomino, C; Deeks, S; Testa, M; Nevin, T; Levin, J; French, V; Fennell, O; Stevens, M; Grosso, R; Dusak, B; Hodder, S; Squibb, M; Brothers, C; Tolson, J; Leavitt, R; Manion, D; Ruiz, N; Morrisey, K; Quart, B; Jennings, C; Dascomb, S; Cooper, M; Murphy, M; Blakelock, K; Doolan, A				Robbins, GK; De Gruttola, V; Shafer, RW; Smeaton, LM; Snyder, SW; Pettinelli, C; Dube, MP; Fischl, MA; Pollard, RB; Delapenha, R; Gedeon, L; van der Horst, C; Murphy, RL; Becker, MI; D'Aquila, RT; Vella, S; Merigan, TC; Hirsch, MS; Nokta, M; Johnson, V; Morse, G; Putnam, B; Klebert, M; Martinez, A; Chiesi, A; Tomino, C; Deeks, S; Testa, M; Nevin, T; Levin, J; French, V; Fennell, O; Stevens, M; Grosso, R; Dusak, B; Hodder, S; Squibb, M; Brothers, C; Tolson, J; Leavitt, R; Manion, D; Ruiz, N; Morrisey, K; Quart, B; Jennings, C; Dascomb, S; Cooper, M; Murphy, M; Blakelock, K; Doolan, A		AIDS Clin Trials Group 384 Team	Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-TRIALS; SUPPRESSION; ZIDOVUDINE; LAMIVUDINE; INDINAVIR	BACKGROUND: The optimal sequencing of antiretroviral regimens for the treatment of infection with human immunodeficiency virus type 1 (HIV-1) is unknown. We compared several different antiretroviral treatment strategies. METHODS: This multicenter, randomized, partially double-blind trial used a factorial design to compare pairs of sequential three-drug regimens, starting with a regimen including zidovudine and lamivudine or a regimen including didanosine and stavudine in combination with either nelfinavir or efavirenz. The primary end point was the length of time to the failure of the second three-drug regimen. RESULTS: A total of 620 subjects who had not previously received antiretroviral therapy were followed for a median of 2.3 years. Starting with a three-drug regimen containing efavirenz combined with zidovudine and lamivudine (but not efavirenz combined with didanosine and stavudine) appeared to delay the failure of the second regimen, as compared with starting with a regimen containing nelfinavir (hazard ratio for failure of the second regimen, 0.71; 95 percent confidence interval, 0.48 to 1.06), as well as to delay the second virologic failure (hazard ratio, 0.56; 95 percent confidence interval, 0.29 to 1.09), and significantly delayed the failure of the first regimen (hazard ratio, 0.39) and the first virologic failure (hazard ratio, 0.34). Starting with zidovudine and lamivudine combined with efavirenz (but not zidovudine and lamivudine combined with nelfinavir) appeared to delay the failure of the second regimen, as compared with starting with didanosine and stavudine (hazard ratio, 0.68), and significantly delayed both the first and the second virologic failures (hazard ratio for the first virologic failure, 0.39; hazard ratio for the second virologic failure, 0.47), as well as the failure of the first regimen (hazard ratio, 0.35). The initial use of zidovudine, lamivudine, and efavirenz resulted in a shorter time to viral suppression. CONCLUSIONS: The efficacy of antiretroviral drugs depends on how they are combined. The combination of zidovudine, lamivudine, and efavirenz is superior to the other antiretroviral regimens used as initial therapy in this study.	Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Stanford Univ, Med Ctr, Stanford, CA 94305 USA; Social & Sci Syst, Silver Spring, MD USA; NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; Indiana Univ, Sch Med, Indianapolis, IN USA; Univ Miami, Sch Med, Miami, FL USA; Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; Howard Univ, Washington, DC 20059 USA; Frontier Sci & Technol Res Fdn Inc, Amherst, NY USA; Univ N Carolina, Sch Med, Chapel Hill, NC USA; Northwestern Univ, Chicago, IL 60611 USA; Agouron Pharmaceut, La Jolla, CA USA; Vanderbilt Univ, Med Ctr, Nashville, TN USA; Ist Super Sanita, I-00161 Rome, Italy	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Stanford University; Social & Scientific Systems; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Indiana University System; Indiana University-Purdue University Indianapolis; University of Miami; University of California System; University of California Davis; Howard University; Frontier Science Foundation; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Northwestern University; Pfizer; Vanderbilt University; Istituto Superiore di Sanita (ISS)	Robbins, GK (corresponding author), Massachusetts Gen Hosp, Infect Dis Unit, 55 Fruit St, Boston, MA 02114 USA.		Becker, María/R-8252-2019; Tomino, Carlo/AAA-7478-2021; Testa, Marianna/L-9768-2019; VELLA, STEFANO/V-8440-2019; Vella, Stefano/GZM-0519-2022; Robbins, Gregory/F-7988-2011; VELLA, STEFANO/ABI-3368-2020; Merigan, Thomas/AGQ-7464-2022; Johnson, Victoria/GVU-7127-2022	VELLA, STEFANO/0000-0003-2347-5984; Robbins, Gregory/0000-0001-7545-5817; Murphy, Robert/0000-0003-3936-2052	NCRR NIH HHS [M01 RR000070, RR00052, M01 RR000052, RR00070, RR05096, M01 RR005096, RR00044, M01 RR000044] Funding Source: Medline; NIAID NIH HHS [AI38858, U01 AI038855, AI38855, R01 AI046148, U01 AI038858] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000070, M01RR005096, M01RR000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI038855, U01AI038858, R01AI046148] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agresti A., 1990, CATEGORICAL DATA ANA, P165; CASELLA G, 2002, STAT INFERENCE, P521; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; COX DR, 1984, ANAL SURVIVAL DATA, P97; *DIV AIDS, 1992, DIV AIDS TABL GRAD S; Gulick RM, 2000, ANN INTERN MED, V133, P35, DOI 10.7326/0003-4819-133-1-200007040-00007; Havlir DV, 2001, AIDS, V15, P1379, DOI 10.1097/00002030-200107270-00007; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; POZNIAK A, 2003, HIV MED S, V4, pS1; Shafer RW, 2003, NEW ENGL J MED, V349, P2304, DOI 10.1056/NEJMoa030265; Smeaton LM, 2001, CONTROL CLIN TRIALS, V22, P142, DOI 10.1016/S0197-2456(00)00126-4; Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501; Walker UA, 2002, AIDS, V16, P2165, DOI 10.1097/00002030-200211080-00009; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222	16	274	283	0	8	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					2293	2303		10.1056/NEJMoa030264	http://dx.doi.org/10.1056/NEJMoa030264			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668455	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000187125000005
J	Cuzick, J; Szarewski, A; Cubie, H; Hulman, G; Kitchener, H; Luesley, D; McGoogan, E; Menon, U; Terry, G; Edwards, R; Brooks, C; Desai, M; Gie, C; Ho, L; Jacobs, I; Pickles, C; Sasieni, P				Cuzick, J; Szarewski, A; Cubie, H; Hulman, G; Kitchener, H; Luesley, D; McGoogan, E; Menon, U; Terry, G; Edwards, R; Brooks, C; Desai, M; Gie, C; Ho, L; Jacobs, I; Pickles, C; Sasieni, P			Management of women who test positive for high-risk types of human papillomavirus: the HART study	LANCET			English	Article							CERVICAL-CANCER; NEOPLASIA; DETECT; MODEL	Background Certain types of human papillomavirus (HPV) are the primary cause of almost all cervical cancers. HPV testing of cervical smears is more sensitive but less specific than cytology for detecting high-grade cervical intraepithelial neoplasia (CIN2+). HPV testing as a primary screening approach requires efficient management of HPV-positive women with negative or borderline cytology. We aimed to compare the detection rate and positive predictive values of HPV assay with cytology and to determine the best management strategy for HPV-positive women. Methods We did a multicentre screening study of 11085 women aged 30-60 years. Women with borderline cytology and women positive for high-risk HPV with negative cytology were randomised to immediate colposcopy or to surveillance by repeat HPV testing, cytology, and colposcopy at 12 months. Findings HPV testing was more sensitive than borderline or worse cytology (97.1% vs 76.6%, p=0002) but less specific (93.3% vs 95.8%, p<0.0001) for detecting CIN2+. Of 825 randomised women, surveillance at 12 months was as effective as immediate colposcopy. In women positive for HPV at baseline, who had surveillance, 73 (45%) of 164 women with negative cytology and eight (35%) of 23 women with borderline cytology were HPV negative at 6-12 months. No CIN2+ was found in these women, nor in women with an initial negative HPV test with borderline (n=211) or mild (32) cytology. Interpretation HPV testing could be used for primary screening in women older than 30 years, with cytology used to triage HPV-positive women. HPV-positive women with normal or borderline cytology (about 6% of screened women) could be managed by repeat testing after 12 months. This approach could potentially improve detection rates of CIN2+ without increasing the colposcopy referral rate.	Barts & London Queen Marys Sch Med & Dent, Canc Res UK, Dept Epidemiol Math & Stat, Wolfson Inst Prevent Med, London EC1M 6BQ, England; Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland; City Hosp, Nottingham NG5 1PB, England; St Marys Hosp, Manchester M13 0JH, Lancs, England; Womens Hosp Med Ctr, Birmingham, W Midlands, England; Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; Canc Res UK, London, England; Christie Hosp, Manchester, Lancs, England; Kings Mill Ctr, Sutton In Ashfield, England	Cancer Research UK; University of London; Queen Mary University London; Royal Infirmary of Edinburgh; University of Edinburgh; University of Nottingham; University of Manchester; Birmingham Women's Hospital; University of Edinburgh; Cancer Research UK; Christie NHS Foundation Trust; Christie Hospital	Cuzick, J (corresponding author), Barts & London Queen Marys Sch Med & Dent, Canc Res UK, Dept Epidemiol Math & Stat, Wolfson Inst Prevent Med, Charterhouse Sq, London EC1M 6BQ, England.	jack.cuzick@cancer.org.uk	Jacobs, Ian J/F-1743-2013; Menon, Usha/C-4716-2008	Jacobs, Ian J/0000-0002-8112-4624; Menon, Usha/0000-0003-3708-1732; Jacobs, Ian/0000-0002-5005-2672; Sasieni, Peter/0000-0003-1509-8744; Brooks, Claire/0000-0002-3410-8971				Clavel C, 1999, BRIT J CANCER, V80, P1306, DOI 10.1038/sj.bjc.6690523; Cuzick J, 1997, NEW DEVELOPMENTS IN CERVICAL CANCER SCREENING AND PREVENTION, P364; Cuzick J, 1999, BRIT J CANCER, V81, P554, DOI 10.1038/sj.bjc.6690730; CUZICK J, 1995, LANCET, V345, P1533, DOI 10.1016/S0140-6736(95)91086-7; CUZICK J, 1999, HEALTH TECHNOL ASSES, V3, P1; Goldie SJ, 2001, AM J MED, V111, P140, DOI 10.1016/S0002-9343(01)00780-X; *GOV STAT SERV, 2002, CERV SCREEN PROGR; *IARC WORK GROUP E, 1995, IARC MON EV CARC RIS, V64; Kuhn L, 2000, JNCI-J NATL CANCER I, V92, P818, DOI 10.1093/jnci/92.10.818; LUESLEY DM, 1996, STANDARDS QUALITY CO; Manos MM, 1999, JAMA-J AM MED ASSOC, V281, P1605, DOI 10.1001/jama.281.17.1605; Moss SM, 2002, 1 DEP HLTH EV LBC; Myers ER, 2000, AM J EPIDEMIOL, V151, P1158, DOI 10.1093/oxfordjournals.aje.a010166; Ratnam S, 2000, CANCER EPIDEM BIOMAR, V9, P945; Sasieni P, 2002, J MED SCREEN, V9, P49, DOI 10.1136/jms.9.2.49; Sasieni PD, 1996, BRIT J CANCER, V73, P1001, DOI 10.1038/bjc.1996.196; Schiffman M, 2000, JAMA-J AM MED ASSOC, V283, P87, DOI 10.1001/jama.283.1.87; Schneider A, 1996, AM J OBSTET GYNECOL, V174, P1534, DOI 10.1016/S0002-9378(96)70602-6; Scott DR, 2002, CANCER CYTOPATHOL, V96, P14, DOI 10.1002/cncr.10317; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; vanBallegooijen M, 1997, BRIT J CANCER, V76, P651, DOI 10.1038/bjc.1997.440; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Womack SD, 2000, BRIT J OBSTET GYNAEC, V107, P33, DOI 10.1111/j.1471-0528.2000.tb11576.x; Wright TC, 2000, JAMA-J AM MED ASSOC, V283, P81, DOI 10.1001/jama.283.1.81	24	403	421	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2003	362	9399					1871	1876		10.1016/S0140-6736(03)14955-0	http://dx.doi.org/10.1016/S0140-6736(03)14955-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667741				2022-12-28	WOS:000187011600006
J	Stringer, JSA; Rouse, DJ; Sinkala, M; Marseille, EA; Vermund, SH; Stringer, EM; Goldenberg, RL				Stringer, JSA; Rouse, DJ; Sinkala, M; Marseille, EA; Vermund, SH; Stringer, EM; Goldenberg, RL			Nevirapine to prevent mother-to-child transmission of HIV-1 among women of unknown serostatus	LANCET			English	Editorial Material							IMMUNODEFICIENCY-VIRUS TYPE-1; RANDOMIZED CONTROLLED-TRIAL; SUB-SAHARAN AFRICA; VERTICAL TRANSMISSION; ORAL ZIDOVUDINE; PREGNANT-WOMEN; COTE-DIVOIRE; INTRAPARTUM; ACCEPTABILITY; STRATEGIES		Ctr Infect Dis Res Zambia, Lusaka, Zambia; Univ Alabama, Sch Med, Birmingham, AL USA; Univ Alabama, Sch Publ Hlth, Birmingham, AL 35294 USA; Univ Zambia, Sch Med, Lusaka, Zambia; Zambian Minist Hlth, Lusaka Urban Dist Hlth Management Board, Lusaka, Zambia; Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Zambia; University of California System; University of California San Francisco	Stringer, JSA (corresponding author), Ctr Infect Dis Res Zambia, Plot 5977 Mwernbeshi Rd,POB 34681, Lusaka, Zambia.		Vermund, Sten/AAD-3592-2020; Stringer, Jeffrey S. A./AAU-2342-2021	Vermund, Sten/0000-0001-7289-8698; Stringer, Jeffrey/0000-0002-9590-7216	NIAID NIH HHS [U01 AI47972, K23 AI52481] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI047972, K23AI052481] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bloland PB, 2002, MALARIA CONTROL MASS; *BOEHR ING, VIRAMUNE R DON PROGR; BUYSE D, 2002, 14 INT AIDS C BARC J; Cartoux M, 1998, AIDS, V12, P2489, DOI 10.1097/00002030-199818000-00019; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Dabis F, 2002, LANCET, V359, P2097, DOI 10.1016/S0140-6736(02)08909-2; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; DORENBAUM ACC, 2002, JAMA-J AM MED ASSOC, V288, P198; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Holm S, 2001, B WORLD HEALTH ORGAN, V78, P194; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; Lallemant M, 2000, NEW ENGL J MED, V343, P982, DOI 10.1056/NEJM200010053431401; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; Mofenson LM, 2002, J ACQ IMMUN DEF SYND, V30, P200, DOI [10.1097/01.QAI.0000018366.28828.86, 10.1097/00042560-200206010-00010]; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; Rekart M, 2000, Can Commun Dis Rep, V26, P101; Richards F, 2000, LANCET, V355, P1663, DOI 10.1016/S0140-6736(00)02235-2; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; SPARROW J, 2003, LACK MEANS WILL THWA; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/00002030-200306130-00012; STRINGER J, 2001, 3 C GLOB STRAT PREV; Stringer JSA, 2003, LANCET, V362, P667, DOI 10.1016/S0140-6736(03)14172-4; Stringer JSA, 2003, JAIDS-J ACQ IMM DEF, V32, P506, DOI 10.1097/00126334-200304150-00007; Stringer JSA, 2002, AM J PUBLIC HEALTH, V92, P365, DOI 10.2105/AJPH.92.3.365; Stringer JSA, 2000, J ACQ IMMUN DEF SYND, V24, P369, DOI 10.1097/00126334-200008010-00012; *UNAIDS WHO, 2003, AIDS EP UPD 2002; Urbani C, 2003, ACTA TROP, V86, P215, DOI 10.1016/S0001-706X(03)00036-6; *US CDCP, 2000, MMWR-MORBID MORTAL W, V49, P1; Vermund SH, 2002, LANCET, V360, P1186, DOI 10.1016/S0140-6736(02)11291-8; *WHO, 2002, US NEV PREV MOTH CHI; *WHO, 2002, WHO EXP COMM MAL 20; WHO, 2002, REP WHO INF CONS US; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9; WILLIAMS G, 1998, WORLD HEALTH FORUM, V9, P7; World Health Organization, 1995, WHO MODEL PRESCRIBIN, V2nd; 2001, WKLY EPIDEMIOL REC, V76, P149	37	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	NOV 29	2003	362	9398					1850	1853		10.1016/S0140-6736(03)14907-0	http://dx.doi.org/10.1016/S0140-6736(03)14907-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654326				2022-12-28	WOS:000186872900027
J	Service, RF				Service, RF			Condensed matter physics - Inverse Doppler demonstration ends a 60-year quest	SCIENCE			English	News Item																			0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1489	1489						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645819				2022-12-28	WOS:000186802200008
J	Elena, SF; Sanjuan, R				Elena, SF; Sanjuan, R			Climb every mountain?	SCIENCE			English	Editorial Material							ECOLOGICAL SPECIALIZATION; EXPERIMENTAL EVOLUTION; RADIATION; FITNESS; BASES		Univ Politecn Valencia, Consejo Super Invest Cient, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain; Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); University of Valencia	Elena, SF (corresponding author), Univ Politecn Valencia, Consejo Super Invest Cient, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain.	sfelena@ibmcp.upv.es; rafael.sanjuan@uv.es	Elena, Santiago F./A-4191-2011	Elena, Santiago F./0000-0001-8249-5593; Sanjuan, Rafael/0000-0002-1844-545X				Buckling A, 2003, SCIENCE, V302, P2107, DOI 10.1126/science.1088848; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Kawecki TJ, 1997, J EVOLUTION BIOL, V10, P407, DOI 10.1007/s000360050032; LEVINS RICHARD, 1968; Novella IS, 1999, J MOL BIOL, V287, P459, DOI 10.1006/jmbi.1999.2635; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Reboud X, 1997, HEREDITY, V78, P507, DOI 10.1038/hdy.1997.79; Spiers AJ, 2002, GENETICS, V161, P33; Turner PE, 2000, GENETICS, V156, P1465; [No title captured]	12	34	35	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2074	2075		10.1126/science.1093165	http://dx.doi.org/10.1126/science.1093165			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684807				2022-12-28	WOS:000187385200027
J	Peterson, CH; Rice, SD; Short, JW; Esler, D; Bodkin, JL; Ballachey, BE; Irons, DB				Peterson, CH; Rice, SD; Short, JW; Esler, D; Bodkin, JL; Ballachey, BE; Irons, DB			Long-term ecosystem response to the Exxon Valdez oil spill	SCIENCE			English	Review							PRINCE-WILLIAM-SOUND; SEA OTTERS; SALMON; RECOVERY; MORTALITY; ALASKA; POPULATIONS; PERSISTENCE; INDUCTION; COMMUNITY	The ecosystem response to the 1989 spill of oil from the Exxon Valdez into Prince William Sound, Alaska, shows that current practices for assessing ecological risks of oil in the oceans and, by extension, other toxic sources should be changed. Previously, it was assumed that impacts to populations derive almost exclusively from acute mortality. However, in the Alaskan coastal ecosystem, unexpected persistence of toxic subsurface oil and chronic exposures, even at sublethal levels, have continued to affect wildlife. Delayed population reductions and cascades of indirect effects postponed recovery. Development of ecosystem-based toxicology is required to understand and ultimately predict chronic, delayed, and indirect long-term risks and impacts.	Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA; NOAA, Alaska Fisheries Sci Ctr, Auke Bay Lab, Natl Marine Fisheries Serv, Juneau, AK 99801 USA; Simon Fraser Univ, Dept Biol Sci, Ctr Wildlife Ecol, Burnaby, BC V5A 1S6, Canada; US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99503 USA; US Fish & Wildlife Serv, US Dept Interior, Anchorage, AK 99503 USA	University of North Carolina; University of North Carolina Chapel Hill; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; Simon Fraser University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service	Peterson, CH (corresponding author), Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA.	cpeters@email.unc.edu	Short, Jeffrey/AAZ-9241-2021					Andres BA, 1997, J WILDLIFE MANAGE, V61, P1322, DOI 10.2307/3802132; Arkoosh MR, 2002, HUM ECOL RISK ASSESS, V8, P265, DOI 10.1080/20028091056908; Bodkin JL, 2002, MAR ECOL PROG SER, V241, P237, DOI 10.3354/meps241237; Bodkin JL, 1999, CONSERV BIOL, V13, P1378, DOI 10.1046/j.1523-1739.1999.98124.x; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; Bue BG, 1998, T AM FISH SOC, V127, P35, DOI 10.1577/1548-8659(1998)127<0035:EODTPS>2.0.CO;2; Carls MG, 2001, MAR ENVIRON RES, V51, P167, DOI 10.1016/S0141-1136(00)00103-3; Christensen NL, 1996, ECOL APPL, V6, P665, DOI 10.2307/2269460; Day RH, 1997, ECOL APPL, V7, P593; Dean TA, 2000, MAR ECOL PROG SER, V199, P281, DOI 10.3354/meps199281; Dill LM, 2003, ECOLOGY, V84, P1151, DOI 10.1890/0012-9658(2003)084[1151:BMIIIM]2.0.CO;2; Driskell WB, 2001, ECOL APPL, V11, P815; Esler D, 2000, J WILDLIFE MANAGE, V64, P839, DOI 10.2307/3802754; Esler D, 2002, MAR ECOL PROG SER, V241, P271, DOI 10.3354/meps241271; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; GARROTT RA, 1993, MAR MAMMAL SCI, V9, P343, DOI 10.1111/j.1748-7692.1993.tb00468.x; Golet GH, 2002, MAR ECOL PROG SER, V241, P287, DOI 10.3354/meps241287; Hawkins S. J., 1992, RESTORING NATIONS MA, P584; Hayes MO, 1999, MAR POLLUT BULL, V38, P92, DOI 10.1016/S0025-326X(99)00099-5; Heintz RA, 1999, ENVIRON TOXICOL CHEM, V18, P494, DOI 10.1002/etc.5620180318; Heintz RA, 2000, MAR ECOL PROG SER, V208, P205, DOI 10.3354/meps208205; Jewett SC, 1999, MAR ECOL PROG SER, V185, P59, DOI 10.3354/meps185059; Jewett SC, 2002, MAR ENVIRON RES, V54, P21, DOI 10.1016/S0141-1136(02)00093-4; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; KIMBALL KD, 1985, BIOSCIENCE, V35, P165, DOI 10.2307/1309866; Loughlin TR, 1994, MARINE MAMMALS EXXON; Marty GD, 1997, CAN J ZOOL, V75, P989, DOI 10.1139/z97-120; MENGE BA, 1995, ECOL MONOGR, V65, P21, DOI 10.2307/2937158; Monson DH, 2000, P NATL ACAD SCI USA, V97, P6562, DOI 10.1073/pnas.120163397; Murphy ML, 1999, T AM FISH SOC, V128, P909, DOI 10.1577/1548-8659(1999)128<0909:ROPSSA>2.0.CO;2; National Research Council, 2002, OIL SEA; Paine RT, 1996, ANNU REV ECOL SYST, V27, P197, DOI 10.1146/annurev.ecolsys.27.1.197; Peterson CH, 2001, ADV MAR BIOL, V39, P1, DOI 10.1016/S0065-2881(01)39008-9; Piatt JF, 1996, AM FISH S S, V18, P712; RICE S D, 1996, P EXX VALD OIL SPILL; Rice Stanley D., 2001, Reviews in Fisheries Science, V9, P165, DOI 10.1080/20016491101744; Schoener T., 1993, MUTUALISM COMMUNITY, P365; Sharp BE, 1996, AM FISH S S, V18, P748; Short JW, 2004, ENVIRON SCI TECHNOL, V38, P19, DOI 10.1021/es0348694; Trust KA, 2000, MAR POLLUT BULL, V40, P397; Wells Peter G., 1995, EXXON VALDEZ OIL SPI, V1219; Wikelski M, 2002, NATURE, V417, P607, DOI 10.1038/417607a; Willette TM, 1999, CAN J FISH AQUAT SCI, V56, P364, DOI 10.1139/cjfas-56-3-364; WOLFE DA, 1994, ENVIRON SCI TECHNOL, V28, pA560, DOI 10.1021/es00062a712	45	1010	1059	20	1077	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 19	2003	302	5653					2082	2086		10.1126/science.1084282	http://dx.doi.org/10.1126/science.1084282			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684812				2022-12-28	WOS:000187385200032
J	Heney, NM; Lawner, BE; Young, RH; Gomery, P; Ongaro, TJ				Heney, NM; Lawner, BE; Young, RH; Gomery, P; Ongaro, TJ			A 33-year-old woman with gross hematuria - Inflammatory pseudotumor of the urinary bladder	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSITIONAL-CELL CARCINOMA; LEIOMYOSARCOMA; PROLIFERATIONS; SARCOMA		Massachusetts Gen Hosp, Urol Serv, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Urol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Heney, NM (corresponding author), Massachusetts Gen Hosp, Urol Serv, Boston, MA 02114 USA.							ALBORESSAAVEDRA J, 1990, CANCER, V66, P1234, DOI 10.1002/1097-0142(19900915)66:6<1234::AID-CNCR2820660625>3.0.CO;2-W; BRODSKY GL, 1992, HEMATOL ONCOL CLIN N, V6, P59, DOI 10.1016/S0889-8588(18)30363-0; Chan JKC, 2001, AM J SURG PATHOL, V25, P761, DOI 10.1097/00000478-200106000-00007; HOJO H, 1995, AM J SURG PATHOL, V19, P1224, DOI 10.1097/00000478-199511000-00002; Iczkowski KA, 2001, MODERN PATHOL, V14, P1043, DOI 10.1038/modpathol.3880434; JONES EC, 1993, AM J SURG PATHOL, V17, P264, DOI 10.1097/00000478-199303000-00007; Jones EC, 1997, MODERN PATHOL, V10, P908; KEATING MA, 1985, J UROLOGY, V133, P465, DOI 10.1016/S0022-5347(17)49027-6; KUTARSKI PW, 1993, BRIT J UROL, V72, P749, DOI 10.1111/j.1464-410X.1993.tb16261.x; LUNDGREN L, 1994, HUM PATHOL, V25, P181, DOI 10.1016/0046-8177(94)90276-3; MESSING EM, 1998, CAMPBELLS UROLOGY, P2327; MILLS SE, 1989, AM J SURG PATHOL, V13, P480, DOI 10.1097/00000478-198906000-00004; NOCHOMOVITZ LE, 1985, AM J SURG PATHOL, V9, P366, DOI 10.1097/00000478-198505000-00007; PROPPE KH, 1984, AM J SURG PATHOL, V8, P101, DOI 10.1097/00000478-198402000-00003; RUSSO P, 1991, UROL CLIN N AM, V18, P581; Scher H, 1998, ONCOLOGY-NY, V12, P225; SWARTZ DA, 1985, J UROLOGY, V133, P200, DOI 10.1016/S0022-5347(17)48880-X; YOUNG RH, 1988, AM J SURG PATHOL, V12, P542, DOI 10.1097/00000478-198807000-00005; Young RH, 1989, PATHOLOGY URINARY BL, P1	19	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 18	2003	349	25					2442	2447		10.1056/NEJMcpc030029	http://dx.doi.org/10.1056/NEJMcpc030029			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754PJ	14681511				2022-12-28	WOS:000187326200012
J	Lo, GH; LaValley, M; McAlindon, T; Felson, DT				Lo, GH; LaValley, M; McAlindon, T; Felson, DT			Intra-articular hyaluronic acid in treatment of knee osteoarthritis - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DOUBLE-BLIND; SODIUM HYALURONATE; TASK-FORCE; EULAR RECOMMENDATIONS; STANDING COMMITTEE; CONTROLLED-TRIAL; CLINICAL-TRIAL; PLACEBO; INJECTIONS; VISCOSUPPLEMENTATION	Context Intra-articular hyaluronic acid is a US Food and Drug Administration-approved treatment for knee osteoarthritis (OA); however, its efficacy is controversial. Objective To evaluate whether intra-articular hyaluronic acid is efficacious in treating knee OA. Data Sources We searched for human clinical trials in MEDLINE (1966 through February 2003) and the Cochrane Controlled Trials Register, using the search terms (osteoarthritis, osteoarthrosis, or degenerative arthritis) and (hyaluronic acid, Hyalgan, Synvisc, Artzal, Suplasyn, BioHy, or Orthovisc). We also hand searched manuscript bibliographies that met inclusion criteria, selected rheumatic disease journals, and abstracts from scientific meetings. Study Selection Included were published or unpublished, English and non-English, single- or double-blinded, randomized controlled trials comparing intraarticular hyaluronic acid with intra-articular placebo injection for the treatment of knee OA. Trials also were required to have extractable data on pain reported by 1 of the outcome measures recommended by the Osteoarthritis Research Society. Data Extraction Two reviewers independently performed data extraction using standardized data forms. For each trial, we calculated an effect size (small-effect sizes, 0.2-0.5; large-effect sizes, 1.0-1.8, equivalent to a total knee replacement). We used a random-effects model to pool study results, the Cochrane Q test to evaluate heterogeneity, and a funnel plot and the Egger test to evaluate publication bias. Data Synthesis The overall dropout rate in the 22 selected trials was 12.4%. The pooled effect size for hyaluronic acid was 0.32 (95% confidence interval [CI], 0.17-0.47). There was significant heterogeneity among studies (P<.001). Two outlier trials, both evaluating the highest-molecular-weight hyaluronic acid, had effect sizes in excess of 1.5. However, the third trial of the same compound showed a nearly null effect. When the 3 trials of this compound were removed, heterogeneity was no longer significant (P=.58), and the pooled effect size for intra-articular hyaluronic acid decreased to 0.19 (95% Cl, 0.10-0.27). There was evidence of publication bias with an asymmetric funnel plot, a positive Egger test, and identification of 2 unpublished trials whose pooled effect size was 0.07 (95% Cl, - 0.15 to 0.28). Conclusion Intra-articular hyaluronic acid has a small effect when compared with an intra-articular placebo. The presence of publication bias suggests even this effect may be overestimated. Compared with lower-molecular-weight hyaluronic acid, the highest-molecular-weight hyaluronic acid may be more efficacious in treating knee OA, but heterogeneity of these studies limits definitive conclusions.	Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA; Boston Univ, Sch Med, Arthrit Ctr, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Lo, GH (corresponding author), 715 Albany St,A203, Boston, MA 02118 USA.	grace.lo@bmc.org	LaValley, Michael/AAA-2030-2020; teng, yj/C-4440-2011	LaValley, Michael/0000-0002-8488-5170; Felson, David/0000-0002-2668-2447	NIAMS NIH HHS [AR 47785] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047785] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Allard S, 2000, CLIN THER, V22, P792, DOI 10.1016/S0149-2918(00)90012-2; Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; Altman RD, 1998, J RHEUMATOL, V25, P2203; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; AVIAD AD, 1994, J RHEUMATOL, V21, P297; Brandt KD, 2000, ARTHRITIS RHEUM-US, V43, P1192, DOI 10.1002/1529-0131(200006)43:6<1192::AID-ANR2>3.0.CO;2-L; Brandt KD, 2001, CLIN ORTHOP RELAT R, P130; Carrabba M., 1995, European Journal of Rheumatology and Inflammation, V15, P25; Cohen J., 1988, STAT POWER ANAL BEHA, P567; COHEN MA, 1994, ARTHRITIS RHEUM S, V34, P6; Corrado E. M., 1995, European Journal of Rheumatology and Inflammation, V15, P47; Creamer P, 1994, Osteoarthritis Cartilage, V2, P133, DOI 10.1016/S1063-4584(05)80063-9; DAHLBERG L, 1994, ARTHRITIS RHEUM, V37, P521, DOI 10.1002/art.1780370412; DIXON ASJ, 1988, CURR MED RES OPIN, V11, P205, DOI 10.1185/03007998809114237; Dougados M, 1993, Osteoarthritis Cartilage, V1, P97, DOI 10.1016/S1063-4584(05)80024-X; Felson DT, 2002, ARCH INTERN MED, V162, P245, DOI 10.1001/archinte.162.3.245; Felson DT, 2001, ARTHRITIS RHEUM-US, V44, P1477, DOI 10.1002/1529-0131(200107)44:7<1477::AID-ART267>3.0.CO;2-O; Formiguera Sala S, 1995, EUR J RHEUMATOL INFL, V15, P33; HENDERSON EB, 1994, ANN RHEUM DIS, V53, P529, DOI 10.1136/ard.53.8.529; Huskisson EC, 1999, RHEUMATOLOGY, V38, P602, DOI 10.1093/rheumatology/38.7.602; Jubb RW, 2003, INT J CLIN PRACT, V57, P467; Karlsson J, 2002, RHEUMATOLOGY, V41, P1240, DOI 10.1093/rheumatology/41.11.1240; Kirwan J, 2001, KNEE, V8, P93, DOI 10.1016/S0968-0160(01)00075-8; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; LIANG MH, 1985, ARTHRITIS RHEUM, V28, P542, DOI 10.1002/art.1780280513; Lohmander LS, 1996, ANN RHEUM DIS, V55, P424, DOI 10.1136/ard.55.7.424; Mazieres B, 2001, JOINT BONE SPINE, V68, P231, DOI 10.1016/S1297-319X(01)00271-8; Pendleton A, 2000, ANN RHEUM DIS, V59, P936, DOI 10.1136/ard.59.12.936; Petrella RJ, 2002, ARCH INTERN MED, V162, P292, DOI 10.1001/archinte.162.3.292; PHAM T, 2003, ARTRITIS RHEUM S, V48, P9; Puhl W, 1993, Osteoarthritis Cartilage, V1, P233, DOI 10.1016/S1063-4584(05)80329-2; ROOS EM, 2002, ARTHRITIS RHEUM S, V46, P9; RUSSELL IJ, 1992, ARTHRITIS RHEUM S, V35, P9; SCALE D, 1994, CURR THER RES CLIN E, V55, P220, DOI 10.1016/S0011-393X(05)80166-3; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Tamir E, 2001, CLIN EXP RHEUMATOL, V19, P265; Wobig M, 1998, CLIN THER, V20, P410, DOI 10.1016/S0149-2918(98)80052-0	37	338	357	1	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2003	290	23					3115	3121		10.1001/jama.290.23.3115	http://dx.doi.org/10.1001/jama.290.23.3115			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753ZB	14679274				2022-12-28	WOS:000187277300030
J	Minkovitz, CS; Hughart, N; Strobino, D; Scharfstein, D; Grason, H; Hou, W; Miller, T; Bishai, D; Augustyn, M; McLearn, KT; Guyer, B				Minkovitz, CS; Hughart, N; Strobino, D; Scharfstein, D; Grason, H; Hou, W; Miller, T; Bishai, D; Augustyn, M; McLearn, KT; Guyer, B			A practice-based intervention to enhance quality of care in the first 3 years of life the - Healthy steps for young children program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY; INFANTS; PARENTS	Context There is growing concern regarding the quality of health care available in the United States for young children, and specific limitations have been noted in developmental and behavioral services provided for children in the first 3 years of life. Objective To determine the impact of the Healthy Steps for Young Children Program on quality of early childhood health care and parenting practices. Design, Setting, and Participants Prospective controlled clinical trial enrolling participants between September 1996 and November 1998 at 6 randomization and 9 quasi-experimental sites across the United States. Participants were 5565 children enrolled at birth and followed up through age 3 years. Intervention Incorporation of developmental specialists and enhanced developmental services into pediatric care in participants' first 3 years of life. Main Outcome Measures Quality of care was operationalized across 4 domains: effectiveness (eg, families received greater than or equal to4 Healthy Steps-related services or discussed >6 anticipatory guidance topics), patient-centeredness (eg, families were satisfied with care provided), timeliness (eg, children received timely well-child visits and vaccinations), and efficiency (eg, families remained at the practice for greater than or equal to20 months). Parenting outcomes included response to child misbehavior (eg, use of severe discipline) and practices to promote child development and safety (eg, mothers at risk for depression discussed their sadness with someone at the practice). Results Of the 5565 enrolled families, 3737 (67.2%) responded to an interview at 30 to 33 months (usual care, 1716 families; Healthy Steps, 2021 families). Families who participated in the Healthy Steps Program had greater odds of receiving 4 or more Healthy Steps-related services (for randomization and quasi-experimental sites, respectively: odds ratio [OR], 16.90 [95% confidence interval (CI), 12.78 to 22.34] and OR, 23.05 [95% Cl, 17.38 to 30.58]), of discussing more than 6 anticipatory guidance topics (OR, 8.56 (95% Cl, 6.47 to 11.32] and OR, 12.31 [95% Cl, 9.35 to 16.19]), of being highly satisfied with care provided (eg, someone in the practice went out of the way for them) (OR, 2.06 [95% Cl, 1.64 to 2.58] and OR, 2.11 [95% Cl, 1.72 to 2.59]), of receiving timely well-child visits and vaccinations (eg, age-appropriate 1-month visit) (OR, 1.98 [95% Cl, 1.08 to 3.62] and OR, 2.11 [95% Cl, 1.16 to 3.85]), and of remaining at the practice for 20 months or longer (OR, 2.02 [95% Cl, 1.61 to 2.55] and OR, 1.75 [95% Cl, 1.43 to 2.15]). They also had reduced odds of using severe discipline (eg, slapping in face or spanking with object) (OR, 0.82 [95% Cl, 0.54 to 1.26] and OR, 0.67 [95% Cl, 0.46 to 0.97]). Among mothers considered at risk for depression, those who participated in the Healthy Steps Program had greater odds of discussing their sadness with someone at the practice (OR: 0.95 [95% Cl, 0.56 to 1.63] and OR, 2.82 [95% Cl, 1.57 to 5.08]). Conclusion Universal, practice-based interventions can enhance quality of care for families of young children and can improve selected parenting practices.	Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat & Family Hlth Sci, Baltimore, MD 21205 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; Columbia Univ, Mailman Sch Publ Hlth, Natl Ctr Children Poverty, New York, NY USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Boston University; Columbia University	Minkovitz, CS (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat & Family Hlth Sci, 624 N Broadway, Baltimore, MD 21205 USA.	cminkovi@jhsph.edu	, David Bishai/GRO-4211-2022	Bishai, David/0000-0003-0714-9062				Achenbach T. M., 1992, MANUAL CHILD BEHAV C; American Academy of Pediatrics, 2000, PEDIATRICS, V105, P645; BENEDICT T, 2001, HLTH STEPS YOUNG CHI, V2, P7; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Bethell C, 2001, PEDIATRICS, V107, P1084, DOI 10.1542/peds.107.5.1084; BLACKWELL DL, 1998, SUMMARY HLTH STAT US; Christakis DA, 2001, PEDIATRICS, V107, P524, DOI 10.1542/peds.107.3.524; CHRISTAKIS DA, 2002, PEDIATRICS, P109; Cochran WG, 1983, PLANNING ANAL OBSERV; *COMM QUAL HLTH CA, 2001, CROSS QUAL CHASM 200; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; DIGGLE PJ, 2002, ANAL LONGITUDINAL D; Dobson A.J., 2002, INTRO GEN LINEAR MOD; ETHELL C, 2002, PARTNERING PARENTS P; Gershoff ET, 2002, PSYCHOL BULL, V128, P539, DOI 10.1037//0033-2909.128.4.539; Goodnow, 1992, PARENTAL BELIEF SYST; GREEN M, 2002, BRIGHT FUTURES NATL; Guyer B, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.3.e33; GUYER B, IN PRESS HLTH STEPS; Hakim RB, 2002, ARCH PEDIAT ADOL MED, V156, P1015, DOI 10.1001/archpedi.156.10.1015; HALFON N, 2000, SUMMARY STAT NATL SU; HURTADO MP, 2001, ENV NATL HLTH CARE Q; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; KAPLANSANOFF M, 1999, HLTH STEPS STRATEGIE; Klass P, 2002, PEDIATRICS, V110, P989, DOI 10.1542/peds.110.5.989; Lawrence P R, 2001, J Pediatr Health Care, V15, P58, DOI 10.1016/S0891-5245(01)02315-X; Leatherman ST, 2002, QUALITY HLTH CARE US; LOVE JM, 2001, BUILDING THEIR FUTUR, V1; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Minkovitz C, 2001, ARCH PEDIAT ADOL MED, V155, P470, DOI 10.1001/archpedi.155.4.470; *NAT CTR HLTH STAT, 2002, HLTH US 2002 CHARTB; NEWELL DJ, 1992, INT J EPIDEMIOL, V21, P837, DOI 10.1093/ije/21.5.837; PETER G, 1997, 1997 RED BOOK REPORT; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RAMEY CT, 1992, PEDIATRICS, V89, P454; Schuster MA, 2000, ARCH PEDIAT ADOL MED, V154, P1191, DOI 10.1001/archpedi.154.12.1191; STPIERRE RG, 1997, NATL IMPACT EVALUATI; Young KT, 1998, ARCH PEDIAT ADOL MED, V152, P255; ZUCKERMAN B, 1997, ZERO 3           JUN, P20	39	150	152	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 17	2003	290	23					3081	3091		10.1001/jama.290.23.3081	http://dx.doi.org/10.1001/jama.290.23.3081			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753ZB	14679271	Bronze			2022-12-28	WOS:000187277300027
J	Geisbert, TW; Hensley, LE; Jahrling, PB; Larsen, T; Geisbert, JB; Paragas, J; Young, HA; Fredeking, TM; Rote, WE; Vlasuk, GP				Geisbert, TW; Hensley, LE; Jahrling, PB; Larsen, T; Geisbert, JB; Paragas, J; Young, HA; Fredeking, TM; Rote, WE; Vlasuk, GP			Treatment of Ebola virus infection with a recombinant inhibitor of factor Vila/tissue factor: a study in rhesus monkeys	LANCET			English	Article							ANTICOAGULANT PROTEIN C2; DISSEMINATED INTRAVASCULAR COAGULATION; TISSUE FACTOR/FACTOR-VIIA; FACTOR VIIA/TISSUE FACTOR; FACTOR PATHWAY; IN-VITRO; ACTIVATION; MECHANISMS; RELEASE; COMPLEX	Background Infection with the Ebola virus induces overexpression of the procoagulant tissue factor in primate monocytes and macrophages, suggesting that inhibition of the tissue-factor pathway could ameliorate the effects of Ebola haemorrhagic fever. Here, we tested the notion that blockade of fVIIa/tissue factor is beneficial after infection with Ebola virus. Methods We used a rhesus macaque model of Ebola haemorrhagic fever, which produces near 100% mortality. We administered recombinant nematode anticoagulant protein c2 (rNAPc2), a potent inhibitor of tissue factor-initiated blood coagulation, to the macaques either 10 min (n=6) or 24 h (n=3) after a high-dose lethal injection of Ebola virus. Three animals served as untreated Ebola virus-positive controls. Historical controls were also used in some analyses. Findings Both treatment regimens prolonged survival time, with a 33% survival rate in each treatment group. Survivors are still alive and healthy after 9 months. All but one of the 17 controls died. The mean survival for the six rNAPc2-treated macaques that died was 11.7 days compared with 8.3 days for untreated controls (p=0.0184). rNAPc2 attenuated the coagulation response as evidenced by modulation of various important coagulation factors, including plasma D dimers, which were reduced in nearly all treated animals; less prominent fibrin deposits and intravascular thromboemboli were observed in tissues of some animals that succumbed to Ebola virus. Furthermore, rNAPc2 attenuated the proinflammatory response with lower plasma concentrations of interleukin 6 and monocyte chemoattractant protein-1 (MCP-1) noted in the treated than in the untreated macaques. Interpretation Post-exposure protection with rNAPc2 against Ebola virus in primates provides a new foundation for therapeutic regimens that target the disease process rather than viral replication.	USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA; USA, Med Res Inst Infect Dis, Div Pathol, Ft Detrick, MD 21702 USA; NCI, Cellular & Mol Immunol Sect, Expt Immunol Lab, FCRDC, Frederick, MD USA; Antibody Syst, Hurst, TX USA; Corvas Int, San Diego, CA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Geisbert, TW (corresponding author), USA, Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21702 USA.		; Young, Howard/A-6350-2008	Hensley, Lisa/0000-0003-1188-4342; Young, Howard/0000-0002-3118-5111; Larsen, Thomas/0000-0002-3609-9490				Arai A, 2000, THROMB RES, V97, P153, DOI 10.1016/S0049-3848(99)00147-4; Bick RL, 1998, SEMIN THROMB HEMOST, V24, P3, DOI 10.1055/s-2007-994971; Bray M, 2001, J COMP PATHOL, V125, P243, DOI 10.1053/jcpa.2001.0503; Bray M, 2000, ANTIVIR RES, V45, P135, DOI 10.1016/S0166-3542(00)00066-8; de Jonge E, 2003, CLIN DIAGN LAB IMMUN, V10, P495, DOI 10.1128/CDLI.10.3.495-497.2003; de Pont ACJM, 2002, BLOOD, V100, p487A; Funahara Y, 1983, Bibl Haematol, P201; Geisbert TW, 2003, J INFECT DIS, V188, P1618, DOI 10.1086/379724; Geisbert TW, 2002, EMERG INFECT DIS, V8, P503; Huggins J, 1999, J INFECT DIS, V179, pS240, DOI 10.1086/514316; Huggins J.W., 1995, ANTIVIR RES, V26, pA301; Iversen N, 2000, BLOOD COAGUL FIBRIN, V11, P591, DOI 10.1097/00001721-200010000-00002; Jahrling PB, 1999, J INFECT DIS, V179, pS224, DOI 10.1086/514310; Johnson K, 1998, J IMMUNOL, V160, P5130; Lee A, 2001, CIRCULATION, V104, P74, DOI 10.1161/hc2601.091386; McVey JH, 1999, BEST PRACT RES CL HA, V12, P361, DOI 10.1053/beha.1999.0030; Moons AHM, 2003, J AM COLL CARDIOL, V41, P2147, DOI 10.1016/S0735-1097(03)00478-9; ROBSON SC, 1994, BRIT J HAEMATOL, V86, P322, DOI 10.1111/j.1365-2141.1994.tb04733.x; Sanchez A, 2001, FIELDS VIROLOGY, P1279; Vlasuk GP, 2002, TRENDS CARDIOVAS MED, V12, P325, DOI 10.1016/S1050-1738(02)00185-8	20	283	330	0	38	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 13	2003	362	9400					1953	1958		10.1016/S0140-6736(03)15012-X	http://dx.doi.org/10.1016/S0140-6736(03)15012-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	753BC	14683653	Green Submitted			2022-12-28	WOS:000187210700006
J	Pretty, J				Pretty, J			Social capital and the collective management of resources	SCIENCE			English	Article								The proposition that natural resources need protection from the destructive actions of people is widely accepted. Yet communities have shown in the past and increasingly today that they can collaborate for long-term resource management. The term social capital captures the idea that social bonds and norms are critical for sustainability. Where social capital is high in formalized groups, people have the confidence to invest in collective activities, knowing that others will do so too. Some 0.4 to 0.5 million groups have been established since the early 1990s for watershed, forest, irrigation, pest, wildlife, fishery, and microfinance management. These offer a route to sustainable management and governance of common resources.	Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	University of Essex	Pretty, J (corresponding author), Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England.	jpretty@essex.ac.uk	Pretty, Jules/D-4071-2012	Nedanov, Aleksandar/0000-0002-4238-9275; Pretty, Jules/0000-0002-3897-6581				[Anonymous], 1999, CULTURAL SPIRITUAL V; [Anonymous], 2002, DRAMA COMMONS; Beck T, 2001, WORLD DEV, V29, P119, DOI 10.1016/S0305-750X(00)00089-9; Callicott JB, 1998, GREAT NEW WILDERNESS; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; DONNELLYROARK P, 2002, GROWTH EQUITY SOCIAL; Dryzek J.S., 2000, DELIBERATIVE DEMOCRA; FLORA CB, 1993, ANN AM ACAD POLIT SS, V529, P48, DOI 10.1177/0002716293529001005; Gadgil Madhav, 2013, THIS FISSURED LAND E; Gardner G.T., 1996, ENV PROBLEMS HUMAN B; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Keohane R. O., 1993, I EARTH; Krishna A., 2002, ACTIVE SOCIAL CAPITA; Landolt P., 1996, AM PROSPECT; Murali K. S., 2002, Environmental Management and Health, V13, P512, DOI 10.1108/09566160210441807; Murali K. S., 2003, International Journal of Environment and Sustainable Development, V2, P19, DOI 10.1504/IJESD.2003.002361; Narayan D., 1997, 1796 WORLD BANK; Nash Roderick, 1973, WILDERNESS AM MIND; ORiordan T., 2002, BIODIVERSITY SUSTAIN; OSTROM E, 1990, GOVT COMMONS; Ostrom E., 2002, DRAMA COMMONS; PONTIUS J, 2001, FARMER FIELD SCH COM; Pretty J, 2001, WORLD DEV, V29, P209, DOI 10.1016/S0305-750X(00)00098-X; Pretty J., 2002, AGRICULTURE RECONNEC; Pretty JN, 2003, AGR ECOSYST ENVIRON, V95, P217, DOI 10.1016/S0167-8809(02)00087-7; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Putnam RD., 2000, BOWLING ALONE COLLAP; SINGLETON S, 1992, J THEORETICAL POLITI, V4, P309, DOI DOI 10.1177/0951692892004003004; Stern P.C., 2002, DRAMA COMMONS, P443; Taylor Michael, 1982, COMMUNITY ANARCHY LI; Uphoff N., 2002, AGROECOLOGICAL INNOV; Wade R., 1994, VILLAGE REPUBLICS; Wilkinson RG, 1999, ANN NY ACAD SCI, V896, P48, DOI 10.1111/j.1749-6632.1999.tb08104.x; WOOLCOCK M, 2001, ISUMA CANADIAN J POL, V0002	34	834	873	8	280	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 12	2003	302	5652					1912	1914		10.1126/science.1090847	http://dx.doi.org/10.1126/science.1090847			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	752NL	14671287	Green Submitted			2022-12-28	WOS:000187174000042
J	Atassi, T; Montgomery, E				Atassi, T; Montgomery, E			Cecal Kaposi's sarcoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA	Johns Hopkins University	Atassi, T (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 11	2003	349	24					2340	2340		10.1056/NEJMicm010829	http://dx.doi.org/10.1056/NEJMicm010829			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752AX	14668460				2022-12-28	WOS:000187125000009
J	Boerma, JT; Ghys, PD; Walker, N				Boerma, JT; Ghys, PD; Walker, N			Estimates of HIV-1 prevalence from national population-based surveys as a new gold standard	LANCET			English	Editorial Material							GENERAL-POPULATION; INFECTION; RISK; SURVEILLANCE; MIGRATION; EPIDEMIC		WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; Joint UN Programme HIV AIDS, Geneva, Switzerland	World Health Organization	Boerma, JT (corresponding author), WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland.	boermat@who.int						Bloom SS, 2002, SEX TRANSM INFECT, V78, P261, DOI 10.1136/sti.78.4.261; Boerma JT, 2001, POPUL DEV REV, V27, P303, DOI 10.1111/j.1728-4457.2001.00303.x; *CDCP, 2001, ET INT PREV IST COMP; *CELL PLAN STAT MI, 2002, HIV TEST MAL FIND 20; Fylkesnes K, 1998, AIDS, V12, P1227, DOI 10.1097/00002030-199810000-00015; Glynn JR, 2001, AIDS, V15, P1717, DOI 10.1097/00002030-200109070-00016; Glynn JR, 2001, AIDS, V15, P2025, DOI 10.1097/00002030-200110190-00016; Gregson S, 2002, AIDS, V16, P643, DOI 10.1097/00002030-200203080-00017; Hodes R, 2002, AIDS, V16, P1, DOI 10.1097/00002030-200201040-00001; Kilian AHD, 1999, AIDS, V13, P391, DOI 10.1097/00002030-199902250-00012; Kwesigabo G, 2000, J ACQ IMMUN DEF SYND, V23, P410; NUNN AJ, 1995, AIDS, V9, P503, DOI 10.1097/00002030-199509050-00013; PISON G, 1993, J ACQ IMMUN DEF SYND, V6, P196; Schwartlander B, 1999, AIDS, V13, P2445, DOI 10.1097/00002030-199912030-00017; Shisana O, 2002, S AFRICAN NATL HIV P; *UNAIDS, 2002, REP GLOB HIV AIDS EP; *UNAIDS WHO, 2002, AIDS EP UPD; WALKER N, IN PRESS AIDS; Zaba B, 1998, AIDS, V12, pS41; [No title captured]	20	100	100	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2003	362	9399					1929	1931		10.1016/S0140-6736(03)14967-7	http://dx.doi.org/10.1016/S0140-6736(03)14967-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667753				2022-12-28	WOS:000187011600027
J	Niu, FL; Silver, PG; Nadeau, RM; McEvilly, TV				Niu, FL; Silver, PG; Nadeau, RM; McEvilly, TV			Migration of seismic scatterers associated with the 1993 Parkfield aseismic transient event	NATURE			English	Article							STRESS TRANSFER; EARTHQUAKE; CALIFORNIA; FAULT; VELOCITY; STRAIN	The time-varying deformation field within a fault zone, particularly at depths where earthquakes occur, is important for understanding fault behaviour and its relation to earthquake occurrence(1-3). But detection of this temporal variation has been extremely difficult, although laboratory studies have long suggested that certain structural changes, such as the properties of crustal fractures, should be seismically detectable(4). Here we present evidence that such structural changes are indeed observable. In particular, we find a systematic temporal variation in the seismograms of repeat microearthquakes that occurred on the Parkfield segment of the San Andreas fault over the decade 1987 - 97. Our analysis reveals a change of the order of 10 m in the location of scatterers which plausibly lie within the fault zone at a depth of similar to3 km. The motion of the scatterers is coincident, in space and time, with the onset of a well documented aseismic transient ( deformation event). We speculate that this structural change is the result of a stress-induced redistribution of fluids in fluid-filled fractures caused by the transient event.	Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA	Rice University; Carnegie Institution for Science; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Niu, FL (corresponding author), Rice Univ, Dept Earth Sci, MS-126,6100 Main St, Houston, TX 77005 USA.		Nadeau, Robert/G-1884-2017; Niu, Fenglin/A-2548-2011	Nadeau, Robert/0000-0003-1255-0643; 				Aki K., 1980, QUANTITATIVE SEISMOL; Baisch S, 2001, J GEOPHYS RES-SOL EA, V106, P16323, DOI 10.1029/2001JB000151; BAKUN WH, 1985, SCIENCE, V229, P619, DOI 10.1126/science.229.4714.619; Bowman DD, 1998, J GEOPHYS RES-SOL EA, V103, P24359, DOI 10.1029/98JB00792; Coutant O., 1996, ANN GEOFIS, V39, P253; Dodge DA, 1997, J GEOPHYS RES-SOL EA, V102, P24437, DOI 10.1029/97JB02024; Freed AM, 2001, NATURE, V411, P180, DOI 10.1038/35075548; Gao SS, 2000, J GEOPHYS RES-SOL EA, V105, P2955, DOI 10.1029/1999JB900383; Gwyther RL, 1996, GEOPHYS RES LETT, V23, P2425, DOI 10.1029/96GL02256; KANAMORI H, 1975, B SEISMOL SOC AM, V65, P1073; Langbein J, 1999, GEOPHYS RES LETT, V26, P2529, DOI 10.1029/1999GL900557; NADEAU R, 1994, B SEISMOL SOC AM, V84, P247; Nadeau RM, 1997, B SEISMOL SOC AM, V87, P1463; Nadeau RM, 1999, SCIENCE, V285, P718, DOI 10.1126/science.285.5428.718; NUR A, 1971, J GEOPHYS RES, V76, P2022, DOI 10.1029/JB076i008p02022; Snieder R, 2002, SCIENCE, V295, P2253, DOI 10.1126/science.1070015; Stein RS, 1999, NATURE, V402, P605, DOI 10.1038/45144; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006	18	69	82	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2003	426	6966					544	548		10.1038/nature02151	http://dx.doi.org/10.1038/nature02151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654837				2022-12-28	WOS:000186944300035
J	Sawalha, AH; Bronze, MS; Saint, S; Blevins, S; Kern, W				Sawalha, AH; Bronze, MS; Saint, S; Blevins, S; Kern, W			Step by step	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SYSTEMIC MASTOCYTOSIS		Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, Oklahoma City, OK 73104 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA; Ann Arbor Vet Affairs Hlth Serv Res & Dev Ctr Exc, Ann Arbor, MI USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Ann Arbor Vet Affairs Med Ctr, Patient Safety Enhancement Program, Ann Arbor, MI USA; Univ Michigan Hlth Syst, Ann Arbor, MI USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Sawalha, AH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, 825 NE 13th St OMRF MS 24, Oklahoma City, OK 73104 USA.	amr-sawalha@omrf.ouhsc.edu	Saint, Sanjay/AAF-5126-2019		AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P20HS011540] Funding Source: NIH RePORTER; AHRQ HHS [P20-HS11540] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Bain BJ, 1999, BRIT J HAEMATOL, V106, P9, DOI 10.1111/j.1365-2141.1999.01458.x; Casassus P, 2002, BRIT J HAEMATOL, V119, P1090, DOI 10.1046/j.1365-2141.2002.03944.x; FANNING SF, 1992, AUST NZ J MED, V22, P170, DOI 10.1111/j.1445-5994.1992.tb02802.x; GRANERUS G, 1983, J INVEST DERMATOL, V80, P410, DOI 10.1111/1523-1747.ep12555351; Hartmann K, 2000, HEMATOL ONCOL CLIN N, V14, P625, DOI 10.1016/S0889-8588(05)70299-9; HORAN RF, 1991, J INVEST DERMATOL, V96, pS5, DOI 10.1111/1523-1747.ep12468899; Ispas L, 2001, ANN ALLERG ASTHMA IM, V87, P6, DOI 10.1016/S1081-1206(10)62314-9; Jensen RT, 2000, HEMATOL ONCOL CLIN N, V14, P579, DOI 10.1016/S0889-8588(05)70298-7; KLUINNELEMANS HC, 1992, NEW ENGL J MED, V326, P619, DOI 10.1056/NEJM199202273260907; Kumar S, 2001, Pediatr Rev, V22, P33, DOI 10.1542/pir.22-1-33; Metcalfe DD, 2000, HEMATOL ONCOL CLIN N, V14, pXI, DOI 10.1016/S0889-8588(05)70292-6; Pardanani A, 2003, LANCET, V362, P535, DOI 10.1016/S0140-6736(03)14115-3; Parker RI, 2000, HEMATOL ONCOL CLIN N, V14, P557, DOI 10.1016/S0889-8588(05)70296-3; Schwartz LB, 2000, HEMATOL ONCOL CLIN N, V14, P641, DOI 10.1016/S0889-8588(05)70300-2; SWOLIN B, 1987, BLOOD, V70, P1928; Tharp MD, 2001, DERMATOL CLIN, V19, P679, DOI 10.1016/S0733-8635(05)70308-9; Topar G, 1998, AM J CLIN PATHOL, V109, P279, DOI 10.1093/ajcp/109.3.279; Worobec AS, 2000, HEMATOL ONCOL CLIN N, V14, P659, DOI 10.1016/S0889-8588(05)70301-4	18	2	2	1	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2003	349	23					2253	2257		10.1056/NEJMcps031245	http://dx.doi.org/10.1056/NEJMcps031245			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LH	14657433				2022-12-28	WOS:000186921700013
J	Venstrom, JM; McBride, MA; Rother, KI; Hirshberg, B; Orchard, TJ; Harlan, DM				Venstrom, JM; McBride, MA; Rother, KI; Hirshberg, B; Orchard, TJ; Harlan, DM			Survival after pancreas transplantation in patients with diabetes and preserved kidney function	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; COMPLICATIONS; MELLITUS; RECIPIENTS; REGISTRY; PROGNOSIS; MORTALITY; IMPACT; ONSET; ERA	Context Solitary pancreas transplantation (ie, pancreas alone or pancreas-after-kidney) for diabetes mellitus remains controversial due to procedure-associated morbidity/ mortality, toxicity of immunosuppression, expense, and unproven effects on the secondary complications of diabetes. Whether transplantation offers a survival advantage over conventional therapies for diabetes is unknown. Objective To determine the association between solitary pancreas transplantation and survival in patients with diabetes and preserved kidney function. Design, Setting, and Patients Retrospective observational cohort study conducted at 124 transplant centers in the United States, in 11572 patients with diabetes mellitus on the waiting list for pancreas transplantation (pancreas alone, pancreas-after-kidney, or simultaneous pancreas-kidney) at the United Network for Organ Sharing/ Organ Procurement and Transplantation Network between January 1, 1995, and December 31, 2000. All patients receiving a multiorgan (other than simultaneous pancreas-kidney) transplant were excluded, as were those listed for solitary pancreas transplantation who had a serum creatinine level greater than 2 mg/dL (176.8 mumol/L) at time of listing, or who ultimately received a simultaneous pancreas-kidney transplant. Main Outcome Measure All-cause mortality Within 4 years following transplantation (or within a comparable time on the waiting list for the group not undergoing transplantation). Results Overall relative risk of all-cause mortality for transplant recipients (compared with patients awaiting the same procedure) over 4 years of follow-up was 1.57 (95% confidence interval [CI], 0.98-2.53; P=.06) for pancreas transplant alone, 1.42 (95% Cl, 1.03-1.94; P=.03) for pancreas-after-kidney transplant, and 0.43 (95% Cl, 0.39-0.48) for simultaneous pancreas-kidney transplant. Transplant patient 1 - and 4-year survival rates were 96.5% and 85.2% for pancreas transplant alone, respectively, and 95.3% and 84.5% for pancreas-after-kidney transplant, while 1 - and 4-year survival rates for patients on the waiting list were 97.6% and 92.1% for pancreas transplant alone, respectively, and 97.1% and 88.1% for pancreas-after-kidney transplant. Conclusion From 1995-2000, survival for those with diabetes and preserved kidney function and receiving a solitary pancreas transplant was significantly worse compared with the survival of waiting-list patients receiving conventional therapy.	NIDDKD, Transplantat & Autoimmun Branch, NIH, US Dept HHS, Bethesda, MD 20892 USA; Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; United Network Organ Sharing, Richmond, VA USA; Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Vanderbilt University; United Network for Organ Sharing; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Uniformed Services University of the Health Sciences - USA	Harlan, DM (corresponding author), NIDDKD, Transplantat & Autoimmun Branch, NIH, US Dept HHS, 10 Ctr Dr,Bldg 10,Room 8N307, Bethesda, MD 20892 USA.			orchard, trevor/0000-0001-9552-3215	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK062000] Funding Source: NIH RePORTER; PHS HHS [231-00-0115] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bunnapradist S, 2003, J AM SOC NEPHROL, V14, P208, DOI 10.1097/01.ASN.0000037678.54984.41; DECKERT T, 1978, DIABETOLOGIA, V14, P363, DOI 10.1007/BF01228130; DECKERT T, 1978, DIABETOLOGIA, V14, P371, DOI 10.1007/BF01228131; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; GROSS CR, 1992, CLIN TRANSPLANT, V6, P165; Gross CR, 1998, CLIN TRANSPLANT, V12, P351; Gruessner AC, 2001, TRANSPLANT P, V33, P1643, DOI 10.1016/S0041-1345(00)02625-7; Gruessner RWG, 1997, TRANSPLANTATION, V64, P1572, DOI 10.1097/00007890-199712150-00011; Gruessner RWG, 1997, J AM COLL SURGEONS, V185, P128, DOI 10.1016/S1072-7515(01)00895-X; Hosenpud JD, 1998, LANCET, V351, P24, DOI 10.1016/S0140-6736(97)06405-2; Humar A, 2000, ANN SURG, V231, P269, DOI 10.1097/00000658-200002000-00017; KATZ H, 1991, NEW ENGL J MED, V325, P1278, DOI 10.1056/NEJM199110313251804; Landgraf R, 1996, DIABETOLOGIA, V39, P1415, DOI 10.1007/s001250050593; Luzi L, 1998, NEW ENGL J MED, V339, P115, DOI 10.1056/NEJM199807093390210; Nishimura R, 2001, DIABETES CARE, V24, P823, DOI 10.2337/diacare.24.5.823; Ojo AO, 2001, TRANSPLANTATION, V71, P82, DOI 10.1097/00007890-200101150-00014; Piehlmeier W, 1996, EUR J SURG, V162, P933; PIEHLMEIER W, 1991, DIABETOLOGIA S1, V34, P150; Reddy KS, 2003, AM J KIDNEY DIS, V41, P464, DOI 10.1053/ajkd.2003.50057; Robertson R Paul, 2003, Diabetes Care, V26 Suppl 1, pS120; Robertson RP, 1998, J CLIN ENDOCR METAB, V83, P1868, DOI 10.1210/jc.83.6.1868; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sutherland DER, 1999, TRANSPLANT P, V31, P597, DOI 10.1016/S0041-1345(98)01573-5; Sutherland DER, 2001, ANN SURG, V233, P463, DOI 10.1097/00000658-200104000-00003; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	25	217	225	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2817	2823		10.1001/jama.290.21.2817	http://dx.doi.org/10.1001/jama.290.21.2817			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QP	14657065				2022-12-28	WOS:000186872800023
J	Wood, WB; Gentile, JM				Wood, WB; Gentile, JM			Education - Teaching in a research context	SCIENCE			English	Editorial Material									Univ Colorado, Boulder, CO 80309 USA; Hope Coll, Holland, MI 49423 USA	University of Colorado System; University of Colorado Boulder; Hope College	Wood, WB (corresponding author), Univ Colorado, Boulder, CO 80309 USA.							Alberts B, 2003, SCIENCE, V302, P1504; Bransford JD., 2000, PEOPLE LEARN; Cech TR, 2003, SCIENCE, V299, P165, DOI 10.1126/science.299.5604.165; Crouch CH, 2001, AM J PHYS, V69, P970, DOI 10.1119/1.1374249; Gollub J. P., 2002, LEARNING UNDERSTANDI; Hackerman N., 2003, EVALUATING IMPROVING; Hake RR, 1998, AM J PHYS, V66, P64, DOI 10.1119/1.18809; Hestenes D., 1992, PHYS TEACH, V30, P141, DOI [DOI 10.1119/1.2343497, https://doi.org/10.1119/1.2343497]; Klymkowsky Michael W, 2003, Cell Biol Educ, V2, P155, DOI 10.1187/cbe.03-03-0014; MCCRAY RA, 2003, IMPROVING UNDERGRADU; Mulford DR, 2002, J CHEM EDUC, V79, P739, DOI 10.1021/ed079p739; *NRC, 1999, TRANSF UND ED SCI MA; NRC, 1997, SCI TEACH REC HDB; STRYER L, 2003, BIO2010 TRANSFORMING; SCALE UP STUDENT CTR	15	23	26	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 28	2003	302	5650					1510	1510		10.1126/science.1091803	http://dx.doi.org/10.1126/science.1091803			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JV	14645829				2022-12-28	WOS:000186802200022
J	Gonnermann, HM; Manga, M				Gonnermann, HM; Manga, M			Explosive volcanism may not be an inevitable consequence of magma fragmentation	NATURE			English	Article							NON-NEWTONIAN RHEOLOGY; VESICULATING MAGMAS; CLIMACTIC ERUPTION; SILICATE MELTS; LAVA FLOW; VISCOSITY; ASCENT; TRANSITION; DYNAMICS; RHYOLITE	The fragmentation of magma, containing abundant gas bubbles, is thought to be the defining characteristic of explosive eruptions(1-3). When viscous stresses associated with the growth of bubbles and the flow of the ascending magma exceed the strength of the melt(2,4-6), the magma breaks into disconnected fragments suspended within an expanding gas phase. Although repeated effusive and explosive eruptions for individual volcanoes are common(7,8), the dynamics governing the transition between explosive and effusive eruptions remain unclear. Magmas for both types of eruptions originate from sources with similar volatile content, yet effusive lavas erupt considerably more degassed than their explosive counterparts(7,8). One mechanism for degassing during magma ascent, consistent with observations, is the generation of intermittent permeable fracture networks generated by non-explosive fragmentation near the conduit walls(9-11). Here we show that such fragmentation can occur by viscous shear in both effusive and explosive eruptions. Moreover, we suggest that such fragmentation may be important for magma degassing and the inhibition of explosive behaviour. This implies that, contrary to conventional views, explosive volcanism is not an inevitable consequence of magma fragmentation.	Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Gonnermann, HM (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.		Manga, Michael/D-3847-2013; Gonnermann, Helge M/B-1054-2012	Manga, Michael/0000-0003-3286-4682				Blower JD, 2001, B VOLCANOL, V63, P497; Boudon G, 1998, GEOPHYS RES LETT, V25, P3693, DOI 10.1029/98GL00985; Dingwell DB, 1996, SCIENCE, V273, P1054, DOI 10.1126/science.273.5278.1054; DINGWELL DB, 1989, PHYS CHEM MINER, V16, P508; EICHELBERGER JC, 1995, ANNU REV EARTH PL SC, V23, P41, DOI 10.1146/annurev.ea.23.050195.000353; Goto A, 1999, GEOPHYS RES LETT, V26, P2541, DOI 10.1029/1999GL900569; Gottsmann J, 2002, B VOLCANOL, V64, P410, DOI 10.1007/s00445-002-0220-7; Hess KU, 1996, AM MINERAL, V81, P1297; JAUPART C, 1991, EARTH PLANET SC LETT, V102, P413, DOI 10.1016/0012-821X(91)90032-D; Klug C, 1996, B VOLCANOL, V58, P87, DOI 10.1007/s004450050128; Klug C, 2002, B VOLCANOL, V64, P486, DOI 10.1007/s00445-002-0230-5; Lensky NG, 2001, EARTH PLANET SC LETT, V186, P1, DOI 10.1016/S0012-821X(01)00227-8; Llewellin EW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015697; Manga M, 2001, J VOLCANOL GEOTH RES, V105, P19, DOI 10.1016/S0377-0273(00)00239-0; Martel C, 2001, B VOLCANOL, V63, P398, DOI 10.1007/s004450100157; MASTIN LG, 2002, GEOCHEM GEOPHYS GEOS, V3; NEWMAN S, 1988, J VOLCANOL GEOTH RES, V35, P75, DOI 10.1016/0377-0273(88)90007-8; Pal R, 2003, EARTH PLANET SC LETT, V207, P165, DOI 10.1016/S0012-821X(02)01104-4; Papale P, 1999, NATURE, V397, P425, DOI 10.1038/17109; Polacci M, 2001, B VOLCANOL, V63, P83, DOI 10.1007/s004450000123; PROUSSEVITCH AA, 1993, J GEOPHYS RES, V3, P22283; Pyle D.M., 2000, ENCY VOLCANOES, P263, DOI DOI 10.1016/B978-0-12-385938-9.00013-4; Rust AC, 2002, J NON-NEWTON FLUID, V104, P53, DOI 10.1016/S0377-0257(02)00013-7; SIMMONS JH, 1982, J APPL PHYS, V53, P4075, DOI 10.1063/1.331272; Smith JV, 1996, J VOLCANOL GEOTH RES, V72, P217, DOI 10.1016/0377-0273(96)00009-1; Stasiuk MV, 1996, B VOLCANOL, V58, P117, DOI 10.1007/s004450050130; Tuffen H, 2003, GEOLOGY, V31, P1089, DOI 10.1130/G19777.1; Villemant B, 1998, NATURE, V392, P65, DOI 10.1038/32144; WEBB SL, 1990, PHYS CHEM MINER, V17, P125, DOI 10.1007/BF00199663; WEBB SL, 1990, J GEOPHYS RES-SOLID, V95, P15695, DOI 10.1029/JB095iB10p15695	30	257	261	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					432	435		10.1038/nature02138	http://dx.doi.org/10.1038/nature02138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647379				2022-12-28	WOS:000186800800035
J	Xiong, W; Ferrell, JE				Xiong, W; Ferrell, JE			A positive-feedback-based bistable 'memory module' that governs a cell fate decision	NATURE			English	Article							XENOPUS OOCYTE MATURATION; RANA PIPIENS OOCYTES; MAP KINASE; INHIBITORY KINASE; CYCLIN-B; ACTIVATION; PROTEIN; MOS; DIFFERENTIATION; INITIATION	The maturation of Xenopus oocytes can be thought of as a process of cell fate induction, with the immature oocyte representing the default fate and the mature oocyte representing the induced fate(1,2). Crucial mediators of Xenopus oocyte maturation, including the p42 mitogen-activated protein kinase (MAPK) and the cell-division cycle protein kinase Cdc2, are known to be organized into positive feedback loops(3). In principle, such positive feedback loops could produce an actively maintained 'memory' of a transient inductive stimulus and could explain the irreversibility of maturation(3-6). Here we show that the p42 MAPK and Cdc2 system normally generates an irreversible biochemical response from a transient stimulus, but the response becomes transient when positive feedback is blocked. Our results explain how a group of intrinsically reversible signal transducers can generate an irreversible response at a systems level, and show how a cell fate can be maintained by a self-sustaining pattern of protein kinase activation.	Stanford Univ, Dept Mol Pharmacol, Sch Med, Stanford, CA 94305 USA	Stanford University	Ferrell, JE (corresponding author), Stanford Univ, Dept Mol Pharmacol, Sch Med, Stanford, CA 94305 USA.							Abrieu A, 2001, J CELL SCI, V114, P257; Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bosch E, 1997, ONCOGENE, V15, P1021, DOI 10.1038/sj.onc.1201270; DETTLAFF TA, 1966, J EMBRYOL EXP MORPH, V16, P183; Dupre A, 2002, EMBO J, V21, P4026, DOI 10.1093/emboj/cdf400; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GOTOH Y, 1995, J BIOL CHEM, V270, P25898, DOI 10.1074/jbc.270.43.25898; Groisman I, 2002, CELL, V109, P473, DOI 10.1016/S0092-8674(02)00733-X; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; KUMAGAI A, 1992, CELL, V70, P139, DOI 10.1016/0092-8674(92)90540-S; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Matten WT, 1996, DEV BIOL, V179, P485, DOI 10.1006/dbio.1996.0277; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; NEBREDA AR, 1995, EMBO J, V14, P5597, DOI 10.1002/j.1460-2075.1995.tb00247.x; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; ROY LM, 1991, J CELL BIOL, V113, P507, DOI 10.1083/jcb.113.3.507; Roy LM, 1996, ONCOGENE, V12, P2203; SCHUETZ AW, 1967, J EXP ZOOL, V166, P347, DOI 10.1002/jez.1401660307; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; SMITH LD, 1968, DEV BIOL, V17, P627, DOI 10.1016/0012-1606(68)90010-9; Sohaskey ML, 1999, MOL BIOL CELL, V10, P3729, DOI 10.1091/mbc.10.11.3729; Thomas R, 2001, CHAOS, V11, P170, DOI 10.1063/1.1350439; YEW N, 1992, NATURE, V355, P649, DOI 10.1038/355649a0	30	555	569	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 27	2003	426	6965					460	465		10.1038/nature02089	http://dx.doi.org/10.1038/nature02089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	747JE	14647386				2022-12-28	WOS:000186800800042
J	Mootha, VK; Bunkenborg, J; Olsen, JV; Hjerrild, M; Wisniewski, JR; Stahl, E; Bolouri, MS; Ray, HN; Sihag, S; Kamal, M; Patterson, N; Lander, ES; Mann, M				Mootha, VK; Bunkenborg, J; Olsen, JV; Hjerrild, M; Wisniewski, JR; Stahl, E; Bolouri, MS; Ray, HN; Sihag, S; Kamal, M; Patterson, N; Lander, ES; Mann, M			Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria	CELL			English	Article							MASS-SPECTROMETRY; CYTOCHROME-C; SEQUENCE DATABASES; PROTEOMIC ANALYSIS; IDENTIFICATION; EXPRESSION; APOPTOSIS; SUBUNIT; COMPLEX; ORIGIN	Mitochondria are tailored to meet the metabolic and signaling needs of each cell. To explore its molecular composition, we performed a proteomic survey of mitochondria from mouse brain, heart, kidney, and liver and combined the results with existing gene annotations to produce a list of 591 mitochondrial proteins, including 163 proteins not previously associated with this organelle. The protein expression data were largely concordant with large-scale surveys of RNA abundance and both measures indicate tissue-specific differences in organelle composition. RNA expression profiles across tissues revealed networks of mitochondrial genes that share functional and regulatory mechanisms. We also determined a larger "neighborhood" of genes whose expression is closely correlated to the mitochondrial genes. The combined analysis identifies specific genes of biological interest, such as candidates for mtDNA repair enzymes, offers new insights into the biogenesis and ancestry of mammalian mitochondria, and provides a framework for understanding the organelle's contribution to human disease.	MIT, Ctr Genome Res, Whitehead Inst, Cambridge, MA 02139 USA; MDS Proteom, DK-5230 Odense, Denmark; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Univ So Denmark, Ctr Expt Bioinformat, DK-5230 Odense, Denmark; MIT, Dept Biol, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Southern Denmark; Massachusetts Institute of Technology (MIT)	Lander, ES (corresponding author), MIT, Ctr Genome Res, Whitehead Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lander@genome.wi.mit.edu; mann@bmb.sdu.dk	Mann, Matthias/A-3454-2013; Olsen, Jesper/ABH-4638-2020; Olsen, Jesper/C-4738-2008	Mann, Matthias/0000-0003-1292-4799; Olsen, Jesper/0000-0002-4747-4938; Bunkenborg, Jakob/0000-0002-2908-9323				Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO;2-8; CHI NW, 1994, J BIOL CHEM, V269, P29984; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Endele S, 1999, GENOMICS, V60, P218, DOI 10.1006/geno.1999.5881; Fearnley IM, 2001, J BIOL CHEM, V276, P38345, DOI 10.1074/jbc.C100444200; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; GHADIALLY FN, 1997, ULTRASTRUCTURAL PATH, V1; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hardman RA, 2001, CANCER RES, V61, P1392; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Karlberg O, 2000, YEAST, V17, P170, DOI 10.1002/1097-0061(20000930)17:3<170::AID-YEA25>3.0.CO;2-V; KLAUSNER RD, 1989, SCIENCE, V246, P870, DOI 10.1126/science.2683086; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lian Z, 2001, BLOOD, V98, P513, DOI 10.1182/blood.V98.3.513; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Lopez MF, 2000, ELECTROPHORESIS, V21, P3427, DOI 10.1002/1522-2683(20001001)21:16<3427::AID-ELPS3427>3.0.CO;2-L; Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; Marc P, 2002, EMBO REP, V3, P159, DOI 10.1093/embo-reports/kvf025; Mason PA, 2003, NUCLEIC ACIDS RES, V31, P1052, DOI 10.1093/nar/gkg167; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Ozawa T, 2003, NAT BIOTECHNOL, V21, P287, DOI 10.1038/nbt791; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PULGSERVER P, 2003, ENDOCR REV, V24, P78; Rabilloud T, 1998, ELECTROPHORESIS, V19, P1006, DOI 10.1002/elps.1150190616; Samuel SJ, 1997, HEPATOLOGY, V25, P1213, DOI 10.1002/hep.510250525; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Scharfe C, 2000, NUCLEIC ACIDS RES, V28, P155, DOI 10.1093/nar/28.1.155; STREYER L, 1988, BIOCHEMISTRY; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; VELTRI KL, 1990, J CELL PHYSIOL, V143, P160, DOI 10.1002/jcp.1041430122; Vijayasarathy C, 1998, BBA-BIOMEMBRANES, V1371, P71, DOI 10.1016/S0005-2736(97)00278-2; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Westermann B, 2003, NAT BIOTECHNOL, V21, P239, DOI 10.1038/nbt0303-239	49	683	728	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 26	2003	115	5					629	640		10.1016/S0092-8674(03)00926-7	http://dx.doi.org/10.1016/S0092-8674(03)00926-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651853	Bronze			2022-12-28	WOS:000186885600012
J	Lewcock, JW; Reed, RR				Lewcock, JW; Reed, RR			ORs rule the roost in the olfactory system	SCIENCE			English	Editorial Material							ODORANT RECEPTOR EXPRESSION; GENE-EXPRESSION; EPITHELIUM; TRANSGENE; MOUSE; MAP		Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Lewcock, JW (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.							Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Ebrahimi FAW, 2000, DEV DYNAM, V217, P225, DOI 10.1002/(SICI)1097-0177(200002)217:2<225::AID-DVDY9>3.0.CO;2-3; LEWCOCK JW, IN PRESS P NATL ACAD; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Qasba P, 1998, J NEUROSCI, V18, P227; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	14	10	11	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 19	2003	302	5653					2078	2079		10.1126/science.1093397	http://dx.doi.org/10.1126/science.1093397			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755CB	14684811				2022-12-28	WOS:000187385200031
J	Kmietowicz, Z				Kmietowicz, Z			Information for patients: Getting professional help	BRITISH MEDICAL JOURNAL			English	Article									BMJ Publishing Grp, London WC1H 9JR, England	BMJ Publishing Group Ltd	Kmietowicz, Z (corresponding author), BMJ Publishing Grp, London WC1H 9JR, England.								0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 13	2003	327	7428					1396	1396		10.1136/bmj.327.7428.1396	http://dx.doi.org/10.1136/bmj.327.7428.1396			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670891	Green Published			2022-12-28	WOS:000187417900029
J	Takwale, A; Tan, E; Agarwal, S; Barclay, G; Ahmed, I; Hotchkiss, K; Thompson, JR; Chapman, T; Berth-Jones, J				Takwale, A; Tan, E; Agarwal, S; Barclay, G; Ahmed, I; Hotchkiss, K; Thompson, JR; Chapman, T; Berth-Jones, J			Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomised, double blind, placebo controlled, parallel group trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EVENING PRIMROSE OIL; FATTY-ACIDS; DERMATITIS	Objective To study the efficacy and tolerability of borage oil, which contains a high concentration of gamma linolenic acid, in children and adults with atopic eczema. Design Single centre, randomised, double blind, placebo controlled, parallel group trial. Setting Acute district general hospital in Nuneaton, England. Participants 151 patients, of whom 11 failed to return for assessment, leaving an evaluable population of 140 (including 69 children). Intervention Adults received four capsules of borage oil twice daily (920 mg gamma linolenic acid), and children received two capsules twice daily, for 12 weeks. Main outcome measures Change in total sign score at 12 weeks measured with the six area, six signs atopic dermatitis (SASSAD) score (primary endpoint); symptom scores, assessed on visual analogue scales; topical corticosteroid requirement, assessed on a five point scale; global assessment of response by participants; adverse events and tolerability. Results The mean SASSAD score fell from 30 to 27 in the borage oil group and from 28 to 23 in the placebo group. The difference between the mean improvements in the two groups was 1.4 (95%, confidence interval - 2.2 to 5.0) points in favour of placebo (P = 0.45). No significant differences occurred between treatment groups in the other assessments. Subset analysis of adults and children did not indicate any difference in response. The treatments were well tolerated. Conclusion gamma linolenic acid is not beneficial in atopic dermatitis.	George Eliot Hosp, Dept Dermatol, Nuneaton CV10 7DJ, England; Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England	University of Leicester	Berth-Jones, J (corresponding author), George Eliot Hosp, Dept Dermatol, Nuneaton CV10 7DJ, England.	johnberthjones@aol.com						BAMFORD JTM, 1985, J AM ACAD DERMATOL, V13, P959, DOI 10.1016/S0190-9622(85)70245-9; Berth-Jones J, 2000, CUTANEOUS BIOMETRICS, P109; BerthJones J, 1996, BRIT J DERMATOL, V135, P25, DOI 10.1111/j.1365-2133.1996.tb00706.x; BERTHJONES J, 1993, LANCET, V341, P1557, DOI 10.1016/0140-6736(93)90697-F; BORDONI A, 1988, DRUG EXP CLIN RES, V14, P291; HANIFIN JM, 1980, ACTA DERM-VENEREOL S, V92, P44, DOI [10.2340/00015555924447, DOI 10.2340/00015555924447]; Henz BM, 1999, BRIT J DERMATOL, V140, P685, DOI 10.1046/j.1365-2133.1999.02771.x; Hoare C, 2000, Health Technol Assess, V4, P1; MELNIK B, 1992, ACTA DERM-VENEREOL, P77; MORSE PF, 1989, BRIT J DERMATOL, V121, P75, DOI 10.1111/j.1365-2133.1989.tb01403.x; RAEDERSTORFF D, 1992, LIPIDS, V27, P1018, DOI 10.1007/BF02535582; SCHALINKARRILA M, 1987, BRIT J DERMATOL, V117, P11, DOI 10.1111/j.1365-2133.1987.tb04085.x; WRIGHT S, 1991, BRIT J DERMATOL, V125, P503, DOI 10.1111/j.1365-2133.1991.tb14786.x; WRIGHT S, 1982, LANCET, V2, P1120	14	42	44	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2003	327	7428					1385	1387		10.1136/bmj.327.7428.1385	http://dx.doi.org/10.1136/bmj.327.7428.1385			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670885	Green Published, Bronze			2022-12-28	WOS:000187417900024
J	Birnbaum, K; Shasha, DE; Wang, JY; Jung, JW; Lambert, GM; Galbraith, DW; Benfey, PN				Birnbaum, K; Shasha, DE; Wang, JY; Jung, JW; Lambert, GM; Galbraith, DW; Benfey, PN			A gene expression map of the Arabidopsis root	SCIENCE			English	Article							LASER CAPTURE MICRODISSECTION; COMPUTATIONAL ANALYSIS; CHROMOSOMAL DOMAINS; DIFFERENTIATION; REVEALS; PHLOEM; CELLS	A global map of gene expression within an organ can identify genes with coordinated expression in localized domains, thereby relating gene activity to cell fate and tissue specialization. Here, we present localization of expression of more than 22,000 genes in the Arabidopsis root. Gene expression was mapped to 15 different zones of the root that correspond to cell types and tissues at progressive developmental stages. Patterns of gene expression traverse traditional anatomical boundaries and show cassettes of hormonal response. Chromosomal clustering defined some coregulated genes. This expression map correlates groups of genes to specific cell fates and should serve to guide reverse genetics.	Duke Univ, Dept Biol, Durham, NC 27708 USA; NYU, Dept Biol, New York, NY 10003 USA; NYU, Courant Inst Math Sci, New York, NY 10003 USA; Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA	Duke University; New York University; New York University; University of Arizona	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Box 91000, Durham, NC 27708 USA.		Galbraith, David/AAG-8891-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM020716] Funding Source: NIH RePORTER; NIGMS NIH HHS [5 F32 GM20716-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asano T, 2002, PLANT J, V32, P401, DOI 10.1046/j.1365-313X.2002.01423.x; BENFEY PN, 1994, TRENDS GENET, V10, P84, DOI 10.1016/0168-9525(94)90230-5; Berleth T, 2000, CURR OPIN PLANT BIOL, V3, P406, DOI 10.1016/S1369-5266(00)00104-7; BIRNBAUM K, UNPUB; BONKE M, IN PRESS NATURE; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Jasper H, 2002, DEV CELL, V3, P511, DOI 10.1016/S1534-5807(02)00297-6; Kerk NM, 2003, PLANT PHYSIOL, V132, P27, DOI 10.1104/pp.102.018127; Lee MM, 1999, CELL, V99, P473, DOI 10.1016/S0092-8674(00)81536-6; Lin Y, 2001, DEVELOPMENT, V128, P3697; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Milioni D, 2002, PLANT CELL, V14, P2813, DOI 10.1105/tpc.005231; Murdock LL, 2002, J AGR FOOD CHEM, V50, P6605, DOI 10.1021/jf020192c; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; TRUERNIT E, 1995, PLANTA, V196, P564, DOI 10.1007/BF00203657; Wittstock U, 2002, TRENDS PLANT SCI, V7, P263, DOI 10.1016/S1360-1385(02)02273-2; Wysocka-Diller JW, 2000, DEVELOPMENT, V127, P595	21	921	958	7	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652					1956	1960		10.1126/science.1090022	http://dx.doi.org/10.1126/science.1090022			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671301				2022-12-28	WOS:000187174000058
J	Sharshar, T; Gray, F; de la Grandmaison, GL; Hopkinson, NS; Ross, E; Dorandeu, A; Orlikowski, D; Raphael, JC; Gajdos, P; Annane, D				Sharshar, T; Gray, F; de la Grandmaison, GL; Hopkinson, NS; Ross, E; Dorandeu, A; Orlikowski, D; Raphael, JC; Gajdos, P; Annane, D			Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock	LANCET			English	Article							HEART-RATE-VARIABILITY; SPECTRAL-ANALYSIS; SEPSIS; ACTIVATION; MODULATION; EXPRESSION; MICROGLIA; BRAIN; SCORE	Background Results of experimental and clinical studies have shown that septic shock is associated with cardiovascular autonomic failure. Thus, we aimed to investigate the existence of ischaemia and apoptosis within the cerebral autonomic centres that control the cardiovascular system in patients with septic shock. Methods In a prospective cohort study, we did post-mortem examinations of supraoptic and paraventricular nuclei, cerebral amygdala, locus coeruleus, and medullary autonomic nuclei in 19 patients with septic shock, seven with non-septic shock and five who died suddenly from extracranial injury. Ischaemic and apoptotic neurons and microglial cells, and expression of tumour necrosis factor alpha (TNFalpha) and inducible nitric oxide synthase (iNOS) were scored. Findings Ischaemic, neuronal, and microglial apoptosis scores differed between groups (p=0.0007, p<0.0001, and p=0.0037, respectively) and were higher in patients with septic shock than in those with non-septic shock (p=0.0033, p=0.0005, and p=0.0235, respectively), and extra-cranial injury related deaths (p=0.0027, p=0.0007, and p=0.0045, respectively). There was little microglial activation and glial expression of TNF alpha. The scores for endothelial iNOS expression were different between the three groups (p<0.0001), and were higher in septic shock than in nonseptic shock (p=0.0009) and than in extracranial injury related deaths (p=0.0007). Vascular expression of iNOS also correlated (Spearman tau=0.57) with autonomic-centre neuronal apoptosis in the combined septic and non-septic shock group. Interpretation Septic shock is associated with neuronal and glial apoptosis within the autonomic centres, which is strongly associated with endothelial iNOS expression.	Hop Raymond Poincare APHP, Fac Med Paris, Serv Reanimat Med, Garches, France; Hop Raymond Poincare APHP, Fac Med Paris, Serv Anat Pathol & Med Legale, Garches, France; Royal Brompton & Harefield NHS Trust, Resp Muscle Lab, London, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital	Annane, D (corresponding author), Hop Raymond Poincare APHP, Fac Med Paris, Serv Reanimat Med, Garches, France.	djillali.annane@rpc.ap-hop-paris.fr	Sharshar, Tarek/ABF-4117-2021; orlikowski, david/R-2162-2019; Annane, Djillali/R-7947-2019; Orlikowski, David/R-8482-2018					Adle-Biassette H, 1999, NEUROPATH APPL NEURO, V25, P123; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 1997, ANN NEUROL, V41, P298; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; Annane D, 1999, AM J RESP CRIT CARE, V160, P458, DOI 10.1164/ajrccm.160.2.9810073; BOLTON CF, 1993, ANN NEUROL, V33, P94, DOI 10.1002/ana.410330115; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Braun JS, 2001, J INFECT DIS, V184, P1300, DOI 10.1086/324013; BREDER CD, 1994, P NATL ACAD SCI USA, V91, P11393, DOI 10.1073/pnas.91.24.11393; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Combs CK, 2001, J NEUROSCI, V21, P1179; Garrard C S, 1993, Clin Auton Res, V3, P5, DOI 10.1007/BF01819137; Godin PJ, 1996, CRIT CARE MED, V24, P1117, DOI 10.1097/00003246-199607000-00009; GOLDSTEIN B, 1995, CRIT CARE MED, V23, P1694, DOI 10.1097/00003246-199510000-00014; Korach M, 2001, CRIT CARE MED, V29, P1380, DOI 10.1097/00003246-200107000-00013; Landry DW, 1997, CIRCULATION, V95, P1122; Lee P, 2001, BRAIN RES, V892, P380, DOI 10.1016/S0006-8993(00)03257-1; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Liu B, 2001, J NEUROCHEM, V77, P182, DOI 10.1046/j.1471-4159.2001.t01-1-00216.x; PARRILLO JE, 1990, ANN INTERN MED, V113, P227, DOI 10.7326/0003-4819-113-3-227; Persson PB, 1996, PHYSIOL REV, V76, P193, DOI 10.1152/physrev.1996.76.1.193; PIEPOLI M, 1995, INTENS CARE MED, V21, P112, DOI 10.1007/BF01726532; Sharshar T, 2002, CRIT CARE MED, V30, P2371, DOI 10.1097/00003246-200210000-00031; SPRUNG CL, 1990, CRIT CARE MED, V18, P801, DOI 10.1097/00003246-199008000-00001; vandeBorne P, 1997, CIRCULATION, V95, P1449; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Winchell RJ, 1996, J SURG RES, V63, P11, DOI 10.1006/jsre.1996.0214; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	28	216	238	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2003	362	9398					1799	1805		10.1016/S0140-6736(03)14899-4	http://dx.doi.org/10.1016/S0140-6736(03)14899-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QQ	14654318				2022-12-28	WOS:000186872900011
J	Gunjan, A; Verreault, A				Gunjan, A; Verreault, A			A Rad53 kinase-dependent surveillsnce mechanism 3that regulates histone protein levels6 in S. cerevisiae	CELL			English	Article							STALLED REPLICATION FORKS; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; CHECKPOINT PATHWAYS; PHASE CHECKPOINT; BUDDING YEAST; MESSENGER-RNA; CHROMATIN; DAMAGE; PROGRESSION	Rad53 and Mec1 are protein kinases required for DNA replication and recovery from DNA damage in Saccharomyces cerevisiae. Here, we show that rad53, but not mec1 mutants, are extremely sensitive to histone overexpression, as Rad53 is required for degradation of excess histones. Consequently, excess histones accumulate in rad53 mutants, resulting in slow growth, DNA damage sensitivity, and chromosome loss phenotypes that are significantly suppressed by a reduction in histone gene dosage. Rad53 monitors excess histones by associating with them in a dynamic complex that is modulated by its kinase activity. Our results argue that Rad53 contributes to genome stability independently of Mec1 by preventing the damaging effects of excess histones both during normal cell cycle progression and in response to DNA damage.	Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Verreault, A (corresponding author), Canc Res UK, London Res Inst, Clare Hall Labs, Blanche Lane, S Mimms EN6 3LD, Herts, England.			Gunjan, Akash/0000-0001-8478-3978				Berloco M, 2001, P NATL ACAD SCI USA, V98, P12126, DOI 10.1073/pnas.211428798; BONNER WM, 1988, BIOCHEMISTRY-US, V27, P6542, DOI 10.1021/bi00417a052; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; COMMERFORD SL, 1982, P NATL ACAD SCI-BIOL, V79, P1163, DOI 10.1073/pnas.79.4.1163; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; DILWORTH SM, 1987, CELL, V51, P1009, DOI 10.1016/0092-8674(87)90587-3; Dominski Z, 2003, MOL CELL, V12, P295, DOI 10.1016/S1097-2765(03)00278-8; Downs JA, 2003, MOL CELL, V11, P1685, DOI 10.1016/S1097-2765(03)00197-7; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; Fay DS, 1997, CURR GENET, V31, P97, DOI 10.1007/s002940050181; FRANCESCONI S, 1991, P NATL ACAD SCI USA, V88, P3877, DOI 10.1073/pnas.88.9.3877; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; HAAS A, 1990, J BIOL CHEM, V265, P21664; HAN M, 1987, CELL, V48, P589, DOI 10.1016/0092-8674(87)90237-6; Holmes SG, 2001, YEAST, V18, P291, DOI 10.1002/1097-0061(20010315)18:4<291::AID-YEA668>3.0.CO;2-V; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Klein HL, 2001, GENETICS, V159, P1501; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; Melo JA, 2001, GENE DEV, V15, P2809; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; Nelson DM, 2002, MOL CELL BIOL, V22, P7459, DOI 10.1128/MCB.22.21.7459-7472.2002; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; PICKART CM, 1988, J BIOL CHEM, V263, P15076; Quivy JP, 2001, EMBO J, V20, P2015, DOI 10.1093/emboj/20.8.2015; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; SOGO JM, 1986, J MOL BIOL, V189, P189, DOI 10.1016/0022-2836(86)90390-6; Steger DJ, 1999, METHODS, V19, P410, DOI 10.1006/meth.1999.0877; Sullivan E, 2001, GENE DEV, V15, P173, DOI 10.1101/gad.862801; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Sutton A, 2001, GENETICS, V158, P587; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; van Beekvelt CA, 2001, NUCLEIC ACIDS RES, V29, P5001, DOI 10.1093/nar/29.24.5001; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; WOODLAND HR, 1977, DEV BIOL, V57, P118, DOI 10.1016/0012-1606(77)90359-1; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Zhao XL, 2001, EMBO J, V20, P3544, DOI 10.1093/emboj/20.13.3544; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	47	237	242	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	NOV 26	2003	115	5					537	549		10.1016/S0092-8674(03)00896-1	http://dx.doi.org/10.1016/S0092-8674(03)00896-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	748XE	14651846	Bronze			2022-12-28	WOS:000186885600005
J	Yildiz, A; Tomishige, M; Vale, RD; Selvin, PR				Yildiz, A; Tomishige, M; Vale, RD; Selvin, PR			Kinesin walks hand-over-hand	SCIENCE			English	Article							MYOSIN-V; MOTOR; MOTILITY; MOVEMENT; BINDING	Kinesin is a processive motor that takes 8.3-nm center-of-mass steps along microtubules for each adenosine triphosphate hydrolyzed. Whether kinesin moves by a "hand-over-hand" or an "inchworm" model has been controversial. We have labeled a single head of the kinesin dimer with a Cy3 fluorophore and localized the position of the dye to within 2 nm before and after a step. We observed that single kinesin heads take steps of 17.3 +/- 3.3 nm. A kinetic analysis of the dwell times between steps shows that the 17-nm steps alternate with 0-nm steps. These results strongly support a hand-over-hand mechanism, and not an inchworm mechanism. In addition, our results suggest that kinesin is bound by both heads to the microtubule while it waits for adenosine triphosphate in between steps.	Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Phys, Urbana, IL 61801 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94107 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94107 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Selvin, PR (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	selvin@uiuc.edu	Yildiz, Ahmet/E-6167-2015	Yildiz, Ahmet/0000-0003-4792-174X	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044420, R29AR044420, P01AR042895] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR44420, AR42895] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ali MY, 2002, NAT STRUCT BIOL, V9, P464, DOI 10.1038/nsb803; Asenjo AB, 2003, NAT STRUCT BIOL, V10, P836, DOI 10.1038/nsb984; Bartko AP, 1999, J PHYS CHEM B, V103, P11237, DOI 10.1021/jp993364q; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; Forkey JN, 2003, NATURE, V422, P399, DOI 10.1038/nature01529; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Kawaguchi K, 2001, SCIENCE, V291, P667, DOI 10.1126/science.291.5504.667; Kawaguchi K, 2003, BIOPHYS J, V84, P1103, DOI 10.1016/S0006-3495(03)74926-1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	20	694	725	5	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 30	2004	303	5658					676	678		10.1126/science.1093753	http://dx.doi.org/10.1126/science.1093753			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	768EN	14684828				2022-12-28	WOS:000188530800042
J	Sackett, DL; Oxman, AD				Sackett, DL; Oxman, AD		HARLOT plc	HARLOT plc: an amalgamation of the world's two oldest professions	BRITISH MEDICAL JOURNAL			English	Article									Trout Res & Educ Ctr, Markdale, ON N0C 1H0, Canada; Norwegian Directorate Hlth & Social Welf, Dept Hlth Serv Res, N-0031 Oslo, Norway		Sackett, DL (corresponding author), Trout Res & Educ Ctr, Markdale, ON N0C 1H0, Canada.		Oxman, Andrew/Y-3004-2019	Oxman, Andrew/0000-0002-5608-5061				Bierce A., 1911, DEVILS DICT; HOLMES OW, 2000, MED QUOTATIONS, P291; Virchow R., 1848, MED REFORM, V5, P21	3	23	25	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 20	2003	327	7429					1442	1445		10.1136/bmj.327.7429.1442	http://dx.doi.org/10.1136/bmj.327.7429.1442			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757LA	14684640	Green Published			2022-12-28	WOS:000187562700011
J	Knox, KL; Litts, DA; Talcott, GW; Feig, JC; Caine, ED				Knox, KL; Litts, DA; Talcott, GW; Feig, JC; Caine, ED			Risk of suicide and related adverse outcomes after exposure to a suicide prevention programme in the US Air Force: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MENTAL-ILLNESS; PEOPLE	Objective To evaluate the impact of the US Air Force suicide prevention programme on risk of suicide and other outcomes that share underlying risk factors. Design Cohort study with quasi-experimental design and analysis of cohorts before (1990-6) and after (1997-2002) the intervention. Participants 5 260 292 US Air Force personnel (around 84% were men). Intervention A multilayered intervention targeted at reducing risk factors and enhancing factors considered protective. The intervention consisted of removing the stigma of seeking help for a mental health or psychosocial problem, enhancing understanding of mental health, and changing policies and social norms. Main outcome measures Relative risk reductions (the prevented fraction) for suicide and other outcomes. hypothesised to be sensitive to broadly based community prevention efforts, (family violence, accidental death, homicide). Additional outcomes not exclusively associated with suicide were included because of the comprehensiveness of the programme. Results Implementation of the programme was associated with a sustained decline in the rate of suicide and other adverse outcomes. A 33% relative risk reduction was observed for suicide after the intervention; reductions for other outcomes ranged from 18-54%. Conclusion A systemic intervention aimed at changing social norms about seeking help and incorporating training in suicide prevention has a considerable impact on promotion of mental health. The impact on adverse outcomes in addition to suicide strengthens the conclusion that the programme was responsible for these reductions in risk.	Univ Rochester, Med Ctr, Ctr Study & Prevent Suiside, Rochester, NY 14642 USA; Dept Hlth & Human Serv, Washington, DC 20007 USA; USAF, Med Operat Agcy, Off Surgeon Gen, Brooks AFB, San Antonio, TX 78235 USA; USAF, Inst Environm Safety & Occupat Hlth Risk Anal, Brooks AFB, San Antonio, TX USA	University of Rochester; United States Department of Defense; United States Air Force; United States Department of Defense; United States Air Force	Knox, KL (corresponding author), Univ Rochester, Med Ctr, Ctr Study & Prevent Suiside, Rochester, NY 14642 USA.	Kerry_knox@urmc.rochester.edu	Shugart, Herman/C-5156-2009	Shugart, Herman/0000-0002-1766-8379	NIMH NIH HHS [K24 MH01759, R13 MH62073, K01 MH066317-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R13MH062073, K24MH001759, K01MH066317] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Clements-Thompson M, 1998, J CONSULT CLIN PSYCH, V66, P1005, DOI 10.1037/0022-006X.66.6.1005; Crisp AH, 2000, BRIT J PSYCHIAT, V177, P4, DOI 10.1192/bjp.177.1.4; Czeizel AE, 2002, EPIDEMIOLOGY, V13, P113, DOI 10.1097/00001648-200201000-00020; GUNNELL D, 1994, BMJ-BRIT MED J, V308, P1227, DOI 10.1136/bmj.308.6938.1227; Hawton K, 1998, BRIT MED J, V317, P441; Jorm AF, 2000, BRIT J PSYCHIAT, V177, P396, DOI 10.1192/bjp.177.5.396; KELLY JA, 1992, AM J PUBLIC HEALTH, V82, P1483, DOI 10.2105/AJPH.82.11.1483; Kelly JA, 1999, AM J PUBLIC HEALTH, V89, P299, DOI 10.2105/AJPH.89.3.299; Link BG, 1999, AM J PUBLIC HEALTH, V89, P1328, DOI 10.2105/AJPH.89.9.1328; Link BG, 1997, J HEALTH SOC BEHAV, V38, P177, DOI 10.2307/2955424; Merzel C, 2003, AM J PUBLIC HEALTH, V93, P557, DOI 10.2105/AJPH.93.4.557; ROGERS EM, 1971, COMMUN INNOVATION, P99; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd	14	246	250	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2003	327	7428					1376	1378A		10.1136/bmj.327.7428.1376	http://dx.doi.org/10.1136/bmj.327.7428.1376			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755PL	14670880	Bronze, Green Published			2022-12-28	WOS:000187417900017
J	Pasquina, P; Tramer, MR; Walder, B				Pasquina, P; Tramer, MR; Walder, B			Prophylactic respiratory physiotherapy after cardiac surgery: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSITIVE AIRWAY PRESSURE; POSTOPERATIVE PULMONARY COMPLICATIONS; PLACEBO-CONTROLLED TRIALS; INCENTIVE SPIROMETRY; BREATHING EXERCISES; CHEST PHYSIOTHERAPY; PHYSICAL-THERAPY; MASK PHYSIOTHERAPY; PREVENTION; HEART	Objective To assess whether respiratory physiotherapy prevents pulmonary complications after cardiac surgery. Data sources Searches through Medline, Embase, Cinahl, the Cochrane library, and bibliographies, for randomised trials comparing any type of prophylactic respiratory physiotherapy with another type or no intervention after cardiac surgery, with a follow up of reporting on respiratory at least two days, and re outcomes. Review methods Investigators assessed trial validity independently. Information on study design, population, interventions, and end points was abstracted by one investigator and checked by the others. Results 18 trials (1457 patients) were identified. Most were of low quality. They tested physical therapy (13 trials), incentive spirometry (eight), continuous positive airway pressure (five), and intermittent positive pressure breathing (three). The maximum follow up was six days.-Four trials only had a no intervention control; none showed any significant benefit of physiotherapy. Across all trials and interventions, average values postoperatively were: incidence of atelectasis, 15-98%; incidence of pneumonia, 0-20%; partial pressure of arterial oxygen per inspired oxygen fraction, 212-329 mm Hg; vital capacity, 37-72% of preoperative values; and forced expiratory volume in one second, 34-72%. No intervention showed superiority for any end point. For the most labour intensive intervention, continuous positive airway pressure, the average labour cost for each patient day was E27 (E19; $32). Conclusions The usefulness of respiratory physiotherapy for the prevention of pulmonary complications after cardiac surgery remains unproved. Large randomised trials are needed with no intervention controls, clinically relevant end points, and reasonable follow up periods.	Univ Hosp Geneva, Div Surg Intens Care, Dept Anaesthesiol Pharmacol & Surg Intens Care, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Div Anaesthesiol, Dept Anaesthesiol Pharmacol & Surg Intens Care, CH-1211 Geneva 14, Switzerland	University of Geneva; University of Geneva	Pasquina, P (corresponding author), Univ Hosp Geneva, Div Surg Intens Care, Dept Anaesthesiol Pharmacol & Surg Intens Care, CH-1211 Geneva 14, Switzerland.	Patrick.Pasquina@hcuge.ch	Nascimento, Bianca N/E-5377-2010					Boldt J, 1998, J CARDIOTHOR VASC AN, V12, P654, DOI 10.1016/S1053-0770(98)90237-3; Carrel TP, 2001, ANN THORAC SURG, V72, P143, DOI 10.1016/S0003-4975(01)02669-8; Crowe JM, 1997, PHYS THER, V77, P260, DOI 10.1093/ptj/77.3.260; Denehy L, 2001, EUR RESPIR J, V17, P821, DOI 10.1183/09031936.01.17408210; DULL JL, 1983, PHYS THER, V63, P655, DOI 10.1093/ptj/63.5.655; Eales CJ, 2000, S AFR J PHYSIOTHER, V56, P24; GALE GD, 1980, CAN ANAESTH SOC J, V27, P475, DOI 10.1007/BF03007047; Hedderich R, 1999, CRIT CARE CLIN, V15, P167, DOI 10.1016/S0749-0704(05)70046-4; INGWERSEN UM, 1993, INTENS CARE MED, V19, P294, DOI 10.1007/BF01690551; IVERSON LIG, 1978, ANN THORAC SURG, V25, P197, DOI 10.1016/S0003-4975(10)63521-7; Jain U, 1991, J Cardiothorac Vasc Anesth, V5, P592; JENKINS S C, 1990, Physiotherapy Theory and Practice, V6, P117, DOI 10.3109/09593989009037789; JENKINS SC, 1989, THORAX, V44, P634, DOI 10.1136/thx.44.8.634; JOHNSON D, 1995, AM J RESP CRIT CARE, V152, P953, DOI 10.1164/ajrccm.152.3.7663809; Johnson D, 1996, CHEST, V109, P638, DOI 10.1378/chest.109.3.638; JOUSELA I, 1994, ACTA ANAESTH SCAND, V38, P311, DOI 10.1111/j.1399-6576.1994.tb03899.x; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; KRASTINS IRB, 1982, CRIT CARE MED, V10, P525, DOI 10.1097/00003246-198208000-00009; Larsen K R, 1994, Ugeskr Laeger, V156, P5689; Larsen K R, 1997, Ugeskr Laeger, V159, P2096; LARSEN KR, 1995, INTENS CARE MED, V21, P469; Lawrence VA, 1995, J GEN INTERN MED, V10, P671, DOI 10.1007/BF02602761; Leal-Noval SR, 2000, CRIT CARE MED, V28, P935, DOI 10.1097/00003246-200004000-00004; MANGANO DT, 1990, ANESTHESIOLOGY, V72, P153, DOI 10.1097/00000542-199001000-00025; Matte P, 2000, ACTA ANAESTH SCAND, V44, P75, DOI 10.1034/j.1399-6576.2000.440114.x; Moore RA, 1998, PAIN, V78, P209, DOI 10.1016/S0304-3959(98)00140-7; OIKKONEN M, 1991, CHEST, V99, P60, DOI 10.1378/chest.99.1.60; OULTON JL, 1981, CAN J SURG, V24, P638; Overend TJ, 2001, CHEST, V120, P971, DOI 10.1378/chest.120.3.971; PINILLA JC, 1990, CRIT CARE MED, V18, P836, DOI 10.1097/00003246-199008000-00008; REINES HD, 1982, ANN SURG, V195, P451, DOI 10.1097/00000658-198204000-00011; RUOFF M, 2000, CLIN INTENSIVE CARE, V11, P29; STILLER K, 1994, CHEST, V105, P741, DOI 10.1378/chest.105.3.741; Stiller Kathy, 1994, Physiotherapy Theory and Practice, V10, P143, DOI 10.3109/09593989409036391; STOCK MC, 1984, CRIT CARE MED, V12, P969, DOI 10.1097/00003246-198411000-00010; TAYLOR GJ, 1990, AM J CARDIOL, V65, P309, DOI 10.1016/0002-9149(90)90293-A; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; THOMAS AN, 1992, ANAESTHESIA, V47, P316, DOI 10.1111/j.1365-2044.1992.tb02172.x; THOMAS JA, 1994, PHYS THER, V74, P3, DOI 10.1093/ptj/74.1.3; Thornlow D K, 1995, Crit Care Nurse, V15, P39; Tramer MR, 1998, BMJ-BRIT MED J, V317, P875, DOI 10.1136/bmj.317.7162.875; VRACIU JK, 1977, PHYS THER, V57, P1367, DOI 10.1093/ptj/57.12.1367; Westerdahl E, 2001, J REHABIL MED, V33, P79	44	118	127	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2003	327	7428					1379	1381		10.1136/bmj.327.7428.1379	http://dx.doi.org/10.1136/bmj.327.7428.1379			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755PL	14670881	Green Published, Bronze			2022-12-28	WOS:000187417900018
J	Brown, M; Bristow, R; Glazer, P; Hill, R; McBride, W; McKenna, G; Muschel, R				Brown, M; Bristow, R; Glazer, P; Hill, R; McBride, W; McKenna, G; Muschel, R			Comment on "Tumor response to radiotherapy regulated by endothelial cell apoptosis" (II)	SCIENCE			English	Editorial Material									Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA; Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada; Yale Univ, Dept Therapeut Radiol Genet, New Haven, CT 06536 USA; Princess Margaret Hosp, Ontario Canc Inst, Dept Res, Toronto, ON M5G 2M9, Canada; Univ Calif Los Angeles, Dept Expt Radiat Oncol, Los Angeles, CA 90095 USA; Univ Penn, Dept Radiat Oncol, Philadelphia, PA 19104 USA; Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA	Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Yale University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of California System; University of California Los Angeles; University of Pennsylvania; University of Pennsylvania	Brown, M (corresponding author), Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA.		Glazer, Peter/S-7651-2019	Bristow, Robert/0000-0002-8553-9544; Hill, Richard Peter/0000-0001-5331-8045; Glazer, Peter/0000-0003-4525-5560				Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; MIRALBELL R, 1990, INT J RADIAT ONCOL, V18, P867, DOI 10.1016/0360-3016(90)90409-D	2	31	32	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 12	2003	302	5652												1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752NL	14671275				2022-12-28	WOS:000187174000029
J	Aungst, JL; Heyward, PM; Puche, AC; Karnup, SV; Hayar, A; Szabo, G; Shipley, MT				Aungst, JL; Heyward, PM; Puche, AC; Karnup, SV; Hayar, A; Szabo, G; Shipley, MT			Centre-surround inhibition among olfactory bulb glomeruli	NATURE			English	Article							MITRAL CELLS; PRESYNAPTIC INHIBITION; 2-DEOXYGLUCOSE UPTAKE; FUNCTIONAL MRI; RAT; LAYER; REPRESENTATIONS; DISCRIMINATION; LOCALIZATION; ORGANIZATION	Centre - surround inhibition - the suppression of activity of neighbouring cells by a central group of neurons - is a fundamental mechanism that increases contrast in patterned sensory processing. The initial stage of neural processing in olfaction occurs in olfactory bulb glomeruli, but evidence for functional interactions between glomeruli is fragmentary. Here we show that the so- called ' short axon' cells, contrary to their name, send interglomerular axons over long distances to form excitatory synapses with inhibitory periglomerular neurons up to 20 - 30 glomeruli away. Interglomerular excitation of these periglomerular cells potently inhibits mitral cells and forms an on- centre, off- surround circuit. This interglomerular centre - surround inhibitory network, along with the well- established mitral - granule - mitral inhibitory circuit, forms a serial, two- stage inhibitory circuit that could enhance spatiotemporal responses to odours.	Univ Maryland, Sch Med, Dept Anat & Neurobiol, Program Neurosci, Baltimore, MD 21201 USA; Hungarian Acad Sci, Inst Expt Med, Dept Gene Technol & Dev Neurobiol, Budapest, Hungary	University System of Maryland; University of Maryland Baltimore; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Shipley, MT (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Program Neurosci, Room 222,685 W Baltimore St, Baltimore, MD 21201 USA.		Szabo, Gabor/A-5087-2008	Szabo, Gabor/0000-0001-5438-5151				Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; AroniadouAnderjaska V, 1997, NEUROSCIENCE, V79, P425, DOI 10.1016/S0306-4522(96)00706-3; ASTIC L, 1982, BRAIN RES, V245, P17, DOI 10.1016/0006-8993(82)90335-3; BENSON TE, 1985, BRAIN RES, V339, P67, DOI 10.1016/0006-8993(85)90622-5; Carlson GC, 2000, J NEUROSCI, V20, P2011; Chen WR, 2002, J NEUROPHYSIOL, V88, P2755, DOI 10.1152/jn.00057.2002; Chen WR, 2000, NEURON, V25, P625, DOI 10.1016/S0896-6273(00)81065-X; CORNWALL J, 1988, J NEUROSCI METH, V24, P1, DOI 10.1016/0165-0270(88)90028-3; GOLGI C, 1875, FINA STRUTTURA BULBI; GREER CA, 1981, BRAIN RES, V217, P279, DOI 10.1016/0006-8993(81)90004-4; GROSSBERG S, 1976, BIOL CYBERN, V23, P121, DOI 10.1007/BF00344744; GROSSBERG S, 1970, J THEOR BIOL, V27, P291, DOI 10.1016/0022-5193(70)90143-8; GUTHRIE KM, 1995, CHEM SENSES, V20, P271, DOI 10.1093/chemse/20.2.271; HALASZ N, 1993, J COMP NEUROL, V337, P307, DOI 10.1002/cne.903370211; Heyward P, 2001, J NEUROSCI, V21, P5311, DOI 10.1523/JNEUROSCI.21-14-05311.2001; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; JASTREBOFF PJ, 1984, P NATL ACAD SCI-BIOL, V81, P5250, DOI 10.1073/pnas.81.16.5250; Johnson BA, 1996, J COMP NEUROL, V376, P557, DOI 10.1002/(SICI)1096-9861(19961223)376:4<557::AID-CNE5>3.0.CO;2-0; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; KAUER JS, 1988, NATURE, V331, P166, DOI 10.1038/331166a0; KAUER JS, 1987, BRAIN RES, V418, P255, DOI 10.1016/0006-8993(87)90093-X; KAWANO T, 1982, J NEUROCHEM, V39, P342, DOI 10.1111/j.1471-4159.1982.tb03953.x; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; MARTINEZ DP, 1984, BRAIN RES, V308, P223, DOI 10.1016/0006-8993(84)91061-8; Mombaerts P, 1996, COLD SPRING HARB SYM, V61, P135; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MUGNAINI E, 1984, NEUROSCI LETT, V47, P221, DOI 10.1016/0304-3940(84)90517-2; ONODA N, 1992, NEUROSCI LETT, V137, P157, DOI 10.1016/0304-3940(92)90393-L; PINCHING AJ, 1971, J CELL SCI, V9, P305; PINCHING AJ, 1972, J CELL SCI, V10, P637; PINCHING AJ, 1971, J CELL SCI, V9, P379; PINCHING AJ, 1971, J CELL SCI, V9, P347; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Ramon y Cajal S, 1909, HISTOLOGIE SYSTEME N; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Rubin BD, 2001, NAT NEUROSCI, V4, P355, DOI 10.1038/85997; Sheikh SN, 1999, NEUROCHEM INT, V35, P73, DOI 10.1016/S0197-0186(99)00063-7; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, V3rd Edn, P133; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; Wachowiak M, 1998, J NEUROPHYSIOL, V80, P1011, DOI 10.1152/jn.1998.80.2.1011; Xu FQ, 2000, P NATL ACAD SCI USA, V97, P10601, DOI 10.1073/pnas.180321397; Yang XJ, 1998, P NATL ACAD SCI USA, V95, P7715, DOI 10.1073/pnas.95.13.7715; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	47	311	315	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					623	629		10.1038/nature02185	http://dx.doi.org/10.1038/nature02185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668854				2022-12-28	WOS:000187132800031
J	Timusk, T				Timusk, T			Bertram N. Brockhouse (1918-2003) - Obituary	NATURE			English	Biographical-Item									McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada	McMaster University	Timusk, T (corresponding author), McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada.								0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 11	2003	426	6967					617	617		10.1038/426617a	http://dx.doi.org/10.1038/426617a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668847	Bronze			2022-12-28	WOS:000187132800025
J	Zarrinpar, A; Park, SH; Lim, WA				Zarrinpar, A; Park, SH; Lim, WA			Optimization of specificity in a cellular protein interaction network by negative selection	NATURE			English	Article							SH3 DOMAIN; PEPTIDE RECOGNITION; CAENORHABDITIS-ELEGANS; PEX13P; SRC; LOCALIZATION; PREDICTION; STABILITY; PATHWAYS; MODULES	Most proteins that participate in cellular signalling networks contain modular protein- interaction domains. Multiple versions of such domains are present within a given organism(1): the yeast proteome, for example, contains 27 different Src homology 3 ( SH3) domains(2). This raises the potential problem of crossreaction. It is generally thought that isolated domain - ligand pairs lack sufficient information to encode biologically unique interactions, and that specificity is instead encoded by the context in which the interaction pairs are presented(3,4). Here we show that an isolated peptide ligand from the yeast protein Pbs2 recognizes its biological partner, the SH3 domain from Sho1, with near- absolute specificity - no other SH3 domain present in the yeast genome cross- reacts with the Pbs2 peptide, in vivo or in vitro. Such high specificity, however, is not observed in a set of non- yeast SH3 domains, and Pbs2 motif variants that cross- react with other SH3 domains confer a fitness defect, indicating that the Pbs2 motif might have been optimized to minimize interaction with competing domains specifically found in yeast. System- wide negative selection is a subtle but powerful evolutionary mechanism to optimize specificity within an interaction network composed of overlapping recognition elements.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biol Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 600 16th St, San Francisco, CA 94143 USA.	wlim@itsa.ucsf.edu						Barnett P, 2000, EMBO J, V19, P6382, DOI 10.1093/emboj/19.23.6382; Bottger G, 2000, MOL BIOL CELL, V11, P3963, DOI 10.1091/mbc.11.11.3963; Cesareni G, 2002, FEBS LETT, V513, P38, DOI 10.1016/S0014-5793(01)03307-5; Fazi B, 2002, J BIOL CHEM, V277, P5290, DOI 10.1074/jbc.M109848200; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Girzalsky W, 1999, J CELL BIOL, V144, P1151, DOI 10.1083/jcb.144.6.1151; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Kwok Pui-Yan, 2003, Methods Mol Biol, V212, P71; Ladbury JE, 2000, CHEM BIOL, V7, pR3, DOI 10.1016/S1074-5521(00)00067-3; LIM WA, 1994, PROTEIN SCI, V3, P1261, DOI 10.1002/pro.5560030812; LIM WA, 1994, NAT STRUCT BIOL, V1, P221, DOI 10.1038/nsb0494-221; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Maxwell KL, 1998, BIOCHEMISTRY-US, V37, P16172, DOI 10.1021/bi981788p; Mayer BJ, 2001, J CELL SCI, V114, P1253; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Orr MR, 1998, TRENDS ECOL EVOL, V13, P502, DOI 10.1016/S0169-5347(98)01511-0; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Park SH, 2003, SCIENCE, V299, P1061, DOI 10.1126/science.1076979; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Schneider TD, 2000, NUCLEIC ACIDS RES, V28, P2794, DOI 10.1093/nar/28.14.2794; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Sudol M, 1998, ONCOGENE, V17, P1469, DOI 10.1038/sj.onc.1202182; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; ZARRINPAR A, SCIENCE, DOI DOI 10.1126/STKE.2003.179.RE8	29	199	206	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 11	2003	426	6967					676	680		10.1038/nature02178	http://dx.doi.org/10.1038/nature02178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752DY	14668868				2022-12-28	WOS:000187132800045
J	Naimi, TS; LeDell, KH; Como-Sabetti, K; Borchardt, SM; Boxrud, DJ; Etienne, J; Johnson, SK; Vandenesch, F; Fridkin, S; O'Boyle, C; Danila, RN; Lynfield, R				Naimi, TS; LeDell, KH; Como-Sabetti, K; Borchardt, SM; Boxrud, DJ; Etienne, J; Johnson, SK; Vandenesch, F; Fridkin, S; O'Boyle, C; Danila, RN; Lynfield, R			Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PANTON-VALENTINE LEUKOCIDIN; CHANGING EPIDEMIOLOGY; SKIN INFECTIONS; RISK-FACTORS; CHILDREN; STRAINS; COLONIZATION; PREVALENCE; POPULATION; PNEUMONIA	Context Methicillin -resistant Staphylococcus aureus (MRSA) has traditionally been considered a health care-associated pathogen in patients with established risk factors. However, MRSA has emerged in patients without established risk factors.(community-associated MRSA). Objective To characterize epidemiological and microbiological characteristics of community-associated MRSA cases compared with health care-associated MRSA cases. Design, Setting, and Patients Prospective cohort study of patients with MRSA infection identified at 12 Minnesota laboratory facilities from January 1 through December 31, 2000, comparing community-associated (median age, 23 years) with health care-associated (median age, 68 years) MRSA cases. Main Outcome Measures Clinical infections associated with either community-associated or health care-associated MRSA, microbiological characteristics of the MRSA isolates including susceptibility testing, pulsed-field gel electrophoresis, and staphylococcal exotoxin gene testing. Results Of 1100 MRSA infections, 131 (12 %) were community-associated and 937 (85%) were health care-associated; 32 3%) could not be classified due to lack of information. Skin and soft tissue infections were more common among community-associated cases (75%) than among health care-associated cases (37%) (odds ratio [OR], 4.25; 95% confidence interval [Cl], 2.97-5.90). Although community-associated MRSA isolates were more likely to be susceptible to 4 antimicrobial classes (adjusted OR, 2.44; 95% Cl, 1.35-3.86), most community-associated infections were initially treated with antimicrobials to which the isolate was nonsusceptible. Community-associated isolates were also more likely to belong to I of 2 pulsed-field gel electrophoresis clonal groups in both univariate and multivariate analysis. Community-associated isolates typically possessed different exotoxin gene profiles (eg, Panton Valentine leukocidin genes) compared with health care-associated isolates. Conclusions Community-associated and health care-associated MRSA cases differ demographically and clinically, and their respective isolates are microbiologically distinct. This suggests that most community-associated MRSA strains did not originate in health care settings, and that their microbiological features may have contributed to their emergence in the community. Clinicians should be aware that therapy with beta-lactam antimicrobials can no longer be relied on as the sole empiric therapy for severely ill outpatients whose infections may be staphylococcal in origin.	Minnesota Dept Hlth, Acute Dis Invest & Control Sect, Minneapolis, MN USA; Minnesota Dept Hlth, Div Publ Hlth Labs, Minneapolis, MN USA; French Reference Ctr Staphylococci, Lyon, France; Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Appl Publ Hlth Training, Epidemiol Program Off, Natl Ctr Chron Dis, Atlanta, GA USA	Minnesota Department of Health (MHD); Minnesota Department of Health (MHD); Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Naimi, TS (corresponding author), K-67,4770 Buford Highway NE, Atlanta, GA 30341 USA.		Vandenesch, Francois/C-7209-2014; ETIENNE, Jerome/C-5471-2014	Vandenesch, Francois/0000-0001-9412-7106; ETIENNE, Jerome/0000-0002-3348-3315; Naimi, Timothy/0000-0001-9849-4413	ODCDC CDC HHS [U50/CCU511190] Funding Source: Medline	ODCDC CDC HHS		Adcock PM, 1998, J INFECT DIS, V178, P577, DOI 10.1086/517478; Archer GL, 1998, CLIN INFECT DIS, V26, P1179, DOI 10.1086/520289; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baggett HC, 2003, INFECT CONT HOSP EP, V24, P397, DOI 10.1086/502221; Boyce JM, 1998, JAMA-J AM MED ASSOC, V279, P623, DOI 10.1001/jama.279.8.623; BRUMFITT W, 1989, NEW ENGL J MED, V320, P1188, DOI 10.1056/NEJM198905043201806; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Charlebois ED, 2002, CLIN INFECT DIS, V34, P425, DOI 10.1086/338069; EMBIL J, 1994, INFECT CONT HOSP EP, V15, P646; ETIENNE J, 2002, 10 INT S STAPH STAPH; Fey PD, 2003, ANTIMICROB AGENTS CH, V47, P196, DOI 10.1128/AAC.47.1.196-203.2003; Frank AL, 1999, PEDIATR INFECT DIS J, V18, P993, DOI 10.1097/00006454-199911000-00012; Frank AL, 1999, CLIN INFECT DIS, V29, P935, DOI 10.1086/520463; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Groom AV, 2001, JAMA-J AM MED ASSOC, V286, P1201, DOI 10.1001/jama.286.10.1201; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Hunt C, 1999, JAMA-J AM MED ASSOC, V282, P1123; JAAUD S, 2002, INFECT IMMUN, V70, P631; Jernigan JA, 2003, INFECT CONT HOSP EP, V24, P445, DOI 10.1086/502223; Johnson LB, 2003, INFECT CONT HOSP EP, V24, P431, DOI 10.1086/502227; JORGENSEN JH, 1986, EUR J CLIN MICROBIOL, V5, P693, DOI 10.1007/BF02013307; KREISWIRTH B, 1993, SCIENCE, V259, P227, DOI 10.1126/science.8093647; LEMAN RF, 2002, 51 ANN EP INT SERV C; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Naimi TS, 2001, CLIN INFECT DIS, V33, P990, DOI 10.1086/322693; National Committee for Clinical Laboratory Standards, 1999, PERF STAND ANT SUSC; National Committee for Clinical Laboratory Standards, 1997, METH DIL ANT SUSC TE; NISHI JI, 1995, J LAB CLIN MED, V126, P29; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Shahin R, 1999, ARCH PEDIAT ADOL MED, V153, P864, DOI 10.1001/archpedi.153.8.864; SIEGEL JD, 1999, 37 ANN M INF DIS SOC; Suggs AH, 1999, PEDIATR INFECT DIS J, V18, P410, DOI 10.1097/00006454-199905000-00003; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Torvaldsen S, 1999, INFECT CONT HOSP EP, V20, P133, DOI 10.1086/501594; VANDENESCH F, 2003, EMERG INFECT DIS AUG; Wielders CLC, 2001, LANCET, V357, P1674, DOI 10.1016/S0140-6736(00)04832-7; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; 2003, MMWR MORB MORTAL WKL, V52, P88	40	1283	1341	0	111	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 10	2003	290	22					2976	2984		10.1001/jama.290.22.2976	http://dx.doi.org/10.1001/jama.290.22.2976			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751WH	14665659	Bronze			2022-12-28	WOS:000187112700029
J	Thomas, RK; Diehl, V				Thomas, RK; Diehl, V			Unhappy neighbourhood: spatial genome organisation and lymphomagenesis in B cells	LANCET			English	Editorial Material							SOMATIC HYPERMUTATION; GENE; LOCI; MUTATION		Univ Cologne, Dept Internal Med 1, D-50924 Cologne, Germany; Univ Cologne, Ctr Mol Med Cologne, D-50924 Cologne, Germany	University of Cologne; University of Cologne	Thomas, RK (corresponding author), Univ Cologne, Dept Internal Med 1, D-50924 Cologne, Germany.							JAEGER U, 1993, BLOOD, V81, P1833; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848	10	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 6	2003	362	9399					1868	1870		10.1016/S0140-6736(03)14998-7	http://dx.doi.org/10.1016/S0140-6736(03)14998-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750RN	14667739				2022-12-28	WOS:000187011600004
J	Tanner, C; Manca, C; Leutwyler, S				Tanner, C; Manca, C; Leutwyler, S			Probing the threshold to H atom transfer along a hydrogen-bonded ammonia wire	SCIENCE			English	Article							STATE PROTON-TRANSFER; EXCITED-STATE; AB-INITIO; PROTOTROPIC EQUILIBRIA; EXCESS PROTON; WATER; CLUSTERS; MECHANISM; SOLVENT; 7-HYDROXYQUINOLINE	We characterized the entrance channel, reaction threshold, and mechanism of an excited-state H atom transfer reaction along a unidirectionally hydrogen-bonded "wire" -O-H...NH3...NH3...NH3...N. Excitation of supersonically cooled 7-hydroxyquinoline.(NH3)(3) to its vibrationless S-1 state produces no reaction, whereas excitation of ammonia-wire vibrations induces H atom transfer with a reaction threshold approximate to 200 wave numbers. Further translocation steps along the wire produce the S-1 state 7-ketoquinoline.(NH3)(3) tautomer. Ab initio calculations show that proton and electron movement along the wire are closely coupled. The rate-controlling S-1 state barriers arise from crossings of a pipi* with a Rydberg-type pisigma* state.	Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	University of Bern	Leutwyler, S (corresponding author), Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland.							Agarwal PK, 2000, J AM CHEM SOC, V122, P4803, DOI 10.1021/ja994456w; AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Bach A, 2000, J CHEM PHYS, V112, P560, DOI 10.1063/1.480548; Bardez E, 1999, ISRAEL J CHEM, V39, P319; BORGIS D, 1993, CHEM PHYS, V170, P315, DOI 10.1016/0301-0104(93)85117-Q; Cui QA, 2002, J PHYS CHEM B, V106, P7927, DOI 10.1021/jp0205057; Cukier RI, 1999, J CHEM PHYS, V110, P9587, DOI 10.1063/1.478924; Cukier RI, 1998, ANNU REV PHYS CHEM, V49, P337, DOI 10.1146/annurev.physchem.49.1.337; Daigoku K, 2003, J CHEM PHYS, V119, P5149, DOI 10.1063/1.1597492; David O, 2002, INT REV PHYS CHEM, V21, P499, DOI 10.1080/01442350210164287; Geissler PL, 2001, SCIENCE, V291, P2121, DOI 10.1126/science.1056991; Hynes JT, 2002, J PHOTOCH PHOTOBIO A, V154, P3, DOI 10.1016/S1010-6030(02)00304-0; Lu DS, 1998, J AM CHEM SOC, V120, P4006, DOI 10.1021/ja973397o; Marx D, 1999, NATURE, V397, P601, DOI 10.1038/17579; MASON SF, 1968, J CHEM SOC A, P3051, DOI 10.1039/j19680003051; Mei HS, 1998, J PHYS CHEM B, V102, P10446, DOI 10.1021/jp982623t; Meuwly M, 2001, J AM CHEM SOC, V123, P11446, DOI 10.1021/ja010893a; Pomes R, 2002, BIOPHYS J, V82, P2304, DOI 10.1016/S0006-3495(02)75576-8; SCHULMAN S, 1968, TETRAHEDRON, V24, P1777, DOI 10.1016/S0040-4020(01)82483-2; Sobolewski AL, 1999, PHYS CHEM CHEM PHYS, V1, P3065, DOI 10.1039/a902565k; Sobolewski AL, 2002, PHYS CHEM CHEM PHYS, V4, P1093, DOI 10.1039/b110941n; Sobolewski AL, 2001, J PHYS CHEM A, V105, P9275, DOI 10.1021/jp011260l; Sobolewski AL, 1999, J PHYS CHEM A, V103, P4494, DOI 10.1021/jp990030s; TOKUMURA K, 1984, J PHYS CHEM-US, V88, P3921, DOI 10.1021/j150662a003; Vuilleumier R, 1998, J PHYS CHEM B, V102, P4261, DOI 10.1021/jp9807423	25	248	251	0	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 5	2003	302	5651					1736	1739		10.1126/science.1091708	http://dx.doi.org/10.1126/science.1091708			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	750AX	14657491				2022-12-28	WOS:000186970100039
J	Cooke, KR; Ferrara, JLM				Cooke, KR; Ferrara, JLM			A protective gene for graft-versus-host disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Michigan, Sch Med, Ctr Comprehens Canc, Blood & Marrow Transplant Program, Ann Arbor, MI 48104 USA; Univ Michigan, Sch Med, Dept Pediat, Ann Arbor, MI USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cooke, KR (corresponding author), Univ Michigan, Sch Med, Ctr Comprehens Canc, Blood & Marrow Transplant Program, Ann Arbor, MI 48104 USA.								0	16	19	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 4	2003	349	23					2183	2184		10.1056/NEJMp038169	http://dx.doi.org/10.1056/NEJMp038169			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LH	14657422				2022-12-28	WOS:000186921700001
J	de Joussineau, C; Soule, J; Martin, M; Anguille, C; Montcourrier, P; Alexandre, D				de Joussineau, C; Soule, J; Martin, M; Anguille, C; Montcourrier, P; Alexandre, D			Delta-promoted filopodia mediate long-range lateral inhibition in Drosophila	NATURE			English	Article							CELL EXTENSION ACTIVITY; NOTCH; EXPRESSION; PROTEIN; EZRIN; MORPHOGENESIS; GENES; DETERMINANTS; EMERGENCE; ENHANCER	Drosophila thoracic mechanosensory bristles originate from cells that are singled out from 'proneural' groups of competent epithelial cells. Neural competence is restricted to individual sensory organ precursors (SOPs) by Delta/Notch-mediated 'lateral inhibition', whereas other cells in the proneural field adopt an epidermal fate. The precursors of the large macrochaetes differentiate separately from individual proneural clusters that comprise about 20 - 30 cells or as heterochronic pairs from groups of more than 100 cells(1), whereas the precursors of the small regularly spaced microchaetes emerge from even larger proneural fields(2). This indicates that lateral inhibition might act over several cell diameters; it was difficult to reconcile with the fact that the inhibitory ligand Delta is membrane-bound until the observation that SOPs frequently extend thin processes(3,4) offered an attractive hypothesis. Here we show that the extension of these planar filopodia - a common attribute of wing imaginal disc cells - is promoted by Delta and that their experimental suppression reduces Notch signalling in distant cells and increases bristle density in large proneural groups, showing that these membrane specializations mediate long- range lateral inhibition.	Univ Montpellier 2, UMR 5539, Lab Dynam Mol Interact Membranaires, F-34095 Montpellier 5, France	Universite de Montpellier	Alexandre, D (corresponding author), Univ Montpellier 2, UMR 5539, Lab Dynam Mol Interact Membranaires, CC 107,Pl Eugene Bataillon, F-34095 Montpellier 5, France.			MARTIN, Marianne/0000-0001-8932-3129				ANDREOLI C, 1994, J CELL SCI, V107, P2509; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; BENDER LB, 1993, GENETICS, V133, P967; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L; HAENLIN M, 1994, MECH DEVELOP, V47, P99, DOI 10.1016/0925-4773(94)90099-X; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; HUANG F, 1991, DEVELOPMENT, V111, P1087; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; KOOH PJ, 1993, DEVELOPMENT, V117, P493; Lai EC, 2001, DEV BIOL, V231, P217, DOI 10.1006/dbio.2000.0124; Lamb RF, 1997, CURR BIOL, V7, P682, DOI 10.1016/S0960-9822(06)00295-8; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LOCKE M, 1981, NATURE, V293, P733, DOI 10.1038/293733a0; MARTIN M, 1995, J CELL BIOL, V128, P1081, DOI 10.1083/jcb.128.6.1081; Martin M, 1997, MOL BIOL CELL, V8, P1543, DOI 10.1091/mbc.8.8.1543; Meir E, 2002, CURR BIOL, V12, P778, DOI 10.1016/S0960-9822(02)00839-4; Milan M, 2001, CELL, V106, P785, DOI 10.1016/S0092-8674(01)00489-5; Mishra-Gorur K, 2002, J CELL BIOL, V159, P313, DOI 10.1083/jcb.200203117; PARKS AL, 1993, DEV BIOL, V157, P484, DOI 10.1006/dbio.1993.1151; Qi HL, 1999, SCIENCE, V283, P91, DOI 10.1126/science.283.5398.91; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Renaud O, 2001, DEV BIOL, V240, P361, DOI 10.1006/dbio.2001.0482; Sanson B, 1999, CELL, V98, P207, DOI 10.1016/S0092-8674(00)81015-6; Seugnet L, 1997, DEVELOPMENT, V124, P2015; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; USUI K, 1993, ROUX ARCH DEV BIOL, V203, P151, DOI 10.1007/BF00365054; Wigglesworth VB, 1940, J EXP BIOL, V17, P180; Zeng CY, 1998, GENE DEV, V12, P1086, DOI 10.1101/gad.12.8.1086	30	143	144	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2003	426	6966					555	559		10.1038/nature02157	http://dx.doi.org/10.1038/nature02157			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749TE	14654840				2022-12-28	WOS:000186944300038
J	Castillo-Chavez, C; Castillo-Garsow, CW; Yakubu, AA				Castillo-Chavez, C; Castillo-Garsow, CW; Yakubu, AA			Mathematical models of isolation and quarantine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Cornell Univ, Ithaca, NY 14853 USA; SUNY Buffalo, Buffalo, NY 14260 USA; Howard Univ, Washington, DC 20059 USA	Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Howard University	Castillo-Chavez, C (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.		Castillo-Chavez, Carlos/E-1412-2014	Castillo-Chavez, Carlos/0000-0002-1046-3901; Castillo-Garsow, Carlos/0000-0001-8426-211X				BROWN D, 2003, WASHINGTON POST 0503, pA7; Chowell G, 2003, J THEOR BIOL, V224, P1, DOI 10.1016/S0022-5193(03)00228-5; Kermack WO, 1932, P R SOC LOND A-CONTA, V138, P55, DOI 10.1098/rspa.1932.0171; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Ross R., 1911, PREVENTION MALARIA	5	48	52	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 3	2003	290	21					2876	2877		10.1001/jama.290.21.2876	http://dx.doi.org/10.1001/jama.290.21.2876			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748QP	14657077	Bronze			2022-12-28	WOS:000186872800035
J	Schreiber, MD; Gin-Mestan, K; Marks, JD; Huo, DZ; Lee, G; Srisuparp, P				Schreiber, MD; Gin-Mestan, K; Marks, JD; Huo, DZ; Lee, G; Srisuparp, P			Inhaled nitric oxide in premature infants with the respiratory distress syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERSISTENT PULMONARY-HYPERTENSION; PLATELET-AGGREGATION; BLEEDING-TIME; EXPRESSION; SYNTHASE; NO; HEMORRHAGE; INHALATION; CHILDREN; ADHESION	Background: Inhaled nitric oxide improves gas exchange, decreases pulmonary vascular lability, and reduces pulmonary inflammation. We hypothesized that the use of inhaled nitric oxide would decrease the incidence of chronic lung disease and death in premature infants with the respiratory distress syndrome. Methods: We conducted a randomized, double-blind, placebo-controlled study of the effect of inhaled nitric oxide during the first week of life on the incidence of chronic lung disease and death in premature infants (less than 34 weeks' gestation) who were undergoing mechanical ventilation for the respiratory distress syndrome. Infants were randomly assigned to receive inhaled nitric oxide (10 ppm on day 1, followed by 5 ppm for six days) or inhaled oxygen placebo for seven days. We further randomly assigned the infants in each group to receive intermittent mandatory or high-frequency oscillatory ventilation. Results: A total of 207 premature infants were enrolled. In the group given inhaled nitric oxide, 51 infants (48.6 percent) died or had chronic lung disease, as compared with 65 infants (63.7 percent) in the placebo group (relative risk, 0.76; 95 percent confidence interval, 0.60 to 0.97; P=0.03). There was no significant difference between the nitric oxide and placebo groups in the overall incidence of intraventricular hemorrhage and periventricular leukomalacia (33.3 percent and 38.2 percent, respectively), but the group given inhaled nitric oxide had a lower incidence of severe intraventricular hemorrhage and periventricular leukomalacia (12.4 percent vs. 23.5 percent; relative risk, 0.53; 95 percent confidence interval, 0.28 to 0.98; P=0.04). The type of ventilation had no significant effect on the outcome. Conclusions: The use of inhaled nitric oxide in premature infants with the respiratory distress syndrome decreases the incidence of chronic lung disease and death.	Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Schreiber, MD (corresponding author), Univ Chicago, Dept Pediat, MC 6060,5841 S Maryland Ave, Chicago, IL 60637 USA.	mschreiber@peds.bsd.uchicago.edu	Marks, Jeremy/W-2087-2019	Marks, Jeremy/0000-0002-2644-5257	NINDS NIH HHS [R01 NS038547] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038547] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Afshar S, 2003, AM J PHYSIOL-LUNG C, V284, pL749, DOI 10.1152/ajplung.00334.2002; Aikio O, 2003, PEDIATR PULM, V35, P8, DOI 10.1002/ppul.10222; [Anonymous], 1997, NEW ENGL J MED, V337, P434; BARNES PJ, 1995, ANN MED, V27, P389, DOI 10.3109/07853899509002592; Cheung PY, 1998, LANCET, V351, P1181, DOI 10.1016/S0140-6736(05)79127-3; Clark RH, 2000, NEW ENGL J MED, V342, P469, DOI 10.1056/NEJM200002173420704; *FRANC BELG COLL N, 1999, LANCET, V354, P1826; GASTON B, 1994, AM J RESP CRIT CARE, V149, P538, DOI 10.1164/ajrccm.149.2.7508323; George TN, 1998, J PEDIATR-US, V132, P731, DOI 10.1016/S0022-3476(98)70370-1; Giacoia GP, 1997, J PEDIATR-US, V130, P400, DOI 10.1016/S0022-3476(97)70231-2; GROOTHUIS JR, 1988, PEDIATRICS, V82, P199; Hallman M, 1998, J PEDIATR-US, V132, P827, DOI 10.1016/S0022-3476(98)70312-9; HOGMAN M, 1993, LANCET, V341, P1664, DOI 10.1016/0140-6736(93)90802-N; Issa A, 1999, PEDIATR RES, V45, P247, DOI 10.1203/00006450-199902000-00016; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; KAWAI N, 1995, AM J PHYSIOL-LUNG C, V268, pL589, DOI 10.1152/ajplung.1995.268.4.L589; Kinsella JP, 1997, PEDIATR RES, V41, P457, DOI 10.1203/00006450-199704000-00002; Kinsella JP, 1999, LANCET, V354, P1061, DOI 10.1016/S0140-6736(99)03558-8; KOUREMBANAS S, 1993, J CLIN INVEST, V92, P99, DOI 10.1172/JCI116604; Lackmann GM, 1996, FREE RADICAL BIO MED, V20, P407, DOI 10.1016/0891-5849(95)00209-X; Lemons JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.1.e1; MacRitchie AN, 2001, AM J PHYSIOL-LUNG C, V281, pL1011, DOI 10.1152/ajplung.2001.281.4.L1011; McCullagh P., 1989, GEN LINEAR MODELS, V2nd; Mercier JC, 1999, LANCET, V354, P1066; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; RADOMSKI MW, 1987, BIOCHEM BIOPH RES CO, V148, P1482, DOI 10.1016/S0006-291X(87)80299-1; Roberts JD, 1997, NEW ENGL J MED, V336, P605, DOI 10.1056/NEJM199702273360902; Roberts JD, 2000, CIRC RES, V87, P140, DOI 10.1161/01.RES.87.2.140; Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124; SHENNAN AT, 1988, PEDIATRICS, V82, P527; Skimming JW, 1997, J PEDIATR-US, V130, P225, DOI 10.1016/S0022-3476(97)70347-0; SKULLERUD K, 1986, ACTA NEUROPATHOL, V70, P257, DOI 10.1007/BF00686080; Snedecor GW, 1980, STAT METHODS, V7th; SPEER CP, 1993, PEDIATRICS, V91, P794; Srisuparp P, 2003, BIOL NEONATE, V84, P31, DOI 10.1159/000071440; Stork E, 1997, NEW ENGL J MED, V336, P597; TAKASHIMA S, 1986, BRAIN DEV-JPN, V8, P25, DOI 10.1016/S0387-7604(86)80116-4; Terada LS, 1996, J APPL PHYSIOL, V81, P2456, DOI 10.1152/jappl.1996.81.6.2456; THOMAE KR, 1995, J SURG RES, V59, P337, DOI 10.1006/jsre.1995.1173; VanMeurs KP, 1997, PEDIATR PULM, V24, P319; Young SL, 2002, AM J PHYSIOL-LUNG C, V282, pL379, DOI 10.1152/ajplung.00462.2000	42	300	315	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 27	2003	349	22					2099	2107		10.1056/NEJMoa031154	http://dx.doi.org/10.1056/NEJMoa031154			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	746ZV	14645637				2022-12-28	WOS:000186779700004
J	Yoshimura, T; Yasuo, S; Watanabe, M; Iigo, M; Yamamura, T; Hirunagi, K; Ebihara, S				Yoshimura, T; Yasuo, S; Watanabe, M; Iigo, M; Yamamura, T; Hirunagi, K; Ebihara, S			Light-induced hormone conversion of T-4 to T-3 regulates photoperiodic response of gonads in birds	NATURE			English	Article							CIRCADIAN CLOCK GENES; JAPANESE-QUAIL; ELECTRICAL-STIMULATION; GONADOTROPHIN RELEASE; TUBERAL HYPOTHALAMUS; TESTICULAR GROWTH; THYROIDECTOMY; EXPRESSION; THYROXINE; RHYTHMICITY	Reproduction of many temperate zone birds is under photoperiodic control. The Japanese quail is an excellent model for studying the mechanism of photoperiodic time measurement because of its distinct and marked response to changing photoperiods. Studies on this animal have suggested that the mediobasal hypothalamus (MBH) is an important centre controlling photoperiodic time measurement(1-8). Here we report that expression in the MBH of the gene encoding type 2 iodothyronine deiodinase (Dio2), which catalyses the intracellular deiodination of thyroxine (T-4) prohormone to the active 3,5,3'-triiodothyronine (T-3), is induced by light in Japanese quail. Intracerebroventricular administration of T-3 mimics the photoperiodic response, whereas the Dio2 inhibitor iopanoic acid prevents gonadal growth. These findings demonstrate that light-induced Dio2 expression in the MBH may be involved in the photoperiodic response of gonads in Japanese quail.	Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Chikusa Ku, Nagoya, Aichi 4648601, Japan; Nagoya Univ Museum, Chikusa Ku, Nagoya, Aichi 4648601, Japan; Utsunomiya Univ, Fac Agr, Dept Appl Biol Chem, Utsunomiya, Tochigi 3218505, Japan	Nagoya University; Nagoya University; Utsunomiya University	Yoshimura, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Div Biomodeling, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.		Yoshimura, Takashi/C-8306-2012; Iigo, Masayuki/I-7110-2013	Yoshimura, Takashi/0000-0001-7018-9652; Iigo, Masayuki/0000-0001-8251-4141				Bernal J, 2002, J ENDOCRINOL INVEST, V25, P268, DOI 10.1007/BF03344003; Chopra I J, 1978, Recent Prog Horm Res, V34, P521; DAVIES DT, 1975, PROC R SOC SER B-BIO, V191, P303, DOI 10.1098/rspb.1975.0130; DAWSON A, 1993, J ENDOCRINOL, V139, P51, DOI 10.1677/joe.0.1390051; Dawson A, 1998, GEN COMP ENDOCR, V110, P196, DOI 10.1006/gcen.1998.7065; Dawson A, 2001, J BIOL RHYTHM, V16, P365, DOI 10.1177/074873001129002079; Dawson A., 2001, P141; FOLLETT BK, 1988, J COMP PHYSIOL B, V157, P829, DOI 10.1007/BF00691015; FOLLETT BK, 1988, J COMP PHYSIOL B, V157, P837, DOI 10.1007/BF00691016; FOLLETT BK, 1969, NATURE, V223, P968, DOI 10.1038/223968b0; FOLLETT BK, 1985, J ENDOCRINOL, V107, P211, DOI 10.1677/joe.0.1070211; FOLLETT BK, 1984, J EXP ZOOL, V232, P573, DOI 10.1002/jez.1402320325; IKUTA K, 1987, GEN COMP ENDOCR, V65, P99, DOI 10.1016/0016-6480(87)90228-0; JUSS TS, 1993, AVIAN ENDOCRINOLOGY, P47; KONISHI H, 1987, J COMP PHYSIOL A, V161, P315, DOI 10.1007/BF00615251; Kuenzel W.J., 1988, STEREOTAXIC ATLAS BR; Leonard JL, 1986, THYROID HORMONE META, P189; MEDDLE SL, 1995, J COMP PHYSIOL A, V176, P79; Meddle SL, 1997, J NEUROSCI, V17, P8909; NICHOLS DH, 1985, CLIN OBSTET GYNECOL, V28, P375, DOI 10.1097/00003081-198528020-00015; OHTA M, 1984, J COMP PHYSIOL, V154, P583, DOI 10.1007/BF00610171; OHTA M, 1987, GEN COMP ENDOCR, V68, P286, DOI 10.1016/0016-6480(87)90040-2; Prendergast BJ, 2002, P NATL ACAD SCI USA, V99, P16291, DOI 10.1073/pnas.232490799; SHARP PJ, 1969, NEUROENDOCRINOLOGY, V5, P205, DOI 10.1159/000121861; SILVER R, 1988, CELL TISSUE RES, V253, P189; TAGAWA M, 1987, GEN COMP ENDOCR, V68, P129, DOI 10.1016/0016-6480(87)90068-2; Yasuo S, 2003, ENDOCRINOLOGY, V144, P3742, DOI 10.1210/en.2003-0435; Yoshimura T, 2000, MOL BRAIN RES, V78, P207, DOI 10.1016/S0169-328X(00)00091-7	28	366	382	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 13	2003	426	6963					178	181		10.1038/nature02117	http://dx.doi.org/10.1038/nature02117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742LA	14614506				2022-12-28	WOS:000186517200043
